Clustering O 0 0.06999888271093369
of O 0 0.029189543798565865
missense O 0 0.04835035279393196
mutations O 0 0.01960962824523449
in O 0 0.01365047786384821
the O 0 0.4713580012321472
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999922513961792
telangiectasia I-Disease 1 0.9999984502792358
gene O 0 0.01773708686232567
in O 0 0.011071241460740566
a O 0 0.04556429013609886
sporadic B-Disease 1 0.9976072311401367
T I-Disease 1 0.9999929666519165
- I-Disease 1 0.999885082244873
cell I-Disease 1 0.9919597506523132
leukaemia I-Disease 1 0.9999896287918091
. O 0 0.05697793513536453

Ataxia B-Disease 1 0.9999942779541016
- I-Disease 1 0.9998297691345215
telangiectasia I-Disease 1 0.9999972581863403
( O 1 0.8327230215072632
A B-Disease 1 0.9995905756950378
- I-Disease 1 0.9999852180480957
T I-Disease 1 0.9999842643737793
) O 0 0.0092214560136199
is O 0 0.007667950354516506
a O 0 0.012183397077023983
recessive B-Disease 1 0.9990070462226868
multi I-Disease 1 0.9999880790710449
- I-Disease 1 0.9999960660934448
system I-Disease 1 0.9996507167816162
disorder I-Disease 1 0.9999992847442627
caused O 1 0.9825184345245361
by O 0 0.009610905312001705
mutations O 0 0.011884319595992565
in O 0 0.008036550134420395
the O 0 0.009075087495148182
ATM O 0 0.05344797670841217
gene O 0 0.010899935849010944
at O 0 0.01135276723653078
11q22 O 1 0.5522695779800415
- O 0 0.49883684515953064
q23 O 1 0.8838602304458618
( O 0 0.017564814537763596
ref O 0 0.39590418338775635
. O 0 0.020108681172132492
3 O 0 0.028897281736135483
) O 0 0.03293628990650177
. O 0 0.05123906955122948

The O 0 0.030852489173412323
risk O 1 0.6658649444580078
of O 1 0.7213136553764343
cancer B-Disease 1 0.999998927116394
, O 1 0.8672759532928467
especially O 1 0.9739949107170105
lymphoid B-Disease 1 0.9999970197677612
neoplasias I-Disease 1 0.9999175071716309
, O 0 0.012776244431734085
is O 0 0.007330814376473427
substantially O 0 0.012914173305034637
elevated O 0 0.2853075861930847
in O 0 0.008715041913092136
A B-Disease 1 0.9973894953727722
- I-Disease 1 0.9999945163726807
T I-Disease 1 0.9999992847442627
patients O 1 0.9972739815711975
and O 0 0.009172228164970875
has O 0 0.009485363028943539
long O 0 0.011525312438607216
been O 0 0.008917218074202538
associated O 0 0.013304324820637703
with O 0 0.02289266139268875
chromosomal O 1 0.9993937015533447
instability O 1 0.9999239444732666
. O 0 0.12876580655574799

By O 0 0.03522384539246559
analysing O 0 0.1128416433930397
tumour B-Disease 1 0.9996161460876465
DNA O 0 0.020148538053035736
from O 0 0.011516070924699306
patients O 0 0.3697926700115204
with O 0 0.010500895790755749
sporadic B-Disease 1 0.8564438223838806
T I-Disease 1 0.999914288520813
- I-Disease 1 0.9974954724311829
cell I-Disease 1 0.9541903734207153
prolymphocytic I-Disease 1 0.9999581575393677
leukaemia I-Disease 1 0.9999997615814209
( O 1 0.9597893357276917
T B-Disease 1 0.9999812841415405
- I-Disease 1 0.99772709608078
PLL I-Disease 1 0.9997755885124207
) O 0 0.013178111054003239
, O 0 0.01169914472848177
a O 0 0.01250781025737524
rare O 0 0.05278464034199715
clonal B-Disease 1 0.9575311541557312
malignancy I-Disease 1 0.9988729357719421
with O 0 0.009236183948814869
similarities O 0 0.01163856964558363
to O 0 0.008384286426007748
a O 0 0.010263524018228054
mature B-Disease 1 0.5794528722763062
T I-Disease 1 0.9996416568756104
- I-Disease 1 0.9901818633079529
cell I-Disease 1 0.7884470224380493
leukaemia I-Disease 1 0.9999368190765381
seen O 0 0.0095448587089777
in O 0 0.007419142872095108
A B-Disease 1 0.8775855898857117
- I-Disease 1 0.9994314312934875
T I-Disease 1 0.9995276927947998
, O 0 0.009157028049230576
we O 0 0.007709518074989319
demonstrate O 0 0.010689662769436836
a O 0 0.008968205191195011
high O 0 0.011215032078325748
frequency O 0 0.012524777092039585
of O 0 0.01255470048636198
ATM O 0 0.08387844264507294
mutations O 0 0.021099993959069252
in O 0 0.021938735619187355
T B-Disease 1 0.9993304014205933
- I-Disease 1 0.9729506373405457
PLL I-Disease 1 0.998873770236969
. O 0 0.06650323420763016

In O 0 0.02882201410830021
marked O 0 0.02698344737291336
contrast O 0 0.016484765335917473
to O 0 0.010496017523109913
the O 0 0.01058899611234665
ATM O 0 0.11358632147312164
mutation O 0 0.011424530297517776
pattern O 0 0.009221107698976994
in O 0 0.008097103796899319
A B-Disease 1 0.9157996773719788
- I-Disease 1 0.9994242191314697
T I-Disease 1 0.9988151788711548
, O 0 0.009067016653716564
the O 0 0.00794473011046648
most O 0 0.007024709135293961
frequent O 0 0.010963165201246738
nucleotide O 0 0.011578278616070747
changes O 0 0.008754933252930641
in O 0 0.010599956847727299
this O 0 0.013680189847946167
leukaemia B-Disease 1 0.9999260902404785
were O 0 0.020114092156291008
missense O 1 0.5223254561424255
mutations O 0 0.04556265100836754
. O 0 0.04391976445913315

These O 0 0.02774783782660961
clustered O 0 0.03296199440956116
in O 0 0.014090575277805328
the O 0 0.011866219341754913
region O 0 0.011440358124673367
corresponding O 0 0.009358104318380356
to O 0 0.007939518429338932
the O 0 0.00928832869976759
kinase O 0 0.055695656687021255
domain O 0 0.01136990636587143
, O 0 0.007907845079898834
which O 0 0.006178415380418301
is O 0 0.006504257209599018
highly O 0 0.008376387879252434
conserved O 0 0.009578578174114227
in O 0 0.007961325347423553
ATM O 0 0.07188905775547028
- O 0 0.031032826751470566
related O 0 0.009835885837674141
proteins O 0 0.010216645896434784
in O 0 0.01016061007976532
mouse O 0 0.03272334113717079
, O 0 0.015537220984697342
yeast O 0 0.033586449921131134
and O 0 0.027733849361538887
Drosophila O 0 0.06462366878986359
. O 0 0.05523264408111572

The O 0 0.03918963670730591
resulting O 0 0.03672224283218384
amino O 0 0.02613360807299614
- O 1 0.5250011682510376
acid O 0 0.03642880171537399
substitutions O 0 0.018157675862312317
are O 0 0.007136687636375427
predicted O 0 0.012466120533645153
to O 0 0.009901587851345539
interfere O 0 0.01538789551705122
with O 0 0.011666896753013134
ATP O 1 0.5198020935058594
binding O 0 0.020421016961336136
or O 0 0.01682322844862938
substrate O 0 0.03568430617451668
recognition O 0 0.037564169615507126
. O 0 0.0460364893078804

Two O 0 0.031525593250989914
of O 0 0.024562940001487732
seventeen O 0 0.07221100479364395
mutated O 1 0.9601665139198303
T B-Disease 1 0.9993164539337158
- I-Disease 1 0.9425129890441895
PLL I-Disease 1 0.9905055165290833
samples O 0 0.016273165121674538
had O 0 0.01086952444165945
a O 0 0.010787034407258034
previously O 0 0.01423699501901865
reported O 0 0.01708655245602131
A B-Disease 1 0.8762280941009521
- I-Disease 1 0.9997448325157166
T I-Disease 1 0.9999339580535889
allele O 0 0.21415261924266815
. O 0 0.05009841173887253

In O 0 0.027024555951356888
contrast O 0 0.02368970401585102
, O 0 0.012239586561918259
no O 0 0.010194748640060425
mutations O 0 0.009790739044547081
were O 0 0.006540953181684017
detected O 0 0.008820075541734695
in O 0 0.007101879455149174
the O 0 0.008436583913862705
p53 O 0 0.04763869568705559
gene O 0 0.008363641798496246
, O 0 0.007455348502844572
suggesting O 0 0.009111717343330383
that O 0 0.0066041843965649605
this O 0 0.010811434127390385
tumour B-Disease 1 0.9999935626983643
suppressor O 1 0.9912159442901611
is O 0 0.011314970441162586
not O 0 0.008428255096077919
frequently O 0 0.01179214846342802
altered O 0 0.014850534498691559
in O 0 0.014354128390550613
this O 0 0.02287445403635502
leukaemia B-Disease 1 0.9997870326042175
. O 0 0.05167426913976669

Occasional O 0 0.06999382376670837
missense O 0 0.07659130543470383
mutations O 0 0.025452889502048492
in O 0 0.012715763412415981
ATM O 0 0.04008578136563301
were O 0 0.008028887212276459
also O 0 0.007583963684737682
found O 0 0.006711243651807308
in O 0 0.007362935692071915
tumour B-Disease 1 0.9989981055259705
DNA O 0 0.00928027555346489
from O 0 0.006969066336750984
patients O 0 0.05727872624993324
with O 0 0.007820039056241512
B B-Disease 1 0.8702704310417175
- I-Disease 1 0.5929454565048218
cell I-Disease 0 0.11691093444824219
non I-Disease 1 0.8695822954177856
- I-Disease 1 0.9999762773513794
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.9999991655349731
( O 1 0.7910837531089783
B B-Disease 1 0.9935506582260132
- I-Disease 1 0.6925082802772522
NHL I-Disease 0 0.34323179721832275
) O 0 0.009186794981360435
and O 0 0.009081576950848103
a O 0 0.013524912297725677
B B-Disease 1 0.8390604257583618
- I-Disease 0 0.3721978962421417
NHL I-Disease 0 0.4962676763534546
cell O 0 0.04494684934616089
line O 0 0.042562518268823624
. O 0 0.045777272433042526

The O 0 0.027919476851820946
evidence O 0 0.016900433227419853
of O 0 0.010277241468429565
a O 0 0.00852796621620655
significant O 0 0.007298116572201252
proportion O 0 0.008170673623681068
of O 0 0.00702899694442749
loss O 1 0.9298675060272217
- O 1 0.9550477862358093
of O 0 0.1069846823811531
- O 1 0.9922268390655518
function O 0 0.010786226019263268
mutations O 0 0.007633094675838947
and O 0 0.005247911904007196
a O 0 0.006184842903167009
complete O 0 0.008307457901537418
absence O 0 0.009820359759032726
of O 0 0.005983556620776653
the O 0 0.006764629855751991
normal O 0 0.007242836058139801
copy O 0 0.010634434409439564
of O 0 0.007134475279599428
ATM O 0 0.015039611607789993
in O 0 0.006433108821511269
the O 0 0.006583793088793755
majority O 0 0.007674157153815031
of O 0 0.011268367990851402
mutated O 1 0.9878366589546204
tumours B-Disease 1 0.9999899864196777
establishes O 1 0.9963617920875549
somatic O 1 0.9614425301551819
inactivation O 1 0.9890340566635132
of O 0 0.01090418454259634
this O 0 0.008079303428530693
gene O 0 0.008223457261919975
in O 0 0.007458630949258804
the O 0 0.008783437311649323
pathogenesis O 1 0.9824689626693726
of O 0 0.02382528781890869
sporadic B-Disease 1 0.9948676824569702
T I-Disease 1 0.9999932050704956
- I-Disease 1 0.9993731379508972
PLL I-Disease 1 0.9998342990875244
and O 0 0.013110321946442127
suggests O 0 0.012676469050347805
that O 0 0.008927562274038792
ATM O 0 0.04285421967506409
acts O 0 0.014228129759430885
as O 0 0.018041417002677917
a O 0 0.1896696835756302
tumour B-Disease 1 0.9999912977218628
suppressor O 1 0.9978331923484802
. O 0 0.059148065745830536

As O 0 0.027862900868058205
constitutional O 0 0.026282742619514465
DNA O 0 0.01635238155722618
was O 0 0.011915122158825397
not O 0 0.007697839289903641
available O 0 0.008055122569203377
, O 0 0.007841511629521847
a O 0 0.010084811598062515
putative O 1 0.903195321559906
hereditary O 1 0.9999432563781738
predisposition O 1 0.99997878074646
to O 1 0.7281086444854736
T B-Disease 1 0.9999953508377075
- I-Disease 1 0.9984014630317688
PLL I-Disease 1 0.998193085193634
will O 0 0.014686242677271366
require O 0 0.015272483229637146
further O 0 0.02118457481265068
investigation O 0 0.029126213863492012
. O 0 0.02742278017103672
. O 0 0.036451853811740875

Myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999998807907104
protein O 1 0.8705040812492371
kinase O 1 0.6886488795280457
is O 0 0.012133638374507427
involved O 0 0.008919729851186275
in O 0 0.006802014075219631
the O 0 0.0074330889619886875
modulation O 0 0.02072690986096859
of O 0 0.010634254664182663
the O 0 0.28283387422561646
Ca2 O 1 0.9998742341995239
+ O 1 0.9599498510360718
homeostasis O 1 0.9891600012779236
in O 0 0.10504921525716782
skeletal O 1 0.9999092817306519
muscle O 1 0.9996547698974609
cells O 0 0.09859100729227066
. O 0 0.04987215995788574

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9996777772903442
DM B-Disease 1 0.9999998807907104
) O 0 0.024544231593608856
, O 0 0.011657806113362312
the O 0 0.010603564791381359
most O 0 0.1365300714969635
prevalent O 1 0.9999933242797852
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9784126877784729
adults O 1 0.9799456596374512
, O 0 0.04492894187569618
is O 0 0.008528292179107666
caused O 0 0.14679276943206787
by O 0 0.007060879375785589
( O 0 0.02172061614692211
CTG O 1 0.9943568110466003
) O 0 0.011745857074856758
n O 0 0.016359439119696617
- O 0 0.016013413667678833
repeat O 0 0.015107566490769386
expansion O 0 0.012857493944466114
in O 0 0.008160118944942951
a O 0 0.009243381209671497
gene O 0 0.00948913674801588
encoding O 0 0.009951295331120491
a O 0 0.010300683788955212
protein O 0 0.01371887419372797
kinase O 0 0.028082486242055893
( O 0 0.01706055924296379
DM B-Disease 1 0.9999529123306274
protein O 0 0.0223211832344532
kinase O 0 0.07903101295232773
; O 0 0.015839383006095886
DMPK O 1 0.9468525648117065
) O 0 0.01182860042899847
and O 0 0.010741624981164932
involves O 0 0.01341353077441454
changes O 0 0.01155359111726284
in O 0 0.014524108730256557
cytoarchitecture O 1 0.9626753926277161
and O 0 0.032898448407649994
ion O 1 0.8243869543075562
homeostasis O 1 0.96677565574646
. O 0 0.058013126254081726

To O 0 0.0347769521176815
obtain O 0 0.02557527646422386
clues O 0 0.02523939311504364
to O 0 0.011975330300629139
the O 0 0.010683028027415276
normal O 0 0.011819853447377682
biological O 0 0.012644780799746513
role O 0 0.011795638129115105
of O 0 0.011216813698410988
DMPK O 1 0.976155161857605
in O 0 0.014151502400636673
cellular O 1 0.9381299614906311
ion O 1 0.8620510697364807
homeostasis O 1 0.8434532284736633
, O 0 0.008485639467835426
we O 0 0.006701587233692408
have O 0 0.005474132485687733
compared O 0 0.007757842540740967
the O 0 0.008101479150354862
resting O 1 0.5280849933624268
[ O 0 0.10928025841712952
Ca2 O 1 0.8689438700675964
+ O 0 0.06452411413192749
] O 0 0.019528165459632874
i O 0 0.012859231792390347
, O 0 0.008912437595427036
the O 0 0.008097421377897263
amplitude O 0 0.012149389833211899
and O 0 0.00739640835672617
shape O 0 0.011648469604551792
of O 0 0.013259236700832844
depolarization O 1 0.9999573230743408
- O 1 0.9999467134475708
induced O 1 0.9999934434890747
Ca2 O 1 0.9998522996902466
+ O 1 0.7050396203994751
transients O 0 0.09049713611602783
, O 0 0.011355722323060036
and O 0 0.00844279583543539
the O 0 0.007214612327516079
content O 0 0.008658195845782757
of O 0 0.008895983919501305
ATP O 1 0.8742942810058594
- O 0 0.22906585037708282
driven O 0 0.026253754273056984
ion O 0 0.03892764449119568
pumps O 0 0.053785406053066254
in O 0 0.014193873852491379
cultured O 0 0.4022330343723297
skeletal O 1 0.9970276951789856
muscle O 1 0.8413892388343811
cells O 0 0.01239125058054924
of O 0 0.008962571620941162
wild O 0 0.014568907208740711
- O 1 0.7222709655761719
type O 0 0.0707094818353653
and O 0 0.012440833263099194
DMPK O 1 0.999090313911438
[ O 0 0.4126330018043518
- O 1 0.9894343018531799
/ O 1 0.9889503121376038
- O 1 0.8843286633491516
] O 0 0.2417551875114441
knockout O 1 0.9174157977104187
mice O 0 0.06702496856451035
. O 0 0.05226405709981918

In O 0 0.03968163952231407
vitro O 0 0.049058955162763596
- O 0 0.07100626081228256
differentiated O 1 0.5308489799499512
DMPK O 1 0.9977365732192993
[ O 1 0.5832749009132385
- O 1 0.9913867115974426
/ O 1 0.9926952123641968
- O 1 0.8949318528175354
] O 0 0.08557694405317307
myotubes O 0 0.32018324732780457
exhibit O 0 0.019445115700364113
a O 0 0.013637783005833626
higher O 0 0.01602686196565628
resting O 1 0.6145583987236023
[ O 0 0.06592805683612823
Ca2 O 1 0.8312755823135376
+ O 0 0.03691933676600456
] O 0 0.020741326734423637
i O 0 0.01260337233543396
than O 0 0.008114339783787727
do O 0 0.008432009257376194
wild O 0 0.011760711669921875
- O 0 0.05558304488658905
type O 0 0.018823906779289246
myotubes O 0 0.15112069249153137
because O 0 0.007911182940006256
of O 0 0.006550891790539026
an O 0 0.006430186331272125
altered O 0 0.00883461069315672
open O 0 0.008902388624846935
probability O 0 0.008160501718521118
of O 0 0.00796987023204565
voltage O 0 0.01718827337026596
- O 0 0.28972646594047546
dependent O 0 0.024949287995696068
l O 1 0.9614076018333435
- O 1 0.9263463616371155
type O 1 0.7287819385528564
Ca2 O 1 0.9765322208404541
+ O 0 0.19976459443569183
and O 0 0.028669077903032303
Na O 1 0.9865715503692627
+ O 0 0.06268572062253952
channels O 0 0.05656306445598602
. O 0 0.05490634962916374

The O 0 0.04664722830057144
mutant O 0 0.10127656906843185
myotubes O 1 0.6841362118721008
exhibit O 0 0.03650059551000595
smaller O 0 0.019973117858171463
and O 0 0.014062192291021347
slower O 0 0.029084544628858566
Ca2 O 0 0.40243834257125854
+ O 0 0.02358992211520672
responses O 0 0.015837697312235832
upon O 0 0.016553401947021484
triggering O 0 0.0313602052628994
by O 0 0.01185259036719799
acetylcholine O 0 0.07425670325756073
or O 0 0.013964426703751087
high O 0 0.023076219484210014
external O 0 0.1990850567817688
K O 1 0.5708997845649719
+ O 0 0.06637797504663467
. O 0 0.04830648750066757

In O 0 0.025181801989674568
addition O 0 0.016691716387867928
, O 0 0.010958057828247547
we O 0 0.008331695571541786
observed O 0 0.007975142449140549
that O 0 0.006327143870294094
these O 0 0.0077087595127522945
Ca2 O 1 0.9575161933898926
+ O 0 0.49478527903556824
transients O 0 0.31036388874053955
partially O 0 0.018044300377368927
result O 0 0.009458976797759533
from O 0 0.008373047225177288
an O 0 0.009232510812580585
influx O 0 0.017548728734254837
of O 0 0.01260367501527071
extracellular O 0 0.0940055102109909
Ca2 O 0 0.22400879859924316
+ O 0 0.018881643190979958
through O 0 0.012166238389909267
the O 0 0.014719296246767044
l O 1 0.8504309058189392
- O 1 0.862113893032074
type O 0 0.4475504457950592
Ca2 O 1 0.7309587001800537
+ O 0 0.05707591027021408
channel O 0 0.06083910912275314
. O 0 0.05395935848355293

Neither O 0 0.04259553924202919
the O 0 0.02200186438858509
content O 0 0.019145863130688667
nor O 0 0.015687059611082077
the O 0 0.011710992082953453
activity O 0 0.011399767361581326
of O 0 0.013211199082434177
Na O 1 0.9999078512191772
+ O 1 0.8575707674026489
/ O 1 0.8838507533073425
K O 0 0.21680761873722076
+ O 0 0.04771657660603523
ATPase O 0 0.22479848563671112
and O 0 0.02933160401880741
sarcoplasmic O 1 0.999160647392273
reticulum O 1 0.9994977712631226
Ca2 O 1 0.9963144659996033
+ O 1 0.7722587585449219
- O 1 0.7277716994285583
ATPase O 1 0.7607333064079285
are O 0 0.017352815717458725
affected O 0 0.022452061995863914
by O 0 0.024749161675572395
DMPK O 1 0.9932326078414917
absence O 0 0.3455033600330353
. O 0 0.04956861957907677

In O 0 0.0287637822329998
conclusion O 0 0.025245817378163338
, O 0 0.014566805213689804
our O 0 0.011844182386994362
data O 0 0.010023104958236217
suggest O 0 0.00928115751594305
that O 0 0.00774829275906086
DMPK O 1 0.8474252820014954
is O 0 0.00756602268666029
involved O 0 0.0061644683592021465
in O 0 0.006138016935437918
modulating O 0 0.021583760157227516
the O 0 0.007201372180134058
initial O 0 0.009660412557423115
events O 0 0.008225655183196068
of O 0 0.009388660080730915
excitation O 0 0.22862660884857178
- O 1 0.933070719242096
contraction O 1 0.9478058815002441
coupling O 0 0.36852091550827026
in O 0 0.038801759481430054
skeletal O 1 0.9998823404312134
muscle O 1 0.9988344311714172
. O 0 0.027673253789544106
. O 0 0.03905705362558365

Constitutional O 0 0.23265154659748077
RB1 O 1 0.9999347925186157
- O 1 0.9833018183708191
gene O 0 0.06556804478168488
mutations O 0 0.033567994832992554
in O 0 0.015483143739402294
patients O 1 0.9727627635002136
with O 0 0.025516517460346222
isolated O 1 0.8573062419891357
unilateral B-Disease 1 0.9911603331565857
retinoblastoma I-Disease 1 0.9999772310256958
. O 0 0.1266479641199112

In O 0 0.026937438175082207
most O 0 0.017745189368724823
patients O 0 0.3379669487476349
with O 0 0.012087918817996979
isolated O 1 0.6309136748313904
unilateral B-Disease 1 0.9981586337089539
retinoblastoma I-Disease 1 0.9999998807907104
, O 1 0.9984577894210815
tumor B-Disease 1 0.9999955892562866
development O 1 0.5149270296096802
is O 0 0.010055264458060265
initiated O 0 0.04353596270084381
by O 0 0.009041826240718365
somatic O 0 0.23249681293964386
inactivation O 1 0.9280432462692261
of O 0 0.011340861208736897
both O 0 0.011575927957892418
alleles O 0 0.018063707277178764
of O 0 0.01662496291100979
the O 0 0.03466406092047691
RB1 O 1 0.9997614026069641
gene O 0 0.042458467185497284
. O 0 0.048674143850803375

However O 0 0.025523042306303978
, O 0 0.014367450959980488
some O 0 0.010093878954648972
of O 0 0.009432910941541195
these O 0 0.009300530888140202
patients O 1 0.9825534224510193
can O 0 0.015154443681240082
transmit O 1 0.9704949259757996
retinoblastoma B-Disease 1 0.9999918937683105
predisposition O 1 0.9996249675750732
to O 0 0.018951550126075745
their O 0 0.020353801548480988
offspring O 0 0.12682893872261047
. O 0 0.04270653426647186

To O 0 0.0297151580452919
determine O 0 0.0201480221003294
the O 0 0.014077365398406982
frequency O 0 0.011282677762210369
and O 0 0.008879131637513638
nature O 0 0.00916033424437046
of O 0 0.007993611507117748
constitutional O 0 0.19166254997253418
RB1 O 1 0.9999960660934448
- O 1 0.9921780228614807
gene O 0 0.022678371518850327
mutations O 0 0.01238167379051447
in O 0 0.007162565365433693
patients O 1 0.7565982937812805
with O 0 0.009511059150099754
isolated O 0 0.33007004857063293
unilateral B-Disease 1 0.7613630890846252
retinoblastoma I-Disease 1 0.9996305704116821
, O 0 0.009729008190333843
we O 0 0.008350828662514687
analyzed O 0 0.010891133919358253
DNA O 0 0.010150623507797718
from O 0 0.01088953111320734
peripheral O 1 0.9982150793075562
blood O 1 0.6454839110374451
and O 0 0.021949904039502144
from O 0 0.1444510966539383
tumor B-Disease 1 0.9999653100967407
tissue O 1 0.9905135631561279
. O 0 0.049055371433496475

The O 0 0.0310658011585474
analysis O 0 0.023858370259404182
of O 0 0.018729297444224358
tumors B-Disease 1 0.9627004861831665
from O 0 0.011268207803368568
54 O 0 0.020974863320589066
( O 0 0.012448691762983799
71 O 0 0.018200157210230827
% O 0 0.010244050994515419
) O 0 0.009847396984696388
of O 0 0.011170775629580021
76 O 0 0.02689897082746029
informative O 0 0.02336996980011463
patients O 0 0.061531729996204376
showed O 0 0.013023517094552517
loss O 0 0.01892557181417942
of O 0 0.012628753669559956
constitutional O 1 0.8255797028541565
heterozygosity O 1 0.9999951124191284
( O 1 0.9880601763725281
LOH O 1 0.9999979734420776
) O 0 0.03291113302111626
at O 0 0.04169737920165062
intragenic O 0 0.4932272434234619
loci O 0 0.08983210474252701
. O 0 0.06466011703014374

Three O 0 0.038934215903282166
of O 0 0.031196080148220062
13 O 0 0.14020787179470062
uninformative O 1 0.9996066689491272
patients O 1 0.9891484379768372
had O 0 0.03930872306227684
constitutional O 0 0.23816432058811188
deletions O 1 0.9312204718589783
. O 0 0.057303424924612045

For O 0 0.03563939034938812
39 O 0 0.03582395613193512
randomly O 0 0.027138901874423027
selected O 0 0.0290623027831316
tumors B-Disease 1 0.9699099063873291
, O 0 0.01937882974743843
SSCP O 1 0.9948110580444336
, O 0 0.0361693911254406
hetero O 1 0.999473512172699
- O 1 0.8646870255470276
duplex O 1 0.5439165234565735
analysis O 0 0.011872377246618271
, O 0 0.009653895162045956
sequencing O 0 0.013226019218564034
, O 0 0.009554912336170673
and O 0 0.009573671966791153
Southern O 0 0.014092562720179558
blot O 0 0.08374842256307602
analysis O 0 0.011947914026677608
were O 0 0.010001062415540218
used O 0 0.012244965881109238
to O 0 0.016108127310872078
identify O 0 0.02750408835709095
mutations O 0 0.03435349836945534
. O 0 0.036005906760692596

Mutations O 0 0.046105340123176575
were O 0 0.018822796642780304
detected O 0 0.019390303641557693
in O 0 0.010925241746008396
21 O 0 0.013753323815762997
( O 0 0.010430680587887764
91 O 0 0.017833130434155464
% O 0 0.010014313273131847
) O 0 0.01124368142336607
of O 0 0.012795498594641685
23 O 0 0.16564711928367615
tumors B-Disease 1 0.9996752738952637
with O 0 0.09299715608358383
LOH O 1 0.9999957084655762
. O 0 0.06548349559307098

In O 0 0.027475090697407722
6 O 0 0.025970323011279106
( O 0 0.018093129619956017
38 O 0 0.019093915820121765
% O 0 0.011254235170781612
) O 0 0.009227226488292217
of O 0 0.00896146148443222
16 O 0 0.022048112004995346
tumors B-Disease 1 0.9994631409645081
without O 0 0.022871794179081917
LOH O 1 0.9999960660934448
, O 0 0.012278496287763119
one O 0 0.009352580644190311
mutation O 0 0.010934578254818916
was O 0 0.010407685302197933
detected O 0 0.009949050843715668
, O 0 0.0067240530624985695
and O 0 0.005910590291023254
in O 0 0.005844627041369677
9 O 0 0.009265636093914509
( O 0 0.007735373452305794
56 O 0 0.011588849127292633
% O 0 0.006947331130504608
) O 0 0.0066902777180075645
of O 0 0.007350215222686529
the O 0 0.011992386542260647
tumors B-Disease 1 0.9998964071273804
without O 0 0.21823455393314362
LOH O 1 0.9999994039535522
, O 0 0.019683459773659706
both O 0 0.013257671147584915
mutations O 0 0.01694994792342186
were O 0 0.012520554475486279
found O 0 0.017986606806516647
. O 0 0.032461971044540405

Thus O 0 0.03230048343539238
, O 0 0.015381011180579662
a O 0 0.011915403418242931
total O 0 0.00927724689245224
of O 0 0.00831783190369606
45 O 0 0.011536487378180027
mutations O 0 0.008505478501319885
were O 0 0.0053588030859827995
identified O 0 0.008455839939415455
in O 0 0.009258788079023361
tumors B-Disease 1 0.9934988021850586
of O 0 0.0192720927298069
36 O 0 0.3586667478084564
patients O 1 0.9685438871383667
. O 0 0.035572782158851624

Thirty O 0 0.05126813054084778
- O 0 0.02908199653029442
nine O 0 0.016910433769226074
of O 0 0.01104335580021143
the O 0 0.01107272319495678
mutations O 0 0.011595569550991058
- O 0 0.015102998353540897
including O 0 0.007609483785927296
34 O 0 0.01152434665709734
small O 0 0.008352266624569893
mutations O 0 0.0082864323630929
, O 0 0.007041159085929394
2 O 0 0.008908280171453953
large O 0 0.007530098780989647
structural O 0 0.08569301664829254
alterations O 0 0.018928304314613342
, O 0 0.007336596492677927
and O 0 0.007951087318360806
hypermethylation O 1 0.7479408979415894
in O 0 0.008639348670840263
3 O 0 0.1397339254617691
tumors O 1 0.9994481205940247
- O 0 0.06644800305366516
were O 0 0.005542689468711615
not O 0 0.0055545722134411335
detected O 0 0.00868687778711319
in O 0 0.007062534336000681
the O 0 0.009363066405057907
corresponding O 0 0.04877128452062607
peripheral O 1 0.9988566637039185
blood O 1 0.5712859630584717
DNA O 0 0.03373199701309204
. O 0 0.041695721447467804

In O 0 0.027616111561655998
6 O 0 0.025848388671875
( O 0 0.01367375161498785
17 O 0 0.014078523963689804
% O 0 0.009078668430447578
) O 0 0.006990522146224976
of O 0 0.0065113939344882965
the O 0 0.00735995639115572
36 O 0 0.014206290245056152
patients O 0 0.2538037896156311
, O 0 0.00689602829515934
a O 0 0.007836971431970596
mutation O 0 0.009958264417946339
was O 0 0.00739247165620327
detected O 0 0.007122173439711332
in O 0 0.005560179706662893
constitutional O 0 0.007657152134925127
DNA O 0 0.006906774826347828
, O 0 0.005950786639004946
and O 0 0.005382859613746405
1 O 0 0.005871763918548822
of O 0 0.004717475734651089
these O 0 0.004262104164808989
mutations O 0 0.0060346489772200584
is O 0 0.004616258665919304
known O 0 0.0056028906255960464
to O 0 0.00564692635089159
be O 0 0.0059892828576266766
associated O 0 0.008858300745487213
with O 0 0.012378857471048832
reduced O 0 0.03719191625714302
expressivity O 1 0.9987646341323853
. O 0 0.04208474978804588

The O 0 0.027504635974764824
presence O 0 0.02022882178425789
of O 0 0.01321862917393446
a O 0 0.012825041078031063
constitutional O 0 0.10374734550714493
mutation O 0 0.1943904608488083
was O 0 0.014618637040257454
not O 0 0.00532027380540967
associated O 0 0.006141117308288813
with O 0 0.004803425166755915
an O 0 0.006230880971997976
early O 0 0.011785782873630524
age O 0 0.03402925655245781
at O 0 0.020351948216557503
treatment O 1 0.6688880920410156
. O 0 0.03534248098731041

In O 0 0.034246776252985
1 O 0 0.034619349986314774
patient O 1 0.7208037972450256
, O 0 0.025853119790554047
somatic O 1 0.9146081209182739
mosaicism O 1 0.9993976354598999
was O 0 0.02987600676715374
demonstrated O 0 0.014650996774435043
by O 0 0.007560474798083305
molecular O 0 0.01013218518346548
analysis O 0 0.008045831695199013
of O 0 0.007971009239554405
DNA O 0 0.010209232568740845
and O 0 0.009991977363824844
RNA O 0 0.01990148425102234
from O 0 0.017643960192799568
peripheral O 1 0.9977401494979858
blood O 1 0.6037275195121765
. O 0 0.036367859691381454

In O 0 0.028467074036598206
2 O 0 0.03224888816475868
patients O 0 0.03503117337822914
without O 0 0.011251937597990036
a O 0 0.013196778483688831
detectable O 1 0.6587697267532349
mutation O 0 0.0355277918279171
in O 0 0.013638630509376526
peripheral O 1 0.9998867511749268
blood O 1 0.857926607131958
, O 0 0.042186494916677475
mosaicism O 1 0.9976592063903809
was O 0 0.012960750609636307
suggested O 0 0.00752508919686079
because O 0 0.005398930981755257
1 O 0 0.006953550968319178
of O 0 0.005953899119049311
the O 0 0.012037606909871101
patients O 1 0.9995306730270386
showed O 1 0.9993190765380859
multifocal O 1 1.0
tumors B-Disease 1 0.9999992847442627
and O 0 0.06147827208042145
the O 0 0.013259693048894405
other O 0 0.008602418936789036
later O 0 0.01997728832066059
developed O 0 0.26517942547798157
bilateral B-Disease 1 0.7791620492935181
retinoblastoma I-Disease 1 0.999714195728302
. O 0 0.04914579540491104

In O 0 0.030685456469655037
conclusion O 0 0.026396237313747406
, O 0 0.014058781787753105
our O 0 0.012203354388475418
results O 0 0.010003728792071342
emphasize O 0 0.015874648466706276
that O 0 0.007023734040558338
the O 0 0.008827109821140766
manifestation O 1 0.9931108951568604
and O 0 0.039966318756341934
transmissibility O 1 0.9998376369476318
of O 1 0.6035819053649902
retinoblastoma B-Disease 1 0.9999861717224121
depend O 0 0.009114351123571396
on O 0 0.006373126059770584
the O 0 0.006002744659781456
nature O 0 0.006498744245618582
of O 0 0.005055799148976803
the O 0 0.004915827885270119
first O 0 0.007216510828584433
mutation O 0 0.007100440561771393
, O 0 0.004874297883361578
its O 0 0.004690420348197222
time O 0 0.004571576602756977
in O 0 0.004293845035135746
development O 0 0.005684823263436556
, O 0 0.004597334191203117
and O 0 0.0038649914786219597
the O 0 0.003957598004490137
number O 0 0.003893668530508876
and O 0 0.004675771575421095
types O 0 0.005438258405774832
of O 0 0.006154706701636314
cells O 0 0.009381260722875595
that O 0 0.006581330206245184
are O 0 0.007911115884780884
affected O 0 0.01580185256898403
. O 0 0.018483156338334084
. O 0 0.029512563720345497

Hereditary B-Disease 1 0.9999951124191284
deficiency I-Disease 1 0.9999990463256836
of I-Disease 0 0.2651330530643463
the I-Disease 1 0.7001486420631409
fifth I-Disease 1 0.9996767044067383
component I-Disease 1 0.9961057305335999
of I-Disease 0 0.18314394354820251
complement I-Disease 1 0.7974694967269897
in O 0 0.02492266707122326
man O 0 0.06633297353982925
. O 0 0.04507023096084595

I O 0 0.17315073311328888
. O 0 0.13491234183311462

Clinical O 1 0.9814183115959167
, O 0 0.05359688401222229
immunochemical O 1 0.9932616353034973
, O 0 0.03005654364824295
and O 0 0.021892564371228218
family O 0 0.03368053957819939
studies O 0 0.03170088306069374
. O 0 0.0419921912252903

The O 0 0.030319949612021446
first O 0 0.0198908019810915
recognized O 0 0.022915814071893692
human O 0 0.024249346926808357
kindred O 1 0.9999508857727051
with O 1 0.9763609170913696
hereditary B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
of I-Disease 1 0.9812183976173401
the I-Disease 1 0.9785277247428894
fifth I-Disease 1 0.999976396560669
component I-Disease 1 0.9998829364776611
of I-Disease 1 0.971513569355011
complement I-Disease 1 0.9989823698997498
( O 1 0.9126574397087097
C5 O 1 0.9997226595878601
) O 0 0.021949375048279762
is O 0 0.02292778715491295
described O 0 0.03679678961634636
. O 0 0.04250572994351387

The O 0 0.038499362766742706
proband O 0 0.0900740772485733
, O 0 0.016847457736730576
a O 0 0.01314252708107233
20 O 0 0.012181933037936687
- O 0 0.02566278912127018
year O 0 0.009503933601081371
- O 0 0.08465145528316498
old O 0 0.023217104375362396
black O 0 0.12279337644577026
female O 1 0.596989095211029
with O 1 0.9919122457504272
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9996874332427979
age O 1 0.9983587861061096
11 O 1 0.959611177444458
, O 1 0.7708632349967957
lacked O 1 0.9999316930770874
serum O 1 0.9999985694885254
hemolytic O 1 1.0
complement O 1 0.9935200810432434
activity O 0 0.023696232587099075
, O 0 0.014754224568605423
even O 0 0.016110824421048164
during O 0 0.03689110279083252
remission O 1 0.9968834519386292
. O 0 0.044538624584674835

C5 O 1 0.998268723487854
was O 0 0.15639258921146393
undetectable O 1 0.9452645182609558
in O 0 0.020561370998620987
her O 0 0.04325585439801216
serum O 1 0.9225591421127319
by O 0 0.015744926407933235
both O 0 0.028502412140369415
immunodiffusion O 1 0.999809205532074
and O 1 0.89634108543396
hemolytic O 1 0.9999996423721313
assays O 1 0.8522089719772339
. O 0 0.0645630806684494

Other O 0 0.025486089289188385
complement O 0 0.028954487293958664
components O 0 0.019594939425587654
were O 0 0.00974645372480154
normal O 0 0.010548598133027554
during O 0 0.013879099860787392
remission O 1 0.996023416519165
of O 1 0.7913307547569275
lupus O 1 1.0
, O 1 0.8878480195999146
but O 0 0.3179907500743866
C1 O 1 0.9999985694885254
, O 0 0.14924080669879913
C4 O 1 0.9996885061264038
, O 0 0.20325665175914764
C2 O 1 0.9999743700027466
, O 0 0.017928993329405785
and O 0 0.02267676405608654
C3 O 1 0.9995911717414856
levels O 0 0.039433252066373825
fell O 0 0.4987166225910187
during O 0 0.05131017044186592
exacerbations O 1 0.9996328353881836
. O 0 0.06182707101106644

A O 0 0.03841901198029518
younger O 0 0.03745487704873085
half O 0 0.020447036251425743
- O 1 0.536363959312439
sister O 0 0.06968717277050018
, O 0 0.0083438316360116
who O 0 0.008094335906207561
had O 0 0.015742620453238487
no O 0 0.082879938185215
underlying O 1 0.9998914003372192
disease O 1 0.999998927116394
, O 1 0.515140175819397
was O 1 0.6126645803451538
also O 0 0.00969915185123682
found O 0 0.008046439848840237
to O 0 0.011304188519716263
lack O 0 0.08813387900590897
immunochemically O 1 0.9989049434661865
detectable O 1 0.9968131184577942
C5 O 1 0.9986677169799805
. O 0 0.06099467724561691

By O 0 0.06410153210163116
hemolytic O 1 0.9999961853027344
assay O 1 0.6561908721923828
, O 0 0.01977577619254589
she O 0 0.019207904115319252
exhibited O 0 0.024628611281514168
1 O 0 0.01393083669245243
- O 0 0.015655139461159706
2 O 0 0.01105068065226078
% O 0 0.007720009423792362
of O 0 0.006902824621647596
the O 0 0.008273237384855747
normal O 0 0.013272938318550587
serum O 1 0.9907327890396118
C5 O 1 0.9948260188102722
level O 0 0.012872977182269096
and O 0 0.010648681782186031
normal O 0 0.012811820954084396
concentrations O 0 0.014598154462873936
of O 0 0.013391084969043732
other O 0 0.014622606337070465
complement O 0 0.035323239862918854
components O 0 0.043982669711112976
. O 0 0.04833349213004112

C5 O 1 0.989534318447113
levels O 0 0.02580835111439228
of O 0 0.014329834841191769
other O 0 0.009006083942949772
family O 0 0.009703874588012695
members O 0 0.006390197668224573
were O 0 0.004948972258716822
either O 0 0.005444617476314306
normal O 0 0.005952665116637945
or O 0 0.0048630633391439915
approximately O 0 0.006804937031120062
half O 0 0.00803875271230936
- O 0 0.016030659899115562
normal O 0 0.009053707122802734
, O 0 0.008246337063610554
consistent O 0 0.011762440204620361
with O 0 0.01229662075638771
autosomal O 1 0.9827955365180969
codominant O 1 0.9898117184638977
inheritance O 0 0.2457641214132309
of O 0 0.014011490158736706
the O 0 0.08969578146934509
gene O 0 0.39760729670524597
determining O 1 0.9107918739318848
C5 B-Disease 1 0.9999960660934448
deficiency I-Disease 1 0.9999994039535522
. O 0 0.10237374156713486

Normal O 1 0.6534633040428162
hemolytic O 1 0.9999972581863403
titers O 1 0.9958717226982117
were O 0 0.018246620893478394
restored O 0 0.02112579345703125
to O 0 0.012869754806160927
both O 0 0.013845712877810001
homozygous O 1 0.6781638860702515
C5 B-Disease 1 0.9999966621398926
- I-Disease 1 0.999963641166687
deficient I-Disease 1 0.9999922513961792
( O 1 0.9044015407562256
C5D B-Disease 1 0.9999836683273315
) O 0 0.0193428136408329
sera O 1 0.5012592077255249
by O 0 0.013552876189351082
addition O 0 0.01521663274616003
of O 0 0.014942009933292866
highly O 0 0.04759065806865692
purified O 1 0.9355608224868774
human O 0 0.1825074404478073
C5 O 1 0.9980354905128479
. O 0 0.05713289603590965

In O 0 0.03441077843308449
specific O 0 0.029745707288384438
C5 O 1 0.9998306035995483
titrations O 1 0.9964815378189087
, O 0 0.01781228929758072
however O 0 0.010737502947449684
, O 0 0.009309453889727592
it O 0 0.006545103620737791
was O 0 0.008962225168943405
noted O 0 0.008445843122899532
that O 0 0.005255614873021841
when O 0 0.0065530212596058846
limited O 0 0.00788695178925991
amounts O 0 0.008474825881421566
of O 0 0.008588461205363274
C5 O 1 0.6517080664634705
were O 0 0.009352199733257294
assayed O 0 0.01779475249350071
in O 0 0.007609764114022255
the O 0 0.007769320160150528
presence O 0 0.008909075520932674
of O 0 0.007914211601018906
low O 0 0.012526379898190498
dilutions O 1 0.6516957879066467
of O 0 0.010721053928136826
either O 0 0.01861785538494587
C5D B-Disease 1 0.9999759197235107
serum O 1 0.9834176898002625
, O 0 0.012543330900371075
curving O 0 0.01969541423022747
rather O 0 0.00937764160335064
than O 0 0.00828919094055891
linear O 0 0.011873584240674973
dose O 0 0.16133113205432892
- O 0 0.03388361632823944
response O 0 0.012430737726390362
plots O 0 0.014232155866920948
were O 0 0.007912736386060715
consistently O 0 0.013327128253877163
obtained O 0 0.011591542512178421
, O 0 0.012805717997252941
suggesting O 0 0.016597675159573555
some O 0 0.014670104719698429
inhibitory O 0 0.03899624943733215
effect O 0 0.03261488303542137
. O 0 0.03907502442598343

Further O 0 0.03725803643465042
studies O 0 0.024727165699005127
suggested O 0 0.02225668542087078
that O 0 0.013601155951619148
low O 0 0.01837257854640484
dilutions O 1 0.5293546319007874
of O 0 0.020993828773498535
C5D B-Disease 1 0.9999812841415405
serum O 1 0.9884266257286072
contain O 0 0.014862475916743279
a O 0 0.01291724480688572
factor O 0 0.1039121225476265
( O 0 0.008594752289354801
or O 0 0.007054219953715801
factors O 0 0.006468203850090504
) O 0 0.00580071983858943
interfering O 0 0.00879789236932993
at O 0 0.006246774457395077
some O 0 0.004694260191172361
step O 0 0.008187266997992992
in O 0 0.00730170588940382
the O 0 0.011644023470580578
hemolytic O 1 0.999998927116394
assay O 0 0.4496391713619232
of O 0 0.058390211313962936
C5 O 1 0.9989612102508545
, O 0 0.010551922023296356
rather O 0 0.008611328899860382
than O 0 0.008324473164975643
a O 0 0.013405071571469307
true O 0 0.1910695880651474
C5 O 1 0.9999576807022095
inhibitor O 1 0.9994277358055115
or O 0 0.028975684195756912
inactivator O 1 0.9438750147819519
. O 0 0.04088389873504639

Of O 0 0.03304196521639824
clinical O 1 0.767921507358551
interest O 0 0.01671499013900757
are O 0 0.0077666956931352615
( O 0 0.008483815006911755
a O 0 0.007519436068832874
) O 0 0.007260096725076437
the O 0 0.007902481593191624
documentation O 0 0.019486078992486
of O 0 0.48812973499298096
membranous O 1 0.9999998807907104
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999394416809082
vasculitis B-Disease 1 1.0
, O 1 0.999273955821991
and O 1 0.9994978904724121
arthritis B-Disease 1 1.0
in O 0 0.19511444866657257
an O 0 0.1839922070503235
individual O 0 0.3368125557899475
lacking O 1 0.9994551539421082
C5 O 1 0.9999744892120361
( O 0 0.011512977071106434
and O 0 0.007501345593482256
its O 0 0.007886916399002075
biologic O 1 0.9480315446853638
functions O 0 0.007991989143192768
) O 0 0.0069601829163730145
, O 0 0.00709754740819335
and O 0 0.006564117968082428
( O 0 0.007697621360421181
b O 0 0.012750708498060703
) O 0 0.006510816980153322
a O 0 0.007864370942115784
remarkable O 0 0.016521025449037552
propensity O 1 0.8093782067298889
to O 0 0.020720327273011208
bacterial B-Disease 1 0.9999818801879883
infections I-Disease 1 0.9999756813049316
in O 0 0.01161379273980856
the O 0 0.06952042132616043
proband O 1 0.9975207448005676
, O 0 0.007326453924179077
even O 0 0.00620748708024621
during O 0 0.006808085832744837
periods O 0 0.008583525195717812
of O 0 0.007528829853981733
low O 0 0.015120165422558784
- O 0 0.24258731305599213
dose O 0 0.4303547143936157
or O 0 0.008873828686773777
alternate O 0 0.01917162537574768
- O 1 0.8741430640220642
day O 0 0.10656831413507462
corticosteroid O 1 0.9998931884765625
therapy O 1 0.991692841053009
. O 0 0.052020344883203506

Other O 0 0.0260518416762352
observations O 0 0.030006663873791695
indicate O 0 0.019792918115854263
that O 0 0.01095436792820692
the O 0 0.013349694199860096
C5D B-Disease 1 0.9475964307785034
state O 0 0.009661835618317127
is O 0 0.007996584288775921
compatible O 0 0.018785955384373665
with O 0 0.007884853519499302
normal O 0 0.01590440608561039
coagulation O 1 0.9899167418479919
function O 0 0.007305637933313847
and O 0 0.006402826402336359
the O 0 0.0067075761035084724
capacity O 0 0.010376634076237679
to O 0 0.010189149528741837
mount O 0 0.10176584124565125
a O 0 0.057372573763132095
neutrophilic O 1 0.9999915361404419
leukocytosis O 1 0.9999915361404419
during O 1 0.9952846169471741
pyogenic B-Disease 1 0.9999984502792358
infection I-Disease 1 0.9999912977218628
. O 0 0.03913004696369171
. O 0 0.04531987011432648

Susceptibility O 1 0.998513400554657
to O 1 0.8241163492202759
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.5685592889785767
twins O 1 0.9942341446876526
: O 0 0.01401927974075079
the O 0 0.01119941659271717
role O 0 0.01198629755526781
of O 0 0.013523240573704243
genes O 0 0.07085885852575302
, O 0 0.35476014018058777
HLA O 1 0.999995231628418
, O 0 0.016841137781739235
and O 0 0.012917651794850826
the O 0 0.016111774370074272
environment O 0 0.030074063688516617
. O 0 0.035467371344566345

OBJECTIVE O 0 0.05190819129347801
To O 0 0.021201515570282936
determine O 0 0.016589956358075142
the O 0 0.011862187646329403
relative O 0 0.012665586546063423
effects O 0 0.01231780182570219
of O 0 0.008105426095426083
genetic O 0 0.023393550887703896
and O 0 0.007627891842275858
environmental O 0 0.1236327588558197
factors O 0 0.01278649177402258
in O 0 0.03480624035000801
susceptibility O 1 0.9999518394470215
to O 1 0.9933211207389832
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9983595013618469
AS B-Disease 1 0.9886720180511475
) O 0 0.03868553787469864
. O 0 0.05026252567768097

METHODS O 0 0.04285595193505287
Twins O 0 0.05184098705649376
with O 0 0.016362447291612625
AS B-Disease 0 0.014369728043675423
were O 0 0.007960353046655655
identified O 0 0.0071447500959038734
from O 0 0.00628075934946537
the O 0 0.00886143185198307
Royal O 1 0.8223110437393188
National O 1 0.9922311902046204
Hospital O 1 0.9999983310699463
for O 1 0.9994621872901917
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9988246560096741
. O 0 0.344023734331131

Clinical O 1 0.9581928849220276
and O 0 0.03114164248108864
radiographic O 1 0.9971020817756653
examinations O 0 0.13276152312755585
were O 0 0.00931980274617672
performed O 0 0.010297063738107681
to O 0 0.00831693783402443
establish O 0 0.048245564103126526
diagnoses O 1 0.9999822378158569
, O 1 0.7288961410522461
and O 1 0.9726993441581726
disease O 1 0.9999994039535522
severity O 1 0.9999686479568481
was O 1 0.9237557053565979
assessed O 0 0.04402301460504532
using O 0 0.00887297373265028
a O 0 0.011592832393944263
combination O 0 0.01803906075656414
of O 0 0.013960788957774639
validated O 0 0.03737133368849754
scoring O 0 0.03052641451358795
systems O 0 0.05772940069437027
. O 0 0.03971720114350319

HLA O 1 0.9977284073829651
typing O 0 0.13622601330280304
for O 0 0.0341203473508358
HLA O 1 0.999876856803894
- O 1 0.9586501717567444
B27 O 1 0.9877289533615112
, O 0 0.06845716387033463
HLA O 1 0.9998892545700073
- O 1 0.8654797673225403
B60 O 1 0.8055647015571594
, O 0 0.015849154442548752
and O 0 0.02967778593301773
HLA O 1 0.9999926090240479
- O 1 0.9971280694007874
DR1 O 1 0.999652624130249
was O 0 0.024671250954270363
performed O 0 0.012764599174261093
by O 0 0.008860250934958458
polymerase O 0 0.02163064479827881
chain O 0 0.014493366703391075
reaction O 0 0.00852467305958271
with O 0 0.0068819220177829266
sequence O 0 0.009636146016418934
- O 0 0.01485251635313034
specific O 0 0.0088723786175251
primers O 0 0.03038107417523861
, O 0 0.008277174085378647
and O 0 0.010083240456879139
zygosity O 0 0.32542431354522705
was O 0 0.01653815619647503
assessed O 0 0.022383883595466614
using O 0 0.022752411663532257
microsatellite O 1 0.82557612657547
markers O 0 0.06363434344530106
. O 0 0.04481503739953041

Genetic O 0 0.041793543845415115
and O 0 0.018365932628512383
environmental O 0 0.021122440695762634
variance O 0 0.015477504581212997
components O 0 0.014331399463117123
were O 0 0.008126161992549896
assessed O 0 0.009135874919593334
with O 0 0.005919862538576126
the O 0 0.0069889468140900135
program O 0 0.01781015843153
Mx O 1 0.9701859354972839
, O 0 0.006558815483003855
using O 0 0.005731822922825813
data O 0 0.004822860471904278
from O 0 0.004205823410302401
this O 0 0.003972718957811594
and O 0 0.004972431343048811
previous O 0 0.006926252041012049
studies O 0 0.007596787065267563
of O 0 0.009796426631510258
twins O 1 0.6080684661865234
with O 0 0.016888068988919258
AS B-Disease 0 0.2746562361717224
. O 0 0.03935357183218002

RESULTS O 0 0.04083600267767906
Six O 0 0.024233000352978706
of O 0 0.01795966364443302
8 O 0 0.026989882811903954
monozygotic O 1 0.9934333562850952
( O 0 0.28097841143608093
MZ O 1 0.9999887943267822
) O 0 0.02325260080397129
twin O 1 0.6238067150115967
pairs O 0 0.026210233569145203
were O 0 0.01414332166314125
disease O 1 0.9994878768920898
concordant O 1 0.9523358941078186
, O 0 0.0089109493419528
compared O 0 0.008265068754553795
with O 0 0.006658385973423719
4 O 0 0.0087863365188241
of O 0 0.007025300990790129
15 O 0 0.011430945247411728
B27 O 0 0.26081863045692444
- O 0 0.05796357989311218
positive O 0 0.012930680997669697
dizygotic O 1 0.9575329422950745
( O 0 0.0181040670722723
DZ O 1 0.9940620064735413
) O 0 0.013938410207629204
twin O 0 0.024231625720858574
pairs O 0 0.013804974034428596
( O 0 0.01037235464900732
27 O 0 0.01405985839664936
% O 0 0.00874981191009283
) O 0 0.00780285382643342
and O 0 0.007040792610496283
4 O 0 0.010454345494508743
of O 0 0.009640838019549847
32 O 0 0.018095118924975395
DZ O 1 0.9892274141311646
twin O 0 0.16028636693954468
pairs O 0 0.015758400782942772
overall O 0 0.0181781817227602
( O 0 0.012787780724465847
12 O 0 0.01553160510957241
. O 0 0.01386405248194933
5 O 0 0.02377850003540516
% O 0 0.024717500433325768
) O 0 0.03081214614212513
. O 0 0.04736161231994629

Nonsignificant O 1 0.8244532346725464
increases O 0 0.023349573835730553
in O 0 0.01265348307788372
similarity O 0 0.013073381967842579
with O 0 0.007019099313765764
regard O 0 0.007675580680370331
to O 0 0.0063474178314208984
age O 0 0.11671291291713715
at O 1 0.5707034468650818
disease O 1 0.999995231628418
onset O 1 0.9999754428863525
and O 0 0.011017654091119766
all O 0 0.004869954194873571
of O 0 0.01655065454542637
the O 1 0.7934181690216064
disease O 1 0.9999979734420776
severity O 1 0.9998774528503418
scores O 0 0.08061210811138153
assessed O 0 0.029639707878232002
were O 0 0.0067490278743207455
noted O 0 0.01065121404826641
in O 0 0.013581120409071445
disease O 1 0.9997088313102722
- O 1 0.997559666633606
concordant O 1 0.999847412109375
MZ O 1 0.9999986886978149
twins O 1 0.9706906080245972
compared O 0 0.033486880362033844
with O 0 0.030081842094659805
concordant O 1 0.9965080618858337
DZ O 1 0.9998880624771118
twins O 1 0.957718014717102
. O 0 0.06666869670152664

HLA O 1 0.9999591112136841
- O 1 0.9802742600440979
B27 O 1 0.9636006355285645
and O 0 0.016179492697119713
B60 O 1 0.5594046711921692
were O 0 0.008148043416440487
associated O 0 0.007104146759957075
with O 0 0.00649432186037302
the O 0 0.1598435640335083
disease O 1 0.9999865293502808
in O 0 0.24403072893619537
probands O 1 0.9999382495880127
, O 0 0.010184010490775108
and O 0 0.0059611499309539795
the O 0 0.006858497392386198
rate O 0 0.00808878242969513
of O 0 0.014997662976384163
disease O 1 0.9996786117553711
concordance O 1 0.8924075961112976
was O 0 0.09396112710237503
significantly O 0 0.010715663433074951
increased O 0 0.010477669537067413
among O 0 0.010642594657838345
DZ O 1 0.9985896944999695
twin O 0 0.1196693405508995
pairs O 0 0.01064394973218441
in O 0 0.007567566353827715
which O 0 0.006144235841929913
the O 0 0.008195603266358376
co O 1 0.8853697180747986
- O 1 0.9507052898406982
twin O 1 0.8336170315742493
was O 0 0.015818540006875992
positive O 0 0.010760379955172539
for O 0 0.010613859631121159
both O 0 0.015128538943827152
B27 O 1 0.8047086596488953
and O 0 0.03150982782244682
DR1 O 1 0.9820460677146912
. O 0 0.060533322393894196

Additive O 0 0.14570389688014984
genetic O 0 0.038506120443344116
effects O 0 0.02473575994372368
were O 0 0.01176405232399702
estimated O 0 0.011145832017064095
to O 0 0.009557101875543594
contribute O 0 0.013816126622259617
97 O 0 0.02210954576730728
% O 0 0.011785713955760002
of O 0 0.011515787802636623
the O 0 0.013329023495316505
population O 0 0.01666799560189247
variance O 0 0.030538439750671387
. O 0 0.03825075179338455

CONCLUSION O 0 0.07337174564599991
Susceptibility O 1 0.6282047033309937
to O 0 0.0186212956905365
AS B-Disease 0 0.019353797659277916
is O 0 0.00953860953450203
largely O 0 0.00980872381478548
genetically O 0 0.010078747756779194
determined O 0 0.008653560653328896
, O 0 0.005939675495028496
and O 0 0.005463524721562862
the O 0 0.006022285670042038
environmental O 0 0.09787888079881668
trigger O 1 0.7030286192893982
for O 0 0.014713591895997524
the O 1 0.8265562057495117
disease O 1 0.999992847442627
is O 0 0.13000328838825226
probably O 0 0.2311715930700302
ubiquitous O 1 0.8983849883079529
. O 0 0.03882985934615135

HLA O 1 0.9999557733535767
- O 1 0.753423273563385
B27 O 0 0.14993798732757568
accounts O 0 0.021067677065730095
for O 0 0.012586536817252636
a O 0 0.013209476135671139
minority O 0 0.01265292800962925
of O 0 0.010314403101801872
the O 0 0.016828684136271477
overall O 1 0.994186282157898
genetic O 1 0.9739404916763306
susceptibility O 1 0.9987216591835022
to O 0 0.022209733724594116
AS B-Disease 0 0.17935603857040405
. O 0 0.03727736696600914

Cell O 0 0.061520468443632126
cycle O 0 0.04241814464330673
- O 0 0.11424233019351959
dependent O 0 0.025063535198569298
colocalization O 1 0.6679633259773254
of O 0 0.023525843396782875
BARD1 O 1 0.9998699426651001
and O 0 0.17374350130558014
BRCA1 O 1 0.998507559299469
proteins O 0 0.01774279586970806
in O 0 0.016431860625743866
discrete O 0 0.02990286983549595
nuclear O 0 0.036620866507291794
domains O 0 0.05532624572515488
. O 0 0.049710605293512344

Germ O 1 0.9885544180870056
- O 0 0.16608278453350067
line O 0 0.03125531226396561
mutations O 0 0.0197625569999218
of O 0 0.012934108264744282
the O 0 0.015421800315380096
BRCA1 O 1 0.9971265196800232
gene O 0 0.016647210344672203
predispose O 1 0.6081462502479553
women O 0 0.00883878767490387
to O 0 0.007943199947476387
early O 0 0.17840418219566345
- O 1 0.9999654293060303
onset O 1 0.9999998807907104
breast B-Disease 1 1.0
and I-Disease 1 0.9999719858169556
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
by O 0 0.17506881058216095
compromising O 1 0.9993712306022644
the O 1 0.5167422294616699
genes O 0 0.30926448106765747
presumptive O 1 0.999933123588562
function O 0 0.01999271847307682
as O 0 0.017782162874937057
a O 0 0.19475825130939484
tumor B-Disease 1 0.9997357726097107
suppressor O 1 0.992133378982544
. O 0 0.049834124743938446

Although O 0 0.028686819598078728
the O 0 0.02061433158814907
biochemical O 0 0.0341658890247345
properties O 0 0.018429717049002647
of O 0 0.03030761145055294
BRCA1 O 1 0.9998626708984375
polypeptides O 0 0.371276319026947
are O 0 0.006594392936676741
not O 0 0.006591429002583027
understood O 0 0.008737487718462944
, O 0 0.0064033870585262775
their O 0 0.005906123202294111
expression O 0 0.009107434190809727
pattern O 0 0.011929918080568314
and O 0 0.00962726678699255
subcellular O 0 0.02898065559566021
localization O 0 0.023287301883101463
suggest O 0 0.011208651587367058
a O 0 0.00926242396235466
role O 0 0.010489357635378838
in O 0 0.01142260804772377
cell O 0 0.04056890308856964
- O 0 0.2587735950946808
cycle O 0 0.032093871384859085
regulation O 0 0.03477348014712334
. O 0 0.036549121141433716

When O 0 0.05887371301651001
resting O 1 0.9151583909988403
cells O 0 0.020961206406354904
are O 0 0.008803732693195343
induced O 0 0.41557663679122925
to O 0 0.010186408646404743
proliferate O 0 0.0273752324283123
, O 0 0.007392912171781063
the O 0 0.006886431016027927
steady O 0 0.012015975080430508
- O 0 0.011483044363558292
state O 0 0.007046034559607506
levels O 0 0.007401559967547655
of O 0 0.007926429621875286
BRCA1 O 1 0.5631726980209351
increase O 0 0.007238086778670549
in O 0 0.007571491878479719
late O 0 0.012989158742129803
G1 O 1 0.9184240698814392
and O 0 0.008992131799459457
reach O 0 0.012496729381382465
a O 0 0.011309530586004257
maximum O 0 0.01563572883605957
during O 0 0.022461608052253723
S O 0 0.4058437943458557
phase O 0 0.05681701749563217
. O 0 0.04894702136516571

Moreover O 0 0.04290076717734337
, O 0 0.0205120500177145
in O 0 0.015207361429929733
S O 1 0.8570083975791931
phase O 1 0.5509398579597473
cells O 0 0.041193265467882156
, O 0 0.016950981691479683
BRCA1 O 1 0.9719995856285095
polypeptides O 0 0.030797716230154037
are O 0 0.01018911600112915
hyperphosphorylated O 0 0.1392574906349182
and O 0 0.011828080751001835
accumulate O 0 0.01781270280480385
into O 0 0.014313720166683197
discrete O 0 0.02797893062233925
subnuclear O 1 0.9934757351875305
foci O 1 0.9903083443641663
termed O 1 0.7900428175926208
" O 0 0.052081864327192307
BRCA1 O 1 0.9954699277877808
nuclear O 0 0.07314543426036835
dots O 0 0.1468077450990677
. O 0 0.05513826385140419

" O 0 0.07332763075828552
BRCA1 O 1 0.9982010126113892
associates O 0 0.4229278266429901
in O 0 0.01899162493646145
vivo O 0 0.09795738011598587
with O 0 0.016497740522027016
a O 0 0.03144978731870651
structurally O 1 0.8788740634918213
related O 0 0.07822699844837189
protein O 0 0.042872942984104156
termed O 0 0.4658515453338623
BARD1 O 1 0.9953331351280212
. O 0 0.06376735121011734

Here O 0 0.03300158306956291
we O 0 0.01760292239487171
show O 0 0.014291885308921337
that O 0 0.008456302806735039
the O 0 0.008788840845227242
steady O 0 0.012625698931515217
- O 0 0.010836165398359299
state O 0 0.006610919255763292
levels O 0 0.00688875000923872
of O 0 0.007441896479576826
BARD1 O 1 0.9899739027023315
, O 0 0.007920212112367153
unlike O 0 0.008168759755790234
those O 0 0.006125390529632568
of O 0 0.010441075079143047
BRCA1 O 1 0.9987360835075378
, O 0 0.009949646890163422
remain O 0 0.010728965513408184
relatively O 0 0.012488658539950848
constant O 0 0.018758932128548622
during O 0 0.02363503724336624
cell O 0 0.04768236353993416
cycle O 0 0.052303746342659
progression O 0 0.2811793386936188
. O 0 0.05143202841281891

However O 0 0.03976205363869667
, O 0 0.03050347790122032
immunostaining O 0 0.16552256047725677
revealed O 0 0.025103064253926277
that O 0 0.014063997194170952
BARD1 O 1 0.9849531054496765
resides O 0 0.05003217235207558
within O 0 0.012935539707541466
BRCA1 O 1 0.9893955588340759
nuclear O 0 0.017653755843639374
dots O 0 0.047640737146139145
during O 0 0.012018200010061264
S O 0 0.26933884620666504
phase O 0 0.014581426978111267
of O 0 0.007635579910129309
the O 0 0.00900757685303688
cell O 0 0.03168061375617981
cycle O 0 0.011195247061550617
, O 0 0.0069909957237541676
but O 0 0.006576873362064362
not O 0 0.006735935807228088
during O 0 0.011116774752736092
the O 0 0.018041828647255898
G1 O 1 0.9957091808319092
phase O 0 0.06189536675810814
. O 0 0.05265127867460251

Nevertheless O 0 0.11062198132276535
, O 0 0.033643849194049835
BARD1 O 1 0.9654903411865234
polypeptides O 0 0.040231626480817795
are O 0 0.011434740386903286
found O 0 0.009477011859416962
exclusively O 0 0.01151422131806612
in O 0 0.008038623258471489
the O 0 0.00819476693868637
nuclear O 0 0.011150115169584751
fractions O 0 0.013186188414692879
of O 0 0.008306503295898438
both O 0 0.009953047148883343
G1 O 1 0.9988576173782349
- O 1 0.6768989562988281
and O 0 0.019644983112812042
S O 1 0.9880495667457581
- O 1 0.8575786352157593
phase O 0 0.1925743967294693
cells O 0 0.03819350153207779
. O 0 0.04373291879892349

Therefore O 0 0.03471145033836365
, O 0 0.02218683250248432
progression O 0 0.20898042619228363
to O 0 0.013752806931734085
S O 1 0.9008195996284485
phase O 0 0.029149195179343224
is O 0 0.01012189406901598
accompanied O 0 0.014498244971036911
by O 0 0.008150309324264526
the O 0 0.009478350169956684
aggregation O 0 0.017058424651622772
of O 0 0.012394835241138935
nuclear O 0 0.024786988273262978
BARD1 O 1 0.979904055595398
polypeptides O 0 0.056438617408275604
into O 0 0.02938038855791092
BRCA1 O 1 0.938635528087616
nuclear O 0 0.05123923718929291
dots O 0 0.07683941721916199
. O 0 0.05213227868080139

This O 0 0.03099927306175232
cell O 0 0.03238445520401001
cycle O 0 0.02789430133998394
- O 0 0.09376722574234009
dependent O 0 0.01834294945001602
colocalization O 1 0.8392518758773804
of O 0 0.01949683576822281
BARD1 O 1 0.99986732006073
and O 0 0.09973184019327164
BRCA1 O 1 0.9962601661682129
indicates O 0 0.016948606818914413
a O 0 0.011125695891678333
role O 0 0.013571517542004585
for O 0 0.012663381174206734
BARD1 O 1 0.9958429932594299
in O 0 0.05919912829995155
BRCA1 O 1 0.9999550580978394
- O 1 0.9995501637458801
mediated O 1 0.9997796416282654
tumor B-Disease 1 0.9999898672103882
suppression O 1 0.9996761083602905
. O 0 0.08401615917682648

Ethnic O 0 0.0510852113366127
differences O 0 0.03058447502553463
in O 0 0.02404184639453888
the O 0 0.025196390226483345
HFE O 1 0.9991220831871033
codon O 0 0.1491096466779709
282 O 1 0.9726911187171936
( O 0 0.37879252433776855
Cys O 1 0.9999388456344604
/ O 1 0.9982951283454895
Tyr O 1 0.9997757077217102
) O 0 0.05711868032813072
polymorphism O 0 0.10109075158834457
. O 0 0.07201448082923889

Recent O 0 0.029385024681687355
studies O 0 0.017849331721663475
have O 0 0.011101552285254002
shown O 0 0.013358579017221928
that O 0 0.03971921280026436
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999986886978149
HH B-Disease 1 1.0
) O 0 0.4126656651496887
is O 0 0.009665112011134624
likely O 0 0.008292225189507008
to O 0 0.006879211403429508
be O 0 0.005884964484721422
caused O 0 0.0090674152597785
by O 0 0.006518933922052383
homozygosity O 0 0.170418381690979
for O 0 0.007918012328445911
a O 0 0.012909931130707264
Cys282Tyr O 1 0.9348971843719482
mutation O 0 0.015026994049549103
in O 0 0.011296053417026997
the O 0 0.018277226015925407
HFE O 1 0.998863935470581
gene O 0 0.025669800117611885
located O 0 0.03383007273077965
4 O 0 0.04057139530777931
. O 0 0.04988795891404152

5 O 0 0.08245528489351273
Mb O 1 0.9003626108169556
telomeric O 1 0.9512448906898499
to O 0 0.055714692920446396
HLA O 1 0.9999427795410156
- O 1 0.842800498008728
A O 0 0.14357146620750427
. O 0 0.057879120111465454

Population O 0 0.027687042951583862
studies O 0 0.018743161112070084
of O 0 0.011281847953796387
this O 0 0.009702738374471664
polymorphism O 0 0.017204323783516884
are O 0 0.005744853988289833
facilitated O 0 0.011617575772106647
by O 0 0.006370010785758495
the O 0 0.006612823344767094
fact O 0 0.007189793977886438
that O 0 0.006742262281477451
the O 0 0.011147071607410908
Cys282Tyr O 1 0.9966727495193481
mutation O 0 0.07305704057216644
creates O 0 0.048887211829423904
a O 0 0.025015242397785187
Rsal O 1 0.9275526404380798
restriction O 0 0.04273618012666702
site O 0 0.05287587270140648
. O 0 0.05005712807178497

We O 0 0.031433966010808945
have O 0 0.018858645111322403
studied O 0 0.02035631239414215
the O 0 0.014501990750432014
codon O 0 0.028450487181544304
282 O 1 0.6669201850891113
( O 0 0.21357625722885132
Cys O 1 0.9999542236328125
/ O 1 0.99623042345047
Tyr O 1 0.9997319579124451
) O 0 0.02332448773086071
polymorphism O 0 0.028324520215392113
in O 0 0.01772337779402733
different O 0 0.0140485605224967
ethnic O 0 0.02282360941171646
groups O 0 0.025149350985884666
. O 0 0.03886609151959419

In O 0 0.027119847014546394
agreement O 0 0.020736567676067352
with O 0 0.01179403718560934
previous O 0 0.012607213109731674
observations O 0 0.01605949178338051
the O 0 0.016237858682870865
Tyr O 1 0.9999358654022217
allele O 0 0.04836871102452278
appeared O 0 0.012078709900379181
to O 0 0.007477179169654846
be O 0 0.005954073742032051
rare O 0 0.009800474159419537
or O 0 0.006574213970452547
absent O 0 0.019157884642481804
in O 0 0.009550021961331367
Asiatic O 1 0.9929928779602051
( O 0 0.013520860113203526
Indian O 0 0.016836466267704964
, O 0 0.015061333775520325
Chinese O 0 0.020345525816082954
) O 0 0.01963474415242672
populations O 0 0.023699143901467323
. O 0 0.03637115657329559

The O 0 0.03669460490345955
highest O 0 0.03270883858203888
allele O 0 0.02474006824195385
frequency O 0 0.01624017395079136
( O 0 0.012775426730513573
7 O 0 0.014980146661400795
. O 0 0.009433598257601261
5 O 0 0.012256990186870098
% O 0 0.010117939673364162
) O 0 0.011170949786901474
was O 0 0.0155099518597126
found O 0 0.014336732216179371
in O 0 0.019116273149847984
Swedes O 0 0.054416488856077194
. O 0 0.03974306210875511

Saamis O 1 0.7204504609107971
( O 0 0.025784794241189957
2 O 0 0.022054744884371758
% O 0 0.012866629287600517
) O 0 0.011219944804906845
and O 0 0.009923686273396015
Mordvinians O 0 0.08828490972518921
( O 0 0.009150173515081406
1 O 0 0.010460924357175827
. O 0 0.0072141713462769985
8 O 0 0.01040401216596365
% O 0 0.0087229423224926
) O 0 0.008166315034031868
had O 0 0.00991147942841053
significantly O 0 0.011589876376092434
lower O 0 0.013418605551123619
frequencies O 0 0.01453754585236311
of O 0 0.016427407041192055
the O 0 0.025450555607676506
Tyr O 1 0.9991768002510071
allele O 0 0.1585828810930252
. O 0 0.05220284312963486

Comparisons O 0 0.04350809007883072
with O 0 0.02061581425368786
allele O 0 0.024890469387173653
frequencies O 0 0.015639375895261765
based O 0 0.013013566844165325
on O 0 0.011413329280912876
prevalence O 0 0.22449269890785217
estimates O 0 0.012327255681157112
of O 0 0.015400371514260769
HH B-Disease 1 0.9999957084655762
showed O 0 0.016745606437325478
some O 0 0.00672660069540143
disagreements O 0 0.014813614077866077
with O 0 0.007971450686454773
the O 0 0.011118216440081596
RFLP O 1 0.643829345703125
data O 0 0.013054954819381237
, O 0 0.013210650533437729
particularly O 0 0.017493920400738716
in O 0 0.02008659392595291
Finns O 0 0.27039217948913574
. O 0 0.041399624198675156

The O 0 0.04112536460161209
newly O 0 0.1360219568014145
described O 0 0.09612350165843964
HFE O 1 0.9999440908432007
marker O 0 0.4709617793560028
provides O 0 0.01695120520889759
a O 0 0.009921123273670673
new O 0 0.007830411195755005
approach O 0 0.00721212662756443
to O 0 0.005850609857589006
the O 0 0.006126325111836195
screening O 0 0.012850843369960785
of O 0 0.016611840575933456
HH B-Disease 1 0.9999983310699463
as O 0 0.007139276247471571
well O 0 0.006294464226812124
as O 0 0.005703356582671404
studies O 0 0.0057230680249631405
of O 0 0.005931966006755829
the O 0 0.0068395198322832584
relationship O 0 0.009188566356897354
between O 0 0.008340304717421532
the O 0 0.01712094619870186
HFE O 1 0.9999938011169434
Tyr O 1 0.9999966621398926
allele O 1 0.884150505065918
and O 0 0.027958480641245842
different O 0 0.020119845867156982
disorders O 1 0.9999942779541016
including O 1 0.9743043184280396
cancer B-Disease 1 0.9999990463256836

Autosomal B-Disease 1 0.9999860525131226
dominant I-Disease 1 0.9999891519546509
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
associated O 0 0.22615619003772736
with O 0 0.01685134321451187
a O 0 0.02512112818658352
missense O 1 0.5713067054748535
mutation O 0 0.03229464218020439
encoding O 0 0.023075222969055176
Gly23 O 1 0.9984742999076843
- O 1 0.9926764965057373
- O 1 0.993409276008606
> O 1 0.9760962128639221
Val O 1 0.9817635416984558
in O 0 0.031341347843408585
neurophysin O 1 0.9788960814476013
II O 1 0.9865747094154358
. O 0 0.06217478960752487

Autosomal B-Disease 1 0.9999467134475708
dominant I-Disease 1 0.9999585151672363
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9998812675476074
ADNDI B-Disease 1 0.9999995231628418
) O 0 0.15576986968517303
is O 0 0.09468544274568558
an O 1 0.9929702877998352
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999912977218628
by O 1 0.9765433669090271
progressive O 1 0.9999997615814209
degeneration O 1 1.0
of O 1 0.9894098043441772
the O 1 0.9970331192016602
magnocellular O 1 0.9999991655349731
neurons O 1 0.8928217887878418
of O 0 0.013920464552938938
the O 0 0.03266591578722
hypothalamus O 1 0.963674783706665
leading O 0 0.20228436589241028
to O 0 0.009292135015130043
decreased O 0 0.016852330416440964
ability O 0 0.009324101731181145
to O 0 0.00889440719038248
produce O 0 0.012595346197485924
the O 0 0.014785658568143845
hormone O 1 0.6615085005760193
arginine O 0 0.3140158951282501
vasopressin O 1 0.9463142156600952
( O 0 0.05661535635590553
AVP O 1 0.9941591024398804
) O 0 0.04570868983864784
. O 0 0.062408559024333954

Affected O 0 0.03880443051457405
individuals O 0 0.014562968164682388
are O 0 0.0089047159999609
not O 0 0.008770843036472797
symptomatic O 1 0.9998862743377686
at O 0 0.0719727948307991
birth O 0 0.3371729850769043
, O 0 0.009154952131211758
but O 0 0.007374947890639305
usually O 0 0.010094907134771347
develop O 1 0.9577561616897583
diabetes B-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.9999984502792358
at O 0 0.17433977127075195
1 O 0 0.12380111217498779
- O 1 0.7921375036239624
6 O 0 0.03904392570257187
yr O 1 0.9556840062141418
of O 0 0.026466719806194305
age O 0 0.039700593799352646
. O 0 0.046043649315834045

The O 0 0.03205225244164467
genetic O 0 0.02434956468641758
locus O 0 0.14237231016159058
of O 0 0.014546738006174564
the O 0 0.13897252082824707
disease O 1 0.9998986721038818
is O 0 0.013690879568457603
the O 0 0.2237321138381958
AVP O 1 0.9999990463256836
- O 1 0.9998273849487305
neurophysin O 1 0.9999856948852539
II O 1 0.9999955892562866
( O 0 0.22631461918354034
NPII O 1 0.9986718893051147
) O 0 0.010403207503259182
gene O 0 0.008443525992333889
, O 0 0.007746958639472723
and O 0 0.006705498322844505
mutations O 0 0.006985205691307783
that O 0 0.005148628260940313
cause O 1 0.7320806384086609
ADNDI B-Disease 1 0.9981837868690491
have O 0 0.005821394268423319
been O 0 0.004876463674008846
found O 0 0.004537682048976421
in O 0 0.0041871280409395695
both O 0 0.004575737752020359
the O 0 0.005896429531276226
signal O 0 0.008736224845051765
peptide O 0 0.01066602673381567
of O 0 0.007657460402697325
the O 0 0.011000058613717556
prepro O 1 0.9988995790481567
- O 1 0.9984911680221558
AVP O 1 0.9999852180480957
- O 1 0.9906294941902161
NPII O 1 0.9983142614364624
precursor O 0 0.10746016353368759
and O 0 0.021361295133829117
within O 0 0.025768863037228584
NPII O 1 0.9823692440986633
itself O 0 0.05074804648756981
. O 0 0.04215945675969124

An O 0 0.035106901079416275
affected O 0 0.03076387196779251
girl O 0 0.04677034169435501
who O 0 0.013449067249894142
presented O 0 0.013332949951291084
at O 0 0.008239654824137688
9 O 0 0.009420550428330898
months O 0 0.0069501870311796665
of O 0 0.006181121803820133
age O 0 0.007972660474479198
and O 0 0.00619613379240036
her O 0 0.017656179144978523
similarly O 0 0.09150990843772888
affected O 0 0.19259865581989288
younger O 1 0.5266211032867432
brother O 0 0.16816940903663635
and O 0 0.008285216987133026
father O 0 0.013675049878656864
were O 0 0.004393806215375662
all O 0 0.004303412977606058
found O 0 0.004545298404991627
to O 0 0.004490377381443977
have O 0 0.004579642321914434
a O 0 0.007143806200474501
novel O 0 0.01254888903349638
missense O 0 0.021685922518372536
mutation O 0 0.012192638590931892
( O 0 0.011109261773526669
G1758 O 1 0.8756621479988098
- O 1 0.9225306510925293
- O 1 0.9643509984016418
> O 1 0.9531311392784119
T O 1 0.5674519538879395
) O 0 0.011556067503988743
encoding O 0 0.01420652400702238
the O 0 0.013028726913034916
amino O 0 0.015524253249168396
acid O 0 0.020263085141777992
substitution O 0 0.027243852615356445
Gly23 O 1 0.871814489364624
- O 1 0.8176084756851196
- O 1 0.8730208873748779
> O 1 0.8411715030670166
Val O 1 0.8309472799301147
within O 0 0.0466773621737957
NPII O 1 0.9234859943389893
. O 0 0.0695984736084938

The O 0 0.0495140366256237
mutation O 0 0.04388192296028137
was O 0 0.031874485313892365
confirmed O 0 0.028359537944197655
by O 0 0.023488041013479233
restriction O 0 0.040409088134765625
endonuclease O 1 0.506973147392273
analysis O 0 0.048618417233228683
. O 0 0.05487535521388054

A O 0 0.1070629134774208
T1 O 1 0.9980023503303528
- O 0 0.09694290161132812
weighted O 0 0.03237217664718628
magnetic O 0 0.030389942228794098
resonance O 0 0.028930319473147392
imaging O 0 0.03431634604930878
of O 0 0.0179673433303833
the O 0 0.022585604339838028
fathers O 1 0.9473996162414551
pituitary O 1 0.9999955892562866
gland O 1 0.9999756813049316
demonstrates O 1 0.9927176237106323
an O 1 0.873401403427124
attenuated O 1 0.9999909400939941
posterior O 1 0.9999878406524658
pituitary O 1 0.999997615814209
bright O 1 0.9995123147964478
spot O 1 0.9304203987121582
. O 0 0.05627726763486862

This O 0 0.02874327450990677
mutation O 0 0.027165541425347328
may O 0 0.01379893347620964
be O 0 0.009274364449083805
valuable O 0 0.012993005104362965
for O 0 0.007760502863675356
developing O 0 0.011425774544477463
models O 0 0.014580851420760155
of O 0 0.024486597627401352
dominantly B-Disease 1 0.9999918937683105
inherited I-Disease 1 0.9999996423721313
neurodegeneration I-Disease 1 1.0
, O 0 0.0424623042345047
as O 0 0.006325914990156889
the O 0 0.005476785823702812
early O 0 0.006572899408638477
age O 0 0.008488091640174389
of O 0 0.02614436112344265
onset O 1 0.999995231628418
of O 1 0.9927802681922913
symptoms O 1 0.9999992847442627
suggests O 1 0.6560279130935669
that O 0 0.006442728452384472
this O 0 0.00641711475327611
mutation O 0 0.016648216173052788
may O 0 0.0068740337155759335
be O 0 0.006298210937529802
particularly O 0 0.009505081921815872
deleterious O 0 0.029717588797211647
to O 0 0.011691979132592678
the O 0 0.02097034826874733
magnocellular O 1 0.9995600581169128
neuron O 1 0.9848988652229309
. O 0 0.0297834612429142
. O 0 0.04358050972223282

Frequent O 0 0.0797760859131813
inactivation O 1 0.9785283207893372
of O 0 0.303898423910141
PTEN O 1 0.999990701675415
/ O 1 0.9996364116668701
MMAC1 O 1 0.9999438524246216
in O 1 0.8222616314888
primary O 1 0.9999088048934937
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 1 0.7155616283416748

Sporadic B-Disease 1 0.9999046325683594
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.1674283891916275
the O 0 0.11726527661085129
most O 0 0.07938588410615921
common O 1 0.9067044258117676
male B-Disease 1 0.9979109168052673
cancer I-Disease 1 0.9999868869781494
in O 0 0.0087199741974473
the O 0 0.009307448752224445
Western O 0 0.01343375165015459
world O 0 0.037404704838991165
, O 0 0.0060975681990385056
yet O 0 0.005689380224794149
many O 0 0.0035848026163876057
of O 0 0.003912362270057201
the O 0 0.004979910794645548
major O 0 0.007848372682929039
genetic O 0 0.006346338428556919
events O 0 0.005011996254324913
involved O 0 0.0050103371031582355
in O 0 0.0045689865946769714
the O 0 0.005132779479026794
progression O 0 0.10455747693777084
of O 0 0.006042995024472475
this O 0 0.00719018280506134
often O 0 0.22430923581123352
fatal O 1 0.9999791383743286
cancer B-Disease 1 0.9999849796295166
remain O 0 0.03265036642551422
to O 0 0.015073081478476524
be O 0 0.02010529860854149
elucidated O 0 0.4063434898853302
. O 0 0.044369038194417953

Numerous O 0 0.05372980609536171
cytogenetic O 1 0.8865259289741516
and O 0 0.02578231319785118
allelotype O 1 0.8718541860580444
studies O 0 0.013617530465126038
have O 0 0.008558286353945732
reported O 0 0.010510968044400215
frequent O 0 0.012737053446471691
loss O 0 0.14317575097084045
of O 0 0.01389332115650177
heterozygosity O 1 0.9987940788269043
on O 0 0.01722421869635582
chromosomal O 1 0.9909432530403137
arm O 1 0.9994848966598511
10q O 1 0.9994331002235413
in O 1 0.7170920372009277
sporadic B-Disease 1 0.9999600648880005
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.6854573488235474

Deletion O 0 0.11764685064554214
mapping O 0 0.042492229491472244
studies O 0 0.022363055497407913
have O 0 0.012634944170713425
unambiguously O 0 0.02254001423716545
identified O 0 0.010784943588078022
a O 0 0.008370306342840195
region O 0 0.010441942140460014
of O 0 0.010759984143078327
chromosome O 0 0.2989776134490967
10q23 O 1 0.6591036915779114
to O 0 0.006945975124835968
be O 0 0.005897701717913151
the O 0 0.008437316864728928
minimal O 0 0.015253134071826935
area O 0 0.01362297497689724
of O 0 0.016266226768493652
loss O 0 0.29275745153427124
. O 0 0.03397127985954285

A O 0 0.04096613824367523
new O 0 0.03449297323822975
tumor B-Disease 1 0.9988541603088379
suppressor O 1 0.9933203458786011
gene O 0 0.0573674701154232
, O 0 0.10486717522144318
PTEN O 1 0.9999840259552002
/ O 1 0.9980307221412659
MMAC1 O 1 0.9991214871406555
, O 0 0.013403603807091713
was O 0 0.01417075376957655
isolated O 0 0.012563569471240044
recently O 0 0.010752682574093342
at O 0 0.008386963047087193
this O 0 0.005638007074594498
region O 0 0.00767600117251277
of O 0 0.007318516261875629
chromosome O 0 0.04553402587771416
10q23 O 0 0.33648693561553955
and O 0 0.006477483548223972
found O 0 0.005462275817990303
to O 0 0.005505395587533712
be O 0 0.005626531317830086
inactivated O 0 0.023465007543563843
by O 0 0.006506060715764761
mutation O 0 0.009686519391834736
in O 0 0.009164208546280861
three O 1 0.6554009914398193
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 1 0.9966456294059753
lines O 0 0.19985221326351166
. O 0 0.038755644112825394

We O 0 0.03805604949593544
screened O 0 0.19687186181545258
80 O 1 0.9158104658126831
prostate B-Disease 1 0.9999996423721313
tumors I-Disease 1 0.999930739402771
by O 0 0.013751992024481297
microsatellite O 1 0.981461226940155
analysis O 0 0.013161255978047848
and O 0 0.010585149750113487
found O 0 0.01097139809280634
chromosome O 0 0.01826508343219757
10q23 O 0 0.03190638870000839
to O 0 0.010819004848599434
be O 0 0.010237193666398525
deleted O 0 0.01952880248427391
in O 0 0.015120228752493858
23 O 0 0.029885170981287956
cases O 0 0.02867567539215088
. O 0 0.03967761993408203

We O 0 0.028392592445015907
then O 0 0.021767806261777878
proceeded O 0 0.027781207114458084
with O 0 0.010895001702010632
sequence O 0 0.00994022749364376
analysis O 0 0.009548303671181202
of O 0 0.009292393922805786
the O 0 0.010383467189967632
entire O 0 0.1505099982023239
PTEN O 1 0.9999768733978271
/ O 1 0.9962871074676514
MMAC1 O 1 0.9987053871154785
coding O 0 0.03972945362329483
region O 0 0.015724020078778267
and O 0 0.010638408362865448
tested O 0 0.014603176154196262
for O 0 0.009013368748128414
homozygous O 0 0.016837317496538162
deletion O 0 0.016372624784708023
with O 0 0.00826253555715084
new O 0 0.01099051721394062
intragenic O 1 0.5926480889320374
markers O 0 0.013687469996511936
in O 0 0.007775126490741968
these O 0 0.006620910484343767
23 O 0 0.011917520314455032
cases O 0 0.010262571275234222
with O 0 0.011965053156018257
10q23 O 1 0.9425272941589355
loss O 1 0.576572060585022
of O 0 0.03738076984882355
heterozygosity O 1 0.9981379508972168
. O 0 0.05082210898399353

The O 0 0.034664325416088104
identification O 0 0.023497534915804863
of O 0 0.014673717319965363
the O 0 0.012820398434996605
second O 0 0.03024376928806305
mutational O 1 0.9807125329971313
event O 0 0.01592371053993702
in O 0 0.007977750152349472
10 O 0 0.009108586236834526
( O 0 0.00942890252918005
43 O 0 0.016552679240703583
% O 0 0.012484065257012844
) O 0 0.016805002465844154
tumors B-Disease 1 0.9951569437980652
establishes O 1 0.9888851642608643
PTEN O 1 0.9999842643737793
/ O 1 0.9962211847305298
MMAC1 O 1 0.9773001670837402
as O 0 0.013462790288031101
a O 0 0.013264566659927368
main O 0 0.01554742269217968
inactivation O 0 0.05307752639055252
target O 0 0.013220631517469883
of O 0 0.011388499289751053
10q O 1 0.6694373488426208
loss O 1 0.7754361629486084
in O 1 0.504911482334137
sporadic B-Disease 1 0.9999901056289673
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.5557515025138855
. O 0 0.04407991096377373

Risk O 0 0.10943333804607391
reversals O 0 0.11409185826778412
in O 0 0.027172142639756203
predictive O 0 0.33079543709754944
testing O 1 0.697511613368988
for O 1 0.9420103430747986
Huntington B-Disease 1 0.9999990463256836
disease I-Disease 1 0.9999992847442627
. O 0 0.39199957251548767

The O 0 0.026532534509897232
first O 0 0.019561897963285446
predictive O 0 0.02856016717851162
testing O 0 0.04528859257698059
for O 1 0.8111916780471802
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
( O 1 0.982393741607666
HD B-Disease 1 0.9948796033859253
) O 0 0.010260138660669327
was O 0 0.009720610454678535
based O 0 0.008317540399730206
on O 0 0.007315672468394041
analysis O 0 0.008661209605634212
of O 0 0.008686380460858345
linked O 0 0.012342928908765316
polymorphic O 0 0.029795899987220764
DNA O 0 0.01105518452823162
markers O 0 0.011754738166928291
to O 0 0.007796828635036945
estimate O 0 0.01191383134573698
the O 0 0.009870363399386406
likelihood O 0 0.014247511513531208
of O 0 0.01171453669667244
inheriting O 1 0.6123716235160828
the O 0 0.019365523010492325
mutation O 0 0.04914117977023125
for O 0 0.02242039330303669
HD B-Disease 1 0.7367551922798157
. O 0 0.05378607288002968

Limits O 0 0.03997379541397095
to O 0 0.01958591863512993
accuracy O 0 0.02329757623374462
included O 0 0.017357634380459785
recombination O 0 0.0184110589325428
between O 0 0.010013353079557419
the O 0 0.009606956504285336
DNA O 0 0.01057382021099329
markers O 0 0.011598514392971992
and O 0 0.0070200334303081036
the O 0 0.007885901257395744
mutation O 0 0.012148509733378887
, O 0 0.00856529176235199
pedigree O 0 0.2470695674419403
structure O 0 0.008808581158518791
, O 0 0.006023775786161423
and O 0 0.005580623634159565
whether O 0 0.005902305245399475
DNA O 0 0.006713388953357935
samples O 0 0.006974385119974613
were O 0 0.005582979414612055
available O 0 0.007758979219943285
from O 0 0.0097904521971941
family O 0 0.017906304448843002
members O 0 0.02065717615187168
. O 0 0.03408759459853172

With O 0 0.024700498208403587
direct O 0 0.019057029858231544
tests O 0 0.013175079599022865
for O 0 0.01020562369376421
the O 0 0.01181668322533369
HD B-Disease 1 0.982768714427948
mutation O 0 0.01890709064900875
, O 0 0.006672798190265894
we O 0 0.005469899624586105
have O 0 0.00459531182423234
assessed O 0 0.008039060980081558
the O 0 0.005714863073080778
accuracy O 0 0.008249730803072453
of O 0 0.005446977447718382
results O 0 0.006171559449285269
obtained O 0 0.006751183420419693
by O 0 0.005360669456422329
linkage O 0 0.015148857608437538
approaches O 0 0.011333051137626171
when O 0 0.007087533362209797
requested O 0 0.009260975755751133
to O 0 0.006982337683439255
do O 0 0.0061690062284469604
so O 0 0.0070953830145299435
by O 0 0.007979187183082104
the O 0 0.011848440393805504
test O 0 0.019779250025749207
individuals O 0 0.02095222845673561
. O 0 0.03467893600463867

For O 0 0.026027731597423553
six O 0 0.01779341883957386
such O 0 0.010641892440617085
individuals O 0 0.008577347733080387
, O 0 0.008588518016040325
there O 0 0.007275664713233709
was O 0 0.012657993473112583
significant O 0 0.011908595450222492
disparity O 0 0.08967222273349762
between O 0 0.01332430075854063
the O 0 0.01803843304514885
tests O 0 0.027550039812922478
. O 0 0.0370447002351284

Three O 0 0.02326284907758236
went O 0 0.01975308731198311
from O 0 0.011725705116987228
a O 0 0.011606262065470219
decreased O 0 0.07617184519767761
risk O 0 0.010754651390016079
to O 0 0.005856142845004797
an O 0 0.006293074693530798
increased O 0 0.014831014908850193
risk O 0 0.06968262791633606
, O 0 0.005598461255431175
while O 0 0.004935319069772959
in O 0 0.004858341533690691
another O 0 0.006612218450754881
three O 0 0.006646516267210245
the O 0 0.010753296315670013
risk O 0 0.4077150523662567
was O 0 0.324640691280365
decreased O 0 0.3652666211128235
. O 0 0.03493047505617142

Knowledge O 0 0.03559122979640961
of O 0 0.016978200525045395
the O 0 0.013262737542390823
potential O 0 0.012495540082454681
reasons O 0 0.00814126804471016
for O 0 0.00586926843971014
these O 0 0.004593560937792063
changes O 0 0.004830221179872751
in O 0 0.004482469521462917
results O 0 0.004752961918711662
and O 0 0.0040700542740523815
impact O 0 0.0052483282051980495
of O 0 0.004621862433850765
these O 0 0.004672769922763109
risk O 0 0.044483549892902374
reversals O 1 0.6089397072792053
on O 0 0.0064493585377931595
both O 0 0.00647389329969883
patients O 0 0.41590288281440735
and O 0 0.0062021235935389996
the O 0 0.007397511973977089
counseling O 1 0.9097350835800171
team O 0 0.01317845843732357
can O 0 0.00492669316008687
assist O 0 0.007933174259960651
in O 0 0.004553406964987516
the O 0 0.005220589227974415
development O 0 0.006330497097223997
of O 0 0.005701623857021332
strategies O 0 0.008190249092876911
for O 0 0.005590563639998436
the O 0 0.008456879295408726
prevention O 1 0.995858371257782
and O 0 0.008043228648602962
, O 0 0.005765038542449474
where O 0 0.005601889453828335
necessary O 0 0.006922970060259104
, O 0 0.006136384326964617
management O 0 0.008014556020498276
of O 0 0.006400575395673513
a O 0 0.009859742596745491
risk O 0 0.1981518417596817
reversal O 0 0.047731295228004456
in O 0 0.007396653760224581
any O 0 0.008928254246711731
predictive O 0 0.07384976744651794
testing O 0 0.020884040743112564
program O 0 0.02407882921397686
. O 0 0.026244331151247025
. O 0 0.03838095813989639

A O 0 0.060581039637327194
novel O 0 0.05220266804099083
common O 0 0.02913433313369751
missense O 0 0.05937943607568741
mutation O 0 0.025313127785921097
G301C O 0 0.04945332184433937
in O 0 0.011821233667433262
the O 0 0.012087373062968254
N O 0 0.02705216407775879
- O 0 0.2866838276386261
acetylgalactosamine O 1 0.9753251671791077
- O 1 0.8744908571243286
6 O 0 0.24020475149154663
- O 1 0.9770652055740356
sulfate O 1 0.9992965459823608
sulfatase O 1 0.9998059868812561
gene O 0 0.037452373653650284
in O 0 0.038110971450805664
mucopolysaccharidosis B-Disease 1 0.9960158467292786
IVA I-Disease 1 0.9998452663421631
. O 0 0.07986558228731155

Mucopolysaccharidosis B-Disease 1 0.9997653365135193
IVA I-Disease 1 0.9999945163726807
( O 1 0.6239709854125977
MPS B-Disease 1 0.9971123933792114
IVA I-Disease 1 0.9999978542327881
) O 0 0.02283329889178276
is O 0 0.01640915870666504
an O 0 0.29149580001831055
autosomal B-Disease 1 0.9999985694885254
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 1.0
storage I-Disease 1 0.9999991655349731
disorder I-Disease 1 1.0
caused O 1 0.9980409741401672
by O 0 0.01885427162051201
a O 1 0.6151840686798096
genetic B-Disease 1 0.9931535720825195
defect I-Disease 1 0.9998188614845276
in O 0 0.03514661639928818
N O 0 0.40748152136802673
- O 1 0.8943684101104736
acetylgalactosamine O 1 0.9862599968910217
- O 1 0.8858150839805603
6 O 0 0.28754279017448425
- O 1 0.9879911541938782
sulfate O 1 0.9998056292533875
sulfatase O 1 0.9999029636383057
( O 0 0.2861696481704712
GALNS O 1 0.997825562953949
) O 0 0.050826869904994965
. O 0 0.05516711622476578

In O 0 0.02455074153840542
previous O 0 0.01862218976020813
studies O 0 0.012939989566802979
, O 0 0.00945527758449316
we O 0 0.0071150390431284904
have O 0 0.005273063667118549
found O 0 0.005954745691269636
two O 0 0.00593362795189023
common O 0 0.0076698437333106995
mutations O 0 0.009135076776146889
in O 0 0.009637092240154743
Caucasians O 1 0.9627419114112854
and O 0 0.014934361912310123
Japanese O 0 0.422353059053421
, O 0 0.02097209170460701
respectively O 0 0.034621309489011765
. O 0 0.041486840695142746

To O 0 0.039013952016830444
characterize O 0 0.04343711957335472
the O 0 0.0229689572006464
mutational O 1 0.9087916016578674
spectrum O 0 0.02529052644968033
in O 0 0.010591734200716019
various O 0 0.009367972612380981
ethnic O 0 0.008309237658977509
groups O 0 0.006659102160483599
, O 0 0.007525438442826271
mutations O 0 0.007636548485606909
in O 0 0.005543893668800592
the O 0 0.007313747890293598
GALNS O 1 0.9842884540557861
gene O 0 0.008588886819779873
in O 0 0.0074656871147453785
Colombian O 1 0.5691799521446228
MPS B-Disease 1 0.999270498752594
IVA I-Disease 1 1.0
patients O 1 0.9982243180274963
were O 0 0.007960876449942589
investigated O 0 0.03317095711827278
, O 0 0.008539586327970028
and O 0 0.006860252469778061
genetic O 0 0.00802903063595295
backgrounds O 0 0.008464431390166283
were O 0 0.0054459962993860245
extensively O 0 0.010456239804625511
analyzed O 0 0.009403875097632408
to O 0 0.007051932159811258
identify O 0 0.008958782069385052
racial O 0 0.011258836835622787
origin O 0 0.008949832059442997
, O 0 0.007766380440443754
based O 0 0.00898736622184515
on O 0 0.008556541986763477
mitochondrial O 0 0.012619218789041042
DNA O 0 0.013727296143770218
( O 0 0.01594327576458454
mtDNA O 0 0.02430320903658867
) O 0 0.023712720721960068
lineages O 0 0.0446571446955204
. O 0 0.041465699672698975

Three O 0 0.03420567139983177
novel O 0 0.0437152199447155
missense O 0 0.24137398600578308
mutations O 0 0.02001911960542202
never O 0 0.013629190623760223
identified O 0 0.008700779639184475
previously O 0 0.008390877395868301
in O 0 0.0058175260201096535
other O 0 0.004699924495071173
populations O 0 0.005444996990263462
and O 0 0.005654111970216036
found O 0 0.0056757149286568165
in O 0 0.0060103521682322025
16 O 0 0.0092846704646945
out O 0 0.009853363037109375
of O 0 0.010710285976529121
19 O 0 0.01839428022503853
Colombian O 0 0.03916652500629425
MPS B-Disease 1 0.7256093621253967
IVA I-Disease 1 0.9999759197235107
unrelated O 0 0.08832834661006927
alleles O 0 0.028845883905887604
account O 0 0.0241159126162529
for O 0 0.02390209771692753
84 O 0 0.06266163289546967
. O 0 0.05323035269975662

2 O 0 0.04208972677588463
% O 0 0.023871444165706635
of O 0 0.016383780166506767
the O 0 0.016049835830926895
alleles O 0 0.02189474366605282
in O 0 0.014810615219175816
this O 0 0.016372479498386383
study O 0 0.030409757047891617
. O 0 0.0387054905295372

The O 0 0.04875660687685013
G301C O 1 0.8023343086242676
and O 0 0.031507689505815506
S162F O 1 0.8383490443229675
mutations O 0 0.02751879021525383
account O 0 0.02650151215493679
for O 0 0.025281736627221107
68 O 0 0.058080729097127914
. O 0 0.04655519127845764

4 O 0 0.07129983603954315
% O 0 0.0372631661593914
and O 0 0.03377683460712433
10 O 0 0.04908992722630501
. O 0 0.053990308195352554

5 O 0 0.040145568549633026
% O 0 0.02074049413204193
of O 0 0.015208140946924686
mutations O 0 0.01643565110862255
, O 0 0.01010169554501772
respectively O 0 0.011390239000320435
, O 0 0.009501657448709011
whereas O 0 0.009336345829069614
the O 0 0.009065632708370686
remaining O 0 0.015599491074681282
F69V O 1 0.8895940780639648
is O 0 0.010759374126791954
limited O 0 0.013559030368924141
to O 0 0.014416232705116272
a O 0 0.02181980200111866
single O 0 0.03350527957081795
allele O 0 0.05776934325695038
. O 0 0.04996754601597786

The O 0 0.04896310716867447
skewed O 0 0.05421080440282822
prevalence O 1 0.656409740447998
of O 0 0.018733637407422066
G301C O 1 0.7951086759567261
in O 0 0.011463613249361515
only O 0 0.00943473819643259
Colombian O 1 0.5310845971107483
patients O 1 0.7647693157196045
and O 0 0.008632187731564045
haplotype O 0 0.01982392743229866
analysis O 0 0.007939748466014862
by O 0 0.007408755831420422
restriction O 0 0.011507737450301647
fragment O 0 0.015096282586455345
length O 0 0.012320910580456257
polymorphisms O 0 0.013972767628729343
in O 0 0.008557513356208801
the O 0 0.00976611115038395
GALNS O 1 0.988896906375885
gene O 0 0.011133993044495583
suggest O 0 0.010414651595056057
that O 0 0.007972953841090202
G301C O 0 0.06935328245162964
originated O 0 0.014889721758663654
from O 0 0.011776876635849476
a O 0 0.017826290801167488
common O 0 0.025190254673361778
ancestor O 0 0.055823493748903275
. O 0 0.03681298717856407

Investigation O 0 0.0409366600215435
of O 0 0.020544786006212234
the O 0 0.014664866961538792
genetic O 0 0.012905430048704147
background O 0 0.01116319838911295
by O 0 0.006272324826568365
means O 0 0.007411610800772905
of O 0 0.007729461416602135
mtDNA O 0 0.010537444613873959
lineages O 0 0.009301339276134968
indicate O 0 0.006790915969759226
that O 0 0.004857493564486504
all O 0 0.005645408760756254
our O 0 0.009397161193192005
patients O 0 0.44747257232666016
are O 0 0.005732817109674215
probably O 0 0.011782023124396801
of O 0 0.012495258823037148
native O 0 0.02423195168375969
American O 0 0.03923190385103226
descent O 0 0.08025497943162918

Low O 0 0.04652118682861328
frequency O 0 0.035427164286375046
of O 0 0.025211751461029053
BRCA1 O 1 0.934664785861969
germline O 0 0.27977636456489563
mutations O 0 0.017144201323390007
in O 0 0.01128623727709055
45 O 0 0.333817720413208
German O 1 0.9999512434005737
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9746931791305542
. O 0 0.06707711517810822

In O 0 0.024157244712114334
this O 0 0.013521821238100529
study O 0 0.012473472394049168
we O 0 0.010053093545138836
investigated O 0 0.013350022956728935
45 O 0 0.021597275510430336
German O 1 0.9980334639549255
breast B-Disease 1 1.0
/ I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.2080027163028717
for O 0 0.021271536126732826
germline O 1 0.9925810098648071
mutations O 0 0.02834986336529255
in O 0 0.014904948882758617
the O 0 0.03119252435863018
BRCA1 O 1 0.999259889125824
gene O 0 0.04343352094292641
. O 0 0.039310555905103683

We O 0 0.029876234009861946
identified O 0 0.02176300249993801
four O 0 0.015571332536637783
germline O 0 0.034524865448474884
mutations O 0 0.013560042716562748
in O 0 0.009577429853379726
three O 0 0.033182524144649506
breast B-Disease 1 0.999998927116394
cancer I-Disease 1 0.9999856948852539
families O 0 0.013424857519567013
and O 0 0.006874626036733389
in O 0 0.020476555451750755
one O 1 0.974906325340271
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9416154026985168
. O 0 0.007802573963999748
among O 0 0.0059157018549740314
these O 0 0.004892537370324135
were O 0 0.005632441025227308
one O 0 0.008354514837265015
frameshift O 1 0.8973057270050049
mutation O 0 0.012408359907567501
, O 0 0.007598692085593939
one O 0 0.007752737496048212
nonsense O 0 0.1417914181947708
mutation O 0 0.011105484329164028
, O 0 0.0075847310945391655
one O 0 0.0071195377968251705
novel O 0 0.013701271265745163
splice O 0 0.09853662550449371
site O 0 0.014261326752603054
mutation O 0 0.014319581910967827
, O 0 0.011125685647130013
and O 0 0.01195556577295065
one O 0 0.01888638362288475
missense O 0 0.07445718348026276
mutation O 0 0.04226996377110481
. O 0 0.042738545686006546

The O 0 0.05541161075234413
missense O 0 0.23973922431468964
mutation O 0 0.04046326503157616
was O 0 0.02495490200817585
also O 0 0.01778573729097843
found O 0 0.016225194558501244
in O 0 0.018602771684527397
2 O 0 0.03202648088335991
. O 0 0.03619305044412613

8 O 0 0.041076526045799255
% O 0 0.01971314661204815
of O 0 0.012273812666535378
the O 0 0.010511232540011406
general O 0 0.0119280144572258
population O 0 0.0070050726644694805
, O 0 0.006781679578125477
suggesting O 0 0.007774633821099997
that O 0 0.005336916074156761
it O 0 0.006122227292507887
is O 0 0.01046006940305233
not O 0 0.012691397219896317
disease O 1 0.9997005462646484
associated O 0 0.047663699835538864
. O 0 0.03510570526123047

The O 0 0.033413954079151154
average O 0 0.02672816999256611
age O 0 0.02974807471036911
of O 0 0.3119037449359894
disease O 1 0.9999982118606567
onset O 1 0.9999905824661255
in O 0 0.11661245673894882
those O 0 0.03267420083284378
families O 1 0.5936309099197388
harbouring O 1 0.9999890327453613
causative O 1 0.9999593496322632
mutations O 0 0.47225815057754517
was O 0 0.05775762349367142
between O 0 0.019887028262019157
32 O 0 0.035960253328084946
. O 0 0.03544514253735542

3 O 0 0.08465548604726791
and O 0 0.05122412368655205
37 O 0 0.07803118228912354
. O 0 0.06452395766973495

4 O 0 0.04524948447942734
years O 0 0.023276666179299355
, O 0 0.01606721058487892
whereas O 0 0.01504953857511282
the O 0 0.011400274001061916
family O 0 0.01704646646976471
harbouring O 1 0.985069990158081
the O 0 0.020771631971001625
missense O 1 0.8282800316810608
mutation O 0 0.019182704389095306
had O 0 0.00828581303358078
an O 0 0.007162737660109997
average O 0 0.010649195872247219
age O 0 0.012079949490725994
of O 0 0.012512498535215855
onset O 1 0.9973419308662415
of O 0 0.03505134582519531
51 O 0 0.3978538513183594
. O 0 0.03796932101249695

2 O 0 0.10595059394836426
years O 0 0.0827709510922432
. O 0 0.08302866667509079

These O 0 0.026117615401744843
findings O 0 0.025182517245411873
show O 0 0.020815296098589897
that O 0 0.012428443878889084
BRCA1 O 1 0.7436420917510986
is O 0 0.00942587573081255
implicated O 0 0.014666080474853516
in O 0 0.006712320726364851
a O 0 0.007866108790040016
small O 0 0.0077342744916677475
fraction O 0 0.013398231007158756
of O 1 0.6735226511955261
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.0612793006002903
suggesting O 0 0.014487327076494694
the O 0 0.009414580650627613
involvement O 0 0.014780601486563683
of O 0 0.01469888724386692
another O 1 0.8747267127037048
susceptibility O 1 0.999749481678009
gene O 0 0.28209125995635986
( O 0 0.05804090574383736
s O 0 0.45673060417175293
) O 0 0.056459035724401474

Paternal O 1 0.9979435801506042
transmission O 1 0.9996936321258545
of O 1 0.9999104738235474
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9998689889907837

We O 0 0.025075841695070267
report O 0 0.019317373633384705
a O 0 0.015391072258353233
rare O 0 0.017121661454439163
case O 0 0.018788347020745277
of O 1 0.8117218613624573
paternally O 1 0.9999996423721313
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 1 0.9825646281242371
. O 0 0.0764572024345398

The O 0 0.03909170255064964
proband O 0 0.09192497283220291
is O 0 0.016904687508940697
a O 0 0.013288022018969059
23 O 0 0.01527104340493679
year O 0 0.013945681974291801
old O 0 0.324361652135849
, O 0 0.08891013264656067
mentally B-Disease 1 0.9999659061431885
retarded I-Disease 1 0.9999688863754272
male O 1 0.999606192111969
who O 1 0.9999780654907227
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 0.9999998807907104
. O 1 0.9960792660713196

He O 0 0.05028298497200012
presented O 0 0.3518766760826111
with O 1 0.8865836262702942
respiratory O 1 1.0
and O 1 0.9682098627090454
feeding O 1 0.9977197051048279
difficulties O 1 0.9999120235443115
at O 1 0.8135496973991394
birth O 1 0.9814648032188416
. O 0 0.04954700171947479

His O 0 0.051742665469646454
two O 0 0.03576534241437912
sibs O 1 0.9998987913131714
suffer O 1 0.9996341466903687
from O 1 0.8708586096763611
childhood O 1 0.999998927116394
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.975651204586029

Their O 0 0.02982954867184162
late O 0 0.024092132225632668
father O 0 0.021311741322278976
had O 0 0.013382521457970142
the O 0 0.010969546623528004
adult O 0 0.016358133405447006
type O 0 0.2958711087703705
of O 0 0.37891024351119995
DM B-Disease 1 1.0
, O 0 0.13897930085659027
with O 0 0.04296327754855156
onset O 1 0.9997504353523254
around O 0 0.0207502581179142
30 O 0 0.025624768808484077
years O 0 0.030071185901761055
. O 0 0.04705047979950905

Only O 0 0.023670025169849396
six O 0 0.01716335117816925
other O 0 0.008932702243328094
cases O 0 0.008533931337296963
of O 0 0.010214423760771751
paternal O 1 0.9963346719741821
transmission O 1 0.9997363686561584
of O 1 0.9999616146087646
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 1 0.9518101215362549
been O 0 0.3938855230808258
reported O 0 0.27657514810562134
recently O 0 0.12347536534070969
. O 0 0.0427088588476181

We O 0 0.02911713905632496
review O 0 0.025066981092095375
the O 0 0.016487624496221542
sex O 0 0.017149174585938454
related O 0 0.014717035926878452
effects O 0 0.06151941791176796
on O 0 0.01675518788397312
transmission O 1 0.9823276996612549
of O 1 0.9886525273323059
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9817292094230652

Decreased O 0 0.06851238757371902
fertility O 0 0.03779805451631546
of O 0 0.013284783810377121
males O 0 0.012146597728133202
with O 0 0.012289818376302719
adult O 1 0.9935680031776428
onset O 1 1.0
DM B-Disease 1 1.0
and O 1 0.8660435676574707
contraction O 1 0.9833400249481201
of O 0 0.013052589260041714
the O 0 0.010543969459831715
repeat O 0 0.10029985755681992
upon O 0 0.010610954836010933
male O 0 0.018900776281952858
transmission O 0 0.021551411598920822
contribute O 0 0.01034893561154604
to O 0 0.007787706330418587
the O 0 0.008180334232747555
almost O 0 0.009535519406199455
absent O 0 0.014804533682763577
occurrence O 0 0.015149448066949844
of O 0 0.014759029261767864
paternal O 1 0.9965797066688538
transmission O 1 0.9993379712104797
of O 1 0.9987768530845642
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9869837760925293

Also O 0 0.03007875196635723
the O 0 0.017445499077439308
fathers O 0 0.017052462324500084
of O 0 0.009869752451777458
the O 0 0.02119297906756401
reported O 1 0.915169358253479
congenitally O 1 0.9999874830245972
affected O 1 0.615247905254364
children O 0 0.04236757382750511
showed O 0 0.012060248292982578
, O 0 0.0071633621118962765
on O 0 0.0070719970390200615
average O 0 0.009071700274944305
, O 0 0.009106731973588467
shorter O 0 0.01673765480518341
CTG O 1 0.5599106550216675
repeat O 0 0.021729953587055206
lengths O 0 0.019773131236433983
and O 0 0.009613418951630592
hence O 0 0.013082355260848999
less O 0 0.012998129241168499
severe O 1 0.9999493360519409
clinical O 1 0.9999862909317017
symptoms O 1 0.999991774559021
than O 0 0.016394058242440224
the O 0 0.10636433959007263
mothers O 1 0.9425293207168579
of O 0 0.2924213111400604
children O 1 0.9893442392349243
with O 1 0.9989540576934814
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.988675594329834

We O 0 0.03073699027299881
conclude O 0 0.031206753104925156
that O 0 0.014819592237472534
paternal O 0 0.4767434895038605
transmission O 1 0.9868274927139282
of O 1 0.9994786381721497
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9954901337623596
rare O 1 0.9978848099708557
and O 0 0.43341392278671265
preferentially O 0 0.4652751386165619
occurs O 0 0.008221914060413837
with O 0 0.008607251569628716
onset O 1 0.9999419450759888
of O 1 0.737432062625885
DM B-Disease 1 1.0
past O 0 0.07634881138801575
30 O 0 0.0128989452496171
years O 0 0.009501149877905846
in O 0 0.009585904888808727
the O 0 0.013313911855220795
father O 0 0.03372519090771675
. O 0 0.020962150767445564
. O 0 0.032316189259290695

The O 0 0.05893797054886818
RB1 O 1 0.995857298374176
gene O 0 0.03359171748161316
mutation O 0 0.02492508478462696
in O 0 0.01577865704894066
a O 0 0.02242804691195488
child O 1 0.994454562664032
with O 1 0.9885618686676025
ectopic B-Disease 1 0.9999997615814209
intracranial I-Disease 1 0.9999998807907104
retinoblastoma I-Disease 1 0.9999990463256836
. O 1 0.6646279692649841

The O 0 0.05587968975305557
RB1 O 1 0.9988600015640259
gene O 0 0.02842899039387703
mutation O 0 0.02484930120408535
was O 0 0.01568235643208027
investigated O 0 0.01613427884876728
in O 0 0.008704946376383305
a O 0 0.013400310650467873
child O 1 0.9500828981399536
with O 1 0.7380949258804321
ectopic B-Disease 1 0.9999992847442627
intracranial I-Disease 1 0.9999996423721313
retinoblastoma I-Disease 1 0.9999611377716064
using O 0 0.011750939302146435
DNA O 0 0.01102463435381651
obtained O 0 0.008855546824634075
from O 0 0.00724994158372283
both O 0 0.007929009385406971
the O 0 0.013162295334041119
pineal B-Disease 1 0.9996974468231201
and I-Disease 1 0.7111640572547913
retinal I-Disease 1 0.9999983310699463
tumours I-Disease 1 0.9999961853027344
of O 0 0.427089124917984
the O 1 0.7715533971786499
patient O 1 0.9997079968452454
. O 0 0.05812104791402817

A O 0 0.05547237768769264
nonsense O 0 0.06001201644539833
mutation O 0 0.031449299305677414
in O 0 0.016134968027472496
exon O 0 0.03487396985292435
17 O 0 0.019615735858678818
( O 0 0.015188143588602543
codon O 0 0.023538194596767426
556 O 0 0.02753935009241104
) O 0 0.011688414961099625
of O 0 0.009928076528012753
the O 0 0.011969137005507946
RB1 O 1 0.9982692003250122
gene O 0 0.010530904866755009
was O 0 0.009760035201907158
found O 0 0.006916514597833157
to O 0 0.005812897812575102
be O 0 0.006314585916697979
present O 0 0.0075636920519173145
homozygously O 0 0.04653768613934517
in O 0 0.007156921084970236
both O 0 0.008438446559011936
the O 0 0.013928432017564774
retinal B-Disease 1 0.9998650550842285
and I-Disease 0 0.05671226233243942
the I-Disease 1 0.5471043586730957
pineal I-Disease 1 0.9999932050704956
tumours I-Disease 1 0.9999938011169434
. O 0 0.056954625993967056

The O 0 0.028043046593666077
same O 0 0.01710163801908493
mutation O 0 0.018574263900518417
was O 0 0.014035751111805439
present O 0 0.01231918204575777
heterozygously O 1 0.6288929581642151
in O 0 0.007012289483100176
the O 0 0.006848248187452555
DNA O 0 0.00732561107724905
from O 0 0.0053156837821006775
the O 0 0.00547197787091136
constitutional O 0 0.008246641606092453
cells O 0 0.007163527887314558
of O 0 0.006896116305142641
the O 0 0.010841794312000275
patient O 1 0.9794475436210632
, O 0 0.011197511106729507
proving O 0 0.18235822021961212
it O 0 0.006425751838833094
to O 0 0.007529999129474163
be O 0 0.00862063281238079
of O 0 0.01348875556141138
germline O 0 0.13303500413894653
origin O 0 0.029518110677599907
. O 0 0.03851955011487007

The O 0 0.03397525101900101
initial O 0 0.03353920578956604
mutation O 0 0.02538507990539074
was O 0 0.01612195186316967
shown O 0 0.010354533791542053
to O 0 0.00798747781664133
have O 0 0.00739759486168623
occurred O 0 0.010256493464112282
in O 0 0.010331389494240284
the O 0 0.016761137172579765
paternally O 1 0.967906653881073
derived O 0 0.05112137272953987
RB1 O 1 0.9981498718261719
allele O 0 0.10590385645627975
. O 0 0.055980779230594635

The O 0 0.03200821578502655
mutation O 0 0.024354051798582077
is O 0 0.010761795565485954
in O 0 0.007763059344142675
an O 0 0.005917623173445463
area O 0 0.0073979138396680355
of O 0 0.005976493004709482
the O 0 0.006072120741009712
gene O 0 0.0058954935520887375
that O 0 0.0048261480405926704
encodes O 0 0.008290363475680351
the O 0 0.006462604273110628
protein O 0 0.007309331092983484
- O 0 0.012155676260590553
binding O 0 0.008509589359164238
region O 0 0.008489350788295269
known O 0 0.0065145716071128845
as O 0 0.005836111027747393
the O 0 0.006871234625577927
pocket O 1 0.9727924466133118
region O 0 0.012771513313055038
and O 0 0.006564317271113396
has O 0 0.006533697713166475
been O 0 0.005802504252642393
detected O 0 0.008766059763729572
in O 0 0.0070655206218361855
other O 0 0.006957536097615957
cases O 0 0.010240590199828148
of O 0 0.029754366725683212
retinoblastoma B-Disease 1 0.9999551773071289
. O 0 0.028393063694238663
. O 0 0.041241079568862915

Low O 0 0.03621251508593559
levels O 0 0.02117440290749073
of O 0 0.014723292551934719
beta O 0 0.05349685996770859
hexosaminidase O 1 0.8382357954978943
A O 0 0.019153835251927376
in O 0 0.009920013137161732
healthy O 0 0.16695348918437958
individuals O 0 0.00943179801106453
with O 0 0.1606675535440445
apparent O 1 0.9999393224716187
deficiency O 1 1.0
of O 1 0.9839581251144409
this O 1 0.6151177287101746
enzyme O 1 0.881392776966095
. O 0 0.04330655187368393

Appreciable O 0 0.3939899206161499
beta O 0 0.13222099840641022
hexosaminidase O 1 0.8458727598190308
A O 0 0.06439818441867828
( O 0 0.018696174025535583
hex O 0 0.050824642181396484
A O 0 0.014751126989722252
) O 0 0.009857374243438244
activity O 0 0.007900171913206577
has O 0 0.006652799900621176
been O 0 0.005901639349758625
detected O 0 0.008807645179331303
in O 0 0.008054406382143497
cultured O 1 0.9877381324768066
skin O 1 0.9999985694885254
fibroblasts O 1 0.9999910593032837
and O 1 0.9987414479255676
melanoma B-Disease 1 1.0
tissue O 1 0.9998779296875
from O 0 0.10205217450857162
healthy O 1 0.9025953412055969
individuals O 0 0.007168501149863005
previously O 0 0.01484146248549223
reported O 0 0.015187451615929604
as O 0 0.011540153995156288
having O 1 0.7030052542686462
deficiency B-Disease 1 0.9999984502792358
of I-Disease 0 0.2873978614807129
hex I-Disease 1 0.954175591468811
A I-Disease 0 0.061982542276382446
activity O 0 0.00947339553385973
indistinguishable O 0 0.011509113945066929
from O 0 0.006201924290508032
that O 0 0.005273813381791115
of O 0 0.007415273226797581
patients O 1 0.9714630842208862
with O 1 0.9540945291519165
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.999650239944458
TSD B-Disease 1 0.9999984502792358
) O 0 0.04899812489748001
. O 0 0.05040062591433525

Identification O 0 0.06859792768955231
and O 0 0.037886377424001694
quantitation O 1 0.6098254323005676
of O 0 0.025946738198399544
hex O 0 0.17691101133823395
A O 0 0.036659110337495804
, O 0 0.022144481539726257
amounting O 0 0.035857461392879486
to O 0 0.02293369360268116
3 O 0 0.03789001703262329
. O 0 0.047243937849998474

5 O 0 0.06495391577482224
% O 0 0.049870993942022324
- O 0 0.09868124127388
6 O 0 0.06177249550819397
. O 0 0.05729028955101967

9 O 0 0.041453566402196884
% O 0 0.021168041974306107
of O 0 0.014954865910112858
total O 0 0.01576739177107811
beta O 0 0.08371613174676895
hexosaminidase O 1 0.7909262180328369
activity O 0 0.013212895020842552
, O 0 0.010814841836690903
has O 0 0.009862620383501053
been O 0 0.007768603973090649
obtained O 0 0.011806810274720192
by O 0 0.011712742038071156
cellulose O 1 0.9690489172935486
acetate O 1 0.9950911998748779
gel O 1 0.991926908493042
electrophoresis O 0 0.4925938844680786
, O 0 0.019786259159445763
DEAE O 1 0.9961435794830322
- O 1 0.8259856700897217
cellulose O 1 0.953962504863739
ion O 0 0.1785547137260437
- O 0 0.14017578959465027
exchange O 0 0.01967473514378071
chromatography O 1 0.5163130760192871
, O 0 0.022099262103438377
radial O 1 0.8471779823303223
immunodiffusion O 1 0.9885431528091431
, O 0 0.022744396701455116
and O 0 0.02576630190014839
radioimmunoassay O 1 0.9604016542434692
. O 0 0.044902388006448746

Previous O 0 0.035670749843120575
family O 0 0.025987649336457253
studies O 0 0.016442783176898956
suggested O 0 0.012692359276115894
that O 0 0.00691291643306613
these O 0 0.005890041124075651
individuals O 0 0.005674143321812153
may O 0 0.005797258578240871
be O 0 0.005428085569292307
compound O 0 0.012527236714959145
heterozygotes O 0 0.0779830813407898
for O 0 0.007208505179733038
the O 0 0.009627443738281727
common O 0 0.03915195167064667
mutant O 1 0.9874010682106018
TSD B-Disease 1 0.9999949932098389
gene O 0 0.016549838706851006
and O 0 0.01006407756358385
a O 0 0.014084846712648869
rare O 1 0.5587065815925598
( O 0 0.05169326066970825
allelic O 1 0.9598342776298523
) O 0 0.03269081562757492
mutant O 0 0.06413204967975616
gene O 0 0.0457000769674778
. O 0 0.05287383869290352

Thus O 0 0.034118711948394775
, O 0 0.018735265359282494
the O 0 0.015009535476565361
postulated O 0 0.03034348040819168
rate O 0 0.015040242113173008
mutant O 0 0.08253549039363861
gene O 0 0.010031121782958508
appears O 0 0.009357653558254242
to O 0 0.005982901435345411
code O 0 0.0070987269282341
for O 0 0.005760743282735348
the O 0 0.006451084744185209
expression O 0 0.008090966381132603
of O 0 0.007812678813934326
low O 0 0.011119678616523743
amounts O 0 0.011677292175590992
of O 0 0.014065464958548546
hex O 0 0.10334137082099915
A O 0 0.037243325263261795
. O 0 0.04021572321653366

Heterozygotes O 1 0.7072123289108276
for O 0 0.023984365165233612
the O 0 0.02083548530936241
rare O 0 0.2943710684776306
mutant O 1 0.7171764969825745
may O 0 0.012646805495023727
be O 0 0.00931972824037075
indistinguishable O 0 0.016809185966849327
from O 0 0.01111570093780756
heterozygotes O 0 0.3716287910938263
for O 0 0.012997175566852093
the O 0 0.020093774423003197
common O 0 0.2906286120414734
TSD B-Disease 1 0.9999758005142212
mutant O 1 0.9642908573150635
. O 0 0.05002093315124512

However O 0 0.03645969554781914
, O 0 0.019945954903960228
direct O 0 0.0172689538449049
visualization O 0 0.05482890456914902
and O 0 0.01431462075561285
quantitation O 1 0.7084659934043884
of O 0 0.01330397929996252
hex O 0 0.11481968313455582
A O 0 0.011829374358057976
by O 0 0.006495078094303608
the O 0 0.0068267351016402245
methods O 0 0.006723868194967508
described O 0 0.008259286172688007
may O 0 0.007116703316569328
prevent O 0 0.009433723986148834
false O 0 0.021934399381279945
- O 1 0.8831549882888794
positive O 0 0.06082232668995857
prenatal O 1 0.9997960925102234
diagnosis O 1 0.9998939037322998
of O 1 0.6776095032691956
TSD B-Disease 1 0.9999990463256836
in O 0 0.036950599402189255
fetuses O 1 0.835015058517456
having O 0 0.011418700218200684
the O 0 0.010009643621742725
incomplete O 0 0.16531938314437866
hex B-Disease 1 0.9838613867759705
A I-Disease 1 0.9909035563468933
deficiency I-Disease 1 0.9999986886978149
of O 0 0.10931530594825745
the O 0 0.35651886463165283
type O 1 0.7827516198158264
described O 0 0.014672861434519291
in O 0 0.009597216732800007
the O 0 0.013055304996669292
four O 0 0.02039497345685959
healthy O 0 0.12604115903377533
individuals O 0 0.03801880031824112

The O 0 0.0660092905163765
tumor B-Disease 1 0.9994518160820007
suppressor O 1 0.9982219338417053
gene O 0 0.4815945625305176
Smad4 O 1 0.9997726082801819
/ O 1 0.9977409839630127
Dpc4 O 1 0.9867532849311829
is O 0 0.011495993472635746
required O 0 0.009335383772850037
for O 0 0.009624112397432327
gastrulation O 1 0.9638846516609192
and O 0 0.010245583020150661
later O 0 0.011215968988835812
for O 0 0.010180400684475899
anterior O 1 0.8853723406791687
development O 0 0.017427805811166763
of O 0 0.0162962693721056
the O 0 0.027743162587285042
mouse O 1 0.5507978796958923
embryo O 0 0.07830079644918442
. O 0 0.0443304181098938

Mutations O 0 0.04158642888069153
in O 0 0.02155713550746441
the O 0 0.023285599425435066
SMAD4 O 1 0.9999792575836182
/ O 1 0.9999798536300659
DPC4 O 1 0.9999988079071045
tumor B-Disease 1 0.999996542930603
suppressor O 1 0.9988419413566589
gene O 0 0.015136036090552807
, O 0 0.010005245916545391
a O 0 0.010256807319819927
key O 0 0.011527051217854023
signal O 0 0.013626563362777233
transducer O 0 0.01967530883848667
in O 0 0.008564073592424393
most O 0 0.00864454172551632
TGFbeta O 1 0.9828000068664551
- O 1 0.8147832155227661
related O 0 0.017461193725466728
pathways O 0 0.014486032538115978
, O 0 0.006809433922171593
are O 0 0.004923118278384209
involved O 0 0.006596348714083433
in O 0 0.007096630055457354
50 O 0 0.011613431386649609
% O 0 0.013826681300997734
of O 0 0.1501951962709427
pancreatic B-Disease 1 0.9999983310699463
cancers I-Disease 1 0.999950647354126
. O 0 0.05221568048000336

Homozygous O 1 0.6522119641304016
Smad4 O 1 0.9956676959991455
mutant O 1 0.9410974979400635
mice O 1 0.6797797083854675
die O 0 0.25331631302833557
before O 0 0.026322079822421074
day O 0 0.03065982460975647
7 O 0 0.04323219135403633
. O 0 0.04662618413567543

5 O 0 0.0861268937587738
of O 0 0.06506849080324173
embryogenesis O 1 0.7346187233924866
. O 0 0.08140169829130173

Mutant O 0 0.07346699386835098
embryos O 0 0.029025372117757797
have O 0 0.01457646768540144
reduced O 0 0.016695018857717514
size O 0 0.015215633437037468
, O 0 0.010575037449598312
fail O 0 0.012330431491136551
to O 0 0.008670787326991558
gastrulate O 0 0.04838012158870697
or O 0 0.00895945355296135
express O 0 0.014583961106836796
a O 0 0.013091418892145157
mesodermal O 1 0.9962183833122253
marker O 1 0.9386317133903503
, O 0 0.0146342096850276
and O 0 0.014695229008793831
show O 0 0.031720761209726334
abnormal O 1 0.9587805867195129
visceral O 1 0.999614953994751
endoderm O 1 0.9998453855514526
development O 0 0.30887195467948914
. O 0 0.06101907044649124

Growth B-Disease 1 0.7105960249900818
retardation I-Disease 1 0.9991809725761414
of O 0 0.02552499808371067
the O 1 0.6232331991195679
Smad4 O 1 0.9999898672103882
- O 1 0.9988676309585571
deficient O 1 0.9819777607917786
embryos O 0 0.013844234868884087
results O 0 0.009947280399501324
from O 0 0.008928557857871056
reduced O 0 0.015661729499697685
cell O 0 0.022445937618613243
proliferation O 0 0.02844310738146305
rather O 0 0.013627011328935623
than O 0 0.013793768361210823
increased O 0 0.027489466592669487
apoptosis O 0 0.14969034492969513
. O 0 0.04713254049420357

Aggregation O 0 0.07191412150859833
of O 0 0.034830592572689056
mutant O 1 0.7681208848953247
Smad4 O 1 0.9994989633560181
ES O 1 0.9931291341781616
cells O 0 0.017908090725541115
with O 0 0.013046016916632652
wild O 0 0.022063180804252625
- O 1 0.8842390775680542
type O 0 0.43030503392219543
tetraploid O 1 0.940667450428009
morulae O 1 0.9946144223213196
rescues O 1 0.9705398678779602
the O 0 0.09459120780229568
gastrulation B-Disease 1 0.9996159076690674
defect I-Disease 1 0.9995385408401489
. O 0 0.06342374533414841

These O 0 0.024019144475460052
results O 0 0.017377406358718872
indicate O 0 0.013448959216475487
that O 0 0.009745570831000805
Smad4 O 1 0.5737075805664062
is O 0 0.009414982050657272
initially O 0 0.00997574906796217
required O 0 0.007415280677378178
for O 0 0.0069983587600290775
the O 0 0.008898325264453888
differentiation O 0 0.012491286732256413
of O 0 0.009745394811034203
the O 0 0.013352422043681145
visceral O 1 0.9963873624801636
endoderm O 1 0.9992929697036743
and O 0 0.010082483291625977
that O 0 0.00736819626763463
the O 0 0.012284766882658005
gastrulation B-Disease 1 0.9997192025184631
defect I-Disease 1 0.9937959909439087
in O 0 0.010450677946209908
the O 0 0.01832522638142109
epiblast O 1 0.9997746348381042
is O 0 0.012786436825990677
secondary O 0 0.04659244418144226
and O 0 0.01301726046949625
non O 0 0.28593552112579346
- O 1 0.8424484729766846
cell O 0 0.04953265190124512
autonomous O 0 0.05175131931900978
. O 0 0.0502789206802845

Rescued O 0 0.226044699549675
embryos O 0 0.04441050440073013
show O 0 0.14947165548801422
severe O 1 0.9999905824661255
anterior O 1 0.9999957084655762
truncations O 1 0.9999954700469971
, O 0 0.20559930801391602
indicating O 0 0.05727403610944748
a O 0 0.01237132865935564
second O 0 0.015278522856533527
important O 0 0.010035173036158085
role O 0 0.012502709403634071
for O 0 0.011978348717093468
Smad4 O 1 0.9926080703735352
in O 0 0.02586495690047741
anterior O 1 0.9991557598114014
patterning O 1 0.9980267882347107
during O 0 0.2524562180042267
embryogenesis O 1 0.9482728838920593
. O 0 0.07318862527608871

Prevalence O 1 0.7686767578125
of O 0 0.03539319336414337
p16 O 1 0.9544904232025146
and O 0 0.026587700471282005
CDK4 O 1 0.9984946250915527
germline O 1 0.85406893491745
mutations O 0 0.023521101102232933
in O 0 0.01713791862130165
48 O 1 0.9567241668701172
melanoma B-Disease 1 1.0
- O 1 0.9999436140060425
prone O 1 0.9996776580810547
families O 0 0.03917843475937843
in O 0 0.022779865190386772
France O 0 0.17487379908561707
. O 0 0.038931142538785934

The O 0 0.13937406241893768
French O 1 0.9982652068138123
Familial B-Disease 1 0.9999985694885254
Melanoma I-Disease 1 1.0
Study O 1 0.9823914170265198
Group O 1 0.8144962191581726
. O 0 0.0608702078461647

Germline O 1 0.5121986269950867
mutations O 0 0.0358373261988163
in O 0 0.01719779521226883
the O 0 0.017373140901327133
p16 O 1 0.9733397364616394
and O 0 0.04424814507365227
CDK4 O 1 0.9996151924133301
genes O 0 0.011183161288499832
have O 0 0.006029046140611172
been O 0 0.006168378051370382
reported O 0 0.0066987499594688416
in O 0 0.0059204064309597015
a O 0 0.007657804526388645
subset O 0 0.017296358942985535
of O 0 0.14619693160057068
melanoma B-Disease 1 0.9999998807907104
pedigrees O 1 0.9954168796539307
, O 0 0.018177013844251633
but O 0 0.007197706028819084
their O 0 0.00799212884157896
prevalence O 1 0.9846035838127136
is O 0 0.009678150527179241
not O 0 0.009957502596080303
well O 0 0.014552651904523373
known O 0 0.024257421493530273
. O 0 0.03163933753967285

We O 0 0.03321565315127373
searched O 0 0.03384529799222946
for O 0 0.013999472372233868
such O 0 0.011911149136722088
germline O 0 0.034575577825307846
mutations O 0 0.013206511735916138
in O 0 0.009649127721786499
48 O 0 0.031231947243213654
French O 1 0.9942907094955444
melanoma B-Disease 1 1.0
- O 1 0.9999252557754517
prone O 1 0.9989400506019592
families O 0 0.00907592847943306
selected O 0 0.007197082042694092
according O 0 0.004966593347489834
to O 0 0.004889152944087982
two O 0 0.004375962540507317
major O 0 0.006369841750711203
criteria O 0 0.00615182239562273
families O 0 0.005404187366366386
with O 0 0.004123142454773188
at O 0 0.004832764156162739
least O 0 0.0048189484514296055
three O 0 0.004608005750924349
affected O 0 0.005622600670903921
members O 0 0.005220734514296055
( O 0 0.006786221172660589
n O 0 0.009064262732863426
= O 0 0.010775342583656311
20 O 0 0.008451626636087894
) O 0 0.006220798008143902
or O 0 0.005102354567497969
families O 0 0.005269230343401432
with O 0 0.004341446328908205
two O 0 0.0047342656180262566
affected O 0 0.005656946450471878
members O 0 0.0040989345870912075
, O 0 0.004223621916025877
one O 0 0.0038692145608365536
of O 0 0.004271208308637142
them O 0 0.0039750030264258385
affected O 0 0.004907284397631884
before O 0 0.00478116562590003
the O 0 0.005011321045458317
age O 0 0.006064941640943289
of O 0 0.005466790404170752
50 O 0 0.008053941652178764
( O 0 0.008147651329636574
n O 0 0.011050242930650711
= O 0 0.013652713038027287
28 O 0 0.013700691051781178
) O 0 0.010829527862370014
, O 0 0.010631944984197617
and O 0 0.00971047580242157
one O 0 0.0133670037612319
additional O 0 0.021075576543807983
minor O 0 0.05054370313882828
criterion O 0 0.20613236725330353
. O 0 0.04500598832964897

Sixteen O 0 0.07078953087329865
different O 0 0.030557703226804733
p16 O 1 0.6435405611991882
germline O 0 0.32218289375305176
mutations O 0 0.019626963883638382
were O 0 0.010528147220611572
found O 0 0.008248344995081425
in O 0 0.00758763263002038
21 O 0 0.009313070215284824
families O 0 0.007719520013779402
, O 0 0.007045854814350605
while O 0 0.00689665274694562
one O 0 0.007763488683849573
germline O 0 0.26319438219070435
mutation O 0 0.014484482817351818
, O 0 0.010584397241473198
Arg24His O 1 0.8737305402755737
, O 0 0.01002684235572815
was O 0 0.012574749067425728
detected O 0 0.014976194128394127
in O 0 0.01250522956252098
the O 0 0.02147681824862957
CDK4 O 1 0.9888842105865479
gene O 0 0.039073992520570755
. O 0 0.046379219740629196

The O 0 0.03057347796857357
frequency O 0 0.02535029500722885
of O 0 0.019285978749394417
p16 O 1 0.5187202095985413
gene O 0 0.014687718823552132
mutation O 0 0.011074494570493698
in O 0 0.007117512170225382
our O 0 0.008139739744365215
sample O 0 0.007947149686515331
( O 0 0.007016188930720091
44 O 0 0.010387863032519817
% O 0 0.007037482690066099
) O 0 0.006200628355145454
is O 0 0.005754081066697836
among O 0 0.004840693902224302
the O 0 0.005005826707929373
highest O 0 0.010784033685922623
rates O 0 0.006382892839610577
yet O 0 0.006048947107046843
reported O 0 0.0060181994922459126
and O 0 0.00530727906152606
the O 0 0.007105680648237467
CDK4 O 1 0.9984080195426941
mutation O 0 0.011572381481528282
is O 0 0.007086583878844976
the O 0 0.008018950931727886
second O 0 0.014567654579877853
mutation O 0 0.013538381084799767
detected O 0 0.012522505596280098
in O 0 0.010252413339912891
this O 0 0.012003617361187935
gene O 0 0.02083435095846653
worldwide O 0 0.031062038615345955
. O 0 0.03796177729964256

In O 0 0.033187754452228546
summary O 0 0.030533835291862488
, O 0 0.016396349295973778
our O 0 0.01305236853659153
results O 0 0.00982474721968174
show O 0 0.01108675729483366
frequent O 0 0.01099412702023983
involvement O 0 0.011887343600392342
of O 0 0.007673796731978655
the O 0 0.010183220729231834
p16 O 1 0.980527400970459
gene O 0 0.01991412043571472
in O 0 0.07403599470853806
familial B-Disease 1 0.9999977350234985
melanoma I-Disease 1 0.9999998807907104
and O 0 0.03797559067606926
confirm O 0 0.011007034219801426
the O 0 0.007174378726631403
role O 0 0.008727483451366425
of O 0 0.007573793176561594
the O 0 0.012261280789971352
CDK4 O 1 0.9996669292449951
gene O 0 0.010609609074890614
as O 0 0.009806593880057335
a O 1 0.5585823655128479
melanoma B-Disease 1 1.0
- O 1 0.9997918009757996
predisposing O 1 0.9992408752441406
gene O 0 0.029572347179055214
. O 0 0.024384649470448494
. O 0 0.03739764541387558

Progression O 0 0.3802894353866577
of O 0 0.03888281062245369
somatic O 1 0.7101547718048096
CTG O 1 0.9949185252189636
repeat O 0 0.08973352611064911
length O 0 0.02028971165418625
heterogeneity O 0 0.036447130143642426
in O 0 0.013503318652510643
the O 0 0.02009817771613598
blood O 1 0.9678965210914612
cells O 1 0.8215967416763306
of O 1 0.9967605471611023
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999994039535522
. O 1 0.9435269832611084

The O 0 0.034351568669080734
genetic O 0 0.02374112978577614
basis O 0 0.019925693050026894
of O 1 0.899626612663269
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999954700469971
DM B-Disease 1 1.0
) O 0 0.025983793660998344
is O 0 0.009527388960123062
the O 0 0.008525294251739979
expansion O 0 0.01422418374568224
of O 0 0.010193820111453533
an O 0 0.013697464019060135
unstable O 1 0.9720718860626221
CTG O 1 0.9929929971694946
repeat O 0 0.01954657770693302
in O 0 0.009505149908363819
the O 0 0.010522888042032719
34 O 0 0.01666359417140484
UTR O 0 0.04410998150706291
of O 0 0.013758701272308826
the O 0 0.020425889641046524
DM B-Disease 1 0.9999982118606567
protein O 0 0.03228311985731125
kinase O 0 0.04057085141539574
gene O 0 0.01898025907576084
on O 0 0.018371229991316795
chromosome O 0 0.03131482005119324
19 O 0 0.041016314178705215
. O 0 0.046506404876708984

One O 0 0.028397155925631523
of O 0 0.0168931782245636
the O 0 0.013361847959458828
principal O 0 0.015718117356300354
features O 0 0.011763643473386765
of O 0 0.011069017462432384
the O 1 0.5373968482017517
DM B-Disease 1 1.0
mutation O 1 0.615424633026123
is O 0 0.00913234893232584
an O 0 0.007936041802167892
extraordinarily O 0 0.38910651206970215
high O 0 0.012683572247624397
level O 0 0.010732144117355347
of O 0 0.01197716873139143
somatic O 1 0.9788830876350403
mosaicism O 1 0.9993507266044617
, O 0 0.009788820520043373
due O 0 0.007292280439287424
to O 0 0.0067578465677797794
an O 0 0.006292876787483692
extremely O 0 0.008778884075582027
high O 0 0.008932371623814106
degree O 0 0.009746278636157513
of O 0 0.009348670952022076
somatic O 1 0.6949518322944641
instability O 1 0.6344878077507019
both O 0 0.007651498541235924
within O 0 0.009004691615700722
and O 0 0.009744695387780666
between O 0 0.011785554699599743
different O 0 0.015008388087153435
tissues O 0 0.1114417314529419
. O 0 0.037397198379039764

This O 0 0.02841314487159252
instability O 1 0.610552966594696
appears O 0 0.02032891847193241
to O 0 0.010248142294585705
be O 0 0.007461625151336193
biased O 0 0.012149923481047153
towards O 0 0.00987121183425188
further O 0 0.0075562139973044395
expansion O 0 0.01012203749269247
and O 0 0.006459703203290701
continuous O 0 0.0074639637023210526
throughout O 0 0.005440562963485718
the O 0 0.005005349405109882
life O 0 0.004756454844027758
of O 0 0.004507712088525295
an O 0 0.005306247156113386
individual O 0 0.006212583743035793
, O 0 0.005643278360366821
features O 0 0.005563719198107719
that O 0 0.0036300993524491787
could O 0 0.003861337900161743
be O 0 0.0035143510904163122
associated O 0 0.004583833739161491
with O 0 0.0045768809504806995
the O 0 0.007027908693999052
progressive O 1 0.8403838276863098
nature O 0 0.045852672308683395
of O 0 0.16507744789123535
the O 1 0.9358306527137756
disease O 1 0.9999938011169434
. O 0 0.1557675302028656

Although O 0 0.027012232691049576
increasing O 0 0.022040661424398422
measured O 0 0.018350567668676376
allele O 0 0.019512053579092026
size O 0 0.013284014537930489
between O 0 0.010788463987410069
patients O 1 0.6177124381065369
clearly O 0 0.011000831611454487
correlates O 0 0.016968151554465294
with O 0 0.0052834609523415565
an O 0 0.006438098847866058
increased O 0 0.09228261560201645
severity O 1 0.9981202483177185
of O 1 0.5275911688804626
symptoms O 1 0.9999608993530273
and O 0 0.009011826477944851
an O 0 0.0069102877750992775
earlier O 0 0.014467025175690651
age O 0 0.05605962872505188
of O 0 0.19491082429885864
onset O 1 0.9999674558639526
, O 0 0.007879967801272869
this O 0 0.005818464793264866
correlation O 0 0.007254234980791807
is O 0 0.005406233482062817
not O 0 0.004530119709670544
precise O 0 0.0075159319676458836
and O 0 0.006596723571419716
measured O 0 0.008763380348682404
allele O 0 0.010593169368803501
length O 0 0.008440528996288776
cannot O 0 0.007386431097984314
be O 0 0.005867323838174343
used O 0 0.0060006193816661835
as O 0 0.006462861783802509
an O 0 0.006886451039463282
accurate O 0 0.013191288337111473
predictor O 0 0.028008518740534782
of O 0 0.013157689943909645
age O 0 0.024677252396941185
of O 0 0.03346364572644234
onset O 1 0.9999079704284668
. O 0 0.05400557443499565

In O 0 0.02938510663807392
order O 0 0.02215556986629963
to O 0 0.01378490962088108
further O 0 0.01483514066785574
characterize O 0 0.019560154527425766
the O 0 0.012397369369864464
dynamics O 0 0.028221510350704193
of O 0 0.07341379672288895
DM B-Disease 1 1.0
CTG O 1 0.9999918937683105
repeat O 1 0.9932716488838196
somatic O 1 0.9832553863525391
instability O 1 0.9790588021278381
, O 0 0.011072592809796333
we O 0 0.0076615046709775925
have O 0 0.0058297403156757355
studied O 0 0.00819339882582426
repeat O 0 0.009453429840505123
length O 0 0.007452181074768305
changes O 0 0.006750454194843769
over O 0 0.00690806657075882
time O 0 0.008021549321711063
in O 0 0.01144525595009327
111 O 1 0.9984508752822876
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9996602535247803
with O 0 0.04884049668908119
varying O 0 0.15188297629356384
clinical O 1 0.9999520778656006
severity O 1 0.9999079704284668
and O 1 0.5712097883224487
CTG O 1 0.9997863173484802
repeat O 0 0.10994253307580948
size O 0 0.01231044065207243
over O 0 0.00916178897023201
time O 0 0.008478249423205853
intervals O 0 0.01042234618216753
of O 0 0.010253612883388996
1 O 0 0.017234941944479942
- O 0 0.024666214361786842
7 O 0 0.024357788264751434
years O 0 0.028088556602597237
. O 0 0.042042192071676254

We O 0 0.025421323254704475
have O 0 0.01412216853350401
found O 0 0.009952051565051079
a O 0 0.00867469422519207
direct O 0 0.00950702652335167
progression O 0 0.021718798205256462
of O 0 0.006467956118285656
the O 0 0.007707239128649235
size O 0 0.009598331525921822
heterogeneity O 0 0.018347471952438354
over O 0 0.006999989040195942
time O 0 0.007167714647948742
related O 0 0.007293326780200005
to O 0 0.00866295862942934
initial O 0 0.014976292848587036
CTG O 1 0.8900666236877441
repeat O 0 0.01893085613846779
size O 0 0.011448363773524761
and O 0 0.007780536077916622
the O 0 0.00744024058803916
time O 0 0.008982589468359947
interval O 0 0.013040383346378803
and O 0 0.01051404420286417
always O 0 0.014606834389269352
biased O 0 0.020142270252108574
towards O 0 0.020805248990654945
further O 0 0.02557549625635147
expansion O 0 0.04635196179151535
. O 0 0.05044283717870712

Attempts O 0 0.040426209568977356
to O 0 0.02183796651661396
mathematically O 0 0.02362143248319626
model O 0 0.016015030443668365
the O 0 0.010378524661064148
dynamics O 0 0.021059874445199966
have O 0 0.006998859345912933
proved O 0 0.016311604529619217
only O 0 0.006565592251718044
partially O 0 0.013790395110845566
successful O 0 0.009091062471270561
suggesting O 0 0.008284496143460274
that O 0 0.004482874181121588
individual O 0 0.004525503143668175
specific O 0 0.005299474112689495
genetic O 0 0.007970957085490227
and O 0 0.009599428623914719
/ O 1 0.7097536325454712
or O 0 0.006605701055377722
environmental O 0 0.014472934417426586
factors O 0 0.0066924006678164005
also O 0 0.005565481726080179
play O 0 0.00699358806014061
a O 0 0.00899423100054264
role O 0 0.013432955369353294
in O 0 0.015197760425508022
somatic O 1 0.8776523470878601
mosaicism O 1 0.9970622658729553
. O 0 0.032765962183475494
. O 0 0.043299201875925064

Aspartylglucosaminuria B-Disease 1 0.9809340834617615
among O 0 0.06630628556013107
Palestinian O 0 0.06593691557645798
Arabs O 0 0.08521631360054016
. O 0 0.07973899692296982

Aspartylglucosaminuria B-Disease 1 0.9999363422393799
( O 1 0.9352026581764221
AGU B-Disease 1 0.9999864101409912
) O 0 0.020714478567242622
is O 0 0.013726798817515373
a O 0 0.018908338621258736
rare O 1 0.9709134697914124
disorder B-Disease 1 0.9999973773956299
of I-Disease 1 0.986640989780426
glycoprotein I-Disease 1 0.9999984502792358
metabolism I-Disease 1 0.9992971420288086
caused O 1 0.9641735553741455
by O 0 0.012405522167682648
the O 1 0.8919228315353394
deficiency B-Disease 1 0.9999998807907104
of I-Disease 1 0.9471404552459717
the I-Disease 1 0.9990293979644775
lysosomal I-Disease 1 0.9999998807907104
enzyme I-Disease 1 0.9996694326400757
aspartylglucosaminidase I-Disease 1 0.9999867677688599
( O 1 0.8843316435813904
AGA O 1 0.9998792409896851
) O 0 0.04648391157388687
. O 0 0.055023714900016785

AGU B-Disease 1 0.9999886751174927
is O 0 0.08196990936994553
inherited O 1 0.9982795715332031
as O 0 0.07144788652658463
an O 1 0.9899117350578308
autosomal O 1 0.9999998807907104
recessive O 1 0.9999998807907104
trait O 1 0.999995231628418
and O 1 0.8841645121574402
occurs O 0 0.045258667320013046
with O 0 0.006970924325287342
a O 0 0.013973699882626534
high O 0 0.019640421494841576
frequency O 0 0.00824935082346201
in O 0 0.00861936155706644
Finland O 0 0.02007591910660267
because O 0 0.010026360861957073
of O 0 0.012241631746292114
a O 0 0.021597955375909805
founder O 1 0.7240026593208313
effect O 0 0.036931827664375305
. O 0 0.0433807373046875

While O 0 0.03114066831767559
very O 0 0.01818552054464817
few O 0 0.017386820167303085
patients O 1 0.8846738338470459
with O 0 0.03854444995522499
AGU B-Disease 1 0.9999985694885254
have O 0 0.008480354212224483
been O 0 0.006884125992655754
reported O 0 0.008257953450083733
from O 0 0.005887527950108051
non O 0 0.017192494124174118
- O 0 0.39282238483428955
Finnish O 1 0.6652200222015381
origin O 0 0.009192464873194695
, O 0 0.009327585808932781
we O 0 0.009302934631705284
diagnosed O 1 0.9999796152114868
the O 0 0.1737273931503296
disorder O 1 0.9998983144760132
in O 0 0.016381142660975456
8 O 0 0.16567778587341309
patients O 0 0.34253203868865967
originating O 0 0.009285284206271172
from O 0 0.006771511398255825
3 O 0 0.009411664679646492
unrelated O 0 0.010630771517753601
families O 0 0.007469932548701763
, O 0 0.005873345769941807
all O 0 0.004879928659647703
Palestinian O 0 0.007943952456116676
Arabs O 0 0.01001862995326519
from O 0 0.008268761448562145
the O 0 0.010788514278829098
region O 0 0.017538538202643394
of O 0 0.018662670627236366
Jerusalem O 0 0.12125731259584427
. O 0 0.039242081344127655

The O 0 0.05671948194503784
clinical O 1 0.999904990196228
diagnosis O 1 0.9999943971633911
of O 1 0.9993273019790649
AGU B-Disease 1 1.0
is O 1 0.8726908564567566
often O 0 0.031389955431222916
difficult O 0 0.018278544768691063
, O 0 0.005246806889772415
in O 0 0.004443463869392872
particular O 0 0.0049286759458482265
early O 0 0.00475766696035862
in O 0 0.004380726721137762
the O 0 0.004559627268463373
course O 0 0.006977199576795101
of O 0 0.006024771835654974
the O 0 0.14775915443897247
disease O 1 0.9998651742935181
, O 0 0.005721120163798332
and O 0 0.004146249499171972
most O 0 0.003939744085073471
of O 0 0.005192667245864868
the O 0 0.10424613207578659
patients O 1 0.9974825978279114
are O 0 0.006842292845249176
diagnosed O 1 0.9999469518661499
after O 0 0.01809261366724968
the O 0 0.009295066818594933
age O 0 0.013050992973148823
of O 0 0.011483678594231606
5 O 0 0.019325723871588707
years O 0 0.024019578471779823
. O 0 0.0375034473836422

However O 0 0.024299396201968193
, O 0 0.01515178196132183
since O 0 0.014185742475092411
these O 0 0.01077340729534626
patients O 1 0.703881561756134
excrete O 1 0.7470782995223999
early O 0 0.010730565525591373
large O 0 0.0086746821179986
amounts O 0 0.008293586783111095
of O 0 0.00878809578716755
aspartylglucosamine O 1 0.6662986278533936
in O 0 0.011363894678652287
urine O 0 0.040633171796798706
, O 0 0.01242747064679861
biochemical O 0 0.04922967776656151
screening O 0 0.01945403590798378
is O 0 0.010945320129394531
easy O 0 0.020193519070744514
by O 0 0.016354575753211975
urine O 0 0.043883487582206726
chromatography O 0 0.1801026612520218
. O 0 0.03266769275069237
. O 0 0.044464439153671265

Detection O 0 0.058178335428237915
of O 0 0.026001060381531715
heterozygous O 0 0.031209347769618034
carriers O 0 0.02571142092347145
of O 0 0.015340241603553295
the O 0 0.4675271809101105
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999982118606567
telangiectasia I-Disease 1 0.9999998807907104
( O 1 0.6957789659500122
ATM O 1 0.8846400380134583
) O 0 0.013306591659784317
gene O 0 0.014233173802495003
by O 0 0.012573009356856346
G2 O 1 0.9992554783821106
phase O 0 0.4671483635902405
chromosomal O 1 0.8843156099319458
radiosensitivity O 1 0.9984511137008667
of O 1 0.8271186351776123
peripheral O 1 0.9999973773956299
blood O 1 0.9999216794967651
lymphocytes O 1 0.9997500777244568
. O 0 0.056694258004426956

In O 0 0.05929477885365486
ataxia B-Disease 1 0.9999969005584717
- I-Disease 1 0.999762237071991
telangiectasia I-Disease 1 0.9999978542327881
( O 1 0.6979562640190125
A B-Disease 1 0.9995728135108948
- I-Disease 1 0.9999970197677612
T I-Disease 1 0.9999978542327881
) O 0 0.05106251314282417
patients O 1 0.8027740120887756
, O 0 0.007639678195118904
mutations O 0 0.006243386305868626
in O 0 0.0046575237065553665
a O 0 0.005785573739558458
single O 0 0.006358793005347252
gene O 0 0.005730213597416878
, O 0 0.005222895182669163
ATM O 0 0.01501416228711605
, O 0 0.004823862574994564
result O 0 0.005022751167416573
in O 0 0.006339981220662594
an O 1 0.9566540122032166
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.33632692694664
embraces O 1 0.9977529644966125
a O 0 0.07124026119709015
variety O 0 0.01466431561857462
of O 0 0.051654595881700516
clinical O 1 0.9989160299301147
features O 0 0.24429555237293243
and O 0 0.030102994292974472
manifests O 1 0.985879123210907
extreme O 1 0.9663709402084351
radiosensitivity O 1 0.9964851140975952
and O 0 0.010393403470516205
a O 0 0.01228896714746952
strong O 0 0.07883463054895401
pre O 1 0.9898521304130554
- O 1 0.9913546442985535
disposition O 1 0.9754543304443359
to O 0 0.033268630504608154
malignancy B-Disease 1 0.9994118213653564
. O 0 0.054813072085380554

Heterozygotes O 0 0.1516343504190445
for O 0 0.02089950069785118
the O 0 0.01670486107468605
ATM O 0 0.2428852617740631
gene O 0 0.009999956004321575
have O 0 0.006232705898582935
no O 0 0.006730925291776657
clinical O 0 0.017758844420313835
expression O 0 0.006506614852696657
of O 0 0.008551571518182755
A B-Disease 1 0.9987549781799316
- I-Disease 1 0.9999943971633911
T I-Disease 1 0.9999940395355225
but O 0 0.008387968875467777
may O 0 0.011230901814997196
be O 0 0.00984746590256691
cancer B-Disease 1 0.9999501705169678
prone O 1 0.9910854697227478
with O 0 0.00939160119742155
a O 0 0.03398296982049942
moderate O 0 0.3521500527858734
increase O 0 0.013103869743645191
in O 0 0.013317682780325413
in O 0 0.0184102151542902
vitro O 0 0.27942854166030884
radiosensitivity O 1 0.7954930663108826
. O 0 0.04750741273164749

We O 0 0.03237700089812279
performed O 0 0.026679188013076782
a O 0 0.019437098875641823
blind O 0 0.06578832119703293
chromosomal O 0 0.026463821530342102
analysis O 0 0.013430718332529068
on O 0 0.014117453247308731
G2 O 1 0.9998475313186646
- O 1 0.6800358295440674
phase O 0 0.0626273900270462
lymphocytes O 0 0.04030032455921173
from O 0 0.008655974641442299
7 O 0 0.01132188644260168
unrelated O 0 0.012410009279847145
A B-Disease 1 0.5212976336479187
- I-Disease 1 0.9983674883842468
T I-Disease 1 0.9996867179870605
patients O 0 0.16982953250408173
, O 0 0.007834631949663162
13 O 0 0.009379874914884567
obligate O 0 0.01799643784761429
A B-Disease 1 0.722566545009613
- I-Disease 1 0.9998533725738525
T I-Disease 1 0.999990701675415
heterozygotes O 1 0.9953029155731201
( O 0 0.008921606466174126
parents O 0 0.007655145134776831
of O 0 0.006122807506471872
the O 0 0.011308416724205017
patients O 1 0.972826361656189
) O 0 0.006409421097487211
, O 0 0.005629782099276781
and O 0 0.005507837515324354
14 O 0 0.007363865617662668
normal O 0 0.006669114343822002
controls O 0 0.009089833125472069
following O 0 0.00925800483673811
X O 0 0.03249348700046539
- O 0 0.02086467482149601
irradiation O 0 0.021848807111382484
with O 0 0.010376458056271076
1 O 0 0.014521010220050812
Gy O 0 0.2953602075576782
in O 0 0.011202270165085793
order O 0 0.01084271352738142
to O 0 0.009034493006765842
evaluate O 0 0.01588832400739193
this O 0 0.010375713929533958
cytogenetic O 0 0.030168790370225906
method O 0 0.01123055163770914
as O 0 0.00912121869623661
a O 0 0.010731734335422516
tool O 0 0.01714392937719822
for O 0 0.0104076461866498
detection O 0 0.03110325150191784
of O 0 0.021531829610466957
ATM O 1 0.8985036611557007
carriers O 0 0.16264908015727997
. O 0 0.047439657151699066

Both O 0 0.03575388342142105
A B-Disease 1 0.664544939994812
- I-Disease 1 0.9998186230659485
T I-Disease 1 0.9999901056289673
homozygotes O 1 0.9995463490486145
and O 0 0.025014584884047508
heterozygotes O 1 0.9274484515190125
showed O 0 0.0147074144333601
significantly O 0 0.010031200014054775
increased O 0 0.009550107643008232
levels O 0 0.009542547166347504
of O 0 0.010231745429337025
radiation O 1 0.9820965528488159
- O 1 0.998340368270874
induced O 1 0.9999436140060425
chromatid O 1 0.9999890327453613
damage O 1 0.9554814100265503
relative O 0 0.015267851762473583
to O 0 0.010362145490944386
that O 0 0.009703058749437332
of O 0 0.013455028645694256
normal O 0 0.021030159667134285
controls O 0 0.03840722143650055
. O 0 0.04114833474159241

These O 0 0.024153243750333786
results O 0 0.018036754801869392
show O 0 0.013379831798374653
that O 0 0.01098628994077444
the O 0 0.014026490040123463
G2 O 1 0.9999372959136963
- O 1 0.9691295623779297
phase O 1 0.8564814329147339
chromosomal O 1 0.9813361763954163
radiosensitivity O 1 0.9956306219100952
assay O 0 0.030365586280822754
can O 0 0.009392932057380676
be O 0 0.007199706044048071
used O 0 0.00784729328006506
for O 0 0.00694506149739027
the O 0 0.008540206588804722
detection O 0 0.01636194810271263
of O 0 0.013601718470454216
A B-Disease 1 0.993928074836731
- I-Disease 1 0.9999033212661743
T I-Disease 1 0.9999698400497437
heterozygotes O 1 0.9936612844467163
. O 0 0.0579206645488739

In O 0 0.029714388772845268
combination O 0 0.03080355003476143
with O 0 0.013370374217629433
molecular O 0 0.022016581147909164
genetic O 0 0.017119769006967545
analyses O 0 0.011342229321599007
, O 0 0.006616251077502966
this O 0 0.005338381975889206
test O 0 0.007378875277936459
may O 0 0.004632129333913326
be O 0 0.0037711511831730604
of O 0 0.004313829820603132
value O 0 0.004757788963615894
in O 0 0.00453033484518528
studies O 0 0.005667575169354677
of O 0 0.007470547687262297
familial B-Disease 1 0.9986312985420227
and I-Disease 0 0.2356330305337906
sporadic I-Disease 1 0.9903662204742432
cancers I-Disease 1 0.9999374151229858
aimed O 0 0.05267120152711868
at O 0 0.008615681901574135
determination O 0 0.01124759390950203
of O 0 0.006825583521276712
the O 0 0.0075315735302865505
potential O 0 0.009414168074727058
involvement O 0 0.011945217847824097
of O 0 0.011307674460113049
ATM O 1 0.9667574763298035
mutations O 0 0.06052247807383537
in O 0 0.026528652757406235
tumor B-Disease 1 0.999977707862854
risk O 1 0.9273526668548584
or O 0 0.014602318406105042
development O 0 0.03307924047112465
. O 0 0.024075333029031754
. O 0 0.03980708494782448

Ataxia B-Disease 1 0.9999980926513672
- I-Disease 1 0.9996742010116577
telangiectasia I-Disease 1 0.9999852180480957
: O 0 0.020797565579414368
identification O 0 0.01561042107641697
and O 0 0.008969355374574661
detection O 0 0.07427587360143661
of O 0 0.013574249111115932
founder O 1 0.9966294169425964
- O 1 0.8562444448471069
effect O 0 0.012173226103186607
mutations O 0 0.010355384089052677
in O 0 0.00788892712444067
the O 0 0.011143255978822708
ATM O 0 0.07214163988828659
gene O 0 0.01435539685189724
in O 0 0.0147254578769207
ethnic O 0 0.022819047793745995
populations O 0 0.027623707428574562
. O 0 0.03724079951643944

To O 0 0.029838252812623978
facilitate O 0 0.02466668002307415
the O 0 0.014781990088522434
evaluation O 0 0.01914558745920658
of O 0 0.01567588746547699
ATM O 1 0.9748929738998413
heterozygotes O 1 0.9395474791526794
for O 0 0.010854150168597698
susceptibility O 1 0.731806755065918
to O 0 0.007841259241104126
other O 0 0.006903654430061579
diseases O 1 0.9996671676635742
, O 0 0.009980540722608566
such O 0 0.021090371534228325
as O 1 0.9927499294281006
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, O 0 0.07050683349370956
we O 0 0.004958658013492823
have O 0 0.004198719747364521
attempted O 0 0.007289829198271036
to O 0 0.004923926666378975
define O 0 0.006641352083534002
the O 0 0.0053251818753778934
most O 0 0.00505140470340848
common O 0 0.005165589042007923
mutations O 0 0.004971902817487717
and O 0 0.004544834140688181
their O 0 0.004496418405324221
frequencies O 0 0.006568973883986473
in O 0 0.010175890289247036
ataxia B-Disease 1 0.9999982118606567
- I-Disease 1 0.9998946189880371
telangiectasia I-Disease 1 0.9999983310699463
( O 0 0.20142775774002075
A B-Disease 1 0.9861153364181519
- I-Disease 1 0.9996391534805298
T I-Disease 1 0.9998162388801575
) O 0 0.01799565926194191
homozygotes O 0 0.2588072717189789
from O 0 0.013315457850694656
10 O 0 0.01843368634581566
ethnic O 0 0.021458687260746956
populations O 0 0.02765474282205105
. O 0 0.03667529299855232

Both O 0 0.0393119677901268
genomic O 0 0.04968365281820297
mutations O 0 0.02652636170387268
and O 0 0.01422084029763937
their O 0 0.013170028105378151
effects O 0 0.020456941798329353
on O 0 0.016875596717000008
cDNA O 0 0.049401480704545975
were O 0 0.01988068036735058
characterized O 0 0.07165464013814926
. O 0 0.04197544977068901

Protein O 0 0.05399608239531517
- O 0 0.04448622465133667
truncation O 0 0.051628559827804565
testing O 0 0.024071166291832924
of O 0 0.01703157275915146
the O 0 0.015436360612511635
entire O 0 0.021400347352027893
ATM O 0 0.03329174593091011
cDNA O 0 0.030433768406510353
detected O 0 0.02038116380572319
92 O 0 0.030066903680562973
( O 0 0.016863394528627396
66 O 0 0.024928057566285133
% O 0 0.016062002629041672
) O 0 0.017977284267544746
truncating O 0 0.0450277179479599
mutations O 0 0.021947743371129036
in O 0 0.019240429624915123
140 O 0 0.04071594774723053
mutant O 0 0.08157967031002045
alleles O 0 0.05729774385690689
screened O 0 0.0688672587275505
. O 0 0.057555489242076874

The O 0 0.03798936307430267
haplotyping O 1 0.7656500935554504
of O 0 0.04352942854166031
patients O 1 0.9802907705307007
with O 0 0.032077398151159286
identical O 1 0.6026237607002258
mutations O 0 0.1454116553068161
indicates O 0 0.010272178798913956
that O 0 0.004324518144130707
almost O 0 0.00460142083466053
all O 0 0.003734336234629154
of O 0 0.004203870892524719
these O 0 0.004145415034145117
represent O 0 0.005949255079030991
common O 0 0.006280943285673857
ancestry O 0 0.008552518673241138
and O 0 0.006217773072421551
that O 0 0.005381358787417412
very O 0 0.008182475343346596
few O 0 0.011075731366872787
spontaneously O 0 0.1588626205921173
recurring O 1 0.9889418482780457
ATM O 1 0.9600226879119873
mutations O 0 0.03381923586130142
exist O 0 0.029473144561052322
. O 0 0.03832429647445679

Assays O 0 0.06906987726688385
requiring O 0 0.03653145581483841
minimal O 0 0.03084995038807392
amounts O 0 0.01685892790555954
of O 0 0.011329307220876217
genomic O 0 0.01875762641429901
DNA O 0 0.010188332758843899
were O 0 0.007206419482827187
designed O 0 0.010992374271154404
to O 0 0.007276653312146664
allow O 0 0.009021238423883915
rapid O 0 0.01577296480536461
screening O 0 0.015109156258404255
for O 0 0.0114910202100873
common O 0 0.014809778891503811
ethnic O 0 0.022417927160859108
mutations O 0 0.036392562091350555
. O 0 0.0343015119433403

These O 0 0.032903384417295456
rapid O 0 0.04182197526097298
assays O 0 0.039330482482910156
detected O 0 0.024409828707575798
mutations O 0 0.016230259090662003
in O 0 0.009284675121307373
76 O 0 0.01710786484181881
% O 0 0.009762251749634743
of O 0 0.008424617350101471
Costa O 0 0.3993586599826813
Rican O 1 0.7902060747146606
patients O 1 0.8937863707542419
( O 0 0.00837585050612688
3 O 0 0.009491113014519215
) O 0 0.006565443240106106
, O 0 0.006897217594087124
50 O 0 0.00750004593282938
% O 0 0.00665052467957139
of O 0 0.0060368431732058525
Norwegian O 0 0.01640445552766323
patients O 0 0.13222523033618927
( O 0 0.006734287366271019
1 O 0 0.008143351413309574
) O 0 0.005870100110769272
, O 0 0.005752271972596645
25 O 0 0.007416017819195986
% O 0 0.006083960644900799
of O 0 0.006515510380268097
Polish O 1 0.9214872717857361
patients O 1 0.9148043990135193
( O 0 0.008482218720018864
4 O 0 0.009860549122095108
) O 0 0.006400587968528271
, O 0 0.006495779845863581
and O 0 0.0052409968338906765
14 O 0 0.006741125602275133
% O 0 0.00575748085975647
of O 0 0.006664841435849667
Italian O 1 0.9347655177116394
patients O 1 0.9850467443466187
( O 0 0.015321864746510983
1 O 0 0.00990400929003954
) O 0 0.006678610108792782
, O 0 0.006294785533100367
as O 0 0.005894520785659552
well O 0 0.005971917416900396
as O 0 0.005926909856498241
in O 0 0.007143533322960138
patients O 0 0.027078768238425255
of O 0 0.011879662051796913
Amish O 1 0.9487530589103699
/ O 1 0.9868254065513611
Mennonite O 1 0.8894762396812439
and O 0 0.018138723447918892
Irish O 0 0.03262196481227875
English O 0 0.02728785201907158
backgrounds O 0 0.039110615849494934
. O 0 0.041445259004831314

Additional O 0 0.03638816624879837
mutations O 0 0.022700339555740356
were O 0 0.011757850646972656
observed O 0 0.011446965858340263
in O 0 0.009472479112446308
Japanese O 0 0.018776319921016693
, O 0 0.01166035607457161
Utah O 0 0.020681306719779968
Mormon O 0 0.023828061297535896
, O 0 0.014296851120889187
and O 0 0.014226310886442661
African O 0 0.035955458879470825
American O 0 0.10163619369268417
patients O 1 0.9507551789283752
. O 0 0.04375850409269333

These O 0 0.031059252098202705
assays O 0 0.036362193524837494
should O 0 0.016623279079794884
facilitate O 0 0.019835492596030235
screening O 0 0.017955418676137924
for O 0 0.011327994056046009
A B-Disease 1 0.8658487200737
- I-Disease 1 0.9998219609260559
T I-Disease 1 0.9999785423278809
heterozygotes O 1 0.9519920349121094
in O 0 0.011452012695372105
the O 0 0.013816683553159237
populations O 0 0.018314974382519722
studied O 0 0.02771425060927868
. O 0 0.02772456593811512
. O 0 0.03900160267949104

The O 0 0.053317051380872726
von B-Disease 1 0.9868502616882324
Hippel I-Disease 1 0.9999630451202393
- I-Disease 1 0.999954342842102
Lindau I-Disease 1 0.9999957084655762
tumor I-Disease 1 0.9999898672103882
suppressor O 1 0.9991293549537659
gene O 0 0.01789425127208233
is O 0 0.00903396401554346
required O 0 0.009845026768743992
for O 0 0.009800104424357414
cell O 0 0.020402327179908752
cycle O 0 0.02217402122914791
exit O 0 0.031601790338754654
upon O 0 0.02921537682414055
serum O 1 0.972258985042572
withdrawal O 0 0.21493776142597198
. O 0 0.05439389497041702

The O 0 0.04143667593598366
inactivation O 0 0.20333896577358246
of O 0 0.023158079013228416
the O 0 0.02375069074332714
von B-Disease 1 0.9980096220970154
Hippel I-Disease 1 0.9999834299087524
- I-Disease 1 0.9998241066932678
Lindau I-Disease 1 0.99997878074646
( I-Disease 1 0.6996750831604004
VHL I-Disease 1 0.999994158744812
) I-Disease 0 0.2091788351535797
tumor I-Disease 1 0.9997438788414001
suppressor O 1 0.9968517422676086
gene O 0 0.02446867898106575
predisposes O 1 0.9767076373100281
affected O 0 0.010731775313615799
individuals O 0 0.006035590078681707
to O 0 0.00657454039901495
the O 0 0.0541103221476078
human O 1 0.9995005130767822
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9841201901435852
is O 0 0.35723990201950073
associated O 0 0.17729821801185608
with O 1 0.7220126986503601
sporadic B-Disease 1 0.9999849796295166
renal I-Disease 1 1.0
cell I-Disease 1 0.9999996423721313
carcinomas I-Disease 1 1.0
( O 1 0.9999228715896606
RCC B-Disease 1 0.9999998807907104
) O 0 0.32577812671661377
and O 0 0.22025948762893677
brain B-Disease 1 0.9897245168685913
hemangioblastomas I-Disease 1 0.9931154847145081
. O 0 0.06305684894323349

VHL O 1 0.9959825277328491
- O 0 0.226265087723732
negative O 0 0.04321502149105072
786 O 1 0.9911513924598694
- O 1 0.975016176700592
0 O 0 0.1865370273590088
RCC B-Disease 1 0.999862790107727
cells O 0 0.02351214736700058
are O 0 0.011925806291401386
tumorigenic O 0 0.26791736483573914
in O 0 0.015647489577531815
nude O 1 0.9317895770072937
mice O 0 0.09737841039896011
which O 0 0.008870542049407959
is O 0 0.009622481651604176
suppressed O 0 0.019709831103682518
by O 0 0.010401105508208275
the O 0 0.014385856688022614
reintroduction O 1 0.7855761647224426
of O 0 0.18920399248600006
VHL B-Disease 1 0.9999375343322754
. O 0 0.06005711480975151

Remarkably O 0 0.39060354232788086
, O 0 0.019434945657849312
this O 0 0.01079993974417448
occurs O 0 0.010133443400263786
without O 0 0.007505414541810751
affecting O 0 0.01027283351868391
the O 0 0.006928053218871355
growth O 0 0.012400573119521141
rate O 0 0.007394146639853716
and O 0 0.006605174858123064
cell O 0 0.010739294812083244
cycle O 0 0.010250492952764034
profile O 0 0.01278567872941494
of O 0 0.009082063101232052
these O 0 0.009112848900258541
cells O 0 0.013002914376556873
in O 0 0.014136693440377712
culture O 0 0.030773188918828964
. O 0 0.0377715565264225

The O 0 0.03771297633647919
786 O 1 0.757813572883606
- O 0 0.3126182556152344
0 O 0 0.0262483898550272
cell O 0 0.01869293861091137
line O 0 0.01505288202315569
, O 0 0.008836770430207253
like O 0 0.008917277678847313
many O 0 0.009743987582623959
cancer B-Disease 1 0.9999675750732422
cells O 0 0.03741868585348129
, O 0 0.00844094343483448
fails O 0 0.015219733119010925
to O 0 0.008346940390765667
exit O 0 0.013925984501838684
the O 0 0.01189366914331913
cell O 0 0.020572494715452194
cycle O 0 0.022198641672730446
upon O 0 0.02361314557492733
serum O 1 0.8631499409675598
withdrawal O 0 0.09627629071474075
. O 0 0.04860382154583931

Here O 0 0.02993432991206646
, O 0 0.018136078491806984
it O 0 0.010572693310678005
is O 0 0.008701667189598083
shown O 0 0.007740894798189402
that O 0 0.005807706154882908
reintroduction O 0 0.012884344905614853
of O 0 0.00718141533434391
the O 0 0.007768128998577595
wild O 0 0.026317071169614792
- O 1 0.9645358920097351
type O 1 0.6286911964416504
VHL B-Disease 1 0.9993770718574524
gene O 0 0.011880983598530293
restores O 0 0.020641380921006203
the O 0 0.009798729792237282
ability O 0 0.011384570971131325
of O 0 0.015108546242117882
VHL O 1 0.9999977350234985
- O 1 0.9999215602874756
negative O 1 0.9917068481445312
RCC B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999681711196899
cells O 0 0.013245755806565285
to O 0 0.008418249897658825
exit O 0 0.012136342003941536
the O 0 0.009828958660364151
cell O 0 0.012503852136433125
cycle O 0 0.013783691450953484
and O 0 0.012240375392138958
enter O 0 0.030111461877822876
G0 O 1 0.9996988773345947
/ O 1 0.9710931777954102
quiescence O 1 0.9483979344367981
in O 0 0.030467169359326363
low O 0 0.10689973831176758
serum O 1 0.8989843130111694
. O 0 0.05932458117604256

Both O 0 0.04138908162713051
VHL O 1 0.999506950378418
- O 1 0.6052289605140686
positive O 0 0.022750576958060265
and O 0 0.08250623196363449
VHL O 1 0.9999926090240479
- O 1 0.9990409016609192
negative O 1 0.7980573773384094
RCC B-Disease 1 0.9999966621398926
cells O 0 0.04936947301030159
exit O 0 0.024279722943902016
the O 0 0.015568554401397705
cell O 0 0.02354579046368599
cycle O 0 0.021893518045544624
by O 0 0.017933905124664307
contact O 0 0.03687184303998947
inhibition O 0 0.195066899061203
. O 0 0.04021438583731651

The O 0 0.06420572847127914
cyclin O 1 0.9520178437232971
- O 1 0.5036714673042297
dependent O 0 0.10679357498884201
kinase O 1 0.8614717721939087
inhibitor O 1 0.9758719801902771
, O 0 0.02016255259513855
p27 O 1 0.9653629064559937
, O 0 0.015449555590748787
accumulates O 0 0.21038566529750824
upon O 0 0.014684074558317661
serum O 1 0.9473719000816345
withdrawal O 0 0.04648365080356598
, O 0 0.007682957220822573
only O 0 0.005818814970552921
in O 0 0.005594061687588692
the O 0 0.006246504839509726
presence O 0 0.008151636458933353
of O 0 0.011495701037347317
VHL B-Disease 1 0.9998902082443237
, O 0 0.008834008127450943
as O 0 0.0070480164140462875
a O 0 0.008101719431579113
result O 0 0.007511937990784645
of O 0 0.00755315413698554
the O 0 0.009184793569147587
stabilization O 0 0.45407918095588684
of O 0 0.016145911067724228
the O 0 0.02202177606523037
protein O 0 0.03195786848664284
. O 0 0.03832727298140526

We O 0 0.02987716719508171
propose O 0 0.03098038211464882
that O 0 0.01214007567614317
the O 0 0.011293631047010422
loss O 0 0.014486482366919518
of O 0 0.00960333738476038
wild O 0 0.12871812283992767
- O 1 0.9994243383407593
type O 1 0.9949145317077637
VHL B-Disease 1 0.9999477863311768
gene O 0 0.009815775789320469
results O 0 0.008411959744989872
in O 0 0.00671750120818615
a O 0 0.00729172071442008
specific O 0 0.007291354238986969
cellular O 0 0.2729886472225189
defect O 1 0.8906577229499817
in O 0 0.011988470330834389
serum O 1 0.9949215054512024
- O 1 0.7858301401138306
dependent O 0 0.013792594894766808
growth O 0 0.014828854240477085
control O 0 0.011030355468392372
, O 0 0.009086024947464466
which O 0 0.009166429750621319
may O 0 0.015528696589171886
initiate O 1 0.7042381763458252
tumor B-Disease 1 0.9991742968559265
formation O 0 0.17207610607147217
. O 0 0.0464368537068367

This O 0 0.03233424201607704
is O 0 0.021671120077371597
corrected O 0 0.02577081508934498
by O 0 0.011006726883351803
the O 0 0.01031549647450447
reintroduction O 0 0.02054131217300892
of O 0 0.010230094194412231
wild O 0 0.08326981961727142
- O 1 0.9953187108039856
type O 1 0.9866125583648682
VHL B-Disease 1 0.9999808073043823
, O 0 0.04991336539387703
implicating O 1 0.993682861328125
VHL B-Disease 1 0.9998111128807068
as O 0 0.011616874486207962
the O 0 0.0121446643024683
first O 0 0.09988843649625778
tumor B-Disease 1 0.999468982219696
suppressor O 1 0.6884401440620422
involved O 0 0.008579306304454803
in O 0 0.005722715053707361
the O 0 0.005493828561156988
regulation O 0 0.006374660413712263
of O 0 0.005417258944362402
cell O 0 0.010542159900069237
cycle O 0 0.00966845266520977
exit O 0 0.012024112045764923
, O 0 0.0064618210308253765
which O 0 0.005124258808791637
is O 0 0.005390882026404142
consistent O 0 0.007777117192745209
with O 0 0.006775607354938984
its O 0 0.009385693818330765
gatekeeper O 1 0.9947742819786072
function O 0 0.012702550739049911
in O 0 0.012131455354392529
the O 0 0.05117529258131981
kidney O 1 0.9999768733978271
. O 0 0.02846057526767254
. O 0 0.040579427033662796

Piebaldism B-Disease 1 0.9996562004089355
with O 1 0.6406755447387695
deafness B-Disease 1 0.9999992847442627
: O 0 0.06252078711986542
molecular O 0 0.02129070647060871
evidence O 0 0.012877171859145164
for O 0 0.012874579057097435
an O 0 0.10946580767631531
expanded O 1 0.9919083714485168
syndrome O 1 0.9999996423721313
. O 0 0.22779372334480286

In O 0 0.030808350071310997
a O 0 0.02409564144909382
South O 0 0.020943308249115944
African O 0 0.019508961588144302
girl O 0 0.049766916781663895
of O 0 0.014873719774186611
Xhosa O 1 0.9998958110809326
stock O 0 0.4442404508590698
with O 0 0.05449743568897247
severe O 1 0.9999986886978149
piebaldism B-Disease 1 0.9999997615814209
and O 1 0.9999425411224365
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 1 0.9260683059692383
identified O 0 0.14708490669727325
a O 0 0.02337011694908142
novel O 0 0.18978644907474518
missense O 0 0.21219679713249207
substitution O 0 0.0159805528819561
at O 0 0.010428136214613914
a O 0 0.009959589689970016
highly O 0 0.01298799179494381
conserved O 0 0.013008778914809227
residue O 0 0.01405248325318098
in O 0 0.008621923625469208
the O 0 0.010502357967197895
intracellular O 0 0.022854458540678024
kinase O 0 0.02257034182548523
domain O 0 0.015177182853221893
of O 0 0.013271376490592957
the O 0 0.020680002868175507
KIT O 1 0.9998823404312134
proto O 1 0.9998898506164551
- O 1 0.9983054399490356
oncogene O 1 0.9997816681861877
, O 0 0.05361217260360718
R796G O 1 0.6000992655754089
. O 0 0.0614142008125782

Though O 0 0.05029398202896118
auditory B-Disease 1 0.9563801288604736
anomalies I-Disease 0 0.40696337819099426
have O 0 0.012352528050541878
been O 0 0.00989907793700695
observed O 0 0.00930208619683981
in O 0 0.008542799390852451
mice O 0 0.010943581350147724
with O 0 0.007492903620004654
dominant O 0 0.1443644016981125
white O 1 0.5891444087028503
spotting O 1 0.9972400665283203
( O 0 0.2276773899793625
W O 1 0.9857816100120544
) O 0 0.009923527017235756
due O 0 0.010536588728427887
to O 0 0.011858907528221607
KIT O 1 0.9997101426124573
mutations O 0 0.26904627680778503
, O 0 0.10335129499435425
deafness B-Disease 1 0.9999951124191284
is O 0 0.012731563299894333
not O 0 0.010378822684288025
typical O 0 0.017789097502827644
in O 0 0.01371682994067669
human O 0 0.022389519959688187
piebaldism B-Disease 1 0.9663763046264648
. O 0 0.04777860268950462

Thus O 0 0.030559834092855453
, O 0 0.019087865948677063
the O 0 0.015069073997437954
occurrence O 0 0.06970145553350449
of O 1 0.5615257024765015
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 1 0.5845276117324829
this O 0 0.023665716871619225
patient O 1 0.9976089000701904
extends O 0 0.38113340735435486
considerably O 0 0.014177203178405762
the O 0 0.009433739818632603
phenotypic O 0 0.015595471486449242
range O 0 0.010530024766921997
of O 0 0.008805717341601849
piebaldism B-Disease 0 0.31940558552742004
due O 0 0.009368064813315868
to O 0 0.010871851816773415
KIT O 1 0.9930155277252197
gene O 0 0.012371286749839783
mutation O 0 0.010259897448122501
in O 0 0.007749011740088463
humans O 0 0.008395698852837086
and O 0 0.009128522127866745
tightens O 1 0.6106501817703247
the O 0 0.011837140657007694
clinical O 1 0.7485265135765076
similarity O 0 0.014276699163019657
between O 0 0.008748786523938179
piebaldism B-Disease 0 0.27487537264823914
and O 0 0.008520650677382946
the O 0 0.007626242935657501
various O 0 0.007541225291788578
forms O 0 0.02867327444255352
of O 1 0.995202898979187
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.7470186352729797
. O 0 0.05445363372564316

Cycloheximide O 1 0.7697979211807251
facilitates O 0 0.05524030327796936
the O 0 0.02309863269329071
identification O 0 0.01979098655283451
of O 0 0.013408810831606388
aberrant O 0 0.35025689005851746
transcripts O 0 0.017424825578927994
resulting O 0 0.012167430482804775
from O 0 0.008422530256211758
a O 0 0.010012275539338589
novel O 0 0.020540062338113785
splice O 0 0.3625064194202423
- O 0 0.06496375054121017
site O 0 0.013441312126815319
mutation O 0 0.01079628337174654
in O 0 0.009254686534404755
COL17A1 O 1 0.6827681064605713
in O 0 0.009767042472958565
a O 0 0.020186729729175568
patient O 1 0.9982330799102783
with O 1 0.6709180474281311
generalized O 1 0.9999943971633911
atrophic B-Disease 1 1.0
benign I-Disease 1 0.9999998807907104
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999997615814209
. O 1 0.9317419528961182

Patients O 1 0.9988839030265808
with O 1 0.6894346475601196
generalized O 1 0.999995231628418
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 1 0.5894393920898438
show O 0 0.030727488920092583
decreased O 0 0.3101406395435333
expression O 0 0.020376693457365036
of O 0 0.3140817880630493
type O 1 0.9998708963394165
XVII O 1 1.0
collagen O 1 0.9999955892562866
, O 0 0.032660793513059616
a O 0 0.03763221576809883
transmembrane O 1 0.9859017133712769
hemidesmosomal O 1 0.9880644679069519
protein O 0 0.02823634259402752
encoded O 0 0.030198341235518456
by O 0 0.031480543315410614
COL17A1 O 1 0.8159798383712769
. O 0 0.05900777503848076

This O 0 0.02831978164613247
report O 0 0.02327106148004532
documents O 0 0.020229099318385124
a O 0 0.01649686135351658
novel O 0 0.0235939659178257
splice O 0 0.11053939163684845
- O 0 0.03064313717186451
site O 0 0.015618341974914074
mutation O 0 0.013211626559495926
in O 0 0.009764703921973705
COL17A1 O 1 0.7081496715545654
in O 0 0.009742516092956066
a O 0 0.013856686651706696
patient O 1 0.9845372438430786
with O 1 0.5375611782073975
generalized O 1 0.9999972581863403
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 1 0.8921638131141663
and O 0 0.0288753192871809
applies O 0 0.01287756022065878
a O 0 0.00996048841625452
new O 0 0.009500020183622837
methodology O 0 0.012863069772720337
to O 0 0.009164298884570599
define O 0 0.014012706466019154
and O 0 0.010918345302343369
characterize O 0 0.022514335811138153
the O 0 0.014744301326572895
resulting O 0 0.02339768595993519
mRNA O 0 0.03795018419623375
splice O 0 0.07960977405309677
variants O 0 0.04851922765374184
. O 0 0.04656155779957771

Mutational O 0 0.14046835899353027
analysis O 0 0.037537358701229095
of O 0 0.026605021208524704
COL17A1 O 1 0.9315544962882996
identified O 0 0.020783891901373863
a O 0 0.022342350333929062
maternally O 1 0.9958874583244324
inherited O 1 0.9997983574867249
G O 1 0.9935451745986938
- O 1 0.653292715549469
to O 0 0.013371865265071392
- O 1 0.854117214679718
T O 1 0.9357327222824097
transversion O 0 0.14210215210914612
at O 0 0.013845314271748066
the O 0 0.013208257965743542
- O 0 0.020591193810105324
1 O 0 0.020663633942604065
position O 0 0.023653974756598473
of O 0 0.024805350229144096
exon O 0 0.06826233118772507
32 O 0 0.053604379296302795
. O 0 0.05721205472946167

This O 0 0.039711564779281616
acceptor O 0 0.05452859029173851
splice O 0 0.22738318145275116
- O 0 0.09880541265010834
site O 0 0.01939206011593342
mutation O 0 0.014613891951739788
led O 0 0.011697803623974323
to O 0 0.008761664852499962
the O 0 0.008280806243419647
formation O 0 0.012243799865245819
of O 0 0.010361083783209324
aberrant O 0 0.1548885554075241
transcripts O 0 0.017334749922156334
present O 0 0.013305939733982086
at O 0 0.015069585293531418
extremely O 0 0.024506734684109688
low O 0 0.02872108295559883
levels O 0 0.02942916378378868
. O 0 0.041725486516952515

Based O 0 0.035929124802351
on O 0 0.01918274722993374
our O 0 0.01876836083829403
recent O 0 0.014686297625303268
finding O 0 0.014533762820065022
that O 0 0.012256135232746601
cycloheximide O 1 0.9870320558547974
stabilized O 1 0.993441104888916
mutant O 1 0.5183526277542114
COL17A1 O 1 0.9843552112579346
transcripts O 0 0.02357490174472332
in O 0 0.013794682919979095
keratinocytes O 0 0.30400678515434265
homozygous O 0 0.01897733472287655
for O 0 0.009752308949828148
a O 0 0.014585277996957302
frameshift O 1 0.9857100248336792
mutation O 0 0.017480412498116493
, O 0 0.008497294969856739
the O 0 0.0069578723050653934
effects O 0 0.009305937215685844
of O 0 0.0069344076327979565
the O 0 0.009986324235796928
splice O 1 0.5767168402671814
- O 0 0.04999261721968651
site O 0 0.011848614551126957
mutation O 0 0.010562650859355927
on O 0 0.008638793602585793
splicing O 0 0.01616596430540085
of O 0 0.011980690062046051
COL17A1 O 0 0.1935492753982544
transcripts O 0 0.016750575974583626
were O 0 0.009931315667927265
determined O 0 0.012640293687582016
using O 0 0.012070655822753906
reverse O 0 0.020702948793768883
transcriptase O 0 0.21651507914066315
polymerase O 0 0.027260717004537582
chain O 0 0.021857459098100662
reaction O 0 0.013572270050644875
of O 0 0.01045907847583294
total O 0 0.013281171210110188
RNA O 0 0.021525615826249123
from O 0 0.015854457393288612
keratinocytes O 0 0.10821445286273956
incubated O 0 0.044868141412734985
for O 0 0.024655019864439964
2 O 0 0.044393494725227356
. O 0 0.04927288368344307

5 O 0 0.046483512967824936
h O 0 0.040115468204021454
in O 0 0.0157642625272274
the O 0 0.012342712841928005
presence O 0 0.013636757619678974
or O 0 0.009556436911225319
absence O 0 0.015567664057016373
of O 0 0.013938621617853642
10 O 0 0.022949350997805595
microg O 1 0.977925181388855
cycloheximide O 1 0.9843956232070923
per O 0 0.03594425693154335
ml O 1 0.6241847276687622
. O 0 0.05474723130464554

Using O 0 0.028581498190760612
this O 0 0.016074078157544136
approach O 0 0.018812337890267372
, O 0 0.013029794208705425
an O 0 0.012560831382870674
abnormally O 0 0.3975997865200043
spliced O 0 0.02605053223669529
transcript O 0 0.0218936949968338
was O 0 0.014267434366047382
identified O 0 0.01010862085968256
that O 0 0.006245721131563187
contains O 0 0.00870951171964407
an O 0 0.007791388779878616
extra O 0 0.012742187827825546
264 O 0 0.018885137513279915
bases O 0 0.015121194534003735
upstream O 0 0.01743691973388195
from O 0 0.011929940432310104
exon O 0 0.025435427203774452
32 O 0 0.017163462936878204
, O 0 0.011865397915244102
resulting O 0 0.011366058140993118
in O 0 0.010032358579337597
a O 0 0.014019442722201347
premature O 0 0.15242616832256317
termination O 0 0.27824053168296814
codon O 0 0.029085798189044
27 O 0 0.026261860504746437
bp O 0 0.036569513380527496
downstream O 0 0.0265472624450922
from O 0 0.017382852733135223
the O 0 0.02178932912647724
cryptic O 0 0.0832114890217781
splice O 0 0.10617948323488235
site O 0 0.04686012864112854
. O 0 0.0499151349067688

Three O 0 0.02784409373998642
other O 0 0.016164621338248253
splice O 0 0.04874296858906746
variants O 0 0.01647454872727394
, O 0 0.00969008170068264
including O 0 0.008237193338572979
one O 0 0.007756700273603201
derived O 0 0.0072578866966068745
from O 0 0.006400351412594318
the O 0 0.0074920570477843285
skipping O 0 0.017529815435409546
of O 0 0.010951918549835682
exon O 0 0.10420045256614685
32 O 0 0.016324108466506004
, O 0 0.012308616191148758
were O 0 0.010594663210213184
also O 0 0.017147986218333244
identified O 0 0.026756128296256065
. O 0 0.03262932226061821

These O 0 0.026480620726943016
results O 0 0.020041001960635185
indicate O 0 0.01482397224754095
the O 0 0.011911025270819664
usefulness O 0 0.04273969307541847
of O 0 0.017102094367146492
cycloheximide O 1 0.9994348883628845
treatment O 1 0.9583122134208679
in O 0 0.009719889611005783
evaluating O 0 0.020557356998324394
the O 0 0.01044820249080658
abnormal O 0 0.01673956960439682
processing O 0 0.010666762478649616
of O 0 0.007531110197305679
mRNA O 0 0.011422877199947834
due O 0 0.008367813192307949
to O 0 0.009169921278953552
splice O 0 0.024050284177064896
- O 0 0.01918448507785797
site O 0 0.012821762822568417
mutations O 0 0.009830292314291
, O 0 0.00768214650452137
because O 0 0.0065077124163508415
( O 0 0.007922541350126266
i O 0 0.011018699035048485
) O 0 0.011226220056414604
aberrant O 0 0.021771807223558426
splicing O 0 0.017625587061047554
often O 0 0.008946644142270088
generates O 0 0.015219384804368019
a O 0 0.010296382941305637
premature O 0 0.06868977844715118
termination O 0 0.3896450996398926
codon O 0 0.021591566503047943
, O 0 0.011775300838053226
( O 0 0.011105724610388279
ii O 0 0.47529271245002747
) O 0 0.008685645647346973
transcripts O 0 0.013137156143784523
with O 0 0.008835935033857822
premature O 0 0.0947471484541893
termination O 0 0.4494834244251251
codons O 0 0.014603642746806145
can O 0 0.006477127317339182
occur O 0 0.006050523836165667
at O 0 0.006548725534230471
low O 0 0.007959551177918911
or O 0 0.007367311045527458
undetectable O 0 0.22656454145908356
levels O 0 0.007467305287718773
due O 0 0.006107939872890711
to O 0 0.006984199862927198
nonsense O 0 0.01411447487771511
- O 0 0.025709571316838264
mediated O 0 0.017665917053818703
mRNA O 0 0.011990110389888287
decay O 0 0.011857633478939533
, O 0 0.006977549754083157
and O 0 0.0068610478192567825
( O 0 0.008717439137399197
iii O 0 0.23213985562324524
) O 0 0.008398852311074734
the O 0 0.0070127020590007305
levels O 0 0.0066103246062994
of O 0 0.006539348978549242
these O 0 0.006197064649313688
transcripts O 0 0.01217169500887394
can O 0 0.007629331201314926
be O 0 0.00940797571092844
increased O 0 0.016580624505877495
by O 0 0.019876249134540558
cycloheximide O 0 0.22222933173179626
. O 0 0.046946343034505844

A O 0 0.05339076370000839
deletion O 0 0.20275633037090302
mutation O 0 0.02692348323762417
in O 0 0.015297666192054749
COL17A1 O 1 0.8649435043334961
in O 0 0.011284380219876766
five O 0 0.013242870569229126
Austrian O 1 0.9187813401222229
families O 0 0.02203953079879284
with O 0 0.358102947473526
generalized O 1 0.9999961853027344
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 1 0.9986501336097717
propagation O 1 0.9617077112197876
of O 0 0.06744939088821411
an O 0 0.2537926435470581
ancestral O 1 0.9898231625556946
allele O 1 0.882050096988678
. O 0 0.05175930634140968

Patients O 1 0.9955867528915405
with O 1 0.5091155767440796
generalized O 1 0.9999901056289673
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 1 0.7853980660438538
a O 0 0.04514050483703613
usually O 0 0.01914188079535961
nonlethal O 0 0.39954033493995667
form O 0 0.021438810974359512
of O 0 0.30332377552986145
junctional B-Disease 1 0.9999994039535522
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999995231628418
, O 0 0.0802743211388588
have O 0 0.013216178864240646
generalized O 1 0.963835597038269
blistering B-Disease 1 0.9999492168426514
, O 1 0.9961361289024353
nail B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
, O 1 0.9996498823165894
patchy B-Disease 1 0.9999998807907104
alopecia I-Disease 1 1.0
, O 1 0.9995519518852234
and O 1 0.9992170333862305
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999982118606567
. O 1 0.5977397561073303

Skin B-Disease 1 0.9999760389328003
fragility I-Disease 1 0.9997501969337463
in O 0 0.02459535002708435
most O 0 0.014761754311621189
cases O 0 0.016648123040795326
is O 0 0.007454614620655775
due O 0 0.006826003547757864
to O 0 0.006246590055525303
mutations O 0 0.0069839684292674065
in O 0 0.005601982120424509
the O 0 0.008084062486886978
gene O 0 0.010719035752117634
encoding O 0 0.018739914521574974
type O 1 0.9875693917274475
XVII O 1 0.9999998807907104
collagen O 1 0.9999964237213135
( O 1 0.7295942902565002
COL17A1 O 1 0.9991747736930847
) O 0 0.04012047126889229
. O 0 0.052202701568603516

Recently O 0 0.043321575969457626
, O 0 0.01802574284374714
we O 0 0.012768080458045006
reported O 0 0.01326463371515274
five O 0 0.01101736817508936
Austrian O 0 0.3052704632282257
families O 0 0.01498993020504713
with O 0 0.3321221172809601
generalized O 1 0.9999971389770508
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 1 0.9875714778900146
share O 0 0.2205757349729538
the O 0 0.026619868353009224
same O 0 0.03510528430342674
COL17A1 O 1 0.9998728036880493
mutation O 0 0.2316548228263855
. O 0 0.04521990194916725

Affected O 0 0.03568476065993309
individuals O 0 0.01650073751807213
in O 0 0.010209093801677227
three O 0 0.009131995029747486
families O 0 0.0077746263705194
are O 0 0.005593875888735056
homozygous O 0 0.012827154248952866
for O 0 0.008407991379499435
4003delTC O 1 0.9721735119819641
, O 0 0.008333440870046616
whereas O 0 0.007582521066069603
those O 0 0.005597935523837805
in O 0 0.00616214657202363
two O 0 0.006983584724366665
others O 0 0.009839974343776703
are O 0 0.011164899915456772
compound O 0 0.03498280420899391
heterozygotes O 1 0.5710723400115967
. O 0 0.04632367566227913

To O 0 0.02541532926261425
determine O 0 0.019434357061982155
if O 0 0.01126233022660017
the O 0 0.010056796483695507
occurrence O 0 0.012041179463267326
of O 0 0.01004912331700325
4003delTC O 1 0.7031874060630798
in O 0 0.009519625455141068
these O 0 0.0070963408797979355
unrelated O 0 0.01635795086622238
families O 0 0.010167093947529793
signifies O 0 0.35944145917892456
propagation O 0 0.015521029010415077
of O 0 0.009899821132421494
an O 0 0.00983470305800438
ancestral O 0 0.3140091001987457
allele O 0 0.019664332270622253
or O 0 0.008597702719271183
a O 0 0.01157340221107006
mutational O 1 0.9981840252876282
hot O 1 0.8655251860618591
spot O 0 0.05255495011806488
, O 0 0.01160676684230566
haplotypes O 0 0.01953272521495819
were O 0 0.008248597383499146
determined O 0 0.009148639626801014
for O 0 0.010754923336207867
polymorphisms O 0 0.019598182290792465
both O 0 0.012554286047816277
within O 0 0.016443248838186264
and O 0 0.02242070622742176
flanking O 1 0.9848259687423706
COL17A1 O 1 0.9993898868560791
. O 0 0.05483298376202583

Five O 0 0.05178837105631828
intragenic O 1 0.7303866744041443
polymorphisms O 0 0.0411025732755661
were O 0 0.01892383210361004
chosen O 0 0.02135585807263851
based O 0 0.016559403389692307
on O 0 0.01663239300251007
their O 0 0.02315833792090416
informativeness O 1 0.6827664375305176
. O 0 0.04683695361018181

One O 0 0.02587524801492691
of O 0 0.01386106014251709
these O 0 0.008856697008013725
, O 0 0.007509170100092888
not O 0 0.005864943377673626
previously O 0 0.007877370342612267
reported O 0 0.008330005221068859
, O 0 0.007244831882417202
was O 0 0.01137587334960699
2988 O 1 0.5190322995185852
A O 0 0.017536098137497902
or O 0 0.00943963322788477
C O 0 0.02060905657708645
that O 0 0.007723304908722639
introduces O 0 0.01918758451938629
a O 0 0.011185254901647568
new O 0 0.013186522759497166
restriction O 0 0.01949421688914299
site O 0 0.018505319952964783
for O 0 0.018103696405887604
Eco0109 O 1 0.586246907711029
I O 0 0.055992282927036285
. O 0 0.05400724336504936

All O 0 0.034098558127880096
the O 0 0.025051023811101913
4003delTC O 1 0.8513970971107483
alleles O 0 0.026173792779445648
showed O 0 0.016240011900663376
the O 0 0.011568057350814342
same O 0 0.010252661071717739
haplotype O 0 0.023333899676799774
for O 0 0.010538091883063316
these O 0 0.011072667315602303
five O 0 0.017442286014556885
polymorphic O 0 0.2617911994457245
markers O 0 0.058742690831422806
. O 0 0.04415421187877655

Fourteen O 0 0.09947187453508377
microsatellite O 1 0.8216984868049622
polymorphisms O 0 0.04638746753334999
were O 0 0.016463516280055046
selected O 0 0.019948476925492287
based O 0 0.013709655962884426
on O 0 0.0116358557716012
their O 0 0.01132864598184824
high O 0 0.015202371403574944
heterozygosity O 0 0.44586318731307983
and O 0 0.010894745588302612
their O 0 0.009885608218610287
location O 0 0.01384786143898964
within O 0 0.014676992781460285
10q23 O 1 0.8129456639289856
- O 0 0.4871894419193268
q25 O 1 0.8171842694282532
near O 0 0.04975598305463791
COL17A1 O 1 0.9040173292160034
. O 0 0.06185522675514221

Three O 0 0.03568660467863083
families O 0 0.0254269577562809
shared O 0 0.027130477130413055
microsatellite O 1 0.9755520224571228
polymorphisms O 0 0.1342163234949112
covering O 0 0.06306464970111847
at O 0 0.011268102563917637
most O 0 0.008839673362672329
19 O 0 0.014153383672237396
cM O 0 0.027565820142626762
, O 0 0.008458523079752922
whereas O 0 0.008268086239695549
the O 0 0.006638684775680304
others O 0 0.006540367379784584
shared O 0 0.0071524060331285
smaller O 0 0.006285682786256075
regions O 0 0.005868514534085989
consistent O 0 0.0071936966851353645
with O 0 0.005956911016255617
cross O 0 0.01163763739168644
- O 0 0.023825909942388535
over O 0 0.006746772676706314
events O 0 0.006918624043464661
during O 0 0.007044033147394657
passage O 0 0.008883081376552582
of O 0 0.007523198612034321
this O 0 0.009053800255060196
mutation O 0 0.012862621806561947
through O 0 0.013051864691078663
several O 0 0.01676192134618759
generations O 0 0.0341031439602375
. O 0 0.03752084821462631

These O 0 0.02581341192126274
results O 0 0.02012450061738491
indicate O 0 0.016851359978318214
that O 0 0.012045490555465221
4003delTC O 0 0.16975921392440796
occurs O 0 0.01198719535022974
on O 0 0.010696093551814556
a O 0 0.013406263664364815
single O 0 0.021716825664043427
ancestral O 0 0.06982885301113129
allele O 0 0.050437264144420624
. O 0 0.03011094406247139
. O 0 0.04521507769823074

The O 0 0.06680688261985779
haptoglobin O 1 0.9879215955734253
- O 1 0.6050873398780823
gene O 0 0.03644522652029991
deletion O 0 0.06841664761304855
responsible O 0 0.03757352754473686
for O 0 0.03845696896314621
anhaptoglobinemia B-Disease 1 0.9930804371833801
. O 0 0.054031986743211746

We O 0 0.02655353955924511
have O 0 0.01416073925793171
found O 0 0.011146756820380688
an O 0 0.00947801023721695
allelic O 0 0.11093486845493317
deletion O 0 0.023660162463784218
of O 0 0.011215715669095516
the O 0 0.156641885638237
haptoglobin O 1 0.9999356269836426
( O 0 0.16002140939235687
Hp O 1 0.9580625891685486
) O 0 0.010744255036115646
gene O 0 0.010526989586651325
from O 0 0.008535707369446754
an O 0 0.010823888704180717
individual O 0 0.01458731945604086
with O 0 0.018271751701831818
anhaptoglobinemia B-Disease 1 0.9547039270401001
. O 0 0.043772872537374496

The O 0 0.0371362678706646
Hp O 1 0.6935724020004272
gene O 0 0.02162805199623108
cluster O 0 0.024172158911824226
consists O 0 0.014155114069581032
of O 0 0.009195596911013126
coding O 0 0.014722450636327267
regions O 0 0.008431467227637768
of O 0 0.007061751093715429
the O 0 0.008223955519497395
alpha O 0 0.0768057256937027
chain O 0 0.01954663172364235
and O 0 0.007908600382506847
beta O 0 0.013623110018670559
chain O 0 0.012517889030277729
of O 0 0.007528288289904594
the O 0 0.008570472709834576
haptoglobin O 1 0.9815094470977783
gene O 0 0.01071461196988821
( O 0 0.008799099363386631
Hp O 0 0.034003619104623795
) O 0 0.008303824812173843
and O 0 0.0074055795557796955
of O 0 0.007097460329532623
the O 0 0.008143393322825432
alpha O 0 0.017895199358463287
chain O 0 0.015898093581199646
and O 0 0.00798794999718666
beta O 0 0.013728477992117405
chain O 0 0.011282115243375301
of O 0 0.007376243360340595
the O 0 0.00888446718454361
haptoglobin O 1 0.9860317707061768
- O 1 0.603487491607666
related O 0 0.024388642981648445
gene O 0 0.01171835232526064
( O 0 0.013128027319908142
Hpr O 1 0.9142528176307678
) O 0 0.01045231893658638
, O 0 0.008984418585896492
in O 0 0.009366879239678383
tandem O 0 0.019094718620181084
from O 0 0.010416868142783642
the O 0 0.014508385211229324
5 O 0 0.02384347654879093
side O 0 0.0326475091278553
. O 0 0.039207905530929565

Southern O 0 0.06186860054731369
blot O 1 0.7863922119140625
and O 0 0.025675667449831963
PCR O 0 0.049359310418367386
analyses O 0 0.020497282966971397
have O 0 0.009444257244467735
indicated O 0 0.010885393247008324
that O 0 0.005951283499598503
the O 0 0.0063253422267735004
individual O 0 0.006931222975254059
with O 0 0.007104267366230488
anhaptoglobinemia B-Disease 1 0.9210243821144104
was O 0 0.014278126880526543
homozygous O 0 0.01100959349423647
for O 0 0.005534282885491848
the O 0 0.006831688806414604
gene O 0 0.007896305061876774
deletion O 0 0.013288327492773533
and O 0 0.005789260379970074
that O 0 0.004716835450381041
the O 0 0.006029414478689432
gene O 0 0.007775851059705019
deletion O 0 0.011837906204164028
was O 0 0.007896249182522297
included O 0 0.007294675800949335
at O 0 0.006741782650351524
least O 0 0.00582894217222929
from O 0 0.006178450770676136
the O 0 0.008045230060815811
promoter O 0 0.02373809926211834
region O 0 0.011185221374034882
of O 0 0.01034556608647108
Hp O 1 0.7204753160476685
to O 0 0.013026409782469273
Hpr O 1 0.9857085943222046
alpha O 0 0.02162475883960724
but O 0 0.00991301890462637
not O 0 0.010286854580044746
to O 0 0.018202224746346474
Hpr O 1 0.9414976835250854
beta O 0 0.106011763215065
( O 0 0.03637760132551193
Hpdel O 1 0.6622721552848816
) O 0 0.04439500719308853
. O 0 0.0576016902923584

In O 0 0.025966931134462357
addition O 0 0.019366011023521423
, O 0 0.01221991516649723
we O 0 0.009387156926095486
found O 0 0.00667530158534646
seven O 0 0.007268638350069523
individuals O 0 0.00519228121265769
with O 0 0.005894331727176905
hypohaptoglobinemia B-Disease 0 0.29974257946014404
in O 0 0.0062165712006390095
three O 0 0.005712679587304592
families O 0 0.006744196638464928
, O 0 0.005366896744817495
and O 0 0.004823391325771809
the O 0 0.005659337155520916
genotypes O 0 0.01769988238811493
of O 0 0.005190874915570021
six O 0 0.005554034374654293
of O 0 0.005016656592488289
the O 0 0.005788838025182486
seven O 0 0.006411836016923189
individuals O 0 0.004891872871667147
were O 0 0.004701383411884308
found O 0 0.005565613508224487
to O 0 0.0078051029704511166
be O 0 0.01255095936357975
Hp2 O 1 0.9589586853981018
/ O 1 0.7017186880111694
Hpdel O 1 0.7204749584197998
. O 0 0.054395291954278946

The O 0 0.049338486045598984
phenotypes O 0 0.43086519837379456
and O 0 0.02058633603155613
genotypes O 0 0.14294368028640747
in O 0 0.009786343201994896
one O 0 0.007944808341562748
of O 0 0.006234331056475639
these O 0 0.005132438149303198
three O 0 0.0052829827181994915
families O 0 0.005833068862557411
showed O 0 0.0068476516753435135
the O 0 0.006431511137634516
father O 0 0.009589921683073044
to O 0 0.006228829734027386
be O 0 0.006191552150994539
hypohaptoglobinemic B-Disease 1 0.8852460384368896
( O 0 0.011068318970501423
Hp2 O 1 0.7883628606796265
) O 0 0.010187567211687565
and O 0 0.010803619399666786
Hp2 O 1 0.9895026683807373
/ O 1 0.9079282879829407
Hpdel O 1 0.7105178236961365
, O 0 0.010066518560051918
the O 0 0.008672635070979595
mother O 0 0.010636179707944393
to O 0 0.007348114158958197
be O 0 0.0070892819203436375
Hp2 O 0 0.18207405507564545
- O 0 0.02104715071618557
1 O 0 0.011698035523295403
and O 0 0.010692941024899483
Hp1 O 1 0.9856486320495605
/ O 1 0.8025000095367432
Hp2 O 0 0.40211552381515503
, O 0 0.008728011511266232
one O 0 0.006859465502202511
of O 0 0.00605693319812417
the O 0 0.005584382917732
two O 0 0.004989108070731163
children O 0 0.005846661515533924
to O 0 0.0054397801868617535
be O 0 0.005717329680919647
hypohaptoglobinemic B-Disease 1 0.6628965139389038
( O 0 0.010056721046566963
Hp2 O 1 0.6206875443458557
) O 0 0.008919919840991497
and O 0 0.010076540522277355
Hp2 O 1 0.9964487552642822
/ O 1 0.9825847744941711
Hpdel O 1 0.975437343120575
, O 0 0.009704571217298508
and O 0 0.00704873027279973
the O 0 0.006608922034502029
other O 0 0.005323984194546938
child O 0 0.008161847479641438
to O 0 0.006516893859952688
be O 0 0.007030002772808075
Hp1 O 1 0.5657897591590881
and O 0 0.013023517094552517
Hp1 O 1 0.9983901977539062
/ O 1 0.9750267863273621
Hpdel O 1 0.9213018417358398
, O 0 0.011846916750073433
showing O 0 0.013295363634824753
an O 0 0.009915411472320557
anomalous O 0 0.09627937525510788
inheritance O 0 0.16224513947963715
of O 0 0.03331665322184563
Hp O 1 0.9987323880195618
phenotypes O 1 0.7903847694396973
in O 0 0.013089529238641262
the O 0 0.018554620444774628
child O 1 0.5187907218933105
with O 0 0.02700178325176239
Hp1 O 1 0.9978533387184143
. O 0 0.050080105662345886

The O 0 0.05028850585222244
Hp2 O 1 0.9985092282295227
/ O 1 0.9920012950897217
Hpdel O 1 0.9435954689979553
individuals O 0 0.013327768072485924
had O 0 0.01127617061138153
an O 0 0.009201663546264172
extremely O 0 0.012642412446439266
low O 0 0.010973986238241196
level O 0 0.009402378462255001
of O 0 0.009048771113157272
Hp O 0 0.33992618322372437
( O 0 0.011264713481068611
mean O 0 0.013111406937241554
+ O 0 0.019844235852360725
/ O 0 0.026446161791682243
- O 0 0.02485313080251217
SD O 0 0.06581616401672363
= O 0 0.024456564337015152
0 O 0 0.021757232025265694
. O 0 0.015086996369063854
049 O 0 0.18213820457458496
+ O 0 0.02861720137298107
/ O 0 0.029118690639734268
- O 0 0.022745441645383835
0 O 0 0.02042553573846817
. O 0 0.014976741746068
043 O 1 0.5286899209022522
mg O 1 0.7167194485664368
/ O 0 0.2083728164434433
ml O 0 0.12613479793071747
; O 0 0.013443272560834885
n O 0 0.016478225588798523
= O 0 0.015953304246068
6 O 0 0.01354474388062954
) O 0 0.00868310034275055
, O 0 0.007305937819182873
compared O 0 0.007176141254603863
with O 0 0.006065746303647757
the O 0 0.005750603508204222
level O 0 0.007319312542676926
( O 0 0.007403602823615074
1 O 0 0.009394311346113682
. O 0 0.00808826182037592
64 O 0 0.01539077889174223
+ O 0 0.01674957014620304
/ O 0 0.019058503210544586
- O 0 0.015175730921328068
1 O 0 0.013918436132371426
. O 0 0.011014698073267937
07 O 0 0.3567190170288086
mg O 1 0.8554068207740784
/ O 0 0.1436951607465744
ml O 0 0.045586831867694855
) O 0 0.01273203082382679
obtained O 0 0.012222395278513432
from O 0 0.009641407988965511
52 O 0 0.018752196803689003
healthy O 0 0.024390459060668945
volunteers O 0 0.028422478586435318
having O 0 0.017727455124258995
phenotype O 1 0.8855373859405518
Hp2 O 1 0.9798556566238403
, O 0 0.012344039045274258
whereas O 0 0.012951354496181011
the O 0 0.011310841888189316
serum O 1 0.9391340017318726
Hp O 0 0.4837982654571533
level O 0 0.011262898333370686
of O 0 0.009117151610553265
an O 0 0.00875563733279705
individual O 0 0.01137901097536087
with O 0 0.015243115834891796
Hp1 O 1 0.9986507296562195
/ O 1 0.9758919477462769
Hpdel O 1 0.952018678188324
was O 0 0.04216825217008591
0 O 0 0.0505647137761116
. O 0 0.049925532191991806

50 O 0 0.058682095259428024
mg O 1 0.9974843263626099
/ O 1 0.9806568026542664
ml O 1 0.9166445732116699
, O 0 0.012162204831838608
which O 0 0.00734387943521142
was O 0 0.007433539256453514
approximately O 0 0.007963388226926327
half O 0 0.006665043067187071
the O 0 0.005999826360493898
level O 0 0.007459775544703007
of O 0 0.0075519029051065445
Hp O 0 0.033834308385849
in O 0 0.008242095820605755
control O 0 0.013360871933400631
sera O 0 0.28620031476020813
from O 0 0.008759801276028156
the O 0 0.009835222736001015
Hp1 O 1 0.9546040892601013
phenotype O 0 0.22645297646522522
( O 0 0.008733181282877922
1 O 0 0.009944307617843151
. O 0 0.008807278238236904
26 O 0 0.013518432155251503
+ O 0 0.01722540333867073
/ O 0 0.021287312731146812
- O 0 0.015871059149503708
0 O 0 0.014912175945937634
. O 0 0.009656015783548355
33 O 0 0.019179625436663628
mg O 0 0.07830207794904709
/ O 0 0.048501480370759964
ml O 0 0.05908619612455368
; O 0 0.012571682222187519
n O 0 0.016214916482567787
= O 0 0.014851554296910763
9 O 0 0.01441797986626625
) O 0 0.010792653076350689
, O 0 0.010958950966596603
showing O 0 0.013507715426385403
a O 0 0.01404800545424223
gene O 0 0.019259300082921982
- O 1 0.6340730786323547
dosage O 1 0.755979061126709
effect O 0 0.03149934113025665
. O 0 0.04065806418657303

The O 0 0.029760019853711128
other O 0 0.016815507784485817
allele O 0 0.030869005247950554
( O 0 0.014846043661236763
Hp2 O 0 0.46143412590026855
) O 0 0.010295256040990353
of O 0 0.0073813628405332565
individuals O 0 0.007038685493171215
with O 0 0.010812378488481045
Hp2 O 1 0.9999431371688843
/ O 1 0.9990460276603699
Hpdel O 1 0.9958490133285522
was O 0 0.012716713361442089
found O 0 0.00637858547270298
to O 0 0.006435254588723183
have O 0 0.005038407631218433
, O 0 0.005429782439023256
in O 0 0.0051755718886852264
all O 0 0.00547230476513505
exons O 0 0.01296162884682417
, O 0 0.008134719915688038
no O 0 0.008568265475332737
mutation O 0 0.012856131419539452
, O 0 0.011838714592158794
by O 0 0.012966406531631947
DNA O 0 0.02399665303528309
sequencing O 0 0.04702140763401985
. O 0 0.04341043159365654

On O 0 0.02384701743721962
the O 0 0.014775047078728676
basis O 0 0.010827990248799324
of O 0 0.00909707322716713
the O 0 0.007650322280824184
present O 0 0.007910669781267643
study O 0 0.007405849639326334
, O 0 0.00633987644687295
the O 0 0.006383297964930534
mechanism O 0 0.009052449837327003
of O 0 0.007751856930553913
anhaptoglobinemia B-Disease 1 0.8557602763175964
and O 0 0.007664764765650034
the O 0 0.008572316728532314
mechanism O 0 0.013648346066474915
of O 0 0.010630853474140167
anomalous O 0 0.4931470453739166
inheritance O 1 0.5606809854507446
of O 0 0.12830111384391785
Hp O 1 0.9989547729492188
phenotypes O 1 0.7982515096664429
were O 0 0.015544035471975803
well O 0 0.02318115532398224
explained O 0 0.04097745567560196
. O 0 0.03924963250756264

However O 0 0.03935755416750908
, O 0 0.025175657123327255
the O 0 0.02522755227982998
mechanism O 0 0.036524709314107895
of O 0 0.030821848660707474
hypohaptoglobinemia B-Disease 1 0.9915378093719482
remains O 0 0.20618189871311188
unknown O 0 0.07802897691726685

ATM O 0 0.2257000207901001
mutations O 0 0.036010127514600754
and O 0 0.019417786970734596
phenotypes O 0 0.38730326294898987
in O 0 0.2634323239326477
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999940395355225
telangiectasia I-Disease 1 0.9999985694885254
families O 0 0.03902453929185867
in O 0 0.009502582252025604
the O 0 0.009547802619636059
British O 0 0.017960572615265846
Isles O 0 0.06356093287467957
: O 0 0.008765335194766521
expression O 0 0.00896137673407793
of O 0 0.007548030000180006
mutant O 0 0.03663778305053711
ATM O 0 0.04820474609732628
and O 0 0.0068608555011451244
the O 0 0.007208924274891615
risk O 1 0.5025030374526978
of O 1 0.9701746106147766
leukemia B-Disease 1 1.0
, O 1 0.9999991655349731
lymphoma B-Disease 1 1.0
, O 1 0.9999908208847046
and O 1 0.9999896287918091
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 1 0.5921278595924377

We O 0 0.029661649838089943
report O 0 0.02233934961259365
the O 0 0.015688877552747726
spectrum O 0 0.018385296687483788
of O 0 0.01296067051589489
59 O 0 0.02304515801370144
ATM O 0 0.11885948479175568
mutations O 0 0.011500393971800804
observed O 0 0.009441519156098366
in O 0 0.011506413109600544
ataxia B-Disease 1 0.9999980926513672
- I-Disease 1 0.9999122619628906
telangiectasia I-Disease 1 0.999998927116394
( O 1 0.5380808115005493
A B-Disease 1 0.9995822310447693
- I-Disease 1 0.9999961853027344
T I-Disease 1 0.999998927116394
) O 0 0.01947161927819252
patients O 0 0.3197227418422699
in O 0 0.011301232501864433
the O 0 0.01664506457746029
British O 0 0.037873126566410065
Isles O 0 0.21771977841854095
. O 0 0.044538263231515884

Of O 0 0.03758251667022705
51 O 0 0.05239538848400116
ATM O 0 0.46240997314453125
mutations O 0 0.019453981891274452
identified O 0 0.011318144388496876
in O 0 0.009295962750911713
families O 0 0.0076077161356806755
native O 0 0.008972615003585815
to O 0 0.006719617173075676
the O 0 0.007347801700234413
British O 0 0.010315297171473503
Isles O 0 0.0180258359760046
, O 0 0.0076848906464874744
11 O 0 0.008754188194870949
were O 0 0.006921947002410889
founder O 0 0.43403494358062744
mutations O 0 0.008639545179903507
, O 0 0.005751240998506546
and O 0 0.005636940710246563
2 O 0 0.007403862196952105
of O 0 0.005720838438719511
these O 0 0.004435394424945116
11 O 0 0.008136422373354435
conferred O 0 0.04011235386133194
a O 0 0.012244568206369877
milder O 1 0.9159544110298157
clinical O 1 0.9943873286247253
phenotype O 1 0.6998026967048645
with O 0 0.007710058242082596
respect O 0 0.009864903055131435
to O 0 0.01168794184923172
both O 0 0.09746691584587097
cerebellar B-Disease 1 0.9999990463256836
degeneration I-Disease 1 1.0
and O 1 0.9774729013442993
cellular O 1 0.998781144618988
features O 0 0.3721539378166199
. O 0 0.04192674905061722

We O 0 0.02740030363202095
report O 0 0.017532704398036003
, O 0 0.010592648759484291
in O 0 0.007549327332526445
two O 0 0.006959871854633093
A B-Disease 0 0.3426472544670105
- I-Disease 1 0.9974096417427063
T I-Disease 1 0.9981294274330139
families O 0 0.008308821357786655
, O 0 0.0073136091232299805
an O 0 0.007866122759878635
ATM O 0 0.035228293389081955
mutation O 0 0.01043216697871685
( O 0 0.010007228702306747
7271T O 0 0.4099612236022949
- O 1 0.5060768127441406
- O 1 0.8088007569313049
> O 1 0.8670895099639893
G O 0 0.3717770278453827
) O 0 0.008711079135537148
that O 0 0.00593888945877552
may O 0 0.0057283504866063595
be O 0 0.004691347014158964
associated O 0 0.0058735995553433895
with O 0 0.004740133415907621
an O 0 0.005083559080958366
increased O 0 0.008637605234980583
risk O 0 0.3951527178287506
of O 1 0.825515866279602
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999974966049194
in O 0 0.038979288190603256
both O 0 0.015612419694662094
homozygotes O 1 0.998731791973114
and O 0 0.023470502346754074
heterozygotes O 1 0.9850227236747742
( O 0 0.009133444167673588
relative O 0 0.009862285107374191
risk O 0 0.007926429621875286
12 O 0 0.007393804378807545
. O 0 0.006283140275627375
7 O 0 0.009797346778213978
; O 0 0.008201370015740395
P O 0 0.01848582923412323
= O 0 0.013112049549818039
. O 0 0.008620200678706169
0025 O 1 0.6999477744102478
) O 0 0.008742032572627068
, O 0 0.006414531264454126
although O 0 0.005804931279271841
there O 0 0.004429725464433432
is O 0 0.004425572697073221
a O 0 0.005830646492540836
less O 0 0.008063066750764847
severe O 1 0.9998847246170044
A B-Disease 1 0.9999405145645142
- I-Disease 1 0.999997615814209
T I-Disease 1 0.9999961853027344
phenotype O 1 0.7019456624984741
in O 0 0.007891274988651276
terms O 0 0.00885671004652977
of O 0 0.008050537668168545
the O 0 0.011815530247986317
degree O 0 0.0956944078207016
of O 1 0.8330329656600952
cerebellar B-Disease 1 0.9999991655349731
degeneration I-Disease 1 0.9999998807907104
. O 1 0.8201424479484558

This O 0 0.03406251594424248
mutation O 0 0.031005140393972397
( O 0 0.020352860912680626
7271T O 1 0.7258636951446533
- O 1 0.972793698310852
- O 1 0.9922375082969666
> O 1 0.9915428161621094
G O 1 0.5931192636489868
) O 0 0.010791090317070484
also O 0 0.008857345208525658
allows O 0 0.008775778114795685
expression O 0 0.00880690012127161
of O 0 0.008669151924550533
full O 0 0.011663668788969517
- O 0 0.016753720119595528
length O 0 0.012735111638903618
ATM O 0 0.021652093157172203
protein O 0 0.011382509022951126
at O 0 0.00921305175870657
a O 0 0.0088826147839427
level O 0 0.010252674110233784
comparable O 0 0.013995043002068996
with O 0 0.008739611133933067
that O 0 0.009127577766776085
in O 0 0.013942652381956577
unaffected O 0 0.15133622288703918
individuals O 0 0.02149626426398754
. O 0 0.03383296728134155

In O 0 0.02795339561998844
addition O 0 0.017650315538048744
, O 0 0.01103128120303154
we O 0 0.007391110062599182
have O 0 0.005493969656527042
studied O 0 0.007682585623115301
18 O 0 0.009082183241844177
A B-Disease 1 0.7793400287628174
- I-Disease 1 0.9999086856842041
T I-Disease 1 0.9999908208847046
patients O 1 0.6532772779464722
, O 0 0.006536911241710186
in O 0 0.005079877562820911
15 O 0 0.007320300675928593
families O 0 0.006167977582663298
, O 0 0.00669338321313262
who O 0 0.020519979298114777
developed O 1 0.9905657172203064
leukemia B-Disease 1 1.0
, O 1 0.9967572093009949
lymphoma B-Disease 1 1.0
, O 1 0.91788649559021
preleukemic O 1 0.9999896287918091
T O 1 0.9999855756759644
- O 1 0.9958887696266174
cell O 1 0.8338003158569336
proliferation O 1 0.9963184595108032
, O 1 0.86641925573349
or O 1 0.9973019361495972
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.8372112512588501
mostly O 0 0.02047465369105339
in O 0 0.027536921203136444
childhood O 1 0.9946118593215942
. O 0 0.03887874260544777

A O 0 0.042138222604990005
wide O 0 0.029400670900940895
variety O 0 0.01922736130654812
of O 0 0.01494118943810463
ATM O 1 0.7217336297035217
mutation O 0 0.01815069653093815
types O 0 0.00865763146430254
, O 0 0.0077326432801783085
including O 0 0.007810323033481836
missense O 0 0.027651207521557808
mutations O 0 0.009887579828500748
and O 0 0.0068565490655601025
in O 0 0.007823036052286625
- O 1 0.6576483845710754
frame O 0 0.18181118369102478
deletions O 0 0.02935502491891384
, O 0 0.010024623945355415
were O 0 0.009056094102561474
seen O 0 0.012576560489833355
in O 0 0.01319664716720581
these O 0 0.017213696613907814
patients O 0 0.27721965312957764
. O 0 0.03556167706847191

We O 0 0.028676167130470276
also O 0 0.017436958849430084
show O 0 0.014277960173785686
that O 0 0.0071803550235927105
25 O 0 0.009995854459702969
% O 0 0.0064896708354353905
of O 0 0.0057962024584412575
all O 0 0.005584202706813812
A B-Disease 1 0.7333593964576721
- I-Disease 1 0.9995980858802795
T I-Disease 1 0.9999743700027466
patients O 1 0.7511004209518433
carried O 0 0.008309335447847843
in O 0 0.0075998143292963505
- O 0 0.402169793844223
frame O 0 0.04928206279873848
deletions O 0 0.019906556233763695
or O 0 0.009479263797402382
missense O 0 0.026270391419529915
mutations O 0 0.009909996762871742
, O 0 0.006824752315878868
many O 0 0.005176101811230183
of O 0 0.005631570238620043
which O 0 0.005037930328398943
were O 0 0.005386958364397287
also O 0 0.006424026098102331
associated O 0 0.006775065790861845
with O 0 0.0072825695388019085
expression O 0 0.013044643215835094
of O 0 0.017050566151738167
mutant O 1 0.8225594162940979
ATM O 1 0.8246796131134033
protein O 0 0.04155910387635231
. O 0 0.04621631279587746

The O 0 0.04257609695196152
DMPK O 1 0.9744894504547119
gene O 0 0.025598078966140747
of O 0 0.10171432793140411
severely O 1 0.9999845027923584
affected O 1 0.9999887943267822
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9996953010559082
hypermethylated O 1 0.9999994039535522
proximal O 1 0.9999899864196777
to O 0 0.020527491346001625
the O 0 0.02389804646372795
largely O 0 0.03166961297392845
expanded O 0 0.1260141134262085
CTG O 1 0.9973710775375366
repeat O 0 0.22101184725761414
. O 0 0.05691872909665108

Using O 0 0.04449259489774704
methylation O 0 0.04465567693114281
- O 0 0.07878058403730392
sensitive O 0 0.03519571200013161
restriction O 0 0.028911937028169632
enzymes O 0 0.018656644970178604
, O 0 0.01310598012059927
we O 0 0.01076519675552845
characterized O 0 0.013612138107419014
the O 0 0.009936793707311153
methylation O 0 0.013775785453617573
pattern O 0 0.009822510182857513
on O 0 0.008187205530703068
the O 0 0.007968359626829624
5 O 0 0.010576404631137848
side O 0 0.010076531209051609
of O 0 0.007813544943928719
the O 0 0.010190731845796108
CTG O 1 0.9403518438339233
repeat O 0 0.015519295819103718
in O 0 0.007785014342516661
the O 0 0.008822806179523468
DMPK O 1 0.968818724155426
gene O 0 0.008017316460609436
of O 0 0.006083077751100063
normal O 0 0.005848023109138012
individuals O 0 0.0046082050539553165
and O 0 0.005018846597522497
of O 0 0.010950359515845776
patients O 1 0.9995055198669434
affected O 1 0.9940080642700195
with O 1 0.9987034797668457
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9433108568191528
showing O 1 0.7749736905097961
expansions O 0 0.3504774868488312
of O 0 0.018099822103977203
the O 0 0.0254445169121027
repetitive O 0 0.33376291394233704
sequence O 0 0.038956549018621445
. O 0 0.050032805651426315

The O 0 0.03828050568699837
gene O 0 0.028811778873205185
segment O 0 0.03245127201080322
analyzed O 0 0.0246974378824234
corresponds O 0 0.02298012189567089
to O 0 0.01442428957670927
the O 0 0.017677951604127884
genomic O 0 0.03781256824731827
SacI O 1 0.9251737594604492
- O 0 0.1600664258003235
HindIII O 0 0.30567020177841187
fragment O 0 0.03501477092504501
carrying O 0 0.026326775550842285
exons O 0 0.038335155695676804
11 O 0 0.029886601492762566
- O 0 0.048558156937360764
15 O 0 0.0425652377307415
. O 0 0.04887254163622856

There O 0 0.03696877881884575
is O 0 0.029390202835202217
constitutive O 0 0.05002620071172714
methylation O 0 0.031431060284376144
in O 0 0.016288483515381813
intron O 0 0.3990924656391144
12 O 0 0.017827101051807404
at O 0 0.01312019769102335
restriction O 0 0.014614989049732685
sites O 0 0.011404143646359444
of O 0 0.011358843185007572
SacII O 0 0.1985815167427063
and O 0 0.012934783473610878
HhaI O 0 0.4740733802318573
, O 0 0.012804446741938591
localized O 0 0.01840926893055439
1 O 0 0.014461817219853401
, O 0 0.011518405750393867
159 O 0 0.021183356642723083
- O 0 0.018423231318593025
1 O 0 0.014662262983620167
, O 0 0.012231649830937386
232 O 0 0.020580701529979706
bp O 0 0.02163052372634411
upstream O 0 0.01552950032055378
of O 0 0.009929751046001911
the O 0 0.01173953153192997
CTG O 1 0.9947022795677185
repeat O 0 0.1339460015296936
, O 0 0.010328561998903751
whereas O 0 0.0092899976298213
most O 0 0.0062027876265347
, O 0 0.005951283499598503
if O 0 0.005020563956350088
not O 0 0.004369159694761038
all O 0 0.00441643875092268
, O 0 0.004657108336687088
of O 0 0.004234268795698881
the O 0 0.0045703984797000885
other O 0 0.004055805504322052
sites O 0 0.005884643644094467
of O 0 0.006076104938983917
SacII O 1 0.9524855613708496
, O 0 0.01070113480091095
HhaI O 1 0.9672624468803406
, O 0 0.00795657280832529
and O 0 0.006810220889747143
HpaII O 0 0.11757349967956543
in O 0 0.006142012309283018
this O 0 0.005874008405953646
region O 0 0.00886309053748846
are O 0 0.006312150973826647
unmethylated O 0 0.04808422550559044
, O 0 0.008728034794330597
in O 0 0.007198267616331577
normal O 0 0.008378908038139343
individuals O 0 0.0064557623118162155
and O 0 0.00773076293990016
most O 0 0.008326394483447075
of O 0 0.01343351136893034
the O 0 0.03337590768933296
patients O 1 0.9877064824104309
. O 0 0.03875504061579704

In O 0 0.02205563895404339
a O 0 0.01637307181954384
number O 0 0.010489813052117825
of O 0 0.009181683883070946
young O 0 0.31913062930107117
and O 1 0.7102250456809998
severely O 1 0.9999778270721436
affected O 1 0.998345136642456
patients O 1 0.9996651411056519
, O 0 0.02603869140148163
however O 0 0.006011414807289839
, O 0 0.005179658532142639
complete O 0 0.006826882716268301
methylation O 0 0.008865436539053917
of O 0 0.00593697652220726
these O 0 0.004962636157870293
restriction O 0 0.00940177496522665
sites O 0 0.009201863780617714
was O 0 0.011188587173819542
found O 0 0.01006903313100338
in O 0 0.010845414362847805
the O 0 0.019063644111156464
mutated O 0 0.25516751408576965
allele O 0 0.06048141419887543
. O 0 0.04324178770184517

In O 0 0.023295808583498
most O 0 0.012393645010888577
of O 0 0.01100150216370821
these O 0 0.008325275965034962
patients O 1 0.6906118392944336
, O 0 0.009458680637180805
the O 0 0.02977154403924942
onset O 1 0.9999840259552002
of O 1 0.9879526495933533
the O 1 0.9999576807022095
disease O 1 1.0
was O 1 0.9999977350234985
congenital O 1 1.0
. O 1 0.9874023795127869

Preliminary O 0 0.05461062118411064
in O 0 0.03348082676529884
vivo O 0 0.062388718128204346
footprinting O 0 0.38560542464256287
data O 0 0.02029878832399845
gave O 0 0.017677802592515945
evidence O 0 0.012041832320392132
for O 0 0.009211067110300064
protein O 0 0.009551014751195908
- O 0 0.014110833406448364
DNA O 0 0.009104417636990547
contact O 0 0.00894202757626772
in O 0 0.0064054690301418304
normal O 0 0.007668254431337118
genes O 0 0.008025292307138443
at O 0 0.008175110444426537
an O 0 0.008912045508623123
Sp1 O 1 0.792336642742157
consensus O 0 0.01215993519872427
binding O 0 0.011099301278591156
site O 0 0.012429618276655674
upstream O 0 0.013307437300682068
of O 0 0.008395826444029808
the O 0 0.00963018648326397
CTG O 1 0.985404908657074
repeat O 0 0.017797434702515602
and O 0 0.006528270430862904
for O 0 0.0059607126750051975
a O 0 0.007035459857434034
significant O 0 0.0068082730285823345
reduction O 0 0.00893546361476183
of O 0 0.006098827812820673
this O 0 0.004822548478841782
interaction O 0 0.007018571719527245
in O 0 0.006373881828039885
cells O 0 0.008232670836150646
with O 0 0.008314606733620167
a O 0 0.01696551963686943
hypermethylated O 1 0.9982970356941223
DMPK O 1 0.9995808005332947
gene O 0 0.031154854223132133
. O 0 0.02838180772960186
. O 0 0.045376960188150406

The O 0 0.0962752103805542
hemochromatosis B-Disease 1 0.9999864101409912
gene O 0 0.03421113267540932
product O 0 0.06642864644527435
complexes O 0 0.06344007700681686
with O 0 0.011752383783459663
the O 0 0.028563302010297775
transferrin O 1 0.999767005443573
receptor O 0 0.14352652430534363
and O 0 0.01702936924993992
lowers O 1 0.89497971534729
its O 0 0.01788623444736004
affinity O 0 0.028552858158946037
for O 0 0.021725384518504143
ligand O 0 0.06056305021047592
binding O 0 0.0499071404337883
. O 0 0.05140179395675659

We O 0 0.033964063972234726
recently O 0 0.030255300924181938
reported O 0 0.019967319443821907
the O 0 0.014039038680493832
positional O 0 0.032583288848400116
cloning O 0 0.021690819412469864
of O 0 0.012101525440812111
a O 0 0.015052637085318565
candidate O 0 0.02679217979311943
gene O 0 0.021872133016586304
for O 0 0.15880003571510315
hereditary B-Disease 1 0.9999996423721313
hemochromatosis I-Disease 1 1.0
called O 1 0.9998582601547241
HFE O 1 0.9999970197677612
. O 0 0.2055457979440689

The O 0 0.034617986530065536
gene O 0 0.02342243120074272
product O 0 0.017238149419426918
, O 0 0.010620015673339367
a O 0 0.009212312288582325
member O 0 0.008766635321080685
of O 0 0.0073856269009411335
the O 0 0.007963459938764572
major O 0 0.4374474287033081
histocompatibility O 1 0.9999974966049194
complex O 0 0.44360679388046265
class O 1 0.8083294034004211
I O 1 0.5006961226463318
- O 0 0.25651970505714417
like O 0 0.010590121150016785
family O 0 0.010961055755615234
, O 0 0.00730269867926836
was O 0 0.008043020032346249
found O 0 0.0060225254856050014
to O 0 0.006228065118193626
have O 0 0.005417120177298784
a O 0 0.009066755883395672
mutation O 0 0.01214116346091032
, O 0 0.009963060729205608
Cys O 1 0.9097781777381897
- O 0 0.18004631996154785
282 O 1 0.78608238697052
- O 1 0.9736751914024353
- O 1 0.9867536425590515
> O 1 0.9881768822669983
Tyr O 1 0.999765932559967
( O 0 0.018661977723240852
C282Y O 0 0.0851743221282959
) O 0 0.012890088371932507
, O 0 0.01107743475586176
in O 0 0.010459172539412975
85 O 0 0.01918323151767254
% O 0 0.01438270602375269
of O 0 0.01677928864955902
patient O 1 0.8234406113624573
chromosomes O 0 0.042717345058918
. O 0 0.03801275044679642

This O 0 0.03728248178958893
mutation O 0 0.036306291818618774
eliminates O 0 0.043783240020275116
the O 0 0.015613732859492302
ability O 0 0.014114095829427242
of O 0 0.012917979620397091
HFE O 1 0.9955850839614868
to O 0 0.01195092499256134
associate O 0 0.01812099665403366
with O 0 0.011660713702440262
beta2 O 1 0.9991297125816345
- O 1 0.9917970895767212
microglobulin O 1 0.9991775155067444
( O 0 0.030669337138533592
beta2m O 1 0.9543306231498718
) O 0 0.012492898851633072
and O 0 0.011994883418083191
prevents O 0 0.11137259006500244
cell O 0 0.12933136522769928
- O 0 0.49520134925842285
surface O 0 0.03153549134731293
expression O 0 0.03533206507563591
. O 0 0.044629331678152084

A O 0 0.03755198046565056
second O 0 0.039989810436964035
mutation O 0 0.018627237528562546
that O 0 0.0070586600340902805
has O 0 0.007223258260637522
no O 0 0.006459739524871111
effect O 0 0.007129977457225323
on O 0 0.007326384540647268
beta2m O 1 0.8986019492149353
association O 0 0.0855167806148529
, O 0 0.011321906000375748
H63D O 1 0.9911993145942688
, O 0 0.007965299300849438
was O 0 0.0077382721938192844
found O 0 0.005682322662323713
in O 0 0.00513049541041255
eight O 0 0.0064782132394611835
out O 0 0.006978712510317564
of O 0 0.007466273847967386
nine O 0 0.013337354175746441
patients O 0 0.4044744670391083
heterozygous O 0 0.020221391692757607
for O 0 0.014230295084416866
the O 0 0.025016363710165024
C282Y O 1 0.953168511390686
mutant O 0 0.23274290561676025
. O 0 0.05059494078159332

In O 0 0.027420617640018463
this O 0 0.016120508313179016
report O 0 0.015378960408270359
, O 0 0.01164292637258768
we O 0 0.01042856927961111
demonstrate O 0 0.014223708771169186
in O 0 0.01285422034561634
cultured O 0 0.025897793471813202
293 O 0 0.24037066102027893
cells O 0 0.02029190957546234
overexpressing O 1 0.8112736940383911
wild O 0 0.021974503993988037
- O 1 0.5540368556976318
type O 0 0.07074855268001556
or O 0 0.011616896837949753
mutant O 1 0.685457170009613
HFE O 1 0.9989051818847656
proteins O 0 0.01138119027018547
that O 0 0.00637981528416276
both O 0 0.006504596211016178
the O 0 0.007884188555181026
wild O 0 0.010943982750177383
- O 1 0.7062713503837585
type O 0 0.175709530711174
and O 0 0.020699353888630867
H63D O 1 0.9999287128448486
HFE O 1 0.9999188184738159
proteins O 0 0.015499340370297432
form O 0 0.013170957565307617
stable O 0 0.04118824005126953
complexes O 0 0.021158944815397263
with O 0 0.01161753199994564
the O 0 0.03369516506791115
transferrin O 1 0.9999524354934692
receptor O 1 0.8511360287666321
( O 0 0.15680722892284393
TfR O 1 0.9992443323135376
) O 0 0.03899720683693886
. O 0 0.04968170449137688

The O 0 0.041560590267181396
C282Y O 1 0.8023735284805298
mutation O 0 0.02997000515460968
nearly O 0 0.01846448704600334
completely O 0 0.019002536311745644
prevents O 0 0.022204065695405006
the O 0 0.010158480145037174
association O 0 0.016712771728634834
of O 0 0.011992103420197964
the O 0 0.0158630833029747
mutant O 1 0.9591889381408691
HFE O 1 0.9999319314956665
protein O 0 0.022914765402674675
with O 0 0.016443856060504913
the O 0 0.029469884932041168
TfR O 1 0.9991387128829956
. O 0 0.05056299269199371

Studies O 0 0.03265601769089699
on O 0 0.02191285975277424
cell O 0 0.026308896020054817
- O 0 0.02852887287735939
associated O 0 0.012805207632482052
transferrin O 0 0.21428421139717102
at O 0 0.01179471518844366
37 O 0 0.015394002199172974
degrees O 0 0.013889512047171593
C O 0 0.018018266186118126
suggest O 0 0.009561431594192982
that O 0 0.006682322360575199
the O 0 0.00900549627840519
overexpressed O 0 0.0768972635269165
wild O 0 0.016333218663930893
- O 1 0.7618497014045715
type O 1 0.5163246393203735
HFE O 1 0.9997609257698059
protein O 0 0.017937609925866127
decreases O 0 0.01764490269124508
the O 0 0.012961317785084248
affinity O 0 0.01873413659632206
of O 0 0.01318711880594492
the O 0 0.021734435111284256
TfR O 1 0.9995187520980835
for O 0 0.03731152042746544
transferrin O 1 0.9954836368560791
. O 0 0.05526154115796089

The O 0 0.04979925602674484
overexpressed O 1 0.9974895715713501
H63D O 1 0.9997474551200867
protein O 0 0.021086229011416435
does O 0 0.010595863685011864
not O 0 0.00713788066059351
have O 0 0.005486149340867996
this O 0 0.005095803644508123
effect O 0 0.006607125047594309
, O 0 0.005893302615731955
providing O 0 0.006651629693806171
the O 0 0.005155505146831274
first O 0 0.006293056067079306
direct O 0 0.006463425233960152
evidence O 0 0.005546767730265856
for O 0 0.0054677389562129974
a O 0 0.007854882627725601
functional O 0 0.014880219474434853
consequence O 0 0.014747454784810543
of O 0 0.011492244899272919
the O 0 0.0699010044336319
H63D O 1 0.9999659061431885
mutation O 1 0.5844969153404236
. O 0 0.04374043270945549

Addition O 0 0.037845395505428314
of O 0 0.0262074563652277
soluble O 0 0.3522489070892334
wild O 0 0.0441545732319355
- O 1 0.9906412959098816
type O 1 0.995191216468811
HFE O 1 0.9999988079071045
/ O 1 0.9997876286506653
beta2m O 1 0.9996596574783325
heterodimers O 1 0.9993342757225037
to O 0 0.016363920643925667
cultured O 0 0.46350914239883423
cells O 0 0.015447249636054039
also O 0 0.010005793534219265
decreased O 0 0.013748318888247013
the O 0 0.008383541367948055
apparent O 0 0.015377501957118511
affinity O 0 0.01218132022768259
of O 0 0.009267435409128666
the O 0 0.010681213811039925
TfR O 1 0.9293310046195984
for O 0 0.009367887862026691
its O 0 0.010251369327306747
ligand O 0 0.017466003075242043
under O 0 0.011052994057536125
steady O 0 0.020718878135085106
- O 0 0.017399240285158157
state O 0 0.007582711987197399
conditions O 0 0.008851530030369759
, O 0 0.007303230464458466
both O 0 0.006653361022472382
in O 0 0.010090410709381104
293 O 1 0.6338529586791992
cells O 0 0.01885143108665943
and O 0 0.016520103439688683
in O 0 0.024019848555326462
HeLa O 1 0.9993565678596497
cells O 0 0.0533016100525856
. O 0 0.04369598254561424

Furthermore O 0 0.042443033307790756
, O 0 0.020816391333937645
at O 0 0.01370531227439642
4 O 0 0.01634163036942482
degrees O 0 0.0169003214687109
C O 0 0.02165680006146431
, O 0 0.010961676016449928
the O 0 0.010707901790738106
added O 0 0.014361072331666946
soluble O 0 0.02402208372950554
complex O 0 0.013862134888768196
of O 0 0.016223924234509468
HFE O 1 0.9999914169311523
/ O 1 0.994259238243103
beta2m O 1 0.9685271382331848
inhibited O 0 0.040857501327991486
binding O 0 0.01573360152542591
of O 0 0.014073183760046959
transferrin O 1 0.9368144869804382
to O 0 0.017215946689248085
HeLa O 1 0.9988378882408142
cell O 0 0.21713294088840485
TfR O 1 0.9812619090080261
in O 0 0.015376136638224125
a O 0 0.021119238808751106
concentration O 1 0.5804916620254517
- O 1 0.5731934905052185
dependent O 0 0.0345262736082077
manner O 0 0.037728264927864075
. O 0 0.04412415623664856

Scatchard O 0 0.08851293474435806
plots O 0 0.03732850030064583
of O 0 0.017319105565547943
these O 0 0.009425625205039978
data O 0 0.009925887919962406
indicate O 0 0.008991468697786331
that O 0 0.00639383215457201
the O 0 0.008308224380016327
added O 0 0.015622515231370926
heterodimer O 1 0.9533347487449646
substantially O 0 0.021642131730914116
reduced O 0 0.015978215262293816
the O 0 0.014596070162951946
affinity O 0 0.024632032960653305
of O 0 0.021598931401968002
TfR O 1 0.9987938404083252
for O 0 0.0397581085562706
transferrin O 1 0.9943860769271851
. O 0 0.061288271099328995

These O 0 0.023670079186558723
results O 0 0.016869334504008293
establish O 0 0.01524717453867197
a O 0 0.012910819612443447
molecular O 0 0.017143486067652702
link O 0 0.01660246215760708
between O 0 0.012303214520215988
HFE O 1 0.9990701079368591
and O 0 0.009632828645408154
a O 0 0.009800623171031475
key O 0 0.011238963343203068
protein O 0 0.007738961838185787
involved O 0 0.006817875429987907
in O 0 0.007050339598208666
iron O 1 0.9520370364189148
transport O 0 0.028342897072434425
, O 0 0.007694670930504799
the O 0 0.009312532842159271
TfR O 1 0.999136745929718
, O 0 0.007870805449783802
and O 0 0.005826535169035196
raise O 0 0.008052242919802666
the O 0 0.006110261660069227
possibility O 0 0.007435228675603867
that O 0 0.004864752758294344
alterations O 0 0.009977256879210472
in O 0 0.005922298412770033
this O 0 0.0062967101112008095
regulatory O 0 0.01296816486865282
mechanism O 0 0.010386372916400433
may O 0 0.007838509976863861
play O 0 0.008326945826411247
a O 0 0.009025536477565765
role O 0 0.009357874281704426
in O 0 0.008908746764063835
the O 0 0.015494117513298988
pathogenesis O 1 0.9999598264694214
of O 1 0.9859825968742371
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.925175130367279
. O 0 0.07579416036605835

Genomic O 0 0.06760801374912262
organization O 0 0.03631372004747391
of O 0 0.024274786934256554
the O 0 0.04689900204539299
UBE3A O 1 0.999993085861206
/ O 1 0.999818742275238
E6 O 1 0.9998179078102112
- O 1 0.9866964221000671
AP O 1 0.7113783359527588
gene O 0 0.03194230794906616
and O 0 0.02496129646897316
related O 0 0.03845381364226341
pseudogenes O 0 0.2359471619129181
. O 0 0.06063701584935188

The O 0 0.056472547352313995
UBE3A O 1 0.9632818698883057
gene O 0 0.029199494048953056
encodes O 0 0.03213048353791237
the O 0 0.02331521548330784
E6 O 1 0.9459515810012817
- O 0 0.49083375930786133
AP O 0 0.22272944450378418
ubiquitin O 1 0.514446496963501
- O 0 0.3168998062610626
protein O 0 0.014952835626900196
ligase O 0 0.025873824954032898
and O 0 0.009380782954394817
has O 0 0.008923562243580818
recently O 0 0.00928556453436613
been O 0 0.005742623470723629
shown O 0 0.005730333272367716
to O 0 0.0060558258555829525
be O 0 0.006460926961153746
mutated O 1 0.6354590058326721
in O 1 0.9351366758346558
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999997615814209
who O 1 0.9985349178314209
lack O 1 0.9996078610420227
15q11 O 1 0.9999939203262329
- O 1 0.9998912811279297
q13 O 1 0.9992389678955078
deletions O 1 0.8502420783042908
or O 0 0.021380089223384857
chromosome O 0 0.06479665637016296
15 O 0 0.039432547986507416
paternal O 1 0.9585582613945007
uniparental B-Disease 1 0.9999774694442749
disomy I-Disease 1 0.9994208812713623
. O 0 0.07272537052631378

Previous O 0 0.06999000906944275
UBE3A O 1 0.879569947719574
cDNA O 0 0.06120792403817177
analysis O 0 0.030455471947789192
has O 0 0.02098073624074459
shown O 0 0.01869947277009487
a O 0 0.01752973161637783
coding O 0 0.024848677217960358
region O 0 0.020259063690900803
of O 0 0.018235359340906143
approximately O 0 0.025443032383918762
2 O 0 0.03636103868484497
. O 0 0.03923848643898964

6 O 0 0.051475610584020615
kb O 0 0.06287703663110733
and O 0 0.017212379723787308
a O 0 0.0160029586404562
3 O 0 0.018050694838166237
- O 0 0.13906274735927582
untranslated O 1 0.8809018135070801
region O 0 0.021446261554956436
( O 0 0.013667681254446507
UTR O 1 0.8092559576034546
) O 0 0.010902446694672108
of O 0 0.01041421014815569
< O 0 0.04000820219516754
50 O 0 0.015451536513864994
bp O 0 0.022774366661906242
, O 0 0.01186662632972002
whereas O 0 0.011332009918987751
Northern O 0 0.011609743349254131
analysis O 0 0.009195266291499138
has O 0 0.008794637396931648
indicated O 0 0.012513522990047932
mRNA O 0 0.014046195894479752
sizes O 0 0.01455625519156456
of O 0 0.011910593137145042
5 O 0 0.019800564274191856
- O 0 0.036193862557411194
8 O 0 0.04209822043776512
kb O 0 0.10204023867845535
. O 0 0.05385740473866463

We O 0 0.029698502272367477
have O 0 0.01564040407538414
analyzed O 0 0.020914198830723763
additional O 0 0.01908707618713379
cDNA O 0 0.03387074917554855
clones O 0 0.032453231513500214
and O 0 0.011960698291659355
provide O 0 0.010910017415881157
evidence O 0 0.009659900330007076
for O 0 0.009248515591025352
an O 0 0.012586027383804321
additional O 0 0.02180122584104538
0 O 0 0.0366610623896122
. O 0 0.039500027894973755

5 O 0 0.05523030087351799
kb O 0 0.06572211533784866
of O 0 0.025336943566799164
5 O 0 0.028526613488793373
- O 0 0.22282546758651733
UTR O 1 0.8749129772186279
and O 0 0.02126898057758808
> O 0 0.05250340700149536
2 O 0 0.027255795896053314
kb O 0 0.049170009791851044
of O 0 0.025911977514624596
3 O 0 0.039913877844810486
- O 0 0.10630015283823013
UTR O 1 0.9125243425369263
. O 0 0.07006172835826874

We O 0 0.025714607909321785
have O 0 0.014248160645365715
established O 0 0.014659852720797062
the O 0 0.011936756782233715
genomic O 0 0.01956692896783352
organization O 0 0.017343364655971527
of O 0 0.014636370353400707
UBE3A O 1 0.9972711205482483
and O 0 0.011629623360931873
the O 0 0.011907177045941353
sequence O 0 0.014990177005529404
of O 0 0.019703324884176254
intron O 1 0.9993876218795776
- O 1 0.9103384017944336
exon O 1 0.5211248397827148
borders O 0 0.048552896827459335
. O 0 0.0501435250043869

We O 0 0.029268251731991768
have O 0 0.015094105154275894
also O 0 0.014676584862172604
mapped O 0 0.023265456780791283
two O 0 0.011023541912436485
highly O 0 0.017119150608778
homologous O 0 0.020228968933224678
processed O 0 0.016419295221567154
pseudogenes O 0 0.03620324656367302
, O 0 0.014352800324559212
UBE3AP1 O 1 0.9593825340270996
and O 0 0.012902435846626759
UBE3AP2 O 1 0.7403809428215027
, O 0 0.009199677035212517
to O 0 0.007812739349901676
chromosomes O 0 0.009738918393850327
2 O 0 0.008823418989777565
and O 0 0.007398439571261406
21 O 0 0.011278637684881687
, O 0 0.008278816938400269
respectively O 0 0.010393314994871616
, O 0 0.008856136351823807
and O 0 0.00875543337315321
determined O 0 0.013010038994252682
their O 0 0.014002467505633831
genomic O 0 0.034397248178720474
organization O 0 0.037814781069755554
. O 0 0.040442343801259995

These O 0 0.024052606895565987
results O 0 0.018002793192863464
will O 0 0.011844421736896038
form O 0 0.009268354624509811
the O 0 0.0072661577723920345
basis O 0 0.007312505040317774
for O 0 0.007351311855018139
studies O 0 0.009625320322811604
of O 0 0.0112948352470994
mutation O 0 0.021453682333230972
and O 0 0.017533214762806892
imprinting O 1 0.850243091583252
of O 0 0.05914781242609024
UBE3A O 1 0.9996153116226196
. O 0 0.05841097608208656

Mutation O 0 0.061955776065588
spectrum O 0 0.05080766975879669
and O 0 0.024828817695379257
genotype O 1 0.9303334951400757
- O 1 0.9542838335037231
phenotype O 1 0.8844427466392517
analyses O 0 0.04826205596327782
in O 0 0.34415799379348755
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999992847442627
and O 1 0.9957249164581299
Bannayan B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 1 0.9878133535385132
two O 1 0.9455207586288452
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 0.9999998807907104
with O 1 0.9985236525535583
germline O 1 0.9999939203262329
PTEN O 1 0.9999955892562866
mutation O 1 0.9855620265007019
. O 0 0.06735091656446457

The O 0 0.2728896737098694
tumour B-Disease 1 0.9999933242797852
suppressor O 1 0.9998207688331604
gene O 1 0.6037198305130005
PTEN O 1 0.9997158646583557
, O 0 0.020913496613502502
which O 0 0.01572086289525032
maps O 0 0.0255204439163208
to O 0 0.02570957876741886
10q23 O 0 0.13952277600765228
. O 0 0.053215716034173965

3 O 0 0.05317772552371025
and O 0 0.02789691463112831
encodes O 0 0.034391578286886215
a O 0 0.02448415942490101
403 O 0 0.03795120492577553
amino O 0 0.021486129611730576
acid O 0 0.02359967865049839
dual O 0 0.02712428756058216
specificity O 0 0.034106187522411346
phosphatase O 1 0.6826819777488708
( O 0 0.017784830182790756
protein O 0 0.016788307577371597
tyrosine O 0 0.030781807377934456
phosphatase O 1 0.6023785471916199
; O 0 0.01425266731530428
PTPase O 1 0.8266026377677917
) O 0 0.011066000908613205
, O 0 0.009511949494481087
was O 0 0.009913375601172447
shown O 0 0.008587591350078583
recently O 0 0.009149918332695961
to O 0 0.007854072377085686
play O 0 0.00901348888874054
a O 0 0.010407430119812489
broad O 0 0.017072519287467003
role O 0 0.017228804528713226
in O 0 0.016716226935386658
human O 0 0.15633945167064667
malignancy B-Disease 1 0.9999750852584839
. O 0 0.05417098104953766

Somatic O 1 0.9444757699966431
PTEN O 1 0.9981011748313904
deletions O 0 0.07634513825178146
and O 0 0.019450854510068893
mutations O 0 0.01616610214114189
were O 0 0.008116628974676132
observed O 0 0.00870204996317625
in O 0 0.007638135924935341
sporadic B-Disease 1 0.706682026386261
breast I-Disease 1 0.9999948740005493
, I-Disease 1 0.9149099588394165
brain I-Disease 1 0.9999516010284424
, I-Disease 1 0.997678816318512
prostate I-Disease 1 1.0
and I-Disease 1 0.9999902248382568
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9986780285835266
lines O 0 0.06350360065698624
and O 0 0.005871094297617674
in O 0 0.004660256206989288
several O 0 0.005908679682761431
primary O 0 0.13913750648498535
tumours B-Disease 1 0.9998735189437866
such O 0 0.011135957203805447
as O 1 0.9733012318611145
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 0.9999997615814209
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9954769015312195

In O 0 0.03098532184958458
addition O 0 0.02469746023416519
, O 0 0.0209348164498806
PTEN O 1 0.9919615387916565
was O 0 0.016148734837770462
identified O 0 0.010481871664524078
as O 0 0.007447731215506792
the O 0 0.008988749235868454
susceptibility O 0 0.2933359742164612
gene O 0 0.008809622377157211
for O 0 0.008641762658953667
two O 0 0.08798347413539886
hamartoma B-Disease 1 0.9999998807907104
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9897274374961853
CD B-Disease 1 0.9979908466339111
; O 0 0.05558924376964569
MIM O 1 0.9997256398200989
158350 O 1 0.8092917203903198
) O 0 0.015838386490941048
and O 0 0.016614723950624466
Bannayan B-Disease 1 0.8681986927986145
- I-Disease 1 0.8075776100158691
Zonana I-Disease 1 0.9986559152603149
( I-Disease 0 0.02537490800023079
BZS I-Disease 1 0.9676687121391296
) I-Disease 0 0.019007302820682526
or I-Disease 0 0.016358694061636925
Ruvalcaba I-Disease 1 0.9970911741256714
- I-Disease 1 0.9760805368423462
Riley I-Disease 1 0.9989233613014221
- I-Disease 1 0.9999265670776367
Smith I-Disease 1 0.9998961687088013
syndrome I-Disease 1 1.0
( O 1 0.9983481168746948
MIM O 1 0.9999991655349731
153480 O 1 0.9998844861984253
) O 0 0.04785272851586342
. O 0 0.05428338795900345

Constitutive O 0 0.09642408043146133
DNA O 0 0.036512356251478195
from O 0 0.020453816279768944
37 O 0 0.027338271960616112
CD B-Disease 0 0.03362831845879555
families O 0 0.016120359301567078
and O 0 0.01332086045295
seven O 0 0.01729561947286129
BZS B-Disease 1 0.9982993006706238
families O 0 0.01801055669784546
was O 0 0.024948162958025932
screened O 0 0.05755256861448288
for O 0 0.03259727731347084
germline O 1 0.9971983432769775
PTEN O 1 0.9998753070831299
mutations O 0 0.11682162433862686
. O 0 0.05280280485749245

PTEN O 1 0.9949636459350586
mutations O 0 0.040980152785778046
were O 0 0.018732218071818352
identified O 0 0.014618842862546444
in O 0 0.01094007771462202
30 O 0 0.011251311749219894
of O 0 0.008903398178517818
37 O 0 0.013769542798399925
( O 0 0.010949610732495785
81 O 0 0.01851057820022106
% O 0 0.01035202294588089
) O 0 0.009645059704780579
CD B-Disease 0 0.0187832098454237
families O 0 0.009384142234921455
, O 0 0.007956535555422306
including O 0 0.008302749134600163
missense O 0 0.015564551576972008
and O 0 0.00864159595221281
nonsense O 0 0.031846534460783005
point O 0 0.011435969732701778
mutations O 0 0.011042897589504719
, O 0 0.009958583861589432
deletions O 0 0.021325791254639626
, O 0 0.011004932224750519
insertions O 0 0.025263376533985138
, O 0 0.011776555329561234
a O 0 0.015274491161108017
deletion O 0 0.2728630304336548
/ O 1 0.6702562570571899
insertion O 0 0.08031444996595383
and O 0 0.02210688591003418
splice O 0 0.0990808755159378
site O 0 0.04336085170507431
mutations O 0 0.049109142273664474
. O 0 0.04401152953505516

These O 0 0.023878177627921104
mutations O 0 0.018474210053682327
were O 0 0.010740368627011776
scattered O 0 0.012282036244869232
over O 0 0.008494555950164795
the O 0 0.008396359160542488
entire O 0 0.011936069466173649
length O 0 0.010317366570234299
of O 0 0.011200922541320324
PTEN O 1 0.9988203644752502
, O 0 0.008236397989094257
with O 0 0.006222925614565611
the O 0 0.006307777017354965
exception O 0 0.008031291887164116
of O 0 0.006445073056966066
the O 0 0.007510858587920666
first O 0 0.009312999434769154
, O 0 0.009397055022418499
fourth O 0 0.019639527425169945
and O 0 0.011906401254236698
last O 0 0.01950189657509327
exons O 0 0.04413463547825813
. O 0 0.03724934533238411

A O 0 0.04572014883160591
hot O 0 0.06961539387702942
spot O 0 0.03412174433469772
for O 0 0.01935451291501522
PTEN O 1 0.9974879026412964
mutation O 0 0.018522538244724274
in O 0 0.011050492525100708
CD B-Disease 0 0.03906926512718201
was O 0 0.012001079507172108
identified O 0 0.008844524621963501
in O 0 0.0074418820440769196
exon O 0 0.016517091542482376
5 O 0 0.008613768965005875
that O 0 0.005357964430004358
contains O 0 0.007102744188159704
the O 0 0.00856497697532177
PTPase O 1 0.8475505709648132
core O 0 0.021862518042325974
motif O 0 0.0159386545419693
, O 0 0.006296880077570677
with O 0 0.005159478634595871
13 O 0 0.0071517047472298145
of O 0 0.006260016467422247
30 O 0 0.007986471988260746
( O 0 0.008322803303599358
43 O 0 0.012700236402451992
% O 0 0.009522107429802418
) O 0 0.010724375955760479
CD B-Disease 0 0.029299871996045113
mutations O 0 0.015462216921150684
identified O 0 0.013430213555693626
in O 0 0.014293423853814602
this O 0 0.02149120718240738
exon O 0 0.08111352473497391
. O 0 0.044309210032224655

Seven O 0 0.029654676094651222
of O 0 0.01601366326212883
30 O 0 0.01450135838240385
( O 0 0.010911272838711739
23 O 0 0.012784823775291443
% O 0 0.0080342972651124
) O 0 0.006726502440869808
were O 0 0.005044001620262861
within O 0 0.00533073116093874
the O 0 0.006117798388004303
core O 0 0.015950093045830727
motif O 0 0.014384153299033642
, O 0 0.006006424780935049
the O 0 0.005610509775578976
majority O 0 0.005179393570870161
( O 0 0.004885048605501652
five O 0 0.004278946202248335
of O 0 0.004038340877741575
seven O 0 0.004599698353558779
) O 0 0.004967047832906246
of O 0 0.0049011618830263615
which O 0 0.004739744588732719
were O 0 0.005272276233881712
missense O 0 0.021604765206575394
mutations O 0 0.0076589640229940414
, O 0 0.007002147380262613
possibly O 0 0.007507066708058119
pointing O 0 0.009159114211797714
to O 0 0.006728143431246281
the O 0 0.0075970240868628025
functional O 0 0.01185915432870388
significance O 0 0.01366625539958477
of O 0 0.012173163704574108
this O 0 0.015567210502922535
region O 0 0.028711965307593346
. O 0 0.03613867238163948

Germline O 1 0.9953415393829346
PTEN O 1 0.9968926906585693
mutations O 0 0.03442305698990822
were O 0 0.016423802822828293
identified O 0 0.014502993784844875
in O 0 0.008974174968898296
four O 0 0.008811541832983494
of O 0 0.00736483559012413
seven O 0 0.008611101657152176
( O 0 0.011674277484416962
57 O 0 0.02702077105641365
% O 0 0.01627742312848568
) O 0 0.022648507729172707
BZS B-Disease 1 0.8159815669059753
families O 0 0.03282637521624565
studied O 0 0.04609040543437004
. O 0 0.04728911817073822

Interestingly O 0 0.09187576919794083
, O 0 0.021972589194774628
none O 0 0.020016947761178017
of O 0 0.012956169433891773
these O 0 0.009846735745668411
mutations O 0 0.012481844052672386
was O 0 0.012163018807768822
observed O 0 0.011909430846571922
in O 0 0.012592755258083344
the O 0 0.019730735570192337
PTPase O 1 0.971469521522522
core O 0 0.3877617120742798
motif O 0 0.20365369319915771
. O 0 0.05475008487701416

It O 0 0.026865588501095772
is O 0 0.01617293618619442
also O 0 0.013278859667479992
worthy O 0 0.019312094897031784
of O 0 0.009693562053143978
note O 0 0.010215157642960548
that O 0 0.005665433593094349
a O 0 0.007787785027176142
single O 0 0.009183205664157867
nonsense O 0 0.027424028143286705
point O 0 0.010385941714048386
mutation O 0 0.012270969338715076
, O 0 0.00896503310650587
R233X O 0 0.12020228803157806
, O 0 0.009336354210972786
was O 0 0.009478019550442696
observed O 0 0.008736356161534786
in O 0 0.007595456670969725
the O 0 0.008523809723556042
germline O 0 0.019367340952157974
DNA O 0 0.011266754008829594
from O 0 0.00865582749247551
two O 0 0.008455623872578144
unrelated O 0 0.015205277130007744
CD B-Disease 0 0.038122665137052536
families O 0 0.015063704922795296
and O 0 0.01715601608157158
one O 0 0.02441420778632164
BZS B-Disease 1 0.9955651164054871
family O 0 0.05734981968998909
. O 0 0.050488073378801346

Genotype O 1 0.9917359948158264
- O 1 0.9778965711593628
phenotype O 1 0.7216043472290039
studies O 0 0.015260445885360241
were O 0 0.009736509062349796
not O 0 0.007853038609027863
performed O 0 0.00991717167198658
on O 0 0.008085587993264198
this O 0 0.00766111770644784
small O 0 0.011795160360634327
group O 0 0.016510682180523872
of O 0 0.01936107687652111
BZS B-Disease 1 0.9978941082954407
families O 0 0.03874935209751129
. O 0 0.043013036251068115

However O 0 0.04140773043036461
, O 0 0.03062484972178936
genotype O 0 0.15132467448711395
- O 0 0.22039663791656494
phenotype O 0 0.09384995698928833
analysis O 0 0.014603429473936558
inthe O 1 0.5778341293334961
group O 0 0.01446251105517149
of O 0 0.010299415327608585
CD B-Disease 0 0.28767716884613037
families O 0 0.010408736765384674
revealed O 0 0.010246919468045235
two O 0 0.00641954131424427
possible O 0 0.006896349135786295
associations O 0 0.009115028195083141
worthy O 0 0.015621943399310112
of O 0 0.008431379683315754
follow O 0 0.010438612662255764
- O 0 0.0404231995344162
up O 0 0.014402078464627266
in O 0 0.014370814897119999
independent O 0 0.024076510220766068
analyses O 0 0.04241384193301201
. O 0 0.04367499798536301

The O 0 0.02673961967229843
first O 0 0.019055068492889404
was O 0 0.01617368683218956
an O 0 0.010483370162546635
association O 0 0.020059967413544655
noted O 0 0.008705844171345234
in O 0 0.006648320239037275
the O 0 0.006776278838515282
group O 0 0.008436950854957104
of O 0 0.009067385457456112
CD B-Disease 1 0.9782316088676453
families O 0 0.12972936034202576
with O 1 0.8133260011672974
breast B-Disease 1 0.9999992847442627
disease I-Disease 1 0.9999963045120239
. O 0 0.11713995039463043

A O 0 0.03790595382452011
correlation O 0 0.027369463816285133
was O 0 0.016151849180459976
observed O 0 0.009946344420313835
between O 0 0.008118498139083385
the O 0 0.00870482251048088
presence O 0 0.010972107760608196
/ O 0 0.4629422724246979
absence O 0 0.015611959621310234
of O 0 0.008778938092291355
a O 0 0.04704195633530617
PTEN O 1 0.9995743632316589
mutation O 0 0.014723798260092735
and O 0 0.006988454610109329
the O 0 0.007987449876964092
type O 0 0.028742296621203423
of O 0 0.03222401812672615
breast O 1 0.9999970197677612
involvement O 1 0.9952666759490967
( O 1 0.9024864435195923
unaffected O 1 0.9997174143791199
versus O 1 0.9998576641082764
benign O 1 0.9999939203262329
versus O 1 0.9998094439506531
malignant O 1 0.9999978542327881
) O 0 0.05353149399161339
. O 0 0.06006983667612076

Specifically O 0 0.0321337915956974
and O 0 0.016659164801239967
more O 0 0.010728844441473484
directly O 0 0.009975175373256207
, O 0 0.007746331859380007
an O 0 0.006901223212480545
association O 0 0.08702027052640915
was O 0 0.011105542071163654
also O 0 0.005772797856479883
observed O 0 0.0052987392991781235
between O 0 0.0040648337453603745
the O 0 0.004963031504303217
presence O 0 0.006023455876857042
of O 0 0.006589886732399464
a O 1 0.5175818800926208
PTEN O 1 0.9999991655349731
mutation O 1 0.9997547268867493
and O 1 0.9999016523361206
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9729189276695251

Secondly O 0 0.3600695729255676
, O 0 0.023069066926836967
there O 0 0.013419779017567635
appeared O 0 0.011482390575110912
to O 0 0.008229413069784641
be O 0 0.006154960487037897
an O 0 0.008610259741544724
interdependent O 1 0.5206395983695984
association O 0 0.046063750982284546
between O 0 0.009181014262139797
mutations O 0 0.01074264943599701
upstream O 0 0.011018013581633568
and O 0 0.006485288497060537
within O 0 0.006994697730988264
the O 0 0.007990149781107903
PTPase O 1 0.9306312799453735
core O 0 0.08237652480602264
motif O 0 0.06817567348480225
, O 0 0.008615812286734581
the O 0 0.008235396817326546
core O 0 0.015243173576891422
motif O 0 0.015752457082271576
containing O 0 0.009260897524654865
the O 0 0.007692901883274317
majority O 0 0.007346110884100199
of O 0 0.00778808631002903
missense O 0 0.3262748420238495
mutations O 0 0.008922268636524677
, O 0 0.005108566489070654
and O 0 0.004606929607689381
the O 0 0.0046944511123001575
involvement O 0 0.006305349990725517
of O 0 0.004901066422462463
all O 0 0.004945019260048866
major O 0 0.02179747261106968
organ O 1 0.8245932459831238
systems O 0 0.25492507219314575
( O 0 0.008936438709497452
central O 0 0.00977538526058197
nervous O 1 0.5996787548065186
system O 0 0.13036856055259705
, O 1 0.7717644572257996
thyroid O 1 0.9999998807907104
, O 1 0.9974461793899536
breast O 1 1.0
, O 1 0.9999033212661743
skin O 1 1.0
and O 1 0.9999881982803345
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9827961325645447
. O 0 0.07005979120731354

However O 0 0.02830396220088005
, O 0 0.016812946647405624
these O 0 0.009868974797427654
observations O 0 0.012277472764253616
would O 0 0.007624258287250996
need O 0 0.008124593645334244
to O 0 0.006581127643585205
be O 0 0.0056899357587099075
confirmed O 0 0.008326209150254726
by O 0 0.006407305132597685
studying O 0 0.010162407532334328
a O 0 0.00995468720793724
larger O 0 0.01130166370421648
number O 0 0.01053041685372591
of O 0 0.013960173353552818
CD B-Disease 0 0.17384247481822968
families O 0 0.029708663001656532
. O 0 0.036820054054260254

Molecular O 0 0.09630145132541656
defects O 1 0.8917130827903748
leading O 0 0.029085470363497734
to O 0 0.01580282486975193
human O 0 0.03855738788843155
complement B-Disease 1 0.9991312623023987
component I-Disease 1 0.9999960660934448
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.10042652487754822
an O 0 0.10821530967950821
African O 1 0.9525449275970459
- O 1 0.9866829514503479
American O 0 0.14409509301185608
family O 0 0.03901773691177368
. O 0 0.03740490600466728

Complement B-Disease 1 0.9914183616638184
component I-Disease 1 0.9999651908874512
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
( O 1 0.9908981919288635
C6D B-Disease 1 0.9999885559082031
) O 0 0.07183822989463806
was O 0 0.286381334066391
diagnosed O 1 0.9988856911659241
in O 0 0.008401775732636452
a O 0 0.010760227218270302
16 O 0 0.013567616231739521
- O 0 0.029538536444306374
year O 0 0.011436345987021923
- O 0 0.04500262811779976
old O 0 0.018298089504241943
African O 0 0.019754398614168167
- O 1 0.5258862972259521
American O 0 0.0699329674243927
male O 1 0.6639012694358826
with O 1 0.9184110164642334
meningococcal B-Disease 1 0.9999998807907104
meningitis I-Disease 1 0.9999998807907104
. O 1 0.7801083326339722

The O 0 0.05026137828826904
patients O 1 0.9593504071235657
father O 0 0.1398373246192932
and O 0 0.011041386984288692
two O 0 0.008524906821548939
brothers O 0 0.19350148737430573
also O 0 0.010565263219177723
had O 0 0.02967185340821743
C6D B-Disease 1 0.9945006370544434
, O 0 0.0072587355971336365
but O 0 0.006134308874607086
gave O 0 0.00892632920295
no O 0 0.006739499978721142
history O 0 0.011407670564949512
of O 0 0.27136677503585815
meningitis B-Disease 1 0.9999997615814209
or O 1 0.5199228525161743
other O 0 0.13767707347869873
neisserial B-Disease 1 0.9999818801879883
infection I-Disease 1 0.9999840259552002
. O 0 0.0588531531393528

By O 0 0.02648390829563141
using O 0 0.0231298990547657
exon O 0 0.058731842786073685
- O 0 0.027974838390946388
specific O 0 0.01230151578783989
polymerase O 0 0.03214257210493088
chain O 0 0.023060165345668793
reaction O 0 0.013475906103849411
( O 0 0.012006445787847042
PCR O 0 0.03236186504364014
) O 0 0.011811934411525726
/ O 0 0.030885374173521996
single O 0 0.015155604109168053
- O 0 0.02965589053928852
strand O 0 0.02234998717904091
conformation O 0 0.01998434029519558
polymorphism O 0 0.019245436415076256
as O 0 0.011255953460931778
a O 0 0.013269640505313873
screening O 0 0.015493192709982395
step O 0 0.01451998669654131
and O 0 0.009496256709098816
nucleotide O 0 0.013766331598162651
sequencing O 0 0.012866339646279812
of O 0 0.008534875698387623
target O 0 0.010878623463213444
exons O 0 0.015504558570683002
, O 0 0.008147689513862133
we O 0 0.007355693727731705
determined O 0 0.008429828099906445
that O 0 0.006134750321507454
the O 0 0.008936891332268715
proband O 0 0.14740540087223053
was O 0 0.012452801689505577
a O 0 0.01227958407253027
compound O 0 0.02210032008588314
heterozygote O 0 0.13850505650043488
for O 0 0.015148453414440155
two O 0 0.020450644195079803
C6 O 1 0.9995903372764587
gene O 0 0.03884638473391533
mutations O 0 0.03847538307309151
. O 0 0.03864382207393646

The O 0 0.033091820776462555
first O 0 0.025666488334536552
, O 0 0.01841762661933899
1195delC O 0 0.045591048896312714
located O 0 0.016908977180719376
in O 0 0.012748944573104382
exon O 0 0.034759048372507095
7 O 0 0.014215854927897453
, O 0 0.008856215514242649
is O 0 0.00793074257671833
a O 0 0.009003398939967155
novel O 0 0.014257720671594143
mutation O 0 0.009922183118760586
, O 0 0.006204076111316681
while O 0 0.005674213636666536
the O 0 0.0062644826248288155
second O 0 0.009517459198832512
, O 0 0.007565484847873449
1936delG O 0 0.04052262008190155
in O 0 0.008415484800934792
exon O 0 0.02720598876476288
12 O 0 0.009974585846066475
, O 0 0.0077327825129032135
has O 0 0.006439066492021084
been O 0 0.00562383234500885
described O 0 0.006261806003749371
before O 0 0.006467713974416256
to O 0 0.007471523247659206
cause O 0 0.060416556894779205
C6D B-Disease 1 0.9375655651092529
in O 0 0.008319908753037453
an O 0 0.009542939253151417
unrelated O 0 0.06632844358682632
African O 0 0.16290415823459625
- O 1 0.8014123439788818
American O 0 0.030172007158398628
individual O 0 0.025307659059762955
. O 0 0.034315623342990875

Both O 0 0.042361464351415634
mutations O 0 0.0318872295320034
result O 0 0.02404780127108097
in O 0 0.022185591980814934
premature O 1 0.9381213784217834
termination O 1 0.9963434338569641
codons O 0 0.49746066331863403
and O 0 0.2245412915945053
C6 O 1 0.9999382495880127
null O 1 0.6995359659194946
alleles O 0 0.09050681442022324
. O 0 0.0665658712387085

Allele O 0 0.0976550355553627
- O 0 0.041736774146556854
specific O 0 0.018770582973957062
PCR O 0 0.02779657579958439
indicated O 0 0.013668480329215527
that O 0 0.007536743767559528
the O 0 0.008590771816670895
probands O 1 0.5277503132820129
two O 0 0.007704842370003462
brothers O 0 0.05907869711518288
also O 0 0.008672362193465233
inherited O 1 0.8729683756828308
the O 0 0.010342130437493324
1195delC O 1 0.9922919869422913
mutation O 0 0.01103047002106905
from O 0 0.0058674016036093235
their O 0 0.006038557272404432
heterozygous O 0 0.01579076237976551
mother O 0 0.028102267533540726
and O 0 0.007111294195055962
the O 0 0.009688500314950943
1936delG O 1 0.9811991453170776
mutation O 0 0.013373305089771748
from O 0 0.009878559969365597
their O 0 0.01220285426825285
homozygous O 0 0.03169233351945877
father O 0 0.03728138655424118
. O 0 0.02653164602816105
. O 0 0.04100077226758003

PAX6 O 1 0.9980272650718689
mutations O 0 0.14848150312900543
reviewed O 0 0.1371816098690033
. O 0 0.09744775295257568

Mutations O 0 0.04691341519355774
in O 0 0.021352002397179604
PAX6 O 1 0.991898775100708
are O 0 0.009543826803565025
responsible O 0 0.011994651518762112
for O 0 0.007878383621573448
human O 0 0.09919345378875732
aniridia B-Disease 1 0.9999849796295166
and O 0 0.01351732574403286
have O 0 0.004730709828436375
also O 0 0.0053369286470115185
been O 0 0.004240020643919706
found O 0 0.00452912412583828
in O 0 0.004766546655446291
patients O 1 0.543258786201477
with O 0 0.01348492968827486
Peters B-Disease 1 0.999835729598999
anomaly I-Disease 1 0.9999604225158691
, O 1 0.9061688184738159
with O 1 0.9974164962768555
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9993682503700256
with O 1 0.9992109537124634
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9999992847442627
keratitis I-Disease 1 1.0
, O 1 0.9282721877098083
and O 0 0.2732934355735779
with O 0 0.4639688730239868
isolated B-Disease 1 0.9956969022750854
foveal I-Disease 1 0.9999932050704956
hypoplasia I-Disease 1 0.9999977350234985
. O 0 0.18673588335514069

No O 0 0.032445840537548065
locus O 0 0.041846588253974915
other O 0 0.01326567679643631
than O 0 0.01102810725569725
chromosome O 0 0.02653714083135128
11p13 O 1 0.5935023427009583
has O 0 0.0088112847879529
been O 0 0.007164171896874905
implicated O 0 0.06315243989229202
in O 0 0.00939291249960661
aniridia B-Disease 1 0.9998437166213989
, O 0 0.03102393075823784
and O 0 0.034622009843587875
PAX6 O 1 0.9998258948326111
is O 0 0.009041821584105492
clearly O 0 0.01045240368694067
the O 0 0.007168053649365902
major O 0 0.011479164473712444
, O 0 0.0077078151516616344
if O 0 0.006018852815032005
not O 0 0.006418136414140463
only O 0 0.008360710926353931
, O 0 0.012750613503158092
gene O 0 0.018086370080709457
responsible O 0 0.02626780793070793
. O 0 0.03685219958424568

Twenty O 0 0.05675847828388214
- O 0 0.03321198374032974
eight O 0 0.02018050104379654
percent O 0 0.014405247755348682
of O 0 0.01139156986027956
identified O 0 0.016781238839030266
PAX6 O 1 0.999832272529602
mutations O 0 0.01987152174115181
are O 0 0.007723282556980848
C O 1 0.7607693672180176
- O 1 0.7271969318389893
T O 1 0.7304665446281433
changes O 0 0.010983284562826157
at O 0 0.012728159315884113
CpG O 0 0.031139837577939034
dinucleotides O 0 0.040598731487989426
, O 0 0.009393534623086452
20 O 0 0.010853632353246212
% O 0 0.008038550615310669
are O 0 0.005874392576515675
splicing O 0 0.011329397559165955
errors O 0 0.010351484641432762
, O 0 0.007401991635560989
and O 0 0.005851655267179012
more O 0 0.004963545128703117
than O 0 0.0053206272423267365
30 O 0 0.008526550605893135
% O 0 0.008639014326035976
are O 0 0.007856103591620922
deletion O 0 0.021004438400268555
or O 0 0.01525165792554617
insertion O 0 0.037481676787137985
events O 0 0.029254300519824028
. O 0 0.03874547779560089

There O 0 0.02729213424026966
is O 0 0.018571170046925545
a O 0 0.017214002087712288
noticeably O 0 0.47885623574256897
elevated O 1 0.7051458358764648
level O 0 0.0135173499584198
of O 0 0.01134917140007019
mutation O 0 0.012944906949996948
in O 0 0.007969900965690613
the O 0 0.010023284703493118
paired O 0 0.018294552341103554
domain O 0 0.012408331967890263
compared O 0 0.009819019585847855
with O 0 0.0074281091801822186
the O 0 0.008681938983500004
rest O 0 0.012141437269747257
of O 0 0.011463343165814877
the O 0 0.016704203560948372
gene O 0 0.026467174291610718
. O 0 0.031175419688224792

Increased O 0 0.041370492428541183
mutation O 0 0.026520341634750366
in O 0 0.014870081096887589
the O 0 0.016104158014059067
homeodomain O 1 0.975318968296051
is O 0 0.013718648813664913
accounted O 0 0.017223775386810303
for O 0 0.009497120976448059
by O 0 0.011647065170109272
the O 0 0.018802419304847717
hypermutable O 1 0.9666560292243958
CpG O 0 0.4545775353908539
dinucleotide O 1 0.5129781365394592
in O 0 0.03104797564446926
codon O 0 0.0706353709101677
240 O 0 0.08406831324100494
. O 0 0.06583555042743683

Very O 0 0.030007271096110344
nearly O 0 0.01860129088163376
all O 0 0.01169067807495594
mutations O 0 0.011439738795161247
appear O 0 0.008186036720871925
to O 0 0.007271060720086098
cause O 0 0.033995892852544785
loss O 0 0.03557630255818367
of O 0 0.007614652626216412
function O 0 0.006817953195422888
of O 0 0.006775560323148966
the O 0 0.010251300409436226
mutant O 1 0.571359395980835
allele O 0 0.016351774334907532
, O 0 0.007280456367880106
and O 0 0.006188703700900078
more O 0 0.005246508866548538
than O 0 0.005751836113631725
80 O 0 0.009206554852426052
% O 0 0.008532814681529999
of O 0 0.011067341081798077
exonic O 0 0.3582952320575714
substitutions O 0 0.027773598209023476
result O 0 0.017762046307325363
in O 0 0.020151659846305847
nonsense O 0 0.05668923631310463
codons O 0 0.06160695105791092
. O 0 0.05245136097073555

In O 0 0.02820933796465397
a O 0 0.020743979141116142
gene O 0 0.016518229618668556
with O 0 0.00942106731235981
such O 0 0.009194454178214073
extraordinarily O 0 0.29622524976730347
high O 0 0.012612080201506615
sequence O 0 0.00907315406948328
conservation O 0 0.010123567655682564
throughout O 0 0.008048252202570438
evolution O 0 0.008559771813452244
, O 0 0.006809762213379145
there O 0 0.005627740174531937
are O 0 0.005647148936986923
presumed O 0 0.013249003328382969
undiscovered O 1 0.5623968839645386
missense O 0 0.4585261046886444
mutations O 0 0.012114688754081726
, O 0 0.007150384597480297
these O 0 0.005522420164197683
are O 0 0.004670359194278717
hypothesized O 0 0.009533493779599667
to O 0 0.00592179037630558
exist O 0 0.0066538527607917786
in O 0 0.00703338161110878
as O 0 0.009470939636230469
- O 0 0.05203671753406525
yet O 0 0.01710154116153717
unidentified O 0 0.05337347090244293
phenotypes O 0 0.1985333412885666
. O 0 0.024800581857562065
. O 0 0.037321560084819794

Genetic O 0 0.06020414084196091
heterogeneity O 0 0.09119096398353577
and O 0 0.02356705628335476
penetrance O 0 0.1248508170247078
analysis O 0 0.014267990365624428
of O 0 0.011889114044606686
the O 0 0.05736001580953598
BRCA1 O 1 0.999943733215332
and O 1 0.8791311383247375
BRCA2 O 1 0.9999974966049194
genes O 1 0.8906603455543518
in O 1 0.9895917773246765
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 1 0.8218465447425842
. O 0 0.0606747530400753

The O 1 0.9931179285049438
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999994039535522
Linkage O 1 0.9997550845146179
Consortium O 1 0.9953018426895142
. O 0 0.08913678675889969

The O 0 0.03640827164053917
contribution O 0 0.0340484157204628
of O 0 0.021281052380800247
BRCA1 O 1 0.9970479607582092
and O 0 0.19237886369228363
BRCA2 O 1 0.9999499320983887
to O 1 0.8991049528121948
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9986475110054016
assessed O 1 0.6678963899612427
by O 0 0.008303592912852764
linkage O 1 0.7195338606834412
and O 0 0.008742007426917553
mutation O 0 0.008645705878734589
analysis O 0 0.006352096330374479
in O 0 0.006590408738702536
237 O 0 0.01741188019514084
families O 0 0.007105041295289993
, O 0 0.006114716175943613
each O 0 0.0050420137122273445
with O 0 0.00431386474519968
at O 0 0.004804075229912996
least O 0 0.004343358799815178
four O 0 0.004858795553445816
cases O 0 0.006197646260261536
of O 0 0.12411855906248093
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999992847442627
, O 0 0.016664836555719376
collected O 0 0.010240450501441956
by O 0 0.010717412456870079
the O 1 0.9773461818695068
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999998807907104
Linkage O 1 0.9996179342269897
Consortium O 1 0.9661860466003418
. O 0 0.05246350169181824

Families O 0 0.03802289441227913
were O 0 0.016590002924203873
included O 0 0.01438986137509346
without O 0 0.010185894556343555
regard O 0 0.0105814253911376
to O 0 0.008990027941763401
the O 0 0.009442255832254887
occurrence O 0 0.16356781125068665
of O 1 0.9152685403823853
ovarian B-Disease 1 1.0
or I-Disease 1 0.9721579551696777
other I-Disease 0 0.2695891261100769
cancers I-Disease 1 0.9999512434005737
. O 0 0.04742933064699173

Overall O 1 0.9488081336021423
, O 0 0.47327691316604614
disease O 1 0.999656081199646
was O 0 0.2156035304069519
linked O 0 0.29089972376823425
to O 0 0.009872585535049438
BRCA1 O 1 0.9227763414382935
in O 0 0.006725628860294819
an O 0 0.00703010568395257
estimated O 0 0.009182143025100231
52 O 0 0.011262569576501846
% O 0 0.007020486518740654
of O 0 0.006541855167597532
families O 0 0.006594155449420214
, O 0 0.006008167285472155
to O 0 0.006645675282925367
BRCA2 O 0 0.03991963714361191
in O 0 0.0058036078698933125
32 O 0 0.009006449952721596
% O 0 0.005875400733202696
of O 0 0.004698276054114103
families O 0 0.00524387089535594
, O 0 0.004435280803591013
and O 0 0.004726886283606291
to O 0 0.004749523010104895
neither O 0 0.007301855366677046
gene O 0 0.005691630765795708
in O 0 0.005701899528503418
16 O 0 0.007577879354357719
% O 0 0.00665005249902606
( O 0 0.007599720731377602
95 O 0 0.013232419267296791
% O 0 0.009759394451975822
confidence O 0 0.015344527550041676
interval O 0 0.017787054181098938
[ O 0 0.020484181120991707
CI O 1 0.7586825489997864
] O 0 0.01965402625501156
6 O 0 0.014766998589038849
% O 0 0.010537072084844112
- O 0 0.014548229053616524
28 O 0 0.015649238601326942
% O 0 0.011887914501130581
) O 0 0.011357061564922333
, O 0 0.012797192670404911
suggesting O 0 0.01839495077729225
other O 0 0.017359143123030663
predisposition O 1 0.7872044444084167
genes O 0 0.03252590447664261
. O 0 0.03938749060034752

The O 0 0.03317646682262421
majority O 0 0.019236184656620026
( O 0 0.015172175131738186
81 O 0 0.02153446339070797
% O 0 0.01020082738250494
) O 0 0.008077037520706654
of O 0 0.008808094076812267
the O 0 0.1819252371788025
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.35342392325401306
were O 0 0.007074411958456039
due O 0 0.011171276681125164
to O 0 0.0077127874828875065
BRCA1 O 1 0.9792530536651611
, O 0 0.005986955016851425
with O 0 0.005299805197864771
most O 0 0.005072737578302622
others O 0 0.0056257122196257114
( O 0 0.006871234625577927
14 O 0 0.011022055521607399
% O 0 0.011224940419197083
) O 0 0.01269473321735859
due O 0 0.016674920916557312
to O 0 0.02545851655304432
BRCA2 O 1 0.8405790328979492
. O 0 0.04228116571903229

Conversely O 0 0.058305032551288605
, O 0 0.020697779953479767
the O 0 0.013922560028731823
majority O 0 0.011114935390651226
of O 0 0.00882371049374342
families O 0 0.008031010627746582
with O 0 0.007054964546114206
male B-Disease 0 0.1994939148426056
and I-Disease 0 0.4854724407196045
female I-Disease 1 0.9999349117279053
breast I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
were O 0 0.044367577880620956
due O 0 0.109270840883255
to O 0 0.017623301595449448
BRCA2 O 1 0.999290943145752
( O 0 0.024479780346155167
76 O 0 0.3462410867214203
% O 0 0.02281576208770275
) O 0 0.028553573414683342
. O 0 0.039266448467969894

The O 0 0.03356983885169029
largest O 0 0.02847902476787567
proportion O 0 0.017065981402993202
( O 0 0.012514890171587467
67 O 0 0.01786847598850727
% O 0 0.008079261519014835
) O 0 0.00671922042965889
of O 0 0.005877545569092035
families O 0 0.005181371700018644
due O 0 0.0049509708769619465
to O 0 0.005274954717606306
other O 0 0.004486659541726112
genes O 0 0.005599862430244684
was O 0 0.005857235752046108
found O 0 0.004232863429933786
in O 0 0.004022298846393824
families O 0 0.0046283164992928505
with O 0 0.004251937381923199
four O 0 0.004332892596721649
or O 0 0.004572094883769751
five O 0 0.005992213264107704
cases O 0 0.008169354870915413
of O 0 0.0861811563372612
female O 1 0.9998799562454224
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
only O 0 0.045565780252218246
. O 0 0.04642335698008537

These O 0 0.02671797387301922
estimates O 0 0.02238234132528305
were O 0 0.012238070368766785
not O 0 0.00963861308991909
substantially O 0 0.01387801580131054
affected O 0 0.009167343378067017
either O 0 0.007703596726059914
by O 0 0.00740267476066947
changing O 0 0.010760334320366383
the O 0 0.01023666188120842
assumed O 0 0.020680585876107216
penetrance O 1 0.7603968381881714
model O 0 0.017042074352502823
for O 0 0.01193281915038824
BRCA1 O 1 0.973060667514801
or O 0 0.00829921942204237
by O 0 0.007979845628142357
including O 0 0.009512281976640224
or O 0 0.015113712288439274
excluding O 0 0.3516421914100647
BRCA1 O 1 0.9978901743888855
mutation O 0 0.03609117120504379
data O 0 0.026293668895959854
. O 0 0.03873704746365547

Among O 0 0.02796979434788227
those O 0 0.01538311317563057
families O 0 0.015442956238985062
with O 0 0.09204541891813278
disease O 1 0.9999942779541016
due O 1 0.5680972337722778
to O 0 0.08425401151180267
BRCA1 O 1 0.999752938747406
that O 0 0.005039923824369907
were O 0 0.004501875024288893
tested O 0 0.007642903830856085
by O 0 0.004804252181202173
one O 0 0.004702246747910976
of O 0 0.004894691053777933
the O 0 0.005967582575976849
standard O 0 0.008570943027734756
screening O 0 0.010132859461009502
methods O 0 0.007528744637966156
, O 0 0.008286290802061558
mutations O 0 0.007271394599229097
were O 0 0.005437809973955154
detected O 0 0.007777370046824217
in O 0 0.005686650983989239
the O 0 0.006909987889230251
coding O 0 0.01138353906571865
sequence O 0 0.008114282973110676
or O 0 0.007637029513716698
splice O 0 0.01473278645426035
sites O 0 0.007823176681995392
in O 0 0.006513646338135004
an O 0 0.0064979251474142075
estimated O 0 0.009339530020952225
63 O 0 0.014314930886030197
% O 0 0.008654244244098663
( O 0 0.009905804879963398
95 O 0 0.017317280173301697
% O 0 0.014082151465117931
CI O 0 0.3425482511520386
51 O 0 0.025383468717336655
% O 0 0.01817803829908371
- O 0 0.03642909228801727
77 O 0 0.037103090435266495
% O 0 0.026997849345207214
) O 0 0.034290287643671036
. O 0 0.04782245308160782

The O 0 0.0359623059630394
estimated O 0 0.027382660657167435
sensitivity O 0 0.038914602249860764
was O 0 0.01820063591003418
identical O 0 0.016243549063801765
for O 0 0.011365019716322422
direct O 0 0.01420908235013485
sequencing O 0 0.020346548408269882
and O 0 0.015064233914017677
other O 0 0.015411978587508202
techniques O 0 0.02965153567492962
. O 0 0.035885997116565704

The O 0 0.05061766132712364
penetrance O 1 0.9186680912971497
of O 0 0.08021842688322067
BRCA2 O 1 0.9990600943565369
was O 0 0.022014856338500977
estimated O 0 0.015131709165871143
by O 0 0.010424175299704075
maximizing O 0 0.023871678858995438
the O 0 0.012844143435359001
LOD O 1 0.8387407064437866
score O 0 0.016476085409522057
in O 0 0.013936784118413925
BRCA2 O 1 0.9987867474555969
- O 1 0.9118844866752625
mutation O 0 0.019114995375275612
families O 0 0.009646106511354446
, O 0 0.008454794995486736
over O 0 0.009750702418386936
all O 0 0.011474096216261387
possible O 0 0.02129601500928402
penetrance O 1 0.5540532469749451
functions O 0 0.03496316820383072
. O 0 0.044997766613960266

The O 0 0.03395746275782585
estimated O 0 0.02791770175099373
cumulative O 0 0.04228834807872772
risk O 1 0.5912021994590759
of O 1 0.615505576133728
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999969005584717
reached O 0 0.49374401569366455
28 O 0 0.021327713504433632
% O 0 0.010010844096541405
( O 0 0.010187768377363682
95 O 0 0.015541225671768188
% O 0 0.012893596664071083
CI O 0 0.15021972358226776
9 O 0 0.01551480870693922
% O 0 0.010693908669054508
- O 0 0.014512442983686924
44 O 0 0.013611817732453346
% O 0 0.008997652679681778
) O 0 0.00751046696677804
by O 0 0.006766497623175383
age O 0 0.008294794708490372
50 O 0 0.009347585029900074
years O 0 0.007202245760709047
and O 0 0.006900811567902565
84 O 0 0.012681948952376842
% O 0 0.007715926971286535
( O 0 0.00796451885253191
95 O 0 0.0134698785841465
% O 0 0.010598802007734776
CI O 0 0.15436287224292755
43 O 0 0.01500494871288538
% O 0 0.010735644027590752
- O 0 0.014520054683089256
95 O 0 0.016005806624889374
% O 0 0.010096995159983635
) O 0 0.010192404501140118
by O 0 0.010147744789719582
age O 0 0.01702188141644001
70 O 0 0.02310185134410858
years O 0 0.028095262125134468
. O 0 0.0427081398665905

The O 0 0.46500805020332336
corresponding O 1 0.9996706247329712
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999468326568604
were O 0 0.3050149381160736
0 O 0 0.06976378709077835
. O 0 0.05057726427912712

4 O 0 0.048621878027915955
% O 0 0.024990087375044823
( O 0 0.01938602328300476
95 O 0 0.024330969899892807
% O 0 0.017732344567775726
CI O 1 0.5408880114555359
0 O 0 0.01812630519270897
% O 0 0.012071269564330578
- O 0 0.014158528298139572
1 O 0 0.01171958353370428
% O 0 0.008804764598608017
) O 0 0.007034944370388985
by O 0 0.005727601703256369
age O 0 0.008197006769478321
50 O 0 0.00888040754944086
years O 0 0.0065518938936293125
and O 0 0.007073627784848213
27 O 0 0.010562687180936337
% O 0 0.008661812171339989
( O 0 0.010386471636593342
95 O 0 0.01692633517086506
% O 0 0.012332690879702568
CI O 0 0.07680201530456543
0 O 0 0.018311183899641037
% O 0 0.01284171361476183
- O 0 0.016040470451116562
47 O 0 0.016271620988845825
% O 0 0.010136539116501808
) O 0 0.009814867749810219
by O 0 0.010979711078107357
age O 0 0.015718530863523483
70 O 0 0.02194536291062832
years O 0 0.02462126314640045
. O 0 0.03863074257969856

The O 0 0.03176801651716232
lifetime O 1 0.941210150718689
risk O 1 0.9952955842018127
of O 1 0.9988864064216614
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
appears O 1 0.8055713176727295
similar O 0 0.007460057269781828
to O 0 0.006135893519967794
the O 0 0.007233969401568174
risk O 0 0.2809044122695923
in O 0 0.09229566156864166
BRCA1 O 1 0.9999737739562988
carriers O 1 0.923184871673584
, O 0 0.006903478875756264
but O 0 0.0051487525925040245
there O 0 0.005375435575842857
was O 0 0.007260962389409542
some O 0 0.00514167919754982
suggestion O 0 0.010203216224908829
of O 0 0.006835571955889463
a O 0 0.008273213170468807
lower O 0 0.015175494365394115
risk O 0 0.0578337162733078
in O 0 0.013264397159218788
BRCA2 O 1 0.999821126461029
carriers O 1 0.764302670955658
< O 0 0.2565699815750122
50 O 0 0.017035549506545067
years O 0 0.01539192721247673
of O 0 0.01691700704395771
age O 0 0.02977672964334488
. O 0 0.03683450445532799

Eye B-Disease 1 0.994034469127655
movement I-Disease 0 0.10686246305704117
abnormalities I-Disease 1 0.927679717540741
correlate O 0 0.056853037327528
with O 0 0.022284919396042824
genotype O 1 0.9857388734817505
in O 1 0.5256596803665161
autosomal O 1 0.9999973773956299
dominant O 1 0.9999970197677612
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999983310699463
I I-Disease 1 0.9993937015533447
. O 0 0.09145953506231308

We O 0 0.03161254897713661
compared O 0 0.02581946551799774
horizontal O 0 0.04200416058301926
eye O 1 0.8406350612640381
movements O 0 0.019513512030243874
( O 0 0.016682757064700127
visually O 0 0.13427983224391937
guided O 1 0.50563645362854
saccades O 1 0.9993506073951721
, O 0 0.019174056127667427
antisaccades O 1 0.9033018946647644
, O 0 0.010973463766276836
and O 0 0.008325084112584591
smooth O 0 0.01578078418970108
pursuit O 0 0.032732728868722916
) O 0 0.007945857010781765
in O 0 0.007281042635440826
control O 0 0.008164010010659695
subjects O 0 0.00994778610765934
( O 0 0.00862274318933487
n O 0 0.012561221607029438
= O 0 0.012212272733449936
14 O 0 0.010273492895066738
) O 0 0.00826701894402504
and O 0 0.00808716006577015
patients O 0 0.009372752159833908
with O 0 0.005448010750114918
three O 0 0.005620782729238272
forms O 0 0.006660865619778633
of O 0 0.010976714082062244
autosomal O 1 0.9998869895935059
dominant O 1 0.9999158382415771
cerebellar B-Disease 1 0.9999998807907104
ataxias I-Disease 1 0.999998927116394
type I-Disease 1 0.9997106194496155
I I-Disease 1 0.9931516647338867
spinocerebellar B-Disease 1 0.9999958276748657
ataxias I-Disease 1 0.9946771860122681
1 I-Disease 0 0.017088210210204124
and I-Disease 0 0.011016806587576866
2 I-Disease 0 0.013880508951842785
( O 0 0.013131772167980671
SCA1 B-Disease 0 0.16706065833568573
, O 0 0.010992249473929405
n O 0 0.016819536685943604
= O 0 0.01875041425228119
11 O 0 0.014586606062948704
; O 0 0.01445063017308712
SCA2 B-Disease 0 0.03131210431456566
, O 0 0.012072684243321419
n O 0 0.015626298263669014
= O 0 0.01662617176771164
10 O 0 0.01287452969700098
) O 0 0.011430698446929455
and O 0 0.011938645504415035
SCA3 B-Disease 1 0.9951478838920593
/ O 1 0.8679976463317871
Machado B-Disease 1 0.9874370098114014
- I-Disease 1 0.9806035161018372
Joseph I-Disease 1 0.9876246452331543
disease I-Disease 1 0.999962568283081
( O 0 0.45102640986442566
MJD B-Disease 1 0.9999847412109375
) O 0 0.01653382182121277
( O 0 0.01584933139383793
n O 0 0.02577676810324192
= O 0 0.032883208245038986
16 O 0 0.032761503010988235
) O 0 0.03678465262055397
. O 0 0.048180729150772095

In O 0 0.04445303604006767
SCA1 B-Disease 1 0.9650110006332397
, O 0 0.03294676914811134
saccade O 1 0.9202044010162354
amplitude O 0 0.040804672986269
was O 0 0.02489570714533329
significantly O 0 0.019764907658100128
increased O 0 0.01764264516532421
, O 0 0.016211440786719322
resulting O 0 0.020020171999931335
in O 0 0.0215659961104393
hypermetria B-Disease 1 0.974973201751709
. O 0 0.048341769725084305

The O 0 0.04748431593179703
smooth O 0 0.06737929582595825
pursuit O 1 0.6685897707939148
gain O 0 0.15266768634319305
was O 0 0.27537801861763
decreased O 0 0.3695496916770935
. O 0 0.048725757747888565

In O 0 0.06266327947378159
SCA2 B-Disease 1 0.9866865873336792
, O 0 0.04229523986577988
saccade O 1 0.9587218165397644
velocity O 0 0.05341191217303276
was O 0 0.05479351431131363
markedly O 0 0.26411256194114685
decreased O 0 0.18236711621284485
. O 0 0.055116500705480576

The O 0 0.030538875609636307
percentage O 0 0.021181827411055565
of O 0 0.01218813844025135
errors O 0 0.018405647948384285
in O 0 0.010924526490271091
antisaccades O 1 0.9873608350753784
was O 0 0.07717539370059967
greatly O 0 0.01652107946574688
increased O 0 0.009113305248320103
and O 0 0.006821950897574425
was O 0 0.01016346737742424
significantly O 0 0.009268175810575485
correlated O 0 0.011328542605042458
with O 0 0.008653407916426659
age O 0 0.4102477431297302
at O 1 0.8537005186080933
disease O 1 0.9999957084655762
onset O 1 0.9999938011169434
. O 0 0.21275879442691803

In O 0 0.026782602071762085
addition O 0 0.019518805667757988
, O 0 0.013682114891707897
a O 0 0.01195496879518032
correlation O 0 0.012253573164343834
between O 0 0.00850224494934082
smooth O 0 0.01649273931980133
pursuit O 0 0.03622777760028839
gain O 0 0.013659430667757988
and O 0 0.00939987413585186
the O 0 0.009452133439481258
number O 0 0.010182741098105907
of O 0 0.014681386761367321
trinucleotide O 1 0.9939963817596436
repeats O 0 0.04179604351520538
was O 0 0.03213592991232872
found O 0 0.03066636063158512
. O 0 0.042651258409023285

In O 0 0.041820839047431946
SCA3 B-Disease 1 0.9987841248512268
, O 0 0.032480448484420776
gaze B-Disease 1 0.9822370409965515
- I-Disease 1 0.9984094500541687
evoked I-Disease 1 0.9998482465744019
nystagmus I-Disease 1 0.9999866485595703
was O 1 0.5891726613044739
often O 0 0.009734522551298141
present O 0 0.009281223639845848
as O 0 0.009811374358832836
was O 0 0.08719974756240845
saccade O 1 0.998428225517273
hypometria O 1 0.9838160872459412
and O 0 0.013662566430866718
smooth O 0 0.033605948090553284
pursuit O 0 0.31049296259880066
gain O 0 0.03809821605682373
was O 0 0.05467585101723671
markedly O 0 0.24661125242710114
decreased O 0 0.11704195290803909
. O 0 0.04900581017136574

Three O 0 0.03703145310282707
major O 0 0.03322893753647804
criteria O 0 0.026903701946139336
, O 0 0.024098984897136688
saccade O 1 0.7051448822021484
amplitude O 0 0.04054286330938339
, O 0 0.021719999611377716
saccade O 1 0.6016843318939209
velocity O 0 0.021113550290465355
, O 0 0.01271791197359562
and O 0 0.010282059200108051
presence O 0 0.011236033402383327
of O 0 0.011896342039108276
gaze B-Disease 1 0.9650605916976929
- I-Disease 1 0.996560275554657
evoked I-Disease 1 0.9992969036102295
nystagmus I-Disease 1 0.9997255206108093
, O 0 0.012689998373389244
permitted O 0 0.013102364726364613
the O 0 0.009482944384217262
correct O 0 0.012484255246818066
assignment O 0 0.015488888137042522
of O 0 0.008372919633984566
90 O 0 0.010428077541291714
% O 0 0.007866033352911472
of O 0 0.0062255957163870335
the O 0 0.0088051687926054
SCA1 B-Disease 1 0.9071546792984009
, O 0 0.0076499092392623425
90 O 0 0.009130566380918026
% O 0 0.0065159546211361885
of O 0 0.006287503056228161
the O 0 0.0075748395174741745
SCA2 B-Disease 1 0.6525425314903259
, O 0 0.007015627808868885
and O 0 0.006931990850716829
93 O 0 0.010537365451455116
% O 0 0.006214436609297991
of O 0 0.005921408534049988
the O 0 0.008303839713335037
patients O 1 0.913456380367279
with O 0 0.011684559285640717
SCA3 B-Disease 1 0.9999396800994873
to O 0 0.00582323782145977
their O 0 0.005315663293004036
genetically O 0 0.009618968702852726
confirmed O 0 0.016111526638269424
patient O 1 0.9036694169044495
group O 0 0.010460997000336647
and O 0 0.006424972787499428
, O 0 0.006324503570795059
therefore O 0 0.005972154904156923
, O 0 0.005668884143233299
may O 0 0.00628319988027215
help O 0 0.010398359037935734
orient O 0 0.03911936655640602
diagnoses O 1 0.7461687326431274
of O 0 0.013533268123865128
SCA1 B-Disease 1 0.99950110912323
, O 0 0.018431829288601875
SCA2 B-Disease 1 0.9929936528205872
, O 0 0.011988013982772827
and O 0 0.01063148956745863
SCA3 B-Disease 1 0.9943718910217285
at O 0 0.010089486837387085
early O 0 0.011071418412029743
clinical O 1 0.5959292054176331
stages O 0 0.02693183906376362
of O 0 0.016898199915885925
the O 1 0.6870229840278625
diseases O 1 0.9999922513961792
. O 0 0.030797716230154037
. O 0 0.037867315113544464

Genetic O 0 0.04124746471643448
basis O 0 0.02392411231994629
and O 0 0.019634507596492767
molecular O 0 0.04045717045664787
mechanism O 1 0.8973511457443237
for O 1 0.9799413084983826
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9899992346763611

Ventricular B-Disease 1 0.9999984502792358
fibrillation I-Disease 1 0.9999788999557495
causes O 1 0.5232802629470825
more O 0 0.01466716080904007
than O 0 0.01092613860964775
300 O 0 0.01580021344125271
, O 0 0.01139563787728548
000 O 0 0.022668762132525444
sudden O 0 0.2030571699142456
deaths O 0 0.014222183264791965
each O 0 0.007817375473678112
year O 0 0.00955580547451973
in O 0 0.010302439332008362
the O 0 0.016395848244428635
USA O 0 0.31192174553871155
alone O 0 0.041046299040317535
. O 0 0.0407392680644989

In O 0 0.02723545953631401
approximately O 0 0.02180393598973751
5 O 0 0.017642075195908546
- O 0 0.017636926844716072
12 O 0 0.013194454833865166
% O 0 0.008750461041927338
of O 0 0.007458564359694719
these O 0 0.005285884719341993
cases O 0 0.004926768131554127
, O 0 0.004529780242592096
there O 0 0.004345153924077749
are O 0 0.003962405491620302
no O 0 0.006454172544181347
demonstrable O 1 0.9995834231376648
cardiac O 1 0.9999986886978149
or O 1 0.844838559627533
non O 1 0.9994801878929138
- O 1 0.9999948740005493
cardiac O 1 0.9999996423721313
causes O 1 0.9465157985687256
to O 0 0.006044321693480015
account O 0 0.005444558337330818
for O 0 0.004909990821033716
the O 0 0.00611647916957736
episode O 0 0.011763231828808784
, O 0 0.007021536584943533
which O 0 0.005918456707149744
is O 0 0.006377357989549637
therefore O 0 0.007820327766239643
classified O 0 0.07506650686264038
as O 1 0.9093082547187805
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999032020568848
IVF B-Disease 1 0.9999974966049194
) O 0 0.08026333898305893
. O 0 0.05434542894363403

A O 0 0.030417688190937042
distinct O 0 0.02074313536286354
group O 0 0.01847550831735134
of O 0 0.07914527505636215
IVF B-Disease 1 0.9999982118606567
patients O 1 0.9997715353965759
has O 0 0.040515169501304626
been O 0 0.007086852565407753
found O 0 0.005213763564825058
to O 0 0.006092945579439402
present O 0 0.007620600517839193
with O 0 0.009001990780234337
a O 0 0.021691255271434784
characteristic O 1 0.9177522659301758
electrocardiographic O 1 0.999514102935791
pattern O 0 0.4397496283054352
. O 0 0.04041152447462082

Because O 0 0.02559395134449005
of O 0 0.015837958082556725
the O 0 0.011666984297335148
small O 0 0.009852070361375809
size O 0 0.009284717962145805
of O 0 0.00639785872772336
most O 0 0.00646104896441102
pedigrees O 0 0.025413628667593002
and O 0 0.0062849740497767925
the O 0 0.006606542970985174
high O 0 0.08367852121591568
incidence O 1 0.987027645111084
of O 0 0.02830939181149006
sudden B-Disease 1 0.9993409514427185
death I-Disease 1 0.6398917436599731
, O 0 0.008452754467725754
however O 0 0.006198110058903694
, O 0 0.0060628498904407024
molecular O 0 0.008395898155868053
genetic O 0 0.007876768708229065
studies O 0 0.007174262776970863
of O 0 0.00867142342031002
IVF B-Disease 1 0.9991111159324646
have O 0 0.007512234151363373
not O 0 0.007878178730607033
yet O 0 0.012068802490830421
been O 0 0.013733817264437675
done O 0 0.024501658976078033
. O 0 0.035101268440485

Because O 0 0.3326479494571686
IVF B-Disease 1 0.9999908208847046
causes O 1 0.9999779462814331
cardiac O 1 0.9999998807907104
rhythm O 1 0.9999850988388062
disturbance O 1 0.9997921586036682
, O 0 0.014525515027344227
we O 0 0.008250708691775799
investigated O 0 0.011233629658818245
whether O 0 0.008727787993848324
malfunction O 1 0.8328807353973389
of O 0 0.008913696743547916
ion O 0 0.15322865545749664
channels O 0 0.010115718469023705
could O 0 0.008305992931127548
cause O 0 0.12717610597610474
the O 0 0.01345090102404356
disorder O 1 0.9991369843482971
by O 0 0.00779465539380908
studying O 0 0.014061114750802517
mutations O 0 0.01184340100735426
in O 0 0.00922726932913065
the O 0 0.049766477197408676
cardiac O 1 0.9999879598617554
sodium O 1 0.882902979850769
channel O 0 0.0434676930308342
gene O 0 0.04783984646201134
SCN5A O 1 0.6146434545516968
. O 0 0.06485302746295929

We O 0 0.0276953037828207
have O 0 0.015966402366757393
now O 0 0.014811046421527863
identified O 0 0.013240914791822433
a O 0 0.012683882378041744
missense O 0 0.031072301790118217
mutation O 0 0.013645123690366745
, O 0 0.010621638968586922
a O 0 0.012399961240589619
splice O 1 0.5968160033226013
- O 1 0.6335805654525757
donor O 0 0.09237780421972275
mutation O 0 0.015679890289902687
, O 0 0.00822632759809494
and O 0 0.008134651929140091
a O 0 0.012419105507433414
frameshift O 1 0.9011873006820679
mutation O 0 0.010840014554560184
in O 0 0.007942434400320053
the O 0 0.008966485038399696
coding O 0 0.016954168677330017
region O 0 0.01299166027456522
of O 0 0.01358458399772644
SCN5A O 1 0.9836624264717102
in O 0 0.01673862710595131
three O 0 0.02114895172417164
IVF B-Disease 1 0.9898149967193604
families O 0 0.04263698309659958
. O 0 0.0494249053299427

We O 0 0.02748134173452854
show O 0 0.01978735253214836
that O 0 0.012444138526916504
sodium O 0 0.017765166237950325
channels O 0 0.011561254039406776
with O 0 0.00802118144929409
the O 0 0.009866598062217236
missense O 0 0.05400320142507553
mutation O 0 0.016768429428339005
recover O 0 0.2432420402765274
from O 0 0.008452977985143661
inactivation O 1 0.8865582346916199
more O 0 0.007635327056050301
rapidly O 0 0.010066798888146877
than O 0 0.00564565509557724
normal O 0 0.0063313753344118595
and O 0 0.005296139046549797
that O 0 0.004837488289922476
the O 0 0.00764084979891777
frameshift O 1 0.9579773545265198
mutation O 0 0.023457275703549385
causes O 0 0.02655688300728798
the O 0 0.00908423401415348
sodium O 0 0.03075925074517727
channel O 0 0.01308493409305811
to O 0 0.010922734625637531
be O 0 0.012281248345971107
non O 0 0.022799650207161903
- O 0 0.11506036669015884
functional O 0 0.0492585226893425
. O 0 0.04697395861148834

Our O 0 0.03758605197072029
results O 0 0.02294342778623104
indicate O 0 0.014556030742824078
that O 0 0.010440484620630741
mutations O 0 0.011676331050693989
in O 0 0.010385525412857533
cardiac O 1 0.9999669790267944
ion O 1 0.9751079678535461
- O 1 0.6444883942604065
channel O 0 0.014051306992769241
genes O 0 0.011759385466575623
contribute O 0 0.013361332938075066
to O 0 0.009676684625446796
the O 0 0.011157268658280373
risk O 0 0.019019557163119316
of O 0 0.01687312312424183
developing O 1 0.7518499493598938
IVF B-Disease 1 0.9998961687088013
. O 0 0.03218795359134674
. O 0 0.044236063957214355

Molecular O 0 0.06746732443571091
heterogeneity O 0 0.09468266367912292
in O 0 0.027880528941750526
mucopolysaccharidosis B-Disease 1 0.9989270567893982
IVA I-Disease 1 0.9999597072601318
in O 0 0.013141228817403316
Australia O 0 0.01343090832233429
and O 0 0.009245727211236954
Northern O 0 0.009674501605331898
Ireland O 0 0.010617194697260857
: O 0 0.008901365101337433
nine O 0 0.008842915296554565
novel O 0 0.013601744547486305
mutations O 0 0.0089063486084342
including O 0 0.007393965497612953
T312S O 1 0.9589082598686218
, O 0 0.007830390706658363
a O 0 0.010072317905724049
common O 0 0.01499414723366499
allele O 0 0.04382024705410004
that O 0 0.011985027231276035
confers O 1 0.998469889163971
a O 1 0.9002588391304016
mild O 1 0.9999665021896362
phenotype O 1 0.9980332255363464
. O 0 0.05763106048107147

Mucopolysaccharidosis B-Disease 1 0.9995094537734985
IVA I-Disease 1 0.9999896287918091
( O 0 0.4655027389526367
MPS B-Disease 1 0.9934877157211304
IVA I-Disease 1 0.9999990463256836
) O 0 0.02184644341468811
is O 0 0.015231360681355
an O 0 0.27369067072868347
autosomal B-Disease 1 0.9999992847442627
recessive I-Disease 1 0.9999998807907104
lysosomal I-Disease 1 1.0
storage I-Disease 1 0.9999996423721313
disorder I-Disease 1 1.0
caused O 1 0.9997473359107971
by O 0 0.04791063815355301
a O 1 0.9254834651947021
genetic B-Disease 1 0.9970898032188416
defect I-Disease 1 0.9999350309371948
in O 0 0.04092070087790489
N O 0 0.4730899930000305
- O 1 0.7999236583709717
acetylgalactosamine O 1 0.9804700016975403
- O 1 0.9251278638839722
6 O 0 0.3395732343196869
- O 1 0.9935998916625977
sulfate O 1 0.9999289512634277
sulfatase O 1 0.9999746084213257
( O 0 0.4580669701099396
GALNS O 1 0.997560977935791
) O 0 0.04670507088303566
. O 0 0.051587458699941635

Previous O 0 0.03459935635328293
studies O 0 0.020423362031579018
of O 0 0.014508761465549469
patients O 0 0.1882779449224472
from O 0 0.007411796133965254
a O 0 0.0103647755458951
British O 0 0.04911276698112488
- O 0 0.3317018151283264
Irish O 0 0.01197703368961811
population O 0 0.005384557880461216
showed O 0 0.007344804238528013
that O 0 0.004851957317441702
the O 0 0.0072073074989020824
I113F O 1 0.9711458086967468
mutation O 0 0.00956486351788044
is O 0 0.005363523028790951
the O 0 0.0059562986716628075
most O 0 0.005176892504096031
common O 0 0.005802630912512541
single O 0 0.009246238507330418
mutation O 0 0.024174965918064117
among O 0 0.03122843988239765
MPS B-Disease 1 0.999832034111023
IVA I-Disease 1 1.0
patients O 1 0.9999774694442749
and O 1 0.7859088778495789
produces O 1 0.9872079491615295
a O 1 0.9883352518081665
severe O 1 0.9999996423721313
clinical O 1 0.9999986886978149
phenotype O 1 0.99996018409729
. O 0 0.2108708769083023

We O 0 0.03766549378633499
studied O 0 0.03266168013215065
mutations O 0 0.02043224684894085
in O 0 0.013448016718029976
the O 0 0.013431659899652004
GALNS O 1 0.5510289072990417
gene O 0 0.01162661425769329
from O 0 0.008854272775352001
23 O 0 0.013634552247822285
additional O 0 0.016511909663677216
MPS B-Disease 1 0.9817699790000916
IVA I-Disease 1 0.9999995231628418
patients O 1 0.9725719094276428
( O 0 0.011620012111961842
15 O 0 0.012431803159415722
from O 0 0.007857714779675007
Australia O 0 0.009656164795160294
, O 0 0.008080881088972092
8 O 0 0.009745297953486443
from O 0 0.006822668481618166
Northern O 0 0.008470279164612293
Ireland O 0 0.009728916920721531
) O 0 0.007112330757081509
, O 0 0.006737205665558577
with O 0 0.005835757125169039
various O 0 0.007277204189449549
clinical O 1 0.9854305982589722
phenotypes O 1 0.9937036633491516
( O 0 0.08685776591300964
severe O 1 0.9980048537254333
, O 0 0.010539980605244637
16 O 0 0.01099817268550396
cases O 0 0.007538666948676109
; O 0 0.006490279920399189
intermediate O 0 0.010795907117426395
, O 0 0.00687081553041935
4 O 0 0.010297122411429882
cases O 0 0.008408881723880768
; O 0 0.009285478852689266
mild O 1 0.8658332228660583
, O 0 0.012892067432403564
3 O 0 0.017108988016843796
cases O 0 0.016495639458298683
) O 0 0.0227612666785717
. O 0 0.03385283425450325

We O 0 0.025094768032431602
found O 0 0.014663618989288807
two O 0 0.010695558972656727
common O 0 0.00941698718816042
mutations O 0 0.009102675132453442
that O 0 0.0057244873605668545
together O 0 0.008039189502596855
accounted O 0 0.010453665629029274
for O 0 0.0066673168912529945
32 O 0 0.01185629889369011
% O 0 0.008347935043275356
of O 0 0.008126119151711464
the O 0 0.008707601577043533
44 O 0 0.01603311114013195
unrelated O 0 0.022354857996106148
alleles O 0 0.016938628628849983
in O 0 0.012943328358232975
these O 0 0.015883300453424454
patients O 0 0.45314711332321167
. O 0 0.03827834874391556

One O 0 0.029554642736911774
is O 0 0.019415445625782013
the O 0 0.018445931375026703
T312S O 1 0.9382176995277405
mutation O 0 0.028074175119400024
, O 0 0.013681849464774132
a O 0 0.013565938919782639
novel O 0 0.028733493760228157
mutation O 0 0.018341215327382088
found O 0 0.011410520412027836
exclusively O 0 0.016256682574748993
in O 0 0.01995004341006279
milder O 1 0.9848417043685913
patients O 1 0.9836920499801636
. O 0 0.04837615787982941

The O 0 0.02631198801100254
other O 0 0.012718559242784977
is O 0 0.01046364288777113
the O 0 0.009757808409631252
previously O 0 0.012081236578524113
described O 0 0.014439516700804234
I113F O 1 0.7500952482223511
that O 0 0.01111316867172718
produces O 0 0.10449597239494324
a O 0 0.3691711127758026
severe O 1 0.9999761581420898
phenotype O 1 0.9993284940719604
. O 0 0.05830995738506317

The O 0 0.04242967441678047
I113F O 0 0.4428916573524475
and O 0 0.0254689808934927
T312S O 0 0.2021428942680359
mutations O 0 0.017627017572522163
accounted O 0 0.014471718110144138
for O 0 0.008381451480090618
8 O 0 0.011714354157447815
( O 0 0.008081707172095776
18 O 0 0.008950009942054749
% O 0 0.006825227290391922
) O 0 0.006285087205469608
and O 0 0.005888567306101322
6 O 0 0.008666816167533398
( O 0 0.007131003309041262
14 O 0 0.008792437613010406
% O 0 0.0074134632013738155
) O 0 0.008042870089411736
of O 0 0.01025803666561842
44 O 0 0.021542206406593323
unrelated O 0 0.02657705545425415
alleles O 0 0.024098312482237816
, O 0 0.019795963540673256
respectively O 0 0.030535265803337097
. O 0 0.03854641318321228

The O 0 0.038189563900232315
relatively O 0 0.03311494365334511
high O 0 0.030623354017734528
residual O 1 0.7641990780830383
GALNS O 1 0.990509033203125
activity O 0 0.01907193847000599
seen O 0 0.015354674309492111
when O 0 0.013141240924596786
the O 0 0.014282001182436943
T312S O 0 0.061909500509500504
mutant O 0 0.028873417526483536
cDNA O 0 0.028986774384975433
is O 0 0.014356869272887707
overexpressed O 0 0.11056257784366608
in O 0 0.011831069365143776
mutant O 0 0.061786990612745285
cells O 0 0.009467882104218006
provides O 0 0.009007236920297146
an O 0 0.006171366199851036
explanation O 0 0.009678129106760025
for O 0 0.00836129579693079
the O 0 0.0687226876616478
mild O 1 0.9999597072601318
phenotype O 1 0.9990209341049194
in O 0 0.20047588646411896
patients O 1 0.9961936473846436
with O 0 0.019364535808563232
this O 0 0.019033370539546013
mutation O 0 0.17603373527526855
. O 0 0.03446522727608681

The O 0 0.03381481021642685
distribution O 0 0.0250313151627779
and O 0 0.013904699124395847
relative O 0 0.013225645758211613
frequencies O 0 0.011485756374895573
of O 0 0.00888886395841837
the O 0 0.01081476453691721
I113F O 1 0.9138115048408508
and O 0 0.01339834462851286
T312S O 1 0.8824540972709656
mutations O 0 0.01190328411757946
in O 0 0.009345860220491886
Australia O 0 0.013121022842824459
corresponded O 0 0.013590170070528984
to O 0 0.007764208596199751
those O 0 0.005555540788918734
observed O 0 0.0061345091089606285
in O 0 0.0060771130956709385
Northern O 0 0.007334423717111349
Ireland O 0 0.008401354774832726
and O 0 0.005897903349250555
are O 0 0.0038950410671532154
unique O 0 0.004644508007913828
to O 0 0.00449262885376811
these O 0 0.0031948843970894814
two O 0 0.003791095456108451
populations O 0 0.004600739572197199
, O 0 0.0043038115836679935
suggesting O 0 0.005983232986181974
that O 0 0.003989390097558498
both O 0 0.004776037763804197
mutations O 0 0.005993297789245844
were O 0 0.0047997971996665
probably O 0 0.007747292518615723
introduced O 0 0.007725457660853863
to O 0 0.0070894500240683556
Australia O 0 0.010851769708096981
by O 0 0.0078023383393883705
Irish O 0 0.014847243204712868
migrants O 0 0.016260746866464615
during O 0 0.015344333834946156
the O 0 0.017891820520162582
19th O 0 0.03830568492412567
century O 0 0.050239451229572296
. O 0 0.04447370022535324

Haplotype O 0 0.07476679235696793
analysis O 0 0.03193820267915726
using O 0 0.020265517756342888
6 O 0 0.02644607611000538
RFLPs O 0 0.04177668318152428
provides O 0 0.015049003064632416
additional O 0 0.012001345865428448
data O 0 0.010561365634202957
that O 0 0.008988074958324432
the O 0 0.011132416315376759
I113F O 1 0.5840644240379333
mutation O 0 0.01680251955986023
originated O 0 0.017188649624586105
from O 0 0.01307032909244299
a O 0 0.01905199885368347
common O 0 0.024530908092856407
ancestor O 0 0.056830618530511856
. O 0 0.040425606071949005

The O 0 0.030758995562791824
other O 0 0.01780138723552227
9 O 0 0.021948406472802162
novel O 0 0.021776428446173668
mutations O 0 0.012310469523072243
identified O 0 0.008234772831201553
in O 0 0.006338696461170912
these O 0 0.0055989171378314495
23 O 0 0.014059184119105339
patients O 0 0.1404133439064026
were O 0 0.006323214620351791
each O 0 0.006300786510109901
limited O 0 0.008315959945321083
to O 0 0.009240509010851383
a O 0 0.013780391775071621
single O 0 0.022218668833374977
family O 0 0.030031602829694748
. O 0 0.03655867278575897

These O 0 0.02207770012319088
data O 0 0.018268784508109093
provide O 0 0.015022817067801952
further O 0 0.012036120519042015
evidence O 0 0.009900391101837158
for O 0 0.009441198781132698
extensive O 0 0.01711464859545231
allelic O 1 0.5478296875953674
heterogeneity O 0 0.41201499104499817
in O 0 0.015082080848515034
MPS B-Disease 1 0.935613214969635
IVA I-Disease 1 0.9999955892562866
in O 0 0.0165111031383276
British O 1 0.7596867680549622
- O 1 0.9975236058235168
Irish O 1 0.9709358215332031
patients O 1 0.9527425169944763
and O 0 0.005586586426943541
provide O 0 0.00553327240049839
evidence O 0 0.004578534513711929
for O 0 0.004205036908388138
their O 0 0.00448398943990469
transmission O 0 0.008138785138726234
to O 0 0.006024874746799469
Australia O 0 0.009677411988377571
by O 0 0.00787932239472866
British O 0 0.017644597217440605
- O 0 0.10601035505533218
Irish O 0 0.026757575571537018
migrants O 0 0.02829183265566826
. O 0 0.026019299402832985
. O 0 0.03758674114942551

Identification O 0 0.04492544010281563
of O 0 0.026911618188023567
constitutional O 0 0.06331595778465271
WT1 O 1 0.9998408555984497
mutations O 0 0.028811167925596237
, O 0 0.012518626637756824
in O 0 0.010644352994859219
patients O 1 0.9533489346504211
with O 0 0.17562955617904663
isolated O 1 0.9994423985481262
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.3575609624385834
and O 0 0.012168622575700283
analysis O 0 0.011817201972007751
of O 0 0.1214246153831482
genotype O 1 0.9995642304420471
/ O 1 0.9989746809005737
phenotype O 1 0.9309287071228027
correlations O 0 0.01817028783261776
by O 0 0.008199500851333141
use O 0 0.00944861676543951
of O 0 0.01154598593711853
a O 0 0.016369085758924484
computerized O 1 0.8043158650398254
mutation O 0 0.037959132343530655
database O 0 0.037431053817272186
. O 0 0.039862800389528275

Constitutional O 0 0.04915730282664299
mutations O 0 0.028241656720638275
of O 0 0.017471035942435265
the O 0 0.01886773481965065
WT1 O 1 0.9991349577903748
gene O 0 0.015960440039634705
, O 0 0.011165698990225792
encoding O 0 0.013542158529162407
a O 0 0.014138284139335155
zinc O 1 0.9985184073448181
- O 1 0.8948196172714233
finger O 1 0.6152318120002747
transcription O 0 0.016565117985010147
factor O 0 0.013441306538879871
involved O 0 0.011293205432593822
in O 0 0.018101289868354797
renal O 1 0.9999994039535522
and O 1 0.627207338809967
gonadal O 1 0.9999785423278809
development O 0 0.10290504992008209
, O 0 0.007352706976234913
are O 0 0.0042602973990142345
found O 0 0.004845757037401199
in O 0 0.00462473277002573
most O 0 0.004776058252900839
patients O 1 0.5433439016342163
with O 0 0.13807673752307892
Denys B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999997615814209
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9994049072265625
DDS B-Disease 1 0.9999998807907104
) O 0 0.033956073224544525
, O 0 0.022783221676945686
or O 0 0.17545582354068756
diffuse B-Disease 1 0.9999945163726807
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9998140931129456
DMS B-Disease 1 0.9999995231628418
) O 0 0.014554784633219242
associated O 0 0.010520504787564278
with O 0 0.011313370428979397
pseudohermaphroditism B-Disease 1 0.9999498128890991
and O 1 0.8665159940719604
/ O 1 0.9999728202819824
or O 1 0.984203577041626
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999977350234985
( O 1 0.9005313515663147
WT B-Disease 1 0.9998401403427124
) O 0 0.05152609199285507
. O 0 0.060103945434093475

Most O 0 0.04136237874627113
mutations O 0 0.04121898487210274
in O 0 0.03266897425055504
DDS B-Disease 1 0.9999985694885254
patients O 1 0.9919237494468689
lie O 0 0.03469419479370117
in O 0 0.012804446741938591
exon O 0 0.18820001184940338
8 O 0 0.01414142083376646
or O 0 0.009830738417804241
exon O 0 0.01949675939977169
9 O 0 0.013997143134474754
, O 0 0.011632177047431469
encoding O 0 0.01394272968173027
zinc O 1 0.5419376492500305
finger O 0 0.04522775858640671
2 O 0 0.0144524360075593
or O 0 0.0112099414691329
zinc O 1 0.9173125624656677
finger O 0 0.1486130952835083
3 O 0 0.012419831939041615
, O 0 0.008425986394286156
respectively O 0 0.009416155517101288
, O 0 0.007642180658876896
with O 0 0.00725347688421607
a O 0 0.010138514451682568
hot O 0 0.19114507734775543
spot O 0 0.059957388788461685
( O 0 0.016411881893873215
R394W O 0 0.05257440358400345
) O 0 0.019603818655014038
in O 0 0.02277260646224022
exon O 0 0.0640672892332077
9 O 0 0.05420476570725441
. O 0 0.05832318216562271

We O 0 0.029467226937413216
analyzed O 0 0.0237527247518301
a O 0 0.013516771607100964
series O 0 0.012230451218783855
of O 0 0.009932789020240307
24 O 0 0.014252929016947746
patients O 0 0.03694213181734085
, O 0 0.006568519864231348
10 O 0 0.00796919222921133
with O 0 0.008467137813568115
isolated B-Disease 1 0.5952385067939758
DMS I-Disease 1 0.999995231628418
( O 0 0.3296020030975342
IDMS B-Disease 1 0.9998757839202881
) O 0 0.01069490797817707
, O 0 0.009196195751428604
10 O 0 0.0102433692663908
with O 0 0.009699715301394463
DDS B-Disease 1 0.9997377991676331
, O 0 0.009527708403766155
and O 0 0.008653671480715275
4 O 0 0.015807630494236946
with O 0 0.03494582697749138
urogenital B-Disease 1 0.9999996423721313
abnormalities I-Disease 1 0.9999911785125732
and O 1 0.9643974900245667
/ O 1 0.9999392032623291
or O 1 0.6738409996032715
WT B-Disease 1 0.999921441078186
. O 0 0.061365045607089996

We O 0 0.036098580807447433
report O 0 0.034210581332445145
WT1 O 1 0.9616328477859497
heterozygous O 0 0.031155532225966454
mutations O 0 0.016044864431023598
in O 0 0.010155066847801208
16 O 0 0.021980859339237213
patients O 1 0.6269885897636414
, O 0 0.008958489634096622
4 O 0 0.012160377576947212
of O 0 0.01116566825658083
whom O 0 0.017319610342383385
presented O 0 0.036965515464544296
with O 0 0.042117033153772354
IDMS B-Disease 1 0.9999595880508423
. O 0 0.0557812824845314

One O 0 0.02853688783943653
male O 0 0.02365891821682453
and O 0 0.015032367780804634
two O 0 0.013244228437542915
female O 1 0.9442223310470581
IDMS B-Disease 1 0.9999998807907104
patients O 1 0.9999672174453735
with O 1 0.9738562703132629
WT1 O 1 0.9999998807907104
mutations O 1 0.9996744394302368
underwent O 1 0.9999986886978149
normal O 1 0.9064509272575378
puberty O 1 0.9957619309425354
. O 0 0.05289972200989723

Two O 0 0.03320131450891495
mutations O 0 0.030784180387854576
associated O 0 0.018079431727528572
with O 0 0.017106661573052406
IDMS B-Disease 1 0.9999504089355469
are O 0 0.007106164935976267
different O 0 0.006062143482267857
from O 0 0.007018032483756542
those O 0 0.007503595668822527
described O 0 0.02900613471865654
in O 1 0.5012351870536804
DDS B-Disease 1 0.9999998807907104
patients O 1 0.9999493360519409
. O 0 0.06597095727920532

No O 0 0.04828575253486633
WT1 O 1 0.9976118803024292
mutations O 0 0.02568749338388443
were O 0 0.012261055409908295
detected O 0 0.012367773801088333
in O 0 0.007737005595117807
the O 0 0.0074613140895962715
six O 0 0.009559819474816322
other O 0 0.013124612160027027
IDMS B-Disease 1 0.9999991655349731
patients O 1 0.9972049593925476
, O 0 0.01605604961514473
suggesting O 0 0.03527151048183441
genetic O 0 0.07293469458818436
heterogeneity O 1 0.8830229043960571
of O 0 0.08441575616598129
this O 0 0.08804930746555328
disease O 1 0.9999803304672241
. O 0 0.08857818692922592

We O 0 0.038706716150045395
analyzed O 0 0.04442218318581581
genotype O 1 0.8829150795936584
/ O 1 0.9803244471549988
phenotype O 1 0.7333871126174927
correlations O 0 0.021598249673843384
, O 0 0.008799739181995392
on O 0 0.007223634514957666
the O 0 0.006349986884742975
basis O 0 0.005802581086754799
of O 0 0.006197863258421421
the O 0 0.006460461765527725
constitution O 0 0.008979723788797855
of O 0 0.008585193194448948
a O 0 0.013180537149310112
WT1 O 1 0.9773854613304138
mutation O 0 0.012793849222362041
database O 0 0.011283114552497864
of O 0 0.008905110880732536
84 O 0 0.24703408777713776
germ O 1 0.9990755319595337
- O 1 0.9526007771492004
line O 0 0.04722752422094345
mutations O 0 0.008357259444892406
, O 0 0.006075390614569187
to O 0 0.005894696805626154
compare O 0 0.008863233961164951
the O 0 0.005503938999027014
distribution O 0 0.006563471630215645
and O 0 0.006091490853577852
type O 0 0.009022402577102184
of O 0 0.006851771846413612
mutations O 0 0.00853115227073431
, O 0 0.006555967498570681
according O 0 0.006699105724692345
to O 0 0.008829385042190552
the O 0 0.01199414860457182
different O 0 0.016597053036093712
symptoms O 1 0.9837750792503357
. O 0 0.04133133217692375

This O 0 0.024718692526221275
demonstrated O 0 0.025839822366833687
( O 0 0.01665194146335125
1 O 0 0.015400254167616367
) O 0 0.009438795037567616
the O 0 0.00866582803428173
association O 0 0.009763935580849648
between O 0 0.007418250665068626
mutations O 0 0.007479529827833176
in O 0 0.006006293930113316
exons O 0 0.010983260348439217
8 O 0 0.009724447503685951
and O 0 0.0072075966745615005
9 O 0 0.011922478675842285
and O 0 0.009424201212823391
DMS B-Disease 1 0.9931066632270813
; O 0 0.007416979875415564
( O 0 0.007519842125475407
2 O 0 0.010850617662072182
) O 0 0.008223092183470726
among O 0 0.00869741290807724
patients O 0 0.152851864695549
with O 0 0.00884869322180748
DMS B-Disease 1 0.9996899366378784
, O 0 0.008015545085072517
a O 0 0.007851839996874332
higher O 0 0.008074730634689331
frequency O 0 0.008616830222308636
of O 0 0.007864854298532009
exon O 0 0.018916109576821327
8 O 0 0.012981550768017769
mutations O 0 0.010158536955714226
among O 0 0.008660976774990559
46 O 0 0.015930233523249626
, O 0 0.016381490975618362
XY O 1 0.9997357726097107
patients O 1 0.7931424975395203
with O 0 0.00959267932921648
female O 0 0.05906534194946289
phenotype O 0 0.27991077303886414
than O 0 0.007121037691831589
among O 0 0.007589452899992466
46 O 0 0.02148159220814705
, O 0 0.028440866619348526
XY O 1 0.9998099207878113
patients O 1 0.5212558507919312
with O 0 0.0072119757533073425
sexual O 0 0.01817123219370842
ambiguity O 0 0.42878320813179016
or O 0 0.036764636635780334
male O 1 0.7496870160102844
phenotype O 1 0.9897052645683289
; O 0 0.00773623026907444
and O 0 0.006474783178418875
( O 0 0.006727483589202166
3 O 0 0.008210081607103348
) O 0 0.0067227911204099655
statistically O 0 0.008896618150174618
significant O 0 0.00699344277381897
evidence O 0 0.006415714044123888
that O 0 0.005025566555559635
mutations O 0 0.00695294514298439
in O 0 0.005998874083161354
exons O 0 0.012151393108069897
8 O 0 0.01012805849313736
and O 0 0.00837972853332758
9 O 0 0.012958371080458164
preferentially O 0 0.01635684259235859
affect O 0 0.012441038154065609
amino O 0 0.01086938101798296
acids O 0 0.010255035944283009
with O 0 0.008657144382596016
different O 0 0.010133066214621067
functions O 0 0.014689409174025059
. O 0 0.017965324223041534
. O 0 0.03167400509119034

The O 0 0.048300545662641525
185delAG O 1 0.9976757168769836
BRCA1 O 1 0.9987372756004333
mutation O 0 0.03929358720779419
originated O 0 0.015217569656670094
before O 0 0.008052966557443142
the O 0 0.007241578307002783
dispersion O 0 0.014245080761611462
of O 0 0.006670605391263962
Jews O 0 0.008593444712460041
in O 0 0.006629301235079765
the O 0 0.008251465857028961
diaspora O 0 0.02900134213268757
and O 0 0.010622701607644558
is O 0 0.009735211730003357
not O 0 0.010472188703715801
limited O 0 0.018261311575770378
to O 0 0.023215580731630325
Ashkenazim O 0 0.28277504444122314
. O 0 0.0416785292327404

The O 0 0.04492919519543648
185delAG O 1 0.9458129405975342
mutation O 0 0.05572227016091347
in O 0 0.018354622647166252
BRCA1 O 1 0.9824619889259338
is O 0 0.011440370231866837
detected O 0 0.013581638224422932
in O 0 0.008593806065618992
Ashkenazi O 0 0.025597691535949707
Jews O 0 0.01001711655408144
both O 0 0.007593264803290367
in O 0 0.0737106204032898
familial B-Disease 1 0.9999996423721313
breast I-Disease 1 1.0
and I-Disease 1 0.999998927116394
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9629124402999878
in O 0 0.06957269459962845
the O 0 0.03765184059739113
general O 0 0.10904761403799057
population O 0 0.027279485017061234
. O 0 0.04103788733482361

All O 0 0.03364820033311844
tested O 0 0.12646280229091644
Ashkenazi O 1 0.8407387733459473
mutation O 0 0.05940529704093933
carriers O 0 0.056590933352708817
share O 0 0.015062169171869755
the O 0 0.012383108958601952
same O 0 0.012834340333938599
allelic O 1 0.6929081678390503
pattern O 0 0.033043231815099716
at O 0 0.021251240745186806
the O 0 0.029821325093507767
BRCA1 O 1 0.997684121131897
locus O 1 0.8925889134407043
. O 0 0.054362695664167404

Our O 0 0.03506403788924217
previous O 0 0.020528748631477356
study O 0 0.015237425453960896
showed O 0 0.013581261970102787
that O 0 0.007855888456106186
this O 0 0.008199084550142288
Ashkenazi O 1 0.9135207533836365
mutation O 0 0.02019747532904148
also O 0 0.009130916558206081
occurs O 0 0.007878253236413002
in O 0 0.007470444776117802
Iraqi O 0 0.011647581122815609
Jews O 0 0.012911778874695301
with O 0 0.01029207929968834
a O 0 0.01831589639186859
similar O 0 0.02401229366660118
allelic O 1 0.9383401274681091
pattern O 0 0.1051044687628746
. O 0 0.04706171527504921

We O 0 0.02723945491015911
extended O 0 0.023224329575896263
our O 0 0.015360292047262192
analysis O 0 0.010563060641288757
to O 0 0.009623157791793346
other O 0 0.008678971789777279
non O 0 0.014855538494884968
- O 0 0.16203618049621582
Ashkenazi O 0 0.06604427844285965
subsets O 0 0.022358199581503868
354 O 0 0.029047923162579536
of O 0 0.012877734377980232
Moroccan O 0 0.026084477081894875
origin O 0 0.014500582590699196
, O 0 0.01463194191455841
200 O 0 0.02215685322880745
Yemenites O 1 0.6340330839157104
and O 0 0.02060742862522602
150 O 0 0.03554009646177292
Iranian O 0 0.04621581733226776
Jews O 0 0.05055679380893707
. O 0 0.05185125768184662

Heteroduplex O 0 0.16664043068885803
analysis O 0 0.04403514787554741
complemented O 0 0.04641422629356384
by O 0 0.01824667677283287
direct O 0 0.01951930671930313
DNA O 0 0.019336963072419167
sequencing O 0 0.022717420011758804
of O 0 0.01689732074737549
abnormally O 1 0.6232336759567261
migrating O 0 0.029808349907398224
bands O 0 0.028091559186577797
were O 0 0.023356812074780464
employed O 0 0.043291185051202774
. O 0 0.04662255197763443

Four O 0 0.030576469376683235
of O 0 0.019254786893725395
Moroccan O 0 0.027378467842936516
origin O 0 0.011006464250385761
( O 0 0.00988729763776064
1 O 0 0.01021027285605669
. O 0 0.0067712292075157166
1 O 0 0.00912771187722683
% O 0 0.006922583095729351
) O 0 0.007128789089620113
and O 0 0.00628425320610404
none O 0 0.007345009129494429
of O 0 0.006915871985256672
the O 0 0.008704856038093567
Yemenites O 1 0.9894006848335266
or O 0 0.008472706191241741
Iranians O 0 0.012710445560514927
was O 0 0.011305227875709534
a O 0 0.012235407717525959
carrier O 0 0.3734358549118042
of O 0 0.014663570560514927
the O 0 0.022902514785528183
185delAG O 1 0.9876526594161987
mutation O 0 0.06926494091749191
. O 0 0.04834383353590965

BRCA1 O 1 0.9979308843612671
allelic O 1 0.7210254073143005
patterns O 0 0.02352796122431755
were O 0 0.011675835587084293
determined O 0 0.009815766476094723
for O 0 0.006264850497245789
four O 0 0.0063475351780653
of O 0 0.005560928490012884
these O 0 0.003799693426117301
individuals O 0 0.003679449437186122
and O 0 0.003870446002110839
for O 0 0.0043381741270422935
12 O 0 0.006888893432915211
additional O 0 0.007580928038805723
non O 0 0.013146833516657352
- O 0 0.4041520357131958
Ashkenazi O 1 0.5938111543655396
185delAG O 1 0.8249756097793579
mutation O 0 0.043600279837846756
carriers O 1 0.6875597238540649
who O 1 0.5223236680030823
had O 1 0.9992000460624695
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.7551841139793396

Six O 0 0.03647709637880325
non O 0 0.04513905197381973
- O 1 0.5846988558769226
Ashkenazi O 0 0.2086857408285141
individuals O 0 0.010275068692862988
shared O 0 0.01384514570236206
the O 0 0.010362657718360424
common O 0 0.10234184563159943
Ashkenazi O 1 0.9939091205596924
haplotype O 1 0.8019249439239502
, O 0 0.007630508858710527
four O 0 0.005806950852274895
had O 0 0.005963518284261227
a O 0 0.005954393185675144
closely O 0 0.005976748187094927
related O 0 0.0066547091118991375
pattern O 0 0.006977790966629982
, O 0 0.00506669282913208
and O 0 0.005387257318943739
the O 0 0.005970762576907873
rest O 0 0.009809765964746475
( O 0 0.009436290711164474
n O 0 0.014510436914861202
= O 0 0.017894593998789787
6 O 0 0.018034914508461952
) O 0 0.014497377909719944
displayed O 0 0.022636545822024345
a O 0 0.01996888965368271
distinct O 0 0.02991681918501854
BRCA1 O 1 0.9902053475379944
allelic O 1 0.9652909636497498
pattern O 0 0.23185592889785767
. O 0 0.04848724603652954

We O 0 0.03127295896410942
conclude O 0 0.031733933836221695
that O 0 0.014841309748589993
the O 0 0.017491888254880905
185delAG O 1 0.9992961883544922
BRCA1 O 1 0.9997937083244324
mutation O 0 0.08788834512233734
occurs O 0 0.007955060340464115
in O 0 0.0057233176194131374
some O 0 0.005878439638763666
non O 0 0.09586262702941895
- O 1 0.9424679279327393
Ashkenazi O 1 0.5628804564476013
populations O 0 0.009929085150361061
at O 0 0.010465312749147415
rates O 0 0.010477932170033455
comparable O 0 0.015108402818441391
with O 0 0.009597877971827984
that O 0 0.011450047604739666
of O 0 0.02121533453464508
Ashkenazim O 1 0.7350200414657593
. O 0 0.04404469206929207

The O 0 0.027412647381424904
majority O 0 0.01868932694196701
of O 0 0.01485287956893444
Jewish O 0 0.025373751297593117
185delAG O 1 0.9988086223602295
mutation O 0 0.43213510513305664
carriers O 0 0.315917044878006
have O 0 0.006171409506350756
a O 0 0.008919700980186462
common O 0 0.026048293337225914
allelic O 1 0.9916281700134277
pattern O 0 0.16697166860103607
, O 0 0.00824812613427639
supporting O 0 0.0097233597189188
the O 0 0.01027255691587925
founder O 1 0.8663120865821838
effect O 0 0.00912579707801342
notion O 0 0.010929500684142113
, O 0 0.006972255185246468
but O 0 0.005758476909250021
dating O 0 0.008202614262700081
the O 0 0.006302050314843655
mutations O 0 0.0062932646833360195
origin O 0 0.005111798644065857
to O 0 0.005534799303859472
an O 0 0.005944982636719942
earlier O 0 0.007985252887010574
date O 0 0.010904348455369473
than O 0 0.011667958460748196
currently O 0 0.019450508058071136
estimated O 0 0.030426805838942528
. O 0 0.038445018231868744

However O 0 0.027858199551701546
, O 0 0.016152260825037956
the O 0 0.012023613788187504
different O 0 0.007848361507058144
allelic O 0 0.02811691351234913
pattern O 0 0.010651806369423866
at O 0 0.008879718370735645
the O 0 0.011581184342503548
BRCA1 O 1 0.9988158941268921
locus O 1 0.5883632302284241
even O 0 0.005870139226317406
in O 0 0.005566497333347797
some O 0 0.0051334998570382595
Jewish O 0 0.01137259230017662
mutation O 0 0.19029003381729126
carriers O 0 0.339864581823349
, O 0 0.00676777632907033
might O 0 0.006885000038892031
suggest O 0 0.007534896954894066
that O 0 0.005903805140405893
the O 0 0.009656754322350025
mutation O 0 0.01467058714479208
arose O 0 0.019254425540566444
independently O 0 0.019752684980630875
. O 0 0.02070457860827446
. O 0 0.03537725657224655

Crystal O 0 0.08156375586986542
structure O 0 0.03368954733014107
of O 0 0.02368500456213951
the O 0 0.1499401181936264
hemochromatosis B-Disease 1 0.9999997615814209
protein O 1 0.9613086581230164
HFE O 1 0.9999828338623047
and O 0 0.01948576793074608
characterization O 0 0.03935512155294418
of O 0 0.013114474713802338
its O 0 0.014029392041265965
interaction O 0 0.02354615181684494
with O 0 0.025797337293624878
transferrin O 1 0.9984642267227173
receptor O 0 0.09578432142734528
. O 0 0.0507061667740345

HFE O 1 0.9912705421447754
is O 0 0.025258952751755714
an O 0 0.02389099821448326
MHC O 1 0.9998695850372314
- O 1 0.9538782835006714
related O 0 0.038069915026426315
protein O 0 0.010116087272763252
that O 0 0.006150190252810717
is O 0 0.00671908026561141
mutated O 0 0.013555311597883701
in O 0 0.008241727948188782
the O 0 0.4764956831932068
iron B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9994596838951111

HFE O 1 0.9967359900474548
binds O 0 0.06957727670669556
to O 0 0.03243362903594971
transferrin O 1 0.9953072667121887
receptor O 0 0.2712431252002716
( O 0 0.028515713289380074
TfR O 1 0.9880747199058533
) O 0 0.015734635293483734
and O 0 0.013189327903091908
reduces O 0 0.017054203897714615
its O 0 0.010277556255459785
affinity O 0 0.014633783139288425
for O 0 0.010773492977023125
iron O 1 0.9861499667167664
- O 1 0.7766057252883911
loaded O 0 0.20361603796482086
transferrin O 1 0.9845240712165833
, O 0 0.02896435745060444
implicating O 1 0.9738057255744934
HFE O 1 0.9999228715896606
in O 0 0.07771729677915573
iron O 1 0.9994600415229797
metabolism O 1 0.8447750806808472
. O 0 0.05384628847241402

The O 0 0.08188480883836746
2 O 0 0.0953623354434967
. O 0 0.09628362208604813

6 O 0 0.04896626994013786
A O 0 0.03255064785480499
crystal O 0 0.15896153450012207
structure O 0 0.022063901647925377
of O 0 0.017946699634194374
HFE O 1 0.9992617964744568
reveals O 0 0.03735005855560303
the O 0 0.01189547311514616
locations O 0 0.011544473469257355
of O 0 0.026784652844071388
hemochromatosis B-Disease 1 0.9999997615814209
mutations O 1 0.7125609517097473
and O 0 0.01613563485443592
a O 0 0.3142755329608917
patch O 1 0.9999750852584839
of O 0 0.4993315041065216
histidines O 1 0.9992850422859192
that O 0 0.007439163513481617
could O 0 0.00672268308699131
be O 0 0.006956854369491339
involved O 0 0.009736011736094952
in O 0 0.012211077846586704
pH O 1 0.745091438293457
- O 0 0.2966077923774719
dependent O 0 0.03573800250887871
interactions O 0 0.03846553713083267
. O 0 0.04250645264983177

We O 0 0.032995741814374924
also O 0 0.020732445642352104
demonstrate O 0 0.023776747286319733
that O 0 0.015259651467204094
soluble O 1 0.9711416363716125
TfR O 1 0.9998793601989746
and O 0 0.26109743118286133
HFE O 1 0.9999728202819824
bind O 0 0.0836770161986351
tightly O 0 0.019958246499300003
at O 0 0.009392958134412766
the O 0 0.00853588804602623
basic O 0 0.013921262696385384
pH O 0 0.033545028418302536
of O 0 0.008538943715393543
the O 0 0.010637861676514149
cell O 0 0.03356180712580681
surface O 0 0.011584289371967316
, O 0 0.007476543076336384
but O 0 0.006408835295587778
not O 0 0.0063169230706989765
at O 0 0.010271834209561348
the O 0 0.013873470015823841
acidic O 0 0.459367573261261
pH O 1 0.5826217532157898
of O 0 0.02964303083717823
intracellular O 1 0.8903157114982605
vesicles O 1 0.8036584854125977
. O 0 0.05922210216522217

TfR O 1 0.9994860887527466
HFE O 1 0.9995197057723999
stoichiometry O 0 0.39471203088760376
( O 0 0.028780611231923103
2 O 0 0.026258200407028198
1 O 0 0.020538097247481346
) O 0 0.014477036893367767
differs O 0 0.015257460065186024
from O 0 0.012713337317109108
TfR O 1 0.9507686495780945
transferrin O 1 0.9117869734764099
stoichiometry O 0 0.11349941790103912
( O 0 0.013984980061650276
2 O 0 0.014849036000669003
2 O 0 0.014068116433918476
) O 0 0.010927761904895306
, O 0 0.009875910356640816
implying O 0 0.012047938071191311
a O 0 0.007386423647403717
different O 0 0.005193411838263273
mode O 0 0.009541266597807407
of O 0 0.00607681879773736
binding O 0 0.008229206316173077
for O 0 0.008696872740983963
HFE O 1 0.9997931122779846
and O 0 0.016053127124905586
transferrin O 1 0.9795666337013245
to O 0 0.01248763408511877
TfR O 1 0.9982831478118896
, O 0 0.00952902715653181
consistent O 0 0.00978113617748022
with O 0 0.006722463760524988
our O 0 0.008368716575205326
demonstration O 0 0.014337966218590736
that O 0 0.009920402429997921
HFE O 1 0.9997664093971252
, O 0 0.021889882162213326
transferrin O 1 0.9837790131568909
, O 0 0.016982022672891617
and O 0 0.018024755641818047
TfR O 1 0.9943228960037231
form O 0 0.02158714085817337
a O 0 0.026794256642460823
ternary O 1 0.8493927717208862
complex O 0 0.06531567126512527
. O 0 0.04792976379394531

Identification O 0 0.037214238196611404
of O 0 0.01857070066034794
three O 0 0.013681760057806969
novel O 0 0.02416040375828743
mutations O 0 0.010138190351426601
and O 0 0.006808059755712748
a O 0 0.007210607640445232
high O 0 0.00832727737724781
frequency O 0 0.007940510287880898
of O 0 0.006638162303715944
the O 0 0.008632375858724117
Arg778Leu O 1 0.9704552888870239
mutation O 0 0.028386356309056282
in O 0 0.011454127728939056
Korean O 1 0.9965225458145142
patients O 1 0.9992457628250122
with O 1 0.8529807925224304
Wilson B-Disease 1 0.9999505281448364
disease I-Disease 1 0.9999951124191284
. O 0 0.10945407301187515

Four O 0 0.0372471921145916
mutations O 0 0.03599834069609642
- O 1 0.5474047660827637
- O 1 0.7430270314216614
R778L O 1 0.8056278228759766
, O 0 0.015264231711626053
A874V O 0 0.16780246794223785
, O 0 0.011915797367691994
L1083F O 0 0.03146345540881157
, O 0 0.009432835504412651
and O 0 0.009738669730722904
2304delC O 0 0.4678567945957184
- O 0 0.07714246213436127
- O 0 0.014519133605062962
in O 0 0.007200595922768116
the O 0 0.008803204633295536
copper O 0 0.2609182298183441
- O 0 0.025982746854424477
transporting O 0 0.016815900802612305
enzyme O 0 0.01144081074744463
, O 0 0.010106411762535572
P O 0 0.19280517101287842
- O 1 0.5293377637863159
type O 0 0.3398638069629669
ATPase O 1 0.9805035591125488
( O 0 0.013980423100292683
ATP7B O 1 0.8567408323287964
) O 0 0.008423354476690292
, O 0 0.007393993902951479
were O 0 0.006694766227155924
identified O 0 0.007892776280641556
in O 0 0.008844252675771713
Korean O 1 0.9818218350410461
Patients O 1 0.9988778233528137
with O 1 0.6919518113136292
Wilson B-Disease 1 0.9999630451202393
disease I-Disease 1 0.9999955892562866
. O 0 0.10036502778530121

Arg778Leu O 1 0.7879182696342468
, O 0 0.021484972909092903
the O 0 0.013987511396408081
most O 0 0.009580334648489952
frequently O 0 0.010555218905210495
reported O 0 0.010110797360539436
mutation O 0 0.008448359556496143
of O 0 0.006206251680850983
this O 0 0.0057973600924015045
enzyme O 0 0.008991052396595478
, O 0 0.006232074461877346
was O 0 0.0065515125170350075
found O 0 0.004809595178812742
in O 0 0.004723019897937775
six O 0 0.006140949670225382
of O 0 0.006588267162442207
eight O 0 0.009866001084446907
unrelated O 0 0.08966878056526184
patients O 0 0.2514704465866089
studied O 0 0.012989018112421036
, O 0 0.01037449948489666
an O 0 0.01005276758223772
allele O 0 0.019595161080360413
frequency O 0 0.016455581411719322
of O 0 0.01887287199497223
37 O 0 0.0385165773332119
. O 0 0.039169833064079285

5 O 0 0.04207254946231842
% O 0 0.020301885902881622
, O 0 0.014328865334391594
which O 0 0.009026627987623215
is O 0 0.00813255924731493
considerably O 0 0.010473033413290977
higher O 0 0.007828626781702042
than O 0 0.006666019093245268
those O 0 0.006860508117824793
in O 0 0.008385230787098408
other O 0 0.009453746490180492
Asian O 0 0.0255169328302145
populations O 0 0.022296587005257607
. O 0 0.03273697569966316

The O 0 0.04172863811254501
novel O 0 0.03955577686429024
single O 0 0.025984883308410645
nucleotide O 0 0.029694804921746254
deletion O 0 0.12037947028875351
, O 0 0.01750309392809868
2304delC O 1 0.8602733612060547
, O 0 0.01305811945348978
was O 0 0.014239637181162834
found O 0 0.010088847950100899
in O 0 0.01246720552444458
one O 0 0.017937643453478813
patient O 1 0.7954774498939514
. O 0 0.035773392766714096

Since O 0 0.0348035991191864
a O 0 0.02549191191792488
mutation O 0 0.0233255997300148
at O 0 0.01664431393146515
cDNA O 0 0.03008817695081234
nucleotide O 0 0.025653734803199768
2302 O 1 0.9890295267105103
( O 0 0.01725905016064644
2302insC O 1 0.5027526617050171
) O 0 0.010597082786262035
had O 0 0.009725830517709255
been O 0 0.006573970895260572
previously O 0 0.008257672190666199
described O 0 0.0076838294044137
, O 0 0.0056847985833883286
this O 0 0.004626447334885597
region O 0 0.006485482677817345
of O 0 0.005580129101872444
the O 0 0.02216481789946556
ATP7B O 1 0.9999802112579346
gene O 0 0.0221538282930851
may O 0 0.007268036715686321
be O 0 0.00637228786945343
susceptible O 0 0.08287809789180756
to O 0 0.010990646667778492
gene O 0 0.04279189184308052
rearrangements O 1 0.992508590221405
causing O 1 0.9976086616516113
Wilson B-Disease 1 0.9997265934944153
disease I-Disease 1 0.9999644756317139
. O 0 0.05440432205796242

Disruption O 0 0.06487589329481125
of O 0 0.02840040624141693
splicing O 0 0.030746661126613617
regulated O 0 0.020466240122914314
by O 0 0.012179231271147728
a O 0 0.016644945368170738
CUG O 1 0.9998440742492676
- O 1 0.935843288898468
binding O 0 0.028513912111520767
protein O 0 0.03236124664545059
in O 0 0.13474823534488678
myotonic B-Disease 1 0.9999984502792358
dystrophy I-Disease 1 0.9999994039535522
. O 0 0.2113570123910904

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999849796295166
DM B-Disease 1 1.0
) O 0 0.3590424656867981
is O 0 0.016544882208108902
caused O 0 0.0599648542702198
by O 0 0.009621989913284779
a O 0 0.01906808838248253
CTG O 1 0.9954525828361511
expansion O 0 0.018076008185744286
in O 0 0.009882841259241104
the O 0 0.011592011898756027
3 O 0 0.01695198379456997
untranslated O 0 0.049623485654592514
region O 0 0.01925777643918991
of O 0 0.017310570925474167
the O 0 0.13743111491203308
DM B-Disease 1 0.9999995231628418
gene O 0 0.08987881988286972
. O 0 0.04916619881987572

One O 0 0.03392522409558296
model O 0 0.03540625050663948
of O 0 0.4910987913608551
DM B-Disease 1 1.0
pathogenesis O 1 0.9999978542327881
suggests O 0 0.18393249809741974
that O 0 0.01050789374858141
RNAs O 0 0.019683368504047394
from O 0 0.0077498909085989
the O 0 0.008068609982728958
expanded O 0 0.011934848502278328
allele O 0 0.0123172327876091
create O 0 0.008532023057341576
a O 0 0.007485592272132635
gain O 0 0.010897818021476269
- O 0 0.04102900251746178
of O 0 0.009075915440917015
- O 0 0.3676805794239044
function O 0 0.008542601019144058
mutation O 0 0.008752889931201935
by O 0 0.006154272239655256
the O 0 0.006846989970654249
inappropriate O 0 0.010169130750000477
binding O 0 0.009511131793260574
of O 0 0.008465748280286789
proteins O 0 0.010125851258635521
to O 0 0.012732583098113537
the O 0 0.01932155340909958
CUG O 1 0.870987594127655
repeats O 0 0.058309510350227356
. O 0 0.0528523251414299

Data O 0 0.03836963698267937
presented O 0 0.03097596950829029
here O 0 0.020107317715883255
indicate O 0 0.0157952681183815
that O 0 0.010332988575100899
the O 0 0.012894639745354652
conserved O 0 0.020948002114892006
heterogeneous O 0 0.02813553437590599
nuclear O 0 0.026044465601444244
ribonucleoprotein O 1 0.971385657787323
, O 0 0.019530197605490685
CUG O 1 0.9497453570365906
- O 0 0.030965281650424004
binding O 0 0.0160786472260952
protein O 0 0.01275474950671196
( O 0 0.013142590411007404
CUG O 1 0.9779824018478394
- O 0 0.3504382073879242
BP O 0 0.1802237182855606
) O 0 0.01160200871527195
, O 0 0.009778846986591816
may O 0 0.008236919529736042
mediate O 0 0.015673348680138588
the O 0 0.011976532638072968
trans O 1 0.5837785005569458
- O 1 0.5499693751335144
dominant O 0 0.0426042266190052
effect O 0 0.013938168063759804
of O 0 0.01418897695839405
the O 0 0.020766684785485268
RNA O 0 0.04762282967567444
. O 0 0.041086193174123764

CUG O 1 0.9974149465560913
- O 1 0.657930850982666
BP O 0 0.24780578911304474
was O 0 0.0219085942953825
found O 0 0.01244096178561449
to O 0 0.00909733958542347
bind O 0 0.011194919236004353
to O 0 0.00835524220019579
the O 0 0.009623844176530838
human O 0 0.10098186135292053
cardiac O 1 0.9999996423721313
troponin O 1 0.9999998807907104
T O 1 0.9999815225601196
( O 0 0.08099081367254257
cTNT O 1 0.9006081819534302
) O 0 0.01490116212517023
pre O 0 0.10830457508563995
- O 0 0.22576309740543365
messenger O 0 0.045671820640563965
RNA O 0 0.02457704208791256
and O 0 0.01648147776722908
regulate O 0 0.02223161980509758
its O 0 0.023628098890185356
alternative O 0 0.0417650081217289
splicing O 0 0.07056728005409241
. O 0 0.05268869921565056

Splicing O 0 0.0668947696685791
of O 0 0.031731683760881424
cTNT O 1 0.6767994165420532
was O 0 0.03992392122745514
disrupted O 1 0.8098330497741699
in O 1 0.680023193359375
DM B-Disease 1 1.0
striated O 1 0.9999996423721313
muscle O 1 0.9999444484710693
and O 0 0.028225982561707497
in O 0 0.01194819901138544
normal O 0 0.016316769644618034
cells O 0 0.013847189955413342
expressing O 0 0.02144571579992771
transcripts O 0 0.022745700553059578
that O 0 0.016132205724716187
contain O 0 0.029823442921042442
CUG O 1 0.9650835990905762
repeats O 0 0.06922203302383423
. O 0 0.058879125863313675

Altered O 0 0.056840866804122925
expression O 0 0.036996398121118546
of O 0 0.02186576835811138
genes O 0 0.020910801365971565
regulated O 0 0.022469356656074524
posttranscriptionally O 1 0.5904393196105957
by O 0 0.014680213294923306
CUG O 1 0.9992843270301819
- O 1 0.920110285282135
BP O 1 0.7906516790390015
therefore O 0 0.01630592718720436
may O 0 0.013374841772019863
contribute O 0 0.02113957330584526
to O 0 0.02729766070842743
DM B-Disease 1 0.9999994039535522
pathogenesis O 1 0.9999589920043945
. O 0 0.03695375472307205
. O 0 0.05082974582910538

Identification O 0 0.04596821591258049
of O 0 0.02406926266849041
a O 0 0.023205526173114777
novel O 0 0.051014870405197144
nonsense O 1 0.663304328918457
mutation O 0 0.021861914545297623
and O 0 0.009599936194717884
a O 0 0.011382648721337318
missense O 0 0.02267460525035858
substitution O 0 0.013718822039663792
in O 0 0.009514852426946163
the O 0 0.010916502214968204
vasopressin O 1 0.5821242332458496
- O 1 0.7911651134490967
neurophysin O 1 0.9897365570068359
II O 1 0.9774755239486694
gene O 0 0.014196394942700863
in O 0 0.011023043654859066
two O 0 0.011000536382198334
Spanish O 0 0.023739339783787727
kindreds O 1 0.9215111136436462
with O 0 0.3154413104057312
familial B-Disease 1 0.9999983310699463
neurohypophyseal I-Disease 1 0.9999998807907104
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999995231628418
. O 1 0.7587966918945312

Familial B-Disease 1 0.9999973773956299
neurohypophyseal I-Disease 1 0.9999997615814209
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9989417195320129
FNDI B-Disease 1 0.9999992847442627
) O 0 0.02153179794549942
is O 0 0.012535708956420422
an O 1 0.5124278664588928
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
caused O 1 0.999998927116394
by O 1 0.9994843006134033
deficiency O 1 1.0
in O 1 0.9852120876312256
the O 1 0.9990299940109253
antidiuretic O 1 0.9999996423721313
hormone O 1 0.9999576807022095
arginine O 1 0.9917550086975098
vasopressin O 1 0.9931967258453369
( O 0 0.02494039013981819
AVP O 1 0.8494442105293274
) O 0 0.014013511128723621
encoded O 0 0.01357993297278881
by O 0 0.010090162977576256
the O 0 0.013435912318527699
AVP O 1 0.9850324392318726
- O 1 0.7898062467575073
neurophysin O 1 0.9960773587226868
II O 1 0.9999425411224365
( O 0 0.45855721831321716
AVP O 1 0.9999514818191528
- O 1 0.9788544178009033
NPII O 1 0.997706413269043
) O 0 0.022609708830714226
gene O 0 0.021391795948147774
on O 0 0.023769669234752655
chromosome O 0 0.04771699756383896
20p13 O 0 0.11557032912969589
. O 0 0.04857909679412842

In O 0 0.02530759945511818
this O 0 0.01585892215371132
study O 0 0.014501998201012611
, O 0 0.009773838333785534
we O 0 0.0078324805945158
analyzed O 0 0.00952464435249567
two O 0 0.006708516739308834
families O 0 0.006917392835021019
with O 0 0.007760116830468178
FNDI B-Disease 1 0.8376940488815308
using O 0 0.009342962875962257
direct O 0 0.010467244312167168
automated O 0 0.01950715482234955
fluorescent O 0 0.03763650357723236
, O 0 0.010051490738987923
solid O 0 0.014456980861723423
phase O 0 0.01590067520737648
, O 0 0.010662625543773174
single O 0 0.014432827942073345
- O 0 0.019020315259695053
stranded O 0 0.021161271259188652
DNA O 0 0.015987295657396317
sequencing O 0 0.02202901802957058
of O 0 0.017595823854207993
PCR O 0 0.05126415938138962
- O 0 0.20002113282680511
amplified O 0 0.29626211524009705
AVP O 1 0.9990418553352356
- O 1 0.7356311082839966
NPII O 1 0.9567612409591675
DNA O 0 0.06953921169042587
. O 0 0.06448259204626083

In O 0 0.023499885573983192
one O 0 0.013750802725553513
of O 0 0.00995275191962719
the O 0 0.009928137995302677
families O 0 0.011339511722326279
, O 0 0.010173540562391281
affected O 0 0.014301023446023464
individuals O 0 0.006394443102180958
presented O 0 0.012088323943316936
a O 0 0.011198044754564762
novel O 0 0.026827065274119377
nonsense O 0 0.04631786420941353
mutation O 0 0.012118342332541943
in O 0 0.008328923024237156
exon O 0 0.01799228973686695
3 O 0 0.010001756250858307
of O 0 0.0073152463883161545
the O 0 0.008084509521722794
gene O 0 0.007170656695961952
, O 0 0.006330940406769514
consisting O 0 0.008352002128958702
in O 0 0.00638638436794281
a O 0 0.008122595027089119
G O 0 0.10043397545814514
to O 0 0.010150734335184097
T O 0 0.06605041772127151
transition O 0 0.016384026035666466
at O 0 0.013810143806040287
nucleotide O 0 0.019473524764180183
2101 O 0 0.36702361702919006
, O 0 0.012527531012892723
which O 0 0.009086192585527897
produces O 0 0.011827930808067322
a O 0 0.00986397173255682
stop O 0 0.012063390575349331
signal O 0 0.014480547979474068
in O 0 0.012601854279637337
codon O 0 0.025226186960935593
82 O 0 0.03573154658079147
( O 0 0.03027193807065487
Glu O 1 0.9979166388511658
) O 0 0.03171350061893463
of O 0 0.03604016453027725
NPII O 1 0.9206551909446716
. O 0 0.05996518209576607

The O 0 0.04133431613445282
premature O 0 0.49787333607673645
termination O 1 0.5028337836265564
eliminates O 0 0.1452113389968872
part O 0 0.016988972201943398
of O 0 0.011876718141138554
the O 0 0.019368590787053108
C O 1 0.9672753214836121
- O 1 0.8215243220329285
terminal O 0 0.13711947202682495
domain O 0 0.01142903883010149
of O 0 0.009759283624589443
NPII O 1 0.9114580750465393
, O 0 0.009379533119499683
including O 0 0.007350403815507889
a O 0 0.009160144254565239
cysteine O 0 0.014285451732575893
residue O 0 0.011530965566635132
in O 0 0.006987395230680704
position O 0 0.009523434564471245
85 O 0 0.0123791778460145
, O 0 0.007129497826099396
which O 0 0.005643732845783234
could O 0 0.005661779083311558
be O 0 0.005177300889045
involved O 0 0.007126734592020512
in O 0 0.006730176974087954
the O 0 0.009760730899870396
correct O 0 0.026448119431734085
folding O 1 0.6195294857025146
of O 0 0.02137317880988121
the O 0 0.039722833782434464
prohormone O 1 0.9994511008262634
. O 0 0.05802490562200546

In O 0 0.02736647054553032
the O 0 0.019504820927977562
second O 0 0.021554768085479736
family O 0 0.014570331200957298
, O 0 0.009527280926704407
a O 0 0.010440750978887081
G279A O 0 0.22306494414806366
substitution O 0 0.011686938814818859
at O 0 0.009025941602885723
position O 0 0.010108883492648602
- O 0 0.012054745107889175
1 O 0 0.009327705949544907
of O 0 0.008211588487029076
the O 0 0.009088892489671707
signal O 0 0.014788880944252014
peptide O 0 0.018620584160089493
was O 0 0.013017316348850727
observed O 0 0.013839717023074627
in O 0 0.011612764559686184
all O 0 0.014000268653035164
affected O 0 0.022320959717035294
individuals O 0 0.024497469887137413
. O 0 0.03704424202442169

This O 0 0.03275346755981445
missense O 0 0.06602553278207779
mutation O 0 0.027418049052357674
, O 0 0.016575811430811882
which O 0 0.012544093653559685
replaces O 1 0.9964755177497864
Ala O 1 0.9999475479125977
with O 0 0.05887206643819809
Thr O 1 0.9999631643295288
, O 0 0.01232532225549221
is O 0 0.009691537357866764
frequent O 0 0.08540036529302597
among O 1 0.6303971409797668
FNDI B-Disease 1 0.9999997615814209
patients O 1 0.9991475343704224
and O 0 0.010961432941257954
is O 0 0.0066109006293118
thought O 0 0.0070526935160160065
to O 0 0.007320058066397905
reduce O 0 0.009313073940575123
the O 0 0.008730176836252213
efficiency O 0 0.01772150956094265
of O 0 0.013772683218121529
cleavage O 0 0.2515908181667328
by O 0 0.017242373898625374
signal O 0 0.038540247827768326
peptidases O 0 0.30193260312080383
. O 0 0.03995208814740181
. O 0 0.050802815705537796

Genetic O 0 0.04568801447749138
heterogeneity O 0 0.07295962423086166
of O 0 0.12195603549480438
Saethre B-Disease 1 0.9999964237213135
- I-Disease 1 0.9999996423721313
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 1 0.7479619979858398
due O 0 0.3377246558666229
to O 0 0.03101325035095215
TWIST O 1 0.9985752105712891
and O 0 0.3207670748233795
FGFR O 1 0.9999160766601562
mutations O 0 0.1162835881114006
. O 0 0.0433671809732914

Thirty O 0 0.06126205623149872
- O 0 0.0413849838078022
two O 0 0.016707945615053177
unrelated O 0 0.026352105662226677
patients O 0 0.06309130787849426
with O 0 0.0076017132960259914
features O 0 0.011963984929025173
of O 0 0.08131811767816544
Saethre B-Disease 1 0.999998927116394
- I-Disease 1 0.9999988079071045
Chotzen I-Disease 1 0.9999997615814209
syndrome I-Disease 1 1.0
, O 0 0.32773858308792114
a O 1 0.6912184357643127
common O 1 0.9684115052223206
autosomal B-Disease 1 0.9999897480010986
dominant I-Disease 1 0.9996230602264404
condition I-Disease 1 0.9996028542518616
of O 1 0.9980891346931458
craniosynostosis B-Disease 1 1.0
and O 1 0.9996340274810791
limb B-Disease 1 0.9999998807907104
anomalies I-Disease 1 0.9997487664222717
, O 0 0.020631857216358185
were O 0 0.0068795345723629
screened O 0 0.014807144179940224
for O 0 0.007830167189240456
mutations O 0 0.010108273476362228
in O 0 0.008515174500644207
TWIST O 1 0.9607089757919312
, O 0 0.0692019835114479
FGFR2 O 1 0.9992699027061462
, O 0 0.0202836561948061
and O 0 0.02648860029876232
FGFR3 O 1 0.9900575280189514
. O 0 0.04796743020415306

Nine O 0 0.04219174012541771
novel O 0 0.033431656658649445
and O 0 0.017581773921847343
three O 0 0.01617181859910488
recurrent O 1 0.9999759197235107
TWIST O 1 0.9990836381912231
mutations O 0 0.07270698249340057
were O 0 0.0097505459561944
found O 0 0.010093674063682556
in O 0 0.0121788764372468
12 O 0 0.021382128819823265
families O 0 0.02788304165005684
. O 0 0.03964352235198021

Seven O 0 0.0334191769361496
families O 0 0.01881352625787258
were O 0 0.010877956636250019
found O 0 0.008255739696323872
to O 0 0.006826077587902546
have O 0 0.005801992490887642
the O 0 0.007962609641253948
FGFR3 O 1 0.9993288516998291
P250R O 1 0.9927961230278015
mutation O 0 0.024918196722865105
, O 0 0.007134954910725355
and O 0 0.00625282758846879
one O 0 0.006229782942682505
individual O 0 0.006280672270804644
was O 0 0.007991297170519829
found O 0 0.005719709675759077
to O 0 0.007194216828793287
have O 0 0.0078234588727355
an O 0 0.013211981393396854
FGFR2 O 1 0.990198016166687
VV269 O 1 0.9389991164207458
- O 0 0.3703925609588623
270 O 0 0.07197586447000504
deletion O 0 0.07798900455236435
. O 0 0.05293300002813339

To O 0 0.02537447027862072
date O 0 0.020258260890841484
, O 0 0.012990472838282585
our O 0 0.010674962773919106
detection O 0 0.014680440537631512
rate O 0 0.008907468058168888
for O 0 0.008059384301304817
TWIST O 0 0.21930614113807678
or O 0 0.010715036652982235
FGFR O 1 0.9610368609428406
mutations O 0 0.013073811307549477
is O 0 0.009199406951665878
68 O 0 0.012939337641000748
% O 0 0.00822974368929863
in O 0 0.0075036026537418365
our O 0 0.011673309840261936
Saethre B-Disease 1 0.9998210072517395
- I-Disease 1 0.999984860420227
Chotzen I-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 1 0.9998862743377686
, O 0 0.02875538170337677
including O 0 0.009325183928012848
our O 0 0.011934394016861916
five O 0 0.014730772003531456
patients O 1 0.9299696683883667
elsewhere O 0 0.015378340147435665
reported O 0 0.019477764144539833
with O 0 0.019387057051062584
TWIST O 1 0.9805071353912354
mutations O 0 0.08173756301403046
. O 0 0.04278961569070816

More O 0 0.026774350553750992
than O 0 0.01727375015616417
35 O 0 0.02065545879304409
different O 0 0.011708785779774189
TWIST O 0 0.07479322701692581
mutations O 0 0.014276450499892235
are O 0 0.007366631180047989
now O 0 0.009507633745670319
known O 0 0.01022425852715969
in O 0 0.012129261158406734
the O 0 0.018289437517523766
literature O 0 0.033811453729867935
. O 0 0.038149163126945496

The O 0 0.03233484923839569
most O 0 0.01899847574532032
common O 0 0.016438134014606476
phenotypic O 0 0.03267265856266022
features O 0 0.015747372061014175
, O 0 0.009139263071119785
present O 0 0.008598223328590393
in O 0 0.0060633099637925625
more O 0 0.005005508661270142
than O 0 0.004442707169800997
a O 0 0.005710645578801632
third O 0 0.007467478979378939
of O 0 0.006569185759872198
our O 0 0.010744133964180946
patients O 1 0.862242579460144
with O 0 0.009235808625817299
TWIST O 1 0.9597437977790833
mutations O 0 0.014196809381246567
, O 0 0.008682837709784508
are O 0 0.007156978361308575
coronal B-Disease 0 0.27160200476646423
synostosis I-Disease 1 0.6589722633361816
, O 0 0.011956996284425259
brachycephaly B-Disease 1 0.8714920878410339
, O 0 0.018986616283655167
low B-Disease 1 0.8504360914230347
frontal I-Disease 1 0.9999914169311523
hairline I-Disease 1 0.9999996423721313
, O 1 0.9122682213783264
facial B-Disease 1 0.999996542930603
asymmetry I-Disease 1 0.9999662637710571
, O 1 0.9902592897415161
ptosis B-Disease 1 0.9999998807907104
, O 1 0.9617845416069031
hypertelorism B-Disease 1 0.9999918937683105
, O 0 0.19244100153446198
broad B-Disease 1 0.9207730293273926
great I-Disease 1 0.9614721536636353
toes I-Disease 1 0.9992433786392212
, O 0 0.034003812819719315
and O 0 0.03285655379295349
clinodactyly B-Disease 1 0.9799139499664307
. O 0 0.05107935890555382

Significant O 0 0.047249238938093185
intra O 1 0.9215432405471802
- O 1 0.7935044765472412
and O 0 0.027652200311422348
interfamilial O 1 0.99479079246521
phenotypic O 0 0.368107408285141
variability O 0 0.058070529252290726
is O 0 0.011212843470275402
present O 0 0.010330243967473507
for O 0 0.010230783373117447
either O 0 0.013756267726421356
TWIST O 1 0.975352942943573
mutations O 0 0.11620045453310013
or O 0 0.02660202607512474
FGFR O 1 0.9991859793663025
mutations O 0 0.057302702218294144
. O 0 0.04883657768368721

The O 0 0.02884949930012226
overlap O 0 0.02172688953578472
in O 0 0.01305419858545065
clinical O 1 0.8614937663078308
features O 0 0.01444678008556366
and O 0 0.007388354744762182
the O 0 0.007031936664134264
presence O 0 0.0072451382875442505
, O 0 0.00585381081327796
in O 0 0.004938610829412937
the O 0 0.005129784811288118
same O 0 0.005016390234231949
genes O 0 0.005785276647657156
, O 0 0.005039192270487547
of O 0 0.005166339222341776
mutations O 0 0.005125907249748707
for O 0 0.004230516962707043
more O 0 0.004734816029667854
than O 0 0.004756859038025141
one O 0 0.005789425689727068
craniosynostotic B-Disease 1 0.9517067670822144
condition I-Disease 0 0.0706954300403595
- O 0 0.016496049240231514
such O 0 0.00641958462074399
as O 0 0.00836565438657999
Saethre B-Disease 1 0.9891151189804077
- I-Disease 1 0.9075085520744324
Chotzen I-Disease 1 0.9786874651908875
, I-Disease 0 0.012483631260693073
Crouzon I-Disease 1 0.9554530382156372
, I-Disease 0 0.014582770876586437
and I-Disease 0 0.07535678148269653
Pfeiffer I-Disease 1 0.999995231628418
syndromes I-Disease 1 0.9999982118606567
- O 1 0.960486650466919
support O 0 0.026134468615055084
the O 0 0.010979649610817432
hypothesis O 0 0.016007231548428535
that O 0 0.007197916973382235
TWIST O 0 0.42919063568115234
and O 0 0.008099788799881935
FGFRs O 1 0.6319926381111145
are O 0 0.005548512097448111
components O 0 0.007805966772139072
of O 0 0.006203763652592897
the O 0 0.006701345555484295
same O 0 0.005979116540402174
molecular O 0 0.009112689644098282
pathway O 0 0.0074735889211297035
involved O 0 0.0060669975355267525
in O 0 0.0059845829382538795
the O 0 0.007297121454030275
modulation O 0 0.16619281470775604
of O 0 0.46426331996917725
craniofacial O 1 1.0
and O 1 0.9957104921340942
limb O 1 0.9999988079071045
development O 1 0.9485483765602112
in O 0 0.07302162796258926
humans O 0 0.02627977915108204
. O 0 0.019089307636022568
. O 0 0.032724156975746155

Mutation O 0 0.06085706502199173
analysis O 0 0.03783011808991432
of O 0 0.056638509035110474
UBE3A O 1 0.9999978542327881
in O 1 0.9999222755432129
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999996423721313
. O 1 0.9850292801856995

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9981493949890137
AS B-Disease 1 0.9955821633338928
) O 0 0.01783321239054203
is O 0 0.011925114318728447
caused O 0 0.02034168504178524
by O 0 0.01140779908746481
chromosome O 0 0.18018838763237
15q11 O 1 0.9737458229064941
- O 1 0.8998417258262634
q13 O 1 0.848794162273407
deletions O 0 0.0317615270614624
of O 0 0.012187769636511803
maternal O 0 0.1479468047618866
origin O 0 0.010342316702008247
, O 0 0.010118640959262848
by O 0 0.011391119100153446
paternal O 1 0.9968066215515137
uniparental B-Disease 1 0.9999996423721313
disomy I-Disease 1 0.9999904632568359
( O 1 0.8625286817550659
UPD B-Disease 1 0.9999912977218628
) O 0 0.014877836219966412
15 O 0 0.015550842508673668
, O 0 0.012308499775826931
by O 0 0.01093581598252058
imprinting O 1 0.9962460398674011
defects O 1 0.9993995428085327
, O 0 0.012879039160907269
and O 0 0.010052810423076153
by O 0 0.011058013886213303
mutations O 0 0.016273165121674538
in O 0 0.014755846932530403
the O 0 0.02505979686975479
UBE3A O 1 0.9994451403617859
gene O 0 0.04552604630589485
. O 0 0.04503380507230759

UBE3A O 1 0.9609577059745789
encodes O 0 0.06502705067396164
a O 0 0.03433678671717644
ubiquitin O 1 0.7912524342536926
- O 1 0.7838187217712402
protein O 0 0.023435546085238457
ligase O 0 0.06979940831661224
and O 0 0.016669362783432007
shows O 0 0.021097037941217422
brain O 1 0.7071570754051208
- O 0 0.2420428842306137
specific O 0 0.029843436554074287
imprinting O 1 0.6964532732963562
. O 0 0.05010656267404556

Here O 0 0.04092887416481972
we O 0 0.028703104704618454
describe O 0 0.03308248519897461
UBE3A O 1 0.9941563606262207
coding O 0 0.19978567957878113
- O 0 0.3330328166484833
region O 0 0.021300189197063446
mutations O 0 0.014072900637984276
detected O 0 0.012519876472651958
by O 0 0.008480205200612545
SSCP O 1 0.7905595302581787
analysis O 0 0.00993298552930355
in O 0 0.008703021332621574
13 O 0 0.013294137082993984
AS B-Disease 0 0.017743537202477455
individuals O 0 0.012649568729102612
or O 0 0.01644689403474331
families O 0 0.02666718326508999
. O 0 0.033539120107889175

Two O 0 0.046731412410736084
identical O 0 0.04692709073424339
de O 0 0.05682393163442612
novo O 0 0.05905470997095108
5 O 0 0.03501264005899429
- O 0 0.036652375012636185
bp O 0 0.047158434987068176
duplications O 0 0.04718325659632683
in O 0 0.021521080285310745
exon O 0 0.05009846016764641
16 O 0 0.027882279828190804
were O 0 0.020937707275152206
found O 0 0.028952758759260178
. O 0 0.04528508335351944

Among O 0 0.029195871204137802
the O 0 0.01765340007841587
other O 0 0.010357159189879894
11 O 0 0.012001016177237034
unique O 0 0.012190624140202999
mutations O 0 0.010308484546840191
, O 0 0.007100286893546581
8 O 0 0.009231002070009708
were O 0 0.006383195519447327
small O 0 0.008085155859589577
deletions O 0 0.014115093275904655
or O 0 0.008175438269972801
insertions O 0 0.027849769219756126
predicted O 0 0.013630518689751625
to O 0 0.00990529078990221
cause O 0 0.04878456890583038
frameshifts O 1 0.9093143939971924
, O 0 0.009111760184168816
1 O 0 0.010523989796638489
was O 0 0.010218462906777859
a O 0 0.009463369846343994
mutation O 0 0.008444149047136307
to O 0 0.00623531686142087
a O 0 0.007851152680814266
stop O 0 0.009326708503067493
codon O 0 0.012900596484541893
, O 0 0.00791863352060318
1 O 0 0.009373420849442482
was O 0 0.008885647170245647
a O 0 0.010063269175589085
missense O 0 0.023158621042966843
mutation O 0 0.01150291133671999
, O 0 0.007479575928300619
and O 0 0.006436037831008434
1 O 0 0.009784983471035957
was O 0 0.009682860225439072
predicted O 0 0.01140858419239521
to O 0 0.009916468523442745
cause O 0 0.012776312418282032
insertion O 0 0.014833349734544754
of O 0 0.009470564313232899
an O 0 0.010453645139932632
isoleucine O 1 0.5820056796073914
in O 0 0.01003771647810936
the O 0 0.010905490256845951
hect O 0 0.136243537068367
domain O 0 0.012652869336307049
of O 0 0.009794516488909721
the O 0 0.01238243654370308
UBE3A O 1 0.9988064765930176
protein O 0 0.011808841489255428
, O 0 0.009292651899158955
which O 0 0.007953284308314323
functions O 0 0.009460181929171085
in O 0 0.01222405955195427
E2 O 1 0.6474514603614807
binding O 0 0.021898863837122917
and O 0 0.02088356576859951
ubiquitin O 0 0.07223936170339584
transfer O 0 0.04088593274354935
. O 0 0.049423698335886

Eight O 0 0.034617118537425995
of O 0 0.019632745534181595
the O 0 0.01612827740609646
cases O 0 0.0164386834949255
were O 0 0.01227650698274374
familial O 1 0.9985255599021912
, O 0 0.017033657059073448
and O 0 0.011582962237298489
five O 0 0.013931079767644405
were O 0 0.015988420695066452
sporadic O 0 0.07665687054395676
. O 0 0.03850951045751572

In O 0 0.029255907982587814
two O 0 0.018728790804743767
familial O 1 0.9754191040992737
cases O 0 0.01809786446392536
and O 0 0.009951891377568245
one O 0 0.008694623596966267
sporadic O 0 0.22227682173252106
case O 0 0.04000789299607277
, O 0 0.02070555090904236
mosaicism O 1 0.9993546605110168
for O 0 0.02134345844388008
UBE3A O 1 0.999977707862854
mutations O 0 0.021059483289718628
was O 0 0.010179655626416206
detected O 0 0.008599523454904556
in O 0 0.005619439296424389
the O 0 0.00581202981993556
mother O 0 0.008808157406747341
of O 0 0.005643803160637617
three O 0 0.00543143879622221
AS B-Disease 0 0.089304618537426
sons O 0 0.08479070663452148
, O 0 0.006073778495192528
in O 0 0.0059879538603127
the O 0 0.00842441339045763
maternal O 1 0.5280309915542603
grandfather O 0 0.19104565680027008
of O 0 0.006161380559206009
two O 0 0.005571921821683645
AS B-Disease 0 0.03627790883183479
first O 0 0.010213382542133331
cousins O 0 0.01832522638142109
, O 0 0.006754279136657715
and O 0 0.005848870147019625
in O 0 0.006401757709681988
the O 0 0.007914477027952671
mother O 0 0.0170768890529871
of O 0 0.009505078196525574
an O 0 0.03480929881334305
AS B-Disease 1 0.8509246110916138
daughter O 1 0.9731308817863464
. O 0 0.03825809434056282

The O 0 0.02941082790493965
frequencies O 0 0.020842701196670532
with O 0 0.012660853564739227
which O 0 0.00910190586000681
we O 0 0.008665484376251698
detected O 0 0.010244606994092464
mutations O 0 0.007865305058658123
were O 0 0.005613780580461025
5 O 0 0.00822108518332243
( O 0 0.006542010232806206
14 O 0 0.008802276104688644
% O 0 0.006857003550976515
) O 0 0.006657670252025127
of O 0 0.006488011218607426
35 O 0 0.00962146744132042
in O 0 0.007572340779006481
sporadic O 0 0.010944061912596226
cases O 0 0.006722426041960716
and O 0 0.006349039264023304
8 O 0 0.009841958060860634
( O 0 0.0077290222980082035
80 O 0 0.011270302347838879
% O 0 0.0077778794802725315
) O 0 0.007478510495275259
of O 0 0.007935560308396816
10 O 0 0.010668654926121235
in O 0 0.011820921674370766
familial O 1 0.8602854609489441
cases O 0 0.022920165210962296
. O 0 0.02106652222573757
. O 0 0.03409038856625557

The O 0 0.0702584981918335
hemochromatosis B-Disease 1 0.9999911785125732
845 O 1 0.9998074173927307
G O 1 0.9972653388977051
- O 1 0.8543444275856018
- O 0 0.2844325602054596
> O 0 0.03548528626561165
A O 0 0.016640622168779373
and O 0 0.013022401370108128
187 O 0 0.02306288294494152
C O 0 0.061260294169187546
- O 0 0.17237813770771027
- O 0 0.48927968740463257
> O 1 0.6427445411682129
G O 1 0.5495997667312622
mutations O 0 0.016484001651406288
: O 0 0.015482823364436626
prevalence O 1 0.6778781414031982
in O 0 0.012637282721698284
non O 1 0.7214678525924683
- O 1 0.9929205775260925
Caucasian O 1 0.9943021535873413
populations O 0 0.03540429100394249
. O 0 0.04029883071780205

Hemochromatosis B-Disease 1 0.9999310970306396
, O 0 0.04690027981996536
the O 1 0.8171365857124329
inherited B-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
of I-Disease 1 0.9999507665634155
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999936819076538
, O 1 0.9629892706871033
leads O 1 0.9878567457199097
, O 0 0.029663730412721634
if O 0 0.011062270030379295
untreated O 1 0.9981110095977783
, O 0 0.00931914709508419
to O 0 0.012063822709023952
progressive O 1 0.9990511536598206
iron B-Disease 1 0.9999847412109375
overload I-Disease 1 0.999996542930603
and O 1 0.5930823683738708
premature B-Disease 1 0.9968204498291016
death I-Disease 1 0.7604424357414246
. O 0 0.048379912972450256

The O 0 0.15428437292575836
hemochromatosis B-Disease 1 0.9999957084655762
gene O 0 0.1252741664648056
, O 0 0.07146371901035309
HFE O 1 0.9999269247055054
, O 0 0.01670122519135475
recently O 0 0.018654027953743935
has O 0 0.009113219566643238
been O 0 0.006723929196596146
identified O 0 0.006867207586765289
, O 0 0.00577082484960556
and O 0 0.005136266816407442
characterization O 0 0.0113243842497468
of O 0 0.005901431664824486
this O 0 0.005080041941255331
gene O 0 0.005995445419102907
has O 0 0.0057447501458227634
shown O 0 0.005379457492381334
that O 0 0.0041162483394145966
it O 0 0.004953381139785051
contains O 0 0.005695722997188568
two O 0 0.005103572271764278
mutations O 0 0.006594695616513491
that O 0 0.004555937834084034
result O 0 0.005762089975178242
in O 0 0.006779395509511232
amino O 0 0.010724680498242378
acid O 0 0.014433933421969414
substitutions O 0 0.018407847732305527
- O 0 0.018349124118685722
cDNA O 0 0.028472447767853737
nucleotides O 0 0.02523205615580082
845 O 0 0.11820650100708008
G O 0 0.07773620635271072
- O 0 0.10887408256530762
- O 0 0.07038141787052155
> O 0 0.03390785679221153
A O 0 0.016902467235922813
( O 0 0.015950608998537064
C282Y O 0 0.030963324010372162
) O 0 0.013551818206906319
and O 0 0.011991522274911404
187 O 0 0.022943079471588135
C O 0 0.044801272451877594
- O 1 0.5581374168395996
- O 1 0.9084103107452393
> O 1 0.9779847860336304
G O 1 0.9409722089767456
( O 0 0.03743671625852585
H63D O 1 0.924060583114624
) O 0 0.04531485587358475
. O 0 0.055203162133693695

Although O 0 0.12834298610687256
hemochromatosis B-Disease 1 0.9999716281890869
is O 0 0.025553155690431595
common O 0 0.018868962302803993
in O 0 0.01492550503462553
Caucasians O 1 0.8602098226547241
, O 0 0.014383247122168541
affecting O 0 0.08936643600463867
> O 1 0.89110267162323
= O 0 0.0289838295429945
1 O 0 0.01558675616979599
/ O 0 0.01869625225663185
300 O 0 0.014260239899158478
individuals O 0 0.007180089130997658
of O 0 0.006691386457532644
northern O 0 0.006839380599558353
European O 0 0.006547261960804462
origin O 0 0.0055273715406656265
, O 0 0.0056495158933103085
it O 0 0.005215909797698259
has O 0 0.005623221397399902
not O 0 0.0044629997573792934
been O 0 0.005751481279730797
recognized O 0 0.009292371571063995
in O 0 0.010042019188404083
other O 0 0.01157271396368742
populations O 0 0.02101787179708481
. O 0 0.03280456364154816

The O 0 0.029269400984048843
present O 0 0.020087119191884995
study O 0 0.014299464412033558
used O 0 0.012654013000428677
PCR O 0 0.02636241354048252
and O 0 0.012316861189901829
restriction O 0 0.0256046075373888
- O 1 0.7086836695671082
enzyme O 0 0.018076296895742416
digestion O 0 0.021862739697098732
to O 0 0.009982749819755554
analyze O 0 0.014310047961771488
the O 0 0.009241592139005661
frequency O 0 0.010564187541604042
of O 0 0.009542880579829216
the O 0 0.011161967180669308
845 O 1 0.8967428803443909
G O 1 0.7423204183578491
- O 0 0.1697312742471695
- O 0 0.049308985471725464
> O 0 0.025151001289486885
A O 0 0.014243097975850105
and O 0 0.0115722781047225
187 O 0 0.020730307325720787
C O 0 0.027869978919625282
- O 0 0.03126120939850807
- O 0 0.03603646159172058
> O 0 0.07075690478086472
G O 0 0.03533829003572464
mutations O 0 0.017076479271054268
in O 0 0.014315725304186344
HLA O 1 0.9974923133850098
- O 0 0.030031921342015266
typed O 0 0.019558563828468323
samples O 0 0.01067875511944294
from O 0 0.009703334420919418
non O 0 0.016008982434868813
- O 0 0.15249890089035034
Caucasian O 0 0.4282850921154022
populations O 0 0.011653379537165165
, O 0 0.011088180355727673
comprising O 0 0.01507417019456625
Australian O 0 0.021184613928198814
Aboriginal O 0 0.03338081017136574
, O 0 0.013303873129189014
Chinese O 0 0.020428277552127838
, O 0 0.01646796613931656
and O 0 0.018476104363799095
Pacific O 0 0.05072006210684776
Islanders O 0 0.06461099535226822
. O 0 0.04813821613788605

Results O 0 0.03527536988258362
showed O 0 0.024482546374201775
that O 0 0.012489440850913525
the O 0 0.014131412841379642
845 O 1 0.9874639511108398
G O 1 0.9901297688484192
- O 1 0.9807420969009399
- O 1 0.9439495801925659
> O 1 0.7129859924316406
A O 0 0.018968796357512474
mutation O 0 0.011326796375215054
was O 0 0.008135637268424034
present O 0 0.007012741174548864
in O 0 0.005548427812755108
these O 0 0.004714487586170435
populations O 0 0.005371592007577419
( O 0 0.0064419712871313095
allele O 0 0.009380915202200413
frequency O 0 0.007536573335528374
0 O 0 0.009177134372293949
. O 0 0.006419115699827671
32 O 0 0.00952205341309309
% O 0 0.007131732534617186
) O 0 0.0061147636733949184
, O 0 0.005507123656570911
and O 0 0.005207786336541176
, O 0 0.005358775146305561
furthermore O 0 0.0072126309387385845
, O 0 0.005797593388706446
it O 0 0.004848857410252094
was O 0 0.007119833957403898
always O 0 0.00745561346411705
seen O 0 0.007164850365370512
in O 0 0.005751121323555708
conjunction O 0 0.011425730772316456
with O 0 0.012289777398109436
HLA O 1 0.999993085861206
haplotypes O 1 0.503078818321228
common O 0 0.008462302386760712
in O 0 0.008151528425514698
Caucasians O 0 0.3480887711048126
, O 0 0.007236410863697529
suggesting O 0 0.009192069061100483
that O 0 0.00734209967777133
845 O 1 0.9336886405944824
G O 1 0.9498575329780579
- O 1 0.9162349104881287
- O 1 0.8894491195678711
> O 1 0.5548367500305176
A O 0 0.01500469446182251
may O 0 0.00843610055744648
have O 0 0.0058390358462929726
been O 0 0.00669056223705411
introduced O 0 0.009239680133759975
into O 0 0.010107842274010181
these O 0 0.010504626668989658
populations O 0 0.01623649336397648
by O 0 0.020120684057474136
Caucasian O 1 0.6501109600067139
admixture O 1 0.5576538443565369
. O 0 0.054571185261011124

187 O 0 0.08163229376077652
C O 0 0.4567330777645111
- O 1 0.780559241771698
- O 1 0.8926898241043091
> O 1 0.9117214679718018
G O 0 0.1402089148759842
was O 0 0.015857381746172905
present O 0 0.012800890952348709
at O 0 0.012735280208289623
an O 0 0.011770347133278847
allele O 0 0.022768935188651085
frequency O 0 0.01755227893590927
of O 0 0.018581783398985863
2 O 0 0.03523273393511772
. O 0 0.04171394929289818

68 O 0 0.06128958612680435
% O 0 0.02589685656130314
in O 0 0.014530273154377937
the O 0 0.012503181584179401
two O 0 0.009452613070607185
populations O 0 0.01150237862020731
analyzed O 0 0.015188043937087059
( O 0 0.013407204300165176
Australian O 0 0.023039311170578003
Aboriginal O 0 0.03117714263498783
and O 0 0.01909869909286499
Chinese O 0 0.029558734968304634
) O 0 0.02872900851070881
. O 0 0.0448581799864769

In O 0 0.02914508245885372
the O 0 0.022025883197784424
Australian O 0 0.02577538974583149
Aboriginal O 0 0.023386269807815552
samples O 0 0.015455127693712711
, O 0 0.012344684451818466
187 O 0 0.02194724977016449
C O 0 0.06583305448293686
- O 0 0.31409740447998047
- O 1 0.640404462814331
> O 1 0.7036264538764954
G O 0 0.0506368950009346
was O 0 0.009792454540729523
found O 0 0.006870544981211424
to O 0 0.00591624341905117
be O 0 0.006328178104013205
associated O 0 0.00804977212101221
with O 0 0.009816044941544533
HLA O 1 0.99997878074646
haplotypes O 1 0.9236992597579956
common O 0 0.03060956485569477
in O 0 0.012405602261424065
Caucasians O 1 0.993728756904602
, O 0 0.00911856908351183
suggesting O 0 0.009062129072844982
that O 0 0.005821300204843283
it O 0 0.006389773916453123
was O 0 0.010683279484510422
introduced O 0 0.013225037604570389
by O 0 0.011410148814320564
recent O 0 0.020032081753015518
admixture O 0 0.15279074013233185
. O 0 0.04130057245492935

In O 0 0.03316556289792061
the O 0 0.023475605994462967
Chinese O 0 0.02300316095352173
samples O 0 0.016362806782126427
analyzed O 0 0.01643955335021019
, O 0 0.011832674965262413
187 O 0 0.020291024819016457
C O 0 0.03239987790584564
- O 0 0.10753978788852692
- O 0 0.4011262059211731
> O 1 0.6493133902549744
G O 0 0.04138262942433357
was O 0 0.01074694748967886
present O 0 0.008544734679162502
in O 0 0.007794983685016632
association O 0 0.00892616156488657
with O 0 0.0059929173439741135
a O 0 0.007553908973932266
wide O 0 0.009378280490636826
variety O 0 0.009124240837991238
of O 0 0.02762562967836857
HLA O 1 0.9999963045120239
haplotypes O 1 0.8216443061828613
, O 0 0.009018647484481335
showing O 0 0.009679870679974556
this O 0 0.005831039045006037
mutation O 0 0.006726785097271204
to O 0 0.0050541129894554615
be O 0 0.0046065011993050575
widespread O 0 0.008134470321238041
and O 0 0.007038238923996687
likely O 0 0.007098098285496235
to O 0 0.00764367775991559
predate O 0 0.014415771700441837
the O 0 0.008126353845000267
more O 0 0.0074943117797374725
genetically O 0 0.01273830235004425
restricted O 0 0.01413380354642868
845 O 1 0.9847389459609985
G O 1 0.984633207321167
- O 1 0.9783929586410522
- O 1 0.9186086058616638
> O 1 0.5917548537254333
A O 0 0.04225989058613777
mutation O 0 0.049945373088121414
. O 0 0.045923862606287

Genotype O 1 0.9740784764289856
- O 1 0.9210763573646545
phenotype O 1 0.9384568929672241
correlations O 0 0.40615543723106384
in O 0 0.30903640389442444
attenuated B-Disease 1 0.9999903440475464
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999990463256836
. O 1 0.9076774716377258

Germ O 1 0.9973322153091431
- O 0 0.4597485661506653
line O 0 0.027804158627986908
mutations O 0 0.01731092855334282
of O 0 0.01244355272501707
the O 0 0.06326448172330856
tumor B-Disease 1 0.9999881982803345
suppressor O 1 0.9999697208404541
APC O 1 0.9997243285179138
are O 0 0.01143909152597189
implicated O 0 0.41750773787498474
in O 0 0.255359411239624
attenuated B-Disease 1 0.9999983310699463
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9998722076416016
AAPC B-Disease 1 0.9999995231628418
) O 0 0.01875692792236805
, O 0 0.013113443739712238
a O 0 0.013938402757048607
variant O 1 0.8950952291488647
of O 1 0.9532802700996399
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999979734420776
FAP B-Disease 1 0.9999998807907104
) O 1 0.7818930149078369
. O 0 0.06154949963092804

AAPC B-Disease 1 0.9997209906578064
is O 0 0.03167574480175972
recognized O 0 0.023980777710676193
by O 0 0.012593483552336693
the O 0 0.011859427206218243
occurrence O 0 0.017802953720092773
of O 0 0.014488319866359234
< O 1 0.9700317978858948
100 O 0 0.06309032440185547
colonic B-Disease 1 0.9998040795326233
adenomas I-Disease 1 0.9981245398521423
and O 0 0.010252815671265125
a O 0 0.009400788694620132
later O 0 0.015595047734677792
onset O 1 0.9999387264251709
of O 1 0.9986409544944763
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.981730580329895
age O 1 0.9571666121482849
> O 1 0.9803965091705322
40 O 0 0.02004103735089302
years O 0 0.019721146672964096
) O 0 0.027299916371703148
. O 0 0.04112786799669266

The O 0 0.031129173934459686
aim O 0 0.031136605888605118
of O 0 0.01628812402486801
this O 0 0.011408045887947083
study O 0 0.01292326394468546
was O 0 0.01319618709385395
to O 0 0.01236102543771267
assess O 0 0.03229452297091484
genotype O 1 0.8911899328231812
- O 1 0.9270356297492981
phenotype O 1 0.9495030641555786
correlations O 0 0.123776376247406
in O 0 0.0333658792078495
AAPC B-Disease 1 0.9999699592590332
families O 0 0.05343452841043472
. O 0 0.048012372106313705

By O 0 0.0374719612300396
protein O 0 0.03639952465891838
- O 0 0.04383891448378563
truncation O 0 0.17725226283073425
test O 0 0.028408104553818703
( O 0 0.021979013457894325
PTT O 0 0.157337486743927
) O 0 0.016105299815535545
assay O 0 0.019793538376688957
, O 0 0.009476657956838608
the O 0 0.008059841580688953
entire O 0 0.01148699689656496
coding O 0 0.012444271706044674
region O 0 0.009786362759768963
of O 0 0.008755041286349297
the O 0 0.010574853047728539
APC B-Disease 1 0.9981728792190552
gene O 0 0.011535486206412315
was O 0 0.012878385372459888
screened O 0 0.014250390231609344
in O 0 0.007467865012586117
affected O 0 0.008624178357422352
individuals O 0 0.006509547121822834
from O 0 0.00746722798794508
11 O 0 0.10449783504009247
AAPC B-Disease 1 0.9999977350234985
kindreds O 1 0.9984415173530579
, O 0 0.013582666404545307
and O 0 0.01066255196928978
their O 0 0.01108616217970848
phenotypic O 0 0.05619260296225548
differences O 0 0.017795421183109283
were O 0 0.019251514226198196
examined O 0 0.04615100473165512
. O 0 0.04355427622795105

Five O 0 0.045984964817762375
novel O 0 0.06724811345338821
germ O 1 0.9987913966178894
- O 1 0.9866976141929626
line O 1 0.6723635196685791
APC B-Disease 1 0.9992268085479736
mutations O 0 0.027583274990320206
were O 0 0.013843134045600891
identified O 0 0.016551779583096504
in O 0 0.01823892816901207
seven O 0 0.029423357918858528
kindreds O 1 0.8464446067810059
. O 0 0.05455663427710533

Mutations O 0 0.036127302795648575
were O 0 0.016178831458091736
located O 0 0.014186869375407696
in O 0 0.00877739954739809
three O 0 0.007110761944204569
different O 0 0.005335730034857988
regions O 0 0.006408309563994408
of O 0 0.005778501275926828
the O 0 0.010025149211287498
APC B-Disease 1 0.9996461868286133
gene O 0 0.009039766155183315
( O 0 0.0073977806605398655
1 O 0 0.008606686256825924
) O 0 0.006757799070328474
at O 0 0.00702435988932848
the O 0 0.005990196950733662
5 O 0 0.008465592749416828
end O 0 0.0077622211538255215
spanning O 0 0.012683511711657047
exons O 0 0.013924412429332733
4 O 0 0.009559445083141327
and O 0 0.007565188221633434
5 O 0 0.008780586533248425
, O 0 0.0069787525571882725
( O 0 0.006831627804785967
2 O 0 0.009355328977108002
) O 0 0.006930612493306398
within O 0 0.00799434445798397
exon O 0 0.014333984814584255
9 O 0 0.009034705348312855
, O 0 0.006715535651892424
and O 0 0.005801998544484377
( O 0 0.006704587023705244
3 O 0 0.008989225141704082
) O 0 0.00690119992941618
at O 0 0.008127376437187195
the O 0 0.008841987699270248
3 O 0 0.014737521298229694
distal O 0 0.03078855574131012
end O 0 0.015314556658267975
of O 0 0.01600310206413269
the O 0 0.021024120971560478
gene O 0 0.03146550431847572
. O 0 0.03954324871301651

Variability O 0 0.04713226109743118
in O 0 0.018039371818304062
the O 0 0.014737099409103394
number O 0 0.011680440977215767
of O 1 0.9499824047088623
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9650088548660278
most O 0 0.010714026167988777
apparent O 0 0.1262662559747696
in O 0 0.00711690541356802
individuals O 0 0.005338427610695362
with O 0 0.0063218362629413605
mutations O 0 0.007290806155651808
in O 0 0.005878994707018137
region O 0 0.008499055169522762
1 O 0 0.009601405821740627
, O 0 0.008155442774295807
and O 0 0.011098348535597324
upper O 1 0.9955734014511108
- O 1 0.9999443292617798
gastrointestinal O 1 0.9999998807907104
manifestations O 1 0.9996973276138306
were O 0 0.02061370387673378
more O 0 0.015971258282661438
severe O 1 0.9997448325157166
in O 0 0.022871842607855797
them O 0 0.021407252177596092
. O 0 0.0353340320289135

In O 0 0.02418604865670204
individuals O 0 0.016177693381905556
with O 0 0.011350862681865692
mutations O 0 0.011036640033125877
in O 0 0.006604265421628952
either O 0 0.006350778043270111
region O 0 0.007725629024207592
2 O 0 0.007562285289168358
or O 0 0.005373320076614618
region O 0 0.007234229240566492
3 O 0 0.008083518594503403
, O 0 0.005646650213748217
the O 0 0.005525904707610607
average O 0 0.00671985000371933
number O 0 0.005920631345361471
of O 0 0.008290586993098259
adenomas B-Disease 1 0.9986360669136047
tended O 0 0.012556538917124271
to O 0 0.007467358373105526
be O 0 0.0056139808148145676
lower O 0 0.0069883749820292
than O 0 0.004789011552929878
those O 0 0.004319180268794298
in O 0 0.004538371227681637
individuals O 0 0.004281197674572468
with O 0 0.004687074106186628
mutations O 0 0.0055478960275650024
in O 0 0.004892256110906601
region O 0 0.00829782709479332
1 O 0 0.009013867005705833
, O 0 0.007074609398841858
although O 0 0.008173787966370583
age O 0 0.011555055156350136
at O 0 0.013482327573001385
diagnosis O 1 0.9822156429290771
was O 0 0.026893815025687218
similar O 0 0.02725565992295742
. O 0 0.03451075032353401

In O 0 0.0399814210832119
all O 0 0.03493894636631012
AAPC B-Disease 1 0.9998181462287903
kindreds O 1 0.7741866707801819
, O 0 0.018732134252786636
a O 0 0.01688685268163681
predominance O 0 0.4294091463088989
of O 0 0.03136971965432167
right O 1 0.9916770458221436
- O 1 0.9999988079071045
sided O 1 0.9999998807907104
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999963045120239
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999788999557495
was O 1 0.9654697179794312
observed O 0 0.04622571915388107
. O 0 0.04485707730054855

No O 0 0.1427847445011139
desmoid B-Disease 1 0.9996040463447571
tumors I-Disease 1 0.9994619488716125
were O 0 0.0207268837839365
found O 0 0.01668228767812252
in O 0 0.016049856320023537
these O 0 0.020941199734807014
kindreds O 1 0.7977889776229858
. O 0 0.04432762786746025

Our O 0 0.03298535197973251
data O 0 0.01825946569442749
suggest O 0 0.016285227611660957
that O 0 0.008997988887131214
, O 0 0.009657246991991997
in O 0 0.010708043351769447
AAPC B-Disease 1 0.9999666213989258
families O 0 0.01072140783071518
, O 0 0.007928994484245777
the O 0 0.006949486210942268
location O 0 0.009044368751347065
of O 0 0.00813308171927929
the O 0 0.015967443585395813
APC B-Disease 1 0.9998717308044434
mutation O 0 0.2854829430580139
may O 0 0.01436846423894167
partially O 0 0.027362802997231483
predict O 0 0.021266994997859
specific O 0 0.019292084500193596
phenotypic O 0 0.044979486614465714
expression O 0 0.040574535727500916
. O 0 0.0453464575111866

This O 0 0.02424735762178898
should O 0 0.014157376252114773
help O 0 0.013826643116772175
in O 0 0.00900459848344326
the O 0 0.008471678011119366
design O 0 0.012281324714422226
of O 0 0.010163160972297192
tailored O 1 0.9865270256996155
clinical O 1 0.9998189806938171
- O 1 0.9971429705619812
management O 1 0.7011480331420898
protocols O 0 0.210143581032753
in O 0 0.00933872815221548
this O 0 0.010456318967044353
subset O 0 0.030977850779891014
of O 0 0.13841384649276733
FAP B-Disease 1 0.9999991655349731
patients O 1 0.9988499879837036
. O 0 0.032824013382196426
. O 0 0.04780285060405731

Wilms B-Disease 1 0.999958872795105
' I-Disease 1 0.6788203716278076
tumor I-Disease 1 0.996505618095398
1 O 0 0.036832358688116074
and O 0 0.026705773547291756
Dax O 1 0.9984266757965088
- O 0 0.24026161432266235
1 O 0 0.02283567190170288
modulate O 0 0.03221656009554863
the O 0 0.017586255446076393
orphan O 1 0.6492449641227722
nuclear O 0 0.028552822768688202
receptor O 0 0.05518273636698723
SF O 1 0.998933732509613
- O 0 0.10853657871484756
1 O 0 0.017602724954485893
in O 0 0.012816403992474079
sex O 0 0.016210908070206642
- O 0 0.04385651275515556
specific O 0 0.016172032803297043
gene O 0 0.02244418114423752
expression O 0 0.031609561294317245
. O 0 0.0420072078704834

Products O 0 0.04653199762105942
of O 0 0.03358045220375061
steroidogenic O 1 0.9977253079414368
factor O 0 0.038092758506536484
1 O 0 0.021925991401076317
( O 0 0.01744561269879341
SF O 1 0.9976173043251038
- O 0 0.06331276148557663
1 O 0 0.0168283861130476
) O 0 0.011850925162434578
and O 0 0.015706731006503105
Wilms B-Disease 1 0.9999909400939941
tumor I-Disease 1 0.9994392991065979
1 O 0 0.09135803580284119
( O 0 0.024657582864165306
WT1 O 1 0.9975985884666443
) O 0 0.012147489003837109
genes O 0 0.010467613115906715
are O 0 0.006758493836969137
essential O 0 0.010941066779196262
for O 0 0.010985907167196274
mammalian O 0 0.02516951411962509
gonadogenesis O 1 0.5796490907669067
prior O 0 0.018169360235333443
to O 0 0.019853556528687477
sexual O 0 0.03515831008553505
differentiation O 0 0.203900545835495
. O 0 0.044745899736881256

In O 0 0.034843865782022476
males O 0 0.030822236090898514
, O 0 0.023667313158512115
SF O 1 0.9998517036437988
- O 1 0.7029345631599426
1 O 0 0.02143619954586029
participates O 0 0.02073899656534195
in O 0 0.00979892909526825
sexual O 0 0.010607841424643993
development O 0 0.009981761686503887
by O 0 0.007786653935909271
regulating O 0 0.013448826037347317
expression O 0 0.012247410602867603
of O 0 0.012032095342874527
the O 0 0.025638824328780174
polypeptide O 1 0.9984889030456543
hormone O 1 0.9995941519737244
Mullerian O 1 0.9999946355819702
inhibiting O 1 0.9989713430404663
substance O 1 0.9946002960205078
( O 1 0.6453518867492676
MIS O 1 0.9996943473815918
) O 0 0.040174126625061035
. O 0 0.04666547849774361

Here O 0 0.0352473258972168
, O 0 0.021807247772812843
we O 0 0.015815183520317078
show O 0 0.016525810584425926
that O 0 0.014289172366261482
WT1 O 1 0.9940326809883118
- O 1 0.724977433681488
KTS O 1 0.9975104331970215
isoforms O 0 0.024716509506106377
associate O 0 0.023649096488952637
and O 0 0.015278193168342113
synergize O 1 0.8835467100143433
with O 0 0.020277488976716995
SF O 1 0.9999815225601196
- O 1 0.758303701877594
1 O 0 0.023012084886431694
to O 0 0.01920395903289318
promote O 0 0.03942803665995598
MIS O 1 0.9900462031364441
expression O 0 0.04664541780948639
. O 0 0.051056426018476486

In O 0 0.03393866494297981
contrast O 0 0.039106763899326324
, O 0 0.028108129277825356
WT1 O 1 0.9992934465408325
missense O 0 0.48751693964004517
mutations O 0 0.021425100043416023
, O 0 0.012233425863087177
associated O 0 0.009638429619371891
with O 0 0.008284770883619785
male B-Disease 0 0.056619737297296524
pseudohermaphroditism I-Disease 1 0.9995974898338318
in O 0 0.21730707585811615
Denys B-Disease 1 0.9999979734420776
- I-Disease 1 0.9999963045120239
Drash I-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999998807907104
, O 0 0.10115448385477066
fail O 0 0.2135547548532486
to O 0 0.01798715628683567
synergize O 1 0.9961109757423401
with O 0 0.07987874001264572
SF O 1 0.9999951124191284
- O 1 0.9832825064659119
1 O 0 0.057151127606630325
. O 0 0.05728698894381523

Additionally O 0 0.043918218463659286
, O 0 0.022026706486940384
the O 0 0.018288034945726395
X O 0 0.29462936520576477
- O 0 0.09793075919151306
linked O 0 0.017416566610336304
, O 0 0.012057425454258919
candidate O 0 0.01751917600631714
dosage O 1 0.8382037281990051
- O 0 0.28620630502700806
sensitive O 0 0.018390053883194923
sex O 0 0.014523439109325409
- O 0 0.07949001342058182
reversal O 0 0.028726069256663322
gene O 0 0.01182838249951601
, O 0 0.012815102934837341
Dax O 1 0.9796541333198547
- O 0 0.02410772070288658
1 O 0 0.013315095566213131
, O 0 0.011784426867961884
antagonizes O 0 0.0928465723991394
synergy O 0 0.06107332929968834
between O 0 0.01345880702137947
SF O 1 0.9999078512191772
- O 1 0.6957955360412598
1 O 0 0.018622172996401787
and O 0 0.013118505477905273
WT1 O 1 0.9949265718460083
, O 0 0.00998126994818449
most O 0 0.008399436250329018
likely O 0 0.0073466855101287365
through O 0 0.00638074055314064
a O 0 0.008091682568192482
direct O 0 0.009682489559054375
interaction O 0 0.012947903014719486
with O 0 0.014710883609950542
SF O 1 0.9999673366546631
- O 1 0.9051586985588074
1 O 0 0.03871681168675423
. O 0 0.04119766876101494

We O 0 0.04203101247549057
propose O 0 0.044088467955589294
that O 0 0.020744629204273224
WT1 O 1 0.989697277545929
and O 0 0.036030955612659454
Dax O 1 0.999902606010437
- O 1 0.7219665050506592
1 O 0 0.022374534979462624
functionally O 0 0.027835983783006668
oppose O 0 0.016338879242539406
each O 0 0.009240309707820415
other O 0 0.008113361895084381
in O 0 0.009991948492825031
testis O 0 0.19166812300682068
development O 0 0.014584763906896114
by O 0 0.013974093832075596
modulating O 1 0.9954841136932373
SF O 1 0.9999918937683105
- O 1 0.9903010129928589
1 O 0 0.07702542841434479
- O 0 0.48027288913726807
mediated O 0 0.19111904501914978
transactivation O 1 0.8642318844795227
. O 0 0.038967765867710114
. O 0 0.052033521234989166

A O 0 0.04877839609980583
mouse O 0 0.054505251348018646
model O 0 0.03630645200610161
for O 0 0.11761434376239777
Prader B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9999997615814209
- O 1 0.9999967813491821
centre O 1 0.9998503923416138
mutations O 1 0.9007394313812256
. O 0 0.05621853098273277

Imprinting O 0 0.09850547462701797
in O 0 0.029581405222415924
the O 0 0.024044835940003395
15q11 O 1 0.9465304613113403
- O 1 0.7099051475524902
q13 O 0 0.4656692147254944
region O 0 0.014580105431377888
involves O 0 0.014187470078468323
an O 0 0.01094870176166296
imprinting O 1 0.9906170964241028
centre O 1 0.9675870537757874
( O 0 0.43674537539482117
IC O 1 0.9997746348381042
) O 0 0.009891747497022152
, O 0 0.008776046335697174
mapping O 0 0.011158362962305546
in O 0 0.0072512696497142315
part O 0 0.008603907190263271
to O 0 0.008509935811161995
the O 0 0.010329010896384716
promoter O 0 0.061460625380277634
and O 0 0.014174750074744225
first O 0 0.020365238189697266
exon O 0 0.11797746270895004
of O 0 0.030838320031762123
SNRPN O 1 0.9954734444618225
. O 0 0.053414035588502884

Deletion O 0 0.06830798834562302
of O 0 0.02874121442437172
this O 0 0.01929348334670067
IC O 1 0.996648371219635
abolishes O 1 0.9379065632820129
local O 0 0.01712307520210743
paternally O 0 0.38859155774116516
derived O 0 0.01156435627490282
gene O 0 0.009288446977734566
expression O 0 0.00935901515185833
and O 0 0.007206371985375881
results O 0 0.01095400657504797
in O 0 0.4266786575317383
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999916553497314
PWS B-Disease 1 1.0
) O 0 0.3850378692150116
. O 0 0.05734303221106529

We O 0 0.028552772477269173
have O 0 0.0155293894931674
created O 0 0.016176555305719376
two O 0 0.01078498549759388
deletion O 0 0.10247930884361267
mutations O 0 0.013133539818227291
in O 0 0.008629516698420048
mice O 0 0.0168249923735857
to O 0 0.00989205576479435
understand O 0 0.03614437207579613
PWS B-Disease 1 0.9999954700469971
and O 0 0.01250819768756628
the O 0 0.012457775883376598
mechanism O 0 0.02193598635494709
of O 0 0.016468646004796028
this O 0 0.02320597879588604
IC O 1 0.9993947744369507
. O 0 0.0494035966694355

Mice O 0 0.1560920923948288
harbouring O 1 0.8890453577041626
an O 0 0.030941054224967957
intragenic O 1 0.9953521490097046
deletion O 1 0.7625010013580322
in O 0 0.020451217889785767
Snrpn O 1 0.9982250332832336
are O 0 0.010694705881178379
phenotypically O 1 0.9162284135818481
normal O 0 0.010962311178445816
, O 0 0.009702143259346485
suggesting O 0 0.010754488408565521
that O 0 0.00785965844988823
mutations O 0 0.01062412466853857
of O 0 0.009650207124650478
SNRPN O 1 0.9652989506721497
are O 0 0.007653848733752966
not O 0 0.00963406078517437
sufficient O 0 0.01747652143239975
to O 0 0.021079499274492264
induce O 1 0.907767117023468
PWS B-Disease 1 0.9999802112579346
. O 0 0.05879804491996765

Mice O 0 0.047443270683288574
with O 0 0.017291098833084106
a O 0 0.015395973809063435
larger O 0 0.015239101834595203
deletion O 0 0.02778851054608822
involving O 0 0.011931346729397774
both O 0 0.009026649408042431
Snrpn O 1 0.8624997735023499
and O 0 0.010488748550415039
the O 0 0.049642108380794525
putative O 1 0.9999511241912842
PWS O 1 1.0
- O 1 0.9998804330825806
IC O 1 0.9998908042907715
lack O 0 0.021433379501104355
expression O 0 0.012264342047274113
of O 0 0.009945318102836609
the O 0 0.013053338043391705
imprinted O 1 0.9689027667045593
genes O 0 0.01646619848906994
Zfp127 O 1 0.8888465166091919
( O 0 0.013572397641837597
mouse O 0 0.021981412544846535
homologue O 0 0.040761806070804596
of O 0 0.013105339370667934
ZNF127 O 1 0.998506486415863
) O 0 0.014469853602349758
, O 0 0.014583180658519268
Ndn O 1 0.9992504715919495
and O 0 0.013985217548906803
Ipw O 1 0.9846232533454895
, O 0 0.012404592707753181
and O 0 0.010992913506925106
manifest O 0 0.04700224846601486
several O 0 0.013841774314641953
phenotypes O 1 0.7678435444831848
common O 0 0.10147395730018616
to O 0 0.09810180962085724
PWS B-Disease 1 0.9999996423721313
infants O 1 0.9997307658195496
. O 0 0.06026167422533035

These O 0 0.02195916883647442
data O 0 0.015903785824775696
demonstrate O 0 0.01453847624361515
that O 0 0.006943713407963514
both O 0 0.005713584832847118
the O 0 0.005630203988403082
position O 0 0.007230421993881464
of O 0 0.006848098710179329
the O 0 0.0125742107629776
IC O 1 0.9997792840003967
and O 0 0.007474526297301054
its O 0 0.006649378687143326
role O 0 0.007277765776962042
in O 0 0.0057314797304570675
the O 0 0.0060840933583676815
coordinate O 0 0.008968960493803024
expression O 0 0.006691183429211378
of O 0 0.00607638992369175
genes O 0 0.0059873065911233425
is O 0 0.005232025403529406
conserved O 0 0.007955726236104965
between O 0 0.005820803809911013
mouse O 0 0.013176258653402328
and O 0 0.006128398235887289
human O 0 0.005622309632599354
, O 0 0.005432154517620802
and O 0 0.004864960443228483
indicate O 0 0.00523386150598526
that O 0 0.00425183679908514
the O 0 0.005776539444923401
mouse O 0 0.013523188419640064
is O 0 0.005510434508323669
a O 0 0.006190566346049309
suitable O 0 0.008192457258701324
model O 0 0.007272802758961916
system O 0 0.005841743666678667
in O 0 0.005006104242056608
which O 0 0.004226584918797016
to O 0 0.005224084481596947
investigate O 0 0.008037942461669445
the O 0 0.006940754596143961
molecular O 0 0.009431106969714165
mechanisms O 0 0.008377046324312687
of O 0 0.008056273683905602
imprinting O 0 0.15250545740127563
in O 0 0.008268939331173897
this O 0 0.007164246402680874
region O 0 0.010529771447181702
of O 0 0.010888745076954365
the O 0 0.015242364257574081
genome O 0 0.03853777423501015
. O 0 0.023621806874871254
. O 0 0.03623998910188675

Mutations O 0 0.038026291877031326
of O 0 0.019710585474967957
the O 0 0.015756407752633095
ATM O 0 0.0751015767455101
gene O 0 0.014110738411545753
detected O 0 0.01304193027317524
in O 0 0.011344913393259048
Japanese O 1 0.9891959428787231
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
telangiectasia I-Disease 1 1.0
patients O 1 0.9995546936988831
: O 0 0.0144493468105793
possible O 0 0.014132993295788765
preponderance O 0 0.33971118927001953
of O 0 0.010707072913646698
the O 0 0.011755796149373055
two O 0 0.013676716946065426
founder O 1 0.9722805619239807
mutations O 0 0.09707920998334885
4612del165 O 1 0.9389976859092712
and O 0 0.03450380265712738
7883del5 O 1 0.8448018431663513
. O 0 0.05888121575117111

The O 0 0.033959683030843735
ATM O 0 0.31987982988357544
( O 0 0.021339235827326775
A O 1 0.9034834504127502
- O 1 0.9996960163116455
T O 1 0.9999665021896362
, O 0 0.01901194266974926
mutated O 0 0.24738937616348267
) O 0 0.011502020061016083
gene O 0 0.01219856645911932
on O 0 0.014756200835108757
human O 0 0.022065145894885063
chromosome O 0 0.06781264394521713
11q22 O 1 0.6390125751495361
. O 0 0.05124787986278534

3 O 0 0.035768695175647736
has O 0 0.019258039072155952
recently O 0 0.01669720932841301
been O 0 0.009519156999886036
identified O 0 0.007691366132348776
as O 0 0.006012095604091883
the O 0 0.005574855953454971
gene O 0 0.006104108411818743
responsible O 0 0.006125506944954395
for O 0 0.005283268168568611
the O 0 0.00838971883058548
human O 1 0.8777247667312622
recessive B-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9997535347938538
A B-Disease 1 0.9999939203262329
- I-Disease 1 0.9999961853027344
T I-Disease 1 0.9999926090240479
) O 0 0.03878844156861305
. O 0 0.04421736299991608

In O 0 0.025382012128829956
order O 0 0.016438281163573265
to O 0 0.010844840668141842
define O 0 0.012595351785421371
the O 0 0.008329383097589016
types O 0 0.009158408269286156
of O 0 0.12032076716423035
disease O 1 0.9999971389770508
- O 1 0.9993225336074829
causing O 1 0.9942008256912231
ATM O 1 0.9571598172187805
mutations O 0 0.009713951498270035
in O 0 0.006686523091048002
Japanese O 0 0.2933943569660187
A B-Disease 1 0.9978320002555847
- I-Disease 1 0.9999939203262329
T I-Disease 1 0.9999984502792358
patients O 1 0.9667760133743286
as O 0 0.00661103893071413
well O 0 0.005987573880702257
as O 0 0.006220817565917969
to O 0 0.006064654793590307
look O 0 0.008804980665445328
for O 0 0.0068323006853461266
possible O 0 0.009825151413679123
mutational O 1 0.6473595499992371
hotspots O 0 0.36708298325538635
, O 0 0.01040303148329258
reverse O 0 0.015191173180937767
- O 0 0.022196663543581963
transcribed O 0 0.014029551297426224
RNA O 0 0.012814070098102093
derived O 0 0.008235237561166286
from O 0 0.005907640792429447
ten O 0 0.009660543873906136
patients O 0 0.009756796061992645
belonging O 0 0.008237242698669434
to O 0 0.0056151882745325565
eight O 0 0.007066608406603336
unrelated O 0 0.010721387341618538
Japanese O 0 0.23056915402412415
A B-Disease 1 0.9917818307876587
- I-Disease 1 0.9997511506080627
T I-Disease 1 0.9992324113845825
families O 0 0.010771466419100761
was O 0 0.009799132123589516
analyzed O 0 0.012117240577936172
for O 0 0.009528577327728271
mutations O 0 0.011551695875823498
by O 0 0.008561676368117332
the O 0 0.013138187117874622
restriction O 0 0.027883779257535934
endonuclease O 1 0.6794129014015198
fingerprinting O 0 0.0590975359082222
method O 0 0.048217419534921646
. O 0 0.05152296647429466

As O 0 0.02347330003976822
has O 0 0.016694899648427963
been O 0 0.010430130176246166
reported O 0 0.009763413108885288
by O 0 0.006106087006628513
others O 0 0.007421558722853661
, O 0 0.007396380417048931
mutations O 0 0.007056123111397028
that O 0 0.004494170658290386
lead O 0 0.007497284561395645
to O 0 0.00774198304861784
exon O 0 0.1209239810705185
skipping O 0 0.05000842735171318
or O 0 0.010174544528126717
premature O 0 0.12425157427787781
protein O 0 0.011172788217663765
truncation O 0 0.0673515573143959
were O 0 0.009089871309697628
also O 0 0.011711693368852139
predominant O 0 0.01926490291953087
in O 0 0.014282885938882828
our O 0 0.024489883333444595
mutants O 0 0.07307174801826477
. O 0 0.04484933614730835

Six O 0 0.03415853530168533
different O 0 0.01614142581820488
mutations O 0 0.01455388218164444
were O 0 0.009266918525099754
identified O 0 0.00956917367875576
on O 0 0.008981455117464066
12 O 0 0.012199348770081997
of O 0 0.01130863931030035
the O 0 0.01470271311700344
16 O 0 0.02803800068795681
alleles O 0 0.03642747551202774
examined O 0 0.047285936772823334
. O 0 0.04213439300656319

Four O 0 0.03836536779999733
were O 0 0.024083279073238373
deletions O 0 0.0345420278608799
involving O 0 0.019138075411319733
a O 0 0.015848135575652122
loss O 0 0.048706941306591034
of O 0 0.013025968335568905
a O 0 0.015724316239356995
single O 0 0.022728288546204567
exon O 0 0.20795319974422455
exon O 0 0.05356656014919281
7 O 0 0.023416120558977127
, O 0 0.019545311108231544
exon O 0 0.03542449325323105
16 O 0 0.023864706978201866
, O 0 0.02112509496510029
exon O 0 0.047747157514095306
33 O 0 0.038024816662073135
or O 0 0.030551569536328316
exon O 0 0.07460985332727432
35 O 0 0.0644708052277565
. O 0 0.0597093440592289

The O 0 0.03813226521015167
others O 0 0.02866891771554947
were O 0 0.019889621064066887
minute O 0 0.03020865097641945
deletions O 0 0.03605451434850693
, O 0 0.01956259272992611
4649delA O 0 0.04524469003081322
in O 0 0.018244197592139244
exon O 0 0.04959632828831673
33 O 0 0.029342282563447952
and O 0 0.023353196680545807
7883del5 O 0 0.06373576074838638
in O 0 0.03073480911552906
exon O 0 0.08470567315816879
55 O 0 0.0641646608710289
. O 0 0.06201530247926712

The O 0 0.04589194804430008
mutations O 0 0.04366244003176689
4612del165 O 0 0.40089893341064453
and O 0 0.019500281661748886
7883del5 O 0 0.22352325916290283
were O 0 0.009888246655464172
found O 0 0.0074091418646276
in O 0 0.0062197474762797356
more O 0 0.005397241096943617
than O 0 0.005343134049326181
two O 0 0.005031165666878223
unrelated O 0 0.008336113765835762
families O 0 0.005550403613597155
; O 0 0.006409166380763054
44 O 0 0.009053128771483898
% O 0 0.0063439784571528435
( O 0 0.006219129078090191
7 O 0 0.007965664379298687
of O 0 0.005896152928471565
16 O 0 0.0077767157927155495
) O 0 0.006769753992557526
of O 0 0.006088453810662031
the O 0 0.00818984117358923
mutant O 0 0.020218368619680405
alleles O 0 0.01152037177234888
had O 0 0.008110111579298973
one O 0 0.007695937994867563
of O 0 0.008555813692510128
the O 0 0.011316591873764992
two O 0 0.01383593026548624
mutations O 0 0.029073374345898628
. O 0 0.03207961469888687

The O 0 0.042039770632982254
4612del165 O 0 0.29697179794311523
mutations O 0 0.02162931300699711
in O 0 0.010813846252858639
three O 0 0.009032145142555237
different O 0 0.006230246275663376
families O 0 0.0061026704497635365
were O 0 0.004886022303253412
all O 0 0.005605319049209356
ascribed O 0 0.009901812300086021
to O 0 0.006209223065525293
the O 0 0.00705372542142868
same O 0 0.008475434966385365
T O 1 0.9953916072845459
- O 0 0.34525951743125916
- O 0 0.11466317623853683
> O 0 0.02310243248939514
A O 0 0.012386538088321686
substitution O 0 0.012546049430966377
at O 0 0.00997187476605177
the O 0 0.011552181094884872
splice O 0 0.02850668504834175
donor O 0 0.018828848376870155
site O 0 0.022830002009868622
in O 0 0.020444665104150772
intron O 1 0.812537431716919
33 O 0 0.053364675492048264
. O 0 0.051356565207242966

Microsatellite O 1 0.8878058195114136
genotyping O 0 0.21470119059085846
around O 0 0.02768584154546261
the O 0 0.02085631713271141
ATM O 1 0.7437517642974854
locus O 0 0.271914005279541
also O 0 0.012311317026615143
indicated O 0 0.01047373004257679
that O 0 0.006642748136073351
a O 0 0.008268887177109718
common O 0 0.009075860492885113
haplotype O 0 0.12858383357524872
was O 0 0.012762864120304585
shared O 0 0.011501072905957699
by O 0 0.007964182645082474
the O 0 0.010915915481746197
mutant O 0 0.2454613596200943
alleles O 0 0.023374149575829506
in O 0 0.014966925606131554
both O 0 0.019605927169322968
mutations O 0 0.03433646634221077
. O 0 0.03708402067422867

This O 0 0.02577534131705761
suggests O 0 0.02180323749780655
that O 0 0.010588336735963821
these O 0 0.007480889093130827
two O 0 0.008298435248434544
founder O 1 0.9290292263031006
mutations O 0 0.024682659655809402
may O 0 0.010211357846856117
be O 0 0.009324625134468079
predominant O 0 0.019937807694077492
among O 0 0.016335438936948776
Japanese O 0 0.1518225520849228
ATM O 1 0.7686189413070679
mutant O 0 0.261773943901062
alleles O 0 0.06555993109941483
. O 0 0.05299881845712662

W474C O 1 0.6325092315673828
amino O 0 0.05030978098511696
acid O 0 0.04409612715244293
substitution O 0 0.028303975239396095
affects O 0 0.020187489688396454
early O 0 0.011132701300084591
processing O 0 0.010779257863759995
of O 0 0.008307776413857937
the O 0 0.008078019134700298
alpha O 0 0.01603703945875168
- O 0 0.014099838212132454
subunit O 0 0.014672697521746159
of O 0 0.009166785515844822
beta O 0 0.025874191895127296
- O 0 0.12025870382785797
hexosaminidase O 0 0.3427896499633789
A O 0 0.01253738533705473
and O 0 0.008441370911896229
is O 0 0.007994228042662144
associated O 0 0.010588926263153553
with O 0 0.06617522239685059
subacute O 1 1.0
G B-Disease 1 0.9999865293502808
( I-Disease 1 0.9734525680541992
M2 I-Disease 1 0.998695433139801
) I-Disease 0 0.04110940918326378
gangliosidosis I-Disease 0 0.3060135245323181
. O 0 0.05803505703806877

Mutations O 0 0.04522736743092537
in O 0 0.024225963279604912
the O 0 0.023188553750514984
HEXA O 1 0.9986364245414734
gene O 0 0.01779322698712349
, O 0 0.011706803925335407
encoding O 0 0.013505936600267887
the O 0 0.011348861269652843
alpha O 0 0.01789088174700737
- O 0 0.016387615352869034
subunit O 0 0.017341535538434982
of O 0 0.011394277215003967
beta O 0 0.02139066718518734
- O 0 0.06086749583482742
hexosaminidase O 0 0.38296109437942505
A O 0 0.018008962273597717
( O 0 0.013103857636451721
Hex O 0 0.029708465561270714
A O 0 0.014623349532485008
) O 0 0.009846792556345463
, O 0 0.009222998283803463
that O 0 0.0077072312124073505
abolish O 0 0.01924222707748413
Hex O 0 0.024270357564091682
A O 0 0.01404112484306097
enzyme O 0 0.013715395703911781
activity O 0 0.011005019769072533
cause O 1 0.9723666310310364
Tay B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999979734420776
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999998807907104
( O 1 0.9934066534042358
TSD B-Disease 1 0.9999986886978149
) O 0 0.011897278018295765
, O 0 0.009180890396237373
the O 0 0.009935437701642513
fatal O 1 0.9893527030944824
infantile B-Disease 1 0.9997602105140686
form I-Disease 0 0.03725045919418335
of I-Disease 0 0.37402674555778503
G I-Disease 1 0.999782145023346
( I-Disease 1 0.6382476687431335
M2 I-Disease 1 0.9976242184638977
) I-Disease 0 0.01873127743601799
gangliosidosis I-Disease 0 0.3502363860607147
, I-Disease 0 0.022769248113036156
Type I-Disease 0 0.0322318896651268
1 I-Disease 0 0.04109835997223854
. O 0 0.04920974746346474

Less O 0 0.04604761675000191
severe O 1 0.999218225479126
, O 0 0.4342643916606903
subacute O 1 0.9999995231628418
( O 1 0.9731342792510986
juvenile O 1 0.9999804496765137
- O 1 0.9999839067459106
onset O 1 0.9999995231628418
) O 1 0.5148901343345642
and O 1 0.8220348358154297
chronic O 1 1.0
( O 1 0.9652467370033264
adult O 1 0.9976535439491272
- O 1 0.9999803304672241
onset O 1 0.9999988079071045
) O 0 0.03613961115479469
variants O 0 0.012912861071527004
are O 0 0.004778094124048948
characterized O 0 0.00775347463786602
by O 0 0.004482603631913662
a O 0 0.0058939289301633835
broad O 0 0.01862756349146366
spectrum O 0 0.12911641597747803
of O 0 0.1508319228887558
clinical O 1 0.9999667406082153
manifestations O 1 0.9999256134033203
and O 0 0.10456988960504532
are O 0 0.005034542176872492
associated O 0 0.006948817986994982
with O 0 0.007762666326016188
residual O 1 0.9407601952552795
levels O 0 0.013638977892696857
of O 0 0.01670907437801361
Hex O 1 0.8065165877342224
A O 0 0.1344272643327713
enzyme O 0 0.03707112744450569
activity O 0 0.033210452646017075
. O 0 0.04402422904968262

We O 0 0.0318753607571125
identified O 0 0.026186468079686165
a O 0 0.02387893572449684
1422 O 1 0.998043417930603
G O 1 0.939185619354248
- O 1 0.9386419057846069
- O 1 0.941908061504364
> O 1 0.9264011979103088
C O 0 0.20297856628894806
( O 0 0.01569906622171402
amino O 0 0.017506692558526993
acid O 0 0.020949585363268852
W474C O 0 0.03135531395673752
) O 0 0.011460031382739544
substitution O 0 0.013742100447416306
in O 0 0.008531293831765652
the O 0 0.008357868529856205
first O 0 0.009155168198049068
position O 0 0.011788497678935528
of O 0 0.01025351695716381
exon O 0 0.02040066011250019
13 O 0 0.012133467942476273
of O 0 0.010472998023033142
HEXA O 1 0.9869918823242188
of O 0 0.010118206962943077
a O 0 0.012534093111753464
non O 0 0.0318438857793808
- O 1 0.6501611471176147
Jewish O 0 0.02031587064266205
proband O 1 0.9676558971405029
who O 0 0.023360492661595345
manifested O 1 0.8656063079833984
a O 0 0.18787160515785217
subacute O 1 0.9999994039535522
variant O 1 0.997066080570221
of O 1 0.9475439786911011
G B-Disease 1 0.9999653100967407
( I-Disease 1 0.9236326217651367
M2 I-Disease 1 0.999539852142334
) I-Disease 0 0.04227062314748764
gangliosidosis I-Disease 0 0.370448499917984
. O 0 0.06316781789064407

On O 0 0.032100215554237366
the O 0 0.025666579604148865
second O 0 0.0978153720498085
maternally O 1 0.997452437877655
inherited O 1 0.9993391633033752
allele O 0 0.10449623316526413
, O 0 0.01035425066947937
we O 0 0.007808202411979437
identified O 0 0.008413813076913357
the O 0 0.010178737342357635
common O 1 0.7950901389122009
infantile O 1 1.0
disease O 1 0.9999998807907104
- O 1 0.9999622106552124
causing O 1 0.9981387853622437
4 O 0 0.42628633975982666
- O 1 0.6922468543052673
bp O 0 0.16531401872634888
insertion O 0 0.32828032970428467
, O 0 0.022427290678024292
+ O 0 0.10154624283313751
TATC O 1 0.9409185647964478
1278 O 1 0.9625959396362305
, O 0 0.028637126088142395
in O 0 0.02806028537452221
exon O 0 0.06961715966463089
11 O 0 0.04921611025929451
. O 0 0.05479228496551514

Pulse O 0 0.3770464062690735
- O 0 0.056507036089897156
chase O 0 0.03583981469273567
analysis O 0 0.020214656367897987
using O 0 0.017079666256904602
proband O 1 0.7885235548019409
fibroblasts O 0 0.09338800609111786
revealed O 0 0.016523951664566994
that O 0 0.008527647703886032
the O 0 0.009613250382244587
W474C O 0 0.19435682892799377
- O 0 0.026920445263385773
containing O 0 0.013323216699063778
alpha O 0 0.02152981422841549
- O 0 0.029270315542817116
subunit O 0 0.019338825717568398
precursor O 0 0.017363131046295166
was O 0 0.011325142346322536
normally O 0 0.010072022676467896
synthesized O 0 0.011699468828737736
, O 0 0.006967670749872923
but O 0 0.005792760755866766
not O 0 0.006464267615228891
phosphorylated O 0 0.015597714111208916
or O 0 0.007921609096229076
secreted O 0 0.014554416760802269
, O 0 0.009495574980974197
and O 0 0.009364521130919456
the O 0 0.011911755427718163
mature O 0 0.10492026805877686
lysosomal O 1 0.999018669128418
alpha O 0 0.3770595192909241
- O 1 0.5248838663101196
subunit O 0 0.039160456508398056
was O 0 0.025047948583960533
not O 0 0.0229610837996006
detected O 0 0.04221421480178833
. O 0 0.04910198599100113

When O 0 0.04235963523387909
the O 0 0.02761826291680336
W474C O 0 0.11523013561964035
- O 0 0.038145747035741806
containing O 0 0.019217656925320625
alpha O 0 0.030124923214316368
- O 0 0.06656325608491898
subunit O 0 0.023923510685563087
was O 0 0.017806407064199448
transiently O 1 0.5904801487922668
co O 0 0.06663597375154495
- O 0 0.015645131468772888
expressed O 0 0.009508904069662094
with O 0 0.007331178057938814
the O 0 0.008370679803192616
beta O 0 0.026094110682606697
- O 0 0.017910422757267952
subunit O 0 0.01416128408163786
to O 0 0.008107983507215977
produce O 0 0.009671092964708805
Hex O 0 0.02016296610236168
A O 0 0.01186589989811182
( O 0 0.010986994951963425
alphabeta O 0 0.04272756353020668
) O 0 0.009380853734910488
in O 0 0.010029982775449753
COS O 1 0.9892772436141968
- O 0 0.06699614226818085
7 O 0 0.012540432624518871
cells O 0 0.009548597037792206
, O 0 0.006976875476539135
the O 0 0.007741506211459637
mature O 0 0.012179058976471424
alpha O 0 0.016247335821390152
- O 0 0.01871844381093979
subunit O 0 0.012944040820002556
was O 0 0.009314890950918198
present O 0 0.007113290950655937
, O 0 0.005755065940320492
but O 0 0.004729502834379673
its O 0 0.005156813655048609
level O 0 0.005516609642654657
was O 0 0.0064872982911765575
much O 0 0.005877656862139702
lower O 0 0.006740767974406481
than O 0 0.00454349210485816
that O 0 0.004610904958099127
from O 0 0.0054360078647732735
normal O 0 0.00812917947769165
alpha O 0 0.014790880493819714
- O 0 0.03246425837278366
subunit O 0 0.018406758084893227
transfections O 0 0.058905959129333496
, O 0 0.009399820119142532
although O 0 0.00804267730563879
higher O 0 0.0074620554223656654
than O 0 0.005876380950212479
in O 0 0.005922876298427582
those O 0 0.007007951848208904
cells O 0 0.009512911550700665
transfected O 0 0.027176719158887863
with O 0 0.008358200080692768
an O 0 0.009638234972953796
alpha O 0 0.07627987861633301
- O 0 0.29035645723342896
subunit O 0 0.036150574684143066
associated O 0 0.02034951187670231
with O 0 0.03078068420290947
infantile O 1 0.9999889135360718
TSD B-Disease 1 0.9999895095825195
. O 0 0.07256979495286942

Furthermore O 0 0.04231489822268486
, O 0 0.02137191779911518
the O 0 0.0133597357198596
precursor O 0 0.016376622021198273
level O 0 0.008900448679924011
of O 0 0.008042803034186363
the O 0 0.009886116720736027
W474C O 1 0.753924548625946
alpha O 0 0.024387961253523827
- O 0 0.030197734013199806
subunit O 0 0.016677454113960266
was O 0 0.010547288693487644
found O 0 0.007280264049768448
to O 0 0.007538491394370794
accumulate O 0 0.011429846286773682
in O 0 0.006826760247349739
comparison O 0 0.008890154771506786
to O 0 0.007355902343988419
the O 0 0.009530512616038322
normal O 0 0.012818172574043274
alpha O 0 0.029370661824941635
- O 0 0.06377670913934708
subunit O 0 0.042842235416173935
precursor O 0 0.046534474939107895
levels O 0 0.03652261570096016
. O 0 0.044380057603120804

We O 0 0.034935299307107925
conclude O 0 0.033155784010887146
that O 0 0.014732087962329388
the O 0 0.01690284162759781
1422 O 1 0.9983760118484497
G O 1 0.9761391282081604
- O 1 0.968930184841156
- O 1 0.9935855269432068
> O 1 0.9891231656074524
C O 1 0.583577573299408
mutation O 0 0.011938105337321758
is O 0 0.00716352416202426
the O 0 0.008170858025550842
cause O 0 0.018266748636960983
of O 0 0.024658573791384697
Hex B-Disease 1 0.9992032647132874
A I-Disease 1 0.9994854927062988
enzyme I-Disease 1 0.9998701810836792
deficiency I-Disease 1 0.9999995231628418
in O 0 0.06416788697242737
the O 0 0.18060217797756195
proband O 1 0.9990131855010986
. O 0 0.044660232961177826

The O 0 0.04254617542028427
resulting O 0 0.03955609351396561
W474C O 0 0.27161267399787903
substitution O 0 0.030139660462737083
clearly O 0 0.020422276109457016
interferes O 0 0.030069682747125626
with O 0 0.011491280980408192
alpha O 0 0.0351022332906723
- O 0 0.1063116192817688
subunit O 0 0.018025439232587814
processing O 0 0.011800035834312439
, O 0 0.007749873213469982
but O 0 0.006399971898645163
because O 0 0.006196462549269199
the O 0 0.006125233601778746
base O 0 0.01207803189754486
substitution O 0 0.01281811948865652
falls O 0 0.014397422783076763
at O 0 0.00880433153361082
the O 0 0.007384168915450573
first O 0 0.007664859294891357
position O 0 0.009074706584215164
of O 0 0.007432216312736273
exon O 0 0.02836318127810955
13 O 0 0.011053390800952911
, O 0 0.009433366358280182
aberrant O 0 0.02175189182162285
splicing O 0 0.013118268921971321
may O 0 0.00757856760174036
also O 0 0.006916743703186512
contribute O 0 0.009498207829892635
to O 0 0.009244740009307861
Hex B-Disease 1 0.5021291375160217
A I-Disease 1 0.75786292552948
deficiency I-Disease 1 0.9999980926513672
in O 0 0.019617699086666107
this O 0 0.017892751842737198
proband O 1 0.9959923624992371
. O 0 0.02881750464439392
. O 0 0.04285838454961777

Two O 0 0.04267598316073418
frequent O 0 0.05997934564948082
missense O 1 0.7951582670211792
mutations O 1 0.6828605532646179
in O 1 0.8122386336326599
Pendred B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
. O 1 0.9400304555892944

Pendred B-Disease 1 0.9999986886978149
syndrome I-Disease 1 1.0
is O 1 0.995152473449707
an O 1 0.9999707937240601
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999991655349731
by O 1 0.9996346235275269
early O 1 0.9999982118606567
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999896287918091
goiter B-Disease 1 1.0
. O 1 0.9968331456184387

A O 0 0.033472221344709396
century O 0 0.024488205090165138
after O 0 0.014170539565384388
its O 0 0.009978053160011768
recognition O 0 0.012789892964065075
as O 0 0.010716906748712063
a O 1 0.511967122554779
syndrome O 1 0.9999997615814209
by O 0 0.07496020197868347
Vaughan O 1 0.9994773268699646
Pendred O 1 0.9998514652252197
, O 0 0.10751038789749146
the O 0 0.47273924946784973
disease O 1 0.9999978542327881
gene O 1 0.5509932637214661
( O 0 0.3178836703300476
PDS O 1 0.999850869178772
) O 0 0.01319288369268179
was O 0 0.016975145787000656
mapped O 0 0.026015162467956543
to O 0 0.021076101809740067
chromosome O 0 0.039627350866794586
7q22 O 1 0.629749059677124
- O 0 0.3170969486236572
q31 O 0 0.48632562160491943
. O 0 0.059654027223587036

1 O 0 0.03835630789399147
and O 0 0.021434098482131958
, O 0 0.016195500269532204
recently O 0 0.018790461122989655
, O 0 0.012783109210431576
found O 0 0.010219388641417027
to O 0 0.012504063546657562
encode O 0 0.02289756014943123
a O 0 0.024661751464009285
putative O 1 0.920228898525238
sulfate O 1 0.9995619654655457
transporter O 1 0.9878550171852112
. O 0 0.06065851077437401

We O 0 0.0291578471660614
performed O 0 0.02289672940969467
mutation O 0 0.01645217277109623
analysis O 0 0.010926819406449795
of O 0 0.009274960495531559
the O 0 0.012343556620180607
PDS B-Disease 1 0.9999490976333618
gene O 0 0.013373324647545815
in O 0 0.008653704077005386
patients O 0 0.17321127653121948
from O 0 0.0067772227339446545
14 O 0 0.012049112468957901
Pendred B-Disease 1 0.6303671002388
families O 0 0.009263014420866966
originating O 0 0.00984908826649189
from O 0 0.006427466403692961
seven O 0 0.007866554893553257
countries O 0 0.00757258478552103
and O 0 0.00857632514089346
identified O 0 0.012039056979119778
all O 0 0.013961209915578365
mutations O 0 0.029061557725071907
. O 0 0.0331161804497242

The O 0 0.031031513586640358
mutations O 0 0.021585613489151
include O 0 0.013320541009306908
three O 0 0.011438491754233837
single O 0 0.013339820317924023
base O 0 0.018330050632357597
deletions O 0 0.023884892463684082
, O 0 0.01239419262856245
one O 0 0.011088833212852478
splice O 0 0.0317811593413353
site O 0 0.019996538758277893
mutation O 0 0.020213115960359573
and O 0 0.01547105424106121
10 O 0 0.027764450758695602
missense O 0 0.07328302413225174
mutations O 0 0.0427815206348896
. O 0 0.04536447301506996

One O 0 0.03757813572883606
missense O 0 0.26136887073516846
mutation O 0 0.10219703614711761
( O 0 0.023614294826984406
L236P O 1 0.6803894639015198
) O 0 0.011922276578843594
was O 0 0.01113631296902895
found O 0 0.00739568006247282
in O 0 0.0065600210800766945
a O 0 0.00716380262747407
homozygous O 0 0.010211671702563763
state O 0 0.0060300203040242195
in O 0 0.006155111826956272
two O 0 0.006857204716652632
consanguineous O 0 0.33039286732673645
families O 0 0.0067862835712730885
and O 0 0.005677022971212864
in O 0 0.005581902340054512
a O 0 0.007261532824486494
heterozygous O 0 0.009809521026909351
state O 0 0.005902210250496864
in O 0 0.0063889226876199245
five O 0 0.00853045005351305
additional O 0 0.01230568252503872
non O 0 0.027969898656010628
- O 1 0.5718337893486023
consanguineous O 1 0.724661648273468
families O 0 0.03218758478760719
. O 0 0.04539305344223976

Another O 0 0.052415020763874054
missense O 1 0.5532357096672058
mutation O 0 0.19771453738212585
( O 0 0.02401731163263321
T416P O 1 0.7919219732284546
) O 0 0.012479151599109173
was O 0 0.01176441926509142
found O 0 0.007194816134870052
in O 0 0.0067533706314861774
a O 0 0.007892327383160591
homozygous O 0 0.009872348047792912
state O 0 0.006247807294130325
in O 0 0.006815515458583832
one O 0 0.0074296984821558
family O 0 0.008888083510100842
and O 0 0.006235258653759956
in O 0 0.006856289226561785
a O 0 0.008984818123281002
heterozygous O 0 0.01521316822618246
state O 0 0.009621486067771912
in O 0 0.011587357148528099
four O 0 0.017174800857901573
families O 0 0.025741765275597572
. O 0 0.03710731118917465

Pendred B-Disease 1 0.9899002909660339
patients O 0 0.2508430480957031
in O 0 0.013082219287753105
three O 0 0.013731726445257664
non O 0 0.1784839630126953
- O 1 0.9760478138923645
consanguineous O 1 0.985270619392395
families O 0 0.011165662668645382
were O 0 0.0070859831757843494
shown O 0 0.00769407395273447
to O 0 0.0074213058687746525
be O 0 0.008398264646530151
compound O 0 0.019402556121349335
heterozygotes O 0 0.4958668351173401
for O 0 0.017835400998592377
L236P O 1 0.8066954612731934
and O 0 0.029700178653001785
T416P O 0 0.4366248548030853
. O 0 0.05723903328180313

In O 0 0.0234870333224535
total O 0 0.017853159457445145
, O 0 0.01155625469982624
one O 0 0.00838780403137207
or O 0 0.005867751780897379
both O 0 0.005412163678556681
of O 0 0.005267047323286533
these O 0 0.0051087443716824055
mutations O 0 0.006462601479142904
were O 0 0.004890257492661476
found O 0 0.005320783704519272
in O 0 0.005601966753602028
nine O 0 0.007758589927107096
of O 0 0.008303361013531685
the O 0 0.01166227925568819
14 O 0 0.02160550281405449
families O 0 0.022880105301737785
analyzed O 0 0.03839567303657532
. O 0 0.040136635303497314

The O 0 0.03165976330637932
identification O 0 0.024770794436335564
of O 0 0.01395347248762846
two O 0 0.011502813547849655
frequent O 1 0.6607574820518494
PDS B-Disease 1 0.999994158744812
mutations O 0 0.0354260578751564
will O 0 0.01070597767829895
facilitate O 0 0.01433806773275137
the O 0 0.012883671559393406
molecular O 0 0.36285725235939026
diagnosis O 1 0.9998536109924316
of O 1 0.9926014542579651
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
. O 1 0.9409814476966858

Insertional O 1 0.9197410941123962
mutation O 0 0.05050259456038475
by O 0 0.024973947554826736
transposable O 1 0.9811015725135803
element O 0 0.11223558336496353
, O 0 0.023771410807967186
L1 O 1 0.990029513835907
, O 0 0.013059779070317745
in O 0 0.010569830425083637
the O 0 0.013243007473647594
DMD B-Disease 1 0.9999810457229614
gene O 0 0.014838777482509613
results O 0 0.012981770560145378
in O 0 0.01499576773494482
X B-Disease 1 0.9957150816917419
- I-Disease 1 0.9993383288383484
linked I-Disease 1 0.9988229870796204
dilated I-Disease 1 0.9999939203262329
cardiomyopathy I-Disease 1 0.9999998807907104
. O 1 0.6099727749824524

X B-Disease 1 0.993703305721283
- I-Disease 1 0.9994391798973083
linked I-Disease 1 0.9997606873512268
dilated I-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 1.0
( O 1 0.9986979961395264
XLDCM B-Disease 1 0.9999827146530151
) O 0 0.016284266486763954
is O 0 0.01070750318467617
a O 0 0.012325722724199295
clinical O 1 0.9871701598167419
phenotype O 1 0.9625430703163147
of O 0 0.15042032301425934
dystrophinopathy B-Disease 1 0.9998540878295898
which O 0 0.008726744912564754
is O 0 0.00861995667219162
characterized O 0 0.23771607875823975
by O 0 0.010918582789599895
preferential O 1 0.9982969164848328
myocardial B-Disease 1 0.9999996423721313
involvement I-Disease 1 0.7567514777183533
without O 0 0.0131645817309618
any O 0 0.01352565735578537
overt O 1 0.940212070941925
clinical O 1 0.9995173215866089
signs O 1 0.9831882119178772
of O 1 0.9723543524742126
skeletal B-Disease 1 0.9999988079071045
myopathy I-Disease 1 0.9999997615814209
. O 1 0.7039167284965515

To O 0 0.026749921962618828
date O 0 0.023088283836841583
, O 0 0.013331186957657337
several O 0 0.010208875872194767
mutations O 0 0.010456981137394905
in O 0 0.00935106910765171
the O 1 0.8694234490394592
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9998373985290527
, O 1 0.9993222951889038
DMD O 1 1.0
, O 0 0.0694325715303421
have O 0 0.005283263046294451
been O 0 0.004904139321297407
identified O 0 0.0066748629324138165
in O 0 0.007011728826910257
patients O 1 0.9617406725883484
with O 0 0.05257965624332428
XLDCM B-Disease 1 0.9998624324798584
, O 0 0.008611639030277729
but O 0 0.005669851321727037
a O 0 0.008095537312328815
pathogenic O 0 0.011262715794146061
correlation O 0 0.00931958295404911
of O 0 0.006347084417939186
these O 0 0.006317249499261379
cardiospecific O 1 0.8065665364265442
mutations O 0 0.012069938704371452
in O 0 0.009894919581711292
DMD O 1 0.9999862909317017
with O 0 0.014210464432835579
the O 0 0.4400053918361664
XLDCM B-Disease 1 0.9999963045120239
phenotype O 1 0.9963920712471008
has O 0 0.03699071332812309
remained O 0 0.041241925209760666
to O 0 0.014299821108579636
be O 0 0.019106335937976837
elucidated O 0 0.20794381201267242
. O 0 0.04262456297874451

We O 0 0.031142765656113625
report O 0 0.02548309788107872
here O 0 0.01849023811519146
the O 0 0.012900954112410545
identification O 0 0.014123203232884407
of O 0 0.009711104445159435
a O 0 0.011646460741758347
unique O 0 0.017042025923728943
de O 0 0.15486279129981995
novo O 1 0.7938470244407654
L1 O 1 0.9630525708198547
insertion O 0 0.02444329857826233
in O 0 0.011015601456165314
the O 0 0.013349883258342743
muscle O 0 0.31107425689697266
exon O 0 0.0777534693479538
1 O 0 0.015743834897875786
in O 0 0.01216037292033434
DMD O 1 0.9998595714569092
in O 0 0.011560535058379173
three O 0 0.012940142303705215
XLDCM B-Disease 1 0.9996644258499146
patients O 1 0.7393585443496704
from O 0 0.010435923002660275
two O 0 0.010662546381354332
unrelated O 0 0.03229639679193497
Japanese O 0 0.09587037563323975
families O 0 0.02993646450340748
. O 0 0.03805474191904068

The O 0 0.03545841947197914
insertion O 0 0.040433119982481
was O 0 0.01941104233264923
a O 0 0.015948865562677383
5 O 0 0.017632534727454185
- O 0 0.02525745891034603
truncated O 0 0.021052563562989235
form O 0 0.010306392796337605
of O 0 0.009696564637124538
human O 0 0.01357880886644125
L1 O 1 0.9984920024871826
inversely O 0 0.024746086448431015
integrated O 0 0.019067196175456047
in O 0 0.009986708872020245
the O 0 0.008801540359854698
5 O 0 0.014399845153093338
- O 0 0.021210703998804092
untranslated O 0 0.052798230201005936
region O 0 0.011389686726033688
in O 0 0.007862485013902187
the O 0 0.009189421311020851
muscle O 1 0.8068615794181824
exon O 1 0.6120002865791321
1 O 0 0.011084917932748795
, O 0 0.006659514736384153
which O 0 0.004943446721881628
affected O 0 0.006564047187566757
the O 0 0.00534087885171175
transcription O 0 0.0079915476962924
or O 0 0.005564621649682522
the O 0 0.005969409830868244
stability O 0 0.0095001719892025
of O 0 0.006474371999502182
the O 0 0.012729118578135967
muscle O 1 0.9776995182037354
form O 0 0.008851106278598309
of O 0 0.01604275591671467
dystrophin O 1 0.9982421398162842
transcripts O 0 0.01166407112032175
but O 0 0.005360473413020372
not O 0 0.004358903970569372
that O 0 0.0036767544224858284
of O 0 0.005216583609580994
the O 0 0.009910468943417072
brain O 1 0.9802362322807312
or O 0 0.05952908471226692
Purkinje O 1 0.9999818801879883
cell O 0 0.26010432839393616
form O 0 0.009789246134459972
, O 0 0.00858667865395546
probably O 0 0.008296002633869648
due O 0 0.00715777138248086
to O 0 0.007785194553434849
its O 0 0.009074118919670582
unique O 0 0.013694049790501595
site O 0 0.01673939637839794
of O 0 0.01588321104645729
integration O 0 0.04446069523692131
. O 0 0.04587176442146301

We O 0 0.032432395964860916
speculate O 0 0.02702159620821476
that O 0 0.011568618938326836
this O 0 0.00851583480834961
insertion O 0 0.014922273345291615
of O 0 0.007896240800619125
an O 0 0.009108156897127628
L1 O 1 0.9962390661239624
sequence O 0 0.010732214897871017
in O 0 0.015167728997766972
DMD O 1 0.9999951124191284
is O 0 0.007823762483894825
responsible O 0 0.007329117506742477
for O 0 0.0055291675962507725
some O 0 0.004720855038613081
of O 0 0.0048729293048381805
the O 0 0.0057013072073459625
population O 0 0.005657327361404896
of O 0 0.009203359484672546
Japanese O 1 0.9095349311828613
patients O 1 0.987098753452301
with O 0 0.028721852228045464
XLDCM B-Disease 1 0.9996131062507629
. O 0 0.028758268803358078
. O 0 0.04013761132955551

Severe O 1 0.9997223019599915
early O 1 0.9319376945495605
- O 1 0.9999982118606567
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999961853027344
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999648332595825
red O 1 0.9999998807907104
hair O 1 0.9999997615814209
pigmentation O 1 0.9999998807907104
caused O 1 0.9999926090240479
by O 1 0.982501208782196
POMC O 1 0.9999998807907104
mutations O 1 0.9660679697990417
in O 0 0.03294353187084198
humans O 0 0.04130719229578972
. O 0 0.04171429201960564

Sequential O 0 0.07937980443239212
cleavage O 0 0.06098014861345291
of O 0 0.022737858816981316
the O 0 0.017775611951947212
precursor O 0 0.026683300733566284
protein O 0 0.018308650702238083
pre O 0 0.056780386716127396
- O 1 0.5784848928451538
pro O 1 0.571021318435669
- O 1 0.9656031727790833
opiomelanocortin O 1 0.9972884654998779
( O 0 0.029127929359674454
POMC O 1 0.989403486251831
) O 0 0.018782980740070343
generates O 0 0.025288881734013557
the O 0 0.016820671036839485
melanocortin O 1 0.9886232018470764
peptides O 0 0.17481489479541779
adrenocorticotrophin O 1 0.9826703667640686
( O 0 0.03914651274681091
ACTH O 1 0.9977311491966248
) O 0 0.01757972314953804
, O 0 0.01992245949804783
melanocyte O 1 0.9997757077217102
- O 1 0.9936580061912537
stimulating O 1 0.9974378347396851
hormones O 1 0.8998855352401733
( O 0 0.06207724288105965
MSH O 1 0.9998798370361328
) O 0 0.01582127995789051
alpha O 0 0.020938212051987648
, O 0 0.012158596888184547
beta O 0 0.016636371612548828
and O 0 0.009220514446496964
gamma O 0 0.01580178551375866
as O 0 0.008113180287182331
well O 0 0.007619810756295919
as O 0 0.00876409187912941
the O 0 0.012377639301121235
opioid O 1 0.9389510154724121
- O 1 0.8921440839767456
receptor O 0 0.07962878048419952
ligand O 0 0.20685164630413055
beta O 0 0.2426481544971466
- O 0 0.32548654079437256
endorphin O 1 0.9203550219535828
. O 0 0.07062949240207672

While O 0 0.02888890542089939
a O 0 0.018495196476578712
few O 0 0.013912207446992397
cases O 0 0.011693676933646202
of O 0 0.10111460834741592
isolated O 1 0.9998561143875122
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.02253270149230957
been O 0 0.029573220759630203
reported O 0 0.24737641215324402
( O 0 0.19410152733325958
OMIM O 1 0.9999688863754272
201400 O 1 0.9880308508872986
) O 0 0.012167371809482574
, O 0 0.01290054153650999
an O 0 0.02529704011976719
inherited O 1 0.999992847442627
POMC O 1 0.9999998807907104
defect O 1 0.9999806880950928
has O 0 0.05194222182035446
not O 0 0.009923582896590233
been O 0 0.010862031951546669
described O 0 0.017093198373913765
so O 0 0.015378759242594242
far O 0 0.025431986898183823
. O 0 0.03414139896631241

Recent O 0 0.035393789410591125
studies O 0 0.02285188063979149
in O 0 0.014935540035367012
animal O 0 0.018619561567902565
models O 0 0.02011565864086151
elucidated O 0 0.03171318769454956
a O 0 0.012104672379791737
central O 0 0.011070463806390762
role O 0 0.011494532227516174
of O 0 0.010818611830472946
alpha O 1 0.5554395318031311
- O 1 0.9327036738395691
MSH O 1 0.9990493655204773
in O 0 0.008995730429887772
the O 0 0.008037413470447063
regulation O 0 0.009631423279643059
of O 0 0.009042389690876007
food O 0 0.012179362587630749
intake O 0 0.014627719298005104
by O 0 0.007357305847108364
activation O 0 0.010903103277087212
of O 0 0.008547846227884293
the O 0 0.010835960507392883
brain O 0 0.4660417139530182
melanocortin O 1 0.9934859871864319
- O 0 0.32064902782440186
4 O 0 0.017537511885166168
- O 0 0.045943114906549454
receptor O 0 0.018617060035467148
( O 0 0.015157332643866539
MC4 O 1 0.9990639090538025
- O 0 0.22052346169948578
R O 0 0.04281531646847725
; O 0 0.010756583884358406
refs O 0 0.024177756160497665
3 O 0 0.014166037552058697
- O 0 0.014685442671179771
5 O 0 0.01094795297831297
) O 0 0.008233769796788692
and O 0 0.0072187394835054874
the O 0 0.007114183157682419
linkage O 0 0.012405802495777607
of O 0 0.007619439624249935
human O 0 0.01634051278233528
obesity B-Disease 1 0.9999003410339355
to O 0 0.008239963091909885
chromosome O 0 0.012189689092338085
2 O 0 0.0093629015609622
in O 0 0.007212836295366287
close O 0 0.009486081078648567
proximity O 0 0.012100305408239365
to O 0 0.009972034953534603
the O 0 0.01321353018283844
POMC O 1 0.998134434223175
locus O 0 0.10513326525688171
, O 0 0.011916317977011204
led O 0 0.011280332691967487
to O 0 0.007896876893937588
the O 0 0.007270889822393656
proposal O 0 0.009646485559642315
of O 0 0.007662204094231129
an O 0 0.008687891066074371
association O 0 0.16260455548763275
of O 0 0.10133171826601028
POMC O 1 0.9999957084655762
with O 0 0.30137696862220764
human O 1 0.93576979637146
obesity B-Disease 1 0.9999974966049194
. O 0 0.11449531465768814

The O 0 0.036821745336055756
dual O 0 0.03403173387050629
role O 0 0.022385302931070328
of O 0 0.01848524622619152
alpha O 1 0.7545848488807678
- O 1 0.973675549030304
MSH O 1 0.9998807907104492
in O 0 0.012574300169944763
regulating O 0 0.01746390014886856
food O 0 0.016895972192287445
intake O 0 0.1468150019645691
and O 0 0.01233762875199318
influencing O 0 0.21931946277618408
hair O 1 0.9784172177314758
pigmentation O 1 0.9996699094772339
predicts O 0 0.40841251611709595
that O 0 0.0075461589731276035
the O 0 0.010243494994938374
phenotype O 1 0.5378410816192627
associated O 0 0.007702670991420746
with O 0 0.006563615053892136
a O 0 0.07265087217092514
defect O 1 0.9996110796928406
in O 0 0.18832868337631226
POMC O 1 0.9999874830245972
function O 0 0.012487630359828472
would O 0 0.009505463764071465
include O 0 0.03079313598573208
obesity B-Disease 1 0.9999798536300659
, O 0 0.041864100843667984
alteration O 1 0.9945533275604248
in O 1 0.8888741731643677
pigmentation O 1 0.9999991655349731
and O 1 0.9994819760322571
ACTH B-Disease 1 0.9999997615814209
deficiency I-Disease 1 1.0
. O 1 0.7845550179481506

The O 0 0.03198271989822388
observation O 0 0.04031672328710556
of O 0 0.017611276358366013
these O 0 0.011761586181819439
symptoms O 1 0.9974094033241272
in O 0 0.009751245379447937
two O 0 0.009055203758180141
probands O 1 0.9523014426231384
prompted O 0 0.021276801824569702
us O 0 0.011281785555183887
to O 0 0.009422313421964645
search O 0 0.013175904750823975
for O 0 0.011254425160586834
mutations O 0 0.014872371219098568
within O 0 0.013767295517027378
their O 0 0.019862167537212372
POMC O 1 0.9994969367980957
genes O 0 0.041436560451984406
. O 0 0.046373412013053894

Patient O 1 0.8816017508506775
1 O 0 0.02860071137547493
was O 0 0.01846546120941639
found O 0 0.011963668279349804
to O 0 0.008151344023644924
be O 0 0.007210392504930496
a O 0 0.010066671296954155
compound O 0 0.014896080829203129
heterozygote O 0 0.03377505764365196
for O 0 0.007652925793081522
two O 0 0.00721015315502882
mutations O 0 0.008482443168759346
in O 0 0.00720540015026927
exon O 0 0.025272712111473083
3 O 0 0.011939196847379208
( O 0 0.012126417830586433
G7013T O 0 0.19937025010585785
, O 0 0.010829802602529526
C7133delta O 1 0.5381534099578857
) O 0 0.00868501327931881
which O 0 0.006736075505614281
interfere O 0 0.0117335245013237
with O 0 0.007436339743435383
appropriate O 0 0.01056674961000681
synthesis O 0 0.015275775454938412
of O 0 0.01573575846850872
ACTH O 1 0.9995670914649963
and O 0 0.03931710496544838
alpha O 1 0.7259669303894043
- O 1 0.9485892653465271
MSH O 1 0.999510645866394
. O 0 0.07114975154399872

Patient O 1 0.7676917910575867
2 O 0 0.031239768490195274
was O 0 0.0244932658970356
homozygous O 0 0.02586241625249386
for O 0 0.012943565845489502
a O 0 0.013658775016665459
mutation O 0 0.015286164358258247
in O 0 0.011086423881351948
exon O 0 0.1763354390859604
2 O 0 0.01823393441736698
( O 0 0.014804597944021225
C3804A O 0 0.2229435294866562
) O 0 0.020574627444148064
which O 0 0.026272336021065712
abolishes O 1 0.9217669367790222
POMC O 1 0.9993558526039124
translation O 0 0.06201064586639404
. O 0 0.05965879186987877

These O 0 0.0253651924431324
findings O 0 0.023170391097664833
represent O 0 0.01459489669650793
the O 0 0.010483202524483204
first O 0 0.00994797982275486
examples O 0 0.00910715851932764
of O 0 0.00721746776252985
a O 0 0.014162789098918438
genetic B-Disease 1 0.8675228953361511
defect I-Disease 1 0.9994170665740967
within O 0 0.009513716213405132
the O 0 0.1809779405593872
POMC O 1 0.9999837875366211
gene O 0 0.010601392015814781
and O 0 0.007776546757668257
define O 0 0.010740895755589008
a O 0 0.010008650831878185
new O 0 0.19329506158828735
monogenic B-Disease 1 0.9999995231628418
endocrine I-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999967813491821
resulting O 1 0.7514229416847229
in O 0 0.15280678868293762
early O 1 0.9946892261505127
- O 1 0.9999991655349731
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999747276306152
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999269247055054
red O 1 0.9999986886978149
hair O 1 0.9999977350234985
pigmentation O 1 0.9999988079071045
. O 0 0.1754271239042282
. O 0 0.05018335580825806

A O 0 0.04803259298205376
European O 0 0.03300928696990013
multicenter O 1 0.7877451181411743
study O 0 0.025251589715480804
of O 0 0.31485888361930847
phenylalanine B-Disease 1 0.9999853372573853
hydroxylase I-Disease 1 0.9999966621398926
deficiency I-Disease 1 0.9999998807907104
: O 0 0.0780767872929573
classification O 0 0.09944245219230652
of O 0 0.0133524090051651
105 O 0 0.3098464608192444
mutations O 0 0.011167442426085472
and O 0 0.007178050931543112
a O 0 0.007740125525742769
general O 0 0.010905459523200989
system O 0 0.009604007005691528
for O 0 0.008966858498752117
genotype O 0 0.17895855009555817
- O 0 0.03323221206665039
based O 0 0.015116735361516476
prediction O 0 0.12167467176914215
of O 0 0.050089456140995026
metabolic O 1 0.9989217519760132
phenotype O 1 0.9783298373222351
. O 0 0.04647946357727051

Phenylketonuria B-Disease 1 0.9999840259552002
( O 1 0.9578437805175781
PKU B-Disease 1 0.9999938011169434
) O 0 0.04245608299970627
and O 0 0.14009521901607513
mild B-Disease 1 0.9999926090240479
hyperphenylalaninemia I-Disease 1 0.9999997615814209
( O 1 0.999728262424469
MHP B-Disease 1 1.0
) O 0 0.2701072692871094
are O 0 0.016610344871878624
allelic B-Disease 1 0.9999827146530151
disorders I-Disease 1 0.9999991655349731
caused O 1 0.9656053781509399
by O 0 0.011733784340322018
mutations O 0 0.013923266902565956
in O 0 0.008536522276699543
the O 0 0.011156921274960041
gene O 0 0.01727837324142456
encoding O 0 0.02881978638470173
phenylalanine O 1 0.9477838277816772
hydroxylase O 1 0.9990218877792358
( O 1 0.8545815348625183
PAH O 1 0.9999948740005493
) O 0 0.0512128621339798
. O 0 0.05773446336388588

Previous O 0 0.03618807718157768
studies O 0 0.02167942002415657
have O 0 0.01157163456082344
suggested O 0 0.012303781695663929
that O 0 0.008647389709949493
the O 0 0.009746730327606201
highly O 0 0.016338765621185303
variable O 0 0.028308382257819176
metabolic O 1 0.9968665242195129
phenotypes O 1 0.9970182180404663
of O 1 0.9995386600494385
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.999925971031189
with O 1 0.9990313053131104
PAH O 1 0.9999998807907104
genotypes O 1 0.9999116659164429
. O 0 0.08625335246324539

We O 0 0.03445553407073021
identified O 0 0.02551628276705742
both O 0 0.017651664093136787
causative O 1 0.5648844838142395
mutations O 0 0.02206568978726864
in O 0 0.016168776899576187
686 O 1 0.9998263716697693
patients O 1 0.9465903639793396
from O 0 0.014280376024544239
seven O 0 0.02064364403486252
European O 0 0.02982007898390293
centers O 0 0.03970078378915787
. O 0 0.045116350054740906

On O 0 0.02722916193306446
the O 0 0.01662314496934414
basis O 0 0.012005421333014965
of O 0 0.009295360185205936
the O 0 0.009395869448781013
phenotypic O 0 0.01841266080737114
characteristics O 0 0.01299235038459301
of O 0 0.013217583298683167
297 O 1 0.9886136054992676
functionally O 1 0.9980425834655762
hemizygous O 1 0.9996633529663086
patients O 1 0.7429345846176147
, O 0 0.009999758563935757
105 O 0 0.013755770400166512
of O 0 0.008754837326705456
the O 0 0.008723524399101734
mutations O 0 0.008910957723855972
were O 0 0.005898165516555309
assigned O 0 0.008440222591161728
to O 0 0.006635364610701799
one O 0 0.007441747933626175
of O 0 0.008451071567833424
four O 0 0.011260708793997765
arbitrary O 0 0.01831256039440632
phenotype O 1 0.6286043524742126
categories O 0 0.03530246391892433
. O 0 0.040532466024160385

We O 0 0.0278081763535738
proposed O 0 0.022946668788790703
and O 0 0.013890676200389862
tested O 0 0.01766490563750267
a O 0 0.012755027040839195
simple O 0 0.013755557127296925
model O 0 0.014560673385858536
for O 0 0.010607700794935226
correlation O 0 0.016904061660170555
between O 0 0.01309589296579361
genotype O 0 0.04435635358095169
and O 0 0.018424000591039658
phenotypic O 0 0.0461425818502903
outcome O 0 0.0366547629237175
. O 0 0.03879579156637192

The O 0 0.03499612584710121
observed O 0 0.02834431640803814
phenotype O 0 0.12328238040208817
matched O 0 0.021278640255331993
the O 0 0.012823717668652534
predicted O 0 0.016374414786696434
phenotype O 0 0.018172455951571465
in O 0 0.008784023113548756
79 O 0 0.028426257893443108
% O 0 0.006893995217978954
of O 0 0.005744175519794226
the O 0 0.00565108610317111
cases O 0 0.0055873338133096695
, O 0 0.0044535500928759575
and O 0 0.004294103942811489
in O 0 0.004034732468426228
only O 0 0.0038577665109187365
5 O 0 0.0054390630684792995
of O 0 0.005581336095929146
184 O 0 0.2058420032262802
patients O 0 0.34234654903411865
was O 0 0.008942129090428352
the O 0 0.007659177295863628
observed O 0 0.008365962654352188
phenotype O 0 0.012753249146044254
more O 0 0.005570239387452602
than O 0 0.005818590987473726
one O 0 0.007143729366362095
category O 0 0.01004753913730383
away O 0 0.010321496985852718
from O 0 0.008601044304668903
that O 0 0.011124190874397755
expected O 0 0.02226678468286991
. O 0 0.03473139926791191

Among O 0 0.025414230301976204
the O 0 0.01554280798882246
seven O 0 0.013126705773174763
contributing O 0 0.014819190837442875
centers O 0 0.011282449588179588
, O 0 0.0074071502313017845
the O 0 0.0070153819397091866
proportion O 0 0.00958943273872137
of O 0 0.00940872635692358
patients O 1 0.9008976221084595
for O 0 0.006721728015691042
whom O 0 0.014447744004428387
the O 0 0.008119814097881317
observed O 0 0.00804221723228693
phenotype O 0 0.0457146130502224
did O 0 0.006603786256164312
not O 0 0.0054915971122682095
match O 0 0.008086619898676872
the O 0 0.006384405307471752
predicted O 0 0.0111531438305974
phenotype O 0 0.011866661719977856
was O 0 0.00864429958164692
4 O 0 0.010428776033222675
% O 0 0.00854489579796791
- O 0 0.011053448542952538
23 O 0 0.011876062490046024
% O 0 0.008642387576401234
( O 0 0.009601772762835026
P O 0 0.0252448208630085
< O 0 0.023625237867236137
. O 0 0.009903832338750362
0001 O 0 0.030781280249357224
) O 0 0.009474474936723709
, O 0 0.00847098883241415
suggesting O 0 0.008145177736878395
that O 0 0.00483312364667654
differences O 0 0.006456640549004078
in O 0 0.005338982213288546
methods O 0 0.005959514528512955
used O 0 0.006162695121020079
for O 0 0.00710018165409565
mutation O 0 0.020516926422715187
detection O 0 0.4108128547668457
or O 0 0.011320406571030617
phenotype O 1 0.6177396178245544
classification O 0 0.10528086125850677
may O 0 0.0075744809582829475
account O 0 0.009060588665306568
for O 0 0.007613359950482845
a O 0 0.009904632344841957
considerable O 0 0.016524696722626686
proportion O 0 0.01801789179444313
of O 0 0.020152855664491653
genotype O 1 0.9937228560447693
- O 1 0.992920458316803
phenotype O 1 0.9683114290237427
inconsistencies O 0 0.21964631974697113
. O 0 0.05170806497335434

Our O 0 0.036694955080747604
data O 0 0.022418931126594543
indicate O 0 0.018018335103988647
that O 0 0.012030910700559616
the O 0 0.025082534179091454
PAH O 1 0.9999996423721313
- O 1 0.9943099021911621
mutation O 0 0.14718486368656158
genotype O 0 0.06945528835058212
is O 0 0.010031900368630886
the O 0 0.009627239778637886
main O 0 0.012175130657851696
determinant O 0 0.2623145580291748
of O 0 0.01579853892326355
metabolic O 1 0.9973815083503723
phenotype O 1 0.9582312107086182
in O 0 0.01833203434944153
most O 1 0.5878250002861023
patients O 1 0.9999922513961792
with O 1 0.9999287128448486
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9505341053009033

In O 0 0.024937713518738747
the O 0 0.017802121117711067
present O 0 0.014623280614614487
study O 0 0.011791781522333622
, O 0 0.008154273964464664
the O 0 0.008353226818144321
classification O 0 0.01364822406321764
of O 0 0.015043631196022034
105 O 1 0.997634768486023
PAH O 1 0.9999998807907104
mutations O 0 0.04272421821951866
may O 0 0.0077374521642923355
allow O 0 0.008259972557425499
the O 0 0.007962101139128208
prediction O 0 0.013103406876325607
of O 0 0.007894523441791534
the O 0 0.008434847928583622
biochemical O 0 0.05710790306329727
phenotype O 0 0.026735510677099228
in O 0 0.008665492758154869
> O 0 0.034157294780015945
10 O 0 0.009752429090440273
, O 0 0.009471682831645012
000 O 0 0.019590944051742554
genotypes O 0 0.32426267862319946
, O 0 0.008274883963167667
which O 0 0.006040879059582949
may O 0 0.0061743734404444695
be O 0 0.005405905190855265
useful O 0 0.00786630529910326
for O 0 0.006580354180186987
the O 0 0.009357915259897709
management O 0 0.023950772359967232
of O 0 0.023487133905291557
hyperphenylalaninemia B-Disease 1 0.9998792409896851
in O 0 0.05952587351202965
newborns O 1 0.9884536862373352
. O 0 0.04591742530465126

Somatic O 0 0.17568916082382202
instability O 0 0.07427676767110825
of O 0 0.02589251846075058
the O 0 0.03148366138339043
CTG O 1 0.9992105960845947
repeat O 0 0.27654388546943665
in O 0 0.01559522282332182
mice O 0 0.02368973009288311
transgenic O 0 0.03167400509119034
for O 0 0.013821701519191265
the O 1 0.9251284599304199
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9894245862960815
is O 0 0.1590273678302765
age O 0 0.23245228826999664
dependent O 0 0.01299369614571333
but O 0 0.00668411934748292
not O 0 0.005867491010576487
correlated O 0 0.009251725859940052
to O 0 0.007300721947103739
the O 0 0.009153962135314941
relative O 0 0.015174889005720615
intertissue O 1 0.8915575742721558
transcription O 0 0.0345110185444355
levels O 0 0.02406296692788601
and O 0 0.029648208990693092
proliferative O 1 0.9998923540115356
capacities O 1 0.76535964012146
. O 0 0.061277247965335846

A O 0 0.05255841463804245
( O 0 0.03768220916390419
CTG O 1 0.979158878326416
) O 0 0.018164724111557007
nexpansion O 0 0.03020736388862133
in O 0 0.01072374451905489
the O 0 0.009690786711871624
3 O 0 0.01298050582408905
- O 0 0.04232851043343544
untranslated O 1 0.6703855991363525
region O 0 0.016173982992768288
( O 0 0.01309983804821968
UTR O 0 0.20711305737495422
) O 0 0.012092089280486107
of O 0 0.010490125976502895
the O 0 0.013465488329529762
DM O 1 0.9999973773956299
protein O 0 0.04178263992071152
kinase O 0 0.2333606630563736
gene O 0 0.01336599700152874
( O 0 0.013596261851489544
DMPK O 1 0.7980003952980042
) O 0 0.011021042242646217
is O 0 0.009473511949181557
responsible O 0 0.012430597096681595
for O 0 0.041920699179172516
causing O 1 0.9999903440475464
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999974966049194
DM B-Disease 1 1.0
) O 1 0.7239179015159607
. O 0 0.0580439567565918

Major O 0 0.3885965049266815
instability O 1 0.9200696349143982
, O 0 0.017386900261044502
with O 0 0.009850083850324154
very O 0 0.008720047771930695
large O 0 0.007314387708902359
expansions O 0 0.014913513325154781
between O 0 0.008132174611091614
generations O 0 0.009643853642046452
and O 0 0.007505666930228472
high O 0 0.009906395338475704
levels O 0 0.009722794406116009
of O 0 0.011030989699065685
somatic O 1 0.9406630992889404
mosaicism O 1 0.9985755681991577
, O 0 0.014250718988478184
is O 0 0.01181150134652853
observed O 0 0.01563415676355362
in O 0 0.018762804567813873
patients O 1 0.7806145548820496
. O 0 0.036620162427425385

There O 0 0.02637411653995514
is O 0 0.016374992206692696
a O 0 0.012633606791496277
good O 0 0.012113114818930626
correlation O 0 0.011376919224858284
between O 0 0.007680877111852169
repeat O 0 0.013465392403304577
size O 0 0.009008130058646202
( O 0 0.005858938675373793
at O 0 0.006040249485522509
least O 0 0.005207611247897148
in O 0 0.006435437127947807
leucocytes O 1 0.8006355166435242
) O 0 0.009289593435823917
, O 0 0.01068952027708292
clinical O 1 0.8683469891548157
severity O 1 0.9702478051185608
and O 0 0.01830238103866577
age O 0 0.07969016581773758
of O 0 0.18106931447982788
onset O 1 0.999970555305481
. O 0 0.05866505205631256

The O 0 0.04719480872154236
trinucleotide O 1 0.992675244808197
repeat O 0 0.399907648563385
instability O 1 0.6879999041557312
mechanisms O 0 0.032928865402936935
involved O 0 0.018663816154003143
in O 1 0.524721622467041
DM B-Disease 1 1.0
and O 1 0.6562504768371582
other O 0 0.028681209310889244
human O 1 0.939189612865448
genetic B-Disease 1 0.9999570846557617
diseases I-Disease 1 0.9999998807907104
are O 0 0.02788313291966915
unknown O 0 0.11067300289869308
. O 0 0.03591812774538994

We O 0 0.03241889923810959
studied O 0 0.03467124328017235
somatic O 0 0.051612019538879395
instability O 0 0.05850578472018242
by O 0 0.012685519643127918
measuring O 0 0.0483291819691658
the O 0 0.01637393981218338
CTG O 1 0.9928354620933533
repeat O 0 0.026324588805437088
length O 0 0.012634498998522758
at O 0 0.010087676346302032
several O 0 0.008053637109696865
ages O 0 0.009924046695232391
in O 0 0.007185264956206083
various O 0 0.007873167283833027
tissues O 0 0.01387763861566782
of O 0 0.008773197419941425
transgenic O 0 0.3846193253993988
mice O 0 0.018837658688426018
carrying O 0 0.014011621475219727
a O 0 0.013420922681689262
( O 0 0.01910632662475109
CTG O 1 0.9840686917304993
) O 0 0.017424326390028
55expansion O 0 0.04707670211791992
surrounded O 0 0.017648151144385338
by O 0 0.010011197999119759
45 O 0 0.015548696741461754
kb O 0 0.028376217931509018
of O 0 0.012046842835843563
the O 0 0.013271976262331009
human O 0 0.05510970577597618
DM B-Disease 1 0.9999994039535522
region O 0 0.08076445758342743
, O 0 0.014115383848547935
using O 0 0.016344791278243065
small O 0 0.018623361364006996
- O 0 0.16284823417663574
pool O 0 0.08042290061712265
PCR O 0 0.0850706398487091
. O 0 0.06140623614192009

These O 0 0.029168985784053802
mice O 0 0.027903277426958084
have O 0 0.010642304085195065
been O 0 0.010182803496718407
shown O 0 0.010180233046412468
to O 0 0.009337165392935276
reproduce O 0 0.0137620335444808
the O 0 0.00987697672098875
intergenerational O 1 0.7610214948654175
and O 0 0.011051060631871223
somatic O 0 0.04584025964140892
instability O 0 0.04282672703266144
of O 0 0.009986959397792816
the O 0 0.012088757008314133
55 O 0 0.0721110850572586
CTG O 1 0.9951581358909607
repeat O 0 0.02552139200270176
suggesting O 0 0.011639788746833801
that O 0 0.006675283424556255
surrounding O 0 0.009896857663989067
sequences O 0 0.007655036635696888
and O 0 0.00683894706889987
the O 0 0.007830427028238773
chromatin O 0 0.017024174332618713
environment O 0 0.011352158151566982
are O 0 0.007043933030217886
involved O 0 0.01134990993887186
in O 0 0.014806073158979416
instability O 1 0.8195130825042725
mechanisms O 0 0.14078576862812042
. O 0 0.042390257120132446

As O 0 0.023656100034713745
observed O 0 0.014830945059657097
in O 0 0.008456815034151077
some O 0 0.005682417191565037
of O 0 0.006660943850874901
the O 0 0.009934359230101109
tissues O 1 0.9965144991874695
of O 1 0.9981112480163574
DM B-Disease 1 1.0
patients O 1 0.999994158744812
, O 0 0.03834765776991844
there O 0 0.005769662093371153
is O 0 0.005441362503916025
a O 0 0.007245661690831184
tendency O 0 0.010244781151413918
for O 0 0.00682869041338563
repeat O 0 0.019198410212993622
length O 0 0.011048809625208378
and O 0 0.010685254819691181
somatic O 0 0.06053866818547249
mosaicism O 0 0.4989144802093506
to O 0 0.00941403117030859
increase O 0 0.008919784799218178
with O 0 0.007341536693274975
the O 0 0.009350416250526905
age O 0 0.012155044823884964
of O 0 0.012384075671434402
the O 0 0.020600272342562675
mouse O 0 0.4376799464225769
. O 0 0.03857501596212387

Furthermore O 0 0.04742341861128807
, O 0 0.021448777988553047
we O 0 0.015058816410601139
observed O 0 0.011811518110334873
no O 0 0.010268171317875385
correlation O 0 0.012325692921876907
between O 0 0.009173344820737839
the O 0 0.010642283596098423
somatic O 0 0.4194789230823517
mutation O 0 0.08252814412117004
rate O 0 0.017470095306634903
and O 0 0.02383320778608322
tissue O 1 0.9730556011199951
proliferation O 1 0.9037901759147644
capacity O 0 0.07708064466714859
. O 0 0.046492379158735275

The O 0 0.04145967587828636
somatic O 0 0.09538621455430984
mutation O 0 0.02761683240532875
rates O 0 0.015394087880849838
in O 0 0.00931429211050272
different O 0 0.00670975586399436
tissues O 0 0.01940109021961689
were O 0 0.005380940157920122
also O 0 0.0056760055013000965
not O 0 0.004731675609946251
correlated O 0 0.007136559579521418
to O 0 0.0047480156645178795
the O 0 0.006263165269047022
relative O 0 0.009403226897120476
inter O 0 0.23482368886470795
- O 1 0.530017077922821
tissue O 0 0.10329229384660721
difference O 0 0.007790437899529934
in O 0 0.006318243220448494
transcriptional O 0 0.011217216029763222
levels O 0 0.007180423475801945
of O 0 0.005603961646556854
the O 0 0.006544905249029398
three O 0 0.006252836436033249
genes O 0 0.007742118090391159
( O 0 0.008753795176744461
DMAHP O 1 0.9287212491035461
, O 0 0.009788372553884983
DMPK O 1 0.6897293329238892
and O 0 0.009717199951410294
59 O 0 0.016745731234550476
) O 0 0.010533041320741177
surrounding O 0 0.01308735366910696
the O 0 0.013158400543034077
repeat O 0 0.02941538579761982
. O 0 0.024831799790263176
. O 0 0.0385843887925148

A O 0 0.04804781451821327
novel O 0 0.04912430793046951
missense O 0 0.238627091050148
mutation O 0 0.024788567796349525
in O 0 0.01230790838599205
patients O 0 0.33279892802238464
from O 0 0.009394182823598385
a O 0 0.13501183688640594
retinoblastoma B-Disease 1 0.9999758005142212
pedigree O 1 0.9905861020088196
showing O 0 0.28389981389045715
only O 0 0.011346599087119102
mild O 1 0.9931879043579102
expression O 0 0.028818409889936447
of O 0 0.052210357040166855
the O 1 0.9094666838645935
tumor B-Disease 1 0.9999932050704956
phenotype O 1 0.999061644077301
. O 0 0.052154287695884705

We O 0 0.03130970150232315
have O 0 0.015664977952837944
used O 0 0.013715061359107494
single O 0 0.015617324970662594
strand O 0 0.01836952194571495
conformation O 0 0.01788558065891266
polymorphism O 0 0.015241154469549656
analysis O 0 0.009376618079841137
to O 0 0.008531357161700726
study O 0 0.00955373514443636
the O 0 0.007183162961155176
27 O 0 0.011622745543718338
exons O 0 0.01573943719267845
of O 0 0.01001117005944252
the O 0 0.012937931343913078
RB1 O 1 0.9968329071998596
gene O 0 0.011175591498613358
in O 0 0.007906596176326275
individuals O 0 0.006584255024790764
from O 0 0.006535901688039303
a O 0 0.009019316174089909
family O 0 0.013775152154266834
showing O 0 0.057319242507219315
mild O 1 0.9909332990646362
expression O 0 0.0361141711473465
of O 0 0.06177794933319092
the O 1 0.8691244721412659
retinoblastoma B-Disease 1 0.9999951124191284
phenotype O 1 0.9986697435379028
. O 0 0.058383550494909286

In O 0 0.02424583211541176
this O 0 0.014166410081088543
family O 0 0.016567466780543327
affected O 0 0.015812823548913002
individuals O 0 0.008989390917122364
developed O 1 0.9810371994972229
unilateral B-Disease 1 0.9996411800384521
tumors I-Disease 1 0.9999996423721313
and O 0 0.18056392669677734
, O 0 0.007894530892372131
as O 0 0.006032387726008892
a O 0 0.006790420040488243
result O 0 0.005766153335571289
of O 0 0.006419462617486715
linkage O 0 0.01929188147187233
analysis O 0 0.008339042775332928
, O 0 0.010211271233856678
unaffected O 0 0.49005648493766785
mutation O 0 0.02887985110282898
carriers O 0 0.027001971378922462
were O 0 0.008375843055546284
also O 0 0.009206420741975307
identified O 0 0.011342939920723438
within O 0 0.0128188356757164
the O 0 0.017562124878168106
pedigree O 0 0.3515482544898987
. O 0 0.0348280631005764

A O 0 0.046445295214653015
single O 0 0.0322888158261776
band O 0 0.030270876362919807
shift O 0 0.026609307155013084
using O 0 0.01792106218636036
SSCP O 1 0.5357186794281006
was O 0 0.015642857179045677
identified O 0 0.01200042199343443
in O 0 0.010450153611600399
exon O 0 0.03069159761071205
21 O 0 0.015048868022859097
which O 0 0.009535686112940311
resulted O 0 0.0118699437007308
in O 0 0.009654460474848747
a O 0 0.013853195123374462
missense O 0 0.027356287464499474
mutation O 0 0.01681552268564701
converting O 0 0.01873922534286976
a O 0 0.017057672142982483
cys O 1 0.9980989098548889
- O 1 0.8446413278579712
- O 1 0.6365359425544739
> O 0 0.2847946584224701
arg O 0 0.3141445815563202
at O 0 0.02080903761088848
nucleotide O 0 0.02757447399199009
position O 0 0.023760013282299042
28 O 0 0.028210435062646866
in O 0 0.022135835140943527
the O 0 0.03601678088307381
exon O 0 0.09051141142845154
. O 0 0.059330880641937256

The O 0 0.05269954726099968
mutation O 0 0.05280522257089615
destroyed O 0 0.04971563443541527
an O 0 0.031166017055511475
NdeI O 1 0.9960057139396667
restriction O 0 0.11009358614683151
enzyme O 0 0.05697952210903168
site O 0 0.05789654701948166
. O 0 0.05878758430480957

Analysis O 0 0.028639070689678192
of O 0 0.017037857323884964
all O 0 0.011525779962539673
family O 0 0.010798901319503784
members O 0 0.008979935199022293
demonstrated O 0 0.009938990697264671
that O 0 0.006197443697601557
the O 0 0.007445895578712225
missense O 0 0.0989174023270607
mutation O 0 0.029442990198731422
co O 1 0.5531116724014282
- O 1 0.7674782872200012
segregated O 0 0.450517863035202
with O 0 0.029408765956759453
patients O 1 0.9993001222610474
with O 1 0.8040035367012024
tumors B-Disease 1 0.9999978542327881
or O 0 0.03607393056154251
who O 0 0.022316187620162964
, O 0 0.005756075028330088
as O 0 0.004843851085752249
a O 0 0.00569950183853507
result O 0 0.004968870431184769
of O 0 0.005648236256092787
linkage O 0 0.045804478228092194
analysis O 0 0.007161295972764492
had O 0 0.007172472309321165
been O 0 0.007244736421853304
predicted O 0 0.012656515464186668
to O 0 0.010944525711238384
carry O 0 0.018089856952428818
the O 0 0.02056862972676754
predisposing O 1 0.7879136204719543
mutation O 0 0.05165569484233856
. O 0 0.0457136407494545

These O 0 0.02516845241189003
observations O 0 0.028622273355722427
point O 0 0.017718788236379623
to O 0 0.010082359425723553
another O 0 0.011530105955898762
region O 0 0.011001958511769772
of O 0 0.00802710559219122
the O 0 0.013631358742713928
RB1 O 1 0.9999032020568848
gene O 0 0.01068503875285387
where O 0 0.008671581745147705
mutations O 0 0.008067538030445576
only O 0 0.005603358615189791
modify O 0 0.010012426413595676
the O 0 0.006210376508533955
function O 0 0.006270107813179493
of O 0 0.005652656778693199
the O 0 0.0056345779448747635
gene O 0 0.006129296030849218
and O 0 0.005211567971855402
raise O 0 0.007768751122057438
important O 0 0.006227362900972366
questions O 0 0.007171196397393942
for O 0 0.00624606991186738
genetic O 0 0.009058198891580105
counseling O 0 0.10880879312753677
in O 0 0.0075612724758684635
families O 0 0.008041730150580406
with O 0 0.007694431114941835
these O 0 0.00918535329401493
distinctive O 1 0.6969866156578064
phenotypes O 1 0.8908239603042603
. O 0 0.02260264940559864
. O 0 0.0330730639398098

Maternal B-Disease 1 0.9939915537834167
disomy I-Disease 1 0.999685525894165
and O 1 0.9944138526916504
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9936328530311584
with O 1 0.8969165086746216
gamete O 1 0.9999719858169556
complementation O 1 0.9999819993972778
in O 0 0.012526982463896275
a O 0 0.011616689153015614
case O 0 0.011475842446088791
of O 0 0.011938042938709259
familial O 1 0.99908447265625
translocation O 1 0.9219545125961304
( O 0 0.011721947230398655
3 O 0 0.010753655806183815
; O 0 0.008653854951262474
15 O 0 0.011462230235338211
) O 0 0.011645318940281868
( O 0 0.0137849235907197
p25 O 0 0.12171322107315063
; O 0 0.01761828362941742
q11 O 0 0.04347054287791252
. O 0 0.017599986866116524
2 O 0 0.027604859322309494
) O 0 0.03152540326118469
. O 0 0.045538000762462616

Maternal B-Disease 1 0.9998372793197632
uniparental I-Disease 1 0.9999972581863403
disomy I-Disease 1 0.999983549118042
( I-Disease 1 0.9607629776000977
UPD I-Disease 1 0.9999954700469971
) I-Disease 0 0.015841078013181686
for I-Disease 0 0.012190618552267551
chromosome I-Disease 0 0.014384099282324314
15 I-Disease 0 0.009786130860447884
is O 0 0.006618410814553499
responsible O 0 0.006586520001292229
for O 0 0.005135645624250174
an O 0 0.004945349879562855
estimated O 0 0.00616275891661644
30 O 0 0.006603770889341831
% O 0 0.00654159439727664
of O 0 0.007042436394840479
cases O 0 0.00980793684720993
of O 1 0.7834296822547913
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999828338623047
PWS B-Disease 1 0.9999998807907104
) O 0 0.4495179057121277
. O 0 0.06495910882949829

We O 0 0.025781244039535522
report O 0 0.01683376543223858
on O 0 0.011310308240354061
an O 0 0.009217789396643639
unusual O 0 0.011499852873384953
case O 0 0.010634293779730797
of O 0 0.010962864384055138
maternal B-Disease 1 0.9846162796020508
disomy I-Disease 1 0.99720698595047
15 I-Disease 0 0.027378812432289124
in O 0 0.035926662385463715
PWS B-Disease 1 0.9999967813491821
that O 0 0.00806940346956253
is O 0 0.006850914563983679
most O 0 0.006078051868826151
consistent O 0 0.007742125540971756
with O 0 0.006986846216022968
adjacent O 0 0.010425607673823833
- O 0 0.014206322841346264
1 O 0 0.010660634376108646
segregation O 0 0.012648021802306175
of O 0 0.008403453044593334
a O 0 0.010178887285292149
paternal O 1 0.6067517995834351
t O 1 0.5272811651229858
( O 0 0.008154110983014107
3 O 0 0.01000643614679575
; O 0 0.007719855289906263
15 O 0 0.010075674392282963
) O 0 0.009255770593881607
( O 0 0.011619770899415016
p25 O 0 0.07617101818323135
; O 0 0.012880312278866768
q11 O 0 0.02878149226307869
. O 0 0.011519871652126312
2 O 0 0.015323750674724579
) O 0 0.01212548092007637
with O 0 0.013282353058457375
simultaneous O 0 0.02372339740395546
maternal O 1 0.8047657012939453
meiotic O 1 0.999196469783783
nondisjunction O 1 0.9494519233703613
for O 0 0.023642798885703087
chromosome O 0 0.04370938241481781
15 O 0 0.0370248407125473
. O 0 0.049982018768787384

The O 0 0.03710201382637024
patient O 1 0.9642407298088074
( O 0 0.17532841861248016
J O 1 0.9989877343177795
. O 0 0.013416667468845844
B O 0 0.2796346843242645
. O 0 0.006848955526947975
) O 0 0.006425292231142521
, O 0 0.005575524177402258
a O 0 0.005951751954853535
17 O 0 0.007965464144945145
- O 0 0.010524705052375793
year O 0 0.007888655178248882
- O 0 0.07482845336198807
old O 0 0.01719728112220764
white O 0 0.01373463124036789
male O 0 0.01338779553771019
with O 0 0.01711067371070385
PWS B-Disease 1 0.9999992847442627
, O 0 0.010295061394572258
was O 0 0.009134533815085888
found O 0 0.005609916988760233
to O 0 0.005679919384419918
have O 0 0.0052677639760077
47 O 0 0.010548245161771774
chromosomes O 0 0.01007831934839487
with O 0 0.006985582411289215
a O 0 0.010490705259144306
supernumerary O 1 0.9749202728271484
, O 0 0.016817990690469742
paternal O 1 0.9435590505599976
der O 1 0.9677473306655884
( O 0 0.008382192812860012
15 O 0 0.009440337307751179
) O 0 0.007560371421277523
consisting O 0 0.008912368677556515
of O 0 0.006213231943547726
the O 0 0.006954554934054613
short O 0 0.010278808884322643
arm O 1 0.5020229816436768
and O 0 0.007833005860447884
the O 0 0.00952912587672472
proximal O 1 0.9879851937294006
long O 0 0.022633995860815048
arm O 1 0.6123780608177185
of O 0 0.011372838169336319
chromosome O 0 0.035968102514743805
15 O 0 0.013948921114206314
, O 0 0.014648579992353916
and O 0 0.020176174119114876
distal O 1 0.9935635328292847
chromosome O 1 0.807686448097229
arm O 1 0.9974421262741089
3p O 1 0.9989218711853027
. O 0 0.06085878238081932

The O 0 0.035497263073921204
t O 0 0.47495603561401367
( O 0 0.015007071197032928
3 O 0 0.013501469977200031
; O 0 0.009087642654776573
15 O 0 0.009482797235250473
) O 0 0.0072368839755654335
was O 0 0.00800975039601326
present O 0 0.005900702439248562
in O 0 0.005348024424165487
the O 0 0.0059450953267514706
balanced O 0 0.008303341455757618
state O 0 0.0056340196169912815
in O 0 0.006694733630865812
the O 0 0.013401104137301445
patients O 1 0.9433215856552124
father O 0 0.10716776549816132
and O 0 0.015181018970906734
a O 0 0.031309936195611954
sister O 0 0.3334503471851349
. O 0 0.04231245070695877

Fluorescent O 0 0.10036750137805939
in O 0 0.03337189182639122
situ O 0 0.0600469708442688
hybridization O 0 0.03594956919550896
analysis O 0 0.01881960965692997
demonstrated O 0 0.020129868760704994
that O 0 0.011830595321953297
the O 0 0.015363609418272972
PWS B-Disease 1 0.9999910593032837
critical O 0 0.07225174456834793
region O 0 0.01882314495742321
resided O 0 0.019519755616784096
on O 0 0.007288469932973385
the O 0 0.0077739981934428215
derivative O 0 0.019408490508794785
chromosome O 0 0.01100227888673544
3 O 0 0.008471589535474777
and O 0 0.006033727899193764
that O 0 0.004613365512341261
there O 0 0.004646985791623592
was O 0 0.00685917679220438
no O 0 0.006223026663064957
deletion O 0 0.010811113752424717
of O 0 0.0075228530913591385
the O 0 0.02334459498524666
PWS B-Disease 1 0.999997615814209
region O 0 0.014576132409274578
on O 0 0.008099505677819252
the O 0 0.008848133496940136
normal O 0 0.011315151117742062
pair O 0 0.017354663461446762
of O 0 0.015938952565193176
15s O 1 0.9660400748252869
present O 0 0.023566342890262604
in O 0 0.026209130883216858
J O 1 0.9687627553939819
. O 0 0.05687955021858215

B O 1 0.7276318073272705
. O 0 0.13691020011901855

Methylation O 0 0.06597845256328583
analysis O 0 0.03469865769147873
at O 0 0.030872419476509094
exon O 0 0.04329843074083328
alpha O 0 0.029030682519078255
of O 0 0.015663353726267815
the O 0 0.01352587342262268
small O 0 0.012541589327156544
nuclear O 0 0.020124519243836403
ribonucleoprotein O 1 0.9746809601783752
- O 0 0.2760987877845764
associated O 0 0.017863290384411812
polypeptide O 1 0.5210912227630615
N O 0 0.028888855129480362
( O 0 0.015361460857093334
SNRPN O 1 0.9381999373435974
) O 0 0.012209414504468441
gene O 0 0.010604595765471458
showed O 0 0.009726932272315025
a O 0 0.008255080319941044
pattern O 0 0.010340549983084202
characteristic O 0 0.008997325785458088
of O 0 0.006929158233106136
only O 0 0.007146549876779318
the O 0 0.011303389444947243
maternal O 1 0.9320279955863953
chromosome O 0 0.04871295019984245
15 O 0 0.020576857030391693
in O 0 0.024396995082497597
J O 1 0.9490606188774109
. O 0 0.047361839562654495

B O 1 0.8428555727005005
. O 0 0.11400307714939117

Maternal B-Disease 1 0.9952638149261475
disomy I-Disease 1 0.9750163555145264
was O 0 0.033827535808086395
confirmed O 0 0.020132755860686302
by O 0 0.01473864447325468
polymerase O 0 0.07595290243625641
chain O 0 0.02277972735464573
reaction O 0 0.013778896071016788
analysis O 0 0.012361316941678524
of O 0 0.011941458098590374
microsatellite O 0 0.0806555226445198
repeats O 0 0.018357157707214355
at O 0 0.012624937109649181
the O 0 0.01330829318612814
gamma O 0 0.05681520327925682
- O 0 0.2624586820602417
aminobutyric O 1 0.925787091255188
acid O 0 0.0858878344297409
receptor O 0 0.044026341289281845
beta3 O 1 0.9271261692047119
subunit O 0 0.09640107303857803
( O 0 0.035679567605257034
GABRB3 O 1 0.9840577244758606
) O 0 0.04382312670350075
locus O 0 0.10021559149026871
. O 0 0.06722338497638702

A O 0 0.06446974724531174
niece O 1 0.9931324124336243
( O 0 0.05284182354807854
B O 1 0.8278517127037048
. O 0 0.011601089499890804
B O 0 0.04296395927667618
. O 0 0.005863103549927473
) O 0 0.005744911264628172
with O 0 0.005422407761216164
45 O 0 0.008300578221678734
chromosomes O 0 0.008274747058749199
and O 0 0.005677615292370319
the O 0 0.0053858268074691296
derivative O 0 0.008628268726170063
3 O 0 0.007075822446495295
but O 0 0.00509084016084671
without O 0 0.005452844314277172
the O 0 0.0063682724721729755
der O 1 0.6702539920806885
( O 0 0.006848955526947975
15 O 0 0.008918487466871738
) O 0 0.008050095289945602
demonstrated O 0 0.010697041638195515
a O 0 0.009232972748577595
phenotype O 0 0.02844785340130329
consistent O 0 0.010254504159092903
with O 0 0.0072486125864088535
that O 0 0.006714858580380678
reported O 0 0.011104525998234749
for O 0 0.011376817710697651
haploinsufficiency O 1 0.5927601456642151
of O 0 0.022026697173714638
distal O 1 0.9857757687568665
3 O 0 0.04354582726955414
p O 0 0.06446464359760284
. O 0 0.04731544852256775

Uniparental B-Disease 1 0.9999817609786987
disomy I-Disease 1 0.9986868500709534
associated O 0 0.030240390449762344
with O 0 0.019090889021754265
unbalanced O 1 0.6747560501098633
segregation O 0 0.28548920154571533
of O 0 0.022568902000784874
non O 1 0.9197971820831299
- O 1 0.9990679621696472
Robertsonian O 1 0.9998778104782104
translocations O 1 0.9194026589393616
has O 0 0.011155642569065094
been O 0 0.0074059925973415375
reported O 0 0.008642102591693401
previously O 0 0.008199384436011314
but O 0 0.005588637199252844
has O 0 0.005592321511358023
not O 0 0.004209139849990606
, O 0 0.004622951149940491
to O 0 0.004993849899619818
our O 0 0.0073306928388774395
knowledge O 0 0.008218161761760712
, O 0 0.007008231244981289
been O 0 0.006218574941158295
observed O 0 0.00811657402664423
in O 0 0.0075650522485375404
a O 0 0.013201099820435047
case O 0 0.01951296627521515
of O 0 0.03205882012844086
PWS B-Disease 1 0.9999899864196777
. O 0 0.05882171913981438

Furthermore O 0 0.04630455747246742
, O 0 0.018251808360219002
our O 0 0.015818994492292404
findings O 0 0.013511515222489834
are O 0 0.007431428413838148
best O 0 0.011262096464633942
interpreted O 0 0.011582574807107449
as O 0 0.011931774206459522
true O 0 0.02079017274081707
gamete O 1 0.9642876386642456
complementation O 1 0.9995600581169128
resulting O 0 0.13076485693454742
in O 0 0.0563918873667717
maternal B-Disease 1 0.999645471572876
UPD I-Disease 1 0.9999972581863403
15 I-Disease 0 0.2798061966896057
and O 0 0.11001003533601761
PWS B-Disease 1 0.9999258518218994

Schwartz B-Disease 1 0.996427595615387
- I-Disease 1 0.9993282556533813
Jampel I-Disease 1 0.9999842643737793
syndrome I-Disease 1 0.9999995231628418
type I-Disease 1 0.9483510851860046
2 I-Disease 0 0.293208509683609
and O 1 0.5146594047546387
Stuve B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999995231628418
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.21809051930904388
a O 0 0.09694831818342209
case O 0 0.03780856728553772
for O 0 0.01657024770975113
" O 0 0.028399314731359482
lumping O 1 0.8288244605064392
" O 0 0.04039476066827774
. O 0 0.048384152352809906

Recent O 0 0.02914309687912464
studies O 0 0.020967449992895126
demonstrated O 0 0.01852988824248314
the O 0 0.01111519243568182
existence O 0 0.010753437876701355
of O 0 0.007489582523703575
a O 0 0.011434374377131462
genetically O 0 0.022415833547711372
distinct O 0 0.00919395498931408
, O 0 0.0075530256144702435
usually O 0 0.006563546136021614
lethal O 0 0.0075700548477470875
form O 0 0.005478936713188887
of O 0 0.006448032334446907
the O 0 0.010069061070680618
Schwartz B-Disease 1 0.9982571005821228
- I-Disease 1 0.9999520778656006
Jampel I-Disease 1 0.9999994039535522
syndrome I-Disease 1 1.0
( O 1 0.9907344579696655
SJS B-Disease 1 0.9999971389770508
) O 0 0.018426626920700073
of O 0 0.09691951423883438
myotonia B-Disease 1 0.9999994039535522
and O 1 0.9940527081489563
skeletal B-Disease 1 0.9999988079071045
dysplasia I-Disease 1 0.9999997615814209
, O 0 0.23387740552425385
which O 0 0.01085603516548872
we O 0 0.012376450933516026
called O 0 0.2745410203933716
SJS B-Disease 1 0.9999860525131226
type I-Disease 0 0.3224734961986542
2 I-Disease 0 0.04207461699843407
. O 0 0.04741942510008812

This O 0 0.05240315571427345
disorder O 1 0.9998284578323364
is O 0 0.01832013763487339
reminiscent O 1 0.7950209379196167
of O 0 0.01713269017636776
another O 0 0.259115606546402
rare O 1 0.74006587266922
condition O 1 0.7716522216796875
, O 0 0.012463996186852455
the O 0 0.23676519095897675
Stuve B-Disease 1 0.9999988079071045
- I-Disease 1 0.9999997615814209
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9993820190429688
SWS B-Disease 1 0.9999984502792358
) O 0 0.01386296283453703
, O 0 0.010410907678306103
which O 0 0.007696113549172878
comprises O 0 0.01446803193539381
campomelia B-Disease 0 0.24708478152751923
at O 0 0.01185351237654686
birth O 1 0.5504801869392395
with O 1 0.87347811460495
skeletal B-Disease 1 0.9999996423721313
dysplasia I-Disease 1 1.0
, O 1 0.9991576671600342
contractures B-Disease 1 0.9999998807907104
, O 1 0.5355830192565918
and O 0 0.023155422881245613
early B-Disease 0 0.026451723650097847
death I-Disease 0 0.14710453152656555
. O 0 0.04021618142724037

To O 0 0.02682855725288391
test O 0 0.024431152269244194
for O 0 0.012848715297877789
possible O 0 0.013099942356348038
nosologic O 1 0.8119466304779053
identity O 0 0.01476592943072319
between O 0 0.01108881738036871
these O 0 0.012707013636827469
disorders O 1 0.9999890327453613
, O 0 0.010189664550125599
we O 0 0.006652808748185635
reviewed O 0 0.00952667836099863
the O 0 0.00603881198912859
literature O 0 0.008269340731203556
and O 0 0.006222678814083338
obtained O 0 0.006537201348692179
a O 0 0.006904786452651024
follow O 0 0.0077345240861177444
- O 0 0.009001458995044231
up O 0 0.006413400638848543
of O 0 0.004847891163080931
the O 0 0.005276809446513653
only O 0 0.0047637689858675
two O 0 0.005687349010258913
surviving O 0 0.2045239359140396
patients O 0 0.2797170877456665
, O 0 0.004757700953632593
one O 0 0.005384115502238274
with O 0 0.008492720313370228
SJS B-Disease 1 0.9999338388442993
type I-Disease 0 0.02890927344560623
2 I-Disease 0 0.008379089646041393
at O 0 0.007051641121506691
age O 0 0.006934709846973419
10 O 0 0.0068589779548347
years O 0 0.006888535339385271
and O 0 0.005903569515794516
another O 0 0.008608761243522167
with O 0 0.008965019136667252
SWS B-Disease 1 0.9948762059211731
at O 0 0.014538809657096863
age O 0 0.02028929442167282
7 O 0 0.026572417467832565
years O 0 0.030333461239933968
. O 0 0.040926478803157806

Patients O 1 0.8401032090187073
reported O 0 0.02460183948278427
as O 0 0.014702065847814083
having O 0 0.055372100323438644
either O 1 0.7361354827880859
neonatal O 1 1.0
SJS B-Disease 1 0.9999996423721313
or O 0 0.3624909818172455
SWS B-Disease 1 0.9995761513710022
presented O 0 0.01952485553920269
a O 0 0.012208707630634308
combination O 0 0.017657816410064697
of O 0 0.008551026694476604
a O 0 0.0835261270403862
severe O 1 0.9999929666519165
, O 1 0.9984801411628723
prenatal O 1 0.9999998807907104
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9999645948410034
with O 1 0.9999754428863525
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999995231628418
respiratory O 1 1.0
and O 1 0.9997199177742004
feeding O 1 0.9998089671134949
difficulties O 1 0.9999418258666992
, O 1 0.6231970191001892
tendency O 1 0.9150050282478333
to O 0 0.05011498183012009
hyperthermia B-Disease 1 0.9999946355819702
, O 0 0.0218805018812418
and O 0 0.009264134801924229
frequent O 0 0.02973623014986515
death O 0 0.18129463493824005
in O 0 0.009633897803723812
infancy O 1 0.9712432026863098
) O 0 0.007577463518828154
with O 0 0.007139252498745918
a O 0 0.010839084163308144
distinct O 0 0.04062012583017349
campomelic B-Disease 1 0.999976634979248
- I-Disease 1 0.9999872446060181
metaphyseal I-Disease 1 0.999996542930603
skeletal I-Disease 1 0.9999974966049194
dysplasia I-Disease 1 0.999998927116394
. O 0 0.3000151813030243

The O 0 0.030997449532151222
similarity O 0 0.026438385248184204
of O 0 0.014267266727983952
the O 0 0.015751320868730545
clinical O 1 0.9983153343200684
and O 0 0.4964635372161865
radiographic O 1 0.999896764755249
findings O 0 0.03688066825270653
is O 0 0.0087253013625741
so O 0 0.006722957827150822
extensive O 0 0.012376905418932438
that O 0 0.007696622982621193
these O 0 0.00848449394106865
disorders O 1 0.9992086291313171
appear O 0 0.009559620171785355
to O 0 0.0079678725451231
be O 0 0.008826176635921001
a O 0 0.014152365736663342
single O 0 0.02253660000860691
entity O 0 0.0435820072889328
. O 0 0.03932873159646988

The O 0 0.028736170381307602
follow O 0 0.022846803069114685
- O 0 0.018728220835328102
up O 0 0.012471340596675873
observation O 0 0.01454349048435688
of O 0 0.0068223681300878525
an O 0 0.006125436630100012
identical O 0 0.00797771941870451
and O 0 0.0051801772788167
unique O 0 0.007371837738901377
pattern O 0 0.109327033162117
of O 1 0.9269837737083435
progressive O 1 0.9999998807907104
bone B-Disease 1 1.0
dysplasia I-Disease 1 0.9999998807907104
in O 0 0.057137198746204376
the O 0 0.03952440619468689
two O 0 0.00845533236861229
patients O 1 0.8534946441650391
( O 0 0.007934804074466228
one O 0 0.007079696282744408
with O 0 0.011177788488566875
SJS B-Disease 1 0.9999290704727173
type I-Disease 0 0.019339123740792274
2 I-Disease 0 0.011811712756752968
, O 0 0.008870004676282406
one O 0 0.008017797954380512
with O 0 0.00939779169857502
SWS B-Disease 1 0.9983081817626953
) O 0 0.013124431483447552
surviving O 0 0.0219256654381752
beyond O 0 0.015345882624387741
infancy O 0 0.14106601476669312
adds O 0 0.014218480326235294
to O 0 0.008842318318784237
the O 0 0.009368108585476875
evidence O 0 0.009105369448661804
in O 0 0.009146399796009064
favor O 0 0.015949683263897896
of O 0 0.018849648535251617
identity O 0 0.03154047578573227
. O 0 0.039600394666194916

The O 0 0.03181994706392288
hypothesis O 0 0.034426942467689514
that O 0 0.016809383407235146
SWS B-Disease 1 0.9998648166656494
and O 0 0.4050472676753998
SJS B-Disease 1 0.9999856948852539
type I-Disease 0 0.43878230452537537
2 I-Disease 0 0.012403780594468117
are O 0 0.0064508370123803616
the O 0 0.008026490919291973
same O 0 0.013578521087765694
disorder O 1 0.9996321201324463
should O 0 0.0077544767409563065
be O 0 0.007808001711964607
testable O 0 0.022720202803611755
by O 0 0.010864132083952427
molecular O 0 0.016584062948822975
methods O 0 0.01733545772731304
. O 0 0.02090352028608322
. O 0 0.033355988562107086

A O 0 0.04021945968270302
mouse O 0 0.047163836658000946
model O 0 0.031215455383062363
of O 1 0.5565735101699829
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.999976634979248
defects O 1 0.9999998807907104
in O 1 0.9998142123222351
hemostasis O 1 1.0
and O 1 0.9998735189437866
thrombosis B-Disease 1 1.0
. O 1 0.8801385164260864

von B-Disease 1 0.9991945624351501
Willebrand I-Disease 1 0.999995231628418
factor I-Disease 1 0.9871039986610413
( I-Disease 1 0.9802431464195251
vWf I-Disease 1 0.9999935626983643
) I-Disease 1 0.9994957447052002
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9990993738174438
humans O 1 0.9859031438827515
. O 0 0.08724705129861832

We O 0 0.030285561457276344
generated O 0 0.026701459661126137
a O 0 0.018873393535614014
mouse O 0 0.02897730842232704
model O 0 0.017854642122983932
for O 0 0.012736432254314423
this O 0 0.012703627347946167
disease O 1 0.9776672720909119
by O 0 0.011662702076137066
using O 0 0.016605570912361145
gene O 0 0.02380356192588806
targeting O 0 0.038547541946172714
. O 0 0.04087834060192108

vWf B-Disease 1 0.9988691210746765
- I-Disease 1 0.9940623641014099
deficient I-Disease 1 0.9952636957168579
mice O 0 0.09813523292541504
appeared O 0 0.019614985212683678
normal O 0 0.01421812642365694
at O 0 0.012622707523405552
birth O 0 0.015616195276379585
; O 0 0.009153082966804504
they O 0 0.0076003605499863625
were O 0 0.010720532387495041
viable O 0 0.022879112511873245
and O 0 0.020293939858675003
fertile O 0 0.22868871688842773
. O 0 0.037490054965019226

Neither O 0 0.10302240401506424
vWf O 1 0.8974794745445251
nor O 0 0.10183467715978622
vWf O 1 0.9806329607963562
propolypeptide O 1 0.9836872220039368
( O 0 0.32333508133888245
von B-Disease 1 0.9994181394577026
Willebrand I-Disease 1 0.9999991655349731
antigen O 1 0.9999110698699951
II O 1 0.9997010827064514
) O 0 0.01585821434855461
were O 0 0.012293749488890171
detectable O 0 0.02338309958577156
in O 0 0.012444829568266869
plasma O 0 0.1190267950296402
, O 0 0.018283016979694366
platelets O 1 0.9696953892707825
, O 0 0.012327109463512897
or O 0 0.011600799858570099
endothelial O 1 0.9587078094482422
cells O 0 0.012779060751199722
of O 0 0.012327655218541622
the O 0 0.018856968730688095
homozygous O 1 0.6876048445701599
mutant O 1 0.9043051600456238
mice O 0 0.39777660369873047
. O 0 0.044165123254060745

The O 0 0.042329441756010056
mutant O 1 0.6274849772453308
mice O 1 0.7097894549369812
exhibited O 1 0.958827018737793
defects O 1 0.9993651509284973
in O 0 0.04247976467013359
hemostasis O 1 0.9999862909317017
with O 0 0.04339500516653061
a O 1 0.5676862597465515
highly O 1 0.9977235198020935
prolonged O 1 0.9999990463256836
bleeding O 1 0.9999998807907104
time O 0 0.42629754543304443
and O 0 0.3597342073917389
spontaneous O 1 0.9710516333580017
bleeding O 1 0.9999418258666992
events O 0 0.010295003652572632
in O 0 0.008632834069430828
approximately O 0 0.011445240117609501
10 O 0 0.013758053071796894
% O 0 0.015510229393839836
of O 0 0.020137405022978783
neonates O 1 0.8547650575637817
. O 0 0.04241109639406204

As O 0 0.02264491841197014
in O 0 0.013398149982094765
the O 0 0.01267632469534874
human O 0 0.24356424808502197
disease O 1 0.9999657869338989
, O 0 0.0365615114569664
the O 0 0.09303518384695053
factor O 1 0.9160924553871155
VIII O 1 0.999931812286377
level O 0 0.010256323963403702
in O 0 0.006550438702106476
these O 0 0.0051432158797979355
mice O 0 0.009746615774929523
was O 0 0.0071737938560545444
reduced O 0 0.006834018975496292
strongly O 0 0.006094323471188545
as O 0 0.005012799985706806
a O 0 0.005867891013622284
result O 0 0.005332046188414097
of O 0 0.005814236588776112
the O 0 0.007318540476262569
lack O 0 0.02258763648569584
of O 0 0.019507387652993202
protection O 1 0.9881380200386047
provided O 0 0.28864213824272156
by O 0 0.02593403495848179
vWf O 1 0.9889944195747375
. O 0 0.0417076013982296

Defective O 1 0.9999796152114868
thrombosis B-Disease 1 0.9999970197677612
in O 0 0.20523367822170258
mutant O 1 0.9953241944313049
mice O 1 0.9102940559387207
was O 0 0.13651183247566223
also O 0 0.01279924064874649
evident O 0 0.015995729714632034
in O 0 0.00825261790305376
an O 0 0.00883542001247406
in O 0 0.011328015476465225
vivo O 0 0.2897776961326599
model O 0 0.17526718974113464
of O 1 0.752162754535675
vascular B-Disease 1 0.9999997615814209
injury I-Disease 1 0.9999828338623047
. O 0 0.13310225307941437

In O 0 0.025808880105614662
this O 0 0.01624121703207493
model O 0 0.01904217153787613
, O 0 0.012913085520267487
the O 0 0.013129052706062794
exteriorized O 1 0.9349063634872437
mesentery O 1 0.9980613589286804
was O 0 0.3466743528842926
superfused O 1 0.9986659288406372
with O 0 0.3019725978374481
ferric O 1 0.9999954700469971
chloride O 1 0.9935280680656433
and O 0 0.012472419999539852
the O 0 0.012242913246154785
accumulation O 1 0.6825586557388306
of O 0 0.09817524254322052
fluorescently O 1 0.9999920129776001
labeled O 1 0.9996631145477295
platelets O 1 0.9991843104362488
was O 0 0.036941640079021454
observed O 0 0.018149539828300476
by O 0 0.020259128883481026
intravital O 1 0.8872900009155273
microscopy O 0 0.06944360584020615
. O 0 0.05692147836089134

We O 0 0.027844222262501717
conclude O 0 0.02854195050895214
that O 0 0.011841828003525734
these O 0 0.008508864790201187
mice O 0 0.01240952406078577
very O 0 0.008472784422338009
closely O 0 0.0119728809222579
mimic O 1 0.9664945006370544
severe O 1 0.9999955892562866
human O 1 0.9999657869338989
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9889839291572571
will O 0 0.023214075714349747
be O 0 0.005401648115366697
very O 0 0.005655565299093723
useful O 0 0.0059308502823114395
for O 0 0.005433706101030111
investigating O 0 0.0083613945171237
the O 0 0.006219178903847933
role O 0 0.008275842294096947
of O 0 0.008012824691832066
vWf O 1 0.9288039207458496
in O 0 0.00821130070835352
normal O 0 0.012110672891139984
physiology O 1 0.9557586908340454
and O 0 0.028331659734249115
in O 0 0.1758679747581482
disease O 1 0.9999810457229614
models O 0 0.2987865209579468
. O 0 0.01908467337489128
. O 0 0.03278551623225212

Oral O 1 0.890792965888977
contraceptives O 1 0.9765918850898743
and O 0 0.026241375133395195
the O 0 0.03281094878911972
risk O 1 0.9965215921401978
of O 1 0.9997870326042175
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9982550740242004

Hereditary B-Disease 1 0.9999998807907104
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999974966049194
Study O 1 0.9880870580673218
Group O 1 0.7207881212234497
. O 0 0.06350374221801758

BACKGROUND O 0 0.05779320001602173
Women O 0 0.028318088501691818
with O 0 0.014906867407262325
mutations O 0 0.01366505865007639
in O 0 0.0077352640219032764
either O 0 0.007707038428634405
the O 0 0.011612435802817345
BRCA1 O 1 0.9982085227966309
or O 0 0.010488446801900864
the O 0 0.06983544677495956
BRCA2 O 1 0.9994493126869202
gene O 0 0.007506580092012882
have O 0 0.005173154640942812
a O 0 0.00867688748985529
high O 0 0.06202812120318413
lifetime O 1 0.9898293614387512
risk O 1 0.9991253018379211
of O 1 0.9990202188491821
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.7797062993049622

Oral O 1 0.980059802532196
contraceptives O 1 0.9998677968978882
protect O 1 0.9993208646774292
against O 1 0.9999696016311646
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.9577729105949402
general O 1 0.9948902130126953
, O 0 0.13560856878757477
but O 0 0.005448858253657818
it O 0 0.004364124499261379
is O 0 0.004386106040328741
not O 0 0.0037042705807834864
known O 0 0.004569441545754671
whether O 0 0.004666201304644346
they O 0 0.004030978307127953
also O 0 0.005504045635461807
protect O 0 0.009371901862323284
against O 0 0.012247076258063316
hereditary B-Disease 1 0.9997497200965881
forms I-Disease 1 0.981092095375061
of I-Disease 1 0.9999395608901978
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9767814874649048

METHODS O 0 0.0410882905125618
We O 0 0.024641355499625206
enrolled O 0 0.03195326775312424
207 O 0 0.14960210025310516
women O 0 0.0631902888417244
with O 1 0.8546307682991028
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9862676858901978
161 O 1 0.9964125752449036
of O 0 0.06277927756309509
their O 0 0.010560798458755016
sisters O 0 0.1875428706407547
as O 0 0.008906533010303974
controls O 0 0.01243697851896286
in O 0 0.008684593252837658
a O 0 0.011496459133923054
case O 0 0.017240531742572784
- O 0 0.25635501742362976
control O 0 0.02921617589890957
study O 0 0.033914580941200256
. O 0 0.04041652753949165

All O 0 0.02728341706097126
the O 0 0.022582337260246277
patients O 0 0.33787256479263306
carried O 0 0.01563078910112381
a O 0 0.013699511997401714
pathogenic O 0 0.18949581682682037
mutation O 0 0.012413257732987404
in O 0 0.00854200404137373
either O 0 0.00943251047283411
BRCA1 O 1 0.9759179353713989
( O 0 0.011992957442998886
179 O 0 0.0915236696600914
women O 0 0.018600299954414368
) O 0 0.013065717183053493
or O 0 0.015576700679957867
BRCA2 O 1 0.9883227944374084
( O 0 0.01887071132659912
28 O 0 0.0281534381210804
women O 0 0.030356181785464287
) O 0 0.03354887291789055
. O 0 0.04716184735298157

The O 0 0.0332653671503067
control O 0 0.0302127692848444
women O 0 0.020686956122517586
were O 0 0.010758907534182072
enrolled O 0 0.039651840925216675
regardless O 0 0.01116000022739172
of O 0 0.007765728980302811
whether O 0 0.007657601963728666
or O 0 0.006538887042552233
not O 0 0.006464304402470589
they O 0 0.007558460347354412
had O 0 0.014665735885500908
either O 0 0.017709212377667427
mutation O 0 0.035605862736701965
. O 0 0.038458820432424545

Lifetime O 0 0.07174603641033173
histories O 0 0.0398891419172287
of O 0 0.02286185696721077
oral O 1 0.9989796280860901
- O 1 0.9996079802513123
contraceptive O 1 0.9999483823776245
use O 0 0.010296500287950039
were O 0 0.007084101438522339
obtained O 0 0.008150325156748295
by O 0 0.005766678135842085
interview O 0 0.009690952487289906
or O 0 0.006098432466387749
by O 0 0.005279120057821274
written O 0 0.006792900152504444
questionnaire O 0 0.012217634357511997
and O 0 0.005530030466616154
were O 0 0.005550556816160679
compared O 0 0.006960581056773663
between O 0 0.006260731723159552
patients O 1 0.7734969854354858
and O 0 0.00757928192615509
control O 0 0.10523513704538345
women O 0 0.06797979027032852
, O 0 0.008283231407403946
after O 0 0.009417152032256126
adjustment O 0 0.09782181680202484
for O 0 0.006931439507752657
year O 0 0.010357022285461426
of O 0 0.013142651878297329
birth O 0 0.1701769232749939
and O 0 0.021946782246232033
parity O 0 0.3189696967601776
. O 0 0.041547805070877075

RESULTS O 0 0.031313423067331314
The O 0 0.021578727290034294
adjusted O 0 0.026181135326623917
odds O 0 0.04094703122973442
ratio O 0 0.14322711527347565
for O 1 0.808864176273346
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
associated O 0 0.07864438742399216
with O 0 0.008119460195302963
any O 0 0.0077498909085989
past O 0 0.00878528505563736
use O 0 0.009549003094434738
of O 0 0.013088659383356571
oral O 1 0.9925582408905029
contraceptives O 1 0.99982750415802
was O 1 0.6661977767944336
0 O 0 0.047386251389980316
. O 0 0.04770589992403984

5 O 0 0.039842769503593445
( O 0 0.024307142943143845
95 O 0 0.02847476117312908
percent O 0 0.018747912719845772
confidence O 0 0.02011190727353096
interval O 0 0.017921213060617447
, O 0 0.011161956936120987
0 O 0 0.012202481739223003
. O 0 0.009150496684014797
3 O 0 0.012639841064810753
to O 0 0.01006384938955307
0 O 0 0.016634942963719368
. O 0 0.01349814236164093
8 O 0 0.026159079745411873
) O 0 0.027674810960888863
. O 0 0.04222660884261131

The O 0 0.038159698247909546
risk O 0 0.4177839756011963
decreased O 0 0.038958482444286346
with O 0 0.009405860677361488
increasing O 0 0.009782434441149235
duration O 0 0.013364456593990326
of O 0 0.007056919392198324
use O 0 0.006640479899942875
( O 0 0.008338096551597118
P O 0 0.014250926673412323
for O 0 0.007133569568395615
trend O 0 0.011608856730163097
, O 0 0.008706420660018921
< O 0 0.019385626539587975
0 O 0 0.013097384013235569
. O 0 0.00880824401974678
001 O 0 0.0368397980928421
) O 0 0.00840251799672842
; O 0 0.00650555407628417
use O 0 0.005656884517520666
for O 0 0.0048339334316551685
six O 0 0.005662194918841124
or O 0 0.00449809804558754
more O 0 0.004447894170880318
years O 0 0.005465356633067131
was O 0 0.006664620712399483
associated O 0 0.005160229746252298
with O 0 0.004941034596413374
a O 0 0.00704039866104722
60 O 0 0.011514306999742985
percent O 0 0.012493034824728966
reduction O 0 0.021113235503435135
in O 0 0.01718909479677677
risk O 0 0.06949753314256668
. O 0 0.035094257444143295

Oral O 1 0.9086834788322449
- O 1 0.9513930082321167
contraceptive O 1 0.9989157915115356
use O 0 0.020390143617987633
protected O 1 0.9767013788223267
against O 1 0.9987590312957764
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
both O 0 0.01570146717131138
for O 0 0.010161790065467358
carriers O 0 0.16729290783405304
of O 0 0.009852372109889984
the O 0 0.09211087226867676
BRCA1 O 1 0.9995480179786682
mutation O 0 0.06640250980854034
( O 0 0.009518141858279705
odds O 0 0.01807749830186367
ratio O 0 0.00991457886993885
, O 0 0.007292666472494602
0 O 0 0.00917887780815363
. O 0 0.005967514589428902
5 O 0 0.008420762605965137
; O 0 0.007003221195191145
95 O 0 0.01199672557413578
percent O 0 0.01085361186414957
confidence O 0 0.012997603043913841
interval O 0 0.012304014526307583
, O 0 0.008331718854606152
0 O 0 0.010019565932452679
. O 0 0.006542403716593981
3 O 0 0.008004722185432911
to O 0 0.0065805260092020035
0 O 0 0.010322908870875835
. O 0 0.007121522910892963
9 O 0 0.009160308167338371
) O 0 0.007347522769123316
and O 0 0.006759591866284609
for O 0 0.006898922845721245
carriers O 0 0.010898404754698277
of O 0 0.00741901621222496
the O 0 0.011762146838009357
BRCA2 O 1 0.9995896220207214
mutation O 0 0.03218082711100578
( O 0 0.00958408135920763
odds O 0 0.018317269161343575
ratio O 0 0.012508892454206944
, O 0 0.008737844415009022
0 O 0 0.010779175907373428
. O 0 0.007227338384836912
4 O 0 0.0105593828484416
; O 0 0.008188420906662941
95 O 0 0.013926134444773197
percent O 0 0.012598305940628052
confidence O 0 0.01519323606044054
interval O 0 0.014454188756644726
, O 0 0.010218213312327862
0 O 0 0.012495187111198902
. O 0 0.0077292053028941154
2 O 0 0.010938095860183239
to O 0 0.008801127783954144
1 O 0 0.013297579251229763
. O 0 0.013839048333466053
1 O 0 0.022685956209897995
) O 0 0.026554329320788383
. O 0 0.042079705744981766

CONCLUSIONS O 0 0.05918937921524048
Oral O 1 0.9306495785713196
- O 1 0.9852690100669861
contraceptive O 1 0.9996094107627869
use O 0 0.01156429573893547
may O 0 0.009936332702636719
reduce O 0 0.01155622024089098
the O 0 0.009642232209444046
risk O 1 0.9651089310646057
of O 1 0.9978087544441223
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.8916847109794617
women O 1 0.9240190386772156
with O 0 0.08030666410923004
pathogenic O 1 0.9155793190002441
mutations O 0 0.046076517552137375
in O 0 0.011953256092965603
the O 0 0.13212339580059052
BRCA1 O 1 0.9999417066574097
or O 0 0.33427533507347107
BRCA2 O 1 0.9995570778846741
gene O 0 0.09632693231105804

A O 0 0.04820021614432335
Japanese O 0 0.0670105516910553
family O 0 0.03044792078435421
with O 0 0.019933225587010384
adrenoleukodystrophy B-Disease 1 0.9999948740005493
with O 0 0.014022771269083023
a O 0 0.01830657199025154
codon O 0 0.04259377345442772
291 O 0 0.3099137246608734
deletion O 0 0.1369585245847702
: O 0 0.012228067964315414
a O 0 0.012979844585061073
clinical O 1 0.9773288369178772
, O 0 0.022089606150984764
biochemical O 1 0.8104674220085144
, O 0 0.01996040903031826
pathological O 1 0.9602985382080078
, O 0 0.016643626615405083
and O 0 0.01745406910777092
genetic O 0 0.05335155129432678
report O 0 0.031390149146318436
. O 0 0.0381438322365284

We O 0 0.028540711849927902
report O 0 0.021842477843165398
a O 0 0.016334909945726395
Japanese O 0 0.0335167832672596
family O 0 0.07703223824501038
with O 1 0.7724817395210266
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.999401330947876
ALD B-Disease 1 1.0
) O 0 0.012158355675637722
with O 0 0.007840528152883053
a O 0 0.009245933033525944
three O 0 0.008163020946085453
base O 0 0.014598222449421883
pair O 0 0.019432740285992622
deletion O 0 0.16594071686267853
( O 0 0.0163299310952425
delGAG O 1 0.7323681712150574
291 O 0 0.0695590078830719
) O 0 0.014993816614151001
in O 0 0.01798243634402752
the O 0 0.029156174510717392
ALD B-Disease 1 0.9999948740005493
gene O 0 0.06180248409509659
. O 0 0.05173758044838905

A O 0 0.0411766953766346
variety O 0 0.028104988858103752
of O 0 0.020421694964170456
phenotypes O 0 0.21708734333515167
were O 0 0.013967735692858696
observed O 0 0.019602466374635696
within O 0 0.01746947318315506
this O 0 0.018271658569574356
family O 0 0.03356464207172394
. O 0 0.04045507311820984

While O 0 0.031768910586833954
the O 0 0.0223687794059515
proband O 1 0.9906997084617615
( O 0 0.027975594624876976
patient O 1 0.9487427473068237
1 O 0 0.04211112856864929
) O 0 0.008389942348003387
was O 0 0.00938909500837326
classified O 0 0.009835904464125633
as O 0 0.006869093980640173
having O 0 0.00682038813829422
a O 0 0.006987765897065401
rare O 0 0.016521310433745384
intermediate O 0 0.06338679790496826
type O 0 0.013324245810508728
of O 0 0.008099225349724293
adult O 0 0.2695205807685852
cerebral O 1 0.9998904466629028
and O 0 0.3961847424507141
cerebello O 1 0.9999916553497314
- O 1 0.9998629093170166
brain O 1 0.9889817833900452
stem O 0 0.026833992451429367
forms O 0 0.00791492685675621
, O 0 0.006746415048837662
his O 0 0.013304193504154682
younger O 0 0.16462810337543488
brother O 0 0.41317492723464966
( O 0 0.01113556232303381
patient O 0 0.33277764916419983
2 O 0 0.010472024790942669
) O 0 0.008290428668260574
and O 0 0.00890623964369297
nephew O 1 0.8249807357788086
( O 0 0.011345041915774345
patient O 1 0.7962959408760071
3 O 0 0.015116174705326557
) O 0 0.010455525480210781
had O 0 0.014732668176293373
a O 0 0.36255213618278503
childhood O 1 0.9999747276306152
ALD B-Disease 1 0.9999998807907104
type O 1 0.9975842237472534
. O 0 0.06146042048931122

Another O 0 0.05351267755031586
nephew O 1 0.9901720881462097
( O 0 0.02366749197244644
patient O 1 0.6375399827957153
4 O 0 0.01649215817451477
) O 0 0.010014303028583527
of O 0 0.010786378756165504
patient O 1 0.5984077453613281
1 O 0 0.015043385326862335
was O 0 0.013946512714028358
classified O 0 0.01420129556208849
as O 0 0.01021954882889986
having O 0 0.014471854083240032
an O 0 0.018782291561365128
adolescent O 1 0.9960989952087402
form O 0 0.03686801716685295
. O 0 0.04006454721093178

The O 0 0.0400439016520977
tau O 0 0.046805791556835175
level O 0 0.01882900670170784
in O 0 0.012785744853317738
the O 0 0.016811778768897057
cerebrospinal O 1 0.9999570846557617
fluid O 1 0.996968686580658
( O 1 0.5919934511184692
CSF O 1 0.9999231100082397
) O 0 0.00962779764086008
in O 0 0.007623243611305952
patient O 0 0.3778340518474579
1 O 0 0.009288697503507137
was O 0 0.008208667859435081
as O 0 0.006142060738056898
high O 0 0.006792125757783651
as O 0 0.00529894046485424
that O 0 0.004828032571822405
of O 0 0.00868529174476862
patients O 1 0.9995244741439819
with O 1 0.9991163611412048
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9986892342567444
AD B-Disease 1 0.9994558691978455
) O 0 0.03196999430656433
. O 0 0.04188667610287666

His O 0 0.05782032012939453
brain O 1 0.5408201813697815
magnetic O 0 0.03032875247299671
resonance O 0 0.034243542701005936
image O 0 0.3075343668460846
( O 0 0.03922191262245178
MRI O 1 0.9714471101760864
) O 0 0.010379372164607048
showed O 0 0.013803151436150074
abnormalities B-Disease 0 0.13377982378005981
in I-Disease 0 0.006433513015508652
the I-Disease 0 0.013534961268305779
bilateral I-Disease 1 0.99800044298172
cerebellar I-Disease 1 0.9999997615814209
hemispheres I-Disease 1 0.9998736381530762
and O 1 0.9642444849014282
brain O 1 0.9996223449707031
stem O 1 0.5240786671638489
, O 0 0.006536914501339197
but O 0 0.003902226220816374
not O 0 0.0033691765274852514
in O 0 0.00434845918789506
the O 0 0.021017586812376976
cerebral O 1 0.9998093247413635
white O 0 0.15596966445446014
matter O 0 0.006780953146517277
, O 0 0.005992679391056299
where O 0 0.005857480224221945
marked O 0 0.007493769284337759
reductions O 0 0.009019661694765091
of O 0 0.007075634319335222
the O 0 0.07826033979654312
cerebral O 1 0.999984860420227
blood O 1 0.9167917966842651
flow O 0 0.01237411331385374
and O 0 0.011519957333803177
oxygen O 0 0.40675121545791626
metabolism O 0 0.022735564038157463
were O 0 0.007150699850171804
clearly O 0 0.011001469567418098
demonstrated O 0 0.012896625325083733
by O 0 0.010924872010946274
positron O 0 0.31982576847076416
emission O 0 0.04629584029316902
tomography O 0 0.14354082942008972
( O 0 0.02850743569433689
PET O 0 0.3908229470252991
) O 0 0.03827139735221863
. O 0 0.04927236586809158

In O 0 0.02757413499057293
patients O 0 0.3176751732826233
2 O 0 0.01716209575533867
and O 0 0.00994189828634262
3 O 0 0.012196125462651253
, O 0 0.008465313352644444
the O 0 0.007146509364247322
autopsy O 0 0.01377909816801548
findings O 0 0.009942819364368916
showed O 0 0.013028065674006939
massive O 1 0.7539732456207275
demyelination B-Disease 1 0.9999902248382568
of I-Disease 0 0.2710396945476532
the I-Disease 1 0.8091656565666199
cerebral I-Disease 1 0.9999797344207764
white I-Disease 0 0.15942992269992828
matter I-Disease 0 0.008184170350432396
with O 0 0.00587614718824625
sparing O 0 0.09053065627813339
of O 0 0.008594444952905178
the O 0 0.2903314530849457
U O 1 0.9999608993530273
- O 1 0.9994006156921387
fibers O 1 0.9829112887382507
, O 0 0.008482467383146286
compatible O 0 0.013435742817819118
with O 0 0.009339521639049053
the O 0 0.011450933292508125
findings O 0 0.019218312576413155
of O 0 0.056565362960100174
childhood O 1 0.999896764755249
ALD B-Disease 1 0.9999996423721313
. O 0 0.3823631703853607

Oleic O 1 0.9693244099617004
and O 0 0.06281007826328278
erucic O 1 0.9993057250976562
acids O 0 0.03596889600157738
( O 0 0.022383851930499077
Lorenzos O 1 0.719090461730957
Oil O 0 0.01791132241487503
) O 0 0.010718302801251411
were O 0 0.007758917286992073
administered O 0 0.010288761928677559
to O 0 0.00745801767334342
patients O 0 0.11631038039922714
1 O 0 0.008731812238693237
and O 0 0.007055502384901047
4 O 0 0.009678119793534279
, O 0 0.0077220299281179905
but O 0 0.0069507332518696785
sufficient O 0 0.01214640960097313
effectiveness O 0 0.025439053773880005
was O 0 0.015758920460939407
not O 0 0.01475929282605648
obtained O 0 0.025810645893216133
. O 0 0.03681013733148575

The O 0 0.02815958485007286
findings O 0 0.024635838344693184
in O 0 0.01317586749792099
this O 0 0.009761214256286621
family O 0 0.01194500457495451
suggest O 0 0.009674236178398132
that O 0 0.006652267184108496
delGAG291 O 0 0.1538945585489273
is O 0 0.00784406065940857
part O 0 0.008246581070125103
of O 0 0.007302474230527878
the O 0 0.010323249734938145
cause O 0 0.4616304039955139
of O 0 0.0893862321972847
Japanese O 1 0.9994706511497498
ALD B-Disease 1 0.9999998807907104
with O 0 0.16266034543514252
phenotypic O 1 0.8024354577064514
variations O 0 0.047650646418333054
. O 0 0.043709710240364075

Moreover O 0 0.04403374344110489
, O 0 0.017505809664726257
although O 0 0.010739123448729515
the O 0 0.008710191585123539
scale O 0 0.009294026531279087
of O 0 0.006173346657305956
the O 0 0.006647149100899696
study O 0 0.007184999994933605
is O 0 0.005980596411973238
limited O 0 0.00671122083440423
, O 0 0.005597908515483141
there O 0 0.004500756971538067
is O 0 0.004609777592122555
a O 0 0.005441893823444843
possibility O 0 0.00720774382352829
that O 0 0.005894549190998077
PET O 0 0.18844984471797943
can O 0 0.006475691217929125
detect O 0 0.013894216157495975
an O 0 0.012200912460684776
insidious B-Disease 1 0.9999059438705444
lesion I-Disease 1 0.999962329864502
which O 0 0.007367227226495743
is O 0 0.008509347215294838
undetectable O 0 0.3737958073616028
by O 0 0.006822607479989529
computed O 0 0.013638938777148724
tomogram O 1 0.9560418725013733
( O 0 0.0345383882522583
CT O 1 0.9845595955848694
) O 0 0.010144995525479317
or O 0 0.00867199245840311
MRI O 0 0.05567135661840439
analysis O 0 0.007113664876669645
, O 0 0.005963332951068878
and O 0 0.005129931028932333
that O 0 0.004522526636719704
the O 0 0.004931216593831778
higher O 0 0.006423614453524351
level O 0 0.006925196386873722
of O 0 0.0073446654714643955
tau O 0 0.03274744004011154
reflects O 0 0.012984861619770527
the O 0 0.00936543196439743
process O 0 0.01094615738838911
of O 0 0.018658462911844254
neuronal B-Disease 1 0.9873895645141602
degeneration I-Disease 1 0.9999986886978149
in O 1 0.901100754737854
ALD B-Disease 1 0.9999998807907104
. O 0 0.23988255858421326

Lorenzos O 1 0.7421433925628662
Oil O 0 0.04199643060564995
should O 0 0.01894243247807026
be O 0 0.010767538100481033
given O 0 0.009832014329731464
in O 0 0.009674692526459694
the O 0 0.011157572269439697
early O 0 0.014537710696458817
stage O 0 0.03726375102996826
. O 0 0.024020273238420486
. O 0 0.03724852576851845

Nonsense O 0 0.0880906879901886
mutation O 0 0.03681132197380066
in O 0 0.019850198179483414
exon O 0 0.03652415797114372
4 O 0 0.01655859686434269
of O 0 0.012334032915532589
human O 0 0.014072740450501442
complement O 1 0.7891736626625061
C9 O 1 0.9998795986175537
gene O 0 0.013372853398323059
is O 0 0.009259330108761787
the O 0 0.00963369756937027
major O 0 0.015825578942894936
cause O 0 0.2355639785528183
of O 0 0.14599846303462982
Japanese O 1 0.9997616410255432
complement B-Disease 1 0.9999769926071167
C9 I-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999997615814209
. O 0 0.31104448437690735

Deficiency B-Disease 1 0.9999533891677856
of I-Disease 0 0.0242699533700943
the I-Disease 0 0.037126604467630386
ninth I-Disease 1 0.9980860948562622
component I-Disease 1 0.8449524641036987
of I-Disease 0 0.020232059061527252
human I-Disease 0 0.2255953699350357
complement I-Disease 1 0.9972773194313049
( O 1 0.8760935664176941
C9 O 1 0.9999887943267822
) O 0 0.008282294496893883
is O 0 0.006287262309342623
the O 0 0.006944975815713406
most O 0 0.006409579887986183
common O 0 0.20466017723083496
complement B-Disease 1 0.9996683597564697
deficiency I-Disease 1 0.9999998807907104
in O 0 0.14787933230400085
Japan O 1 0.9657577872276306
but O 0 0.010137921199202538
is O 0 0.009149105288088322
rare O 0 0.014837432652711868
in O 0 0.009715565480291843
other O 0 0.011901622638106346
countries O 0 0.01806977577507496
. O 0 0.03290526196360588

We O 0 0.030773555859923363
studied O 0 0.02403642050921917
the O 0 0.014326811768114567
molecular O 0 0.01462497841566801
basis O 0 0.01230568252503872
of O 0 0.01907762512564659
C9 B-Disease 1 0.9999939203262329
deficiency I-Disease 1 0.9999949932098389
in O 0 0.013076076284050941
four O 0 0.019749503582715988
Japanese O 1 0.9976856708526611
C9 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999830722808838
deficient I-Disease 1 0.9999942779541016
patients O 1 0.9996522665023804
who O 1 0.9293359518051147
had O 1 0.9946942925453186
suffered O 1 0.9999997615814209
from O 1 0.9997281432151794
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.9842627644538879

Direct O 0 0.0499439500272274
sequencing O 0 0.048163168132305145
of O 0 0.031437162309885025
amplified O 0 0.08264473080635071
C9 O 1 0.9963738322257996
cDNA O 0 0.045950308442115784
and O 0 0.017695309594273567
DNA O 0 0.017429169267416
revealed O 0 0.01696559228003025
a O 0 0.013406497426331043
nonsense O 0 0.02391674369573593
substitution O 0 0.0190459992736578
( O 0 0.015888093039393425
CGA O 0 0.4933565855026245
- O 1 0.8705755472183228
- O 1 0.8381065130233765
> O 1 0.7495054602622986
TGA O 1 0.8997218608856201
) O 0 0.015785472467541695
at O 0 0.015111745335161686
codon O 0 0.021556498482823372
95 O 0 0.019781792536377907
in O 0 0.013775371946394444
exon O 0 0.02286558784544468
4 O 0 0.014851385727524757
in O 0 0.0111162094399333
the O 0 0.012986951507627964
four O 0 0.021432431414723396
C9 B-Disease 1 0.9999567270278931
- I-Disease 1 0.9813327789306641
deficient I-Disease 1 0.9786996841430664
individuals O 0 0.03358311206102371
. O 0 0.043120693415403366

An O 0 0.0379001647233963
allele O 0 0.044727664440870285
- O 0 0.04104939103126526
specific O 0 0.014612585306167603
polymerase O 0 0.12864316999912262
chain O 0 0.03415380045771599
reaction O 0 0.01217320840805769
system O 0 0.009807038120925426
designed O 0 0.011510188691318035
to O 0 0.007826374843716621
detect O 0 0.011040013283491135
exclusively O 0 0.009025916457176208
only O 0 0.005571655463427305
one O 0 0.005024257581681013
of O 0 0.00509976502507925
the O 0 0.005866267252713442
normal O 0 0.006466683465987444
and O 0 0.007111876271665096
mutant O 0 0.03456749767065048
alleles O 0 0.009420448914170265
indicated O 0 0.006462408695369959
that O 0 0.003968310076743364
all O 0 0.0041581327095627785
the O 0 0.005732632242143154
four O 0 0.007360666990280151
patients O 0 0.0699828565120697
were O 0 0.005444384645670652
homozygous O 0 0.00913670752197504
for O 0 0.005785096436738968
the O 0 0.007134482264518738
mutation O 0 0.0090749841183424
in O 0 0.007526814006268978
exon O 0 0.032493915408849716
4 O 0 0.011111308820545673
and O 0 0.007677051238715649
that O 0 0.0064084772020578384
the O 0 0.008559556677937508
parents O 0 0.012494788505136967
of O 0 0.01137598603963852
patient O 1 0.6496167778968811
2 O 0 0.024489061906933784
were O 0 0.02408149652183056
heterozygous O 0 0.046641021966934204
. O 0 0.0434148833155632

The O 0 0.03269350901246071
common O 0 0.021035490557551384
mutation O 0 0.020429298281669617
at O 0 0.014876263216137886
codon O 0 0.0212253350764513
95 O 0 0.020223459228873253
in O 0 0.011869882233440876
exon O 0 0.029629681259393692
4 O 0 0.014645778574049473
might O 0 0.009948641061782837
be O 0 0.008038322441279888
responsible O 0 0.010042721405625343
for O 0 0.009831378236413002
most O 0 0.016183553263545036
Japanese O 1 0.9979403614997864
C9 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
. O 0 0.049179863184690475
. O 0 0.04906613752245903

BRCA1 O 1 0.6761243343353271
required O 0 0.025282077491283417
for O 0 0.021268676966428757
transcription O 0 0.05487590283155441
- O 1 0.8387665152549744
coupled O 1 0.898812472820282
repair O 1 0.9981247782707214
of O 0 0.11810553818941116
oxidative O 1 0.9962987303733826
DNA O 0 0.13058049976825714
damage O 1 0.8313277959823608
. O 0 0.04652763903141022

The O 1 0.6929455995559692
breast B-Disease 1 0.9999991655349731
and I-Disease 1 0.9997220635414124
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 0.9999994039535522
gene O 1 0.9986677169799805
BRCA1 O 1 0.9999918937683105
encodes O 1 0.9576485753059387
a O 1 0.9488146901130676
zinc O 1 0.9999914169311523
finger O 1 0.9499886631965637
protein O 0 0.019013306125998497
of O 0 0.017560241743922234
unknown O 0 0.02601962722837925
function O 0 0.028916357085108757
. O 0 0.03733240067958832

Association O 0 0.039618123322725296
of O 0 0.02090364694595337
the O 0 0.02136913314461708
BRCA1 O 1 0.9847050905227661
protein O 0 0.012699094600975513
with O 0 0.008055537939071655
the O 0 0.009891364723443985
DNA O 0 0.01491515338420868
repair O 1 0.9820764064788818
protein O 0 0.015019106678664684
Rad51 O 1 0.8507311344146729
and O 0 0.007958165369927883
changes O 0 0.006822396535426378
in O 0 0.006299703381955624
the O 0 0.006745136342942715
phosphorylation O 0 0.009092087857425213
and O 0 0.006691864691674709
cellular O 0 0.011966136284172535
localization O 0 0.012372801080346107
of O 0 0.006621988490223885
the O 0 0.007034800946712494
protein O 0 0.007540297228842974
after O 0 0.007888497784733772
exposure O 0 0.010932176373898983
to O 0 0.008254013955593109
DNA O 0 0.009547930210828781
- O 0 0.05879834294319153
damaging O 0 0.02449348196387291
agents O 0 0.008841636590659618
are O 0 0.005748267285525799
consistent O 0 0.009576886892318726
with O 0 0.006718392483890057
a O 0 0.008950834162533283
role O 0 0.013147124089300632
for O 0 0.013746216893196106
BRCA1 O 1 0.9923595786094666
in O 0 0.018937010318040848
DNA O 0 0.03902772441506386
repair O 1 0.9734881520271301
. O 0 0.0484134666621685

Here O 0 0.03094799816608429
, O 0 0.01749100536108017
it O 0 0.010811975225806236
is O 0 0.008699310943484306
shown O 0 0.008509380742907524
that O 0 0.0068550752475857735
mouse O 0 0.026230493560433388
embryonic O 0 0.041879940778017044
stem O 0 0.09582246094942093
cells O 0 0.028322773054242134
deficient B-Disease 1 0.9788013100624084
in I-Disease 0 0.021887941285967827
BRCA1 I-Disease 1 0.9993435740470886
are O 0 0.006297938991338015
defective O 1 0.8038671016693115
in O 0 0.0063132187351584435
the O 0 0.006274624727666378
ability O 0 0.006953392177820206
to O 0 0.006114587187767029
carry O 0 0.007719805464148521
out O 0 0.008608553558588028
transcription O 0 0.012151079252362251
- O 0 0.05699620768427849
coupled O 0 0.10249987244606018
repair O 1 0.8668281435966492
of O 0 0.014053374528884888
oxidative O 1 0.9667841196060181
DNA O 0 0.03740834444761276
damage O 1 0.6143745183944702
, O 0 0.009923292323946953
and O 0 0.008786704391241074
are O 0 0.0076494598761200905
hypersensitive O 1 0.9422875046730042
to O 0 0.01779096946120262
ionizing O 1 0.9956099390983582
radiation O 1 0.9556722640991211
and O 0 0.0318281464278698
hydrogen O 0 0.17155228555202484
peroxide O 1 0.7809486389160156
. O 0 0.05555688217282295

These O 0 0.023675424978137016
results O 0 0.016146697103977203
suggest O 0 0.014641237445175648
that O 0 0.010515875183045864
BRCA1 O 1 0.9949970245361328
participates O 0 0.033126939088106155
, O 0 0.00927654653787613
directly O 0 0.007998229935765266
or O 0 0.006822391413152218
indirectly O 0 0.009045761078596115
, O 0 0.006873099133372307
in O 0 0.007343601435422897
transcription O 0 0.018805649131536484
- O 1 0.608121395111084
coupled O 1 0.7270784378051758
repair O 1 0.9894540309906006
of O 0 0.0856047123670578
oxidative O 1 0.9967275857925415
DNA O 0 0.1141493022441864
damage O 1 0.5804702639579773
. O 0 0.025903278961777687
. O 0 0.04047892615199089

Truncation O 0 0.2937571406364441
mutations O 0 0.03330608829855919
in O 0 0.01766945794224739
the O 0 0.01554636936634779
transactivation O 1 0.9612253904342651
region O 0 0.02621048502624035
of O 0 0.04841278865933418
PAX6 O 1 0.9999949932098389
result O 0 0.27867719531059265
in O 0 0.02926183119416237
dominant O 1 0.9938949942588806
- O 1 0.9934992790222168
negative O 0 0.10069884359836578
mutants O 0 0.41266024112701416
. O 0 0.04280250146985054

PAX6 O 1 0.995276689529419
is O 0 0.02844308130443096
a O 0 0.022542966529726982
transcription O 0 0.021475594490766525
factor O 0 0.015448713675141335
with O 0 0.008765725418925285
two O 0 0.007884069345891476
DNA O 0 0.010566315613687038
- O 0 0.017607547342777252
binding O 0 0.011333880946040154
domains O 0 0.014137432910501957
( O 0 0.010146360844373703
paired O 0 0.022704612463712692
box O 0 0.047515761107206345
and O 0 0.012967168353497982
homeobox O 1 0.8921440839767456
) O 0 0.011255868710577488
and O 0 0.011309062130749226
a O 0 0.014641527086496353
proline O 0 0.11356110870838165
- O 0 0.37696996331214905
serine O 0 0.16248860955238342
- O 1 0.8221043348312378
threonine O 1 0.5596884489059448
( O 0 0.024509869515895844
PST O 1 0.9684910774230957
) O 0 0.025273628532886505
- O 0 0.04603859409689903
rich O 0 0.04588792100548744
transactivation O 1 0.6292624473571777
domain O 0 0.06207253783941269
. O 0 0.0574941411614418

PAX6 O 1 0.9998393058776855
regulates O 1 0.8646278977394104
eye O 1 0.9808273315429688
development O 0 0.038541410118341446
in O 0 0.014332200400531292
animals O 0 0.012601854279637337
ranging O 0 0.01722286269068718
from O 0 0.011230858974158764
jellyfish O 0 0.03365800157189369
to O 0 0.015235044993460178
Drosophila O 0 0.032988663762807846
to O 0 0.020917857065796852
humans O 0 0.031356342136859894
. O 0 0.03855837509036064

Heterozygous O 0 0.06585663557052612
mutations O 0 0.029273061081767082
in O 0 0.015219442546367645
the O 0 0.014221862889826298
human O 0 0.048811789602041245
PAX6 O 1 0.9999686479568481
gene O 0 0.016456469893455505
result O 0 0.008883518166840076
in O 0 0.007499250583350658
various O 0 0.008700701408088207
phenotypes O 0 0.028480909764766693
, O 0 0.009326480329036713
including O 0 0.011144213378429413
aniridia B-Disease 1 0.9989849925041199
, O 0 0.02652599662542343
Peters B-Disease 1 0.9957772493362427
anomaly I-Disease 1 0.9984488487243652
, O 0 0.3270416259765625
autosomal B-Disease 1 0.9998960494995117
dominant I-Disease 1 0.999874472618103
keratitis I-Disease 1 0.9999998807907104
, O 1 0.9830828905105591
and O 1 0.9899695515632629
familial B-Disease 1 0.9999996423721313
foveal I-Disease 1 0.9999994039535522
dysplasia I-Disease 1 0.9999997615814209
. O 1 0.6292365789413452

It O 0 0.028731631115078926
is O 0 0.01637694239616394
believed O 0 0.014256935566663742
that O 0 0.008686039596796036
the O 0 0.011325618252158165
mutated O 0 0.11026008427143097
allele O 0 0.0298885740339756
of O 0 0.015472594648599625
PAX6 O 1 0.9999594688415527
produces O 0 0.040560103952884674
an O 0 0.011469797231256962
inactive O 1 0.6432125568389893
protein O 0 0.015445943921804428
and O 0 0.012132976204156876
aniridia B-Disease 1 0.9987309575080872
is O 0 0.015159903094172478
caused O 0 0.1333402693271637
due O 0 0.01659131795167923
to O 0 0.020195312798023224
genetic O 0 0.06999235600233078
haploinsufficiency O 1 0.9659517407417297
. O 0 0.04873960465192795

However O 0 0.029963407665491104
, O 0 0.01801111362874508
several O 0 0.01464794110506773
truncation O 0 0.22631220519542694
mutations O 0 0.01226560678333044
have O 0 0.006211830768734217
been O 0 0.005920398514717817
found O 0 0.005196437705308199
to O 0 0.0050931693986058235
occur O 0 0.004587964620441198
in O 0 0.004482865799218416
the O 0 0.006330103613436222
C O 0 0.2960751950740814
- O 0 0.08343242108821869
terminal O 0 0.016445783898234367
half O 0 0.00985539611428976
of O 0 0.00940333679318428
PAX6 O 1 0.9978306889533997
in O 0 0.011935788206756115
patients O 1 0.829156756401062
with O 0 0.01165645383298397
Aniridia B-Disease 1 0.9998339414596558
resulting O 0 0.04255903512239456
in O 0 0.008908209390938282
mutant O 0 0.0437469407916069
proteins O 0 0.007926278747618198
that O 0 0.00542336655780673
retain O 0 0.01054807472974062
the O 0 0.00822706613689661
DNA O 0 0.010579493828117847
- O 0 0.023763315752148628
binding O 0 0.011140536516904831
domains O 0 0.012664918787777424
but O 0 0.007120403461158276
have O 0 0.007766384165734053
lost O 0 0.013056373223662376
most O 0 0.009701666422188282
of O 0 0.013341695070266724
the O 0 0.020802555605769157
transactivation O 1 0.975985050201416
domain O 0 0.06038511544466019
. O 0 0.05153574049472809

It O 0 0.025799240916967392
is O 0 0.01574959047138691
not O 0 0.009642473421990871
clear O 0 0.011245552450418472
whether O 0 0.009026658721268177
such O 0 0.00816506426781416
mutants O 0 0.06417431682348251
really O 0 0.01165844313800335
behave O 0 0.010566893965005875
as O 0 0.007645873818546534
loss O 0 0.19566762447357178
- O 0 0.43758514523506165
of O 0 0.014097029343247414
- O 1 0.9227571487426758
function O 0 0.014961428008973598
mutants O 0 0.03068351186811924
as O 0 0.014838548377156258
predicted O 0 0.027949145063757896
by O 0 0.024317333474755287
haploinsufficiency O 0 0.4768875539302826
. O 0 0.055319733917713165

Contrary O 0 0.038730498403310776
to O 0 0.017694950103759766
this O 0 0.011212034150958061
theory O 0 0.011745037510991096
, O 0 0.008415993303060532
our O 0 0.008177321404218674
data O 0 0.007517945487052202
showed O 0 0.008572453632950783
that O 0 0.005593848880380392
these O 0 0.0054139974527060986
mutants O 0 0.011922945268452168
are O 0 0.005833984352648258
dominant O 0 0.01851714961230755
- O 0 0.0847453773021698
negative O 0 0.011340871453285217
in O 0 0.01088931504637003
transient O 1 0.9259389638900757
transfection O 1 0.9823001027107239
assays O 0 0.01879001408815384
when O 0 0.009986512362957
they O 0 0.0068749613128602505
are O 0 0.00679557491093874
coexpressed O 0 0.026335984468460083
with O 0 0.011514529585838318
wild O 0 0.03836958855390549
- O 1 0.9821234345436096
type O 1 0.8853674530982971
PAX6 O 1 0.9994018077850342
. O 0 0.0552770234644413

We O 0 0.025790072977542877
found O 0 0.014605817385017872
that O 0 0.009218106046319008
the O 0 0.010860085487365723
dominant O 0 0.18408545851707458
- O 1 0.7754760384559631
negative O 0 0.013571632094681263
effects O 0 0.022900700569152832
result O 0 0.007660913281142712
from O 0 0.0066412948071956635
the O 0 0.008532806299626827
enhanced O 0 0.02342187613248825
DNA O 0 0.0141249168664217
binding O 0 0.012440184131264687
ability O 0 0.013426662422716618
of O 0 0.013760712929069996
these O 0 0.01761522889137268
mutants O 0 0.062458716332912445
. O 0 0.04468410834670067

Kinetic O 0 0.07378390431404114
studies O 0 0.030834173783659935
of O 0 0.02021290361881256
binding O 0 0.019630156457424164
and O 0 0.014149507507681847
dissociation O 0 0.05160045623779297
revealed O 0 0.01573934592306614
that O 0 0.008128675632178783
various O 0 0.009928971529006958
truncation O 0 0.025975191965699196
mutants O 0 0.01736540161073208
have O 0 0.006823062896728516
3 O 0 0.010521597228944302
- O 0 0.013469548895955086
5 O 0 0.011463776230812073
- O 0 0.014781027100980282
fold O 0 0.014876795001327991
higher O 0 0.008258962072432041
affinity O 0 0.009901720099151134
to O 0 0.006738309748470783
various O 0 0.006164692807942629
DNA O 0 0.00830991379916668
- O 0 0.009557322598993778
binding O 0 0.007028448395431042
sites O 0 0.007438494823873043
when O 0 0.007431991398334503
compared O 0 0.007326487917453051
with O 0 0.007597426418215036
the O 0 0.012197164818644524
wild O 0 0.025465572252869606
- O 1 0.9203049540519714
type O 1 0.6337219476699829
PAX6 O 1 0.9987872242927551
. O 0 0.05476575344800949

These O 0 0.02366510033607483
results O 0 0.01980224810540676
provide O 0 0.013968247920274734
a O 0 0.011247805319726467
new O 0 0.010690368711948395
insight O 0 0.01855218969285488
into O 0 0.008634380996227264
the O 0 0.00815076194703579
role O 0 0.01175492163747549
of O 0 0.01610702835023403
mutant O 1 0.9813845157623291
PAX6 O 1 0.9999860525131226
in O 0 0.07285961508750916
causing O 1 0.9930744171142578
aniridia B-Disease 1 0.999853253364563
. O 0 0.032169271260499954
. O 0 0.04503260925412178

Reversal O 1 0.9225995540618896
of O 1 0.9876598715782166
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9997244477272034
excellent O 1 0.999729335308075
neuropsychologic O 1 0.9998213648796082
outcome O 0 0.019136857241392136
in O 0 0.009172871708869934
very B-Disease 0 0.010116763412952423
- I-Disease 0 0.3104391396045685
long I-Disease 0 0.027306335046887398
- I-Disease 1 0.819817841053009
chain I-Disease 1 0.8506084680557251
acyl I-Disease 1 0.9980518817901611
- I-Disease 1 0.9959728121757507
coenzyme I-Disease 1 0.9987844824790955
A I-Disease 1 0.9947091341018677
dehydrogenase I-Disease 1 0.9998111128807068
deficiency I-Disease 1 0.9999971389770508
. O 0 0.08913765847682953

Very B-Disease 0 0.04065656661987305
- I-Disease 0 0.04989401251077652
long I-Disease 0 0.026449868455529213
- I-Disease 1 0.6737281084060669
chain I-Disease 1 0.6140791773796082
acyl I-Disease 1 0.9898989796638489
- I-Disease 1 0.974877119064331
coenzyme I-Disease 1 0.9922885298728943
A I-Disease 1 0.9101242423057556
dehydrogenase I-Disease 1 0.998445451259613
( I-Disease 1 0.9224329590797424
VLCAD I-Disease 1 0.9999980926513672
) I-Disease 1 0.8446759581565857
deficiency I-Disease 1 0.9999967813491821
is O 0 0.028913864865899086
a O 1 0.9236754775047302
disorder O 1 0.9999997615814209
of O 1 0.9980382323265076
fatty O 1 0.9999915361404419
acid O 1 0.9988897442817688
beta O 1 0.793580949306488
oxidation O 0 0.03631168231368065
that O 0 0.006722276099026203
reportedly O 0 0.013884328305721283
has O 0 0.008582491427659988
high O 0 0.013251478783786297
rates O 0 0.013580603525042534
of O 0 0.018755221739411354
morbidity O 1 0.9999289512634277
and O 0 0.21888910233974457
mortality O 1 0.9948246479034424
. O 0 0.04241029545664787

We O 0 0.029861638322472572
describe O 0 0.023897236213088036
the O 0 0.01255916990339756
outcome O 0 0.012490610592067242
of O 0 0.008837892673909664
a O 0 0.009063396602869034
5 O 0 0.00999558623880148
- O 0 0.01923208124935627
year O 0 0.009073982015252113
- O 0 0.09542866796255112
old O 0 0.03582892194390297
girl O 1 0.8426470756530762
with O 1 0.5657530426979065
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.8823764324188232
was O 0 0.24424710869789124
first O 0 0.007830368354916573
seen O 0 0.006748127285391092
at O 0 0.006440097000449896
5 O 0 0.007665722630918026
months O 0 0.00713823176920414
of O 0 0.00760730542242527
age O 0 0.01690799929201603
with O 0 0.4856082797050476
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999998807907104
hepatomegaly B-Disease 1 1.0
, O 1 0.9999979734420776
encephalopathy B-Disease 1 1.0
, O 1 0.999395489692688
and O 1 0.9913663268089294
hypotonia B-Disease 1 0.9999924898147583
. O 0 0.09727202355861664

Biochemical O 0 0.47782617807388306
studies O 0 0.09690447896718979
indicated O 1 0.9966440200805664
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
caused O 1 0.9988079071044922
by O 0 0.03116651624441147
a O 1 0.7169334292411804
stable O 1 0.9945653676986694
yet O 0 0.4667257070541382
inactive O 1 0.9918026328086853
enzyme O 0 0.09240945428609848
. O 0 0.04959661886096001

Molecular O 0 0.05359158292412758
genetic O 0 0.027907978743314743
analysis O 0 0.0176790039986372
of O 0 0.01643179915845394
her O 0 0.13346871733665466
VLCAD O 1 0.9997816681861877
gene O 0 0.018716461956501007
revealed O 0 0.01852908916771412
a O 0 0.01704609952867031
T1372C O 1 0.9879849553108215
( O 0 0.020644569769501686
F458L O 1 0.7778105735778809
) O 0 0.017721550539135933
missense O 0 0.036335818469524384
mutation O 0 0.02112206630408764
and O 0 0.017388304695487022
a O 0 0.02691592462360859
1668 O 1 0.9994193315505981
ACAG O 1 0.999504566192627
1669 O 1 0.9988892674446106
splice O 1 0.7674798965454102
site O 0 0.0629923865199089
mutation O 0 0.07061924785375595
. O 0 0.057500600814819336

After O 0 0.03505421802401543
initial O 0 0.03353617340326309
treatment O 1 0.8790825009346008
with O 0 0.19005295634269714
intravenous O 1 0.9999972581863403
glucose O 1 0.999495267868042
and O 1 0.7503072023391724
carnitine O 1 0.9999841451644897
, O 0 0.01967710256576538
the O 0 0.017742399126291275
patient O 1 0.9560039639472961
has O 0 0.009391140192747116
thrived O 0 0.11504071205854416
on O 0 0.007557223085314035
a O 0 0.009456975385546684
low O 0 0.021149881184101105
- O 0 0.20342758297920227
fat O 0 0.022071341052651405
diet O 0 0.020317578688263893
supplemented O 0 0.01726117730140686
with O 0 0.010234961286187172
medium O 0 0.02218436263501644
- O 0 0.23413056135177612
chain O 0 0.09345123916864395
triglyceride O 0 0.09174488484859467
oil O 0 0.016608381643891335
and O 0 0.015290593728423119
carnitine O 1 0.9993762373924255
and O 0 0.02223704196512699
avoidance O 1 0.9989321827888489
of O 0 0.21203331649303436
fasting O 1 0.919203519821167
. O 0 0.04773825779557228

Her O 1 0.9943087697029114
ventricular O 1 0.9999974966049194
hypertrophy O 1 0.9999958276748657
resolved O 0 0.36569780111312866
significantly O 0 0.017804456874728203
over O 0 0.010579264722764492
1 O 0 0.012340388260781765
year O 0 0.009578312747180462
, O 0 0.009237965568900108
and O 0 0.011173057369887829
cognitively O 1 0.990436851978302
, O 0 0.009893178008496761
she O 0 0.010793400928378105
is O 0 0.007184857036918402
in O 0 0.008227206766605377
the O 0 0.011582908220589161
superior O 0 0.023974092677235603
range O 0 0.018508827313780785
for O 0 0.0191964078694582
age O 0 0.031919464468955994
. O 0 0.040988340973854065

Clinical O 1 0.9728910326957703
recognition O 1 0.8562444448471069
of O 1 0.9993711113929749
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.8919661641120911
important O 0 0.08666499704122543
because O 0 0.006887334864586592
it O 0 0.004942989908158779
is O 0 0.004476545844227076
one O 0 0.004367683082818985
of O 0 0.00480680912733078
the O 0 0.0056521473452448845
few O 0 0.008629202842712402
directly O 0 0.04295806214213371
treatable O 1 0.9999983310699463
causes O 1 0.9982470273971558
of O 1 0.9934816360473633
cardiomyopathy B-Disease 1 1.0
in O 1 0.9517452120780945
children O 1 0.9402381181716919
. O 0 0.028183309361338615
. O 0 0.038627661764621735

Cloning O 0 0.048215270042419434
of O 0 0.022035758942365646
a O 0 0.016982903704047203
novel O 0 0.018890373408794403
member O 0 0.013251514174044132
of O 0 0.009501640684902668
the O 0 0.012528722174465656
low O 1 0.6803750991821289
- O 1 0.9975659847259521
density O 1 0.6227453947067261
lipoprotein O 1 0.9998273849487305
receptor O 0 0.08623502403497696
family O 0 0.03591669723391533
. O 0 0.04205116629600525

A O 0 0.03877472132444382
gene O 0 0.025524858385324478
encoding O 0 0.021593671292066574
a O 0 0.015425123274326324
novel O 0 0.0298528503626585
transmembrane O 1 0.850486695766449
protein O 0 0.012811942026019096
was O 0 0.011569211259484291
identified O 0 0.00913966167718172
by O 0 0.006609209347516298
DNA O 0 0.008783277124166489
sequence O 0 0.007476255763322115
analysis O 0 0.007636603433638811
within O 0 0.00623452290892601
the O 0 0.008871229365468025
insulin B-Disease 1 0.999301552772522
- I-Disease 1 0.9998658895492554
dependent I-Disease 1 0.9998263716697693
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9911098480224609
IDDM B-Disease 1 0.9999529123306274
) O 0 0.03781697526574135
locus O 1 0.8882632255554199
IDDM4 O 1 0.9968119263648987
on O 0 0.032430119812488556
chromosome O 0 0.14437584578990936
11q13 O 1 0.5939919948577881
. O 0 0.05727803334593773

Based O 0 0.02832433395087719
on O 0 0.017402077093720436
its O 0 0.013900673016905785
chromosomal O 0 0.3446238338947296
position O 0 0.013985099270939827
, O 0 0.00821524765342474
this O 0 0.006321309134364128
gene O 0 0.007571391295641661
is O 0 0.006696559954434633
a O 0 0.008833492174744606
candidate O 0 0.012955925427377224
for O 0 0.012204532511532307
conferring O 1 0.919671893119812
susceptibility O 1 0.9986523985862732
to O 0 0.08530916273593903
diabetes B-Disease 1 0.9999957084655762
. O 0 0.056582871824502945

The O 0 0.031253982335329056
gene O 0 0.022137286141514778
, O 0 0.01562381349503994
termed O 0 0.02217068150639534
low O 0 0.02272077277302742
- O 1 0.7407750487327576
density O 0 0.03676875680685043
lipoprotein O 1 0.9872768521308899
receptor O 0 0.016300857067108154
related O 0 0.010541959665715694
protein O 0 0.01149288471788168
5 O 0 0.013094056397676468
( O 0 0.012433136813342571
LRP5 O 1 0.5435222387313843
) O 0 0.011591240763664246
, O 0 0.010409055277705193
encodes O 0 0.014380800537765026
a O 0 0.009996813721954823
protein O 0 0.010111198760569096
of O 0 0.009981567040085793
1615 O 0 0.08696906268596649
amino O 0 0.013041377067565918
acids O 0 0.010582644492387772
that O 0 0.006949150003492832
contains O 0 0.009842506609857082
conserved O 0 0.01287812925875187
modules O 0 0.015894265845417976
which O 0 0.007554162759333849
are O 0 0.005739158950746059
characteristic O 0 0.007883804850280285
of O 0 0.006434279028326273
the O 0 0.007541895844042301
low O 0 0.06639716029167175
- O 1 0.9750851988792419
density O 1 0.6750665903091431
lipoprotein O 1 0.9998952150344849
( O 1 0.5790426135063171
LDL O 1 0.9996780157089233
) O 0 0.02078995294868946
receptor O 0 0.03553660586476326
family O 0 0.03559885174036026
. O 0 0.04274824261665344

These O 0 0.031372472643852234
modules O 0 0.04254404082894325
include O 0 0.020684808492660522
a O 0 0.019425686448812485
putative O 0 0.08920707553625107
signal O 0 0.020210955291986465
peptide O 0 0.01917579583823681
for O 0 0.009225674904882908
protein O 0 0.00964038260281086
export O 0 0.011160492897033691
, O 0 0.008685731329023838
four O 0 0.009468631818890572
epidermal O 1 0.9297378659248352
growth O 0 0.043076034635305405
factor O 0 0.03430024906992912
( O 0 0.015391507185995579
EGF O 1 0.9609067440032959
) O 0 0.012319844216108322
repeats O 0 0.014737003482878208
with O 0 0.008282380178570747
associated O 0 0.009870204143226147
spacer O 0 0.04494205489754677
domains O 0 0.013120937161147594
, O 0 0.009485148824751377
three O 0 0.010867360979318619
LDL O 1 0.9997414946556091
- O 1 0.9584227800369263
receptor O 0 0.03788761422038078
( O 0 0.01418977789580822
LDLR O 1 0.7565308213233948
) O 0 0.012038586661219597
repeats O 0 0.018902519717812538
, O 0 0.011243256740272045
a O 0 0.011296043172478676
single O 0 0.013349758461117744
transmembrane O 0 0.04837317392230034
spanning O 0 0.022490637376904488
domain O 0 0.017204590141773224
, O 0 0.012286964803934097
and O 0 0.011671317741274834
a O 0 0.020139021798968315
cytoplasmic O 0 0.2103898674249649
domain O 0 0.045305781066417694
. O 0 0.03964206948876381

The O 0 0.029965002089738846
encoded O 0 0.022646380588412285
protein O 0 0.01576841250061989
has O 0 0.010098057799041271
a O 0 0.009526295587420464
unique O 0 0.010341915301978588
organization O 0 0.011250604875385761
of O 0 0.01419857144355774
EGF O 1 0.9999144077301025
and O 0 0.08026338368654251
LDLR O 1 0.9996554851531982
repeats O 0 0.19040797650814056
; O 0 0.01068979874253273
therefore O 0 0.009670636616647243
, O 0 0.010370113886892796
LRP5 O 1 0.830984890460968
likely O 0 0.010291670449078083
represents O 0 0.011986066587269306
a O 0 0.008958002552390099
new O 0 0.011147161945700645
category O 0 0.014344882220029831
of O 0 0.013189407996833324
the O 0 0.020671062171459198
LDLR O 1 0.9990560412406921
family O 0 0.04801269993185997
. O 0 0.03974274545907974

Both O 0 0.0317816436290741
human O 0 0.022377289831638336
and O 0 0.023245058953762054
mouse O 1 0.9762338995933533
LRP5 O 1 0.9999725818634033
cDNAs O 1 0.9958415627479553
have O 0 0.00909306388348341
been O 0 0.008693363517522812
isolated O 0 0.010526453144848347
and O 0 0.006695812568068504
the O 0 0.0074751912616193295
encoded O 0 0.008258755318820477
mature O 0 0.012309971265494823
proteins O 0 0.00764462910592556
are O 0 0.005267119035124779
95 O 0 0.011351697146892548
% O 0 0.008769214153289795
identical O 0 0.009361429139971733
, O 0 0.007393321022391319
indicating O 0 0.009410558268427849
a O 0 0.009265903383493423
high O 0 0.012191938236355782
degree O 0 0.01414049044251442
of O 0 0.013858056627213955
evolutionary O 0 0.025261100381612778
conservation O 0 0.03194611519575119
. O 0 0.026247968897223473
. O 0 0.04276732727885246

The O 0 0.044041089713573456
APC B-Disease 1 0.997077465057373
variants O 0 0.04035881161689758
I1307K O 1 0.5164139270782471
and O 0 0.012532133609056473
E1317Q O 1 0.538104772567749
are O 0 0.008066676557064056
associated O 1 0.5109487771987915
with O 1 0.9993013143539429
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.4901731312274933
but O 0 0.007783827837556601
not O 0 0.006761518772691488
always O 0 0.010011509992182255
with O 0 0.0090830372646451
a O 0 0.014020866714417934
family O 0 0.023229122161865234
history O 0 0.031865473836660385
. O 0 0.039082713425159454

Classical O 1 0.9208571314811707
familial B-Disease 1 0.9999995231628418
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999700784683228
FAP B-Disease 1 0.9999998807907104
) O 0 0.024326274171471596
is O 0 0.011718329042196274
a O 0 0.012082693167030811
high O 1 0.7681902647018433
- O 1 0.9998953342437744
penetrance O 1 0.9999988079071045
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999874830245972
disease I-Disease 1 0.9999979734420776
that O 0 0.028409907594323158
predisposes O 1 0.9990361928939819
to O 0 0.006973925977945328
hundreds O 0 0.007478714920580387
or O 0 0.006386051885783672
thousands O 0 0.01719801314175129
of O 1 0.9960840940475464
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999948740005493
carcinoma I-Disease 1 1.0
and O 1 0.6089333891868591
that O 0 0.0077307927422225475
results O 0 0.009825985878705978
from O 0 0.010060646571218967
truncating O 1 0.802020251750946
mutations O 0 0.01569351926445961
in O 0 0.013664423488080502
the O 0 0.020767364650964737
APC B-Disease 1 0.997965931892395
gene O 0 0.04126327112317085
. O 0 0.04477880522608757

A O 0 0.0461135134100914
variant O 0 0.25706177949905396
of O 0 0.17907416820526123
FAP B-Disease 1 0.9999996423721313
is O 1 0.9980132579803467
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999996423721313
, O 0 0.2083088457584381
which O 0 0.008238783106207848
results O 0 0.008256071247160435
from O 0 0.008443391881883144
germ O 1 0.9995853304862976
- O 1 0.8436354994773865
line O 0 0.014533017762005329
mutations O 0 0.008944081142544746
in O 0 0.006521408446133137
the O 0 0.007091131526976824
5 O 0 0.00966314971446991
and O 0 0.008845514617860317
3 O 0 0.010690630413591862
regions O 0 0.009492984041571617
of O 0 0.011881532147526741
the O 0 0.02005448006093502
APC B-Disease 1 0.9992733597755432
gene O 0 0.04012051224708557
. O 0 0.03999532014131546

Attenuated B-Disease 1 0.999993085861206
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 0.9999998807907104
patients O 1 0.9999675750732422
have O 0 0.030043533071875572
" O 0 0.1888924539089203
multiple O 1 0.9863426089286804
" O 1 0.9997898936271667
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 1 0.597140371799469
typically O 0 0.012883950024843216
fewer O 0 0.010594721883535385
than O 0 0.0077256071381270885
100 O 0 0.011685027740895748
) O 0 0.010396219789981842
without O 0 0.012081618420779705
the O 0 0.01676073484122753
florid O 1 0.8512205481529236
phenotype O 1 0.5480807423591614
of O 0 0.02846992015838623
classical O 0 0.21598216891288757
FAP B-Disease 1 0.9999421834945679
. O 0 0.07515833526849747

Another O 0 0.033577002584934235
group O 0 0.024054592475295067
of O 0 0.016107356175780296
patients O 1 0.9376994967460632
with O 0 0.03734267130494118
multiple O 1 0.9049569368362427
adenomas B-Disease 1 0.9999985694885254
has O 0 0.08351738750934601
no O 0 0.00919017568230629
mutations O 0 0.008177530020475388
in O 0 0.005911814048886299
the O 0 0.015078037045896053
APC B-Disease 1 0.9997856020927429
gene O 0 0.010823593474924564
, O 0 0.0068818870931863785
and O 0 0.005614933557808399
their O 0 0.006089932285249233
phenotype O 0 0.07045034319162369
probably O 0 0.006684727501124144
results O 0 0.006182217039167881
from O 0 0.005818039644509554
variation O 0 0.007900803349912167
at O 0 0.007752066478133202
a O 0 0.009132805280387402
locus O 0 0.17863298952579498
, O 0 0.009648185223340988
or O 0 0.009188231080770493
loci O 0 0.016740556806325912
, O 0 0.010839452035725117
elsewhere O 0 0.012273292988538742
in O 0 0.011809620074927807
the O 0 0.018750062212347984
genome O 0 0.03878701105713844
. O 0 0.03879363462328911

Recently O 0 0.04459117352962494
, O 0 0.021005865186452866
however O 0 0.015356944873929024
, O 0 0.011528159491717815
a O 0 0.011194422841072083
missense O 0 0.02642793394625187
variant O 0 0.12614408135414124
of O 0 0.053165141493082047
APC B-Disease 1 0.9999910593032837
( O 1 0.502978503704071
I1307K O 1 0.9833316802978516
) O 0 0.009821931831538677
was O 0 0.00899106077849865
described O 0 0.008201807737350464
that O 0 0.005297073163092136
confers O 0 0.06961088627576828
an O 0 0.00733296200633049
increased O 0 0.12309104949235916
risk O 1 0.9978854060173035
of O 1 0.9997853636741638
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.8325287699699402
including O 0 0.2816750407218933
multiple O 1 0.9780386090278625
adenomas B-Disease 1 0.9999964237213135
, O 0 0.07985121011734009
in O 0 0.03407880291342735
Ashkenazim O 1 0.9395573139190674
. O 0 0.051651813089847565

We O 0 0.02735474519431591
have O 0 0.014182782731950283
studied O 0 0.014654170721769333
a O 0 0.01030489057302475
set O 0 0.009623875841498375
of O 0 0.00766968447715044
164 O 0 0.1114228367805481
patients O 1 0.8401752710342407
with O 0 0.10150052607059479
multiple O 1 0.9998219609260559
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9986416697502136
/ I-Disease 1 0.9999802112579346
or I-Disease 1 0.7840470671653748
carcinoma I-Disease 1 0.9999984502792358
and O 0 0.015231217257678509
analyzed O 0 0.01992657035589218
codons O 0 0.03253572806715965
1263 O 1 0.9893056154251099
- O 1 0.823452353477478
1377 O 1 0.9898239970207214
( O 0 0.024921845644712448
exon O 0 0.058762747794389725
15G O 0 0.0805555209517479
) O 0 0.014869941398501396
of O 0 0.013512366451323032
the O 0 0.014320382848381996
APC B-Disease 1 0.985672116279602
gene O 0 0.01540679857134819
for O 0 0.015138881281018257
germ O 1 0.9996084570884705
- O 1 0.9854626655578613
line O 0 0.12251961976289749
variants O 0 0.042833924293518066
. O 0 0.041580215096473694

Three O 0 0.032044027000665665
patients O 0 0.058830033987760544
with O 0 0.014371889643371105
the O 0 0.017342574894428253
I1307K O 1 0.9845452308654785
allele O 0 0.03919646516442299
were O 0 0.010048478841781616
detected O 0 0.0131881358101964
, O 0 0.010003062896430492
each O 0 0.009982222691178322
of O 0 0.014037289656698704
Ashkenazi O 1 0.6676260828971863
descent O 0 0.05519234761595726
. O 0 0.037675607949495316

Four O 0 0.039141152054071426
patients O 0 0.2578762173652649
had O 0 0.01589021645486355
a O 0 0.017795037478208542
germ O 1 0.9997641444206238
- O 1 0.9882825016975403
line O 0 0.2682020366191864
E1317Q O 1 0.9871970415115356
missense O 1 0.5057913661003113
variant O 0 0.23607583343982697
of O 0 0.0131483543664217
APC O 1 0.9946545362472534
that O 0 0.006919173989444971
was O 0 0.008097518235445023
not O 0 0.004858182743191719
present O 0 0.005353021901100874
in O 0 0.0052348049357533455
controls O 0 0.007804703898727894
; O 0 0.00526761868968606
one O 0 0.004740058910101652
of O 0 0.004615895450115204
these O 0 0.003990285564213991
individuals O 0 0.0038897122722119093
had O 0 0.005157699342817068
an O 0 0.005418543703854084
unusually O 0 0.0115423072129488
large O 0 0.007302823010832071
number O 0 0.00766217615455389
of O 0 0.011587456800043583
metaplastic B-Disease 1 0.9949702620506287
polyps I-Disease 1 0.9807055592536926
of I-Disease 0 0.021695232018828392
the I-Disease 0 0.03243352100253105
colorectum I-Disease 1 0.9717760682106018
. O 0 0.048237044364213943

There O 0 0.022491198033094406
is O 0 0.013681534677743912
increasing O 0 0.011853438802063465
evidence O 0 0.009089764207601547
that O 0 0.005577872507274151
there O 0 0.005424796603620052
exist O 0 0.006787716411054134
germ O 1 0.9059210419654846
- O 0 0.22438111901283264
line O 0 0.011760988272726536
variants O 0 0.008945594541728497
of O 0 0.007497394923120737
the O 0 0.010713248513638973
APC B-Disease 1 0.9986421465873718
gene O 0 0.0077079059556126595
that O 0 0.005406048148870468
predispose O 0 0.012372778728604317
to O 0 0.005337919108569622
the O 0 0.005461659748107195
development O 0 0.007160679902881384
of O 0 0.07753010094165802
multiple O 1 0.9998202919960022
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999927282333374
carcinoma I-Disease 1 1.0
, O 0 0.34592780470848083
but O 0 0.007258519064635038
without O 0 0.006674385163933039
the O 0 0.009456617757678032
florid O 1 0.9947860240936279
phenotype O 1 0.6410560607910156
of O 0 0.019858291372656822
classical O 1 0.7325029969215393
FAP B-Disease 1 0.999997615814209
, O 0 0.010093153454363346
and O 0 0.006516936235129833
possibly O 0 0.0065816412679851055
with O 0 0.005697926506400108
importance O 1 0.5679621696472168
for O 1 0.9991004467010498
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.9997187256813049
in O 0 0.057007256895303726
the O 0 0.019873006269335747
general O 0 0.08760339021682739
population O 0 0.014839342795312405
. O 0 0.02050131931900978
. O 0 0.03370160609483719

Genomic O 0 0.05049494281411171
structure O 0 0.02578873187303543
of O 0 0.018695635721087456
the O 1 0.5133433938026428
human O 1 0.999976396560669
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999996423721313
CLD B-Disease 1 1.0
) O 1 0.9126744270324707
gene O 0 0.09259429574012756
. O 0 0.046399205923080444

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999994039535522
CLD B-Disease 1 1.0
) O 1 0.782442569732666
is O 0 0.02833431400358677
caused O 0 0.29895782470703125
by O 0 0.00825804378837347
mutations O 0 0.009491893462836742
in O 0 0.007774376776069403
a O 0 0.009881637990474701
gene O 0 0.01163953635841608
which O 0 0.010064413771033287
encodes O 0 0.04218780994415283
an O 0 0.19737660884857178
intestinal O 1 0.9999996423721313
anion O 1 0.9999138116836548
transporter O 1 0.99850994348526
. O 0 0.06432317942380905

We O 0 0.024957681074738503
report O 0 0.018369125202298164
here O 0 0.01227955985814333
the O 0 0.009678485803306103
complete O 0 0.012116915546357632
genomic O 0 0.016206907108426094
organization O 0 0.011772648431360722
of O 0 0.009632187895476818
the O 0 0.0120145995169878
human O 0 0.0916154533624649
CLD B-Disease 1 0.9999926090240479
gene O 0 0.015771305188536644
which O 0 0.011271875351667404
spans O 0 0.020406773313879967
approximately O 0 0.017661193385720253
39kb O 0 0.4657076597213745
, O 0 0.01634002849459648
and O 0 0.017142169177532196
comprises O 0 0.030857766047120094
21 O 0 0.03347514942288399
exons O 0 0.05933181196451187
. O 0 0.048323631286621094

All O 0 0.055567417293787
exon O 0 0.3444713056087494
/ O 0 0.37314388155937195
intron O 0 0.3852335512638092
boundaries O 0 0.029347259551286697
conform O 0 0.03155572712421417
to O 0 0.020416369661688805
the O 0 0.02581797167658806
GT O 1 0.9997304081916809
/ O 1 0.9991130232810974
AG O 1 0.999363124370575
rule O 0 0.0545208640396595
. O 0 0.05319296941161156

An O 0 0.031060507521033287
analysis O 0 0.022496193647384644
of O 0 0.01680659130215645
the O 0 0.01538759097456932
putative O 0 0.4887358546257019
promoter O 1 0.6039631366729736
region O 0 0.015886034816503525
sequence O 0 0.011085664853453636
shows O 0 0.011869322508573532
a O 0 0.01391535997390747
putative O 1 0.9883878827095032
TATA O 1 0.9999834299087524
box O 1 0.7643657922744751
and O 0 0.014099718071520329
predicts O 0 0.06546913087368011
multiple O 0 0.019962377846240997
transcription O 0 0.026449205353856087
factor O 0 0.027045095339417458
binding O 0 0.026519933715462685
sites O 0 0.03194257989525795
. O 0 0.04422964155673981

The O 0 0.03401309996843338
genomic O 0 0.041723039001226425
structure O 0 0.023888282477855682
was O 0 0.015466973185539246
determined O 0 0.012086108326911926
using O 0 0.008274419233202934
DNA O 0 0.008154088631272316
from O 0 0.005592801608145237
several O 0 0.005604998208582401
sources O 0 0.005786821246147156
including O 0 0.006190143991261721
multiple O 0 0.007407388649880886
large O 0 0.008086387999355793
- O 1 0.6400092244148254
insert O 1 0.826273500919342
libaries O 1 0.5884830951690674
and O 0 0.009796181693673134
genomic O 0 0.01650550402700901
DNA O 0 0.012581701390445232
from O 0 0.013610364869236946
Finnish O 1 0.9999593496322632
CLD B-Disease 1 0.9999998807907104
patients O 1 0.9996260404586792
and O 0 0.039664968848228455
controls O 0 0.3064599335193634
. O 0 0.04693381115794182

Exon O 0 0.4504142701625824
- O 0 0.10215241461992264
specific O 0 0.021898675709962845
primers O 0 0.17420071363449097
developed O 0 0.013768686912953854
in O 0 0.009229633025825024
this O 0 0.006967882160097361
study O 0 0.008228017017245293
will O 0 0.007673437707126141
facilitate O 0 0.011010007932782173
mutation O 0 0.011295974254608154
screening O 0 0.012540520168840885
studies O 0 0.010051419027149677
of O 0 0.01186766754835844
patients O 1 0.9758226871490479
with O 0 0.041114725172519684
the O 1 0.9147545099258423
disease O 1 0.9999890327453613
. O 0 0.13472312688827515

Genomic O 0 0.0624035969376564
sequencing O 0 0.04125787690281868
of O 0 0.022272329777479172
a O 0 0.03221575543284416
BAC O 1 0.9999665021896362
clone O 1 0.9998998641967773
H O 1 0.999953031539917
_ O 0 0.056683674454689026
RG364P16 O 1 0.5924341678619385
revealed O 0 0.012507160194218159
the O 0 0.009104008786380291
presence O 0 0.008898468688130379
of O 0 0.007937277667224407
another O 0 0.00922021921724081
, O 0 0.00842046644538641
highly O 0 0.009559312835335732
homologous O 0 0.01112732756882906
gene O 0 0.006900053005665541
3 O 0 0.008098984137177467
of O 0 0.00730936648324132
the O 0 0.009980903007090092
CLD B-Disease 1 0.9999710321426392
gene O 0 0.009136452339589596
, O 0 0.0065474133007228374
with O 0 0.004728665575385094
a O 0 0.005896450020372868
similar O 0 0.006163454614579678
genomic O 0 0.012121242471039295
structure O 0 0.008126999251544476
, O 0 0.006674596574157476
recently O 0 0.007034507114440203
identified O 0 0.0064377854578197
as O 0 0.006739151664078236
the O 0 0.1106131374835968
Pendred B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
gene O 1 0.9938247203826904
( O 1 0.9889016151428223
PDS B-Disease 1 0.9999970197677612
) O 0 0.03055562824010849
. O 0 0.030528239905834198
. O 0 0.040822651237249374

The O 0 0.04820717126131058
APCI1307K O 1 0.999738872051239
allele O 1 0.9334509372711182
and O 1 0.6663609743118286
cancer B-Disease 1 0.9999474287033081
risk O 1 0.6584352254867554
in O 0 0.009692801162600517
a O 0 0.06151068955659866
community O 0 0.028483260422945023
- O 1 0.59394371509552
based O 0 0.013446250930428505
study O 0 0.014575132168829441
of O 0 0.01883094571530819
Ashkenazi O 0 0.4641290605068207
Jews O 0 0.04147868975996971
. O 0 0.04595368355512619

Mutations O 0 0.052073344588279724
in O 0 0.025474024936556816
APC O 1 0.971992015838623
are O 0 0.012822543270885944
classically O 1 0.9850093126296997
associated O 0 0.19785325229167938
with O 1 0.9796375632286072
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999991655349731
FAP B-Disease 1 1.0
) O 0 0.35068103671073914
, O 0 0.013894150964915752
a O 0 0.03712272271513939
highly O 1 0.9883670210838318
penetrant O 1 0.9999997615814209
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 0.9999979734420776
disorder I-Disease 1 1.0
characterized O 1 0.9999693632125854
by O 1 0.9877552390098572
multiple O 1 0.9999966621398926
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.9782521724700928
, O 1 0.5943787693977356
without O 0 0.14657318592071533
surgical O 1 0.9999969005584717
intervention O 1 0.9637770056724548
, O 0 0.010598906315863132
the O 0 0.012182576581835747
development O 1 0.9247964024543762
of O 1 0.9999501705169678
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999698400497437
CRC B-Disease 1 0.9999984502792358
) O 0 0.06095566600561142
. O 0 0.04383399337530136

APC B-Disease 1 0.9647834897041321
is O 0 0.030314836651086807
a O 0 0.07793106883764267
tumour O 1 0.9999966621398926
- O 1 0.9992161989212036
suppressor O 1 0.9992521405220032
gene O 0 0.020620975643396378
, O 0 0.012093080207705498
and O 0 0.013551614247262478
somatic O 1 0.868391215801239
loss O 1 0.9659607410430908
occurs O 0 0.07435443997383118
in O 0 0.03622313588857651
tumours B-Disease 1 0.9999270439147949
. O 0 0.048858799040317535

The O 0 0.04466741904616356
germline O 1 0.9818189144134521
T O 1 0.9954257607460022
- O 0 0.15832965075969696
to O 0 0.013345262967050076
- O 0 0.08025023341178894
A O 0 0.0175288375467062
transversion O 1 0.5877243280410767
responsible O 0 0.012491609901189804
for O 0 0.008379506878554821
the O 0 0.012752311304211617
APC O 1 0.9988101720809937
I1307K O 1 0.882540762424469
allele O 0 0.02031240612268448
converts O 0 0.014059145003557205
the O 0 0.009018464013934135
wild O 0 0.01147795282304287
- O 0 0.015515770763158798
type O 0 0.009350636042654514
sequence O 0 0.006662184372544289
to O 0 0.007458599749952555
a O 0 0.014728862792253494
homopolymer O 1 0.9999622106552124
tract O 1 0.9999969005584717
( O 1 0.9638766646385193
A8 O 1 0.9999905824661255
) O 0 0.012922541238367558
that O 0 0.0087495232000947
is O 0 0.010466941632330418
genetically O 0 0.024259328842163086
unstable O 1 0.9092093110084534
and O 0 0.025108208879828453
prone O 1 0.9893970489501953
to O 0 0.026569059118628502
somatic O 1 0.9410998225212097
mutation O 0 0.11713969707489014
. O 0 0.046408217400312424

The O 0 0.05754521116614342
I1307K O 1 0.8775337934494019
allele O 0 0.051959432661533356
was O 0 0.028174763545393944
found O 0 0.01935434713959694
in O 0 0.02031823806464672
6 O 0 0.03897158056497574
. O 0 0.04356585070490837

1 O 0 0.05395388975739479
% O 0 0.027753902599215508
of O 0 0.024433283135294914
unselected O 1 0.9916563034057617
Ashkenazi O 1 0.8960521221160889
Jews O 0 0.020486103370785713
and O 0 0.01309406291693449
higher O 0 0.01348131988197565
proportions O 0 0.05319707840681076
of O 0 0.014725570566952229
Ashkenazim O 1 0.9708875417709351
with O 0 0.009899605996906757
family O 0 0.0199971292167902
or O 0 0.0074921101331710815
personal O 0 0.08491185307502747
histories O 0 0.3791678249835968
of O 1 0.7297165393829346
CRC B-Disease 1 0.9999984502792358
( O 1 0.7649286389350891
ref O 1 0.9930905699729919
. O 0 0.017099209129810333
2 O 0 0.027768561616539955
) O 0 0.03313123807311058
. O 0 0.04401397705078125

To O 0 0.0315137580037117
evaluate O 0 0.03444301709532738
the O 0 0.017893707379698753
role O 0 0.016325971111655235
of O 0 0.01571967452764511
I1307K O 1 0.9940047860145569
in O 0 0.1320095658302307
cancer B-Disease 1 0.999805748462677
, O 0 0.011785713955760002
we O 0 0.011171028017997742
genotyped O 0 0.47105294466018677
5 O 0 0.020103277638554573
, O 0 0.020829498767852783
081 O 1 0.9749838709831238
Ashkenazi O 0 0.32512933015823364
volunteers O 0 0.03340565413236618
in O 0 0.016996268182992935
a O 0 0.023880789056420326
community O 0 0.030445599928498268
survey O 0 0.04197365418076515
. O 0 0.04693789780139923

Risk O 0 0.1268729865550995
of O 0 0.07363487035036087
developing O 1 0.9995143413543701
colorectal B-Disease 1 1.0
, I-Disease 1 0.9983752965927124
breast I-Disease 1 0.9999996423721313
and I-Disease 1 0.8138698935508728
other I-Disease 0 0.07030433416366577
cancers I-Disease 1 0.9996234178543091
were O 0 0.006933580152690411
compared O 0 0.009875910356640816
between O 0 0.00896749459207058
genotyped O 1 0.9697974324226379
I1307K O 1 0.8971230983734131
carriers O 0 0.10460395365953445
and O 0 0.009904000908136368
non O 0 0.03536851704120636
- O 0 0.46423012018203735
carriers O 0 0.027614163234829903
and O 0 0.0077616930939257145
their O 0 0.007634135894477367
first O 0 0.012943090870976448
- O 0 0.23541833460330963
degree O 0 0.031051648780703545
relatives O 0 0.0365421324968338
. O 0 0.04216775670647621

Sperm O 0 0.058312248438596725
DNA O 0 0.03278248384594917
analysis O 0 0.02410532534122467
in O 0 0.02078866772353649
a O 0 0.038828931748867035
Friedreich B-Disease 1 0.9999964237213135
ataxia I-Disease 1 0.9999991655349731
premutation O 1 0.9999765157699585
carrier O 1 0.9996763467788696
suggests O 0 0.0814952626824379
both O 0 0.01988629251718521
meiotic O 1 0.9976479411125183
and O 0 0.0222297552973032
mitotic O 1 0.7254263758659363
expansion O 0 0.03279061242938042
in O 0 0.023088714107871056
the O 0 0.03072701208293438
FRDA B-Disease 1 0.9967970252037048
gene O 0 0.05238707736134529
. O 0 0.05629730224609375

Friedreich B-Disease 1 0.9999967813491821
ataxia I-Disease 1 0.9999972581863403
is O 0 0.25829070806503296
usually O 0 0.020016934722661972
caused O 0 0.07306380569934845
by O 0 0.007780816406011581
an O 0 0.008518529124557972
expansion O 0 0.018580002710223198
of O 0 0.01142903883010149
a O 0 0.02503545954823494
GAA O 1 0.9385003447532654
trinucleotide O 1 0.9923241138458252
repeat O 0 0.031002234667539597
in O 0 0.01628204435110092
intron O 1 0.5108458995819092
1 O 0 0.02188490331172943
of O 0 0.016367681324481964
the O 0 0.023040441796183586
FRDA B-Disease 1 0.993952214717865
gene O 0 0.04206468164920807
. O 0 0.046662382781505585

Occasionally O 0 0.03679318353533745
, O 0 0.020504942163825035
a O 0 0.015427101403474808
fully O 0 0.019371235743165016
expanded O 0 0.02124202810227871
allele O 0 0.01892443560063839
has O 0 0.008988464251160622
been O 0 0.007531271781772375
found O 0 0.005838379729539156
to O 0 0.006784646771848202
arise O 0 0.009655932895839214
from O 0 0.006935573183000088
a O 0 0.008867775090038776
premutation O 0 0.1402379721403122
of O 0 0.010293088853359222
100 O 0 0.015270747244358063
or O 0 0.0124686099588871
less O 0 0.021588051691651344
triplet O 1 0.7102170586585999
repeats O 0 0.05864688381552696
. O 0 0.04900352656841278

We O 0 0.03068697080016136
have O 0 0.016776300966739655
examined O 0 0.023337120190262794
the O 0 0.015440245158970356
sperm O 0 0.01729503646492958
DNA O 0 0.016484880819916725
of O 0 0.015608645975589752
a O 0 0.02905409224331379
premutation O 1 0.9950562715530396
carrier O 1 0.9622047543525696
. O 0 0.058365412056446075

This O 0 0.03992471843957901
mans O 0 0.11275193840265274
leucocyte O 0 0.2343287467956543
DNA O 0 0.023648753762245178
showed O 0 0.019270196557044983
one O 0 0.012611831538379192
normal O 0 0.01392118539661169
allele O 0 0.01767008751630783
and O 0 0.011311806738376617
one O 0 0.011982699856162071
allele O 0 0.017873547971248627
of O 0 0.012164869345724583
approximately O 0 0.019639793783426285
100 O 0 0.028727175667881966
repeats O 0 0.04840623959898949
. O 0 0.04968072474002838

His O 0 0.04087705537676811
sperm O 0 0.027059281244874
showed O 0 0.02071278542280197
an O 0 0.011640390381217003
expanded O 0 0.01823192834854126
allele O 0 0.016933223232626915
in O 0 0.009544603526592255
a O 0 0.010716229677200317
tight O 0 0.018199842423200607
range O 0 0.014141486957669258
centering O 0 0.019702231511473656
on O 0 0.009991472586989403
a O 0 0.011867924593389034
size O 0 0.014278356917202473
of O 0 0.014397706836462021
approximately O 0 0.021099433302879333
320 O 0 0.05951989069581032
trinucleotide O 1 0.8950325846672058
repeats O 0 0.07784728705883026
. O 0 0.06163609400391579

His O 0 0.06814606487751007
affected O 0 0.07408313453197479
son O 1 0.6862326264381409
has O 0 0.020977314561605453
repeat O 0 0.049223870038986206
sizes O 0 0.026213211938738823
of O 0 0.023019883781671524
1040 O 1 0.9514155387878418
and O 0 0.032369084656238556
540 O 0 0.4450778365135193
. O 0 0.056609682738780975

These O 0 0.0215301550924778
data O 0 0.015192096121609211
suggest O 0 0.013270627707242966
that O 0 0.008173981681466103
expansion O 0 0.013630710542201996
occurs O 0 0.007606848143041134
in O 0 0.006585177965462208
two O 0 0.0060579669661819935
stages O 0 0.009773061610758305
, O 0 0.005992871709167957
the O 0 0.006519240327179432
first O 0 0.008829998783767223
during O 0 0.012029614299535751
meiosis O 0 0.030777057632803917
followed O 0 0.015303803607821465
by O 0 0.012147879227995872
a O 0 0.017482532188296318
second O 0 0.03418926149606705
mitotic O 1 0.7480096817016602
expansion O 0 0.05683419480919838
. O 0 0.051869917660951614

We O 0 0.025264203548431396
also O 0 0.01487787812948227
show O 0 0.012385995127260685
that O 0 0.007185014430433512
in O 0 0.006647936068475246
all O 0 0.007210270036011934
informative O 0 0.018115457147359848
carrier O 0 0.27739042043685913
father O 0 0.011753525584936142
to O 0 0.007040778640657663
affected O 0 0.010771339759230614
child O 0 0.12576942145824432
transmissions O 0 0.020621908828616142
, O 0 0.005790127906948328
with O 0 0.005032757762819529
the O 0 0.006016728468239307
notable O 0 0.007603958249092102
exception O 0 0.008191379718482494
of O 0 0.006457123439759016
the O 0 0.0092393783852458
premutation O 1 0.9943248629570007
carrier O 1 0.8459228277206421
, O 0 0.008861071430146694
the O 0 0.009757081978023052
expansion O 0 0.02074560709297657
size O 0 0.022137707099318504
decreases O 0 0.031286150217056274
. O 0 0.02659832313656807
. O 0 0.04051653668284416

The O 0 0.04730626195669174
R496H O 0 0.4744311571121216
mutation O 0 0.035169653594493866
of O 0 0.021896222606301308
arylsulfatase O 1 0.9956607222557068
A O 0 0.4367021322250366
does O 0 0.02202661521732807
not O 0 0.018818829208612442
cause O 1 0.993708610534668
metachromatic B-Disease 1 0.9999901056289673
leukodystrophy I-Disease 1 0.999998927116394
. O 0 0.13112559914588928

Deficiency B-Disease 1 0.999936580657959
of I-Disease 0 0.10452453047037125
arylsulfatase I-Disease 1 0.9996703863143921
A I-Disease 1 0.9702362418174744
( O 1 0.9372668862342834
ARSA O 1 0.9999932050704956
) O 0 0.04317034035921097
enzyme O 0 0.046595558524131775
activity O 0 0.02711881697177887
causes O 1 0.9963524341583252
metachromatic B-Disease 1 0.9999984502792358
leukodystrophy I-Disease 1 1.0
( O 1 0.9992573857307434
MLD B-Disease 1 0.999998927116394
) O 0 0.07227180153131485
. O 0 0.06441137939691544

A O 0 0.04024714231491089
number O 0 0.023686066269874573
of O 0 0.022805415093898773
ARSA O 1 0.9999016523361206
gene O 0 0.028399037197232246
mutations O 0 0.020498966798186302
responsible O 0 0.01824665255844593
for O 0 0.021783549338579178
MLD B-Disease 1 0.9999948740005493
have O 0 0.01535091269761324
been O 0 0.01822318136692047
identified O 0 0.026704201474785805
. O 0 0.03596995770931244

Recently O 0 0.044884517788887024
, O 0 0.023051371797919273
the O 0 0.018393926322460175
R496H O 1 0.568936824798584
mutation O 0 0.02095414698123932
of O 0 0.01621316745877266
ARSA O 1 0.9998383522033691
was O 0 0.016575710847973824
proposed O 0 0.010617399588227272
to O 0 0.007712808903306723
be O 0 0.005723382346332073
a O 0 0.009141769260168076
cause O 0 0.020986761897802353
of O 0 0.036621302366256714
MLD B-Disease 1 0.9999988079071045
( O 0 0.20408731698989868
Draghia O 1 0.9928673505783081
et O 0 0.057228412479162216
al O 0 0.027380527928471565
. O 0 0.015648774802684784
, O 0 0.016944896429777145
1997 O 0 0.03368239477276802
) O 0 0.02800845354795456
. O 0 0.03714197129011154

We O 0 0.027536192908883095
have O 0 0.016096007078886032
investigated O 0 0.020567912608385086
the O 0 0.014544372446835041
R496H O 1 0.8161351084709167
mutation O 0 0.014722470194101334
and O 0 0.008330278098583221
found O 0 0.006313813850283623
this O 0 0.0056572649627923965
mutation O 0 0.008293762803077698
at O 0 0.0056823305785655975
a O 0 0.00593721866607666
relatively O 0 0.006212680600583553
high O 0 0.006516733206808567
frequency O 0 0.006261775735765696
in O 0 0.0044785174541175365
an O 0 0.005073866341263056
African O 0 0.0065452889539301395
American O 0 0.006959006190299988
population O 0 0.005349222104996443
( O 0 0.007397315464913845
f O 0 0.01471670251339674
= O 0 0.014358008280396461
0 O 0 0.012728375382721424
. O 0 0.010286368429660797
09 O 0 0.026222921907901764
, O 0 0.013846656307578087
n O 0 0.021185675635933876
= O 0 0.029540423303842545
61 O 0 0.03422490507364273
subjects O 0 0.03446056321263313
) O 0 0.03806028515100479
. O 0 0.04841245710849762

The O 0 0.05992022156715393
ARSA O 1 0.999508261680603
enzyme O 0 0.0354437418282032
activity O 0 0.016163522377610207
in O 0 0.0100731635466218
subjects O 0 0.011241723783314228
with O 0 0.007561215665191412
and O 0 0.006953293923288584
without O 0 0.0068170358426868916
the O 0 0.011853539384901524
R496H O 1 0.9965066313743591
mutation O 0 0.05225604772567749
was O 0 0.015121848322451115
determined O 0 0.00983904954046011
and O 0 0.00847038347274065
found O 0 0.008687538094818592
to O 0 0.009824004955589771
be O 0 0.012120384722948074
normal O 0 0.023763507604599
. O 0 0.036058343946933746

It O 0 0.026568235829472542
is O 0 0.018312223255634308
therefore O 0 0.012632078491151333
concluded O 0 0.012723750434815884
that O 0 0.007390536833554506
the O 0 0.010066380724310875
R496H O 1 0.6484346389770508
mutation O 0 0.023538554087281227
of O 0 0.016832906752824783
ARSA O 1 0.9999405145645142
does O 0 0.011444803327322006
not O 0 0.008011432364583015
negatively O 0 0.010162646882236004
influence O 0 0.009496121667325497
the O 0 0.008288145065307617
activity O 0 0.010443213395774364
of O 0 0.012477360665798187
ARSA O 1 0.9999622106552124
and O 0 0.012946258299052715
is O 0 0.009578810073435307
not O 0 0.009906535036861897
a O 0 0.01835913211107254
cause O 0 0.41241124272346497
of O 0 0.10715154558420181
MLD B-Disease 1 0.9999897480010986

Down O 0 0.049333006143569946
- O 0 0.039661284536123276
regulation O 0 0.023848513141274452
of O 0 0.02030319534242153
transmembrane O 1 0.9888767600059509
carbonic O 1 0.999664306640625
anhydrases O 1 0.9998679161071777
in O 1 0.9877179861068726
renal B-Disease 1 1.0
cell I-Disease 1 0.9999936819076538
carcinoma I-Disease 1 1.0
cell O 1 0.9413406252861023
lines O 0 0.019930720329284668
by O 0 0.011869165115058422
wild O 0 0.03707940876483917
- O 1 0.978640615940094
type O 1 0.9103767275810242
von B-Disease 1 0.997391939163208
Hippel I-Disease 1 0.999864935874939
- I-Disease 1 0.9956762194633484
Lindau I-Disease 1 0.9971562623977661
transgenes O 1 0.784693717956543
. O 0 0.07502732425928116

To O 0 0.031887248158454895
discover O 0 0.035049524158239365
genes O 0 0.018221775069832802
involved O 0 0.013097668997943401
in O 0 0.011834765784442425
von B-Disease 1 0.9905303120613098
Hippel I-Disease 1 0.9999818801879883
- I-Disease 1 0.9995995163917542
Lindau I-Disease 1 0.999963641166687
( O 0 0.31025537848472595
VHL B-Disease 1 0.9998249411582947
) O 0 0.016500504687428474
- O 1 0.5505921244621277
mediated O 1 0.6487575769424438
carcinogenesis O 1 0.9987118244171143
, O 0 0.010497740469872952
we O 0 0.01039474830031395
used O 0 0.02170834131538868
renal B-Disease 1 0.9999997615814209
cell I-Disease 1 0.9995830655097961
carcinoma I-Disease 1 1.0
cell O 1 0.8254821300506592
lines O 0 0.0344841443002224
stably O 1 0.8577370047569275
transfected O 1 0.8416071534156799
with O 0 0.016689499840140343
wild O 0 0.07260896265506744
- O 1 0.9974520802497864
type O 1 0.9966248273849487
VHL O 1 0.9999816417694092
- O 1 0.977080225944519
expressing O 1 0.6079993844032288
transgenes O 1 0.9664850831031799
. O 0 0.06488950550556183

Large O 0 0.038922183215618134
- O 0 0.03627229109406471
scale O 0 0.024222375825047493
RNA O 0 0.024138720706105232
differential O 0 0.022289758548140526
display O 0 0.01661202497780323
technology O 0 0.014866706915199757
applied O 0 0.012763441540300846
to O 0 0.008397867903113365
these O 0 0.007804944179952145
cell O 0 0.01006287895143032
lines O 0 0.00904044508934021
identified O 0 0.008117117919027805
several O 0 0.007337062153965235
differentially O 0 0.018745552748441696
expressed O 0 0.009743154048919678
genes O 0 0.009124507196247578
, O 0 0.007612843997776508
including O 0 0.008405884727835655
an O 0 0.012414462864398956
alpha O 0 0.4696238338947296
carbonic O 1 0.9974773526191711
anhydrase O 1 0.9985707998275757
gene O 0 0.02955791726708412
, O 0 0.031610410660505295
termed O 0 0.13687902688980103
CA12 O 1 0.9829832315444946
. O 0 0.06830209493637085

The O 0 0.041278403252363205
deduced O 0 0.04135527461767197
protein O 0 0.020185943692922592
sequence O 0 0.013386109843850136
was O 0 0.011937249451875687
classified O 0 0.012137046083807945
as O 0 0.0076156617142260075
a O 0 0.008498302660882473
one O 0 0.008153594098985195
- O 0 0.0894957035779953
pass O 0 0.018238918855786324
transmembrane O 1 0.6790953874588013
CA O 0 0.0264135729521513
possessing O 0 0.015767456963658333
an O 0 0.011157196015119553
apparently O 0 0.016985977068543434
intact O 0 0.024199556559324265
catalytic O 0 0.02111654542386532
domain O 0 0.019184637814760208
in O 0 0.01526213251054287
the O 0 0.018429117277264595
extracellular O 0 0.3045012056827545
CA O 0 0.4211427867412567
module O 1 0.6031750440597534
. O 0 0.06042788177728653

Reintroduced O 0 0.07595118880271912
wild O 0 0.0545300655066967
- O 1 0.9606258869171143
type O 1 0.8885855078697205
VHL B-Disease 1 0.9992620348930359
strongly O 0 0.023548683151602745
inhibited O 0 0.039546169340610504
the O 0 0.014941954985260963
overexpression O 0 0.17994555830955505
of O 0 0.01165703684091568
the O 0 0.01261526346206665
CA12 O 1 0.9935624599456787
gene O 0 0.011075936257839203
in O 0 0.010200018994510174
the O 0 0.08331792056560516
parental O 1 0.9999872446060181
renal B-Disease 1 1.0
cell I-Disease 1 0.9999994039535522
carcinoma I-Disease 1 1.0
cell O 1 0.9994619488716125
lines O 0 0.41188445687294006
. O 0 0.04300795868039131

Similar O 0 0.03213779628276825
results O 0 0.01892038993537426
were O 0 0.01103668101131916
obtained O 0 0.011840186081826687
with O 0 0.012212882749736309
CA9 O 1 0.9979056119918823
, O 0 0.012823580764234066
encoding O 0 0.015067970380187035
another O 0 0.01685546711087227
transmembrane O 1 0.6346944570541382
CA O 0 0.0297971460968256
with O 0 0.012730699963867664
an O 0 0.017197012901306152
intact O 0 0.2903769314289093
catalytic O 0 0.07225148379802704
domain O 0 0.045668233186006546
. O 0 0.04613596200942993

Although O 0 0.03328912705183029
both O 0 0.021418219432234764
domains O 0 0.023604808375239372
of O 0 0.014857868663966656
the O 0 0.023488443344831467
VHL B-Disease 1 0.9999244213104248
protein O 0 0.016376664862036705
contribute O 0 0.014766041189432144
to O 0 0.010809327475726604
regulation O 0 0.012697570957243443
of O 0 0.012190524488687515
CA12 O 1 0.9444341063499451
expression O 0 0.012974659912288189
, O 0 0.010787091217935085
the O 0 0.012491734698414803
elongin O 0 0.4659899175167084
binding O 0 0.018338648602366447
domain O 0 0.021946262568235397
alone O 0 0.0215537641197443
could O 0 0.017818711698055267
effectively O 0 0.03399398922920227
regulate O 0 0.0467301607131958
CA9 O 1 0.9946786165237427
expression O 0 0.05864129215478897
. O 0 0.06170332804322243

We O 0 0.05121390521526337
mapped O 0 0.07494523376226425
CA12 O 1 0.9755909442901611
and O 0 0.0376703254878521
CA9 O 1 0.9989835619926453
loci O 0 0.04640042036771774
to O 0 0.026202687993645668
chromosome O 0 0.04433245584368706
bands O 0 0.039993781596422195
15q22 O 1 0.8040220141410828
and O 0 0.03663301840424538
17q21 O 1 0.5976029634475708
. O 0 0.060391299426555634

2 O 0 0.042716074734926224
respectively O 0 0.030585724860429764
, O 0 0.018701817840337753
regions O 0 0.016764869913458824
prone O 0 0.3853360116481781
to O 0 0.014100435189902782
amplification O 0 0.03231261670589447
in O 0 0.014004331082105637
some O 0 0.01712029054760933
human O 0 0.045959871262311935
cancers B-Disease 1 0.9991451501846313
. O 0 0.04121312499046326

Additional O 0 0.035217542201280594
experiments O 0 0.027271931990981102
are O 0 0.011308369226753712
needed O 0 0.011933905072510242
to O 0 0.0098282964900136
define O 0 0.011087312363088131
the O 0 0.008499423041939735
role O 0 0.01145446952432394
of O 0 0.012872517108917236
CA O 1 0.9703195095062256
IX O 1 0.9999802112579346
and O 0 0.1930152177810669
CA O 1 0.966735303401947
XII O 1 0.9996451139450073
enzymes O 0 0.012710141949355602
in O 0 0.008034836500883102
the O 0 0.00801818072795868
regulation O 0 0.010650510899722576
of O 0 0.008991328999400139
pH O 0 0.06822922080755234
in O 0 0.007621906232088804
the O 0 0.011186446063220501
extracellular O 0 0.038805194199085236
microenvironment O 0 0.2739564776420593
and O 0 0.009613038040697575
its O 0 0.00933225266635418
potential O 0 0.014119393192231655
impact O 0 0.02008545771241188
on O 0 0.030611751601099968
cancer B-Disease 1 0.9999359846115112
cell O 1 0.5138581395149231
growth O 0 0.0807424858212471
. O 0 0.0426306389272213

A O 0 0.04162312299013138
gene O 0 0.026323119178414345
encoding O 0 0.021983129903674126
a O 0 0.017527392134070396
transmembrane O 0 0.1985548883676529
protein O 0 0.012877585366368294
is O 0 0.008662978187203407
mutated O 0 0.028982602059841156
in O 0 0.012454585172235966
patients O 1 0.9998053908348083
with O 1 0.9997785687446594
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999998807907104
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999997615814209
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.9521429538726807
. O 0 0.07844477146863937

Wolfram B-Disease 1 0.9999978542327881
syndrome I-Disease 1 1.0
( O 1 0.9976279139518738
WFS B-Disease 1 0.9999994039535522
; O 1 0.9408587217330933
OMIM O 1 0.9999973773956299
222300 O 1 0.9994680285453796
) O 0 0.016737300902605057
is O 0 0.013487321324646473
an O 1 0.6627823114395142
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.973607063293457
by O 0 0.3757174015045166
young O 1 0.9994930028915405
- O 1 0.9999920129776001
onset O 1 0.9999998807907104
non O 1 0.9999591112136841
- O 1 0.9999995231628418
immune O 1 1.0
insulin B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
dependent I-Disease 1 0.9999991655349731
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999945163726807
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999998807907104
. O 1 0.9634638428688049

Linkage O 0 0.06798189878463745
to O 0 0.031344927847385406
markers O 0 0.03187444433569908
on O 0 0.02263496071100235
chromosome O 0 0.11552245914936066
4p O 1 0.9989294409751892
was O 0 0.02694261446595192
confirmed O 0 0.023576630279421806
in O 0 0.01962936669588089
five O 0 0.02710540033876896
families O 0 0.033569272607564926
. O 0 0.0442400686442852

On O 0 0.027471978217363358
the O 0 0.017939424142241478
basis O 0 0.014353912323713303
of O 0 0.016589412465691566
meiotic O 1 0.9999382495880127
recombinants O 1 0.999954104423523
and O 1 0.9678472280502319
disease O 1 0.9999970197677612
- O 1 0.9986294507980347
associated O 0 0.24564601480960846
haplotypes O 1 0.9092342853546143
, O 0 0.011694397777318954
the O 0 0.019081229344010353
WFS B-Disease 1 0.999987006187439
gene O 0 0.01570603996515274
was O 0 0.01574106141924858
localized O 0 0.022091221064329147
to O 0 0.013646087609231472
a O 0 0.026483090594410896
BAC O 1 0.9997323155403137
/ O 1 0.9716758728027344
P1 O 1 0.9460063576698303
contig O 0 0.11503034830093384
of O 0 0.020736822858452797
less O 0 0.017826426774263382
than O 0 0.021758779883384705
250 O 0 0.04362412914633751
kb O 0 0.13095076382160187
. O 0 0.05341207608580589

Mutations O 0 0.040820103138685226
in O 0 0.01788095012307167
a O 0 0.01655692607164383
novel O 0 0.03829510509967804
gene O 0 0.013693224638700485
( O 0 0.012268714606761932
WFS1 O 1 0.9439419507980347
) O 0 0.009320798330008984
encoding O 0 0.011159493587911129
a O 0 0.011258438229560852
putative O 0 0.09082341194152832
transmembrane O 0 0.3106589913368225
protein O 0 0.008978908881545067
were O 0 0.006280586589127779
found O 0 0.005799594800919294
in O 0 0.004710234235972166
all O 0 0.004522285889834166
affected O 0 0.005212355870753527
individuals O 0 0.004151913803070784
in O 0 0.005162499379366636
six O 0 0.01212104968726635
WFS B-Disease 1 0.9999788999557495
families O 0 0.00925354938954115
, O 0 0.0063718464225530624
and O 0 0.005922168958932161
these O 0 0.0044129760935902596
mutations O 0 0.006472391076385975
were O 0 0.005169829819351435
associated O 0 0.007848629727959633
with O 0 0.011877971701323986
the O 1 0.8696116805076599
disease O 1 0.9999983310699463
phenotype O 1 0.9998476505279541
. O 0 0.21779628098011017

WFS1 O 1 0.9811935424804688
appears O 0 0.033805202692747116
to O 0 0.016242748126387596
function O 0 0.013403904624283314
in O 0 0.009384701028466225
survival O 0 0.20111730694770813
of O 0 0.01757531799376011
islet O 1 0.9992610812187195
beta O 1 0.9960463643074036
- O 1 0.9990766048431396
cells O 0 0.219328835606575
and O 0 0.021306632086634636
neurons O 0 0.04685162007808685
. O 0 0.022902198135852814
. O 0 0.03843511641025543

Stable O 0 0.048871960490942
interaction O 0 0.024909282103180885
between O 0 0.013578004203736782
the O 0 0.011690067127346992
products O 0 0.01264137215912342
of O 0 0.010036995634436607
the O 0 0.33598124980926514
BRCA1 O 1 0.9999938011169434
and O 1 0.9919044375419617
BRCA2 O 1 0.9999992847442627
tumor B-Disease 1 0.9999971389770508
suppressor O 1 0.9995515942573547
genes O 0 0.022644834592938423
in O 0 0.018510039895772934
mitotic O 1 0.9910895824432373
and O 0 0.09373277425765991
meiotic O 1 0.9997735619544983
cells O 0 0.09699147194623947
. O 0 0.050769977271556854

BRCA1 O 1 0.9989762306213379
and O 0 0.04219316318631172
BRCA2 O 1 0.8791301250457764
account O 0 0.016912804916501045
for O 0 0.01014715526252985
most O 0 0.00741302827373147
cases O 0 0.007470366545021534
of O 0 0.008416367694735527
familial O 1 0.9981034994125366
, O 0 0.03588838502764702
early O 1 0.7228023409843445
onset O 1 0.9999996423721313
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9989199638366699
/ I-Disease 1 0.9999995231628418
or I-Disease 1 0.9999202489852905
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 1 0.7208316922187805
encode O 0 0.15955741703510284
products O 0 0.06189123913645744
that O 0 0.007623600773513317
each O 0 0.009421303868293762
interact O 0 0.020234886556863785
with O 0 0.018092868849635124
hRAD51 O 1 0.694242000579834
. O 0 0.04732758551836014

Results O 0 0.03317052498459816
presented O 0 0.02682063728570938
here O 0 0.01758173294365406
show O 0 0.01602741703391075
that O 0 0.011825166642665863
BRCA1 O 1 0.9968199729919434
and O 0 0.07865679264068604
BRCA2 O 1 0.9992913007736206
coexist O 0 0.02257801592350006
in O 0 0.008913809433579445
a O 0 0.01206363458186388
biochemical O 0 0.12954042851924896
complex O 0 0.013806850649416447
and O 0 0.009972481057047844
colocalize O 1 0.7133355140686035
in O 0 0.01188917551189661
subnuclear O 1 0.9949893355369568
foci O 1 0.9616464376449585
in O 0 0.012212492525577545
somatic O 0 0.3807540833950043
cells O 0 0.01189690362662077
and O 0 0.008804610930383205
on O 0 0.009320396929979324
the O 0 0.011540546081960201
axial O 0 0.02239607460796833
elements O 0 0.016082119196653366
of O 0 0.01781076192855835
developing O 0 0.3403654396533966
synaptonemal O 1 0.9978581070899963
complexes O 0 0.3683360517024994
. O 0 0.048200830817222595

Like O 0 0.08679050952196121
BRCA1 O 1 0.9969338178634644
and O 0 0.08178959041833878
RAD51 O 1 0.9999442100524902
, O 0 0.12673431634902954
BRCA2 O 1 0.9979315996170044
relocates O 1 0.8705224990844727
to O 0 0.019820446148514748
PCNA O 1 0.9982218146324158
+ O 0 0.03285254165530205
replication O 0 0.018390769138932228
sites O 0 0.011275574564933777
following O 0 0.010602163150906563
exposure O 0 0.018180569633841515
of O 0 0.012224053964018822
S O 1 0.9770564436912537
phase O 0 0.2902321517467499
cells O 0 0.01829499751329422
to O 0 0.01910058967769146
hydroxyurea O 1 0.9989839196205139
or O 0 0.043195031583309174
UV O 1 0.9994413256645203
irradiation O 1 0.8786362409591675
. O 0 0.06148015707731247

Thus O 0 0.04076755419373512
, O 0 0.035240884870290756
BRCA1 O 1 0.9986403584480286
and O 0 0.04820944741368294
BRCA2 O 1 0.997452437877655
participate O 0 0.01483583077788353
, O 0 0.009134631603956223
together O 0 0.00906436052173376
, O 0 0.006582087837159634
in O 0 0.0059890951961278915
a O 0 0.008238677866756916
pathway O 0 0.13202044367790222
( O 0 0.012393031269311905
s O 0 0.06086960807442665
) O 0 0.0068705580197274685
associated O 0 0.005587450228631496
with O 0 0.0048432182520627975
the O 0 0.005463830661028624
activation O 0 0.008873987942934036
of O 0 0.006894680671393871
double O 0 0.040535006672143936
- O 0 0.3558442294597626
strand O 0 0.021705446764826775
break O 0 0.022812914103269577
repair O 1 0.9587003588676453
and O 0 0.019039051607251167
/ O 1 0.7651317715644836
or O 0 0.0216832235455513
homologous O 0 0.04486951604485512
recombination O 0 0.05497504770755768
. O 0 0.04714736342430115

Dysfunction O 1 0.9998272061347961
of O 0 0.027231665328145027
this O 0 0.01348798256367445
pathway O 0 0.268081933259964
may O 0 0.00897425226867199
be O 0 0.005525191780179739
a O 0 0.0066544790752232075
general O 0 0.009662192314863205
phenomenon O 0 0.008374190889298916
in O 0 0.0048839133232831955
the O 0 0.004813001491129398
majority O 0 0.004708162508904934
of O 0 0.004942996893078089
cases O 0 0.0064506265334784985
of O 0 0.15867185592651367
hereditary B-Disease 1 0.9999997615814209
breast I-Disease 1 1.0
and I-Disease 1 0.9999934434890747
/ I-Disease 1 1.0
or I-Disease 1 0.9999948740005493
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.42128852009773254
. O 0 0.04573408141732216

A O 0 0.05647877976298332
novel O 0 0.06148644909262657
Arg362Ser O 1 0.7857943177223206
mutation O 0 0.02198335900902748
in O 0 0.012760682962834835
the O 0 0.013011828064918518
sterol O 0 0.30354586243629456
27 O 0 0.03426709398627281
- O 1 0.7669565081596375
hydroxylase O 1 0.8944966793060303
gene O 0 0.015872808173298836
( O 0 0.013963153585791588
CYP27 O 1 0.8694760203361511
) O 0 0.011808217503130436
: O 0 0.010219977237284184
its O 0 0.01072060689330101
effects O 0 0.011617947369813919
on O 0 0.010526100173592567
pre O 0 0.02387419156730175
- O 0 0.02684985101222992
mRNA O 0 0.02596738561987877
splicing O 0 0.03351308032870293
and O 0 0.023286359384655952
enzyme O 0 0.03406238183379173
activity O 0 0.030950913205742836
. O 0 0.03816421702504158

A O 0 0.04914185777306557
novel O 0 0.04622069001197815
C O 0 0.034492939710617065
to O 0 0.01691284403204918
A O 0 0.01568264327943325
mutation O 0 0.013895458541810513
in O 0 0.008407633751630783
the O 0 0.009545219130814075
sterol O 0 0.3187564015388489
27 O 0 0.026567311957478523
- O 1 0.6253371834754944
hydroxylase O 1 0.8673192858695984
gene O 0 0.01638690009713173
( O 0 0.015314032323658466
CYP27 O 1 0.8290603160858154
) O 0 0.012566142715513706
was O 0 0.012056811712682247
identified O 0 0.010707598179578781
by O 0 0.008575644344091415
sequencing O 0 0.020014578476548195
amplified O 0 0.028411583974957466
CYP27 O 1 0.7370924949645996
gene O 0 0.01703345775604248
products O 0 0.014133731834590435
from O 0 0.010245800949633121
a O 0 0.01352513488382101
patient O 1 0.8323774337768555
with O 0 0.07963201403617859
cerebrotendinous B-Disease 1 0.9999946355819702
xanthomatosis I-Disease 1 0.9999955892562866
( O 1 0.9848198890686035
CTX B-Disease 1 0.9999953508377075
) O 0 0.050827670842409134
. O 0 0.06724380701780319

The O 0 0.0428902842104435
mutation O 0 0.03414636477828026
changed O 0 0.026113862171769142
the O 0 0.02076536975800991
adrenodoxin O 1 0.9755633473396301
cofactor O 1 0.9576604962348938
binding O 0 0.025018736720085144
residue O 0 0.033447958528995514
362Arg O 0 0.11272941529750824
to O 0 0.015878671780228615
362Ser O 1 0.6157655715942383
( O 0 0.019482487812638283
CGT O 1 0.8486093878746033
362Arg O 1 0.6647610664367676
to O 0 0.02133110724389553
AGT O 1 0.9999978542327881
362Ser O 1 0.9948487877845764
) O 0 0.013883101753890514
, O 0 0.010844523087143898
and O 0 0.007958424277603626
was O 0 0.009886709973216057
responsible O 0 0.011247348971664906
for O 0 0.014362875372171402
deficiency O 1 0.9999916553497314
in O 0 0.008954311721026897
the O 0 0.013710212893784046
sterol O 1 0.9873613119125366
27 O 1 0.5876625776290894
- O 1 0.9559524655342102
hydroxylase O 1 0.6315550208091736
activity O 0 0.010802069678902626
, O 0 0.007860979065299034
as O 0 0.007640061900019646
confirmed O 0 0.00833115167915821
by O 0 0.006043691188097
expression O 0 0.008622304536402225
of O 0 0.00892688613384962
mutant O 0 0.022410789504647255
cDNA O 0 0.029415452852845192
into O 0 0.020653346553444862
COS O 1 0.9998853206634521
- O 1 0.6781813502311707
1 O 0 0.03526255115866661
cells O 0 0.04087396711111069
. O 0 0.046803634613752365

Quantitative O 0 0.04496508464217186
analysis O 0 0.021360289305448532
showed O 0 0.01645096018910408
that O 0 0.008428409695625305
the O 0 0.008357271552085876
expression O 0 0.009004279971122742
of O 0 0.010288971476256847
CYP27 O 1 0.9968384504318237
gene O 0 0.01163930632174015
mRNA O 0 0.013755550608038902
in O 0 0.01046909112483263
the O 0 0.01346764899790287
patient O 0 0.152772918343544
represented O 0 0.025638610124588013
52 O 0 0.044962141662836075
. O 0 0.042263537645339966

5 O 0 0.04544108733534813
% O 0 0.02576008066534996
of O 0 0.021392595022916794
the O 0 0.02087276242673397
normal O 0 0.025237321853637695
level O 0 0.03193853422999382
. O 0 0.03816968575119972

As O 0 0.03249119594693184
the O 0 0.02473050355911255
mutation O 0 0.024643292650580406
occurred O 0 0.019229775294661522
at O 0 0.015203534625470638
the O 0 0.014192119240760803
penultimate O 0 0.04185095056891441
nucleotide O 0 0.01847977750003338
of O 0 0.01257044542580843
exon O 0 0.027099398896098137
6 O 0 0.01633344776928425
( O 0 0.011881889775395393
- O 0 0.014801711775362492
2 O 0 0.013172848150134087
position O 0 0.013371317647397518
of O 0 0.011859707534313202
exon O 0 0.023925427347421646
6 O 0 0.01687772572040558
- O 0 0.0209725983440876
intron O 0 0.36238110065460205
6 O 0 0.01689595729112625
splice O 0 0.021550266072154045
site O 0 0.01352451927959919
) O 0 0.007979191839694977
of O 0 0.007589988876134157
the O 0 0.00791798997670412
gene O 0 0.00742800347507
, O 0 0.006714912131428719
we O 0 0.006485690828412771
hypothesized O 0 0.009607283398509026
that O 0 0.005012721288949251
the O 0 0.0068725887686014175
mutation O 0 0.011266381479799747
may O 0 0.00690061179921031
partially O 0 0.010607796721160412
affect O 0 0.007232883479446173
the O 0 0.006447482388466597
normal O 0 0.007618607021868229
splicing O 0 0.012403289787471294
efficiency O 0 0.012737642042338848
in O 0 0.009229867719113827
exon O 0 0.02420990727841854
6 O 0 0.011952405795454979
and O 0 0.00867376383394003
cause O 0 0.00976433977484703
alternative O 0 0.009750439785420895
splicing O 0 0.013082168996334076
elsewhere O 0 0.009922417812049389
, O 0 0.008265106938779354
which O 0 0.006403596606105566
resulted O 0 0.010234835557639599
in O 0 0.008718469180166721
decreased O 0 0.01666201651096344
transcript O 0 0.01786869205534458
in O 0 0.014662759378552437
the O 0 0.02236967720091343
patient O 1 0.7046013474464417
. O 0 0.04200797900557518

Transfection O 0 0.4612129330635071
of O 0 0.030113371089100838
constructed O 0 0.2709275484085083
minigenes O 1 0.9792152643203735
, O 0 0.010915647260844707
with O 0 0.007477200590074062
or O 0 0.006302128080278635
without O 0 0.006517627742141485
the O 0 0.006645014509558678
mutation O 0 0.007936345413327217
, O 0 0.006864798255264759
into O 0 0.009032844565808773
COS O 1 0.9999043941497803
- O 1 0.6358100771903992
1 O 0 0.013228977099061012
cells O 0 0.009701666422188282
confirmed O 0 0.008983330801129341
that O 0 0.005937184672802687
the O 0 0.008256657980382442
mutant O 0 0.03107614442706108
minigene O 1 0.5450636148452759
was O 0 0.012012018822133541
responsible O 0 0.010321954265236855
for O 0 0.007933237589895725
a O 0 0.010500926524400711
mRNA O 0 0.015042606741189957
species O 0 0.010700449347496033
alternatively O 0 0.015088706277310848
spliced O 0 0.018687499687075615
at O 0 0.011975239962339401
an O 0 0.011260167695581913
activated O 0 0.0352284237742424
cryptic O 0 0.02909488044679165
5 O 0 0.01893695816397667
splice O 0 0.03209606930613518
site O 0 0.01859222538769245
88 O 0 0.026666982099413872
bp O 0 0.02800373174250126
upstream O 0 0.021553492173552513
from O 0 0.01181061565876007
the O 0 0.012647985480725765
3 O 0 0.01645081304013729
end O 0 0.020256206393241882
of O 0 0.021192315965890884
exon O 0 0.06334178894758224
6 O 0 0.046655960381031036
. O 0 0.04451023414731026

Our O 0 0.03175398334860802
data O 0 0.01890253648161888
suggest O 0 0.015367021784186363
that O 0 0.008626486174762249
the O 0 0.009531178511679173
C O 0 0.015586741268634796
to O 0 0.009696070104837418
A O 0 0.01165776140987873
mutation O 0 0.010301846079528332
at O 0 0.00909848790615797
the O 0 0.009417610242962837
penultimate O 0 0.03480915725231171
nucleotide O 0 0.014239128679037094
of O 0 0.009383591823279858
exon O 0 0.01942673698067665
6 O 0 0.011577760800719261
of O 0 0.0078002517111599445
the O 0 0.009402697905898094
CYP27 O 1 0.9766621589660645
gene O 0 0.008963901549577713
not O 0 0.005736412014812231
only O 0 0.006854318547993898
causes O 0 0.0576624721288681
the O 0 0.01698964275419712
deficiency B-Disease 1 0.9999792575836182
in I-Disease 0 0.008446908555924892
the I-Disease 0 0.011807054281234741
sterol I-Disease 1 0.9656571745872498
27 I-Disease 0 0.2273327261209488
- I-Disease 1 0.8938682675361633
hydroxylase I-Disease 0 0.49313196539878845
activity I-Disease 0 0.010044741444289684
, O 0 0.008379851467907429
but O 0 0.0076636215671896935
also O 0 0.008620811626315117
partially O 0 0.012100881896913052
leads O 0 0.011151235550642014
to O 0 0.008810505270957947
alternative O 0 0.012395541183650494
pre O 0 0.021042002364993095
- O 0 0.01916046254336834
mRNA O 0 0.02114684507250786
splicing O 0 0.023657651618123055
of O 0 0.01663958467543125
the O 0 0.021336844190955162
gene O 0 0.03093511052429676
. O 0 0.03785126283764839

To O 0 0.024162137880921364
our O 0 0.01901453360915184
knowledge O 0 0.016858961433172226
, O 0 0.009832710027694702
this O 0 0.007570553105324507
is O 0 0.006369178183376789
the O 0 0.0066532474011182785
first O 0 0.00789144728332758
report O 0 0.008053194731473923
regarding O 0 0.009038626216351986
effects O 0 0.009942500852048397
on O 0 0.008271792903542519
pre O 0 0.018453557044267654
- O 0 0.015178845264017582
mRNA O 0 0.012706690467894077
splicing O 0 0.012876991182565689
of O 0 0.007906016893684864
a O 0 0.008151872083544731
mutation O 0 0.008681638166308403
at O 0 0.007063805125653744
the O 0 0.007243542931973934
- O 0 0.012227007187902927
2 O 0 0.010838163085281849
position O 0 0.010212196037173271
of O 0 0.009052098728716373
a O 0 0.013558520004153252
5 O 0 0.026089724153280258
splice O 0 0.05577177181839943
site O 0 0.042247019708156586
. O 0 0.04497614875435829

ATM O 0 0.2521803081035614
germline O 0 0.12566448748111725
mutations O 0 0.032002758234739304
in O 0 0.02131924033164978
classical O 1 0.9770601987838745
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
patients O 1 0.9999797344207764
in O 0 0.03857044503092766
the O 0 0.12417066842317581
Dutch O 1 0.8380016088485718
population O 0 0.02790619432926178
. O 0 0.043902426958084106

Germline O 1 0.5138089656829834
mutations O 0 0.027984384447336197
in O 0 0.013673217967152596
the O 0 0.012945922091603279
ATM O 0 0.22370390594005585
gene O 0 0.00937676802277565
are O 0 0.00557173416018486
responsible O 0 0.007010959088802338
for O 0 0.007626982871443033
the O 1 0.8635669350624084
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999589920043945
A B-Disease 1 0.9999966621398926
- I-Disease 1 0.9999973773956299
T I-Disease 1 0.9999933242797852
) O 0 0.03720955550670624
. O 0 0.04653404653072357

In O 0 0.025460047647356987
our O 0 0.0187723059207201
study O 0 0.013714746572077274
, O 0 0.009422607719898224
we O 0 0.007488323375582695
have O 0 0.006086359266191721
determined O 0 0.008565475232899189
the O 0 0.008356094360351562
ATM O 0 0.019706513732671738
mutation O 0 0.01081664115190506
spectrum O 0 0.010240517556667328
in O 0 0.0064878943376243114
19 O 0 0.010345502756536007
classical O 0 0.01212405227124691
A B-Disease 1 0.9361264705657959
- I-Disease 1 0.999910831451416
T I-Disease 1 0.9999861717224121
patients O 1 0.8734431862831116
, O 0 0.007198935374617577
including O 0 0.005612981505692005
some O 0 0.005684623494744301
immigrant O 0 0.00899191852658987
populations O 0 0.006303176283836365
, O 0 0.006180289667099714
as O 0 0.006316929589956999
well O 0 0.007418524473905563
as O 0 0.0076347640715539455
12 O 0 0.011445880867540836
of O 0 0.0114694619551301
Dutch O 0 0.028582334518432617
ethnic O 0 0.022037433460354805
origin O 0 0.026452109217643738
. O 0 0.03829920291900635

Both O 0 0.031179651618003845
the O 0 0.022231683135032654
protein O 0 0.020130828022956848
truncation O 0 0.06549929827451706
test O 0 0.0198989138007164
( O 0 0.015290722250938416
PTT O 0 0.12331748753786087
) O 0 0.010407636873424053
and O 0 0.008677695877850056
the O 0 0.008750283159315586
restriction O 0 0.01460733450949192
endonuclease O 0 0.2629939615726471
fingerprinting O 0 0.07576660066843033
( O 0 0.016525913029909134
REF O 1 0.8709071278572083
) O 0 0.012072338722646236
method O 0 0.009577239863574505
were O 0 0.00680966954678297
used O 0 0.006251471117138863
and O 0 0.0068329027853906155
compared O 0 0.007634229492396116
for O 0 0.005873785354197025
their O 0 0.006543323863297701
detection O 0 0.01310897059738636
efficiency O 0 0.013322815299034119
, O 0 0.00877576507627964
identifying O 0 0.011007573455572128
76 O 0 0.016451740637421608
% O 0 0.00791348796337843
and O 0 0.00771917263045907
60 O 0 0.009387333877384663
% O 0 0.008263017050921917
of O 0 0.009758067317306995
the O 0 0.012807364575564861
mutations O 0 0.018545905128121376
, O 0 0.0205276757478714
respectively O 0 0.031914688646793365
. O 0 0.037637971341609955

Most O 0 0.040376704186201096
patients O 1 0.7298092246055603
were O 0 0.011791837401688099
found O 0 0.011479966342449188
to O 0 0.013380732387304306
be O 0 0.01670239306986332
compound O 0 0.05752180889248848
heterozygote O 1 0.9339886903762817
. O 0 0.05668923631310463

Seventeen O 0 0.07118790596723557
mutations O 0 0.027186932042241096
were O 0 0.01255095936357975
distinct O 0 0.011474923230707645
, O 0 0.007606182247400284
of O 0 0.00628643948584795
which O 0 0.006341892760246992
10 O 0 0.008211773820221424
were O 0 0.00797767098993063
not O 0 0.009473677724599838
reported O 0 0.016760246828198433
previously O 0 0.025634782388806343
. O 0 0.03302490711212158

Mutations O 0 0.051362544298172
are O 0 0.02033652737736702
small O 0 0.022349923849105835
deletions O 0 0.037551771849393845
or O 0 0.017286311835050583
point O 0 0.022014005109667778
mutations O 0 0.02532150410115719
frequently O 0 0.025353819131851196
affecting O 0 0.03818682208657265
splice O 0 0.06761571019887924
sites O 0 0.04612912982702255
. O 0 0.054357435554265976

Moreover O 0 0.08557429909706116
, O 0 0.04480376094579697
a O 0 0.043821386992931366
16 O 0 0.061028528958559036
. O 0 0.06443130970001221

7 O 0 0.05567995831370354
- O 0 0.08859065175056458
kb O 0 0.24999427795410156
genomic O 0 0.027561794966459274
deletion O 0 0.021660111844539642
of O 0 0.009847819805145264
the O 0 0.007955060340464115
3 O 0 0.007693389430642128
end O 0 0.007557791657745838
of O 0 0.0057356879115104675
the O 0 0.006365472916513681
gene O 0 0.006263387389481068
, O 0 0.005329734645783901
most O 0 0.004380025900900364
likely O 0 0.005033450201153755
a O 0 0.0052444059401750565
result O 0 0.005342557094991207
of O 0 0.006572911981493235
recombination O 0 0.010945381596684456
between O 0 0.007074549328535795
two O 0 0.007625953294336796
LINE O 0 0.016002904623746872
elements O 0 0.011920648626983166
, O 0 0.012240825220942497
was O 0 0.01968548633158207
identified O 0 0.025045782327651978
. O 0 0.03155430406332016

The O 0 0.02860184572637081
most O 0 0.01594323106110096
frequently O 0 0.014711379073560238
found O 0 0.009672307409346104
mutation O 0 0.010096241720020771
, O 0 0.006790092680603266
identified O 0 0.006064855493605137
in O 0 0.005158673971891403
three O 0 0.00496074091643095
unrelated O 0 0.008099137805402279
Turkish O 0 0.024688156321644783
A B-Disease 1 0.975278913974762
- I-Disease 1 0.9998699426651001
T I-Disease 1 0.9999035596847534
individuals O 0 0.006771235726773739
, O 0 0.006695291958749294
was O 0 0.008019337430596352
previously O 0 0.007794622331857681
described O 0 0.007098672911524773
to O 0 0.005599494557827711
be O 0 0.006095111835747957
a O 0 0.009446412324905396
Turkish O 0 0.018533246591687202
A B-Disease 1 0.8648896813392639
- I-Disease 1 0.9996148347854614
T I-Disease 1 0.9998999834060669
founder O 1 0.979732871055603
mutation O 0 0.09256858378648758
. O 0 0.044603895395994186

The O 0 0.03102610819041729
presence O 0 0.023939484730362892
of O 0 0.015035932883620262
a O 0 0.018748700618743896
founder O 1 0.9839668869972229
mutation O 0 0.13023611903190613
among O 0 0.008770709857344627
relatively O 0 0.008037486113607883
small O 0 0.0060554551891982555
ethnic O 0 0.005422634072601795
population O 0 0.004085715394467115
groups O 0 0.004294510465115309
in O 0 0.004360474646091461
Western O 0 0.00650552986189723
Europe O 0 0.008104759268462658
could O 0 0.005788461770862341
indicate O 0 0.0069605023600161076
a O 0 0.007872340269386768
high O 0 0.013718687929213047
carrier O 0 0.483512282371521
frequency O 0 0.012066124938428402
in O 0 0.010715896263718605
such O 0 0.015049123205244541
communities O 0 0.02354762703180313
. O 0 0.0339069738984108

In O 0 0.03124656341969967
patients O 0 0.06696914881467819
of O 0 0.014827705919742584
Dutch O 0 0.23641915619373322
ethnic O 0 0.011232002638280392
origin O 0 0.009211275726556778
, O 0 0.008677924983203411
however O 0 0.00762784481048584
, O 0 0.007360781542956829
no O 0 0.009182797744870186
significant O 0 0.012104525230824947
founder O 0 0.42258623242378235
effect O 0 0.014910698868334293
could O 0 0.013649950735270977
be O 0 0.01708785817027092
identified O 0 0.030208822339773178
. O 0 0.040489401668310165

The O 0 0.03629688546061516
observed O 0 0.029092736542224884
genetic O 0 0.01942739263176918
heterogeneity O 0 0.026149200275540352
including O 0 0.010560638271272182
the O 0 0.009695812128484249
relative O 0 0.01025408785790205
high O 0 0.00884680263698101
percentage O 0 0.008166253566741943
of O 0 0.008147804997861385
splice O 0 0.3794870674610138
- O 0 0.38222843408584595
site O 0 0.013611972332000732
mutations O 0 0.010321151465177536
had O 0 0.00782216340303421
no O 0 0.00867565255612135
reflection O 0 0.017743926495313644
on O 0 0.01450110599398613
the O 0 0.025333700701594353
phenotype O 1 0.6419646143913269
. O 0 0.043327927589416504

All O 0 0.0341370552778244
patients O 1 0.5242398977279663
manifested O 1 0.6801172494888306
classical O 0 0.06713365018367767
A B-Disease 1 0.9977297186851501
- I-Disease 1 0.9999685287475586
T I-Disease 1 0.9999715089797974
and O 0 0.022137656807899475
increased O 0 0.02848893404006958
cellular O 0 0.45489147305488586
radioresistant O 1 0.8570497035980225
DNA O 0 0.041096046566963196
synthesis O 0 0.05241049453616142
. O 0 0.05383448675274849

Determination O 0 0.04971173405647278
of O 0 0.020951874554157257
the O 0 0.0164298415184021
genomic O 0 0.021239012479782104
structure O 0 0.013188683427870274
of O 0 0.010844850912690163
the O 0 0.013891139067709446
COL4A4 O 1 0.9990121126174927
gene O 0 0.012385918758809566
and O 0 0.009249082766473293
of O 0 0.011788630858063698
novel O 1 0.9433853626251221
mutations O 1 0.9936705827713013
causing O 1 0.9999904632568359
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.999691367149353

Autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9767182469367981
a O 1 0.997721254825592
progressive O 1 0.9999995231628418
hematuric B-Disease 1 0.9999998807907104
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9999651908874512
by O 1 0.9793425798416138
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999983310699463
membrane I-Disease 1 0.9993219375610352
abnormalities I-Disease 1 0.9993528723716736
and O 0 0.015484314411878586
associated O 0 0.010507720522582531
with O 0 0.007396422326564789
mutations O 0 0.008280337788164616
in O 0 0.005953012499958277
either O 0 0.007250768132507801
the O 0 0.008133682422339916
COL4A3 O 1 0.9710832238197327
or O 0 0.008504580706357956
the O 0 0.01087129395455122
COL4A4 O 1 0.9633827209472656
gene O 0 0.01080000214278698
, O 0 0.007869387976825237
which O 0 0.007230367977172136
encode O 0 0.012306928634643555
the O 0 0.009299740195274353
alpha3 O 0 0.11632249504327774
and O 0 0.014780220575630665
alpha4 O 1 0.9980847835540771
type O 1 0.9971150159835815
IV O 1 0.999998927116394
collagen O 1 0.9999935626983643
chains O 1 0.9359943866729736
, O 0 0.02894739806652069
respectively O 0 0.04123155400156975
. O 0 0.04399191215634346

To O 0 0.032011978328228
date O 0 0.025206265971064568
, O 0 0.01777670904994011
mutation O 0 0.014762711711227894
screening O 0 0.012314362451434135
in O 0 0.007171980571001768
the O 0 0.00703068170696497
two O 0 0.0061209676787257195
genes O 0 0.006651788018643856
has O 0 0.006068524904549122
been O 0 0.006884331349283457
hampered O 0 0.4784065783023834
by O 0 0.006730813533067703
the O 0 0.00904218852519989
lack O 0 0.01503600925207138
of O 0 0.013069087639451027
genomic O 0 0.04925347492098808
structure O 0 0.02651691995561123
information O 0 0.026006421074271202
. O 0 0.03407976031303406

We O 0 0.03291034698486328
report O 0 0.022907940670847893
here O 0 0.015877151861786842
the O 0 0.01199115440249443
complete O 0 0.014720229431986809
characterization O 0 0.015781043097376823
of O 0 0.008678729645907879
the O 0 0.0077231512404978275
48 O 0 0.010969577357172966
exons O 0 0.012985986657440662
of O 0 0.008302508853375912
the O 0 0.009700099937617779
COL4A4 O 1 0.9950549602508545
gene O 0 0.009495403617620468
, O 0 0.00697370758280158
a O 0 0.007998408749699593
comprehensive O 0 0.015017745085060596
gene O 0 0.009192912839353085
screen O 0 0.012472530826926231
, O 0 0.007026818115264177
and O 0 0.005794235970824957
the O 0 0.006602751091122627
subsequent O 0 0.009868219494819641
detection O 0 0.010333096608519554
of O 0 0.006149592809379101
10 O 0 0.007482301909476519
novel O 0 0.01046833023428917
mutations O 0 0.00722274836152792
in O 0 0.006813940592110157
eight O 0 0.3247022330760956
patients O 1 0.9999892711639404
diagnosed O 1 1.0
with O 1 0.999971866607666
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9996405839920044

Furthermore O 0 0.04878903180360794
, O 0 0.02300987020134926
we O 0 0.016169894486665726
identified O 0 0.014240581542253494
a O 0 0.013638727366924286
glycine O 0 0.0233240257948637
to O 0 0.01166723296046257
alanine O 0 0.024928996339440346
substitution O 0 0.015301358886063099
in O 0 0.01024907547980547
the O 0 0.012700015679001808
collagenous O 1 0.9994223117828369
domain O 0 0.013918527401983738
that O 0 0.007466732989996672
is O 0 0.008119829930365086
apparently O 0 0.010812305845320225
silent O 0 0.013551454059779644
in O 0 0.008051416836678982
the O 0 0.010283858515322208
heterozygous O 0 0.0228388961404562
carriers O 0 0.05157717317342758
, O 0 0.01287552248686552
in O 0 0.01632540486752987
11 O 0 0.028836186975240707
. O 0 0.03412916511297226

5 O 0 0.037795666605234146
% O 0 0.01839713752269745
of O 0 0.011713934130966663
all O 0 0.008557593449950218
control O 0 0.010570786893367767
individuals O 0 0.006231097038835287
, O 0 0.006618689280003309
and O 0 0.005535505246371031
in O 0 0.005372815299779177
one O 0 0.00703324843198061
control O 0 0.011752927675843239
individual O 0 0.009771623648703098
homozygous O 0 0.017211953178048134
for O 0 0.012756149284541607
this O 0 0.0159725621342659
glycine O 0 0.0482451468706131
substitution O 0 0.04747936874628067
. O 0 0.04801907390356064

There O 0 0.022562241181731224
has O 0 0.015580061823129654
been O 0 0.009871356189250946
no O 0 0.009313161484897137
previous O 0 0.009585710242390633
finding O 0 0.009850939735770226
of O 0 0.007923377677798271
a O 0 0.010846934281289577
glycine O 0 0.11400016397237778
substitution O 0 0.01220549363642931
that O 0 0.005988583900034428
is O 0 0.006029792129993439
not O 0 0.0055565317161381245
associated O 0 0.006675532553344965
with O 0 0.006904145237058401
any O 0 0.009871464222669601
obvious O 0 0.041058290749788284
phenotype O 0 0.3450247347354889
in O 0 0.01813538931310177
homozygous O 0 0.04784844070672989
individuals O 0 0.03122117929160595
. O 0 0.04202788695693016

Founder O 1 0.9960054755210876
BRCA1 O 1 0.9997243285179138
and O 0 0.1697321981191635
BRCA2 O 1 0.9997288584709167
mutations O 0 0.029461625963449478
in O 0 0.01640920154750347
French O 1 0.9952985644340515
Canadian O 1 0.999970555305481
breast B-Disease 1 1.0
and I-Disease 1 0.9999963045120239
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9911324381828308
. O 0 0.22641658782958984

We O 0 0.02411789633333683
have O 0 0.012883204035460949
identified O 0 0.01070342306047678
four O 0 0.009578452445566654
mutations O 0 0.007272437214851379
in O 0 0.004882008768618107
each O 0 0.004240232054144144
of O 0 0.005497639533132315
the O 0 0.41319650411605835
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 0.9999890327453613
susceptibility O 1 0.9999681711196899
genes O 0 0.16428212821483612
, O 0 0.06838705390691757
BRCA1 O 1 0.9988716244697571
and O 0 0.01747351698577404
BRCA2 O 1 0.987855851650238
, O 0 0.0061487858183681965
in O 0 0.006391917355358601
French O 0 0.3820250630378723
Canadian O 1 0.9969960451126099
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999973773956299
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9713913202285767
from O 0 0.13369742035865784
Quebec O 1 0.9752680063247681
. O 0 0.05279725417494774

To O 0 0.029476391151547432
identify O 0 0.027371589094400406
founder O 1 0.8170853853225708
effects O 0 0.05915563553571701
, O 0 0.009810438379645348
we O 0 0.008990542963147163
examined O 0 0.01200532540678978
independently O 0 0.01049052644520998
ascertained O 0 0.03764313459396362
French O 0 0.3618810772895813
Canadian O 1 0.7750421762466431
cancer B-Disease 1 0.9993195533752441
families O 0 0.00932339671999216
for O 0 0.00749205332249403
the O 0 0.008574129082262516
distribution O 0 0.009547392837703228
of O 0 0.010116597637534142
these O 0 0.011408488266170025
eight O 0 0.024586256593465805
mutations O 0 0.03477141633629799
. O 0 0.041140682995319366

Mutations O 0 0.049585942178964615
were O 0 0.023457970470190048
found O 0 0.016594314947724342
in O 0 0.015830690041184425
41 O 0 0.02629946731030941
of O 0 0.019811905920505524
97 O 0 0.06524711847305298
families O 0 0.036619316786527634
. O 0 0.04808887839317322

Six O 0 0.03423471003770828
of O 0 0.021864915266633034
eight O 0 0.020124686881899834
mutations O 0 0.018153639510273933
were O 0 0.012169230729341507
observed O 0 0.01527344435453415
at O 0 0.015685632824897766
least O 0 0.01743057370185852
twice O 0 0.033998407423496246
. O 0 0.037862394005060196

The O 0 0.0508652999997139
BRCA1 O 1 0.9988786578178406
C4446T O 1 0.9913033246994019
mutation O 0 0.07583615928888321
was O 0 0.016334297135472298
the O 0 0.00921339076012373
most O 0 0.008033131249248981
common O 0 0.010784761048853397
mutation O 0 0.013199013657867908
found O 0 0.007154119201004505
, O 0 0.007914829067885876
followed O 0 0.010861651971936226
by O 0 0.011545800603926182
the O 0 0.028685547411441803
BRCA2 O 1 0.9996205568313599
8765delAG O 1 0.9963850975036621
mutation O 0 0.16290459036827087
. O 0 0.04413376748561859

Together O 0 0.030320314690470695
, O 0 0.016268789768218994
these O 0 0.010012805461883545
mutations O 0 0.009796698577702045
were O 0 0.005823768209666014
found O 0 0.00500118313357234
in O 0 0.005399391986429691
28 O 0 0.008167300373315811
of O 0 0.006214412860572338
41 O 0 0.011111262254416943
families O 0 0.007918438874185085
identified O 0 0.007793874479830265
to O 0 0.00779028981924057
have O 0 0.008718485943973064
a O 0 0.016916751861572266
mutation O 0 0.03254183009266853
. O 0 0.03273941949009895

The O 0 0.034617308527231216
odds O 0 0.03558240458369255
of O 0 0.015956193208694458
detection O 0 0.019600097090005875
of O 0 0.009564344771206379
any O 0 0.007449634838849306
of O 0 0.008436519652605057
the O 0 0.010432584211230278
four O 0 0.037166811525821686
BRCA1 O 1 0.9998125433921814
mutations O 0 0.03870636224746704
was O 0 0.026765888556838036
18 O 0 0.031411342322826385
. O 0 0.03974887728691101

7x O 1 0.9864779710769653
greater O 0 0.03289536386728287
if O 0 0.013972852379083633
one O 0 0.010249868035316467
or O 0 0.007456026040017605
more O 0 0.006607099901884794
cases O 0 0.017324229702353477
of O 1 0.9945969581604004
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.45919573307037354
also O 0 0.038881875574588776
present O 0 0.010831687599420547
in O 0 0.011725599877536297
the O 0 0.018499119207262993
family O 0 0.031487394124269485
. O 0 0.036309681832790375

The O 0 0.03536655381321907
odds O 0 0.0327860489487648
of O 0 0.016296377405524254
detection O 0 0.017136121168732643
of O 0 0.008364488370716572
any O 0 0.0072198049165308475
of O 0 0.007973585277795792
the O 0 0.01326621975749731
four O 0 0.23453006148338318
BRCA2 O 1 0.9999440908432007
mutations O 0 0.09039270877838135
was O 0 0.04317591339349747
5 O 0 0.030689189210534096
. O 0 0.03702278062701225

3x O 1 0.743473470211029
greater O 0 0.029773160815238953
if O 0 0.013290741480886936
there O 0 0.008975901640951633
were O 0 0.0064035202376544476
at O 0 0.006750243250280619
least O 0 0.006284298375248909
five O 0 0.006892320234328508
cases O 0 0.010044627822935581
of O 1 0.7969871759414673
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
in O 0 0.13454094529151917
the O 0 0.20287324488162994
family O 0 0.1576501876115799
. O 0 0.03736620023846626

Interestingly O 0 0.05529129505157471
, O 0 0.01943003013730049
the O 0 0.012739813886582851
presence O 0 0.012114141136407852
of O 0 0.011708050966262817
a O 1 0.9704453349113464
breast B-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
case O 1 0.6036128997802734
< O 1 0.9709141254425049
36 O 0 0.012556774541735649
years O 0 0.007366871926933527
of O 0 0.0068603199906647205
age O 0 0.008166910149157047
was O 0 0.007503712549805641
strongly O 0 0.007831026799976826
predictive O 0 0.00969958771020174
of O 0 0.006237900350242853
the O 0 0.005792565643787384
presence O 0 0.006234460510313511
of O 0 0.006073309574276209
any O 0 0.005983919370919466
of O 0 0.007913331501185894
the O 0 0.012062516063451767
eight O 0 0.02089955098927021
mutations O 0 0.030942494049668312
screened O 0 0.05215088278055191
. O 0 0.04474441334605217

Carriers O 0 0.05101274698972702
of O 0 0.020754942670464516
the O 0 0.01501474715769291
same O 0 0.011374560184776783
mutation O 0 0.013501565903425217
, O 0 0.007596743758767843
from O 0 0.005738233216106892
different O 0 0.005348925478756428
families O 0 0.006468295585364103
, O 0 0.006240351125597954
shared O 0 0.007936309091746807
similar O 0 0.007490767166018486
haplotypes O 0 0.09587767720222473
, O 0 0.006670589558780193
indicating O 0 0.007116167340427637
that O 0 0.004641997627913952
the O 0 0.006680616177618504
mutant O 0 0.045283012092113495
alleles O 0 0.011178633198142052
were O 0 0.005748488008975983
likely O 0 0.00697708735242486
to O 0 0.006148881744593382
be O 0 0.005724695976823568
identical O 0 0.007154451217502356
by O 0 0.006293926388025284
descent O 0 0.010793350636959076
for O 0 0.007546372711658478
a O 0 0.011285226792097092
mutation O 0 0.013697193004190922
in O 0 0.011874871328473091
the O 0 0.015594549477100372
founder O 1 0.6137688755989075
population O 0 0.0286555252969265
. O 0 0.037122566252946854

The O 0 0.0327109768986702
identification O 0 0.027736399322748184
of O 0 0.018775302916765213
common O 1 0.5589868426322937
BRCA1 O 1 0.9999668598175049
and O 1 0.8978580832481384
BRCA2 O 1 0.9999860525131226
mutations O 0 0.06037196144461632
will O 0 0.007329610176384449
facilitate O 0 0.013464626856148243
carrier O 0 0.4432194232940674
detection O 0 0.018170421943068504
in O 0 0.007869390770792961
French O 0 0.2916739284992218
Canadian O 1 0.9956758618354797
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
and O 1 0.9999960660934448
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.9829960465431213
. O 0 0.10984034836292267

Are O 0 0.03537902235984802
Dp71 O 1 0.7545090913772583
and O 0 0.036427296698093414
Dp140 O 1 0.9974321722984314
brain O 1 0.9927757978439331
dystrophin O 1 0.995424211025238
isoforms O 0 0.03225117176771164
related O 0 0.024379055947065353
to O 0 0.021630674600601196
cognitive B-Disease 1 0.9987673759460449
impairment I-Disease 1 0.999998927116394
in O 1 0.9999051094055176
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9998828172683716

Molecular O 0 0.0556226447224617
study O 0 0.029074855148792267
and O 0 0.017752762883901596
neuropsychological O 0 0.040666453540325165
analysis O 0 0.012653250247240067
were O 0 0.00867692194879055
performed O 0 0.011710931546986103
concurrently O 0 0.014074653387069702
on O 0 0.009586222469806671
49 O 0 0.05645456537604332
patients O 1 0.9826394319534302
with O 1 0.9947081804275513
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999990463256836
DMD B-Disease 1 1.0
) O 0 0.05721261724829674
in O 0 0.00842229649424553
order O 0 0.008452842943370342
to O 0 0.007127054501324892
find O 0 0.00829419307410717
a O 0 0.008161110803484917
molecular O 0 0.00846902746707201
explanation O 0 0.008823569864034653
for O 0 0.007234907243400812
the O 0 0.011193472892045975
cognitive B-Disease 1 0.9547678828239441
impairment I-Disease 1 0.9999243021011353
observed O 0 0.021820668131113052
in O 0 0.03322575241327286
most O 1 0.7786044478416443
DMD B-Disease 1 1.0
patients O 1 0.9999351501464844
. O 0 0.0542595349252224

Complete O 0 0.03851477801799774
analysis O 0 0.02427848055958748
of O 0 0.01700875721871853
the O 0 0.017880596220493317
dystrophin O 1 0.9991055130958557
gene O 0 0.015325050801038742
was O 0 0.01193799264729023
performed O 0 0.010443243198096752
to O 0 0.00827670656144619
define O 0 0.01124453917145729
the O 0 0.00884129386395216
localization O 0 0.01916947029531002
of O 0 0.01011188980191946
deletions O 0 0.02473311498761177
and O 0 0.01261184923350811
duplications O 0 0.04521669074892998
in O 0 0.011061524040997028
relation O 0 0.013719551265239716
to O 0 0.014084998518228531
the O 0 0.017159106209874153
different O 0 0.022366518154740334
DMD B-Disease 1 0.999967098236084
promoters O 1 0.7122594118118286
. O 0 0.06040193513035774

Qualitative O 0 0.04516392573714256
analysis O 0 0.021310312673449516
of O 0 0.016547782346606255
the O 0 0.014424087479710579
Dp71 O 1 0.8288541436195374
transcript O 0 0.019276514649391174
and O 0 0.009294531308114529
testing O 0 0.009318971075117588
for O 0 0.006659503094851971
the O 0 0.007360311225056648
specific O 0 0.007443566340953112
first O 0 0.00955465529114008
exon O 0 0.02445308119058609
of O 0 0.01128672156482935
Dp140 O 0 0.3218834400177002
were O 0 0.01168801635503769
also O 0 0.014447310008108616
carried O 0 0.020991317927837372
out O 0 0.02770054340362549
. O 0 0.03982331231236458

Neuropsychological O 0 0.27622002363204956
analysis O 0 0.03556414693593979
assessed O 0 0.03871981054544449
verbal O 0 0.07610364258289337
and O 0 0.021181458607316017
visuospatial O 1 0.9910716414451599
intelligence O 0 0.03706962987780571
, O 0 0.0205363892018795
verbal O 1 0.8670968413352966
memory O 1 0.9811069965362549
, O 0 0.021311534568667412
and O 0 0.02004428766667843
reading O 0 0.05161095783114433
skills O 0 0.31687742471694946
. O 0 0.04144342616200447

Comparison O 0 0.04512164741754532
of O 0 0.023752912878990173
molecular O 0 0.02525845542550087
and O 0 0.0159987173974514
psychometric O 0 0.39877966046333313
findings O 0 0.016819629818201065
demonstrated O 0 0.018857359886169434
that O 0 0.007826101034879684
deletions O 0 0.04695987328886986
and O 0 0.008460503071546555
duplications O 0 0.14163900911808014
that O 0 0.0056783659383654594
were O 0 0.005234850104898214
localized O 0 0.013098112307488918
in O 0 0.005661510396748781
the O 0 0.007989257574081421
distal O 1 0.8386107087135315
part O 0 0.008293475955724716
of O 0 0.00719628157094121
the O 0 0.008702510967850685
gene O 0 0.007985150441527367
seemed O 0 0.008384119719266891
to O 0 0.005862091667950153
be O 0 0.006677784491330385
preferentially O 0 0.017626354470849037
associated O 0 0.012227274477481842
with O 0 0.014493810012936592
cognitive B-Disease 1 0.9866389036178589
impairment I-Disease 1 0.9999314546585083
. O 0 0.051009487360715866

Two O 0 0.04685702174901962
altered O 0 0.047725554555654526
Dp71 O 0 0.058967992663383484
transcripts O 0 0.033870819956064224
and O 0 0.016363512724637985
two O 0 0.013423922471702099
deleted O 0 0.01919339969754219
Dp140 O 0 0.028418662026524544
DNA O 0 0.010884493589401245
sequences O 0 0.008408952504396439
were O 0 0.0050916182808578014
found O 0 0.005033786874264479
in O 0 0.006883613765239716
four O 0 0.011741113848984241
patients O 1 0.99825519323349
with O 1 0.9804896712303162
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9922947883605957

These O 0 0.02608824521303177
findings O 0 0.023134469985961914
suggest O 0 0.015290298499166965
that O 0 0.007995759136974812
some O 0 0.007500454317778349
sequences O 0 0.008420423604547977
located O 0 0.008717546239495277
in O 0 0.006622860673815012
the O 0 0.0073767914436757565
distal O 0 0.06637319177389145
part O 0 0.007585072424262762
of O 0 0.006368574686348438
the O 0 0.007191343232989311
gene O 0 0.0071510449051856995
and O 0 0.00575717817991972
, O 0 0.0056267692707479
in O 0 0.0050710695795714855
particular O 0 0.005134863313287497
, O 0 0.005877322982996702
some O 0 0.006415631156414747
DMD B-Disease 1 0.9999411106109619
isoforms O 0 0.012388847768306732
expressed O 0 0.008707371540367603
in O 0 0.006681809201836586
the O 0 0.028176480904221535
brain O 1 0.930044412612915
may O 0 0.006124706007540226
be O 0 0.005230992566794157
related O 0 0.006464430131018162
to O 0 0.0064436993561685085
the O 0 0.011842133477330208
cognitive B-Disease 1 0.9704120755195618
impairment I-Disease 1 0.9999657869338989
associated O 0 0.3872170150279999
with O 1 0.5805474519729614
DMD B-Disease 1 0.9999996423721313
. O 0 0.044201720505952835
. O 0 0.047285981476306915

I1307K O 1 0.9868255257606506
APC O 1 0.9975491166114807
and O 0 0.032440610229969025
hMLH1 O 1 0.6811131834983826
mutations O 0 0.019913747906684875
in O 0 0.012007566168904305
a O 0 0.011717334389686584
non O 0 0.01765143871307373
- O 0 0.1377633810043335
Jewish O 0 0.011879706755280495
family O 0 0.011508668772876263
with O 0 0.05390448123216629
hereditary B-Disease 1 0.9999996423721313
non I-Disease 1 0.9999997615814209
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9937137961387634

We O 0 0.034683942794799805
describe O 0 0.028758376836776733
a O 0 0.01871262863278389
French O 0 0.022765476256608963
Canadian O 0 0.05814112722873688
hereditary B-Disease 1 0.9999830722808838
non I-Disease 1 0.9999856948852539
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.999998927116394
HNPCC B-Disease 1 1.0
) O 1 0.9102018475532532
kindred O 1 0.9996300935745239
which O 0 0.015263192355632782
carries O 0 0.026832375675439835
a O 0 0.02386225387454033
novel O 0 0.15917865931987762
truncating O 1 0.9369975328445435
mutation O 0 0.051036007702350616
in O 0 0.03403876721858978
hMLH1 O 1 0.8189350962638855
. O 0 0.05783930420875549

Interestingly O 0 0.06785504519939423
, O 0 0.029978932812809944
the O 0 0.024088457226753235
I1307K O 1 0.9766033887863159
APC O 1 0.9993657469749451
polymorphism O 0 0.22222396731376648
, O 0 0.010074053891003132
associated O 0 0.006922838743776083
with O 0 0.0051208664663136005
an O 0 0.0057640052400529385
increased O 0 0.2569546103477478
risk O 1 0.9992828965187073
of O 1 0.9999803304672241
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9716702699661255
is O 0 0.05694122239947319
also O 0 0.009730497375130653
present O 0 0.010358140803873539
in O 0 0.01120503805577755
this O 0 0.015123218297958374
family O 0 0.03022691234946251
. O 0 0.039488036185503006

The O 0 0.04208321124315262
I1307K O 1 0.7527380585670471
polymorphism O 0 0.035232994705438614
has O 0 0.0151628153398633
previously O 0 0.012853313237428665
only O 0 0.0074394941329956055
been O 0 0.006934630684554577
identified O 0 0.007174619007855654
in O 0 0.005652351304888725
individuals O 0 0.0064186896197497845
of O 0 0.009305650368332863
self O 1 0.884272038936615
- O 1 0.9920578598976135
reported O 0 0.28291237354278564
Ashkenazi O 1 0.7547274231910706
Jewish O 0 0.035721346735954285
origins O 0 0.05209062993526459
. O 0 0.048007939010858536

In O 0 0.02177008055150509
addition O 0 0.015898652374744415
, O 0 0.009863962419331074
in O 0 0.007685516029596329
this O 0 0.005988207180052996
family O 0 0.008290092460811138
, O 0 0.005188743118196726
there O 0 0.004573208745568991
appears O 0 0.006238107103854418
to O 0 0.004878831095993519
be O 0 0.004034222569316626
no O 0 0.004742714110761881
relationship O 0 0.005876380950212479
between O 0 0.005036290269345045
the O 0 0.006236623506993055
I1307K O 0 0.4508203864097595
polymorphism O 0 0.012598690576851368
and O 0 0.0060852584429085255
the O 0 0.006619379390031099
presence O 0 0.009003194980323315
or O 0 0.008424999192357063
absence O 1 0.5506665110588074
of O 1 0.8250575661659241
cancer B-Disease 1 0.999996542930603
. O 0 0.03441738337278366
. O 0 0.03462724760174751

Identification O 0 0.042523689568042755
of O 0 0.02403384819626808
a O 0 0.01883590593934059
novel O 0 0.022689612582325935
mutation O 0 0.015205461531877518
of O 0 0.010410116985440254
the O 0 0.020037194713950157
CPO O 1 0.9942757487297058
gene O 0 0.013820544816553593
in O 0 0.011643859557807446
a O 0 0.017229216173291206
Japanese O 1 0.9313360452651978
hereditary B-Disease 1 0.9999849796295166
coproporphyria I-Disease 1 0.9999669790267944
family O 1 0.6974814534187317
. O 0 0.046397432684898376

Hereditary B-Disease 1 0.9998934268951416
coproporphyria I-Disease 1 0.9999479055404663
( O 1 0.8775650262832642
HCP B-Disease 1 0.9999479055404663
) O 0 0.01894179731607437
is O 0 0.014032389037311077
an O 0 0.35955795645713806
autosomal B-Disease 1 0.9999985694885254
dominant I-Disease 1 0.9999830722808838
disease I-Disease 1 0.9999990463256836
characterized O 1 0.9965978264808655
by O 0 0.20748211443424225
a O 1 0.9992985725402832
deficiency B-Disease 1 1.0
of I-Disease 1 0.9999803304672241
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9999995231628418
( O 1 0.9896350502967834
CPO O 1 0.9997757077217102
) O 0 0.014799347147345543
caused O 0 0.014740533195436
by O 0 0.008752566762268543
a O 0 0.012677405960857868
mutation O 0 0.016942527145147324
in O 0 0.012617009691894054
the O 0 0.020552825182676315
CPO O 1 0.9762335419654846
gene O 0 0.040287621319293976
. O 0 0.0472564771771431

Only O 0 0.025422286242246628
11 O 0 0.026019468903541565
mutations O 0 0.01722036860883236
of O 0 0.010869083926081657
the O 0 0.009890682995319366
gene O 0 0.009404527954757214
have O 0 0.0066702160984277725
been O 0 0.00876323040574789
reported O 0 0.016233980655670166
in O 0 0.023859059438109398
HCP B-Disease 1 0.9999563694000244
patients O 1 0.9932990074157715
. O 0 0.04528728500008583

We O 0 0.034688085317611694
report O 0 0.0304301418364048
another O 0 0.023557517677545547
mutation O 0 0.024518685415387154
in O 0 0.015173065476119518
a O 0 0.02270660735666752
Japanese O 0 0.22387096285820007
family O 0 0.041866835206747055
. O 0 0.045423634350299835

Polymerase O 0 0.18170852959156036
chain O 0 0.06561173498630524
reaction O 0 0.03066198155283928
- O 0 0.05529262125492096
single O 0 0.018863357603549957
strand O 0 0.02274457737803459
conformational O 0 0.025029240176081657
polymorphism O 0 0.019527779892086983
and O 0 0.009817772544920444
direct O 0 0.009894106537103653
sequence O 0 0.010556863620877266
analyses O 0 0.013241443783044815
demonstrated O 0 0.012052778154611588
a O 0 0.011051931418478489
C O 0 0.02692956104874611
to O 0 0.012791108340024948
T O 0 0.054260849952697754
substitution O 0 0.016580864787101746
in O 0 0.01051159854978323
exon O 0 0.020954260602593422
1 O 0 0.012973572127521038
of O 0 0.009960243478417397
the O 0 0.011048387736082077
CPO O 0 0.06346233934164047
gene O 0 0.012497999705374241
at O 0 0.011270769871771336
nucleotide O 0 0.014363886788487434
position O 0 0.011716044507920742
85 O 0 0.014823039062321186
, O 0 0.01001349464058876
which O 0 0.008387327194213867
lies O 0 0.012962514534592628
in O 0 0.009928305633366108
the O 0 0.013625871390104294
putative O 0 0.15853779017925262
presequence O 0 0.4035453796386719
for O 0 0.01669146493077278
targeting O 0 0.026299232617020607
to O 0 0.0249346774071455
mitochondria O 0 0.056618768721818924
. O 0 0.04927194491028786

This O 0 0.03443768993020058
mutation O 0 0.03054366447031498
changes O 0 0.015394275076687336
the O 0 0.0146389901638031
codon O 0 0.022219739854335785
for O 0 0.012695950455963612
glutamine O 0 0.023934347555041313
to O 0 0.012396047823131084
a O 0 0.013532491400837898
termination O 0 0.042321860790252686
codon O 0 0.025267481803894043
at O 0 0.018965255469083786
amino O 0 0.022338449954986572
acid O 0 0.02500428445637226
position O 0 0.031820930540561676
29 O 0 0.04572714492678642
. O 0 0.0467684231698513

MaeI O 0 0.4377492368221283
restriction O 0 0.035245101898908615
analysis O 0 0.022260276600718498
showed O 0 0.018655257299542427
two O 0 0.012428740970790386
other O 0 0.012268252670764923
carriers O 0 0.023195507004857063
in O 0 0.013964690268039703
the O 0 0.02187524177134037
family O 0 0.03419897332787514
. O 0 0.038524363189935684

The O 0 0.05197399482131004
C O 1 0.9897084832191467
- O 1 0.9916679263114929
T O 1 0.996807873249054
mutation O 0 0.02401604689657688
is O 0 0.012488128617405891
located O 0 0.014215768314898014
within O 0 0.010183106176555157
a O 0 0.010663296096026897
recently O 0 0.012565977871418
proposed O 0 0.010770824737846851
putative O 0 0.018358910456299782
alternative O 0 0.011990945786237717
translation O 0 0.01206838060170412
initiation O 0 0.015606449916958809
codon O 0 0.018934305757284164
( O 0 0.014307142235338688
TIC O 1 0.9685701727867126
- O 0 0.05174912139773369
1 O 0 0.012098765932023525
) O 0 0.008519354276359081
, O 0 0.007919352501630783
supporting O 0 0.010027477517724037
that O 0 0.008345309644937515
TIC O 1 0.988163948059082
- O 0 0.08471070975065231
1 O 0 0.012618417851626873
is O 0 0.008014124818146229
the O 0 0.009432697668671608
real O 0 0.014252803288400173
TIC O 1 0.876437246799469
rather O 0 0.013769762590527534
than O 0 0.012938863597810268
TIC O 1 0.9990286827087402
- O 0 0.4878607392311096
2 O 0 0.029004884883761406
. O 0 0.02713700942695141
. O 0 0.04214184358716011

Human B-Disease 0 0.050915420055389404
complement I-Disease 1 0.9403946399688721
factor I-Disease 1 0.9997014403343201
H I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
associated O 1 0.9999713897705078
with O 1 0.9999994039535522
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999542236328125

This O 0 0.021235059946775436
study O 0 0.01610281504690647
reports O 0 0.010957334190607071
on O 0 0.009030215442180634
six O 0 0.009222579188644886
cases O 0 0.01064580399543047
of O 0 0.13795925676822662
deficiency B-Disease 1 0.999998927116394
in I-Disease 0 0.010856653563678265
the I-Disease 0 0.010035821236670017
human I-Disease 0 0.009224405512213707
complement I-Disease 0 0.028102150186896324
regulatory I-Disease 0 0.09768620133399963
protein I-Disease 0 0.018186455592513084
Factor I-Disease 1 0.655396580696106
H I-Disease 1 0.9991556406021118
( O 0 0.018699822947382927
FH O 1 0.9903743267059326
) O 0 0.011192492209374905
in O 0 0.009266135282814503
the O 0 0.009464706294238567
context O 0 0.012446224689483643
of O 0 0.020446479320526123
an O 1 0.9988058805465698
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9997244477272034

Five O 0 0.025694403797388077
of O 0 0.014643069356679916
the O 0 0.010714925825595856
cases O 0 0.008432558737695217
were O 0 0.006430943962186575
observed O 0 0.006601405795663595
in O 0 0.006081222090870142
children O 0 0.04833488166332245
presenting O 1 0.9966403245925903
with O 1 0.9999939203262329
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.9988963603973389
. O 0 0.43899986147880554

Two O 0 0.02316269837319851
of O 0 0.0155417425557971
the O 0 0.015282847918570042
children O 0 0.07137032598257065
exhibited O 1 0.9693490266799927
a O 1 0.9941145777702332
homozygous O 1 0.9999890327453613
deficiency O 1 1.0
characterized O 1 0.9881224036216736
by O 0 0.00883486494421959
the O 0 0.01001383550465107
absence O 0 0.020376386120915413
of O 0 0.00862532015889883
the O 0 0.008901257067918777
150 O 0 0.019714631140232086
- O 1 0.5153266191482544
kD O 1 0.8412935137748718
form O 0 0.010087253525853157
of O 0 0.009821982122957706
Factor O 0 0.11678440123796463
H O 1 0.9306173324584961
and O 0 0.008531107567250729
the O 0 0.0076838294044137
presence O 0 0.008701654151082039
, O 0 0.007579507306218147
upon O 0 0.007600440178066492
immunoblotting O 0 0.028577810153365135
, O 0 0.0077507677488029
of O 0 0.006917769555002451
the O 0 0.008759085088968277
42 O 0 0.01729663461446762
- O 0 0.4459344148635864
kD O 1 0.9877843856811523
Factor O 0 0.033232491463422775
H O 1 0.5842660665512085
- O 0 0.016927756369113922
like O 0 0.01044840831309557
protein O 0 0.011358719319105148
1 O 0 0.012493250891566277
( O 0 0.011938297189772129
FHL O 1 0.9308070540428162
- O 0 0.018489724025130272
1 O 0 0.01258087158203125
) O 0 0.01018199697136879
and O 0 0.008429150097072124
other O 0 0.008105257526040077
FH O 1 0.9994980096817017
- O 1 0.804667592048645
related O 0 0.07257027179002762
protein O 0 0.021666163578629494
( O 0 0.022277282550930977
FHR O 1 0.971241295337677
) O 0 0.027566587552428246
bands O 0 0.05430731177330017
. O 0 0.04852212592959404

Southern O 0 0.05636855587363243
blot O 0 0.29928794503211975
and O 0 0.021902937442064285
PCR O 0 0.029767237603664398
analysis O 0 0.012904774397611618
of O 0 0.009111006744205952
DNA O 0 0.008617119863629341
of O 0 0.006699860095977783
one O 0 0.007748846895992756
patient O 1 0.9910033941268921
with O 1 0.6401057243347168
homozygous O 1 0.9997749924659729
deficiency O 1 0.9999998807907104
ruled O 1 0.6983110308647156
out O 0 0.00910498108714819
the O 0 0.006951207295060158
presence O 0 0.00717116566374898
of O 0 0.006037512794137001
a O 0 0.006090693641453981
large O 0 0.006054304074496031
deletion O 0 0.01088977325707674
of O 0 0.006053762510418892
the O 0 0.010855277068912983
FH O 1 0.9998962879180908
gene O 0 0.010200239717960358
as O 0 0.008217481896281242
the O 0 0.010300572030246258
underlying O 1 0.8427918553352356
defect O 1 0.9983958601951599
for O 0 0.22153346240520477
the O 1 0.9655987024307251
deficiency O 1 0.9999997615814209
. O 0 0.3460303544998169

The O 0 0.02462480217218399
other O 0 0.012148681096732616
four O 0 0.011098024435341358
children O 0 0.011971911415457726
presented O 0 0.037944696843624115
with O 0 0.25793877243995667
heterozygous O 1 0.999303936958313
deficiency O 1 1.0
and O 1 0.9116942286491394
exhibited O 1 0.9924436211585999
a O 1 0.5408648252487183
normal O 0 0.18322405219078064
immunoblotting O 1 0.9741447567939758
pattern O 0 0.01552953664213419
of O 0 0.01212309766560793
proteins O 0 0.013937624171376228
of O 0 0.01603831723332405
the O 0 0.032625891268253326
FH O 1 0.9998776912689209
family O 0 0.15118932723999023
. O 0 0.04942944645881653

Factor B-Disease 1 0.9994969367980957
H I-Disease 1 0.9999924898147583
deficiency I-Disease 1 0.9999945163726807
is O 0 0.023523658514022827
the O 0 0.06793469190597534
only O 0 0.41067495942115784
complement B-Disease 1 0.9999889135360718
deficiency I-Disease 1 1.0
associated O 1 0.9932023882865906
with O 1 0.9901226162910461
HUS B-Disease 1 0.9999998807907104
. O 1 0.5387872457504272

These O 0 0.025206854566931725
observations O 0 0.025337787345051765
suggest O 0 0.017749587073922157
a O 0 0.011649282649159431
role O 0 0.012259935028851032
for O 0 0.013018847443163395
FH O 1 0.9999198913574219
and O 0 0.13957494497299194
/ O 1 0.9906042218208313
or O 0 0.023997178301215172
FH O 1 0.99992835521698
receptors O 0 0.0212758406996727
in O 0 0.011250722222030163
the O 0 0.042999956756830215
pathogenesis O 1 0.9999961853027344
of O 1 0.9987156391143799
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.8632858991622925
. O 0 0.06222399324178696

Further O 0 0.03131365403532982
evidence O 0 0.019844718277454376
for O 0 0.012375523336231709
a O 0 0.013693894259631634
major O 0 0.01928468607366085
ancient O 0 0.20289960503578186
mutation O 1 0.9966264963150024
underlying O 1 0.9999904632568359
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9960417747497559
linkage O 1 0.9999843835830688
disequilibrium O 1 0.9999916553497314
studies O 0 0.02739824540913105
in O 0 0.015217171050608158
the O 0 0.01734681986272335
Japanese O 0 0.1983187347650528
population O 0 0.030334755778312683
. O 0 0.04667918384075165

The O 1 0.9749667644500732
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.999977707862854
DM B-Disease 1 1.0
) O 1 0.7397845387458801
mutation O 0 0.32822883129119873
is O 0 0.010478455573320389
an O 0 0.03005976788699627
unstable O 1 0.9995957016944885
( O 1 0.5419429540634155
CTG O 1 0.9998291730880737
) O 0 0.013243436813354492
n O 0 0.016393696889281273
repeat O 0 0.01623545214533806
, O 0 0.009498822502791882
present O 0 0.009181548841297626
at O 0 0.0083458898589015
a O 0 0.008963223546743393
copy O 0 0.010750962421298027
number O 0 0.006307074800133705
of O 0 0.0074971080757677555
5 O 0 0.009595525451004505
- O 0 0.012730994261801243
37 O 0 0.012848800979554653
repeats O 0 0.013884811662137508
on O 0 0.00967872329056263
normal O 0 0.011937396600842476
chromosomes O 0 0.014377056621015072
but O 0 0.00967886857688427
amplified O 0 0.016640927642583847
to O 0 0.011719356290996075
50 O 0 0.017181772738695145
- O 0 0.02753850445151329
3000 O 0 0.041661523282527924
copies O 0 0.030802089720964432
on O 0 0.03275319188833237
DM B-Disease 1 0.9998846054077148
chromosomes O 0 0.07925140857696533
. O 0 0.06276814639568329

Previous O 0 0.04617888107895851
findings O 0 0.02906622923910618
in O 0 0.018289782106876373
Caucasian O 0 0.05072245001792908
populations O 0 0.011873483657836914
of O 0 0.012727870605885983
a O 1 0.9043833613395691
DM B-Disease 1 1.0
founder O 1 0.9999377727508545
chromosome O 1 0.756471574306488
raise O 0 0.017443686723709106
a O 0 0.009338890202343464
question O 0 0.009589903987944126
about O 0 0.007236911449581385
the O 0 0.007770154625177383
molecular O 0 0.010826723650097847
events O 0 0.008796562440693378
involved O 0 0.009662989526987076
in O 0 0.010552400723099709
the O 0 0.015247547067701817
expansion O 0 0.03820919245481491
mutation O 0 0.04355202615261078
. O 0 0.04193636775016785

To O 0 0.02920723892748356
investigate O 0 0.029436422511935234
whether O 0 0.01674048788845539
a O 0 0.012551914900541306
founder O 0 0.14602181315422058
chromosome O 0 0.014976875856518745
for O 0 0.009469463489949703
the O 0 0.3422645330429077
DM B-Disease 1 1.0
mutation O 1 0.5521745681762695
exists O 0 0.009541059844195843
in O 0 0.005981222726404667
the O 0 0.006571563892066479
Japanese O 0 0.01731383241713047
population O 0 0.006400254555046558
, O 0 0.007245710585266352
we O 0 0.007501061074435711
genotyped O 0 0.021709557622671127
families O 0 0.008618032559752464
using O 0 0.008745144121348858
polymorphic O 0 0.020006224513053894
markers O 0 0.013452381826937199
near O 0 0.011550216004252434
the O 0 0.009388810023665428
( O 0 0.013499774970114231
CTG O 1 0.9892001152038574
) O 0 0.014391680248081684
n O 0 0.020038669928908348
repeat O 0 0.023719023913145065
region O 0 0.020592451095581055
and O 0 0.02143101394176483
constructed O 0 0.045906566083431244
haplotypes O 0 0.07719458639621735
. O 0 0.0485505536198616

Six O 0 0.03611954301595688
different O 0 0.018350034952163696
haplotypes O 0 0.027649708092212677
were O 0 0.010598303750157356
found O 0 0.011244810186326504
and O 0 0.023457927629351616
DM B-Disease 1 0.9999997615814209
alleles O 0 0.3979222774505615
were O 0 0.014345604926347733
always O 0 0.023593701422214508
haplotype O 0 0.27753499150276184
A O 0 0.05089662969112396
. O 0 0.038855865597724915

To O 0 0.026452669873833656
find O 0 0.020598750561475754
an O 0 0.01167329866439104
origin O 0 0.011032665148377419
of O 0 0.008962503634393215
the O 0 0.010467267595231533
( O 0 0.022897595539689064
CTG O 1 0.9983246922492981
) O 0 0.01229032687842846
n O 0 0.015815287828445435
repeat O 0 0.017247674986720085
mutation O 0 0.010343404486775398
and O 0 0.005864348728209734
to O 0 0.006137271411716938
investigate O 0 0.008192898705601692
the O 0 0.005798432044684887
mechanism O 0 0.007817339152097702
of O 0 0.0058513665571808815
the O 0 0.006283491384238005
expansion O 0 0.017171453684568405
mutation O 0 0.00900193490087986
in O 0 0.00568217970430851
the O 0 0.006964012980461121
Japanese O 0 0.012726386077702045
population O 0 0.00618708273395896
we O 0 0.006877103820443153
have O 0 0.005766541697084904
studied O 0 0.010843919590115547
90 O 0 0.013737359084188938
Japanese O 0 0.03958360105752945
DM B-Disease 1 0.9999462366104126
families O 0 0.01724572852253914
comprising O 0 0.0207980889827013
190 O 0 0.036945890635252
affected O 0 0.018590042367577553
and O 0 0.017552444711327553
130 O 0 0.037552665919065475
unaffected O 0 0.06437709927558899
members O 0 0.0357806533575058
. O 0 0.04990129545331001

The O 0 0.037344008684158325
results O 0 0.022185098379850388
suggest O 0 0.01710665598511696
that O 0 0.008785862475633621
a O 0 0.008990908972918987
few O 0 0.008769425563514233
common O 0 0.007614710368216038
ancestral O 0 0.0255619827657938
mutations O 0 0.008303617127239704
in O 0 0.006496780086308718
both O 0 0.007221637759357691
Caucasian O 1 0.966297447681427
and O 0 0.01235075481235981
Japanese O 0 0.13946488499641418
populations O 0 0.008178150281310081
have O 0 0.005551196169108152
originated O 0 0.008021398447453976
by O 0 0.0055702184326946735
expansion O 0 0.010523061268031597
of O 0 0.0075389244593679905
an O 0 0.00781234772875905
ancestral O 0 0.017173247411847115
n O 0 0.01446892973035574
= O 0 0.014528915286064148
5 O 0 0.012166215106844902
repeat O 0 0.0146112609654665
to O 0 0.011154970154166222
n O 0 0.019147386774420738
= O 0 0.02266131341457367
19 O 0 0.024959614500403404
- O 0 0.03374863415956497
37 O 0 0.03938455134630203
copies O 0 0.040075432509183884
. O 0 0.0431775227189064

These O 0 0.025833217427134514
data O 0 0.024503782391548157
support O 0 0.022329147905111313
multistep O 0 0.03566475585103035
models O 0 0.02295180782675743
of O 0 0.016155138611793518
triplet O 1 0.7888815402984619
repeat O 0 0.08053524792194366
expansion O 0 0.018276141956448555
that O 0 0.00760933943092823
have O 0 0.006264221854507923
been O 0 0.007016986142843962
proposed O 0 0.007920507341623306
for O 0 0.008756229653954506
both O 0 0.016869183629751205
DM B-Disease 1 0.9999998807907104
and O 1 0.9285352826118469
Friedreichs B-Disease 1 0.9999769926071167
ataxia I-Disease 1 0.999994158744812
. O 0 0.03807061165571213
. O 0 0.04435054585337639

The O 0 0.03492089360952377
molecular O 0 0.03509240224957466
basis O 0 0.02395760826766491
of O 1 0.7293789386749268
C6 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
in O 0 0.0780271366238594
the O 0 0.045110609382390976
western O 0 0.07874934375286102
Cape O 1 0.926170825958252
, O 0 0.02780649997293949
South O 0 0.037917330861091614
Africa O 0 0.0494663268327713
. O 0 0.04765411093831062

Deficiency B-Disease 1 0.9998680353164673
of I-Disease 0 0.024882005527615547
the I-Disease 0 0.022531887516379356
sixth I-Disease 1 0.9567878842353821
component I-Disease 0 0.3774981200695038
of I-Disease 0 0.014221776276826859
human I-Disease 0 0.03328312188386917
complement I-Disease 1 0.9835802912712097
( O 1 0.8127633929252625
C6 O 1 0.9999792575836182
) O 0 0.011356242932379246
has O 0 0.007995427586138248
been O 0 0.006886340212076902
reported O 0 0.007142227608710527
in O 0 0.005562856327742338
a O 0 0.006462883669883013
number O 0 0.005588282365351915
of O 0 0.006688825786113739
families O 0 0.006391097325831652
from O 0 0.0061743115074932575
the O 0 0.008165843784809113
western O 0 0.013587945140898228
Cape O 0 0.21038635075092316
, O 0 0.017822301015257835
South O 0 0.027641156688332558
Africa O 0 0.03894012048840523
. O 0 0.04404376447200775

Meningococcal B-Disease 1 0.9999991655349731
disease I-Disease 1 0.9999978542327881
is O 0 0.13817767798900604
endemic O 1 0.9366053938865662
in O 0 0.012899581342935562
the O 0 0.016212519258260727
Cape O 0 0.2706242501735687
and O 0 0.007487413007766008
almost O 0 0.006274410989135504
all O 0 0.00605924753472209
pedigrees O 0 0.014709499664604664
of O 0 0.011547536589205265
total O 1 0.9816606044769287
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.994482159614563
C6Q0 O 1 0.9999768733978271
) O 0 0.009788238443434238
have O 0 0.006854620762169361
been O 0 0.008366911672055721
ascertained O 0 0.021984826773405075
because O 0 0.012075820006430149
of O 0 0.32898277044296265
recurrent O 1 0.9999997615814209
disease O 1 0.9999994039535522
. O 1 0.7739574909210205

We O 0 0.03679394721984863
have O 0 0.01940556988120079
sequenced O 0 0.023892076686024666
the O 0 0.013497551903128624
expressed O 0 0.013070004060864449
exons O 0 0.01897990144789219
of O 0 0.010275646112859249
the O 0 0.023044532164931297
C6 O 1 0.9999762773513794
gene O 0 0.009297285228967667
from O 0 0.006387655157595873
selected O 0 0.008600149303674698
cases O 0 0.006293849088251591
and O 0 0.0047740391455590725
have O 0 0.0041890074498951435
found O 0 0.004003777168691158
three O 0 0.005167706403881311
molecular O 0 0.009456751868128777
defects O 1 0.8856562376022339
leading O 0 0.033602237701416016
to O 0 0.007335364352911711
total O 1 0.6852551102638245
deficiency O 1 1.0
879delG O 1 0.9999666213989258
, O 0 0.018023911863565445
which O 0 0.005611111409962177
is O 0 0.005378131289035082
the O 0 0.006228312849998474
common O 0 0.009383086115121841
defect O 1 0.8103217482566833
in O 0 0.006565299816429615
the O 0 0.008606583811342716
Cape O 1 0.6026309132575989
and O 0 0.0080978162586689
hitherto O 0 0.47035449743270874
unreported O 0 0.034910913556814194
, O 0 0.007162462919950485
and O 0 0.007832449860870838
1195delC O 1 0.9727919697761536
and O 0 0.010356518439948559
1936delG O 1 0.913691520690918
, O 0 0.007373223081231117
which O 0 0.0053984238766133785
have O 0 0.004580107983201742
been O 0 0.005824375431984663
previously O 0 0.008207709528505802
reported O 0 0.008714011870324612
in O 0 0.009125222451984882
African O 0 0.025662392377853394
- O 0 0.4602600932121277
Americans O 0 0.028075607493519783
. O 0 0.03372974693775177

We O 0 0.024806128814816475
also O 0 0.014807394705712795
show O 0 0.012652135454118252
that O 0 0.007860918529331684
the O 0 0.010466596111655235
879delG O 1 0.9661715030670166
and O 0 0.025133294984698296
1195delC O 1 0.9968435764312744
defects O 1 0.9779974818229675
are O 0 0.0071551259607076645
associated O 0 0.008809984661638737
with O 0 0.01065968070179224
characteristic O 1 0.9850000143051147
C6 O 1 0.9999990463256836
/ O 1 0.9999017715454102
C7 O 1 0.9999494552612305
region O 0 0.04314558953046799
DNA O 0 0.022318396717309952
marker O 1 0.6007402539253235
haplotypes O 0 0.16321848332881927
, O 0 0.012879802845418453
although O 0 0.011977124027907848
small O 0 0.013355794362723827
variations O 0 0.015921955928206444
were O 0 0.016593700274825096
observed O 0 0.02854498289525509
. O 0 0.037194836884737015

The O 0 0.05027756839990616
1936delG O 1 0.9959591031074524
defect O 1 0.9845923781394958
was O 0 0.022496918216347694
observed O 0 0.01301510538905859
only O 0 0.008296975865960121
once O 0 0.008966396562755108
in O 0 0.007010474801063538
the O 0 0.008549729362130165
Cape O 0 0.15772272646427155
, O 0 0.008874327875673771
but O 0 0.006630309857428074
its O 0 0.00964741874486208
associated O 0 0.012115477584302425
haplotype O 0 0.038715798407793045
could O 0 0.01642172411084175
be O 0 0.017991043627262115
deduced O 0 0.048923809081315994
. O 0 0.04106952250003815

The O 0 0.025349711999297142
data O 0 0.015818264335393906
from O 0 0.011251306161284447
the O 0 0.011335033923387527
haplotypes O 0 0.020896151661872864
indicate O 0 0.008535618893802166
that O 0 0.005823895335197449
these O 0 0.004639112390577793
three O 0 0.005936970468610525
molecular O 0 0.013079189695417881
defects O 1 0.7998811602592468
account O 0 0.006605797912925482
for O 0 0.005757008213549852
the O 0 0.008560795336961746
defects O 1 0.9013118147850037
in O 0 0.006111136171966791
all O 0 0.005789966322481632
the O 0 0.007666331250220537
38 O 0 0.016751203685998917
unrelated O 0 0.030257530510425568
C6Q0 O 1 0.9633640646934509
individuals O 0 0.009828587993979454
we O 0 0.008198969066143036
have O 0 0.007389585021883249
studied O 0 0.014424717985093594
from O 0 0.01280650869011879
the O 0 0.020636463537812233
Cape O 0 0.07186480611562729
. O 0 0.042313989251852036

We O 0 0.029285861179232597
have O 0 0.016667252406477928
also O 0 0.012582910247147083
observed O 0 0.012388181872665882
the O 0 0.011272395960986614
879delG O 1 0.7399762868881226
defect O 1 0.5487840175628662
in O 0 0.010086038149893284
two O 0 0.011641796678304672
Dutch O 1 0.9983396530151367
C6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999581575393677
deficient I-Disease 1 0.9999701976776123
kindreds O 1 0.9959650039672852
, O 0 0.010814866051077843
but O 0 0.008285460062325
the O 0 0.010637790895998478
879delG O 1 0.9938061237335205
defect O 1 0.9733864068984985
in O 0 0.010025802068412304
the O 0 0.012637948617339134
Cape O 1 0.6882755160331726
probably O 0 0.011990776285529137
did O 0 0.008591576479375362
not O 0 0.0069245342165231705
come O 0 0.009922468103468418
from O 0 0.008403293788433075
The O 0 0.014418990351259708
Netherlands O 0 0.03142251819372177
. O 0 0.02449171431362629
. O 0 0.03972048684954643

Complement B-Disease 1 0.999717652797699
C7 I-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999985694885254
: O 0 0.027891652658581734
seven O 0 0.019703861325979233
further O 0 0.021495115011930466
molecular O 1 0.8743481636047363
defects O 1 0.9992426633834839
and O 0 0.015501297079026699
their O 0 0.01379402820020914
associated O 0 0.07419577240943909
marker O 1 0.9168714284896851
haplotypes O 1 0.8150297999382019
. O 0 0.05108052119612694

Seven O 0 0.03825642168521881
further O 0 0.028767302632331848
molecular O 0 0.030470116063952446
bases O 0 0.03691723570227623
of O 1 0.9842772483825684
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.1388063132762909
described O 1 0.839743435382843
. O 0 0.05248130112886429

All O 0 0.02310369163751602
these O 0 0.013937374576926231
new O 0 0.017203420400619507
molecular O 0 0.022891053929924965
defects O 1 0.8206164240837097
involve O 0 0.015590399503707886
single O 0 0.01531852688640356
- O 0 0.08080292493104935
nucleotide O 0 0.01625603437423706
events O 0 0.010280627757310867
, O 0 0.010303644463419914
deletions O 0 0.015206819400191307
and O 0 0.008036425337195396
substitutions O 0 0.012256886810064316
, O 0 0.007816266268491745
some O 0 0.006219577044248581
of O 0 0.007486258167773485
which O 0 0.006826353259384632
alter O 0 0.013405035249888897
splice O 0 0.021658020094037056
sites O 0 0.01290068682283163
, O 0 0.013401570729911327
and O 0 0.015695249661803246
others O 0 0.0221170075237751
codons O 0 0.04993041977286339
. O 0 0.045316193252801895

They O 0 0.02429814077913761
are O 0 0.012534752488136292
distributed O 0 0.014524593949317932
along O 0 0.012120592407882214
the O 0 0.014364049769937992
C7 O 1 0.9999264478683472
gene O 0 0.015495643019676208
, O 0 0.01055057905614376
but O 0 0.008938824757933617
predominantly O 0 0.012050407007336617
towards O 0 0.01398392766714096
the O 0 0.013935068622231483
3 O 0 0.024211246520280838
end O 0 0.0346403568983078
. O 0 0.0448264554142952

All O 0 0.031182192265987396
were O 0 0.02027447707951069
found O 0 0.0169229619204998
in O 0 0.01848009042441845
compound O 0 0.03685082122683525
heterozygous O 0 0.038147784769535065
individuals O 0 0.024911975488066673
. O 0 0.039816029369831085

The O 0 0.26702621579170227
C6 O 1 0.9999856948852539
/ O 1 0.9998613595962524
C7 O 1 0.9999911785125732
marker O 1 0.9900704026222229
haplotypes O 1 0.8747435808181763
associated O 0 0.02207152172923088
with O 0 0.019608965143561363
most O 1 0.501222550868988
C7 B-Disease 1 0.999998927116394
defects I-Disease 1 0.9999403953552246
are O 0 0.018593695014715195
tabulated O 0 0.04496220126748085
. O 0 0.026775121688842773
. O 0 0.04087163507938385

A O 0 0.04063383862376213
genome O 0 0.037661898881196976
- O 0 0.02774149365723133
wide O 0 0.015642261132597923
search O 0 0.016314374282956123
for O 0 0.011672803200781345
chromosomal O 1 0.7093480825424194
loci O 0 0.06422752141952515
linked O 0 0.055122390389442444
to O 0 0.012865842320024967
mental O 1 0.9999828338623047
health O 1 0.9997689127922058
wellness O 1 0.9999688863754272
in O 0 0.017841048538684845
relatives O 0 0.028693556785583496
at O 0 0.015334250405430794
high O 1 0.586658239364624
risk O 1 0.9982656836509705
for O 1 0.9994034767150879
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 1 0.9785063862800598
the O 1 0.9307742714881897
Old O 1 0.9903020262718201
Order O 0 0.15626047551631927
Amish O 1 0.5582561492919922
. O 0 0.05137813836336136

Bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
( O 1 0.9999897480010986
BPAD B-Disease 1 1.0
; O 1 0.9999984502792358
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.9154840707778931
is O 0 0.015442066825926304
characterized O 0 0.14497338235378265
by O 0 0.0062677753157913685
episodes O 0 0.02611132338643074
of O 0 0.3665122985839844
mania B-Disease 1 0.9999998807907104
and O 1 0.9885623455047607
/ O 1 0.9999326467514038
or O 0 0.39876794815063477
hypomania B-Disease 1 0.9999877214431763
interspersed O 0 0.13921692967414856
with O 0 0.01514927763491869
periods O 0 0.042980827391147614
of O 0 0.14322048425674438
depression B-Disease 1 0.9999756813049316
. O 0 0.07634270191192627

Compelling O 0 0.05185747891664505
evidence O 0 0.02304229699075222
supports O 0 0.022929366677999496
a O 0 0.014290125109255314
significant O 0 0.015004392713308334
genetic O 0 0.033755648881196976
component O 0 0.3112342953681946
in O 0 0.011463397182524204
the O 0 0.07808688282966614
susceptibility O 1 0.9974287152290344
to O 0 0.025909753516316414
develop O 1 0.921034574508667
BPAD B-Disease 1 0.9998039603233337
. O 0 0.05412469059228897

To O 0 0.027978140860795975
date O 0 0.021456403657794
, O 0 0.014096459373831749
however O 0 0.010446688160300255
, O 0 0.009672526270151138
linkage O 0 0.014509906060993671
studies O 0 0.009187676012516022
have O 0 0.005512964446097612
attempted O 0 0.009153464809060097
only O 0 0.005780224222689867
to O 0 0.006908655632287264
identify O 0 0.009757057763636112
chromosomal O 0 0.08983764052391052
loci O 0 0.01554898265749216
that O 0 0.007357893977314234
cause O 0 0.06224784627556801
or O 0 0.007947349920868874
increase O 0 0.009541938081383705
the O 0 0.012495952658355236
risk O 0 0.20106643438339233
of O 0 0.02332499995827675
developing O 1 0.8887950778007507
BPAD B-Disease 1 0.9999651908874512
. O 0 0.05279620364308357

To O 0 0.024884914979338646
determine O 0 0.01763942278921604
whether O 0 0.011984958313405514
there O 0 0.009761076420545578
could O 0 0.009022628888487816
be O 0 0.0072853825986385345
protective O 1 0.9419055581092834
alleles O 0 0.01221409160643816
that O 0 0.005494330078363419
prevent O 0 0.012388071976602077
or O 0 0.005775924306362867
reduce O 0 0.008732149377465248
the O 0 0.006766676437109709
risk O 0 0.0262383371591568
of O 0 0.010009865276515484
developing O 1 0.898759126663208
BPAD B-Disease 1 0.9999972581863403
, O 0 0.008161843754351139
similar O 0 0.005028821993619204
to O 0 0.004784261342138052
what O 0 0.0050567942671477795
is O 0 0.00470778439193964
observed O 0 0.005248059052973986
in O 0 0.005384672898799181
other O 0 0.006441483274102211
genetic B-Disease 1 0.9904546141624451
disorders I-Disease 1 0.9999995231628418
, O 0 0.22583656013011932
we O 0 0.008587287738919258
used O 0 0.03911483287811279
mental O 1 0.9999885559082031
health O 1 0.9999750852584839
wellness O 1 0.9999980926513672
( O 0 0.21424099802970886
absence O 0 0.40310904383659363
of O 0 0.19942404329776764
any O 1 0.8729836344718933
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.4412460923194885
as O 0 0.011064685881137848
the O 0 0.010243702679872513
phenotype O 0 0.3137986361980438
in O 0 0.007825249806046486
our O 0 0.01032576896250248
genome O 0 0.016094060614705086
- O 0 0.02090197615325451
wide O 0 0.015919942408800125
linkage O 0 0.02359914965927601
scan O 0 0.02086549438536167
of O 0 0.011151478625833988
several O 0 0.009470023214817047
large O 0 0.01325422152876854
multigeneration O 0 0.20732754468917847
Old O 0 0.02002754807472229
Order O 0 0.01664421148598194
Amish O 0 0.04700109735131264
pedigrees O 0 0.06860967725515366
exhibiting O 0 0.061637457460165024
an O 0 0.013799892738461494
extremely O 0 0.21788187325000763
high O 1 0.5457128286361694
incidence O 1 0.9983635544776917
of O 1 0.5326153635978699
BPAD B-Disease 1 0.9999843835830688
. O 0 0.06093938648700714

We O 0 0.02665104530751705
have O 0 0.014020425267517567
found O 0 0.012492316775023937
strong O 0 0.011269823648035526
evidence O 0 0.008641378954052925
for O 0 0.00818224623799324
a O 0 0.010826380923390388
locus O 0 0.0465976744890213
on O 0 0.012973201461136341
chromosome O 0 0.030799807980656624
4p O 1 0.9916280508041382
at O 0 0.016422362998127937
D4S2949 O 0 0.10016950964927673
( O 0 0.015092072077095509
maximum O 0 0.01956484280526638
GENEHUNTER O 1 0.6792938709259033
- O 0 0.027414070442318916
PLUS O 0 0.02707754075527191
nonparametric O 0 0.038331445306539536
linkage O 0 0.02543920837342739
score O 0 0.01845298707485199
= O 0 0.01944606937468052
4 O 0 0.016172926872968674
. O 0 0.01226435974240303
05 O 0 0.032945070415735245
, O 0 0.012601906433701515
P O 0 0.019805366173386574
= O 0 0.01418293546885252
5 O 0 0.011753182858228683
. O 0 0.007279987912625074
22 O 0 0.01074265968054533
x O 0 0.012446587905287743
10 O 0 0.010322353802621365
( O 0 0.009932104498147964
- O 0 0.015209876000881195
4 O 0 0.013587184250354767
) O 0 0.011380014941096306
; O 0 0.01165812462568283
SIBPAL O 0 0.03691508248448372
Pempirical O 0 0.030839739367365837
value O 0 0.014000637456774712
< O 0 0.020885756239295006
3 O 0 0.013110155239701271
x O 0 0.014320234768092632
10 O 0 0.009974374435842037
( O 0 0.009387502446770668
- O 0 0.01613515615463257
5 O 0 0.010182365775108337
) O 0 0.007570972666144371
) O 0 0.008962338790297508
and O 0 0.00836134422570467
suggestive O 0 0.01394484844058752
evidence O 0 0.008287332952022552
for O 0 0.006889624986797571
a O 0 0.01031286921352148
locus O 0 0.025403685867786407
on O 0 0.01290844939649105
chromosome O 0 0.023468894883990288
4q O 1 0.9144926071166992
at O 0 0.017036914825439453
D4S397 O 0 0.0911896675825119
( O 0 0.01448243297636509
maximum O 0 0.020373588427901268
GENEHUNTER O 1 0.8685628771781921
- O 0 0.028965981677174568
PLUS O 0 0.027079928666353226
nonparametric O 0 0.03958499804139137
linkage O 0 0.025463907048106194
score O 0 0.016957499086856842
= O 0 0.01963123120367527
3 O 0 0.013493026606738567
. O 0 0.009386505000293255
29 O 0 0.014427606016397476
, O 0 0.010763704776763916
P O 0 0.01830669306218624
= O 0 0.016263509169220924
2 O 0 0.012381079606711864
. O 0 0.008931473828852177
57 O 0 0.01554172858595848
x O 0 0.015108360908925533
10 O 0 0.011945567093789577
( O 0 0.01165040209889412
- O 0 0.01729450188577175
3 O 0 0.015172046609222889
) O 0 0.013206623494625092
; O 0 0.01458832249045372
SIBPAL O 0 0.040050603449344635
Pempirical O 0 0.033124133944511414
value O 0 0.014284295961260796
< O 0 0.022207098081707954
1 O 0 0.016082972288131714
x O 0 0.017902564257383347
10 O 0 0.013871577568352222
( O 0 0.01086001843214035
- O 0 0.015104366466403008
3 O 0 0.012108482420444489
) O 0 0.008634735830128193
) O 0 0.008605335839092731
that O 0 0.007292943075299263
are O 0 0.00709475576877594
linked O 0 0.014156585559248924
to O 0 0.018195217475295067
mental O 1 0.9999773502349854
health O 1 0.9999744892120361
wellness O 1 0.9999943971633911
. O 0 0.3959052264690399

These O 0 0.02529674395918846
findings O 0 0.023339994251728058
are O 0 0.009687382727861404
consistent O 0 0.012002537027001381
with O 0 0.007886572740972042
the O 0 0.008586296811699867
hypothesis O 0 0.011168206110596657
that O 0 0.00570559361949563
certain O 0 0.006551112048327923
alleles O 0 0.00830899365246296
could O 0 0.005473924335092306
prevent O 0 0.006971122696995735
or O 0 0.00515010068193078
modify O 0 0.009619449265301228
the O 0 0.00835037138313055
clinical O 1 0.964148223400116
manifestations O 1 0.9879946112632751
of O 1 0.8089147210121155
BPAD B-Disease 1 0.9999996423721313
and O 1 0.5195369720458984
perhaps O 1 0.5825117826461792
other O 0 0.03477242588996887
related O 1 0.9970399737358093
affective B-Disease 1 0.9999986886978149
disorders I-Disease 1 0.9999996423721313
. O 1 0.7158801555633545

Segregation O 1 0.9800695180892944
distortion O 1 0.9959119558334351
in O 1 0.8688696622848511
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999992847442627
. O 1 0.6301286816596985

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9999210834503174
DM B-Disease 1 1.0
) O 0 0.09162057191133499
is O 0 0.0179592277854681
an O 1 0.5717989802360535
autosomal B-Disease 1 0.9999980926513672
dominant I-Disease 1 0.9999966621398926
disease I-Disease 1 0.9999996423721313
which O 0 0.1278199851512909
, O 0 0.00866587832570076
in O 0 0.006322687491774559
the O 0 0.009929337538778782
typical O 0 0.04998009651899338
pedigree O 0 0.1956302672624588
, O 0 0.009141725488007069
shows O 0 0.010085376910865307
a O 0 0.011005165986716747
three O 0 0.013835306279361248
generation O 0 0.0785290077328682
anticipation O 0 0.16516602039337158
cascade O 1 0.5510139465332031
. O 0 0.05268152430653572

This O 0 0.02511095069348812
results O 0 0.02229502983391285
in O 0 0.09716520458459854
infertility B-Disease 1 0.9999998807907104
and O 1 0.9999974966049194
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999984502792358
CDM B-Disease 1 0.9999997615814209
) O 0 0.02710646204650402
with O 0 0.011313476599752903
the O 0 0.013070834800601006
disappearance O 0 0.14863410592079163
of O 0 0.1717129647731781
DM B-Disease 1 0.9999997615814209
in O 0 0.03288500756025314
that O 0 0.023167693987488747
pedigree O 1 0.6330320835113525
. O 0 0.0420185886323452

The O 0 0.03249523416161537
concept O 0 0.027705103158950806
of O 0 0.019855957478284836
segregation O 1 0.9346237778663635
distortion O 1 0.9557563066482544
, O 0 0.012692724354565144
where O 0 0.008588903583586216
there O 0 0.006823889911174774
is O 0 0.007383797783404589
preferential O 0 0.0127023346722126
transmission O 0 0.009870950132608414
of O 0 0.0062728323973715305
the O 0 0.006384027656167746
larger O 0 0.008615213446319103
allele O 0 0.010970193892717361
at O 0 0.008457954041659832
the O 0 0.015437339432537556
DM B-Disease 1 0.9999996423721313
locus O 1 0.9565795660018921
, O 0 0.01010242011398077
has O 0 0.0077734822407364845
been O 0 0.005790018010884523
put O 0 0.008420112542808056
forward O 0 0.010007994249463081
to O 0 0.008166307583451271
explain O 0 0.01180343795567751
partially O 0 0.012458983808755875
the O 0 0.00997834000736475
maintenance O 1 0.5922845005989075
of O 0 0.07283719629049301
DM B-Disease 1 0.9999995231628418
in O 0 0.019166745245456696
the O 0 0.02243908680975437
population O 0 0.024401966482400894
. O 0 0.04238642379641533

In O 0 0.027470149099826813
a O 0 0.022348541766405106
survey O 0 0.022131850942969322
of O 0 0.021036628633737564
DM B-Disease 1 0.9999985694885254
in O 0 0.01704227365553379
Northern O 0 0.01981147564947605
Ireland O 0 0.02171121910214424
, O 0 0.016610927879810333
59 O 0 0.03607291728258133
pedigrees O 0 0.05738336220383644
were O 0 0.02498934045433998
ascertained O 0 0.07869038730859756
. O 0 0.051602087914943695

Sibships O 0 0.4564683735370636
where O 0 0.02149183675646782
the O 0 0.013026227243244648
status O 0 0.011560916900634766
of O 0 0.006847103126347065
all O 0 0.005425581708550453
the O 0 0.005826231557875872
members O 0 0.005624016746878624
had O 0 0.006109774578362703
been O 0 0.00468664662912488
identified O 0 0.005810828413814306
were O 0 0.004715261980891228
examined O 0 0.00704951211810112
to O 0 0.00525474501773715
determine O 0 0.005885304417461157
the O 0 0.005618187133222818
transmission O 0 0.008094538003206253
of O 0 0.006805323529988527
the O 0 0.0887170061469078
DM B-Disease 1 0.9999998807907104
expansion O 1 0.7843708992004395
from O 0 0.014138421975076199
affected O 0 0.019027678295969963
parents O 0 0.013750880025327206
to O 0 0.014292167499661446
their O 0 0.017653262242674828
offspring O 0 0.0415436290204525
. O 0 0.038818515837192535

Where O 0 0.04327165707945824
the O 0 0.02992771752178669
transmitting O 0 0.17518624663352966
parent O 0 0.15135438740253448
was O 0 0.03557121381163597
male O 0 0.0402122437953949
, O 0 0.027665402740240097
58 O 0 0.056306593120098114
. O 0 0.04958659037947655

3 O 0 0.036003123968839645
% O 0 0.02021781913936138
of O 0 0.014602572657167912
the O 0 0.012205538339912891
offspring O 0 0.035488251596689224
were O 0 0.007856893353164196
affected O 0 0.01116438303142786
, O 0 0.006809269543737173
and O 0 0.006023849826306105
in O 0 0.005660053342580795
the O 0 0.00641830125823617
case O 0 0.007303880527615547
of O 0 0.007487073075026274
a O 0 0.01419246569275856
female O 0 0.31545957922935486
transmitting O 1 0.8108596801757812
parent O 1 0.6714820861816406
, O 0 0.02319236472249031
68 O 0 0.053119439631700516
. O 0 0.042046573013067245

7 O 0 0.07002638280391693
% O 0 0.04294160380959511
were O 0 0.035925623029470444
affected O 0 0.044590357691049576
. O 0 0.04626994952559471

Studies O 0 0.03817965090274811
on O 0 0.02556939423084259
meiotic O 1 0.981082558631897
drive O 0 0.04683727025985718
in O 0 0.027908604592084885
DM B-Disease 1 0.9999988079071045
have O 0 0.011286073364317417
shown O 0 0.009455643594264984
increased O 0 0.009330886416137218
transmission O 0 0.012594717554748058
of O 0 0.0072974287904798985
the O 0 0.007080661598592997
larger O 0 0.009916014038026333
allele O 0 0.012867421843111515
at O 0 0.010139270685613155
the O 0 0.013849705457687378
DM B-Disease 1 0.9999929666519165
locus O 1 0.6509168744087219
in O 0 0.018214020878076553
non O 1 0.800451397895813
- O 1 0.9998051524162292
DM O 1 0.9999997615814209
heterozygotes O 1 0.9990233182907104
for O 0 0.044924911111593246
CTGn O 1 0.9861531257629395
. O 0 0.059557728469371796

This O 0 0.024375438690185547
study O 0 0.018496127799153328
provides O 0 0.014901475980877876
further O 0 0.010873138904571533
evidence O 0 0.0084337517619133
that O 0 0.0064380173571407795
the O 0 0.035819798707962036
DM B-Disease 1 0.9999998807907104
expansion O 1 0.8594563603401184
tends O 0 0.04713774472475052
to O 0 0.01657746732234955
be O 0 0.017504438757896423
transmitted O 0 0.03604172170162201
preferentially O 0 0.05429043620824814
. O 0 0.045006781816482544

Diagnosis O 1 0.9997169375419617
of O 1 0.8662976622581482
hemochromatosis B-Disease 1 0.9999972581863403
. O 0 0.2740025520324707

If O 0 0.0791405513882637
untreated O 1 0.9999531507492065
, O 1 0.9434939026832581
hemochromatosis B-Disease 1 1.0
can O 1 0.6866469383239746
cause O 1 0.9997666478157043
serious O 1 0.9999895095825195
illness O 1 0.9999998807907104
and O 1 0.9558640122413635
early B-Disease 1 0.9127402901649475
death I-Disease 1 0.9888467192649841
, O 0 0.051685720682144165
but O 0 0.007318668998777866
the O 0 0.09331653267145157
disease O 1 0.9998871088027954
is O 0 0.011808996088802814
still O 0 0.021354632452130318
substantially O 0 0.26880303025245667
under O 1 0.7129610776901245
- O 1 0.9998003840446472
diagnosed O 1 0.999992847442627
. O 0 0.04501035436987877

The O 0 0.034229494631290436
cornerstone O 1 0.8429781794548035
of O 0 0.021011777222156525
screening O 0 0.1507064253091812
and O 0 0.01145604532212019
case O 0 0.013519380241632462
detection O 0 0.046625491231679916
is O 0 0.006898883264511824
the O 0 0.007849891670048237
measurement O 0 0.01486239954829216
of O 0 0.013699343428015709
serum O 1 0.9932801127433777
transferrin O 1 0.9979668259620667
saturation O 1 0.643429696559906
and O 0 0.020663632079958916
the O 0 0.02755538746714592
serum O 1 0.9975712895393372
ferritin O 1 0.9979700446128845
level O 0 0.04723753780126572
. O 0 0.04825412109494209

Once O 0 0.04162251204252243
the O 0 0.02902776561677456
diagnosis O 1 0.9994413256645203
is O 0 0.01842799223959446
suspected O 0 0.23065324127674103
, O 0 0.036543961614370346
physicians O 1 0.8301572799682617
must O 0 0.010331579484045506
use O 0 0.012442157603800297
serum O 1 0.9986470341682434
ferritin O 1 0.9987397789955139
levels O 0 0.018644904717803
and O 0 0.020878123119473457
hepatic O 1 0.9999392032623291
iron O 1 0.9985843896865845
stores O 0 0.03708299994468689
on O 0 0.019756797701120377
liver O 1 0.9999176263809204
biopsy O 1 0.9938051700592041
specimens O 0 0.01619388349354267
to O 0 0.009051358327269554
assess O 0 0.020250625908374786
patients O 0 0.06948340684175491
for O 0 0.0076406728476285934
the O 0 0.01117683481425047
presence O 0 0.024286065250635147
of O 0 0.14915087819099426
iron B-Disease 1 0.9999558925628662
overload I-Disease 1 0.9999589920043945
. O 0 0.0579431988298893

Liver O 1 0.9999841451644897
biopsy O 1 0.9979439377784729
is O 0 0.017717700451612473
also O 0 0.009303511120378971
used O 0 0.006226019933819771
to O 0 0.005844979081302881
establish O 0 0.007100346498191357
the O 0 0.006532229948788881
presence O 0 0.007101207971572876
or O 0 0.0062998137436807156
absence O 0 0.21751117706298828
of O 1 0.7177795767784119
cirrhosis B-Disease 1 1.0
, O 1 0.7033015489578247
which O 0 0.015332184731960297
can O 0 0.009998520836234093
affect O 0 0.06608729809522629
prognosis O 1 0.99996018409729
and O 0 0.032701436430215836
management O 1 0.7374365925788879
. O 0 0.03984598070383072

A O 0 0.03661045432090759
DNA O 0 0.022089112550020218
- O 0 0.019577112048864365
based O 0 0.010654988698661327
test O 0 0.010525851510465145
for O 0 0.008445749059319496
the O 0 0.012292632833123207
HFE O 1 0.9998648166656494
gene O 0 0.010329021140933037
is O 0 0.007246238645166159
commercially O 0 0.009516379795968533
available O 0 0.006739950738847256
, O 0 0.00565030612051487
but O 0 0.004745206329971552
its O 0 0.005211859941482544
place O 0 0.0057534449733793736
in O 0 0.00615967670455575
the O 0 0.012659048661589622
diagnosis O 1 0.9999023675918579
of O 1 0.953972578048706
hemochromatosis B-Disease 1 1.0
is O 0 0.39106088876724243
still O 0 0.033125631511211395
being O 0 0.02130870334804058
evaluated O 0 0.05263090878725052
. O 0 0.04120146110653877

Currently O 0 0.037075161933898926
, O 0 0.017319627106189728
the O 0 0.012246130034327507
most O 0 0.008569934405386448
useful O 0 0.008611069060862064
role O 0 0.007676320616155863
for O 0 0.005693970713764429
this O 0 0.005265203304588795
test O 0 0.006831238977611065
is O 0 0.005490737967193127
in O 0 0.0053811464458703995
the O 0 0.006989400368183851
detection O 0 0.03229990229010582
of O 0 0.01320223044604063
hemochromatosis B-Disease 1 0.9999889135360718
in O 0 0.009090980514883995
the O 0 0.008834359236061573
family O 0 0.0087096206843853
members O 0 0.007223197259008884
of O 0 0.008621797896921635
patients O 1 0.8199062347412109
with O 0 0.00761159835383296
a O 0 0.03813086822628975
proven O 1 0.7660394906997681
case O 0 0.025319093838334084
of O 0 0.021093187853693962
the O 1 0.6236164569854736
disease O 1 0.9999618530273438
. O 0 0.048358287662267685

It O 0 0.02589169703423977
is O 0 0.017717227339744568
crucial O 0 0.023374399170279503
to O 0 0.023636292666196823
diagnose O 1 0.9999985694885254
hemochromatosis B-Disease 1 1.0
before O 1 0.9998637437820435
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999991655349731
because O 1 0.998446524143219
phlebotomy O 1 1.0
therapy O 1 0.9999992847442627
can O 1 0.9764866232872009
avert O 1 0.9999998807907104
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9992917776107788
can O 0 0.16000403463840485
even O 0 0.010539419017732143
lead O 0 0.016808411106467247
to O 0 0.010523255914449692
normal O 0 0.015007768757641315
life O 0 0.020767726004123688
expectancy O 0 0.46810176968574524
. O 0 0.022306010127067566
. O 0 0.035916801542043686

Prevalence O 1 0.6543416380882263
of O 0 0.022637587040662766
the O 0 0.092726930975914
I1307K O 1 0.9999411106109619
APC B-Disease 1 0.9999707937240601
gene O 0 0.03777860477566719
variant O 0 0.04962856322526932
in O 0 0.00920774694532156
Israeli O 0 0.012250521220266819
Jews O 0 0.011191828176379204
of O 0 0.00774492509663105
differing O 0 0.010595983825623989
ethnic O 0 0.00956451054662466
origin O 0 0.010421729646623135
and O 0 0.06435433030128479
risk O 1 0.99905925989151
for O 1 0.9997922778129578
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9791456460952759

BACKGROUND O 0 0.21292409300804138
& O 1 0.7791962027549744
AIMS O 0 0.06554453074932098
Israeli O 0 0.01906657963991165
Jews O 0 0.01492300909012556
of O 0 0.009798629209399223
European O 0 0.012769052758812904
birth O 0 0.14424508810043335
, O 0 0.008723754435777664
i O 0 0.011083547957241535
. O 0 0.0068593877367675304
e O 0 0.009770856238901615
. O 0 0.006596892606467009
, O 0 0.007918027229607105
Ashkenazim O 0 0.019291842356324196
, O 0 0.006779508199542761
have O 0 0.006441870238631964
the O 0 0.011308025568723679
highest O 1 0.9999376535415649
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999920129776001
of O 0 0.37191611528396606
any O 0 0.018675416707992554
Israeli O 0 0.06224564462900162
ethnic O 0 0.02905433252453804
group O 0 0.041651491075754166
. O 0 0.0426294282078743

The O 0 0.05817233771085739
I1307K O 1 0.9940429329872131
APC B-Disease 1 0.999256432056427
gene O 0 0.04210890829563141
variant O 0 0.20956926047801971
was O 0 0.024998368695378304
found O 0 0.019496241584420204
in O 0 0.021132923662662506
6 O 0 0.04285162687301636
. O 0 0.04295145720243454

1 O 0 0.03989677131175995
% O 0 0.01970965415239334
of O 0 0.013792387209832668
American O 0 0.013531562872231007
Jews O 0 0.010182289406657219
, O 0 0.00777703570201993
28 O 0 0.009619740769267082
% O 0 0.007087916601449251
of O 0 0.007715368177741766
their O 0 0.08109503984451294
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9989487528800964
, O 0 0.24823498725891113
but O 0 0.0066419560462236404
not O 0 0.005851380527019501
in O 0 0.0088922418653965
non O 0 0.02508530393242836
- O 0 0.39983248710632324
Jews O 0 0.028274167329072952
. O 0 0.036435239017009735

We O 0 0.03708922490477562
assessed O 0 0.035992786288261414
the O 0 0.022791894152760506
I1307K O 1 0.9430932402610779
prevalence O 1 0.8317563533782959
in O 0 0.010201338678598404
Israeli O 0 0.012021671049296856
Jews O 0 0.011258565820753574
of O 0 0.008894184604287148
differing O 0 0.01045732107013464
ethnic O 0 0.010296281427145004
origin O 0 0.009937933646142483
and O 0 0.03267039358615875
risk O 1 0.9987967014312744
for O 1 0.999724805355072
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9844732284545898

METHODS O 0 0.042162880301475525
DNA O 0 0.02400876395404339
samples O 0 0.016527874395251274
from O 0 0.010909163393080235
500 O 0 0.01491638645529747
unrelated O 0 0.011119884438812733
Jews O 0 0.008731122128665447
of O 0 0.005830284208059311
European O 0 0.007588052190840244
or O 0 0.006120237056165934
non O 0 0.012570913881063461
- O 0 0.09546633809804916
European O 0 0.007530526723712683
origin O 0 0.005755862221121788
, O 0 0.004623143933713436
with O 0 0.0039803506806492805
or O 0 0.0038049204740673304
without O 0 0.004030311945825815
a O 0 0.0058937580324709415
personal O 0 0.2817525565624237
and O 0 0.012008770368993282
/ O 1 0.6634147763252258
or O 0 0.006750479806214571
family O 0 0.00847766362130642
history O 0 0.008925515227019787
of O 0 0.010491413064301014
neoplasia B-Disease 1 0.9998793601989746
, O 0 0.008744611404836178
were O 0 0.007530319970101118
examined O 0 0.010875390842556953
for O 0 0.007649402599781752
the O 0 0.0097311120480299
I1307K O 0 0.3927724361419678
variant O 0 0.016439398750662804
by O 0 0.008741280063986778
the O 0 0.010845393873751163
allele O 0 0.023622354492545128
- O 0 0.06544603407382965
specific O 0 0.01787164993584156
oligonucleotide O 1 0.7188308835029602
( O 0 0.03763113170862198
ASO O 1 0.9988123178482056
) O 0 0.0327334851026535
method O 0 0.03776871785521507
. O 0 0.04670299217104912

RESULTS O 0 0.0332719162106514
In O 0 0.01651124097406864
persons O 0 0.013005301356315613
at O 0 0.012293227016925812
average O 0 0.014978225342929363
risk O 1 0.8093317151069641
for O 1 0.9872428178787231
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.984495222568512
I1307K O 1 0.9992923736572266
was O 0 0.08013568073511124
found O 0 0.015215219929814339
in O 0 0.017278358340263367
5 O 0 0.03053990937769413
. O 0 0.04202989116311073

0 O 0 0.05857349559664726
% O 0 0.02806188352406025
of O 0 0.02053060755133629
120 O 0 0.028970621526241302
European O 0 0.02711203321814537
and O 0 0.026667336001992226
1 O 0 0.04396666958928108
. O 0 0.05399050936102867

6 O 0 0.04587787762284279
% O 0 0.022532105445861816
of O 0 0.015984714031219482
188 O 0 0.027826111763715744
non O 0 0.020225584506988525
- O 0 0.06080178916454315
European O 0 0.015050599351525307
Jews O 0 0.015319131314754486
( O 0 0.014112702570855618
P O 0 0.14851103723049164
= O 0 0.025450468063354492
0 O 0 0.02316945418715477
. O 0 0.021221624687314034
08 O 0 0.06271715462207794
) O 0 0.04112311452627182
. O 0 0.055962953716516495

It O 0 0.04557187855243683
occurred O 0 0.041343461722135544
in O 0 0.03542615473270416
15 O 0 0.05024236440658569
. O 0 0.05468420684337616

4 O 0 0.03923660144209862
% O 0 0.02113320119678974
of O 0 0.01440863311290741
52 O 0 0.02187586948275566
Ashkenazi O 0 0.10625536739826202
Israelis O 0 0.01563187502324581
with O 0 0.016518892720341682
familial O 1 0.9999877214431763
cancer B-Disease 1 0.9999994039535522
( O 1 0.9029727578163147
P O 1 0.9912183880805969
= O 0 0.04326453059911728
0 O 0 0.013199733570218086
. O 0 0.009281929582357407
02 O 1 0.8769667744636536
) O 0 0.008644986897706985
and O 0 0.007190692704170942
was O 0 0.007167822681367397
not O 0 0.004722699522972107
detected O 0 0.007152249570935965
in O 0 0.005099135916680098
51 O 0 0.010073944926261902
non O 0 0.008770731277763844
- O 0 0.016759773716330528
European O 0 0.009541078470647335
Jews O 0 0.010891006328165531
at O 0 0.01726352423429489
increased O 1 0.6961830854415894
cancer B-Disease 1 0.9999858140945435
risk O 1 0.9472076296806335
. O 0 0.039273787289857864

Colorectal B-Disease 1 0.9999985694885254
neoplasia I-Disease 1 0.9999810457229614
occurred O 0 0.12023714929819107
personally O 0 0.15366841852664948
or O 0 0.012263954617083073
in O 0 0.009229336865246296
the O 0 0.007651349529623985
families O 0 0.006408622954040766
of O 0 0.005671529099345207
13 O 0 0.007463409099727869
of O 0 0.007068402133882046
20 O 0 0.012085391208529472
Ashkenazi O 1 0.7112745046615601
I1307K O 1 0.8949491381645203
carriers O 0 0.03742288053035736
, O 0 0.006950051989406347
8 O 0 0.008901264518499374
of O 0 0.007025367114692926
whom O 0 0.007383778691291809
also O 0 0.006271224468946457
had O 0 0.006860634777694941
a O 0 0.007326582446694374
personal O 0 0.06441272795200348
or O 0 0.007945917546749115
family O 0 0.012135611847043037
history O 0 0.019287969917058945
of O 0 0.09903579205274582
noncolonic O 1 0.9999499320983887
neoplasia B-Disease 1 0.9999884366989136
. O 0 0.06065945699810982

CONCLUSIONS O 0 0.05129900574684143
The O 0 0.03268076851963997
I1307K O 1 0.9960007071495056
APC O 1 0.9997746348381042
variant O 1 0.6602928042411804
may O 0 0.012280740775167942
represent O 0 0.011290372349321842
a O 0 0.01271336805075407
susceptibility O 1 0.9702965021133423
gene O 0 0.020603138953447342
for O 0 0.07635244727134705
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 0.04087849706411362
or I-Disease 0 0.006415551993995905
other I-Disease 0 0.004956405144184828
, I-Disease 0 0.014256889931857586
cancers I-Disease 1 0.994065523147583
in O 0 0.008899969980120659
Ashkenazi O 1 0.9208031892776489
Jews O 0 0.009743784554302692
, O 0 0.007287400774657726
and O 0 0.007027216721326113
partially O 0 0.021592548117041588
explains O 0 0.011437619104981422
the O 0 0.008417434059083462
higher O 0 0.026028120890259743
incidence O 1 0.9995014667510986
of O 1 0.9980579018592834
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 0.43429580330848694
European O 0 0.3826569616794586
Israelis O 0 0.06017221137881279
. O 0 0.04255355894565582

Systematic O 0 0.0492764487862587
analysis O 0 0.031064627692103386
of O 0 0.0283376332372427
coproporphyrinogen O 1 0.9996640682220459
oxidase O 1 0.9992983341217041
gene O 1 0.5668084621429443
defects O 1 0.9997732043266296
in O 0 0.27798840403556824
hereditary B-Disease 1 0.9999960660934448
coproporphyria I-Disease 1 0.9999927282333374
and O 1 0.898456871509552
mutation O 1 0.9065880179405212
update O 1 0.7592363357543945
. O 0 0.05118284374475479

Hereditary B-Disease 1 0.9999641180038452
coproporphyria I-Disease 1 0.9999327659606934
( O 1 0.9664603471755981
HC B-Disease 1 0.9999982118606567
) O 0 0.035626742988824844
is O 0 0.017484063282608986
an O 1 0.7673825621604919
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999983310699463
autosomal O 1 1.0
dominant O 1 0.9999997615814209
inheritance O 1 0.9999991655349731
caused O 1 0.9999669790267944
by O 0 0.3165142834186554
deficient B-Disease 1 0.9996373653411865
activity I-Disease 0 0.02467351220548153
of I-Disease 0 0.2846565842628479
coproporphyrinogen I-Disease 1 0.9999885559082031
III I-Disease 1 0.9999978542327881
oxidase I-Disease 1 0.999846339225769
( O 0 0.21670158207416534
CPO O 1 0.9519820809364319
) O 0 0.051697973161935806
. O 0 0.0606892928481102

Clinical O 1 0.9533424377441406
manifestations O 1 0.9050244092941284
of O 0 0.17151957750320435
the O 1 0.9658471941947937
disease O 1 0.9999943971633911
are O 0 0.009175182320177555
characterized O 1 0.9858742952346802
by O 0 0.32143762707710266
acute O 1 1.0
attacks O 1 0.9999551773071289
of O 1 0.9999991655349731
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9998729228973389
precipitated O 1 0.9999998807907104
by O 1 0.9008369445800781
drugs O 1 0.9994756579399109
, O 1 0.5179399251937866
fasting O 1 0.9638980627059937
, O 0 0.36616092920303345
cyclical O 1 0.999964714050293
hormonal O 1 0.9999605417251587
changes O 1 0.5448662638664246
, O 1 0.9439989924430847
or O 1 0.9937343001365662
infectious B-Disease 1 0.9999998807907104
diseases I-Disease 1 0.9999996423721313
. O 1 0.6882133483886719

Skin O 1 0.9999991655349731
photosensitivity O 1 0.9999951124191284
may O 0 0.18753089010715485
also O 0 0.027651024982333183
be O 0 0.023009736090898514
present O 0 0.034481387585401535
. O 0 0.049365125596523285

The O 0 0.03631989285349846
seven O 0 0.028498312458395958
exons O 0 0.03408337011933327
, O 0 0.016301194205880165
the O 0 0.01556008867919445
exon O 1 0.8424823880195618
/ O 1 0.8238679766654968
intron O 1 0.5086645483970642
boundaries O 0 0.013685976155102253
and O 0 0.008539989590644836
part O 0 0.00871850736439228
of O 0 0.007882947102189064
3 O 0 0.010907989926636219
noncoding O 0 0.019363321363925934
sequence O 0 0.00817926786839962
of O 0 0.008009645156562328
the O 0 0.009145008400082588
CPO O 0 0.3422808051109314
gene O 0 0.009191648103296757
were O 0 0.006748264655470848
systematically O 0 0.011032581329345703
analyzed O 0 0.009251931682229042
by O 0 0.00642554834485054
an O 0 0.00874556228518486
exon O 0 0.02585303969681263
- O 0 0.017587589100003242
by O 0 0.010385441593825817
- O 0 0.09941793978214264
exon O 0 0.38330772519111633
denaturing O 1 0.9785932302474976
gradient O 1 0.7496464252471924
gel O 1 0.9990986585617065
electrophoresis O 1 0.9747992753982544
( O 0 0.034650932997465134
DGGE O 1 0.9773170351982117
) O 0 0.014273585751652718
strategy O 0 0.018327469006180763
followed O 0 0.012361654080450535
by O 0 0.008396386168897152
direct O 0 0.00988292507827282
sequencing O 0 0.013970861211419106
in O 0 0.010510269552469254
seven O 0 0.012271767482161522
unrelated O 0 0.01952044852077961
heterozygous O 0 0.07255051285028458
HC B-Disease 1 0.9999914169311523
patients O 1 0.9896203279495239
from O 0 0.013650022447109222
France O 1 0.6299035549163818
, O 0 0.027408579364418983
Holland O 1 0.6158061623573303
, O 0 0.015595603734254837
and O 0 0.019556470215320587
Czech O 0 0.35687264800071716
Republic O 0 0.06617195159196854
. O 0 0.050787847489118576

Seven O 0 0.047382328659296036
novel O 0 0.046924248337745667
mutations O 0 0.022353339940309525
and O 0 0.014015858061611652
two O 0 0.013150731101632118
new O 0 0.018962020054459572
polymorphisms O 0 0.05109039321541786
were O 0 0.02182486280798912
detected O 0 0.047790978103876114
. O 0 0.04776672646403313

Among O 0 0.035309139639139175
these O 0 0.01763831451535225
mutations O 0 0.016867434605956078
two O 0 0.010079851374030113
are O 0 0.008068152703344822
missense O 0 0.03138890489935875
( O 0 0.014964859001338482
G197W O 0 0.47998711466789246
, O 0 0.013405035249888897
W427R O 0 0.2011663317680359
) O 0 0.008962028659880161
, O 0 0.00904789473861456
two O 0 0.0068861208856105804
are O 0 0.005770151969045401
nonsense O 0 0.018519122153520584
( O 0 0.012063156813383102
Q306X O 1 0.5073596239089966
, O 0 0.011594032868742943
Q385X O 0 0.21699625253677368
) O 0 0.009374470449984074
, O 0 0.008596532046794891
two O 0 0.007465143222361803
are O 0 0.006630707997828722
small O 0 0.009714956395328045
deletions O 0 0.01720484159886837
( O 0 0.012878069654107094
662de14bp O 0 0.07614247500896454
; O 0 0.012081271037459373
1168del3bp O 0 0.03253776952624321
removing O 0 0.015899362042546272
a O 0 0.012974478304386139
glycine O 0 0.019367799162864685
at O 0 0.00999807845801115
position O 0 0.01205431204289198
390 O 0 0.023485463112592697
) O 0 0.009016930125653744
, O 0 0.007728297729045153
and O 0 0.006805954501032829
one O 0 0.0069599151611328125
is O 0 0.007378258742392063
a O 0 0.008462103083729744
splicing O 0 0.013770980760455132
mutation O 0 0.011150220409035683
( O 0 0.010368283838033676
IVS1 O 1 0.875992476940155
- O 1 0.6500266194343567
15c O 1 0.9890825748443604
- O 1 0.868097722530365
- O 1 0.9445878863334656
> O 1 0.9286117553710938
g O 0 0.037047918885946274
) O 0 0.01316854078322649
which O 0 0.012628652155399323
creates O 0 0.021706871688365936
a O 0 0.018270324915647507
new O 0 0.023869134485721588
acceptor O 0 0.04728269577026367
splice O 0 0.07437170296907425
site O 0 0.049670055508613586
. O 0 0.05086127668619156

The O 0 0.04378221929073334
pathological O 0 0.045624617487192154
significance O 0 0.02659487910568714
of O 0 0.013496167957782745
the O 0 0.013227388262748718
point O 0 0.015084213577210903
mutations O 0 0.016913272440433502
G197W O 0 0.3533678650856018
, O 0 0.01022812444716692
W427R O 0 0.0860908105969429
, O 0 0.008754192851483822
and O 0 0.006452185567468405
the O 0 0.006734717171639204
in O 0 0.007604667451232672
- O 1 0.5650908946990967
frame O 0 0.057870179414749146
deletion O 0 0.10878970474004745
390delGly O 0 0.261101096868515
were O 0 0.008083626627922058
assessed O 0 0.009655294939875603
by O 0 0.0060661351308226585
their O 0 0.0059468867257237434
respective O 0 0.008355059660971165
expression O 0 0.008032888174057007
in O 0 0.007450505159795284
a O 0 0.009429633617401123
prokaryotic O 0 0.02253997139632702
system O 0 0.012959134764969349
using O 0 0.013227414339780807
site O 0 0.02670285478234291
- O 0 0.04444058611989021
directed O 0 0.038107581436634064
mutagenesis O 0 0.08903134614229202
. O 0 0.05056533217430115

These O 0 0.026943132281303406
mutations O 0 0.022118784487247467
resulted O 0 0.016989057883620262
in O 0 0.01132180541753769
the O 0 0.011467060074210167
absence O 0 0.09189222007989883
or O 0 0.010627522133290768
a O 0 0.014787721447646618
dramatic O 1 0.5335303544998169
decrease O 0 0.1079760491847992
of O 0 0.024752836674451828
CPO O 1 0.9827784895896912
activity O 0 0.04246104136109352
. O 0 0.04780593141913414

The O 0 0.03565916419029236
two O 0 0.022677753120660782
polymorphisms O 0 0.031990308314561844
were O 0 0.013344972394406796
localized O 0 0.025480937212705612
in O 0 0.012276530265808105
noncoding O 0 0.02811509370803833
part O 0 0.011393311433494091
of O 0 0.008244706317782402
the O 0 0.008785376325249672
gene O 0 0.009667421691119671
1 O 0 0.011734099127352238
) O 0 0.01022253092378378
a O 0 0.011249609291553497
C O 0 0.10287384688854218
/ O 0 0.10773725807666779
G O 0 0.027107737958431244
polymorphism O 0 0.020488496869802475
in O 0 0.012169930152595043
the O 0 0.014079133048653603
promotor O 1 0.9325224161148071
region O 0 0.016385070979595184
, O 0 0.012028842233121395
142 O 0 0.02442486397922039
bp O 0 0.02440943755209446
upstream O 0 0.017128508538007736
from O 0 0.009996304288506508
the O 0 0.008847517892718315
transcriptional O 0 0.01561504602432251
initiation O 0 0.015535755082964897
site O 0 0.01360356155782938
( O 0 0.011829976923763752
- O 0 0.12499186396598816
142C O 1 0.9583031535148621
/ O 1 0.8511080741882324
G O 0 0.09154582768678665
) O 0 0.010087343864142895
, O 0 0.009003432467579842
and O 0 0.008001650683581829
2 O 0 0.011118568480014801
) O 0 0.008980369195342064
a O 0 0.010440804064273834
6 O 0 0.014063163660466671
bp O 0 0.02113983780145645
deletion O 0 0.018704600632190704
polymorphism O 0 0.016003798693418503
in O 0 0.009230880066752434
the O 0 0.00883554108440876
3 O 0 0.0120948925614357
noncoding O 0 0.020532755181193352
part O 0 0.011651775799691677
of O 0 0.009200124070048332
the O 0 0.010782212018966675
CPO O 1 0.7454714179039001
gene O 0 0.012713206931948662
, O 0 0.01085188239812851
574 O 0 0.128213569521904
bp O 0 0.02082899957895279
downstream O 0 0.014736156910657883
of O 0 0.008413514122366905
the O 0 0.008337169885635376
last O 0 0.008580365218222141
base O 0 0.010230624116957188
of O 0 0.0071716043166816235
the O 0 0.00828561745584011
normal O 0 0.011152387596666813
termination O 0 0.11165287345647812
codon O 0 0.02632325328886509
( O 0 0.02084043249487877
+ O 0 0.04549012705683708
574 O 0 0.4516030251979828
delATTCTT O 0 0.49805817008018494
) O 0 0.04389121010899544
. O 0 0.05977775156497955

Five O 0 0.044123630970716476
intragenic O 1 0.9896504878997803
dimorphisms O 1 0.9393675923347473
are O 0 0.011578911915421486
now O 0 0.011274144053459167
well O 0 0.008382576517760754
characterized O 0 0.014742777682840824
and O 0 0.007229885086417198
the O 0 0.007890431210398674
high O 0 0.009751927107572556
degree O 0 0.010533299297094345
of O 0 0.01133925560861826
allelic O 1 0.9943861961364746
heterogeneity O 1 0.9762207269668579
in O 0 0.062211085110902786
HC B-Disease 1 0.9999953508377075
is O 0 0.012376934289932251
demonstrated O 0 0.012846000492572784
with O 0 0.007611814420670271
seven O 0 0.008199007250368595
new O 0 0.008231908082962036
different O 0 0.00612963642925024
mutations O 0 0.007123903837054968
making O 0 0.00742350472137332
a O 0 0.008002584800124168
total O 0 0.00934806652367115
of O 0 0.009650139138102531
nineteen O 1 0.8381865620613098
CPO O 1 0.9997825026512146
gene B-Disease 1 0.6324191689491272
defects I-Disease 1 0.9981325268745422
reported O 0 0.018438560888171196
so O 0 0.013789747841656208
far O 0 0.017845746129751205
. O 0 0.020021921023726463
. O 0 0.03612278774380684

Coincidence O 0 0.06433738768100739
of O 0 0.02653343230485916
two O 0 0.019279401749372482
novel O 0 0.028256617486476898
arylsulfatase O 1 0.5830486416816711
A O 0 0.024441387504339218
alleles O 0 0.02412991225719452
and O 0 0.014159487560391426
mutation O 0 0.052919868379831314
459 O 1 0.9984918832778931
+ O 1 0.9102686643600464
1G O 1 0.9966819882392883
> O 0 0.04965689033269882
A O 0 0.015339182689785957
within O 0 0.012133839540183544
a O 0 0.012492388486862183
family O 0 0.01605803892016411
with O 0 0.021066049113869667
metachromatic B-Disease 1 0.9999855756759644
leukodystrophy I-Disease 1 0.9999988079071045
: O 0 0.023677855730056763
molecular O 0 0.01983335055410862
basis O 0 0.018305670469999313
of O 0 0.021951179951429367
phenotypic O 0 0.1468002200126648
heterogeneity O 1 0.5410095453262329
. O 0 0.053026821464300156

In O 0 0.031391166150569916
a O 0 0.022339601069688797
family O 0 0.018339047208428383
with O 0 0.011460242792963982
three O 0 0.010180054232478142
siblings O 0 0.022056035697460175
, O 0 0.009174910373985767
one O 0 0.007734787650406361
developed O 0 0.01109110377728939
classical O 0 0.015498023480176926
late O 0 0.26237183809280396
infantile O 1 0.9999991655349731
metachromatic B-Disease 1 0.9999995231628418
leukodystrophy I-Disease 1 1.0
( O 1 0.997984766960144
MLD B-Disease 1 0.9999997615814209
) O 0 0.019840117543935776
, O 0 0.012814518064260483
fatal O 0 0.4501427114009857
at O 0 0.008205990307033062
age O 0 0.00924875121563673
5 O 0 0.008717815391719341
years O 0 0.007691541220992804
, O 0 0.007144662085920572
with O 0 0.007585112005472183
deficient O 1 0.9837122559547424
arylsulfatase O 1 0.9940084218978882
A O 0 0.28211238980293274
( O 0 0.1450105458498001
ARSA O 1 0.9995322227478027
) O 0 0.013141773641109467
activity O 0 0.010936806909739971
and O 0 0.011849770322442055
increased O 0 0.019709359854459763
galactosylsulfatide O 1 0.9906476140022278
( O 0 0.2662554085254669
GS O 1 0.999984622001648
) O 0 0.04709935933351517
excretion O 0 0.18957637250423431
. O 0 0.057294540107250214

The O 0 0.026417654007673264
two O 0 0.01584176905453205
other O 0 0.012699046172201633
siblings O 0 0.022187599912285805
, O 0 0.00908664334565401
apparently O 0 0.00949837826192379
healthy O 0 0.009685521014034748
at O 0 0.006658521480858326
12 O 0 0.007664692122489214
( O 0 0.0070894500240683556
1 O 0 0.008710416965186596
/ O 0 0.013336599804461002
2 O 0 0.00845987070351839
) O 0 0.006380613427609205
and O 0 0.0054632993414998055
15 O 0 0.006839296780526638
years O 0 0.006293339189141989
, O 0 0.0058124493807554245
respectively O 0 0.006666754838079214
, O 0 0.0050507523119449615
and O 0 0.005008559208363295
their O 0 0.004801458213478327
father O 0 0.016364548355340958
, O 0 0.007460007909685373
apparently O 0 0.011912102811038494
healthy O 0 0.024585962295532227
as O 0 0.006267122458666563
well O 0 0.007191144861280918
, O 0 0.007753774989396334
presented O 0 0.026373645290732384
ARSA O 1 0.9998007416725159
and O 0 0.0195283442735672
GS O 1 0.9995125532150269
values O 0 0.014246398583054543
within O 0 0.012586572207510471
the O 0 0.013082575984299183
range O 0 0.021220752969384193
of O 0 0.03833652660250664
MLD B-Disease 1 0.9999974966049194
patients O 1 0.9981468915939331
. O 0 0.055088676512241364

Mutation O 0 0.054258428514003754
screening O 0 0.03359390050172806
and O 0 0.01554383710026741
sequence O 0 0.012945477850735188
analysis O 0 0.011158457957208157
disclosed O 0 0.014293404296040535
the O 0 0.008350268937647343
involvement O 0 0.009937886148691177
of O 0 0.007177408318966627
three O 0 0.0070611098781228065
different O 0 0.007806162815541029
ARSA O 1 0.9998757839202881
mutations O 0 0.014283954165875912
being O 0 0.009500563144683838
the O 0 0.009816248901188374
molecular O 0 0.01535155437886715
basis O 0 0.013623608276247978
of O 0 0.01946187950670719
intrafamilial O 1 0.8978385329246521
phenotypic O 0 0.3444884717464447
heterogeneity O 0 0.3634641468524933
. O 0 0.053378310054540634

The O 0 0.04074063152074814
late O 1 0.5020841956138611
infantile O 1 0.9999938011169434
patient O 1 0.9998862743377686
inherited O 1 0.9998331069946289
from O 0 0.018349207937717438
his O 1 0.5998191237449646
mother O 1 0.6920430660247803
the O 0 0.012137121520936489
frequent O 0 0.09837214648723602
0 O 0 0.020395871251821518
- O 0 0.10276442766189575
type O 0 0.02717653475701809
mutation O 0 0.02130686119198799
459 O 1 0.9700342416763306
+ O 0 0.42952343821525574
1G O 1 0.9924909472465515
> O 0 0.15889133512973785
A O 0 0.015239016152918339
, O 0 0.009869882836937904
and O 0 0.007126500830054283
from O 0 0.006809617392718792
his O 0 0.011030811816453934
father O 0 0.03031245991587639
a O 0 0.011859451420605183
novel O 0 0.01769842393696308
, O 0 0.010420974344015121
single O 0 0.013723578304052353
basepair O 0 0.2915215790271759
microdeletion O 0 0.04902253672480583
of O 0 0.013018829748034477
guanine O 0 0.023195141926407814
at O 0 0.011875017546117306
nucleotide O 0 0.015521780587732792
7 O 0 0.01620345748960972
in O 0 0.013279085047543049
exon O 0 0.039004500955343246
1 O 0 0.02593063935637474
( O 0 0.027825649827718735
7delG O 0 0.15336042642593384
) O 0 0.04012339189648628
. O 0 0.05013526976108551

The O 0 0.04817155376076698
two O 0 0.035316985100507736
clinically O 1 0.7440037727355957
unaffected O 0 0.17995381355285645
siblings O 0 0.03843462094664574
carried O 0 0.018651574850082397
the O 0 0.0173256266862154
maternal O 1 0.9768819212913513
mutation O 1 0.7145233154296875
459 O 1 0.9999039173126221
+ O 1 0.9955124258995056
1G O 1 0.9998397827148438
> O 1 0.6369086503982544
A O 0 0.015185210853815079
and O 0 0.009069077670574188
, O 0 0.008165651001036167
on O 0 0.00873806606978178
their O 0 0.009494219906628132
paternal O 0 0.169148251414299
allele O 0 0.02037099003791809
, O 0 0.01068350113928318
a O 0 0.013150650076568127
novel O 0 0.02149544097483158
cytosine O 0 0.029263531789183617
to O 0 0.015736274421215057
thymidine O 0 0.03463827818632126
transition O 0 0.02498614601790905
at O 0 0.018101289868354797
nucleotide O 0 0.02797534503042698
2435 O 0 0.1329272985458374
in O 0 0.015789058059453964
exon O 0 0.03559994325041771
8 O 0 0.019484668970108032
, O 0 0.013293074443936348
resulting O 0 0.01267043687403202
in O 0 0.01229704450815916
substitution O 0 0.019005177542567253
of O 0 0.01685197465121746
alanine O 0 0.05517493560910225
464 O 1 0.6983247399330139
by O 0 0.021303420886397362
valine O 1 0.9770985245704651
( O 0 0.041496433317661285
A464V O 1 0.7245436310768127
) O 0 0.04719303548336029
. O 0 0.054492104798555374

The O 0 0.05753204971551895
fathers O 0 0.07047183811664581
genotype O 0 0.35265734791755676
thus O 0 0.034935362637043
was O 0 0.20864368975162506
7delG O 1 0.9986182451248169
/ O 1 0.9846013784408569
A464V O 1 0.9545263051986694
. O 0 0.06531689316034317

Mutation O 0 0.18178199231624603
A464V O 0 0.3130604922771454
was O 0 0.021724902093410492
not O 0 0.011215551756322384
found O 0 0.009763902053236961
in O 0 0.009903019294142723
18 O 0 0.021335387602448463
unrelated O 1 0.9535693526268005
MLD B-Disease 1 0.9999995231628418
patients O 1 0.993320882320404
and O 0 0.025173667818307877
50 O 0 0.03081931732594967
controls O 0 0.05136754736304283
. O 0 0.04379548877477646

A464V O 0 0.4255892336368561
, O 0 0.029647989198565483
although O 0 0.021375296637415886
clearly O 0 0.026427745819091797
modifying O 0 0.06849701702594757
ARSA O 1 0.9999204874038696
and O 0 0.29276198148727417
GS O 1 0.9999974966049194
levels O 0 0.02508111298084259
, O 0 0.012070286087691784
apparently O 0 0.014377172105014324
bears O 0 0.014756442978978157
little O 0 0.012525536119937897
significance O 0 0.01296952459961176
for O 0 0.010436976328492165
clinical O 1 0.9806444048881531
manifestation O 1 0.9990735054016113
of O 1 0.9348488450050354
MLD B-Disease 1 0.9999997615814209
, O 0 0.33319103717803955
mimicking O 1 0.9660584330558777
the O 0 0.04567810148000717
frequent O 1 0.9161763787269592
ARSA O 1 0.9999856948852539
pseudodeficiency O 1 0.9996461868286133
allele O 1 0.5020438432693481
. O 0 0.0664893165230751

Our O 0 0.03467359021306038
results O 0 0.022640032693743706
demonstrate O 0 0.02059279754757881
that O 0 0.009120861068367958
in O 0 0.010033764876425266
certain O 0 0.010483000427484512
genetic O 0 0.016546929255127907
conditions O 0 0.44491899013519287
MLD B-Disease 1 0.9999992847442627
- O 1 0.9984303116798401
like O 1 0.6514636278152466
ARSA O 1 0.999991774559021
and O 0 0.2894066572189331
GS O 1 0.9999909400939941
values O 0 0.012186634354293346
need O 0 0.009183995425701141
not O 0 0.006041423417627811
be O 0 0.005342637188732624
paralleled O 0 0.016023335978388786
by O 0 0.009609034284949303
clinical O 1 0.9999629259109497
disease O 1 0.9999961853027344
, O 0 0.035865798592567444
a O 0 0.024337690323591232
finding O 0 0.02278798259794712
with O 0 0.018861521035432816
serious O 1 0.9955065250396729
diagnostic O 1 0.9998103976249695
and O 1 0.6616435647010803
prognostic O 1 0.9999518394470215
implications O 1 0.9618421196937561
. O 0 0.05096881091594696

Moreover O 0 0.055148813873529434
, O 0 0.029977673664689064
further O 0 0.028805486857891083
ARSA O 1 0.9992407560348511
alleles O 0 0.03211357071995735
functionally O 0 0.038916174322366714
similar O 0 0.011328077875077724
to O 0 0.0096401646733284
A464V O 0 0.33977434039115906
might O 0 0.008750895969569683
exist O 0 0.006810823921114206
which O 0 0.005268688313663006
, O 0 0.0060638729482889175
together O 0 0.006882763002067804
with O 0 0.005733507685363293
0 O 0 0.011028243228793144
- O 0 0.3816150426864624
type O 0 0.07235893607139587
mutations O 0 0.010368342511355877
, O 0 0.007469175383448601
may O 0 0.008098972029983997
cause O 0 0.30841633677482605
pathological O 1 0.9991738200187683
ARSA O 1 0.9999988079071045
and O 1 0.9793601036071777
GS O 1 0.9999998807907104
levels O 0 0.062214285135269165
, O 0 0.007326415739953518
but O 0 0.005925137083977461
not O 0 0.006286070682108402
clinical O 1 0.8287888765335083
outbreak O 1 0.9913309812545776
of O 0 0.25775089859962463
the O 1 0.9869272112846375
disease O 1 0.9999978542327881
. O 0 0.0765044093132019
. O 0 0.03748023509979248

Human O 1 0.9899711608886719
MLH1 O 1 0.9999992847442627
deficiency O 1 1.0
predisposes O 1 0.9999960660934448
to O 1 0.987514078617096
hematological B-Disease 1 0.9999998807907104
malignancy I-Disease 1 1.0
and O 1 0.9999545812606812
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9998899698257446
1 I-Disease 1 0.8409263491630554
. O 0 0.04790998622775078

Heterozygous O 0 0.13927502930164337
germ O 1 0.9960687160491943
- O 1 0.712908148765564
line O 0 0.027997905388474464
mutations O 0 0.01716349646449089
in O 0 0.009534357115626335
the O 0 0.010417482815682888
DNA O 0 0.01553279533982277
mismatch O 1 0.9966260194778442
repair O 1 0.9904447197914124
genes O 0 0.014705064706504345
lead O 0 0.022703690454363823
to O 0 0.027291765436530113
hereditary B-Disease 1 0.9999988079071045
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9419897198677063

The O 1 0.8442291021347046
disease O 1 0.999982476234436
susceptibility O 1 0.9974114298820496
of O 0 0.0850420743227005
individuals O 0 0.04101492092013359
who O 1 0.5693268179893494
constitutionally O 1 0.9553572535514832
lack O 1 0.7460933327674866
both O 0 0.012762394733726978
wild O 0 0.48427608609199524
- O 1 0.9989404082298279
type O 1 0.858680009841919
alleles O 0 0.03287605941295624
is O 0 0.018099652603268623
unknown O 0 0.0281550083309412
. O 0 0.03481623902916908

We O 0 0.024246837943792343
have O 0 0.01273252721875906
identified O 0 0.012102140113711357
three O 0 0.00785006769001484
offspring O 0 0.010660217143595219
in O 0 0.007675692904740572
a O 0 0.46384990215301514
hereditary B-Disease 1 0.9999997615814209
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.999506950378418
who O 1 0.997535228729248
developed O 1 0.9998226761817932
hematological B-Disease 1 0.9999996423721313
malignancy I-Disease 1 0.9999992847442627
at O 0 0.03561720624566078
a O 0 0.008979834616184235
very O 0 0.006763453595340252
early O 0 0.006809994578361511
age O 0 0.006569456774741411
, O 0 0.0046131727285683155
and O 0 0.004020451568067074
at O 0 0.004577651619911194
least O 0 0.004509578924626112
two O 0 0.003688937285915017
of O 0 0.0048032496124506
them O 0 0.005550706293433905
displayed O 0 0.011271147057414055
signs O 0 0.020008934661746025
of O 0 0.051643166691064835
neurofibromatosis B-Disease 1 0.9999997615814209
type I-Disease 1 0.9911605715751648
1 I-Disease 0 0.44032034277915955
( O 0 0.08455001562833786
NF1 B-Disease 1 0.9953576922416687
) O 0 0.039886023849248886
. O 0 0.046976156532764435

DNA O 0 0.03734923526644707
sequence O 0 0.021557891741394997
analysis O 0 0.017517467960715294
and O 0 0.013365544378757477
allele O 0 0.018327943980693817
- O 0 0.0168268084526062
specific O 0 0.010163255967199802
amplification O 0 0.015369064174592495
in O 0 0.008824336342513561
two O 0 0.008334572426974773
siblings O 0 0.01693059504032135
revealed O 0 0.014112889766693115
a O 0 0.012890496291220188
homozygous O 0 0.28001704812049866
MLH1 O 1 0.9999457597732544
mutation O 0 0.26066240668296814
( O 0 0.03167751431465149
C676T O 1 0.9921455979347229
- O 1 0.9915987253189087
- O 1 0.9928240776062012
> O 1 0.9880906343460083
Arg226Stop O 1 0.9661173820495605
) O 0 0.05078637972474098
. O 0 0.06050330772995949

Thus O 0 0.03958046808838844
, O 0 0.022553738206624985
a O 0 0.020956803113222122
homozygous O 0 0.07114268094301224
germ O 1 0.9994887113571167
- O 1 0.9933405518531799
line O 1 0.8816753029823303
MLH1 O 1 0.9999909400939941
mutation O 1 0.8331477642059326
and O 0 0.41990116238594055
consequent O 1 0.9999978542327881
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.1988643854856491
in O 0 0.014682378619909286
a O 1 0.6063843965530396
mutator O 1 0.9999963045120239
phenotype O 1 0.9980252981185913
characterized O 1 0.978875994682312
by O 0 0.41082775592803955
leukemia B-Disease 1 1.0
and O 1 0.9981465339660645
/ O 1 0.9999973773956299
or O 1 0.9935020804405212
lymphoma B-Disease 1 1.0
associated O 1 0.8871581554412842
with O 1 0.9767157435417175
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9989461302757263
1 I-Disease 0 0.42165276408195496
. O 0 0.026044288650155067
. O 0 0.04064895585179329

Missense O 0 0.2182053178548813
mutations O 0 0.032770801335573196
in O 0 0.0168928112834692
the O 0 0.013675044290721416
most O 0 0.009605096653103828
ancient O 0 0.013166830874979496
residues O 0 0.0120799969881773
of O 0 0.0091318404302001
the O 0 0.014312832616269588
PAX6 O 1 0.9999639987945557
paired O 1 0.5069412589073181
domain O 0 0.019623341038823128
underlie O 0 0.12191142141819
a O 0 0.014085481874644756
spectrum O 0 0.46173158288002014
of O 1 0.6202160120010376
human O 1 0.9998300075531006
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 0.9999998807907104
. O 1 0.9886437654495239

Mutations O 0 0.0419393815100193
of O 0 0.018947027623653412
the O 0 0.016107242554426193
human O 0 0.02410067804157734
PAX6 O 1 0.999992847442627
gene O 1 0.9106889367103577
underlie O 1 0.9999796152114868
aniridia B-Disease 1 0.9999997615814209
( O 1 0.9992295503616333
congenital B-Disease 1 0.9999998807907104
absence I-Disease 1 0.9892252087593079
of I-Disease 1 0.7672567367553711
the I-Disease 1 0.9838255047798157
iris I-Disease 1 0.9999779462814331
) O 0 0.016944007948040962
, O 0 0.008061107248067856
a O 0 0.011469212360680103
rare O 0 0.3284817636013031
dominant O 1 0.9681356549263
malformation B-Disease 1 0.9999511241912842
of I-Disease 0 0.3673865795135498
the I-Disease 1 0.9013216495513916
eye I-Disease 1 0.9999598264694214
. O 0 0.09913738071918488

The O 0 0.03634177893400192
spectrum O 0 0.04055782034993172
of O 0 0.03205433115363121
PAX6 O 1 0.9999885559082031
mutations O 1 0.6991775631904602
in O 0 0.3351425528526306
aniridia B-Disease 1 0.9999974966049194
patients O 1 0.9967445135116577
is O 0 0.010209551081061363
highly O 0 0.012014028616249561
biased O 0 0.010574275627732277
, O 0 0.0063767749816179276
with O 0 0.005397389642894268
92 O 0 0.014377185143530369
% O 0 0.0060602524317801
of O 0 0.005468724761158228
all O 0 0.004880454856902361
reported O 0 0.008007833734154701
mutations O 0 0.008465656079351902
leading O 0 0.008058324456214905
to O 0 0.007128434721380472
premature O 0 0.03682290390133858
truncation O 0 0.047496818006038666
of O 0 0.008190539665520191
the O 0 0.008709615096449852
protein O 0 0.009768735617399216
( O 0 0.008961181156337261
nonsense O 0 0.014469319023191929
, O 0 0.010087095201015472
splicing O 0 0.015208904631435871
, O 0 0.010549811646342278
insertions O 0 0.02389710396528244
and O 0 0.009559182450175285
deletions O 0 0.017349988222122192
) O 0 0.00912800058722496
and O 0 0.008331960067152977
just O 0 0.008142265491187572
2 O 0 0.010386588983237743
% O 0 0.008286409080028534
leading O 0 0.008797168731689453
to O 0 0.007940787822008133
substitution O 0 0.012066795490682125
of O 0 0.008718287572264671
one O 0 0.009496526792645454
amino O 0 0.0121375797316432
acid O 0 0.0147194629535079
by O 0 0.010827525518834591
another O 0 0.01594601571559906
( O 0 0.02124183252453804
missense O 0 0.04926633462309837
) O 0 0.034384313970804214
. O 0 0.0482100211083889

The O 0 0.03158298507332802
extraordinary O 0 0.02966131456196308
conservation O 0 0.02039940468966961
of O 0 0.012272610329091549
the O 0 0.015123567543923855
PAX6 O 1 0.9998447895050049
protein O 0 0.012070462107658386
at O 0 0.007754557766020298
the O 0 0.00786287896335125
amino O 0 0.009329501539468765
acid O 0 0.011838012374937534
level O 0 0.008879341185092926
amongst O 0 0.012320993468165398
vertebrates O 0 0.018268609419465065
predicts O 0 0.02740013413131237
that O 0 0.008704215288162231
pathological O 1 0.6041738986968994
missense O 1 0.5628273487091064
mutations O 0 0.010616898536682129
should O 0 0.006368143018335104
in O 0 0.0057214293628931046
fact O 0 0.00617961585521698
be O 0 0.0044912430457770824
common O 0 0.004946791101247072
even O 0 0.004562170244753361
though O 0 0.004812791012227535
they O 0 0.003998748492449522
are O 0 0.004324992187321186
hardly O 0 0.012233234010636806
ever O 0 0.011128365993499756
seen O 0 0.014725894667208195
in O 0 0.01842143014073372
aniridia B-Disease 1 0.9998623132705688
patients O 1 0.9928845167160034
. O 0 0.042313557118177414

This O 0 0.02514692209661007
indicates O 0 0.021324656903743744
that O 0 0.01079168077558279
there O 0 0.00809770543128252
is O 0 0.008557500317692757
a O 0 0.010747753083705902
heavy O 0 0.32133394479751587
ascertainment O 1 0.9932374954223633
bias O 0 0.016988391056656837
in O 0 0.007728415075689554
the O 0 0.007814062759280205
selection O 0 0.010493922978639603
of O 0 0.010666611604392529
patients O 1 0.9571983814239502
for O 0 0.023342322558164597
PAX6 O 1 0.999984860420227
mutation O 0 0.04690499231219292
analysis O 0 0.007829267531633377
and O 0 0.006522276438772678
that O 0 0.005839221645146608
the O 0 0.008846058510243893
missing O 0 0.07243900746107101
PAX6 O 1 0.9999475479125977
missense O 1 0.9594886898994446
mutations O 0 0.035295065492391586
frequently O 0 0.018826574087142944
may O 0 0.01820921152830124
underlie O 1 0.630499005317688
phenotypes O 0 0.1206156387925148
distinct O 0 0.024501629173755646
from O 0 0.028646374121308327
textbook O 1 0.997692346572876
aniridia B-Disease 1 0.9998931884765625
. O 0 0.06436527520418167

Here O 0 0.03220563381910324
we O 0 0.016807710751891136
present O 0 0.016370713710784912
four O 0 0.015654923394322395
novel O 0 0.07440434396266937
PAX6 O 1 0.999860405921936
missense O 1 0.7193161249160767
mutations O 0 0.014771931804716587
, O 0 0.008350343443453312
two O 0 0.006709956098347902
in O 0 0.006866153795272112
association O 0 0.012160983867943287
with O 0 0.010487854480743408
atypical O 1 0.9998588562011719
phenotypes O 1 0.9988974332809448
ectopia B-Disease 1 0.9999743700027466
pupillae I-Disease 1 0.9999382495880127
( O 0 0.11716850101947784
displaced B-Disease 1 0.525436282157898
pupils I-Disease 1 0.7354335188865662
) O 0 0.05567843094468117
and O 1 0.8080913424491882
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9999990463256836
( O 1 0.5719141960144043
searching B-Disease 0 0.33223026990890503
gaze I-Disease 1 0.9493374824523926
) O 0 0.008627159520983696
, O 0 0.007528509013354778
and O 0 0.0066049243323504925
two O 0 0.006476059556007385
in O 0 0.007881768979132175
association O 0 0.014346937648952007
with O 0 0.011932711116969585
more O 0 0.017780756577849388
recognizable O 1 0.9287474751472473
aniridia B-Disease 1 0.9991059899330139
phenotypes O 1 0.7999768853187561
. O 0 0.05918985977768898

Strikingly O 0 0.06705661863088608
, O 0 0.02189079113304615
all O 0 0.014577138237655163
four O 0 0.012861447408795357
mutations O 0 0.011659624055027962
are O 0 0.006891027558594942
located O 0 0.010879588313400745
within O 0 0.00897626206278801
the O 0 0.009956806898117065
PAX6 O 1 0.9996108412742615
paired O 0 0.21921168267726898
domain O 0 0.012693440541625023
and O 0 0.008756414987146854
affect O 0 0.010597603395581245
amino O 0 0.009360747411847115
acids O 0 0.009551682509481907
which O 0 0.006527394987642765
are O 0 0.004721187055110931
highly O 0 0.008328748866915703
conserved O 0 0.011265001259744167
in O 0 0.007908073253929615
all O 0 0.009267834015190601
known O 0 0.016268346458673477
paired O 0 0.03728213906288147
domain O 0 0.033356912434101105
proteins O 0 0.04019219055771828
. O 0 0.04867091029882431

Our O 0 0.02857949212193489
results O 0 0.015254272148013115
support O 0 0.015009014867246151
the O 0 0.01082754135131836
hypothesis O 0 0.014114377088844776
that O 0 0.007201502099633217
the O 0 0.00683825695887208
under O 0 0.009325673803687096
- O 0 0.017290150746703148
representation O 0 0.009140482172369957
of O 0 0.009720714762806892
missense O 1 0.5052004456520081
mutations O 0 0.013132117688655853
is O 0 0.007961726747453213
caused O 0 0.04561491683125496
by O 0 0.007989388890564442
ascertainment O 1 0.9999090433120728
bias O 0 0.36175402998924255
and O 0 0.008747454732656479
suggest O 0 0.008807782083749771
that O 0 0.0056086694821715355
a O 0 0.0075386203825473785
substantial O 0 0.011712532490491867
burden O 1 0.8558490872383118
of O 1 0.5822332501411438
PAX6 B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999908208847046
related I-Disease 1 0.9993683695793152
disease I-Disease 1 0.9999948740005493
remains O 1 0.5131700038909912
to O 0 0.011708658188581467
be O 0 0.011631814762949944
uncovered O 0 0.037386540323495865
. O 0 0.020162513479590416
. O 0 0.03536035493016243

The O 0 0.038185540586709976
chromosomal O 0 0.04126548767089844
order O 0 0.017298296093940735
of O 0 0.013161602430045605
genes O 0 0.013019104488193989
controlling O 0 0.02353333681821823
the O 0 0.011857996694743633
major O 1 0.8094313144683838
histocompatibility O 1 0.999997615814209
complex O 1 0.5511207580566406
, O 0 0.05477696284651756
properdin O 1 0.9993910789489746
factor O 1 0.8325223326683044
B O 1 0.972359299659729
, O 0 0.013768247328698635
and O 0 0.014705105684697628
deficiency B-Disease 1 0.9998888969421387
of I-Disease 0 0.012454291805624962
the I-Disease 0 0.016120925545692444
second I-Disease 0 0.33397650718688965
component I-Disease 0 0.4806912839412689
of I-Disease 0 0.027124423533678055
complement I-Disease 0 0.09680775552988052
. O 0 0.04771101474761963

The O 0 0.03401831537485123
relationship O 0 0.02261461690068245
of O 0 0.014296414330601692
the O 0 0.012443417683243752
genes O 0 0.012853531166911125
coding O 0 0.02032225951552391
for O 0 0.010529771447181702
HLA O 1 0.9831477403640747
to O 0 0.010450330562889576
those O 0 0.008135944604873657
coding O 0 0.014405491761863232
for O 0 0.00970553420484066
properdin O 1 0.9831568598747253
Factor O 1 0.5010260939598083
B O 1 0.8930206298828125
allotypes O 1 0.807120144367218
and O 0 0.010527417063713074
for O 0 0.010881091468036175
deficiency B-Disease 1 0.999943733215332
of I-Disease 0 0.008045756258070469
the I-Disease 0 0.009219656698405743
second I-Disease 0 0.10439971834421158
component I-Disease 0 0.3711099326610565
of I-Disease 0 0.010646280832588673
complement I-Disease 1 0.754180371761322
( O 0 0.20974700152873993
C2 O 1 0.9997443556785583
) O 0 0.008506507612764835
was O 0 0.008092167787253857
studied O 0 0.008563773706555367
in O 0 0.006708618253469467
families O 0 0.007968060672283173
of O 0 0.013583292253315449
patients O 1 0.999724805355072
with O 1 0.9969543218612671
connective O 1 1.0
tissue O 1 0.9999998807907104
disorders O 1 1.0
. O 1 0.979199230670929

Patients O 1 0.6186844706535339
were O 0 0.018529381603002548
selected O 0 0.02202416956424713
because O 0 0.012341491878032684
they O 0 0.009349383413791656
were O 0 0.01044397708028555
heterozygous O 0 0.019252261146903038
or O 0 0.013826796784996986
homozygous O 0 0.27246564626693726
for O 1 0.9207985401153564
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.7994307279586792

12 O 0 0.04866115748882294
families O 0 0.02827727049589157
with O 0 0.018381420522928238
15 O 0 0.024892255663871765
matings O 0 0.20787085592746735
informative O 1 0.5260566473007202
for O 1 0.953466534614563
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.06137106567621231
found O 0 0.03610185906291008
. O 0 0.043677374720573425

Of O 0 0.046803221106529236
57 O 0 0.0505678728222847
informative O 0 0.045228008180856705
meioses O 0 0.21426710486412048
, O 0 0.01362643577158451
two O 0 0.009643115103244781
crossovers O 0 0.014722483232617378
were O 0 0.006823285482823849
noted O 0 0.008550627157092094
between O 0 0.007775531150400639
the O 0 0.2551223337650299
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.11440835148096085
and O 0 0.013569493778049946
the O 0 0.4040716886520386
HLA O 1 0.9999998807907104
- O 1 0.999907374382019
B O 1 0.9937655925750732
gene O 0 0.01148194633424282
, O 0 0.010281942784786224
with O 0 0.009652882814407349
a O 0 0.014388433657586575
recombinant O 0 0.029257887974381447
fraction O 0 0.025063535198569298
of O 0 0.02135522849857807
0 O 0 0.038849759846925735
. O 0 0.04333188384771347

035 O 1 0.9507207870483398
. O 0 0.15032662451267242

A O 0 0.04722832888364792
lod O 0 0.4229814112186432
score O 0 0.024179523810744286
of O 0 0.012673615477979183
13 O 0 0.014596783556044102
was O 0 0.01108750980347395
calculated O 0 0.011094748042523861
for O 0 0.009053184650838375
linkage O 0 0.1330709457397461
between O 1 0.5131665468215942
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9997783303260803
HLA O 1 1.0
- O 1 0.9998856782913208
B O 1 0.9641287922859192
at O 0 0.011912546120584011
a O 0 0.010373608209192753
maximum O 0 0.012203993275761604
likelihood O 0 0.012557686306536198
value O 0 0.011014355346560478
of O 0 0.010091524571180344
the O 0 0.013305951841175556
recombinant O 0 0.032490767538547516
fraction O 0 0.02910544164478779
of O 0 0.024657830595970154
0 O 0 0.04182916134595871
. O 0 0.045489486306905746

04 O 1 0.9051966667175293
. O 0 0.1514979600906372

18 O 0 0.043324608355760574
families O 0 0.0261983685195446
with O 0 0.016280898824334145
21 O 0 0.020976927131414413
informative O 0 0.026912080124020576
matings O 0 0.0265684574842453
for O 0 0.012097649276256561
both O 0 0.012931259348988533
properdin O 1 0.8755520582199097
Factor O 0 0.09649951010942459
B O 1 0.8478355407714844
allotype O 1 0.9788603186607361
and O 0 0.16194990277290344
HLA O 1 0.9999982118606567
- O 1 0.9989233613014221
B O 1 0.9318113923072815
were O 0 0.018578000366687775
found O 0 0.025618257001042366
. O 0 0.039640672504901886

Of O 0 0.0465058796107769
72 O 0 0.06046239659190178
informative O 0 0.05191820487380028
meioses O 0 0.4483526945114136
, O 0 0.017110159620642662
three O 0 0.012568604201078415
recombinants O 0 0.28579431772232056
were O 0 0.010279565118253231
found O 0 0.009523352608084679
, O 0 0.009626558050513268
giving O 0 0.013704654760658741
a O 0 0.01397725474089384
recombinant O 0 0.0370987169444561
fraction O 0 0.026709429919719696
of O 0 0.02263813465833664
0 O 0 0.04043034836649895
. O 0 0.041774407029151917

042 O 1 0.6090536713600159
. O 0 0.16302357614040375

A O 0 0.04485050588846207
lod O 0 0.06540472060441971
score O 0 0.0227223951369524
of O 0 0.015739236027002335
16 O 0 0.016379961743950844
between O 0 0.015597265213727951
HLA O 1 0.9999861717224121
- O 1 0.9981683492660522
B O 1 0.987236499786377
and O 0 0.016761591657996178
Factor O 0 0.27203112840652466
B O 1 0.7088324427604675
allotypes O 0 0.3717941641807556
was O 0 0.013837725855410099
calculated O 0 0.012746292166411877
at O 0 0.00899671670049429
a O 0 0.009734587743878365
maximum O 0 0.011423243209719658
likelihood O 0 0.012093563564121723
value O 0 0.009529495611786842
of O 0 0.009533258154988289
the O 0 0.013320189900696278
recombinant O 0 0.030709493905305862
fraction O 0 0.027280082926154137
of O 0 0.02364216186106205
0 O 0 0.04493962228298187
. O 0 0.047030236572027206

04 O 1 0.8694965839385986
. O 0 0.1612006425857544

A O 0 0.04585440456867218
crossover O 0 0.04957810044288635
was O 0 0.022623272612690926
shown O 0 0.012907932512462139
to O 0 0.009674198925495148
have O 0 0.007063296623528004
occurred O 0 0.007927179336547852
between O 0 0.0064098769798874855
genes O 0 0.00678219273686409
for O 0 0.006247194483876228
Factor O 0 0.01815955340862274
B O 1 0.6393420100212097
and O 0 0.016874466091394424
HLA O 1 0.9999871253967285
- O 1 0.9615540504455566
D O 1 0.5227219462394714
, O 0 0.009048189036548138
in O 0 0.007961912080645561
which O 0 0.009588907472789288
HLA O 1 0.9997883439064026
- O 1 0.9784227013587952
D O 1 0.9928398132324219
segregared O 1 0.9533190727233887
with O 0 0.031588487327098846
HLA O 1 0.9999828338623047
- O 1 0.841331958770752
A O 0 0.12858650088310242
and O 0 0.03588990122079849
B O 1 0.5228103399276733
. O 0 0.048343680799007416

These O 0 0.023439617827534676
studies O 0 0.017587672919034958
suggest O 0 0.015213518403470516
that O 0 0.007943320088088512
the O 0 0.008469387888908386
genes O 0 0.008191162720322609
for O 0 0.008874282240867615
Factor O 1 0.803085207939148
B O 1 0.9993852376937866
and O 1 0.977546751499176
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
are O 0 0.006372688803821802
located O 0 0.00898375641554594
outside O 0 0.008183492347598076
those O 0 0.0060700890608131886
for O 0 0.007547730579972267
HLA O 1 0.9992086291313171
, O 0 0.007674424909055233
that O 0 0.005267878994345665
the O 0 0.006230588536709547
order O 0 0.008002347312867641
of O 0 0.008116593584418297
genese O 1 0.6450766921043396
is O 0 0.012407380156219006
HLA O 1 0.9986206293106079
- O 0 0.03848506882786751
A O 0 0.013375482521951199
, O 0 0.010365432128310204
- O 0 0.0916249006986618
B O 0 0.08721648156642914
, O 0 0.011313476599752903
- O 0 0.33179542422294617
D O 1 0.690468966960907
, O 0 0.013057245872914791
Factor O 0 0.11279697716236115
B O 1 0.9834643006324768
allotype O 1 0.9994733929634094
, O 1 0.9794037938117981
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999995231628418
, O 0 0.0102436114102602
that O 0 0.006479594856500626
the O 0 0.007733525242656469
genes O 0 0.00942174345254898
coding O 0 0.13438159227371216
for O 1 0.7801969051361084
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.8804808855056763
Factor O 1 0.9395317435264587
B O 1 0.8152745962142944
allotypes O 0 0.043905921280384064
are O 0 0.0069069769233465195
approximately O 0 0.008926169015467167
3 O 0 0.01047427300363779
- O 0 0.013354677706956863
- O 0 0.012929683551192284
5 O 0 0.011761381290853024
centimorgans O 0 0.018833789974451065
from O 0 0.008767340332269669
the O 0 0.0103911766782403
HLA O 1 0.9984632730484009
- O 0 0.13290628790855408
A O 0 0.023296954110264778
and O 0 0.08795987069606781
HLA O 1 0.9999990463256836
- O 1 0.9997127652168274
B O 1 0.9939024448394775
loci O 0 0.017040643841028214
, O 0 0.00732356496155262
and O 0 0.005772986449301243
that O 0 0.004473840817809105
the O 0 0.005471900105476379
apparent O 0 0.00976923294365406
lack O 0 0.008539356291294098
of O 0 0.007558275014162064
recombinants O 1 0.8587669134140015
between O 0 0.007042489014565945
the O 0 0.008795014582574368
Factor O 0 0.3918803930282593
B O 1 0.9792607426643372
gene O 0 0.07897640019655228
and O 1 0.9020825028419495
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.11315272748470306
suggests O 0 0.00950564444065094
that O 0 0.005110377911478281
these O 0 0.004370140843093395
two O 0 0.005553547292947769
genes O 0 0.006718637887388468
lie O 0 0.008734217844903469
in O 0 0.007112424820661545
close O 0 0.010644513182342052
proximity O 0 0.01243057381361723
to O 0 0.011674607172608376
one O 0 0.017266323789954185
another O 0 0.02626771293580532
. O 0 0.03286387771368027

Distribution O 0 0.04187900200486183
of O 0 0.029141243547201157
emerin O 1 0.8743301033973694
and O 0 0.021502535790205002
lamins O 1 0.9891611933708191
in O 0 0.013994759880006313
the O 0 0.019178075715899467
heart O 1 0.9951104521751404
and O 0 0.015165123157203197
implications O 1 0.6420518755912781
for O 1 0.5376825928688049
Emery B-Disease 1 0.9999852180480957
- I-Disease 1 0.9999951124191284
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999998807907104
. O 1 0.8569828867912292

Emerin O 1 0.576596200466156
is O 0 0.022281622514128685
a O 0 0.01906406506896019
nuclear O 0 0.023102043196558952
membrane O 0 0.026879604905843735
protein O 0 0.012534882873296738
which O 0 0.007756739854812622
is O 0 0.00787732470780611
missing O 0 0.012277761474251747
or O 0 0.009627074934542179
defective O 1 0.7087453603744507
in O 0 0.018961919471621513
Emery B-Disease 1 0.9999344348907471
- I-Disease 1 0.9999970197677612
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999603033065796
EDMD B-Disease 1 0.9999991655349731
) O 0 0.15061265230178833
. O 0 0.05785302072763443

It O 0 0.026788780465722084
is O 0 0.015804292634129524
one O 0 0.01100974716246128
member O 0 0.011046490631997585
of O 0 0.007838521152734756
a O 0 0.009287731721997261
family O 0 0.01308116689324379
of O 0 0.0749656930565834
lamina O 1 0.9999970197677612
- O 1 0.9876781105995178
associated O 0 0.012990087270736694
proteins O 0 0.009035722352564335
which O 0 0.007565982639789581
includes O 0 0.011899800971150398
LAP1 O 1 0.9586921334266663
, O 0 0.016037603840231895
LAP2 O 1 0.9914817810058594
and O 0 0.058170925825834274
lamin O 1 0.9999639987945557
B O 1 0.9997461438179016
receptor O 1 0.6022117733955383
( O 0 0.05171854421496391
LBR O 1 0.9990118741989136
) O 0 0.04721483960747719
. O 0 0.053791750222444534

A O 0 0.03742404282093048
panel O 0 0.03265776485204697
of O 0 0.020601356402039528
16 O 0 0.043784644454717636
monoclonal O 1 0.9947226047515869
antibodies O 1 0.9818779826164246
( O 0 0.13190940022468567
mAbs O 1 0.9639652967453003
) O 0 0.012687860056757927
has O 0 0.009790012612938881
been O 0 0.00784289836883545
mapped O 0 0.011994121596217155
to O 0 0.007100252900272608
six O 0 0.007112257182598114
specific O 0 0.006839436013251543
sites O 0 0.007242679130285978
throughout O 0 0.008218297734856606
the O 0 0.007823891937732697
emerin O 0 0.0683257058262825
molecule O 0 0.01258306298404932
using O 0 0.011183112859725952
phage O 1 0.939704418182373
- O 0 0.43157958984375
displayed O 0 0.06325080990791321
peptide O 0 0.017266960814595222
libraries O 0 0.010760349221527576
and O 0 0.006679289974272251
has O 0 0.006580400746315718
been O 0 0.006192776374518871
used O 0 0.006300566252321005
to O 0 0.008870567195117474
localize O 0 0.06996435672044754
emerin O 0 0.4058816730976105
in O 0 0.013769030570983887
human O 0 0.018001189455389977
and O 0 0.035870619118213654
rabbit O 1 0.9986312985420227
heart O 1 0.9994379878044128
. O 0 0.04736137390136719

Several O 0 0.03829742595553398
mAbs O 0 0.19048431515693665
against O 0 0.024803685024380684
different O 0 0.01585233025252819
emerin O 1 0.860032320022583
epitopes O 1 0.5339535474777222
did O 0 0.012723558582365513
not O 0 0.008351041935384274
recognize O 0 0.013238446786999702
intercalated O 1 0.964417576789856
discs O 0 0.07620511949062347
in O 0 0.00872957892715931
the O 0 0.012556657195091248
heart O 1 0.9929988384246826
, O 0 0.007659007795155048
though O 0 0.0067724441178143024
they O 0 0.004990152083337307
recognized O 0 0.010191847570240498
cardiomyocyte O 1 0.8452765345573425
nuclei O 0 0.0138547383248806
strongly O 0 0.009011128917336464
, O 0 0.007326033897697926
both O 0 0.006124443840235472
at O 0 0.0074691688641905785
the O 0 0.008311771787703037
rim O 0 0.18444284796714783
and O 0 0.010716128163039684
in O 0 0.013384245336055756
intranuclear O 1 0.9344335198402405
spots O 0 0.03727370500564575
or O 0 0.02090725675225258
channels O 0 0.03450095281004906
. O 0 0.039036475121974945

A O 0 0.10048937797546387
polyclonal O 1 0.9953959584236145
rabbit O 1 0.981962263584137
antiserum O 1 0.9928021430969238
against O 0 0.04693889617919922
emerin O 1 0.9818183779716492
did O 0 0.017414197325706482
recognize O 0 0.015613818541169167
both O 0 0.009886826388537884
nuclear O 0 0.01692016050219536
membrane O 0 0.0278843492269516
and O 0 0.013311844319105148
intercalated O 1 0.992112398147583
discs O 0 0.08498550951480865
but O 0 0.00999443419277668
, O 0 0.009120533242821693
after O 0 0.010103026404976845
affinity O 0 0.014225039631128311
purification O 0 0.041879139840602875
against O 0 0.010450726374983788
a O 0 0.011345956474542618
pure O 0 0.05601879209280014
- O 1 0.5061837434768677
emerin O 1 0.5481421947479248
band O 0 0.015696508809924126
on O 0 0.009951826184988022
a O 0 0.010271141305565834
western O 0 0.012827197089791298
blot O 1 0.7664027810096741
, O 0 0.011833426542580128
it O 0 0.011102190241217613
stained O 1 0.9701205492019653
only O 0 0.01140157412737608
the O 0 0.018134519457817078
nuclear O 0 0.035825472325086594
membrane O 0 0.05651593580842018
. O 0 0.044635724276304245

These O 0 0.022270211949944496
results O 0 0.015324404463171959
would O 0 0.009767932817339897
not O 0 0.006566413678228855
be O 0 0.005739474669098854
expected O 0 0.00828493945300579
if O 0 0.008198434486985207
immunostaining O 0 0.0328981913626194
at O 0 0.009560183621942997
intercalated O 1 0.7918644547462463
discs O 0 0.01782720908522606
were O 0 0.006523895543068647
due O 0 0.006293014623224735
to O 0 0.00547023443505168
a O 0 0.005687335971742868
product O 0 0.006268895231187344
of O 0 0.00572963198646903
the O 0 0.006905250251293182
emerin O 1 0.9902644157409668
gene O 0 0.009375719353556633
and O 0 0.006552828010171652
, O 0 0.006364478264003992
therefore O 0 0.005685185082256794
, O 0 0.005349315702915192
cast O 0 0.006075048353523016
some O 0 0.004749178420752287
doubt O 0 0.006980434060096741
upon O 0 0.005676864180713892
the O 0 0.006467781029641628
hypothesis O 0 0.01716882921755314
that O 0 0.011434384621679783
cardiac B-Disease 1 0.9999983310699463
defects I-Disease 1 0.9999492168426514
in O 0 0.43862470984458923
EDMD B-Disease 1 0.9999980926513672
are O 0 0.008752021007239819
caused O 0 0.0801614448428154
by O 0 0.00850333459675312
absence O 0 0.09668030589818954
of O 0 0.019769491627812386
emerin O 1 0.9970807433128357
from O 0 0.02901621162891388
intercalated O 1 0.9990195035934448
discs O 1 0.8117760419845581
. O 0 0.05445168539881706

Although O 0 0.03863620012998581
emerin O 0 0.38457316160202026
was O 0 0.023508332669734955
abundant O 0 0.01743309572339058
in O 0 0.009486887603998184
the O 0 0.009417876601219177
membranes O 0 0.07388494908809662
of O 0 0.014233828522264957
cardiomyocyte O 1 0.9988504648208618
nuclei O 0 0.06442970782518387
, O 0 0.00866698008030653
it O 0 0.006475948728621006
was O 0 0.009180325083434582
absent O 0 0.01009543240070343
from O 0 0.006630582269281149
many O 0 0.006508212070912123
non O 0 0.030898448079824448
- O 1 0.9848083257675171
myocyte O 1 0.9999408721923828
cells O 0 0.025124290958046913
in O 0 0.015541407279670238
the O 0 0.024309314787387848
heart O 1 0.9360918998718262
. O 0 0.04295553267002106

This O 0 0.025761108845472336
distribution O 0 0.019720152020454407
of O 0 0.015930984169244766
emerin O 1 0.9423959255218506
was O 0 0.015075352974236012
similar O 0 0.008554350584745407
to O 0 0.00759083591401577
that O 0 0.006845284719020128
of O 0 0.009359625168144703
lamin O 1 0.9720288515090942
A O 0 0.018907321617007256
, O 0 0.009584994986653328
a O 0 0.009351696819067001
candidate O 0 0.012781539931893349
gene O 0 0.009667654521763325
for O 0 0.008703158237040043
an O 0 0.013078747317194939
autosomal O 1 0.9540289044380188
form O 0 0.025019634515047073
of O 0 0.11604548245668411
EDMD B-Disease 1 0.9999738931655884
. O 0 0.058132246136665344

In O 0 0.04143849387764931
contrast O 0 0.042157623916864395
, O 0 0.061620138585567474
lamin O 1 0.9999586343765259
B1 O 1 0.9999961853027344
was O 0 0.19119109213352203
absent O 0 0.18920481204986572
from O 0 0.012620718218386173
cardiomyocyte O 1 0.9735473990440369
nuclei O 0 0.026061123237013817
, O 0 0.012386174872517586
showing O 0 0.019567325711250305
that O 0 0.015112689696252346
lamin O 1 0.9999661445617676
B1 O 1 0.9999692440032959
is O 0 0.012897990643978119
not O 0 0.009187879972159863
essential O 0 0.011821601539850235
for O 0 0.010599027387797832
localization O 0 0.024405905976891518
of O 0 0.01435063499957323
emerin O 1 0.6578105688095093
to O 0 0.020946728065609932
the O 0 0.02740667387843132
nuclear O 0 0.06288010627031326
lamina O 1 0.995595395565033
. O 0 0.070951908826828

Lamin O 1 0.9999698400497437
B1 O 1 0.9999524354934692
is O 0 0.024048741906881332
also O 0 0.017762387171387672
almost O 0 0.016309430822730064
completely O 0 0.02411513961851597
absent O 0 0.1824120432138443
from O 0 0.05193130671977997
skeletal O 1 0.9999386072158813
muscle O 1 0.999832034111023
nuclei O 1 0.6923615336418152
. O 0 0.053836409002542496

In O 0 0.04239029064774513
EDMD B-Disease 1 0.9566249847412109
, O 0 0.019913483411073685
the O 0 0.01388324424624443
additional O 0 0.013352585956454277
absence O 0 0.0190432108938694
of O 0 0.04123329371213913
lamin O 1 0.9999909400939941
B1 O 1 0.9999983310699463
from O 0 0.26114049553871155
heart O 1 0.9999860525131226
and O 1 0.9794719219207764
skeletal O 1 0.9999984502792358
muscle O 1 0.9999889135360718
nuclei O 1 0.9470990896224976
which O 0 0.01667713187634945
already O 0 0.12412319332361221
lack O 1 0.6198643445968628
emerin O 1 0.9972273707389832
may O 0 0.008943532593548298
offer O 0 0.007854602299630642
an O 0 0.006088191643357277
alternative O 0 0.008405005559325218
explanation O 0 0.008686203509569168
of O 0 0.006675077136605978
why O 0 0.01017299946397543
these O 0 0.007078261114656925
tissues O 0 0.18252256512641907
are O 0 0.0069768293760716915
particularly O 0 0.015835490077733994
affected O 0 0.02883029170334339
. O 0 0.018463153392076492
. O 0 0.03226450830698013

Genetic O 0 0.052344076335430145
mapping O 0 0.04294223710894585
of O 0 0.02430560439825058
the O 0 0.027126198634505272
copper B-Disease 1 0.9974483251571655
toxicosis I-Disease 1 0.9999301433563232
locus O 1 0.9292395710945129
in O 0 0.02249102108180523
Bedlington O 1 0.9972236156463623
terriers O 0 0.20795616507530212
to O 0 0.011920670978724957
dog O 0 0.021291742101311684
chromosome O 0 0.01310573797672987
10 O 0 0.009103359654545784
, O 0 0.007487913127988577
in O 0 0.006972350645810366
a O 0 0.00903412513434887
region O 0 0.01279007364064455
syntenic O 0 0.2348981350660324
to O 0 0.011243600398302078
human O 0 0.014007794670760632
chromosome O 0 0.03382259979844093
region O 0 0.04475721716880798
2p13 O 1 0.9887794256210327
- O 1 0.9372729659080505
p16 O 1 0.8744396567344666
. O 0 0.060699764639139175

Abnormal O 1 0.9995852112770081
hepatic B-Disease 1 0.9999958276748657
copper I-Disease 1 0.9996504783630371
accumulation I-Disease 1 0.9664525389671326
is O 0 0.013983400538563728
recognized O 0 0.05727239325642586
as O 0 0.025620650500059128
an O 1 0.9581137895584106
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9776493906974792
man O 1 0.9994811415672302
, O 1 0.8696586489677429
mouse O 1 0.9918835163116455
, O 0 0.09623923897743225
rat O 1 0.9884706735610962
and O 0 0.02563503198325634
dog O 0 0.26576098799705505
. O 0 0.036593664437532425

The O 0 0.03324577957391739
major O 0 0.03636140748858452
cause O 1 0.8381058573722839
of O 1 0.956559419631958
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999958276748657
accumulation I-Disease 1 0.9992126226425171
in O 0 0.02119080349802971
man O 0 0.11050447076559067
is O 0 0.009109224192798138
a O 0 0.012971857562661171
dysfunctional O 1 0.9742310643196106
ATP7B O 1 0.9997743964195251
gene O 0 0.03868541121482849
, O 0 0.0732395350933075
causing O 1 0.9950802326202393
Wilson B-Disease 1 0.9999778270721436
disease I-Disease 1 0.9999997615814209
( O 1 0.994819700717926
WD B-Disease 1 0.9999970197677612
) O 0 0.04138689488172531
. O 0 0.04692700505256653

Mutations O 0 0.034399114549160004
in O 0 0.016489434987306595
the O 0 0.019238397479057312
ATP7B O 1 0.9992744326591492
genes O 0 0.013533510267734528
have O 0 0.0068390765227377415
also O 0 0.008318405598402023
been O 0 0.00808864738792181
demonstrated O 0 0.015135709196329117
in O 0 0.01394801028072834
mouse O 0 0.14135494828224182
and O 0 0.026352230459451675
rat O 1 0.5833806991577148
. O 0 0.054192304611206055

The O 0 0.05019901320338249
ATP7B O 1 0.9818792939186096
gene O 0 0.022201459854841232
has O 0 0.01404421404004097
been O 0 0.009934326633810997
excluded O 0 0.011298151686787605
in O 0 0.006504174321889877
the O 0 0.006579036358743906
much O 0 0.00932818092405796
rarer O 1 0.9863079190254211
human O 1 0.7691002488136292
copper B-Disease 1 0.9999946355819702
overload I-Disease 1 0.9999998807907104
disease O 1 0.9999998807907104
non B-Disease 1 0.999942421913147
- I-Disease 1 0.9999921321868896
Indian I-Disease 1 0.999578058719635
childhood I-Disease 1 0.9999996423721313
cirrhosis I-Disease 1 1.0
, O 1 0.8297552466392517
indicating O 1 0.7550910711288452
genetic O 0 0.34497082233428955
heterogeneity O 1 0.9103663563728333
. O 0 0.046981535851955414

By O 0 0.024807963520288467
investigating O 0 0.02615704946219921
the O 0 0.02104434184730053
common O 1 0.8216661810874939
autosomal O 1 0.9999985694885254
recessive O 1 0.9999998807907104
copper B-Disease 1 0.9999998807907104
toxicosis I-Disease 1 1.0
( O 1 0.9985017776489258
CT B-Disease 1 0.9999634027481079
) O 0 0.014587595127522945
in O 0 0.013661294244229794
Bedlington O 1 0.9983602166175842
terriers O 1 0.6735325455665588
, O 0 0.008354813791811466
we O 0 0.006479661911725998
have O 0 0.004899166524410248
identified O 0 0.005561809055507183
a O 0 0.005961427930742502
new O 0 0.007486909627914429
locus O 0 0.4458201229572296
involved O 0 0.02108628861606121
in O 1 0.7908605337142944
progressive O 1 0.9999990463256836
liver B-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
. O 1 0.7525086402893066

We O 0 0.031024977564811707
examined O 0 0.03423507511615753
whether O 0 0.018322328105568886
the O 0 0.018561705946922302
WD B-Disease 1 0.9999303817749023
gene O 0 0.12284133583307266
ATP7B O 1 0.9995537400245667
was O 0 0.15504740178585052
also O 0 0.013469237834215164
causative O 0 0.3890458643436432
for O 0 0.008856547065079212
CT B-Disease 1 0.5947050452232361
by O 0 0.008284695446491241
investigating O 0 0.011992504820227623
the O 0 0.011096229776740074
chromosomal O 1 0.7508065104484558
co O 0 0.49999555945396423
- O 1 0.5829657912254333
localization O 0 0.1464422047138214
of O 0 0.015563295222818851
ATP7B O 1 0.9990159273147583
and O 0 0.01568603701889515
C04107 O 0 0.3107767105102539
, O 0 0.01163486298173666
using O 0 0.010823716409504414
fluorescence O 0 0.019812846556305885
in O 0 0.015518131665885448
situ O 0 0.14850851893424988
hybridization O 0 0.03410359472036362
( O 0 0.026456646621227264
FISH O 0 0.03595992550253868
) O 0 0.03626200184226036
. O 0 0.04663686454296112

C04107 O 0 0.14196635782718658
is O 0 0.03645865619182587
an O 0 0.027067383751273155
anonymous O 0 0.04143596813082695
microsatellite O 1 0.9760878086090088
marker O 1 0.5547469258308411
closely O 0 0.02823210507631302
linked O 0 0.038776785135269165
to O 0 0.028085770085453987
CT B-Disease 1 0.9945571422576904
. O 0 0.058766718953847885

However O 0 0.049655720591545105
, O 0 0.042638231068849564
BAC O 1 0.9499977231025696
clones O 0 0.29011908173561096
containing O 0 0.03684389963746071
ATP7B O 1 0.9727455973625183
and O 0 0.018439000472426414
C04107 O 0 0.07800346612930298
mapped O 0 0.02219431661069393
to O 0 0.012284176424145699
the O 0 0.013349859043955803
canine O 1 0.8347864747047424
chromosome O 0 0.023302072659134865
regions O 0 0.013497787527740002
CFA22q11 O 1 0.977663516998291
and O 0 0.015019741840660572
CFA10q26 O 1 0.9867390394210815
, O 0 0.010032420046627522
respectively O 0 0.011058629490435123
, O 0 0.009056894108653069
demonstrating O 0 0.014076394028961658
that O 0 0.01012042723596096
WD B-Disease 1 0.9989308714866638
cannot O 0 0.014746580272912979
be O 0 0.012032304890453815
homologous O 0 0.026061590760946274
to O 0 0.022753028199076653
CT B-Disease 1 0.9023136496543884
. O 0 0.043584395200014114

The O 0 0.04171842336654663
copper O 1 0.5959705114364624
transport O 0 0.04959041625261307
genes O 0 0.022572867572307587
CTR1 O 1 0.9967283010482788
and O 0 0.01908472366631031
CTR2 O 1 0.9949287176132202
were O 0 0.008864138275384903
also O 0 0.00855740811675787
excluded O 0 0.010964415036141872
as O 0 0.007521408144384623
candidate O 0 0.010451234877109528
genes O 0 0.007592208217829466
for O 0 0.007455792743712664
CT B-Disease 1 0.7974641919136047
since O 0 0.00821015890687704
they O 0 0.00719692837446928
both O 0 0.007861175574362278
mapped O 0 0.017500273883342743
to O 0 0.015132519416511059
canine O 1 0.9550597667694092
chromosome O 0 0.05758422240614891
region O 0 0.04494471848011017
CFA11q22 O 1 0.9861087203025818
. O 0 0.04820341244339943

2 O 0 0.08305858820676804
- O 0 0.10575488954782486
22 O 0 0.07292009145021439
. O 0 0.07313691824674606

5 O 0 0.14918184280395508
. O 0 0.12003272026777267

A O 0 0.04188986495137215
transcribed O 0 0.03385969251394272
sequence O 0 0.017984136939048767
identified O 0 0.013141339644789696
from O 0 0.009446934796869755
the O 0 0.010651570744812489
C04107 O 1 0.6946288347244263
- O 1 0.5201927423477173
containing O 0 0.03587503731250763
BAC O 1 0.9928387999534607
was O 0 0.01195429265499115
found O 0 0.005934722255915403
to O 0 0.007128951605409384
be O 0 0.0055954731069505215
homologous O 0 0.008474202826619148
to O 0 0.006003012415021658
a O 0 0.007153645157814026
gene O 0 0.007971733808517456
expressed O 0 0.008631608448922634
from O 0 0.007379536516964436
human O 0 0.009007960557937622
chromosome O 0 0.035640131682157516
2p13 O 1 0.9762504696846008
- O 1 0.9377297759056091
p16 O 1 0.8122718930244446
, O 0 0.011279445141553879
a O 0 0.013617509976029396
region O 0 0.015180142596364021
devoid O 0 0.028242845088243484
of O 0 0.012804795056581497
any O 0 0.016216157004237175
positional O 0 0.4095137417316437
candidate O 0 0.04146246239542961
genes O 0 0.03786960616707802
. O 0 0.047506287693977356

Molecular O 0 0.04624127224087715
analysis O 0 0.022032849490642548
of O 0 0.01603475958108902
the O 0 0.015006518922746181
APC B-Disease 1 0.956903338432312
gene O 0 0.013080745935440063
in O 0 0.010543541982769966
205 O 0 0.0218059029430151
families O 0 0.00940797571092844
: O 0 0.009556875564157963
extended O 0 0.014348846860229969
genotype O 1 0.6102110147476196
- O 1 0.8397663831710815
phenotype O 1 0.6969533562660217
correlations O 0 0.02528906986117363
in O 0 0.012751958332955837
FAP B-Disease 1 0.999816358089447
and O 0 0.010491476394236088
evidence O 0 0.008425147272646427
for O 0 0.006466396152973175
the O 0 0.00777988089248538
role O 0 0.010333348996937275
of O 0 0.013369569554924965
APC B-Disease 1 0.9991881251335144
amino O 0 0.017173416912555695
acid O 0 0.09057733416557312
changes O 0 0.018896136432886124
in O 1 0.9108466506004333
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999974966049194
. O 1 0.5318562388420105

BACKGROUND O 0 0.10293406248092651
/ O 1 0.545429527759552
AIMS O 0 0.06528414785861969
The O 0 0.018204480409622192
development O 1 0.664523184299469
of O 1 0.9996134638786316
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.47649627923965454
a O 0 0.028419990092515945
variable O 0 0.011507092043757439
range O 0 0.010471299290657043
of O 0 0.011034958995878696
extracolonic O 1 0.9881278872489929
manifestations O 1 0.9909001588821411
in O 1 0.9046459197998047
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999949932098389
FAP B-Disease 1 1.0
) O 0 0.08414822816848755
is O 0 0.008711542002856731
the O 0 0.008623925037682056
result O 0 0.007372898980975151
of O 0 0.007306267041712999
the O 0 0.008821266703307629
dominant O 0 0.42784297466278076
inheritance O 1 0.9912932515144348
of O 1 0.999416708946228
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999816417694092
APC B-Disease 1 0.9999986886978149
) O 0 0.2049044668674469
gene O 0 0.041782256215810776
mutations O 0 0.04175681620836258
. O 0 0.0456111766397953

In O 0 0.023609735071659088
this O 0 0.01307687722146511
study O 0 0.012006513774394989
, O 0 0.00926912110298872
direct O 0 0.010384070686995983
mutation O 0 0.009231268428266048
analysis O 0 0.007413097657263279
of O 0 0.006769930943846703
the O 0 0.012141861952841282
APC B-Disease 1 0.9995362758636475
gene O 0 0.010129168629646301
was O 0 0.009092479944229126
performed O 0 0.00938714761286974
to O 0 0.008582133799791336
determine O 0 0.011443533934652805
genotype O 0 0.023823201656341553
- O 0 0.044226352125406265
phenotype O 0 0.03303569182753563
correlations O 0 0.014307774603366852
for O 0 0.008401704020798206
nine O 0 0.014403690584003925
extracolonic O 1 0.987143337726593
manifestations O 1 0.6779152154922485
and O 0 0.009034902788698673
to O 0 0.008680116385221481
investigate O 0 0.012873681262135506
the O 0 0.011303485371172428
incidence O 1 0.7591773867607117
of O 0 0.016842283308506012
APC B-Disease 1 0.99986732006073
mutations O 0 0.12655247747898102
in O 0 0.0623282790184021
non O 1 0.9994587302207947
- O 1 0.9999995231628418
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 1 0.6872679591178894

METHODS O 0 0.04280881583690643
The O 0 0.031621117144823074
APC B-Disease 1 0.9937532544136047
gene O 0 0.019933488219976425
was O 0 0.017161235213279724
analysed O 0 0.02149003930389881
in O 0 0.012961635366082191
190 O 0 0.02457508072257042
unrelated O 0 0.021331842988729477
FAP B-Disease 1 0.9949501752853394
and O 0 0.013596908189356327
15 O 0 0.026674991473555565
non O 1 0.9805221557617188
- O 1 0.9999980926513672
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999409914016724
using O 0 0.12168685346841812
denaturing O 1 0.9999654293060303
gradient O 1 0.9977272152900696
gel O 1 0.9998317956924438
electrophoresis O 1 0.8769952654838562
, O 0 0.015100267715752125
the O 0 0.014428066089749336
protein O 0 0.015389390289783478
truncation O 0 0.09738213568925858
test O 0 0.018423378467559814
, O 0 0.01517360657453537
and O 0 0.015613301657140255
direct O 0 0.027589133009314537
sequencing O 0 0.04781537875533104
. O 0 0.04386992007493973

RESULTS O 0 0.04680008441209793
Chain O 0 0.044669657945632935
terminating O 0 0.02882368303835392
signals O 0 0.018050657585263252
were O 0 0.01014000829309225
only O 0 0.00857134535908699
identified O 0 0.008486057631671429
in O 0 0.007892776280641556
patients O 0 0.19351138174533844
belonging O 0 0.011365978047251701
to O 0 0.009748746640980244
the O 0 0.018991224467754364
FAP B-Disease 1 0.9999939203262329
group O 0 0.20502279698848724
( O 0 0.07301343232393265
105 O 1 0.6086224317550659
patients O 1 0.9527482390403748
) O 0 0.02786385454237461
. O 0 0.040882665663957596

Amino O 0 0.04432835429906845
acid O 0 0.027697140350937843
changes O 0 0.013562168926000595
were O 0 0.009379019029438496
identified O 0 0.0088264811784029
in O 0 0.0072341300547122955
four O 0 0.008608357980847359
patients O 0 0.22243253886699677
, O 0 0.006172981113195419
three O 0 0.0052740792743861675
of O 0 0.006242554634809494
whom O 0 0.007972951047122478
belonged O 0 0.009214609861373901
to O 0 0.006385352928191423
the O 0 0.00795665942132473
non O 0 0.1521148681640625
- O 1 0.9993155002593994
FAP O 1 0.9999995231628418
group O 1 0.9916730523109436
of O 1 0.9999371767044067
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999982118606567
. O 1 0.8269644975662231

Genotype O 1 0.9491249918937683
- O 1 0.8919925093650818
phenotype O 1 0.7273018956184387
correlations O 0 0.037274304777383804
identified O 0 0.014951950870454311
significant O 0 0.011269425973296165
differences O 0 0.010286718606948853
in O 0 0.006692457478493452
the O 0 0.007483346853405237
nature O 0 0.008267438039183617
of O 0 0.007853726856410503
certain O 0 0.01231835875660181
extracolonic O 1 0.9998408555984497
manifestations O 1 0.999722421169281
in O 1 0.9779840111732483
FAP B-Disease 1 1.0
patients O 1 0.9998237490653992
belonging O 0 0.11234349012374878
to O 0 0.016120577231049538
three O 0 0.021577786654233932
mutation O 0 0.04752855747938156
subgroups O 0 0.061787914484739304
. O 0 0.04630313441157341

CONCLUSIONS O 0 0.05928530544042587
Extended O 0 0.05381461977958679
genotype O 1 0.932113766670227
- O 1 0.9784331321716309
phenotype O 1 0.8795068860054016
correlations O 0 0.023854905739426613
made O 0 0.010291069746017456
in O 0 0.00659148907288909
this O 0 0.00507776252925396
study O 0 0.007081788033246994
may O 0 0.005498218350112438
have O 0 0.0038772691041231155
the O 0 0.004668717738240957
potential O 0 0.0062359110452234745
to O 0 0.00515545392408967
determine O 0 0.005311615765094757
the O 0 0.00467307586222887
most O 0 0.005330938380211592
appropriate O 0 0.007320196833461523
surveillance O 0 0.012939740903675556
and O 0 0.013080471195280552
prophylactic O 1 0.999832272529602
treatment O 1 0.9994949102401733
regimens O 1 0.9995296001434326
for O 0 0.01051107794046402
those O 0 0.010267172008752823
patients O 1 0.9748938679695129
with O 0 0.031090671196579933
mutations O 0 0.2528248727321625
associated O 0 0.01515644509345293
with O 0 0.017824789509177208
life O 1 0.7218649387359619
threatening O 1 0.9954451322555542
conditions O 1 0.8606930375099182
. O 0 0.04494701698422432

This O 0 0.02385072037577629
study O 0 0.018948236480355263
also O 0 0.0121532017365098
provided O 0 0.010813158005475998
evidence O 0 0.00854234304279089
for O 0 0.007233434356749058
the O 0 0.008407680317759514
pathological O 0 0.4326523244380951
nature O 0 0.009505733847618103
of O 0 0.00909614097326994
amino O 0 0.010158105753362179
acid O 0 0.011184868402779102
changes O 0 0.007664122153073549
in O 0 0.008771891705691814
APC O 1 0.870479941368103
associated O 0 0.00926231499761343
with O 0 0.008340847678482533
both O 0 0.009756924584507942
FAP B-Disease 1 0.999976634979248
and O 1 0.5663038492202759
non O 1 0.9998557567596436
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9999990463256836
. O 1 0.7063050270080566
. O 0 0.06198682263493538

Inherited B-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.999968409538269
cancer B-Disease 1 0.9999998807907104
risk O 1 0.9998430013656616
of O 1 0.9736344814300537
the O 1 0.9975997805595398
APC O 1 0.9999991655349731
I1307K O 1 0.9999616146087646
polymorphism O 1 0.9672614932060242
. O 0 0.057929713279008865

Germ O 1 0.9977647066116333
- O 1 0.6258116960525513
line O 0 0.03174779564142227
and O 0 0.016580460593104362
somatic O 0 0.1041775643825531
truncating O 1 0.6788964867591858
mutations O 0 0.015369267202913761
of O 0 0.010848591104149818
the O 0 0.0193202942609787
APC B-Disease 1 0.9994074106216431
gene O 0 0.010778967291116714
are O 0 0.006199444178491831
thought O 0 0.008326521143317223
to O 0 0.010065288282930851
initiate O 1 0.9004508256912231
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999762773513794
formation O 1 0.9914425015449524
in O 1 0.996802806854248
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999997615814209
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9984443783760071
respectively O 1 0.8395949602127075
. O 0 0.05077940225601196

Recently O 0 0.04817165061831474
, O 0 0.024773085489869118
an O 0 0.02120261639356613
isoleucine O 1 0.9973956346511841
- O 1 0.9711787700653076
- O 1 0.8298400044441223
> O 1 0.5407257080078125
lysine O 0 0.03879256173968315
polymorphism O 0 0.027717402204871178
at O 0 0.017362739890813828
codon O 0 0.02497946098446846
1307 O 0 0.23338252305984497
( O 0 0.016426190733909607
I1307K O 0 0.03077896125614643
) O 0 0.011875621974468231
of O 0 0.010010914877057076
the O 0 0.010982254520058632
APC B-Disease 1 0.9898015856742859
gene O 0 0.010455776937305927
has O 0 0.00790955126285553
been O 0 0.005958054680377245
identified O 0 0.006616946775466204
in O 0 0.006041892804205418
6 O 0 0.009286613203585148
% O 0 0.007937520742416382
- O 0 0.011284401640295982
7 O 0 0.010363401845097542
% O 0 0.00836238358169794
of O 0 0.009338462725281715
the O 0 0.012514401227235794
Ashkenazi O 0 0.2607784867286682
Jewish O 0 0.02063710242509842
population O 0 0.024112850427627563
. O 0 0.03764202818274498

To O 0 0.029851999133825302
assess O 0 0.03259151056408882
the O 0 0.01803503930568695
risk O 0 0.017488816753029823
of O 0 0.011338924989104271
this O 0 0.00981295295059681
common O 0 0.03137720003724098
APC B-Disease 1 0.9998458623886108
allelic O 1 0.999737560749054
variant O 1 0.9994810223579407
in O 1 0.9842584133148193
colorectal O 1 1.0
carcinogenesis O 1 0.9999995231628418
, O 0 0.023645419627428055
we O 0 0.00843604002147913
have O 0 0.006554998457431793
analyzed O 0 0.010933990590274334
a O 0 0.009804853238165379
large O 0 0.01089242473244667
cohort O 0 0.024111492559313774
of O 0 0.011543720960617065
unselected O 1 0.9784865379333496
Ashkenazi O 1 0.6227198243141174
Jewish O 0 0.01543052215129137
subjects O 0 0.025795958936214447
with O 0 0.11972218006849289
adenomatous B-Disease 1 0.9999997615814209
polyps I-Disease 1 0.9999951124191284
and O 1 0.8237636685371399
. O 1 0.7851365208625793
or O 1 0.9987965822219849
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, I-Disease 0 0.16821497678756714
for O 0 0.01988726295530796
the O 0 0.17872820794582367
APC O 1 0.9999035596847534
I1307K O 1 0.9963321089744568
polymorphism O 0 0.35838082432746887
. O 0 0.057615600526332855

The O 0 0.05342194065451622
APC O 1 0.9991664886474609
I1307K O 1 0.9669768214225769
allele O 0 0.03258892148733139
was O 0 0.016520172357559204
identified O 0 0.010268844664096832
in O 0 0.007740957662463188
48 O 0 0.0116964653134346
( O 0 0.007710029371082783
10 O 0 0.008912571705877781
. O 0 0.007090040948241949
1 O 0 0.011069163680076599
% O 0 0.010736565105617046
) O 0 0.013217620551586151
of O 0 0.017888939008116722
476 O 1 0.9765830039978027
patients O 1 0.9110646843910217
. O 0 0.04389891028404236

Compared O 0 0.029908016324043274
with O 0 0.013569613918662071
the O 0 0.009532091207802296
frequency O 0 0.009035187773406506
in O 0 0.006600286811590195
two O 0 0.005842073354870081
separate O 0 0.006721467711031437
population O 0 0.0055629960261285305
control O 0 0.007680376060307026
groups O 0 0.005183390341699123
, O 0 0.006839529611170292
the O 0 0.010887106880545616
APC O 1 0.9998354911804199
I1307K O 1 0.9960131645202637
allele O 0 0.027943776920437813
is O 0 0.00881204567849636
associated O 0 0.007071176543831825
with O 0 0.006110684014856815
an O 0 0.00784437544643879
estimated O 0 0.011170713230967522
relative O 0 0.014584935270249844
risk O 0 0.017643878236413002
of O 0 0.017996614798903465
1 O 0 0.028699049726128578
. O 0 0.03603101894259453

5 O 0 0.09304683655500412
- O 0 0.12101907283067703
1 O 0 0.08019034564495087
. O 0 0.07852081209421158

7 O 0 0.05644817277789116
for O 0 0.0707285925745964
colorectal B-Disease 1 0.9999997615814209
neoplasia I-Disease 1 0.9999974966049194
( O 0 0.07793121784925461
both O 0 0.01982039399445057
P O 1 0.9536889791488647
= O 0 0.1820390373468399
. O 0 0.02685575932264328
01 O 1 0.983074963092804
) O 0 0.04155232384800911
. O 0 0.05517228692770004

Furthermore O 0 0.04892891272902489
, O 0 0.021870283409953117
compared O 0 0.018756773322820663
with O 0 0.014971663244068623
noncarriers O 1 0.981955349445343
, O 0 0.04283617436885834
APC O 1 0.9996102452278137
I1307K O 1 0.9376224279403687
carriers O 0 0.03738865256309509
had O 0 0.012509400025010109
increased O 0 0.010252423584461212
numbers O 0 0.010145138949155807
of O 0 0.013092824257910252
adenomas B-Disease 1 0.9999899864196777
and O 1 0.9878044128417969
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9999978542327881
per O 0 0.07100997865200043
patient O 1 0.992711067199707
( O 0 0.065414659678936
P O 1 0.8385722637176514
= O 0 0.02071915939450264
. O 0 0.00955207459628582
03 O 1 0.5027128458023071
) O 0 0.009641489945352077
, O 0 0.008586452342569828
as O 0 0.007232092786580324
well O 0 0.007378038018941879
as O 0 0.007542942184954882
a O 0 0.01160156074911356
younger O 0 0.024502163752913475
age O 0 0.025880929082632065
at O 0 0.028653651475906372
diagnosis O 1 0.9973746538162231
. O 0 0.03884315490722656

We O 0 0.03408607095479965
conclude O 0 0.03318267688155174
that O 0 0.01615464687347412
the O 0 0.016635684296488762
APC O 1 0.9949862957000732
I1307K O 1 0.9825546145439148
variant O 0 0.37127378582954407
leads O 0 0.03200191631913185
to O 0 0.011554521508514881
increased O 1 0.5382826328277588
adenoma B-Disease 1 0.9999995231628418
formation O 0 0.22764411568641663
and O 0 0.00887270551174879
directly O 0 0.008610978722572327
contributes O 0 0.01076529361307621
to O 0 0.006297622807323933
3 O 0 0.008224572986364365
% O 0 0.00663036247715354
- O 0 0.010149704292416573
4 O 0 0.010435736738145351
% O 0 0.008331743068993092
of O 0 0.008967693895101547
all O 0 0.012185795232653618
Ashkenazi O 1 0.9922521710395813
Jewish O 1 0.9872692823410034
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
. O 0 0.49264952540397644

The O 0 0.029462700709700584
estimated O 0 0.02168218232691288
relative O 0 0.018176725134253502
risk O 0 0.12128108739852905
for O 0 0.011118505150079727
carriers O 1 0.8025466799736023
may O 0 0.00955864880234003
justify O 0 0.01305573619902134
specific O 0 0.0071909003891050816
clinical O 1 0.5357445478439331
screening O 0 0.011151277460157871
for O 0 0.006130943540483713
the O 0 0.007573849521577358
360 O 0 0.016864020377397537
, O 0 0.008853720501065254
000 O 0 0.012734932824969292
Americans O 0 0.009949547238647938
expected O 0 0.007490858901292086
to O 0 0.0075163873843848705
harbor O 0 0.014942542649805546
this O 0 0.008272087201476097
allele O 0 0.01241876557469368
, O 0 0.007157316897064447
and O 0 0.006103882100433111
genetic O 0 0.006064597051590681
testing O 0 0.006346945650875568
in O 0 0.004845634568482637
the O 0 0.005479344632476568
setting O 0 0.006369602866470814
of O 0 0.005291405599564314
long O 0 0.008721536956727505
- O 0 0.12559057772159576
term O 0 0.010978231206536293
- O 0 0.03637860715389252
outcome O 0 0.007023883983492851
studies O 0 0.005764355417340994
may O 0 0.006125480402261019
impact O 0 0.009946590289473534
significantly O 0 0.027091138064861298
on O 1 0.6961240172386169
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9999958276748657
in O 0 0.08149590343236923
this O 0 0.015019445680081844
population O 0 0.020847460255026817
. O 0 0.036477308720350266

Localization O 0 0.0737757459282875
of O 0 0.02544761635363102
human O 0 0.02529011480510235
BRCA1 O 1 0.9793286323547363
and O 0 0.01153133437037468
its O 0 0.008800595998764038
loss O 0 0.11467993259429932
in O 0 0.008215699344873428
high O 0 0.15719541907310486
- O 1 0.9778690934181213
grade O 1 0.7106634974479675
, O 0 0.019627146422863007
non B-Disease 1 0.8906888365745544
- I-Disease 1 0.9999555349349976
inherited I-Disease 1 0.9999995231628418
breast I-Disease 1 0.9999998807907104
carcinomas I-Disease 1 0.9999996423721313
. O 0 0.3563729226589203

Although O 0 0.028192317113280296
the O 0 0.017966629937291145
link O 0 0.020052531734108925
between O 0 0.01235354132950306
the O 0 0.015957487747073174
BRCA1 O 1 0.9999796152114868
tumour B-Disease 1 0.9999995231628418
- O 1 0.9998254179954529
suppressor O 1 0.999854326248169
gene O 0 0.2180732637643814
and O 1 0.7661340236663818
hereditary B-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.975102961063385
established O 1 0.6430279016494751
, O 0 0.011608533561229706
the O 0 0.007773751392960548
role O 0 0.009634125977754593
, O 0 0.006181678269058466
if O 0 0.004835683852434158
any O 0 0.005476534366607666
, O 0 0.006094470154494047
of O 0 0.006705714855343103
BRCA1 O 1 0.9095202684402466
in O 0 0.011480918154120445
non B-Disease 1 0.9871184825897217
- I-Disease 1 0.9999861717224121
familial I-Disease 1 0.9999992847442627
cancers I-Disease 1 0.9999983310699463
is O 0 0.18541531264781952
unclear O 0 0.04068853333592415
. O 0 0.0406106673181057

BRCA1 O 1 0.9992344379425049
mutations O 0 0.03418648615479469
are O 0 0.010813336819410324
rare O 0 0.01565658487379551
in O 0 0.012085779570043087
sporadic B-Disease 1 0.9856114387512207
cancers I-Disease 1 0.9999783039093018
, O 0 0.012253296561539173
but O 0 0.006958178710192442
loss O 1 0.5973030924797058
of O 0 0.1234365925192833
BRCA1 O 1 0.9998452663421631
resulting O 0 0.1800830364227295
from O 0 0.00767806451767683
reduced O 0 0.012666767463088036
expression O 0 0.010909199714660645
or O 0 0.00867880042642355
incorrect O 0 0.01586301438510418
subcellular O 0 0.05927429720759392
localization O 0 0.0235417652875185
is O 0 0.009240967221558094
postulated O 0 0.01295590028166771
to O 0 0.006291538942605257
be O 0 0.005365797318518162
important O 0 0.006379180587828159
in O 0 0.006662077270448208
non B-Disease 1 0.6283668279647827
- I-Disease 1 0.9999780654907227
familial I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 0.9999985694885254
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 1 0.8885030746459961

Epigenetic O 1 0.5027825832366943
loss O 1 0.7169469594955444
, O 0 0.016910646110773087
however O 0 0.010693666525185108
, O 0 0.008392425253987312
has O 0 0.005955741740763187
not O 0 0.004808614030480385
received O 0 0.008234618231654167
general O 0 0.011127137579023838
acceptance O 0 0.04788957163691521
due O 0 0.0069982497952878475
to O 0 0.006628581788390875
controversy O 0 0.010438632220029831
regarding O 0 0.010194783098995686
the O 0 0.010798260569572449
subcellular O 0 0.026566829532384872
localization O 0 0.02796015329658985
of O 0 0.013338370248675346
BRCA1 O 1 0.9825431108474731
proteins O 0 0.009429908357560635
, O 0 0.0071229999884963036
reports O 0 0.007817701436579227
of O 0 0.006118374411016703
which O 0 0.004519305191934109
have O 0 0.004243364091962576
ranged O 0 0.007951813749969006
from O 0 0.005637474823743105
exclusively O 0 0.009162681177258492
nuclear O 0 0.009729977697134018
, O 0 0.006594848819077015
to O 0 0.007104987278580666
conditionally O 0 0.018210941925644875
nuclear O 0 0.012595511972904205
, O 0 0.008556587621569633
to O 0 0.008124876767396927
the O 0 0.011937081813812256
ER O 1 0.9995560050010681
/ O 1 0.858414351940155
golgi O 1 0.7545644044876099
, O 0 0.015374419279396534
to O 0 0.016721324995160103
cytoplasmic O 0 0.032729621976614
invaginations O 0 0.05580030009150505
into O 0 0.02195197157561779
the O 0 0.025205975398421288
nucleus O 0 0.05495360493659973
. O 0 0.045890383422374725

In O 0 0.022573508322238922
an O 0 0.014787380583584309
attempt O 0 0.016089530661702156
to O 0 0.01049063540995121
resolve O 0 0.016374176368117332
this O 0 0.006943867541849613
issue O 0 0.011422059498727322
, O 0 0.007889527827501297
we O 0 0.0073454724624753
have O 0 0.007618242409080267
comprehensively O 0 0.06430818140506744
characterized O 0 0.11190643906593323
19 O 0 0.16144852340221405
anti O 1 0.9898676872253418
- O 1 0.9991962313652039
BRCA1 O 1 0.9998111128807068
antibodies O 1 0.8923887610435486
. O 0 0.05450577288866043

These O 0 0.03809170424938202
reagents O 0 0.05989218130707741
detect O 0 0.038851093500852585
a O 0 0.023107437416911125
220 O 0 0.03645775094628334
- O 1 0.5574798583984375
kD O 1 0.9764606952667236
protein O 0 0.02079670876264572
localized O 0 0.022106822580099106
in O 0 0.013046256266534328
discrete O 0 0.017988773062825203
nuclear O 0 0.01697230525314808
foci O 0 0.03088308684527874
in O 0 0.009747033007442951
all O 0 0.009488428942859173
epithelial O 1 0.9791807532310486
cell O 0 0.03570927307009697
lines O 0 0.011139485985040665
, O 0 0.007912845350801945
including O 0 0.007656224071979523
those O 0 0.007705455645918846
derived O 0 0.012072737328708172
from O 0 0.03180978447198868
breast B-Disease 1 0.9999951124191284
malignancies I-Disease 1 0.9999539852142334
. O 0 0.059485312551259995

Immunohistochemical O 1 0.9962222576141357
staining O 1 0.5833080410957336
of O 0 0.029951157048344612
human O 1 0.5486985445022583
breast O 1 0.9999946355819702
specimens O 0 0.4911249279975891
also O 0 0.024011075496673584
revealed O 1 0.50532466173172
BRCA1 O 1 0.9980477094650269
nuclear O 0 0.06619089841842651
foci O 1 0.9882733821868896
in O 0 0.12071223556995392
benign O 1 0.9999945163726807
breast O 1 0.9999992847442627
, O 1 0.9902459383010864
invasive B-Disease 1 0.9999996423721313
lobular I-Disease 1 1.0
cancers I-Disease 1 0.9999996423721313
and O 1 0.934537947177887
low B-Disease 1 0.9992679953575134
- I-Disease 1 0.9999805688858032
grade I-Disease 1 0.9999706745147705
ductal I-Disease 1 0.9999997615814209
carcinomas I-Disease 1 0.9999986886978149
. O 0 0.12478230893611908

Conversely O 0 0.2707749903202057
, O 0 0.03396863490343094
BRCA1 O 1 0.943710207939148
expression O 0 0.021087735891342163
was O 0 0.027215346693992615
reduced O 0 0.02773776277899742
or O 0 0.009182008914649487
undetectable O 0 0.2211885303258896
in O 0 0.006081359926611185
the O 0 0.006057978607714176
majority O 0 0.0052876826375722885
of O 0 0.005900251213461161
high O 0 0.13671879470348358
- O 1 0.9951079487800598
grade O 1 0.9823660254478455
, O 1 0.7258633971214294
ductal B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 0.9999978542327881
, O 0 0.01296959351748228
suggesting O 0 0.011564001441001892
that O 0 0.006993346381932497
absence O 0 0.02003956027328968
of O 0 0.0273519828915596
BRCA1 O 1 0.9994632601737976
may O 0 0.008478381671011448
contribute O 0 0.009998838417232037
to O 0 0.007560736034065485
the O 0 0.009143514558672905
pathogenesis O 1 0.8531830310821533
of O 0 0.007553732953965664
a O 0 0.008095319382846355
significant O 0 0.009593037888407707
percentage O 0 0.013190289959311485
of O 0 0.028315125033259392
sporadic B-Disease 1 0.9992176294326782
breast I-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999924898147583
. O 0 0.029649043455719948
. O 0 0.038269005715847015

